{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_intra_doc",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 750,
    "successful_questions_in_experiment": 750,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 750,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e2_page_window/qualitative_2hop_intra_doc.json",
    "timestamp": "2026-02-05T00:38:34.043534"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron’s outstanding long‑term loan to Petroboscan was **$560 million**, and Chevron owned **approximately 39.2 % of Petroboscan** as of the 2022 reporting period【...】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the outstanding loan amount and Chevron's ownership percentage in Petroboscan as of the 2022 reporting period. The only discrepancy is in the formatting of the loan amount: the ground truth states '$560', while the LLM reports '$560 million'. Given that financial figures in SEC filings typically use millions or billions as implied units, and considering common reporting conventions, this is likely a formatting interpretation rather than a factual error. However, since the original truth does not specify 'million', this introduces slight ambiguity, warranting a minor deduction. (2) Quantitatively, the percentage (39.2%) is exact and correctly reported. The dollar amount is contextually accurate but technically differs in magnitude due to the added 'million'—though in practice, a $560 loan would be implausibly low for a company like Chevron, suggesting the LLM may have interpreted the unit correctly based on real-world context. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct pieces of information—loan amount and ownership stake—from the same reporting period (2022) and entity (Petroboscan). (4) Scores reflect near-perfect factual alignment, with a small reduction in quantitative accuracy due to unit specification variance. Semantic equivalence is otherwise preserved, and the answer fully addresses both parts of the question with high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 402,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "Target received $356 million in cash from the February 2021 sale of Dermstore LLC and recorded a $335 million pretax gain on that transaction. Together, the cash proceeds and the recognized gain represent a total financial impact of about **$691 million**.【Source: Note 3 – Dermstore Sale (cash $356 m, pretax gain $335 m)】【Source: Cash‑flow statement – Proceeds from Dermstore sale $356 m】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC. The total financial impact is correctly calculated as $691 million ($356M + $335M). (2) Quantitative accuracy is perfect: the individual figures match the ground truth, and the sum is mathematically correct. Minor formatting differences (e.g., using 'm' vs 'million') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information about cash proceeds and pretax gain is synthesized from different sources (Note 3 and cash-flow statement), correctly combined to compute total financial impact. (4) The answer is semantically equivalent to the original, includes relevant context (February 2021 sale), and directly addresses all parts of the question. Sources are appropriately cited. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 280,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen recorded product‑sales revenue from its collaboration with BeiGene of **$125 million in 2023, $64 million in 2022 and $72 million in 2021**. Combined, these three years total **$261 million** of product‑sales revenue to BeiGene【source: BeiGene collaboration paragraph, AMGN 10‑K 2023, pages 129‑130】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $72 million in 2021, $64 million in 2022, and $125 million in 2023 — matching the original answer exactly. The total sum of $261 million is correctly calculated. (2) The answer is complete, addressing each year's revenue and the three-year total as required by the question. (3) Entities are correctly identified: Amgen (AMGN), BeiGene, the collaboration agreement, and the relevant financial metric 'Product Sales revenue' are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis across time periods, with correct aggregation. The answer also includes a citation to the source (AMGN 10-K 2023, pages 129-130), enhancing credibility. Minor formatting differences (e.g., en-dash in 'product‑sales', bolding, order of years listed) do not affect semantic meaning. The information is presented in reverse chronological order but retains full accuracy. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 308,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorizes roughly **127 million shares** of Danaher common stock for issuance, and **about 50 million of those shares** were still available for issuance as of December 31 2021【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: 127 million shares were authorized under the 2007 Omnibus Incentive Plan, and approximately 50 million remained available as of December 31, 2021. (2) Quantitative accuracy is perfect—both numbers match the original answer exactly, with acceptable formatting variations (e.g., '127 million' vs '127 million'). (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the relevant SEC filing, correctly identifying both the total authorized shares and the remaining available shares as of the specified date. (4) The answer is contextually precise, directly addressing both parts of the question with no extraneous or missing information. Minor wording differences (e.g., 'roughly', 'about') are acceptable and do not affect factual accuracy, as they reflect the original answer's use of 'approximately'.)",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 276,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Lilly received a total of **$1.355 billion** from Cheplapharm for the olanzapine portfolio (including Zyprexa) – **$1.05 billion in cash in 2023** and **$305 million in cash in 2024**【Divestitures – “In July 2023… we received $1.05 billion in cash in 2023 and an additional $305.0 million in cash in 2024.”】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: total cash received is $1.355 billion, with $1.05 billion in 2023 and $305 million in 2024—these values exactly match the original answer, including the precise figure of $305.0 million (represented as $305 million, which is semantically equivalent). (2) The answer is complete, addressing both parts of the question: the total amount received and its distribution across 2023 and 2024. (3) Entity accuracy is correct: LLY (Lilly) and Cheplapharm are properly identified, and the olanzapine portfolio including Zyprexa is accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis, correctly pulling and combining the two cash installments from the divestiture transaction. The citation reference supports the claim, indicating accurate grounding. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 300,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded **$298 million of goodwill** arising from its acquisition of Terran Orbital.  The total purchase price was $314 million, of which **$231 million was paid in cash** (the balance $83 million reflected the value of previously‑held Terran Orbital shares).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $298 million (goodwill), $314 million (total purchase consideration), and $231 million (cash paid) are all accurately reported. The breakdown of the remaining $83 million as the value of previously-held shares is consistent with the acquisition accounting and adds contextual accuracy without contradicting the ground truth. (2) The answer addresses both parts of the question: the total goodwill recorded ($298 million) and the cash portion of the purchase consideration ($231 million). (3) Entities are correctly identified: Lockheed Martin as the acquirer, Terran Orbital as the target. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the acquisition event to goodwill recognition and purchase price allocation. The additional detail about the non-cash portion enhances clarity and demonstrates accurate understanding of purchase accounting. All information is semantically equivalent to the original answer and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 304,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron reported a carrying value of **$3.6 billion** for its investment in GS Caltex Corporation at December 31 2021.  Chevron’s ownership stake in the joint‑venture is **50 percent** of the equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's carrying value of its investment in GS Caltex Corporation as $3.6 billion at the end of 2021, which is equivalent to the ground truth value of $3,616 million (rounded to one decimal place in billions). The equity ownership percentage is accurately reported as 50 percent, matching the ground truth. (2) Quantitatively, $3.6 billion is semantically equivalent to $3,616 million (difference due to rounding), and 50 percent is exact. No calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: linking Chevron (CVX) to its investment in GS Caltex, retrieving the correct carrying value from the 2021 financial statements, and correctly identifying the ownership stake. (4) The answer is fully contextually relevant and complete, addressing both parts of the question. The minor deduction in qualitative accuracy is due to rounding the carrying value without specifying it's approximate, though this is common practice and still acceptable. Overall, the answer is factually correct and conveys the same information as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 320,
        "total_tokens": 1422
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The Forest Products segment generated **$1,357 million** of freight revenue in 2021 versus **$1,160 million** in 2020 – an increase of **$197 million**.  The average revenue per car for this segment rose from **$5,269** in 2020 to **$5,424** in 2021, a **$155 per‑car** increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $197 million increase in total revenue is accurate: $1,357 million (2021) - $1,160 million (2020) = $197 million. The average revenue per car increased from $5,269 in 2020 to $5,424 in 2021, which is a $155 increase ($5,424 - $5,269), matching the ground truth. (2) The answer is complete, addressing both parts of the question: the dollar change in total revenue and the change in average revenue per car. (3) Entity accuracy is correct—'Forest Products' is the right segment, and years 2020 and 2021 are properly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: it pulls revenue figures and car volume data (implied in average calculation) across two years and correctly computes changes. (5) Semantic equivalence is maintained—the LLM provides more detailed base figures than the ground truth but conveys the same net changes accurately. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 291,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Restasis generated **$224 million** in net revenue in 2024. Compared with 2023’s $436 million, that represents a **48.7 % decline** on an actual‑currency basis.【source】(Restasis – United States $172 M, International $52 M; Total $224 M in 2024 vs $436 M in 2023; % change (48.7) %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net revenue for Restasis in 2024 is correctly stated as $224 million, and the percentage decline of 48.7% compared to 2023 is accurate. The implied 2023 revenue of $436 million aligns with the calculation: $224M represents a 48.7% decline from $436M (i.e., (436 - 224) / 436 ≈ 0.486, which rounds to 48.7%). (2) The answer is complete, addressing both parts of the question: total 2024 net revenue and the year-over-year percentage decline based on actual currency rates. (3) Entities are correct—Restasis, 2024 and 2023 time periods, and the financial metric 'net revenue' are all accurately referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by referencing both years and computing the correct decline percentage. The source breakdown (U.S. $172M, International $52M) adds contextual detail and correctly sums to $224M. (5) Semantic equivalence is maintained—despite slightly expanded wording and formatting, the core factual content matches the original answer exactly. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 324,
        "total_tokens": 1434
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31 2023, Capital One’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**, while the regulatory minimum (Minimum Capital Adequacy) for CET1 is **4.5 %**【COF_10k_2023.pdf page 79‑80, Table 12】. The company’s CET1 ratio therefore exceeded the minimum requirement by **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the CET1 ratio of 12.9% and the minimum requirement of 4.5% are accurately reported, and the difference is correctly calculated as 8.4 percentage points. The calculation (12.9% - 4.5% = 8.4%) is accurate. (2) The answer is complete, addressing both the company's CET1 ratio and the regulatory minimum, and correctly computes the difference. (3) Entity accuracy is correct: Capital One Financial Corp, the metric (Common Equity Tier 1), and the date (December 31, 2023) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it pulls the firm-specific ratio from its 10-K (referencing Table 12 on pages 79–80) and compares it to the regulatory minimum, a standard benchmark. The phrasing 'exceeded the minimum requirement by 8.4 percentage points' is semantically equivalent to the original answer's 'difference... is 8.4%'. All criteria are met with high precision and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 291,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "Lockheed Martin recorded **$64 million** of pretax pension expense for its non‑qualified defined‑benefit pension plans in 2023. That was lower than the **$81 million** expense recognized in 2022, but higher than the **$56 million** expense reported in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $64 million for 2023, $81 million for 2022, and $56 million for 2021. The comparisons (decrease from 2022, increase from 2021) are correctly stated. (2) The answer is complete, addressing both parts of the question: the 2023 expense and the comparison to the two prior years. (3) Entities are accurate—Lockheed Martin, nonqualified defined benefit pension plans, and the correct fiscal years (2021, 2022, 2023) are properly identified. (4) The reasoning is sound: the model correctly synthesizes multi-hop information by retrieving three years of data and making valid year-over-year comparisons. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'non-qualified' vs 'nonqualified') that do not affect accuracy. All scores are 10 due to perfect factual alignment, correct calculations, and complete, relevant response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 286,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of the “Investor/customer relationships” intangible fell from **$492 million at 12/31/2022 to $447 million at 12/31/2023**, a **decrease of $45 million**.  This change reflects an **$84 million rise in accumulated amortization (from $254 million to $338 million)** that more than offset the $39 million increase in the gross carrying amount (from $746 million to $785 million), resulting in the $45 million net decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net carrying amount decreased from $492 million to $447 million, a $45 million decline; accumulated amortization increased from $254 million to $338 million ($84 million increase); gross carrying amount rose from $746 million to $785 million ($39 million increase). The calculations are correct: $84M (amortization increase) - $39M (gross increase) = $45M (net decrease), which aligns with the observed change in net carrying amount. (2) The answer is complete, addressing both parts of the question: the change in net carrying amount and the contribution of accumulated amortization. (3) Entities are accurate—BlackRock’s 'investor/customer relationships' intangible asset, correct fiscal dates (December 31, 2022 and 2023), and proper financial terms are used. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: it explains that despite an increase in gross carrying amount, the net carrying amount declined due to a larger increase in accumulated amortization. The LLM correctly infers the causal relationship between amortization and net carrying value. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual and logical content as the original answer. No errors in facts, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 384,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The 2.200 % senior notes had a principal balance of **$400 million** outstanding at December 31 2023.  Although they mature in September 2024, UPS continues to record them as **long‑term debt** on its consolidated balance sheet, reflecting its intent and ability to refinance the notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $400 million is accurately reported, and the maturity in 2024 (specifically September 2024, which is consistent with known UPS filings) is correctly noted. (2) The classification of the debt as long-term despite its 2024 maturity is properly explained by referencing UPS's intent and ability to refinance, which aligns with accounting standards (ASC 470) for debt classification. (3) The multi-hop reasoning is sound: the model correctly identifies the specific senior notes (2.200%), retrieves the outstanding principal as of December 31, 2023, and synthesizes the balance sheet classification logic based on management's intent—requiring integration of both quantitative and qualitative disclosures from the filing. (4) All entities (UPS, 2.200% senior notes, consolidated balance sheet) and time periods are accurate. The answer is semantically equivalent to the ground truth, with slightly more detail (mentioning September 2024) that enhances precision without introducing error. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 326,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments fell from $15.6 billion at July 29 2023 to $9.9 billion at July 27 2024 – a decline of **about $5.7 billion**. Because cash and cash equivalents also dropped, the combined total of cash + cash equivalents, available‑for‑sale debt investments and marketable equity securities fell from $26.1 billion to $17.9 billion – a **decrease of roughly $8.3 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in available-for-sale debt investments as approximately $5.7 billion, which aligns with the ground truth of $5,727 million (rounded to $5.7 billion). The total decrease in the sum of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities is reported as roughly $8.3 billion, matching the ground truth calculation of $8,292 million (sum of $5,727M decrease in debt investments, $2,615M decrease in cash, and $50M increase in equity securities: 5,727 + 2,615 - 50 = 8,292). The LLM rounds this to $8.3 billion, which is semantically equivalent. (2) All numeric values are accurate within acceptable rounding. The starting and ending figures implied by the totals ($26.1B to $17.9B) also support the $8.2B–$8.3B decrease, consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across multiple asset categories and computes the net impact on the total. It references the correct fiscal years (July 29, 2023 to July 27, 2024) and correctly identifies Cisco as the entity. (4) Minor rounding is acceptable and common in financial reporting; the use of 'about' and 'roughly' appropriately qualifies the approximated figures. No critical facts are missing or incorrect. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a minor deduction in quantitative accuracy due to rounding without explicit mention of exact figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 423,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, the 2021 Linde plc Long‑Term Incentive Plan had **7,661,431 shares** still available for equity grants, and **2,452,443 of those shares** could be issued as awards other than stock options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The numbers provided—7,661,431 total shares available and 2,452,443 shares available for awards other than options or stock appreciation rights—are exactly correct and match the original answer. Minor formatting differences (e.g., use of en-dash, spacing) do not affect accuracy. (2) Quantitative accuracy is perfect: both figures are correctly reported with no calculation or transcription errors. (3) The reasoning is sound and reflects proper multi-hop synthesis, correctly identifying the plan (2021 Linde plc Long-Term Incentive Plan), the date (December 31, 2023), and the two required metrics. (4) The answer is contextually precise, directly addressing both parts of the question with clear, unambiguous phrasing. Semantic equivalence is maintained, and all entities (company, plan, date, share types) are accurately referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 266,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received **$247 million** for the 2023 Notes swaps, **$143 million** for the March 2022 Notes swaps, and **$136 million** for the September 2022 Notes swaps – a combined cash receipt of **$526 million**. This inflow was recorded in the cash‑flow statement as a financing‑activity cash receipt, boosting the company’s liquidity and overall cash‑flow position by more than half a billion dollars.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all individual payments: $247 million for the 2023 Notes, $143 million for the March 2022 Notes, and $136 million for the September 2022 Notes, which sum to the correct total of $526 million. All numeric values match the ground truth exactly, and the calculation is accurate. (2) Quantitative accuracy is perfect—each dollar amount is correct, and the total is properly computed. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three separate note issuances and their associated swap settlements. The financial impact on cash flow is addressed, though with slightly more specificity than the original answer by classifying the inflow as a 'financing-activity cash receipt.' While this detail is plausible and consistent with typical accounting treatment (and thus not factually incorrect), the original answer states that classification is 'based on the nature of the underlying hedged items,' which is more general. The LLM adds a minor inference not explicitly confirmed in the ground truth, which prevents a perfect qualitative score. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the total payment received and the financial impact on cash flow. The statement about boosting liquidity and cash-flow position by over half a billion dollars is a reasonable interpretation. Overall, the answer is factually correct and comprehensive, with only a slight over-specificity in cash flow classification preventing a full 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 457,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "NextEra’s equity‑method stake in XPLR falls within the same band as its other principal equity‑method investees – roughly **33 % to 85 %** of the partnership.  The investees, XPLR included, **primarily own electric‑generation assets (wind, solar and battery‑storage projects) and natural‑gas pipeline assets**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the ownership range of '33% to 85%' matches the original answer's 'approximately 33.3% to 85.0%'—minor rounding differences are acceptable and common in reporting; the core range is accurate. (2) The answer correctly identifies that principal equity method investees, including XPLR, primarily own electric generation facilities and natural gas pipelines, and adds specific detail (wind, solar, battery storage) that is consistent with and elaborates on the ground truth without introducing error. (3) The multi-hop reasoning is sound: the model correctly links NextEra Energy’s ownership stake in XPLR to its broader portfolio of equity-method investees and synthesizes the asset types from the category to the specific case of XPLR. (4) All entities (NextEra Energy, XPLR) and financial concepts (equity-method investees) are accurately used. The answer is contextually complete, directly addressing both parts of the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 303,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The fair‑value hierarchy table shows corporate notes and obligations valued at **$2,978 million** (Level 2). Their amortized‑cost carrying amount is $3,014 million, so the securities are recorded at a **$45 million unrealized loss**, meaning the fair value is lower than cost.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the fair value of Corporate notes and obligations is $3,354 million, but the LLM reports $2,978 million. Similarly, the amortized cost is reported as $3,442 million in the original answer, while the LLM states $3,014 million. The resulting unrealized loss is $92 million according to the ground truth, but the LLM calculates $45 million. These discrepancies affect all key financial figures. (2) Quantitative accuracy is very low: none of the three core numbers (fair value, amortized cost, unrealized loss) match the ground truth, and the difference between fair value and amortized cost in the LLM answer ($3,014M - $2,978M = $36M) does not even correctly compute the stated $45M loss, indicating a calculation inconsistency. (3) While the LLM demonstrates correct qualitative reasoning in comparing fair value to amortized cost to derive unrealized loss and references Level 2 of the fair value hierarchy, it fails at multi-hop synthesis—either pulling data from the wrong entity, year, or financial statement. The logic structure is sound but built on incorrect data. (4) Contextual relevance is high because the answer addresses the right concepts (fair value hierarchy, amortized cost, unrealized loss) and attempts the correct comparison. However, due to severe numerical inaccuracies, the overall correctness score is low—only 2 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 399,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "In 2024 Union Pacific operated **7,026 locomotives**. This total consists of **6,106 owned locomotives** plus **920 leased locomotives**, together forming the full fleet used on the railroad’s network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the total number of locomotives operated by UNP in 2024 is 7,026, composed of 6,106 owned and 920 leased locomotives. These values exactly match the ground truth. (2) Quantitative verification: 6,106 + 920 = 7,026, which is accurate and correctly presented. No calculation errors or number discrepancies exist. (3) The reasoning is sound and reflects proper multi-hop synthesis—combining owned and leased locomotives to derive the total fleet size. The model correctly attributes the components to UNP in 2024 without confusing entities or time periods. (4) The answer is semantically equivalent to the original, with clear, concise wording that preserves factual integrity. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 242,
        "total_tokens": 1330
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net carrying amount of Brands/Tradenames fell from $2,376 million at 12/31/2023 to $2,239 million at 12/31/2024, a decrease of **$137 million**. The decline was driven primarily by a **$107 million foreign‑currency translation loss on the cost side** (with a $5 million translation gain on the amortization side) and a **$36 million amortization expense** (partly offset by the $5 million translation gain), which together increased accumulated amortization by $32 million; these effects, together with a $2 million disposal and a $4 million “other” adjustment, sum to the $137 million net change.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. The starting value for Brands/Tradenames in 2023 is incorrect: LLM states $2,376 million, while the ground truth is $2,609 million. This leads to an incorrect net change of $137 million instead of the correct $370 million reduction. The ending value ($2,239 million in 2024) and amortization expense ($36 million) are correct. The foreign currency translation effect of $107 million reduction is correctly identified, but the LLM introduces a non-existent $5 million translation gain on amortization, which distorts the reasoning. The 'Other' adjustment of $4 million is correct, but the LLM adds a $2 million disposal not mentioned in the original and not supported by the ground truth. (2) Calculations are fundamentally flawed: $2,609M - $2,239M = $370M, not $137M. The LLM’s explanation of $107M (FX) + $36M (amortization) - $5M (gain) + $2M (disposal) + $4M (other) does not align with the ground truth and misrepresents the drivers. The original states that additions were $0 and the $143M decline from FX and amortization was partially offset by 'Other', leading to a $370M drop. (3) Multi-hop reasoning is partially sound in that the model identifies relevant factors (FX, amortization, other adjustments), but it fails to correctly synthesize the full picture due to incorrect base values and invented components (e.g., $5M gain, $2M disposal). (4) Scores reflect major quantitative inaccuracies (especially the $233M error in net change), partial qualitative accuracy in identifying relevant factors, and high contextual relevance as the answer attempts to address all parts of the question with appropriate financial logic, albeit with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 474,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "Coca‑Cola reported that the fair‑value of its corporate bonds and other debt securities was **$1,023 million at December 31 2021** (Level 2 $994 m + Level 3 $29 m) versus **$1,042 million at December 31 2020** (Level 2 $1,011 m + Level 3 $31 m)【...table showing “Corporate bonds and debt securities … 1,023 … 1,042”】. Thus, the fair‑value declined by **about $19 million** from 2020 to 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,023 million (2021) and $1,042 million (2020) are accurately reported, and the dollar change of $19 million decrease is correctly calculated ($1,042M - $1,023M = $19M). Minor formatting differences (e.g., using 'm' vs 'million') are acceptable and do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the total fair value at the end of 2021 and the year-over-year dollar change. (3) Entity accuracy is correct: Coca-Cola (KO), the financial instrument (Corporate Bonds and Debt Securities), and the years (2021 and 2020) are all properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by comparing two annual values and deriving the correct conclusion of a $19 million decline. The inclusion of Level 2 and Level 3 breakdowns adds contextual detail without introducing error. (5) The semantic meaning is equivalent to the original answer, with slightly more detail but no factual deviation. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 316,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The 2023 Long‑Term Incentive (LTI) Program states that the performance‑based portion of the LTIP awards can have a **maximum potential grant‑date fair value of $42.5 million**.  These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because they are performance‑based, have not yet been earned or vested, and the potential dilution from the outstanding LTIP units is deemed immaterial; consequently, they are excluded from the diluted‑EPS calculation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The explanation for why these units are not reflected as a material dilutive effect is substantially correct: the units are performance-based, not yet earned or vested, and thus not included in diluted EPS. The LLM adds that the dilution is 'deemed immaterial,' which aligns with the ground truth statement that 'no securities had a material dilutive effect.' While the phrasing differs slightly—ground truth emphasizes that performance conditions haven't been met, and the LLM emphasizes non-vesting and immateriality—the semantic meaning and reasoning are equivalent. (3) The multi-hop reasoning is sound: the model connects the performance-based nature of the LTIP units to their exclusion from diluted EPS calculations, synthesizing accounting principles with the specific facts of the 2023 LTI Program. (4) Minor deduction in qualitative accuracy due to slight rephrasing that could imply the immateriality is an assumption rather than a result of unmet conditions, but overall logic remains valid. No issues in entity accuracy (2023 LTI Program, LTIP units, net income attributable to common stockholders) or contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 376,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "In 2023 the company reported covered‑bond investments with an amortized‑cost balance of **$105 million** and a fair‑value balance of **$101 million**, a $4 million difference that reflects an **unrealized loss of $4 million** on those bonds【CRM_10k_2023.pdf page 75‑76】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the amortized cost ($105 million), fair value ($101 million), and the resulting unrealized loss ($4 million) are correctly reported. (2) Quantitative accuracy is perfect — the difference between amortized cost and fair value is correctly calculated as $4 million, and all numbers match the original answer exactly. Minor formatting differences (e.g., $4 million vs $4 million) are acceptable and do not affect meaning. (3) The reasoning is sound: the model correctly identifies the two financial values, computes the difference, and labels it as an unrealized loss, which aligns with accounting principles. (4) The answer addresses both parts of the question: the difference between amortized cost and fair value, and the unrealized loss. Entity accuracy is correct — CRM is properly identified, and the year 2023 is accurately referenced. The citation to CRM_10k_2023.pdf page 75-76 adds contextual support. Overall, the answer demonstrates precise multi-hop synthesis and semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 320,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Union Pacific’s multiple‑purpose fleet is about 13 percent leased (920 leased ÷ 6,893 total ≈ 13 %). In contrast, none of the locomotives classified as “Switching” (122 owned) or “Other” (11 owned) are leased, so the combined leased proportion for those two categories is 0 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) Quantitatively, the percentage of leased Multiple Purpose locomotives is correctly calculated as approximately 13% (920 leased out of 6,893 total), which rounds to the ground truth value of 13.35%—the slight discrepancy is due to rounding but does not constitute a factual error given the context. The statement that no Switching (122 owned) or Other (11 owned) locomotives are leased matches the ground truth exactly, leading to a 0% leased proportion for those combined categories. (2) Calculations are sound: 920 / 6,893 ≈ 0.1335 (i.e., 13.35%), and the LLM appropriately rounds to about 13%, which is acceptable for semantic equivalence. The absence of leased units in the other categories is correctly interpreted. (3) Multi-hop reasoning is accurate: the model correctly identifies Union Pacific, distinguishes locomotive types, retrieves ownership data across categories, and synthesizes the comparison between Multiple Purpose vs. Switching+Other. (4) All entities (Union Pacific, locomotive categories) are correct, and the response fully addresses both parts of the question. The only minor shortcoming is the rounding down to '13%' instead of reporting '13.35%', which slightly reduces quantitative precision but does not mislead. Hence, all scores are high, with correctness at 9 due to this small approximation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 390,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined proved NGL reserves in the Lower 48 grew from **230 million barrels at the end of 2020** to **797 million barrels at the end of 2023**, an increase of **567 million barrels**【131†L1-L8】.  \n\nFor 2023, ConocoPhillips recorded **$5.729 billion** of depreciation, depletion, amortization and impairments for the Lower 48 segment【140†L1-L4】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the NGLs volume increase is accurately calculated: 797 million barrels (end of 2023) minus 230 million barrels (end of 2020) equals 567 million barrels, which is correctly reported. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 is stated as $5.729 billion, which is equivalent to $5,729 million in the ground truth—format variation is acceptable. (2) The answer is complete, addressing both parts of the multi-part question: the volume increase and the financial figure for 2023. (3) Entity accuracy is correct: 'Lower 48', 'NGLs', '2020', '2023', and the financial metric are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across time periods and financial reporting categories. The use of citations (e.g., 【131†L1-L8】) suggests grounding in source data. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'proved NGL reserves' vs. 'NGLs volume'), but the meaning aligns with the ground truth. All scores are maximized due to full factual accuracy, correct calculations, and appropriate contextual response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 340,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent $0.4 billion to buy out the Massmart non‑controlling interest and another $0.4 billion to acquire 100 % of Alert Innovation in fiscal 2023 – a total cash outlay of about **$0.8 billion**.  In fiscal 2025 the Alert Innovation entity was **sold and consequently de‑consolidated** from Walmart’s consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the answer correctly states that Walmart spent $0.4 billion on Massmart and $0.4 billion on Alert Innovation, totaling $0.8 billion in fiscal 2023—this aligns exactly with the original answer, including the breakdown and sum. (2) The answer is complete, addressing both parts of the question: the total cash spent in fiscal 2023 and the financial treatment of Alert Innovation in fiscal 2025. (3) Entity accuracy is perfect: Walmart, Massmart, and Alert Innovation are correctly identified, and the fiscal years (2023 for acquisition, 2025 for deconsolidation) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines acquisition costs for two entities in one year and correctly links the subsequent sale and deconsolidation of Alert Innovation in a later fiscal year. (5) The semantic meaning is equivalent to the ground truth—phrasing such as 'sold and consequently de-consolidated' conveys the same financial outcome as 'subsequently sold and deconsolidated.' No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 324,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "In 2021 Union Pacific shipped 697 thousand carloads of metals & minerals. Multiplying the 697,000 carloads by the average revenue per car of $2,598 yields ≈ $1,810.8 million, i.e., about **$1.8 billion** in revenue from metals & minerals shipments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of carloads (697,000) and the average revenue per car ($2,598) for Metals & Minerals for UNP in 2021. The calculation 697,000 × $2,598 = $1,810,806,000 is accurate and matches the ground truth exactly. The LLM reports the result as ≈ $1,810.8 million or about $1.8 billion, which is a valid rounding and formatting variation of the exact figure. (2) All numeric values are correct: 697 thousand carloads and $2,598 average revenue per car are accurate inputs, and the multiplication yields the correct total. The final answer is presented with appropriate rounding and unit conversion (millions/billions), which is semantically equivalent to the ground truth of $1,810,806,000. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: combining carload volume with revenue per unit from the same category and year for UNP. The model correctly identifies the entities (UNP, 2021, Metals & Minerals), retrieves the correct metrics, and applies the required arithmetic. (4) The correctness score is 9 because the answer is factually and quantitatively accurate, though it presents the result in rounded form rather than the exact figure. However, this is acceptable under semantic equivalence. Quantitative accuracy is 9 due to the correct inputs and calculation, with only minor presentation-level rounding. Qualitative accuracy is 9 due to correct reasoning and entity identification. Contextual relevance is 10 as the answer directly addresses the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1071,
        "completion_tokens": 431,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The 2023 securitization created **$1.3 billion** of Series 2023‑1A Securities (the Trust issued $1.3 billion aggregate principal amount of Secured Tower Revenue Securities, Series 2023‑1, Subclass A)【...】.  \n\nThe March 2023 repayment of the older securities also covered **$1.3 billion** of principal for the Series 2013‑2A Securities (the Company repaid the entire $1.3 billion aggregate principal amount outstanding)【...】.  \n\nThus, the amount issued for the Series 2023‑1A Securities is the same as the amount repaid for the Series 2013‑2A Securities – both equal to $1.3 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.3 billion principal amount for both the Series 2023-1A issuance and the Series 2013-2A repayment is accurately reported, with no discrepancies in numbers or units (allowing for formatting variations like 'billion' vs 'B'). (2) The answer is complete, addressing both parts of the question: the amount issued in 2023 and the amount repaid in March 2023. (3) Entity accuracy is correct—Series 2023-1A and Series 2013-2A are properly identified with their respective years and contexts. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the same dollar amount indicates a direct refinancing, even if not explicitly labeled as such, by stating the amounts are 'the same.' (5) The semantic meaning is equivalent to the original answer, conveying both factual values and the implied financial relationship. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 289,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the company drew $3.0 billion and repaid $6.1 billion (including €842.6 million, or $919.1 million) of revolving indebtedness under its 2021 Multicurrency Credit Facility.  The facility’s total borrowing capacity is $6.0 billion, so the amount borrowed was below the available limit, while the repayments exceeded the facility’s full borrowing capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $3.0 billion borrowed and $6.1 billion repaid during the year ended December 31, 2023, under the 2021 Multicurrency Credit Facility, matching the ground truth. The total borrowing capacity of $6.0 billion is also accurately stated. (2) All numeric values are correct and consistent with the original answer. The inclusion of €842.6 million (converted to $919.1 million) as part of the $6.1 billion repayment is an additional detail not contradicted by the ground truth and may reflect a breakdown of the repayment amount; this does not introduce inaccuracy but adds specificity. (3) The multi-hop reasoning is sound: the model correctly compares borrowed and repaid amounts to the facility's capacity. It correctly notes that borrowings were below the $6.0 billion limit and that repayments exceeded the total capacity, which is logically valid (as cumulative repayments can exceed capacity over time). (4) The answer is fully contextually relevant and semantically equivalent to the ground truth, with only minor additional detail. The one-point deduction in qualitative accuracy is due to the slight risk of confusion in stating that repayments exceeded the facility’s 'full borrowing capacity' without clarifying that this is permissible over time and does not imply over-borrowing. However, this does not make the statement incorrect. Overall, the answer is factually precise and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 400,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "UNP’s Intermodal freight revenue rose from $3.989 billion in 2020 to $4.504 billion in 2021 – an increase of **$515 million** (about 13%).  During the same period, average revenue per Intermodal car grew from $1,267 to $1,403, a **$136‑per‑car** increase (≈11%).  Thus, total Intermodal revenue grew by $515 million, while the per‑car revenue rose modestly by $136.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $515 million increase in total Intermodal revenue and the $136 increase in average revenue per car are both accurately reported. The LLM provides additional context (exact revenue figures: $3.989 billion in 2020 and $4.504 billion in 2021), which are consistent with the $515 million difference (4.504 - 3.989 = 0.515 billion). Similarly, the average revenue per car increase from $1,267 to $1,403 correctly results in a $136 increase. (2) The answer is complete, addressing both parts of the question: the total revenue increase and the per-car revenue increase. (3) Entities are accurate: UNP is correctly identified, the metric 'Intermodal revenue' is properly used, and the time period (2020 to 2021) is correct. (4) The reasoning is sound and demonstrates multi-hop synthesis—pulling revenue figures and per-unit metrics from different parts of financial data and correctly calculating differences. (5) The semantic meaning fully aligns with the original answer, with added precision that does not contradict but enhances clarity. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 344,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "In 2021 ConocoPhillips spent **$534 million** on capital expenditures in its Europe, Middle East and North Africa (EMENA) segment.  For the same year the EMENA segment reported a **net gain of $24 million** (a credit arising from the impairment reversal), indicating that the region’s operating result was a modest positive amount compared with the capital outlay.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the capital expenditure amount of $534 million in the EMENA region for 2021, which matches the ground truth. However, it incorrectly states that the region reported a 'net gain of $24 million' due to an impairment reversal, whereas the ground truth specifies a 'net loss of $24 million.' This is a critical factual error in the interpretation of the financial result, despite correctly referencing the $24 million figure. (2) Quantitatively, both numbers ($534 million and $24 million) are accurate in magnitude and unit, and the year 2021 is correctly referenced. The error lies not in the numbers themselves but in the sign/direction (gain vs. loss). (3) The multi-hop reasoning is partially sound—the model correctly links capital expenditure and operating results for the EMENA region in 2021—but fails in synthesizing the correct nature of the operating result. The mention of 'impairment reversal' may provide context for why a gain was recorded, but this contradicts the ground truth which clearly states a net loss. This suggests a possible confusion between pre-impairment and post-impairment figures or a misinterpretation of the financial statement. (4) The contextual relevance is high as the answer addresses both parts of the question and focuses on the correct company (implied as ConocoPhillips), region, and year. Due to the significant error in characterizing a loss as a gain, the qualitative accuracy is reduced, but the quantitative accuracy remains perfect. Hence, correctness is scored as 7—core data is right, but key interpretation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 442,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft places Copilot Pro as a key element of its “reinvent productivity and business processes” ambition – a consumer‑focused, AI‑first subscription that delivers faster, more powerful assistance across Microsoft 365 apps and the web. In its financial reporting, Copilot Pro revenue is grouped under **Office Consumer products and cloud services** (the Office Consumer line within the Productivity and Business Processes segment).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures Microsoft's strategic positioning of Copilot Pro as part of its 'reinvent productivity and business processes' ambition and correctly identifies it as a consumer-focused AI subscription service enhancing Microsoft 365 apps and web experiences. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the answer correctly synthesizes strategic intent from Microsoft’s stated ambitions and maps Copilot Pro to the appropriate financial reporting category. (4) The revenue classification 'Office Consumer products and cloud services' is precisely stated, with additional context that it falls under the Office Consumer line within the Productivity and Business Processes segment—this aligns with and enriches the ground truth without introducing error. Wording differs slightly but meaning is preserved. All aspects of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 333,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The 2024 special‑dividend adjustment added **128,000 RSU shares** to the number of shares that could be granted under the 2019 Incentive Plan. The increase was calculated by applying the same 1.018 adjustment factor used for the outstanding RSUs—derived from the Nasdaq price ratio of the closing price $674.62 on December 26, 2023 to the opening price $662.70 on December 27, 2023—to the plan’s maximum share pool, thereby proportionally raising the grant‑available shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the increase of 128,000 RSU shares, the 2019 Incentive Plan, the 2024 special dividend adjustment, and the use of Nasdaq price data from December 26 and 27, 2023. (2) Quantitative accuracy is perfect: the closing price ($674.62) and opening price ($662.70) are correctly cited, and the implied adjustment factor of 1.018 (674.62 / 662.70 ≈ 1.018) matches the ground truth. The increase of 128,000 shares is consistent with a proportional adjustment applied to the plan's share pool using this factor. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the same adjustment factor used for outstanding RSUs was applied to the maximum share pool, which aligns with standard equity plan anti-dilution provisions. (4) The answer addresses both parts of the question: the total increase and how it was determined based on Nasdaq stock price movement. Wording differs slightly but meaning is identical. No errors in entities, dates, or logic. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 320,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "In 2024 the Transportation & Electronics segment reported **$8.38 billion in sales**, a **1.4 % decline** versus the prior year. When the PFAS‑related headwinds are stripped out (the non‑GAAP “adjusted sales” measure), sales are shown as **$7.44 billion**, reflecting a **3.1 % increase** year‑over‑year. Thus, the PFAS exit pressure turned what would have been a 3.1 % sales gain into a 1.4 % decline – a swing of roughly **4.5 percentage points** and about **$945 million** of sales impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dollar amounts, which are not supported by the ground truth. The original answer does not provide absolute sales figures like $8.38 billion or $7.44 billion, nor does it mention a $945 million sales impact. These figures are fabricated or incorrectly inferred. While the percentage changes (-1.4% reported decline and +3.1% adjusted growth) are correct, and the 4.5 percentage point difference is accurately calculated (3.1 - (-1.4) = 4.5), the addition of unsupported absolute revenue numbers undermines quantitative accuracy. (2) The calculation of the 4.5 percentage point swing is correct and matches the ground truth reasoning. However, the claim that adjusted sales are $7.44 billion (implying a lower revenue base despite higher growth) contradicts logic—adjusted sales should reflect what sales would have been without headwinds, meaning they should be higher than reported sales, not lower. This indicates a fundamental error in interpretation. The $945 million impact also cannot be verified and appears inconsistent with the direction of adjustment. (3) The multi-hop reasoning is partially sound—the model correctly identifies the impact of PFAS headwinds as the difference between reported and adjusted growth rates. However, it fails in synthesizing the correct financial magnitude, incorrectly assigning absolute values that contradict the conceptual framework (adjusted > reported). (4) The contextual relevance is high because the answer addresses the core question about PFAS headwinds and their quantitative impact on sales performance using the correct segment, year, and metric types. The qualitative reasoning about the 'swing' is conceptually appropriate, but the inclusion of incorrect dollar figures severely damages factual correctness. Thus, while the directional and percentage-based analysis is accurate, the introduction of false absolute values results in a partially incorrect answer, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 542,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "In 2021 the company recorded a **$2 million after‑tax gain** on its equity‑method investment contracts 【source: Economic Hedges table showing “Equity method investment contracts 2 … $2 million gain”】.  \n\nThe fair‑value of those contracts at December 31 2021 was **$3 million (a liability, shown as –$3 million)** 【source: Derivatives‑fair‑value table listing “Equity method investment contracts … (3) million”】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) Quantitatively, the recognized gain of $2 million in 2021 and the fair value of $(3) million as of December 31, 2021, are correctly reported. The LLM correctly interprets the negative fair value (liability) as -$3 million, which matches the ground truth's $(3) million notation. (2) The sources cited (Economic Hedges table and Derivatives-fair-value table) align with plausible locations in SEC filings, supporting accurate data retrieval. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different financial tables—gain recognition (income-related) and fair value (balance sheet-related)—for the same instrument class and year. (4) The only minor nuance is that the ground truth explicitly uses parentheses $(3) million to denote a negative value/liability, while the LLM uses a minus sign (-$3 million), which is semantically equivalent in financial reporting. The addition of 'after-tax' in the LLM answer is a slight elaboration not present in the original, but does not contradict it and may reflect source detail. All entities (equity method investment contracts, 2021 year, December 31 measurement date) are correct. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 369,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott’s $2.2 billion of interest‑rate swap contracts are designated as fair‑value hedges of a portion of its fixed‑rate long‑term debt; the swaps are recorded at fair value (a $51 million liability) and an offsetting adjustment is made to the carrying amount of the hedged debt, effectively converting that $2.2 billion of fixed‑rate obligations into variable‑rate exposure. As a result, the fair‑value of the debt that is subject to the hedge is shown as about $2.1 billion, which is included in the total fair‑value of Abbott’s long‑term debt of $13.7 billion as of December 31 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical quantitative inaccuracy that affects the overall correctness. The ground truth states that the $2.2 billion notional value of interest rate hedges reduces the volatility of the fair value of the $13.7 billion long-term debt by converting fixed-rate debt to variable-rate debt. However, the LLM introduces a specific figure — that the hedged portion of debt has a fair value of 'about $2.1 billion' — which is not present in the original answer and cannot be derived from the provided information. This implies a calculation or misinterpretation (e.g., $2.2B minus $51M liability = $2.149B ≈ $2.1B), but such a calculation is conceptually flawed because the fair value adjustment applies to the carrying amount of the debt, not its notional. The $51 million liability for the swaps is mentioned in the LLM answer but absent from the ground truth, suggesting the model introduced unsupported data. While the core reasoning — that Abbott uses fair-value hedges to convert fixed-rate debt to variable-rate and thereby reduce fair value volatility — is sound and aligns with the original, the inclusion of unverified numbers and the misrepresentation of how the hedge impacts the reported fair value of debt (i.e., implying only $2.1B of debt is at fair value) undermines factual accuracy. The entities (Abbott Laboratories, interest rate hedges, long-term debt), dates (December 31, 2024), and overall strategy are correctly identified, and the answer addresses the impact on fair value as required. However, the incorrect inference about the $2.1 billion fair value of hedged debt introduces a material error. Thus, while qualitatively and contextually strong, the quantitative accuracy is compromised, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 484,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "ExxonMobil reports **2,779 million oil‑equivalent barrels** of proved reserves for its equity‑company assets in Asia (1,276 million bbl developed + 1,503 million bbl undeveloped).  \n\nThe consolidated‑subsidiary assets in Asia total **3,601 million oil‑equivalent barrels** (2,286 million bbl developed + 1,315 million bbl undeveloped), which is about **822 million barrels higher** than the equity‑company total.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides incorrect total values for both equity companies and consolidated subsidiaries in Asia. The ground truth states equity company reserves are 1,276 million barrels, but the LLM claims 2,779 million (sum of 1,276 developed + 1,503 undeveloped), which is factually wrong — the 1,276 million in the ground truth already represents the total, not just developed. Similarly, for consolidated subsidiaries, the ground truth reports 2,286 million barrels, but the LLM incorrectly calculates 3,601 million (2,286 + 1,315), again treating 2,286 as only the developed portion when it is the total. (2) Calculations are fundamentally flawed: the LLM adds numbers that should not be added, misinterpreting the structure of the data. The comparison stating consolidated subsidiaries have '822 million more' is incorrect; the actual difference is 2,286 - 1,276 = 1,010 million barrels. The ratio in the original answer (1.8x) is accurate (2,286 / 1,276 ≈ 1.79), but the LLM fails to provide this correct comparative analysis. (3) Multi-hop reasoning is unsound: the model fails to correctly identify which figures represent totals versus components, leading to erroneous synthesis across entities. It introduces 'undeveloped' reserves not mentioned in the question or ground truth, suggesting hallucination or misreading of source data. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses the right region (Asia), the correct company (ExxonMobil), and the right concept (proved oil-equivalent reserves comparison between equity companies and consolidated subsidiaries). However, due to severe quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 470,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform drove Mondelēz’s 2019 effective tax rate down to essentially 0.1 % (versus the 22‑plus % rate that would have applied without the reform).  The reform produced a net financial benefit of roughly **$767 million** in 2019 – a $769 million reduction in deferred‑tax expense offset by a $2 million indirect‑tax charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the $767 million net financial benefit matches the original answer exactly, and the breakdown into a $769 million deferred-tax reduction and $2 million indirect-tax charge adds up correctly. While the original answer states a 22.3 percentage point reduction in the effective tax rate, the LLM describes the post-reform rate as 0.1% versus a 22-plus% rate otherwise, which is semantically equivalent and factually consistent—this is a valid rephrasing that preserves accuracy. (2) The fiscal year (2019) and company (Mondelēz International) are correctly identified. (3) The reasoning is sound and reflects multi-hop synthesis: the answer links the Swiss tax reform to both the effective tax rate impact and the net financial benefit, explaining the components of the benefit. (4) The answer is fully contextually relevant, addressing both parts of the question. The only minor shortcoming is that the exact 22.3 percentage point figure is rounded conceptually to '22-plus%', which slightly reduces precision in qualitative expression but does not affect factual correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 373,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "PepsiCo’s 2022 financial impact from the two items was $145 million for the pension‑and‑retiree‑medical obligation it transferred to TBG, plus a $520 million gain from the fair‑value remeasurement of its 39 % stake in TBG – a combined effect of roughly $665 million 【92†L...】【94†L...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: the $145 million pension obligation transfer and the $520 million gain from remeasurement of PepsiCo's 39% stake in TBG are correctly stated, and their sum ($665 million) is accurately calculated. (2) Quantitative accuracy is perfect: the individual amounts and the total match the ground truth exactly, with acceptable formatting variations (e.g., 'roughly $665 million' is semantically equivalent to the exact figure). (3) The multi-hop reasoning is sound—information about two separate financial events (pension transfer and equity stake remeasurement) is correctly synthesized into a single total impact, demonstrating proper cross-entity and cross-metric integration. (4) Entities (PepsiCo, TBG, 39% ownership stake, 2022 time frame) and financial terms (pension obligation, remeasurement gain) are correctly identified and used. The answer is also contextually precise, directly addressing the question with no irrelevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 295,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "Merck paid **$200 million** in sales‑based milestone payments to Eisai for Lenvima during 2021.  As of December 31 2021, **$600 million** of sales‑based milestone payments were accrued but still unpaid – three times the amount that had actually been paid that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $200 million (paid in 2021) and $600 million (accrued but unpaid as of December 31, 2021) are accurately reported, with the correct comparison that the unpaid amount is three times the paid amount. (2) The answer addresses both parts of the question: the total payments made in 2021 and the accrued but unpaid balance at year-end. (3) Entities—Merck, Eisai, Lenvima, and the time frame (2021/December 31, 2021)—are correctly identified. (4) The reasoning is sound: it correctly synthesizes the payment data and draws the logical conclusion about the 3x ratio, demonstrating proper multi-hop understanding. Wording differs slightly but maintains semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 241,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received roughly **$3.5 billion in cash** from the sale of the Naked brand (along with Tropicana and other juice brands) to PAI Partners, and it kept a **39 % non‑controlling ownership interest in TBG** as part of the transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the cash amount of $3.5 billion and the 39% non-controlling ownership interest in TBG are accurately reported. (2) Quantitative accuracy is perfect—$3.5 billion and 39% are correct values with acceptable formatting (e.g., '3.5 billion' = '$3.5 billion', '39 %' = '39%'). (3) The multi-hop reasoning is sound: the answer correctly synthesizes that PepsiCo sold the Naked brand and other juice brands (including Tropicana, as contextually accurate) to PAI Partners and retained a minority stake in the resulting entity, TBG. (4) Entity names (PepsiCo, PAI Partners, TBG), ownership type ('non-controlling'), and transaction structure are correctly identified. The answer is complete, precise, and directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 251,
        "total_tokens": 1370
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "By switching to the fair‑value method for liability‑hedging securities, Southern Company now records any change in the market value of those securities **immediately** in the market‑related value of plan assets. That current market‑related value is used to calculate the expected return on plan assets, so the change is reflected right away in net periodic pension cost, whereas under the prior calculated‑value approach the change would have been amortized over five years and thus smoothed and deferred.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Southern Company's adoption of the fair value approach leads to immediate recognition of changes in market value of liability-hedging securities, as opposed to the five-year amortization under the calculated value approach. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts, or dates), but the key time frame of 'five years' is correctly referenced and aligns with the original answer. (3) The multi-hop reasoning is sound: the answer correctly links the immediate recognition of market value changes to the market-related value of plan assets, which in turn affects the expected return on plan assets and thus the net periodic pension cost. This reflects proper synthesis of accounting cause-and-effect across valuation method and financial impact. (4) The answer is fully contextually relevant, directly addressing how the change in approach affects the recognition of asset value changes in pension cost measurement. Wording differs slightly but meaning is preserved and technically precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 325,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "Netflix’s total content spending rose from $9.216 billion in 2019 to $12.230 billion in 2021 – an increase of about $3.0 billion【page 52】.  Within that increase, produced‑content spending grew by roughly $2.2 billion (from $1.973 billion to $4.175 billion), while licensed‑content spending rose by about $0.8 billion (from $7.243 billion to $8.056 billion)【page 52】.  Thus, the growth in produced content was roughly three times the growth in licensed content over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) Quantitatively: The total spending increase is reported as $3.0 billion (~$3,000,000,000), which rounds the ground truth $3,014,120,000—this is acceptable per format variation policy. Produced content growth is given as $2.2 billion (~$2,200,000,000), close to the exact $2,201,108,000. Licensed content growth is $0.8 billion (~$800,000,000), slightly under the actual $813,012,000, but within reasonable rounding. The individual spending figures cited (e.g., $1.973B to $4.175B for produced) yield a correct difference of $2.202B, supporting the rounded figure. Similarly, licensed content from $7.243B to $8.056B is a $0.813B increase, consistent with ground truth. (2) Completeness: The answer fully addresses both parts of the question—total spending increase and comparative growth between produced and licensed content. (3) Entity and time period accuracy: Correct company (Netflix), correct years (2019–2021), correct metrics (content spending, produced vs. licensed). (4) Reasoning: The multi-hop synthesis across spending categories and years is sound. The conclusion that produced content growth was roughly three times licensed growth ($2.2B vs $0.8B) is logically valid and matches the relative growth pattern in the ground truth. (5) Semantic equivalence is maintained despite rounding. Only a minor deduction in quantitative accuracy due to the slight underreporting of the licensed content increase, but not enough to affect overall correctness. Thus, the answer is factually solid, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 450,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo recorded a **pre‑tax impairment charge of $321 million in 2023** for its 39 % non‑controlling interest in TBG. In contrast, **the 2022 remeasurement of that same investment generated a $520 million pre‑tax gain**. Thus, the 2023 impairment was about $199 million smaller than the gain recognized in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $321 million pre-tax impairment charge in 2023 and the $520 million pre-tax gain in 2022, both of which match the ground truth exactly. These numbers are presented with accurate formatting and context. (2) The quantitative comparison is mostly correct: the difference between the 2022 gain and 2023 charge is $520M - $321M = $199M. However, the LLM states that 'the 2023 impairment was about $199 million smaller than the gain recognized in 2022', which, while mathematically accurate, reverses the economic impact (a charge vs. a gain) and slightly misrepresents the net effect. The ground truth emphasizes the net pre-tax difference of -$199 million, highlighting the overall negative swing. The LLM omits this directional framing, which is a minor but relevant nuance in financial interpretation. (3) The multi-hop reasoning is sound—information from two different years and events (impairment vs. remeasurement gain) is correctly attributed to the same investment (39% noncontrolling interest in TBG) and synthesized into a comparison. (4) Scores reflect near-perfect accuracy: full points for quantitative accuracy and contextual relevance; a minor deduction in qualitative accuracy due to the lack of emphasis on the net negative impact, though the core facts and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 373,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "Netflix’s larger spend on original programming drove a **$1.4 billion increase in content‑amortization expense in 2021** (the bulk of the $2.1 billion rise in cost of revenues). Even with that higher amortization, revenue grew faster, so **cost of revenues fell to about 58 % of total revenue**, down from 61 % in 2020.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1.4 billion increase in content amortization, which aligns with the ground truth of $1,423 million (rounded appropriately). The cost of revenues as a percentage of revenue is accurately reported as decreasing from 61% to 58%. These numbers match the original answer, allowing for rounding and format variation ($1.4 billion ≈ $1,423 million).\n\n2) Quantitatively, all figures are correct: the $1.4 billion amortization increase, the 58% and 61% cost-of-revenue percentages, and the context of revenue growth outpacing amortization are all factually consistent with the ground truth. The mention of a $2.1 billion rise in cost of revenues is additional context not in the original but does not contradict it and may reflect broader cost trends.\n\n3) The qualitative reasoning is mostly sound: the answer correctly infers that despite higher amortization, the cost of revenues as a percentage decreased due to faster revenue growth. However, it omits the key explanatory factor from the original answer — that delays in content releases due to the COVID-19 pandemic slowed amortization growth relative to revenue. This missing causal link slightly weakens the multi-hop reasoning, though the conclusion remains valid.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the impact on content amortization and on cost of revenues as a percentage of revenue. The synthesis across financial metrics and cause-effect logic is strong, with only minor omission of pandemic-related delays affecting amortization timing. Hence, high scores across all dimensions, with a 9 in correctness due to the omitted nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 459,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "In 2024 Ozurdex generated total net revenue of **$494 million** (U.S. $138 million + International $356 million). Its international sales rose **about 8.3 %** versus 2023 when measured at actual currency rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the total net revenue of $494 million is accurate, and the international revenue growth of 8.3% compared to the previous year at actual currency rates is correctly stated. The breakdown into U.S. ($138 million) and international ($356 million) components is consistent with the total: $138M + $356M = $494M. (2) The percentage change of 'about 8.3%' aligns with the exact 8.3% in the ground truth; the word 'about' does not detract from accuracy given typical reporting conventions. (3) The multi-hop reasoning is sound—revenue components from different regions are correctly aggregated, and the year-over-year international growth is accurately referenced at actual currency rates. (4) All entities (Ozurdex, 2024, international revenue) and time periods (versus 2023) are correctly identified. The answer is semantically equivalent to the original, with no omissions or errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 292,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target recognized a **$335 million pretax gain** on the February 2021 cash sale of Dermstore LLC.  The gain was **recorded in the “Net Other (Income) / Expense” line** of the consolidated statement of income (i.e., included in Net Other Income).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the pretax gain of $335 million is accurately reported, and the date of the sale (February 2021) is consistent with the source data. (2) The answer correctly identifies that the gain was recorded in 'Net Other (Income) / Expense,' which is semantically equivalent to 'Net Other Income' as stated in the original answer—this line item is commonly referred to as Net Other Income in financial statements. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the sale event to the financial impact and its presentation in the income statement. (4) All entities—Target Corporation, Dermstore LLC—are accurate, and the response addresses both parts of the question: the amount of the gain and its treatment in the financial statements. Wording differs slightly but conveys the same factual content, meeting semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 273,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "Salesforce’s mortgage‑backed obligations were carried at an amortized cost of **$244 million** versus a fair‑value of **$236 million**, a difference of **$8 million**. That $8 million represents roughly **0.14 %** of the company’s total marketable securities measured at fair value ($5,722 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: amortized cost ($244 million), fair value ($236 million), difference ($8 million), total marketable securities at fair value ($5,722 million), and the calculated percentage (0.14%) are all correct. The calculation of the difference (244 - 236 = 8) and the percentage (8 / 5,722 ≈ 0.14%) are accurate. (2) The answer is complete, addressing both parts of the question: the dollar difference and its percentage of total marketable securities. (3) Entity accuracy is correct: Salesforce (CRM), mortgage-backed obligations, and the 2024 10-K context are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines data from different parts of the filing (obligations valuation and total marketable securities) and performs correct cross-metric calculation. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em dashes, bolding) that do not affect factual content. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 319,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its primary financial statements – the consolidated balance sheet, statement of operations (income statement), statement of comprehensive income, statement of equity, and statement of cash‑flows 【5†L1-L24】【6†L1-L24】【7†L1-L24】【8†L1-L24】【9†L1-L24】.  The adjustments were made to the comparative periods presented in the 2023 Form 10‑K, i.e., the 2022 and 2021 fiscal years (with equity balances also restated back to the 2020 year‑end) 【5†L1-L12】【6†L1-L12】【7†L1-L12】【8†L1-L12】【9†L1-L12】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies compared to the ground truth. (1) The original answer specifies that only the consolidated statements of comprehensive income and the consolidated balance sheet were retrospectively adjusted due to LDTI adoption. However, the LLM answer incorrectly states that *all* primary financial statements—including the statement of operations, statement of equity, and statement of cash flows—were adjusted, which is not supported by the ground truth. (2) Regarding time periods, the ground truth indicates that balance sheet adjustments were applied as of December 31, 2022, and income statement adjustments reflect effects as of December 31 (implied 2022, within the 2023 10-K context). The LLM answer claims adjustments cover 2022 and 2021 fiscal years, with equity restated back to 2020, which goes beyond the information in the original answer and introduces unverified details. While it's plausible that retrospective application affects prior periods, the specific mention of 2021 and 2020 is not confirmed in the ground truth and thus represents an overextension. (3) The multi-hop reasoning is flawed because the model fails to accurately identify which financial statements were actually adjusted, instead generalizing to all statements without justification. This reflects a failure in precise synthesis from the source material. (4) Despite these issues, the answer correctly identifies the retrospective nature of the adjustment and references the 2023 10-K context appropriately, maintaining some relevance. Number formats and dates are reasonably handled, but the inclusion of unsupported financial statements and extended time periods reduces quantitative and qualitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 480,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Disney’s two cruise‑ship credit facilities each provide up to $1.1 billion, giving a total potential financing commitment of **$2.2 billion**. The facility used for the Disney Treasure carries a **fixed 3.80% rate**, while the facility that can be used for the Disney Destiny is priced at a **fixed 3.74% rate**; both loans are amortized semi‑annually over 12 years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, derived correctly from two $1.1 billion facilities. The interest rates—3.80% for Disney Treasure and 3.74% for Disney Destiny—are exactly as stated in the original answer. Number formats are consistent and acceptable. (2) The answer is complete, addressing both parts of the question: total financing and the differing interest rate structures. (3) Entity accuracy is perfect: both cruise ships (Disney Treasure and Disney Destiny) are correctly identified with their respective facilities and rates. (4) The reasoning is sound and reflects proper synthesis across the two credit facilities, correctly distinguishing between the fixed rates tied to each ship. The additional detail about semi-annual amortization over 12 years is contextually relevant and does not contradict the ground truth. (5) Semantic equivalence is maintained—the LLM conveys the same core facts with slightly expanded but accurate context. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 311,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron recorded **$405 million** of equity‑in‑earnings from Angola LNG Limited in 2024. That amount represents roughly **11 % of its total upstream equity earnings of $3.58 billion** for the year. Because Chevron owns about **36.4 % of Angola LNG Limited**, the contribution shows that the company has a material, equity‑based participation in Angola’s natural‑gas production and liquefaction operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's equity in earnings from Angola LNG Limited was $405 million in 2024, matching the ground truth. It also accurately reports total upstream equity earnings as $3.58 billion (equivalent to $3,580 million), and correctly calculates the percentage contribution as approximately 11% (405 / 3580 ≈ 0.1131 or 11.31%, rounded to 11% is acceptable). These figures are quantitatively accurate with proper formatting variations accepted. (2) The entity identification is correct: 'Angola LNG Limited', 'Chevron', '2024', and financial metrics ('equity in earnings', 'upstream equity earnings') are all accurate. (3) The reasoning is sound and adds value by noting Chevron's 36.4% ownership stake, which, while not in the original answer, is consistent with public knowledge and enhances the conclusion about material involvement in Angola’s gas operations. This demonstrates strong multi-hop synthesis—linking ownership percentage to earnings contribution and inferring strategic production involvement. (4) The answer addresses both parts of the question: the quantitative contribution and what it indicates about Chevron's production role in Angola. The original answer emphasizes 'significant production involvement' due to upstream earnings and production volume inclusion; the LLM infers similar significance through equity-based participation and operational involvement. While the LLM does not explicitly mention 'production volumes' or that Angola LNG is an 'equity method affiliate', these omissions are minor and do not detract from the overall correctness. Semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness—excellent but not perfect—due to slight under-articulation of the structural accounting relationship (equity method affiliate) present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 503,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Disney had Canadian‑dollar senior notes totaling **C$2.6 billion** (approximately **US$1.9 billion**) outstanding on September 28, 2024.  The company entered into cross‑currency swaps covering essentially the whole foreign‑currency portion of its debt, with a notional swap amount of **about US$1.9 billion (US$1,887 million)** that converts those Canadian notes into U.S.‑dollar‑denominated borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total Canadian dollar denominated notes outstanding as C$2.6 billion, which matches the ground truth (CAD $1.3 billion + CAD $1.3 billion). However, it incorrectly states that the entire amount was converted into U.S. dollar denominated borrowings via cross-currency swaps. The ground truth specifies that only C$1.3 billion (US$1.0 billion) was converted through swaps, while the other C$1.3 billion (US$0.9 billion) was paid off in October 2024 and thus not swapped. The LLM answer fails to reflect this critical distinction. (2) The LLM reports a notional swap amount of 'about US$1.9 billion (US$1,887 million)', which inaccurately implies the full C$2.6 billion was swapped. This contradicts the ground truth where only US$1.0 billion (C$1.3 billion) was swapped. The conversion rate implied by the LLM (C$2.6B ≈ US$1.9B) is roughly accurate (~0.73), but the fundamental error lies in assuming 100% of the debt was swapped. (3) The multi-hop reasoning is flawed: the model should have recognized that only half of the Canadian notes were subject to cross-currency swaps, based on the maturity and repayment timing. It failed to synthesize the repayment event (October 2024) with the swap coverage, leading to an overstatement of the swapped amount. (4) While the total debt figure and context are correct, the key quantitative and qualitative error—failing to distinguish between the portion swapped and the portion repaid—significantly undermines the answer's correctness. The contextual relevance is high as the response addresses the right topic and uses appropriate financial terminology, but the core factual synthesis is partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 463,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "Honeywell reported private‑fund investments of **$1,265 million** in its U.S. pension plans and **$115 million** in its non‑U.S. pension plans at December 31 2023, for a combined fair‑value total of **approximately $1.38 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: $1,265 million for U.S. Plans and $115 million for Non-U.S. Plans are correctly reported. (2) The total fair value is calculated accurately: $1,265M + $115M = $1,380M, which the model correctly reports as approximately $1.38 billion—this is an acceptable and common format variation (1.38 billion = 1,380 million). (3) The multi-hop reasoning is sound: the model correctly identifies and synthesizes data from both U.S. and Non-U.S. pension plans, as required by the question. (4) Entities are accurate: Honeywell, December 31, 2023, private funds, and the distinction between U.S. and Non-U.S. Plans are all correctly referenced. The answer is concise, relevant, and conveys the same information as the original answer using slightly different but equivalent phrasing and formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 261,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle’s “choice‑and‑flexibility” strategy means that the company records two fundamentally different types of performance obligations.  For cloud‑based subscriptions (Oracle Cloud Services) the contract is for a service that is delivered over the term, so revenue is recognized **ratably** (or, for metered usage, as the customer consumes the service) throughout the subscription period.  By contrast, when a customer purchases a perpetual cloud or on‑premise software license, the obligation is satisfied when the software is made available for download or use, so that **license revenue is recognized at a point in time** (with any accompanying license‑support contract then recognized ratably over its one‑year term).  This split reflects Oracle’s flexible deployment models that allow customers to buy either ongoing cloud services or one‑time licenses, each with its own revenue‑recognition timing. 【Revenue Recognition for Cloud Services】【Cloud license and on‑premise license revenues… recognized as revenues up front at the point in time…】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Oracle Cloud Services revenue is recognized ratably over the subscription period, while on-premise and cloud license revenues are recognized up front at the point of delivery—this matches the original answer's key distinction. The explanation of performance obligations under ASC 606 is sound and contextually appropriate. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the absence of any incorrect numerical claims earns full marks. (3) The multi-hop reasoning is solid: the model correctly synthesizes Oracle’s deployment strategy with its accounting treatment, linking flexible models (cloud vs. license) to differing revenue recognition patterns. It references both cloud subscriptions and perpetual licenses accurately, and even adds nuanced detail about metered usage and support contracts, which, while not in the original, are factually correct and enhance the response. (4) The only reason for not scoring a perfect 10 is minor: the original emphasizes the business impact—'more predictable and stable revenue streams' from ratable recognition—whereas the LLM answer focuses more on the accounting mechanism than the strategic financial outcome. Still, the core facts, entities (Oracle, cloud services, license models), and reasoning are correct and relevant. Semantic equivalence is achieved with slightly different emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 430,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "ERLEADA’s worldwide sales rose from $1,291 million in 2021 to $2,387 million in 2023 – an increase of about 85 percent (45.7 % growth in 2022 vs 2021 plus a further 26.9 % in 2023 vs 2022)【...】.  \n\nThe Oncology segment’s total worldwide sales grew 10.5 % from $15,983 million in 2022 to $17,661 million in 2023, and ERLEADA’s 26.9 % rise (adding roughly $506 million) was a major contributor to that segment‑wide improvement【...】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports ERLEADA's sales of $1,291 million in 2021 and $2,387 million in 2023, and calculates the overall growth as approximately 85%, which is accurate (exact: 84.9%). It correctly states the 2023 vs 2022 growth as 26.9%, matching the ground truth. The Oncology segment growth of 10.5% from $15,983 million to $17,661 million is correctly reported and aligns with the context. The incremental sales contribution of ~$506 million from ERLEADA is a reasonable derivation (2022 ERLEADA sales = $2,387M / 1.269 ≈ $1,881M; difference ≈ $506M), though not explicitly required. (2) Minor issue: The LLM incorrectly breaks down the 85% total growth as '45.7% growth in 2022 vs 2021 plus a further 26.9%', which is misleading—percentage changes are not additive. The correct compound growth from 2021 to 2023 is 84.9%, but adding 45.7% + 26.9% = 72.6% is mathematically incorrect and reflects flawed reasoning. The individual year-over-year percentages may be factually correct (if 2022 was indeed ~45.7% higher than 2021), but presenting them as summing to the total growth is a significant quantitative reasoning error. (3) The multi-hop synthesis is mostly sound: the model connects ERLEADA’s growth to the Oncology segment’s performance and correctly identifies its role as a major contributor. However, it omits the comparative ranking mentioned in the ground truth—ERLEADA being the third-largest contributor after DARZALEX and TREMFYA—which reduces completeness. (4) Despite the incorrect additive percentage explanation, all key numbers are accurate, and the core answer about total growth and segment contribution is correct. Hence, correctness is high but not perfect—warranting an 8. Quantitative accuracy is 9 due to the calculation reasoning flaw. Qualitative accuracy is 8 due to missing comparative context. Contextual relevance is 10—response is fully on-topic and addresses both parts of the question with strong supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 531,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, Mondelēz International had net‑investment‑hedge contracts with a total notional amount of **$7.456 billion** and also held non‑U.S.‑dollar debt used as net‑investment hedges (Euro notes $3.516 billion + Swiss‑franc notes $0.386 billion + Canadian‑dollar notes $0.453 billion) for a combined notional of **$11.811 billion**.  \n\nThe fair value of the derivative assets recorded on the balance sheet (the sum of the amounts shown in “other current assets” and “other assets”) was **$1.597 billion** at that date, meaning the notional amount of net‑investment‑hedge instruments was roughly **seven‑times larger** than the recorded fair‑value of derivative assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the notional amount of net investment hedge derivatives is correctly stated as $7.456 billion (equivalent to $7,456 million), and the breakdown of non-U.S. dollar denominated debt—$3.516 billion (Euro), $0.386 billion (Swiss franc), and $0.453 billion (Canadian dollar)—sums to $4.355 billion, leading to a combined total of $11.811 billion, which matches the ground truth. The fair value of derivative assets is correctly reported as $1.347 billion in other current assets and $0.250 billion in other assets, totaling $1.597 billion. (2) The calculation comparing notional amount to fair value is sound, and the statement that the notional amount is roughly seven times larger is reasonable (11,811 / 1,597 ≈ 7.4). (3) The multi-hop reasoning is correct: the model synthesizes data across derivative contracts and debt instruments used as hedges, aggregates their notional amounts, and compares them to the fair value of derivative assets pulled from two balance sheet line items. (4) All entities—Mondelēz International (MDLZ), the date (December 31, 2023), financial metrics (notional amount, fair value, net investment hedges), and balance sheet categories—are accurately identified and used. The answer is semantically equivalent to the original, with only formatting differences (e.g., billion vs. million, decimal vs. comma separators), which are acceptable. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 418,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Honeywell’s pension plans held **$676 million** of mortgage‑/asset‑backed securities in its U.S. plans and **$10 million** in its non‑U.S. plans, for a combined total of **$686 million** as of December 31, 2023【106†L31-L35】【107†L31-L35】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the U.S. Plans held $676 million and the Non-U.S. Plans held $10 million in Mortgage/Asset-backed securities as of December 31, 2023. The combined total is correctly calculated as $686 million. (2) Quantitative accuracy is perfect: all dollar amounts are correct, and the sum ($676M + $10M = $686M) is accurate. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly synthesized to compute the total. (4) The entities (Honeywell, pension plans, Mortgage/Asset-backed securities, correct date) are accurately identified. The answer is semantically equivalent to the original, with clear, concise presentation and proper citation markers. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 265,
        "total_tokens": 1390
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "Starbucks still has **about $5.98 billion** of the Nestlé up‑front prepaid royalty to recognize – the sum of the $177 million classified as current deferred revenue and the $5.8 billion classified as long‑term deferred revenue as of September 29 2024.  This balance is being amortized on a straight‑line basis over the **40‑year economic life of the Global Coffee Alliance licensing arrangement**, so the remaining amount will be recognized gradually over the remaining years of that 40‑year contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only a minor rounding discrepancy. (1) Quantitatively, the LLM states 'about $5.98 billion' as the total remaining deferred revenue, which correctly sums $177 million (current) and $5.8 billion (long-term). The ground truth specifies $177.0 million and $5.8 billion, which sum to $5.977 billion—properly rounded to $5.98 billion, so this is acceptable. (2) The LLM correctly identifies the 40-year economic life of the Global Coffee Alliance and the straight-line recognition method, aligning with the original answer. (3) The multi-hop reasoning is sound: it synthesizes the current and long-term deferred revenue components from the $7 billion up-front payment and links them to the 40-year amortization period. (4) All entities (Starbucks, Nestlé, Global Coffee Alliance), financial terms (deferred revenue, straight-line basis), and timeframes (as of September 29, 2024) are accurate. The only reason for not scoring a 10 is the use of 'about $5.98 billion' instead of explicitly breaking out both components as in the original, but this does not reduce factual accuracy. The answer is contextually complete, logically structured, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 355,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Exxon Mobil reported a fair‑value of **$1,896 million** for its long‑term obligations to equity companies and guarantees tied to those equity‑company obligations of **$1,862 million**. Combined, the total fair value is **about $3,758 million (≈ $3.8 billion)**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurately reported: the fair value of long-term obligations to equity companies is correctly stated as $1,896 million, and guarantees related to equity company obligations are accurately given as $1,862 million. The combined total of $3,758 million is correctly calculated and also reasonably approximated as $3.8 billion. (2) Quantitative accuracy is perfect: all numbers match the original answer, and the sum (1,896 + 1,862 = 3,758) is mathematically correct. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (3) The reasoning is sound and demonstrates proper synthesis of two financial figures from XOM's 2023 10-K to arrive at a total, fulfilling the multi-hop requirement. (4) The entities—ExxonMobil (XOM), the 2023 10-K filing, and the specific financial metrics—are correctly identified and contextually appropriate. The answer is semantically equivalent to the ground truth, with clear, concise, and relevant information directly addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 308,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "Honeywell’s pension‑plan assets show **$676 million** of mortgage‑/asset‑backed securities in the U.S. plans and **$10 million** in the non‑U.S. plans as of December 31 2023 – a combined **$686 million**. The U.S. plans therefore hold virtually all of the exposure (about 98 % of the total), while the non‑U.S. plans hold only a very small portion (roughly 2 %).【106†L31-L38】【106†L71-L78】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $676 million for U.S. plans, $10 million for Non-U.S. plans, and a total of $686 million, which matches the ground truth exactly. These numbers are presented clearly and accurately. (2) The calculation of the total ($676M + $10M = $686M) is correct, and the percentage breakdown is nearly exact — the LLM states 'about 98%' for U.S. plans, while the ground truth specifies 98.5%. This minor rounding difference (98% vs 98.5%) does not constitute a factual error but represents a slight imprecision in presentation. The 2% attribution to Non-U.S. plans is consistent with rounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from both U.S. and Non-U.S. plans, computes the total, and draws a valid comparative conclusion about allocation disparity. (4) The answer is contextually complete and relevant, addressing both parts of the question — total value and comparative allocation. The only reason for not awarding a perfect 10 is the slight softening of '98.5%' to 'about 98%', which, while reasonable in context, slightly reduces precision. All entities (Honeywell, Mortgage/Asset-backed securities, U.S./Non-U.S. plans, December 31, 2023) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 363,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The “Medical device regulations” non‑GAAP adjustment added **$102 million** to income before income taxes in fiscal 2022 and **$83 million** in fiscal 2021. Together, these adjustments represent a total pre‑tax impact of **$185 million** across the two years【source lines showing 102 for 2022 and 83 for 2021】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $83 million in fiscal year 2021 and $102 million in fiscal year 2022, with a total pre-tax impact of $185 million. The sum ($83M + $102M = $185M) is correctly calculated. Minor formatting differences (e.g., using ' ' as a thousands separator or bolding) do not affect accuracy. (2) The answer is complete, addressing both individual year impacts and the total across the two years, as required by the question. (3) Entity accuracy is correct: Medtronic is the implied company (context from source lines), the fiscal years 2021 and 2022 are properly identified, and the metric 'pre-tax financial impact on Non-GAAP income before income taxes' is correctly interpreted as the sum of the adjustments. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by combining data from two separate years and computing the total impact. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement of the same facts. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 318,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "Booking Holdings recorded a total goodwill impairment of **$1.062 billion** for the OpenTable and KAYAK reporting unit in 2020 ($489 million in the March‑31 interim test plus $573 million in the September‑30 annual test).  \n\nThe impairment persisted in the September‑30, 2020 test because the **COVID‑19 pandemic continued to depress the unit’s cash‑flow forecasts**, extending the recovery horizon—particularly the hit to KAYAK’s flight‑booking vertical and a weakened outlook for monetizing OpenTable’s restaurant‑reservation services.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total goodwill impairment of $1.062 billion is accurate, with the correct breakdown of $489 million in the March 2020 interim test and $573 million in the September 30, 2020 annual test. The sum ($489M + $573M = $1,062M) is mathematically correct. Dates (March-31 and September-30) align with the annual test reference as of September 30, 2020. (2) The answer is complete, addressing both the total impairment amount and the key factor behind the continued impairment. (3) Entities—OpenTable, KAYAK, Booking Holdings (implied parent), and the reporting unit—are correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it links the ongoing impact of the COVID-19 pandemic to reduced cash-flow forecasts, specifically citing KAYAK’s flight-booking vertical (airline travel) and OpenTable’s monetization challenges, which matches the ground truth’s explanation of slower recovery in airline travel and lowered monetization outlook. The phrasing differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 331,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart’s stake in Flipkart rose from roughly 75 % at the end of fiscal 2023 to about 85 % at the end of fiscal 2024 – an increase of ≈ 10 percentage points.  This gain was driven by a $3.5 billion cash purchase of Flipkart non‑controlling‑interest shares (and related liability settlement) during fiscal 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Walmart's ownership increased from approximately 75% to 85%, a 10 percentage point increase, matching the original answer. The $3.5 billion transaction amount is correctly stated. (2) Quantitative elements are precise: the percentage increase (10 points), starting and ending stakes (75% to 85%), and dollar amount ($3.5 billion) are all correct, with acceptable formatting variations (e.g., '≈ 10 percentage points' vs '10%'). (3) The reasoning is sound and reflects multi-hop synthesis: the answer correctly links the ownership change to a specific financial transaction involving noncontrolling interest holders, and adds contextual detail (cash purchase and liability settlement) that aligns with and enriches the ground truth without introducing errors. (4) Entities (Walmart, Flipkart, fiscal 2023–2024, noncontrolling interest holders) and time periods are accurately referenced. The answer fully addresses both parts of the question: the magnitude of stake increase and the supporting financial transaction. All criteria—factual accuracy, completeness, entity correctness, and logical synthesis—are met, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 348,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for **about 24 % of Procter & Gamble’s total net sales**. Within that segment, the Bounty paper‑towel brand commands **north‑American market share of over 40 %** in the paper‑towel category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the Baby, Feminine & Family Care segment represents about 24% of Procter & Gamble's total net sales, which matches the ground truth. It also accurately reports that the Bounty brand holds over 40% North American market share in the paper towel category. (2) Both percentages—24% and over 40%—are factually correct and match the original answer exactly in value and meaning; minor formatting differences (e.g., 'about 24%' vs '24%') do not affect accuracy. (3) The question requires a multi-hop synthesis: first identifying the segment's contribution to total net sales, then drilling into that segment to extract a specific brand's market share in a specific category and region. The LLM successfully performs this two-step reasoning with correct entity alignment (Procter & Gamble → Baby, Feminine & Family Care → Bounty → paper towel category → North America). (4) All scores are maximized because the answer is factually precise, fully complete, contextually appropriate, and demonstrates sound reasoning across multiple data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 311,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "RTX recorded a **pre‑tax charge of $364 million in 2024** attributable to the resolution of the Thales‑Raytheon Systems and Related Matters. That charge arose because the company settled the underlying criminal and civil investigations by entering into a Deferred Prosecution Agreement with the DOJ and an **SEC Administrative Order**—the SEC proceeding that resolved the payments‑related allegations and triggered the related compliance and financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the pre-tax charge of $364 million in 2024, matching the ground truth exactly in both amount and year. The connection to the SEC Administrative Order is accurately described as resolving investigations into improper payments, and the mention of the DOJ Deferred Prosecution Agreement aligns with the broader settlement context. 2) Quantitatively, the $364 million figure is correct and properly attributed to 2024. No calculations are required, and the number format ($364 million) is acceptable. 3) The multi-hop reasoning is sound: the LLM correctly links the financial charge to the resolution of legal matters involving Thales-Raytheon Systems and ties it to the SEC Administrative Order. While the ground truth adds detail about the three-year compliance monitor and cooperation obligations, the LLM captures the core causal relationship—that the SEC proceeding triggered financial and compliance obligations. The omission of the monitor’s duration and specific disclosure requirements is a minor gap but does not undermine the essential accuracy. 4) The answer is highly relevant, directly addressing both parts of the question: the charge amount and its connection to the SEC order. The use of 'attributable to' and 'triggered' shows appropriate causal reasoning. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only slight less detail on post-settlement obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 401,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "- As of April 2021 Trodelvy had **two approved indications** – (i) accelerated approval for locally advanced or metastatic urothelial cancer and (ii) full approval for unresectable locally advanced or metastatic triple‑negative breast cancer【61†L‑...】.  \n\n- By September 2021 the drug was approved for metastatic triple‑negative breast cancer in **five countries**: the United States, Canada, Australia, Great Britain and Switzerland (the latter four joining the United States under the Project Orbis collaborative review)【62†L‑...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of approved indications as of April 2021 is correctly stated as two, and the five countries where Trodelvy was approved for metastatic triple-negative breast cancer by September 2021—United States, Canada, Australia, Great Britain, and Switzerland—are all accurately listed. (2) The answer addresses both parts of the multi-hop question completely: first, the total number of approved indications by April 2021, and second, the specific countries of approval for TNBC by September 2021. (3) Entity accuracy is perfect: the drug name (Trodelvy), indications (urothelial cancer and TNBC), timeframes (April 2021, September 2021), and countries are all correct. (4) The reasoning is sound and reflects proper synthesis across time points and regulatory approvals, including the mention of Project Orbis adds contextual accuracy without distorting facts. (5) Semantic equivalence is maintained—though the LLM provides slightly more detail (e.g., accelerated vs. full approval, Project Orbis), all added information is factually consistent with the ground truth. No errors in facts, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 338,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "As of September 29 2024, the “Foreign currency – other” cash‑flow hedge shows a **net gain of $11.5 million** recorded in AOCI. Of that amount, the company expects **$9.5 million** to be reclassified from AOCI into earnings within the next 12 months—about $2 million less than the total gain currently sitting in AOCI.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $11.5 million (total net gain in AOCI) and $9.5 million (expected reclassification within 12 months) are accurately reported, with no calculation or formatting issues. The comparison stating that $9.5 million is about $2 million less than $11.5 million is also correct ($11.5M - $9.5M = $2M), adding useful context without introducing error. (2) The date 'September 29, 2024' is correctly used. (3) The entities—'Foreign currency – other' derivatives, AOCI, and earnings reclassification—are accurately identified and properly contextualized within the financial reporting framework. (4) The multi-hop reasoning is sound: the model correctly synthesizes two pieces of information—the total gain in AOCI and the portion expected to be reclassified—into a coherent, accurate response that directly answers both parts of the question. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced explanatory detail (the $2 million difference) that improves clarity without distorting facts. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 332,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "Starbucks has two yen‑denominated facilities that together provide about **$103.6 million** of borrowing capacity ($34.5 million for the ¥5 billion facility plus $69.1 million for the ¥10 billion facility). The ¥5 billion line matures on **December 30, 2024** and bears interest at **TIBOR + 0.400%**, while the ¥10 billion line matures on **March 27, 2025** and bears interest at **TIBOR + 0.300%**.【source】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the ¥5.0 billion facility is correctly converted to $34.5 million, the ¥10.0 billion facility to $69.1 million, and their sum is correctly stated as $103.6 million. The maturity dates—December 30, 2024, and March 27, 2025—are exact. The interest rate margins (0.400% and 0.300% over TIBOR) are also precisely reported. (2) The answer is complete, addressing both parts of the question: total dollar value and the differences in maturity dates and interest rate margins. (3) Entity accuracy is correct: Starbucks is the subject, fiscal year-end context is implied as of September 29, 2024 (consistent with the ground truth), and financial terms (TIBOR, yen-denominated facilities) are used appropriately. (4) Multi-hop reasoning is sound—the model correctly synthesized data from two separate credit facilities, converted yen amounts to USD using implied exchange rates, compared maturity dates, and contrasted interest rate margins. (5) The semantic meaning is equivalent to the original answer, with clear, concise rewording that preserves all factual content. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 342,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "Accenture bought a total of **2,072,563 Class A ordinary shares** in the fourth quarter of fiscal 2024 – 2,000,308 shares through its publicly announced open‑market repurchase program and 72,255 shares in transactions unrelated to any announced share plan.  The open‑market program cost about $605 million, giving an **average price of roughly $302.5 per share**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate with only a minor discrepancy in the total number of shares. The ground truth states the total shares purchased were 2,072,263 (2,000,308 + 72,255), but the LLM reports 2,072,563, which is off by 300 shares. This appears to be a typographical error in summing. All other numbers are correct: 2,000,308 shares under the open-market program and 72,255 unrelated shares are accurately reported. The aggregate cost of $605 million is correct, and the average price calculation is sound: $605,000,000 ÷ 2,000,308 ≈ $302.45. The LLM rounds this to 'roughly $302.5', which is acceptable and semantically equivalent. The answer addresses both parts of the multi-part question: total shares and average price. Entity accuracy (Accenture plc Class A ordinary shares, fiscal 2024 Q4, open-market program) is correct. The reasoning and synthesis across components (separating program vs. unrelated purchases, calculating average price) are logically sound. The minor numerical error prevents a perfect score, but overall the answer is factually strong, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 315,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The 6.375 % notes due 2037 have a total carrying value of **$478 million**, and **$74 million** of principal on those notes was exchanged in the 2020 debt‑exchange transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the total carrying value of the 6.375% 2037 Notes ($478 million) and the principal amount exchanged ($74 million), matching the ground truth exactly. (2) All numeric values are accurate and presented in an acceptable format (e.g., $478 million is equivalent to $478 million). There are no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis—linking the specific bond (6.375% due 2037) to its carrying value and to the debt-exchange transaction in 2020 where $74 million of principal was exchanged. (4) The answer is fully relevant, complete, and semantically equivalent to the original answer, with no omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1088,
        "completion_tokens": 235,
        "total_tokens": 1323
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "Netflix expects the **average amortization period for its content assets to be about five years**. Because the company amortizes content on an **accelerated basis**, most of the expense is recognized early – in fact, **more than 90 % of a licensed or produced title is amortized within the first four years** after it becomes available, front‑loading the cost of the asset rather than spreading it evenly over its useful life.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: it accurately states that more than 90% of a licensed or produced content asset is amortized within the first four years, which matches the ground truth. It also correctly describes the accelerated amortization policy and its effect of front-loading expenses, particularly due to higher initial viewing. The only minor discrepancy is the mention of an 'average amortization period of about five years,' which is not directly stated in the ground truth. However, this is not contradicted by the provided information and may reflect a reasonable inference given that over 90% is amortized within four years, implying a weighted average slightly above four years. This does not constitute a factual error but rather a slight expansion not present in the original.\n\n2) Quantitative accuracy is perfect: 'more than 90%' aligns with 'over 90%' in the ground truth. No calculations are required, and all percentages and timeframes (four years, first availability) are consistent.\n\n3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects the accelerated amortization policy to the pattern of viewing (especially films vs. TV series), explaining why expenses are front-loaded. While the original answer mentions films specifically as having more upfront viewing, the LLM captures the essence of this logic by linking acceleration to early usage.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: the expected amortization period (with a reasonable approximation) and the impact of the accelerated policy on expense distribution, especially in the first four years. The explanation of front-loading is semantically equivalent to the ground truth’s description.\n\nOverall, the answer is highly accurate with only a minor addition (five-year average) that does not detract from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 514,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the 2023 market‑risk table, BlackRock’s foreign‑exchange‑rate‑risk investments had a disclosed exposure of $1,125 million, and a 10 % adverse move would affect them by **approximately $112 million**. This $112 million represents the total potential financial impact if all such investments experienced a –10 % change in exchange rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the disclosed exposure of $1,125 million and the resulting $112 million impact from a -10% exchange rate change are accurately reported. The calculation (10% of $1,125 million = $112.5 million, rounded to $112 million) is consistent with the original answer, and the use of 'approximately' accounts for rounding. (2) The answer is complete, addressing the total potential financial impact, the underlying exposure, and the assumed -10% change. (3) Entities are correct: BLK (BlackRock), 2023, foreign exchange rate risk investments, and the relevant financial metrics are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the disclosed exposure to the hypothetical 10% adverse move and calculating the financial impact. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 291,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 Form 10‑K lists **three amendments** to the Target Corporation Deferred Compensation Trust Agreement:\n\n* Amendment dated **June 8, 2011** (exhibit Q*)【66†L31-L33】  \n* Amendment dated **October 25, 2017** (exhibit R*)【66†L34-L35】  \n* Amendment dated **December 18, 2020** (exhibit S*)【66†L35-L36】\n\nThus, three amendments are disclosed, with effective dates of June 8 2011, October 25 2017, and December 18 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K, which aligns with the original answer. (2) The effective dates provided—June 8, 2011; October 25, 2017; and December 18, 2020—are all correct and match the ground truth exactly. Minor formatting differences (e.g., 'June 8, 2011' vs 'June 8, 2011') are acceptable and do not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly identified the relevant document (2022 10-K), extracted the number of amendments, and synthesized the correct effective dates from the listed exhibits. (4) The answer is contextually precise, directly addressing both parts of the question (number of amendments and their effective dates) with no irrelevant information. All scores are maximized due to complete factual accuracy, correct entity identification, and proper synthesis of information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 289,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90% 2038 Notes have a total carrying value of **$254 million**, and in the 2020 debt‑exchange transaction **$37 million** of principal of those notes was tendered and cancelled.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total carrying value of $254 million and the principal amount exchanged of $37 million are accurately reported, with acceptable formatting (e.g., $254 million = $254 million). (2) The answer addresses both parts of the question: the total carrying value and the amount of principal exchanged in the debt exchange transaction. (3) Entity accuracy is correct—the 6.90% 2038 Notes are properly identified, and the reference to the 2020 debt-exchange transaction adds relevant context without contradicting the ground truth. (4) The reasoning is sound and demonstrates correct synthesis of multi-hop financial data from the disclosures, correctly associating the carrying value with the specific note and identifying the exchanged principal amount. The slight addition of '2020' for temporal context does not introduce error, as it aligns with known disclosure timelines. Overall, the answer is factually precise, complete, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1089,
        "completion_tokens": 305,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The 2023 filing says that the Space segment’s product‑sales rose by about **$940 million** – “mostly due to … higher volume in the Fleet Ballistic Missile (FBM) program” – and that Space’s product‑costs rose by about **$815 million** for the same reasons.  Those changes helped lift overall product sales by $799 million and product costs by $849 million, which in turn added roughly **$192 million to gross profit** (from $8.287 billion to $8.479 billion) and about **$159 million to operating profit** (from $8.348 billion to $8.507 billion) for Lockheed Martin in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $940 million increase in product sales and $815 million increase in product costs at the Space segment due to the FBM program, which matches the ground truth. However, it introduces incorrect net financial impact figures: it claims a $192 million increase in gross profit and $159 million in operating profit for Lockheed Martin overall, which is not supported by the original answer. The correct net impact is a $125 million increase in gross profit ($940M - $815M) specifically for the Space segment, not company-wide. (2) Quantitatively, the two main figures ($940M and $815M) are accurate, but the derived values (e.g., $192M gross profit increase) are incorrect. The actual gross profit increase from FBM should be $125M, not $192M. The LLM appears to have misattributed broader segment or company-level changes to the FBM program. (3) The reasoning is flawed in the multi-hop synthesis: while it correctly links FBM to sales and cost increases, it incorrectly extrapolates these to overall gross and operating profit changes for Lockheed Martin without isolating the FBM-specific impact. The original answer focuses only on the Space segment’s gross profit impact, which the LLM fails to replicate accurately. (4) Contextual relevance is high because the response addresses the core elements of the question and cites relevant data from the correct segment and year, but the incorrect net impact calculation and overgeneralization to company-wide profits reduce factual accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 425,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The 5.375 % notes due 2043 had a carrying value of **$185 million**, which is roughly **0.6 % of AMGN’s total debt (≈$33.3 billion) reported for 2022**. In the 2020 exchange offer, **$76 million** of principal of these 2043 notes was tendered and cancelled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key quantitative facts: the carrying value of the 5.375% 2043 Notes is $185 million, the total debt is approximately $33.3 billion (matching $33,309 million in ground truth), and $76 million in principal was exchanged. The percentage is reported as 'roughly 0.6%', which is a rounded but acceptable approximation of the exact 0.555% (185 / 33,309 ≈ 0.00555). (2) All numbers are factually accurate with acceptable formatting variations: $33.3 billion = $33,300 million (close to $33,309 million; minor rounding is reasonable in context). The principal exchanged ($76 million) and carrying value ($185 million) are exact matches. (3) The multi-hop reasoning is sound—synthesizing the note-specific carrying value, total debt, percentage calculation, and exchange activity across the required data points. The only minor issue is the reference to '2020 exchange offer', which introduces an incorrect year (not specified in the original answer); however, the fact that $76 million was exchanged is correct, and the timing is not part of the explicit question. (4) The answer is semantically equivalent and contextually complete, addressing both sub-questions. The slight rounding of the percentage and the extraneous but non-factual error in the year of the exchange do not undermine the core correctness. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 407,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "- As of December 31 2023, BlackRock had about **$259 billion** of securities out on loan that were covered by borrower‑default indemnifications.  \n- The firm held roughly **$276 billion** of cash and securities as collateral for those indemnified loans at the same date.  \n- If a large number of borrowers were to default at the same time that the pledged collateral’s market value fell sharply (or the loaned securities’ value rose), the collateral could become insufficient, creating **material indemnity liabilities that could materially reduce BlackRock’s revenue and earnings**【page 95‑96】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $259 billion for securities on loan subject to indemnification and $276 billion for collateral held are accurately reported, with correct date (December 31, 2023). Format variations (e.g., $259 billion vs $259B) are acceptable and semantically equivalent. (2) The answer is complete, addressing all three parts of the multi-part question: the value of securities on loan, the amount of collateral held, and the potential financial impact of simultaneous borrower defaults and collateral value declines. (3) Entity accuracy is correct—BlackRock is properly identified, and the financial terms (securities on loan, collateral, indemnification, borrower defaults) are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the existence of indemnifications with the risk of collateral shortfalls under adverse market conditions, and correctly infers the potential material impact on revenue and earnings. The semantic meaning is equivalent to the original answer, with only minor rephrasing for clarity. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 335,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The filing lists the original Pharmacy Operating Agreement (dated December 16, 2015) and two subsequent amendments – the First Amendment (Nov 30, 2016) and the Second Amendment (Jan 9, 2018)【66†L31-L38】. Therefore, **two amendments** were made to the Pharmacy Operating Agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that there are two amendments to the Pharmacy Operating Agreement, which matches the ground truth. The original agreement date (December 16, 2015), First Amendment (November 30, 2016), and Second Amendment (January 9, 2018) are all accurately cited. (2) All dates and the count of amendments (two) are factually correct and consistent with the documented 2022 10-K filing. No calculations are required beyond counting the amendments, which is done accurately. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying the original agreement and each amendment, then correctly concluding the total number of amendments. The citation reference 【66†L31-L38】 indicates accurate sourcing from the filing. (4) The answer is fully complete, contextually relevant, and semantically equivalent to the ground truth, with added detail that enhances clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 277,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology‑related finite‑lived intangible assets fell from **$180 million at 12/31/2022 to $142 million at 12/31/2023**, a **decrease of $38 million**.  Over the same period, the accumulated amortization for this category rose from **$81 million to $118 million**, an **increase of $37 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the net carrying amount decreased from $180 million to $142 million, a $38 million decrease, and accumulated amortization increased from $81 million to $118 million, a $37 million increase—these match the original answer exactly. (2) Calculations are correct: $180M - $142M = $38M decrease; $118M - $81M = $37M increase. (3) The multi-hop reasoning is sound—information from two time points (2022 and 2023) for two related financial metrics (net carrying amount and accumulated amortization) is correctly synthesized. (4) While the LLM answer omits the interpretive sentence about the decline being 'primarily due to' amortization, it still fully addresses the two explicit sub-questions (change in net carrying amount and change in accumulated amortization), making it complete for the question asked. The omission does not detract from factual correctness or completeness of requested data. Semantic equivalence is maintained, and all entities (Technology-related finite-lived intangible assets, correct dates, correct financial metrics) are accurately identified and reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 335,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The “Subscriptions and services” line shows that Asia Pacific revenue rose from $657 million in FY 2023 to $2,203 million in FY 2024 – an increase of **$1.55 billion** year‑over‑year.  In the Americas, the same category grew from $5,678 million to $12,726 million, a **$7.05 billion** increase – roughly four‑times the growth seen in Asia Pacific【AVGO 10‑K FY 2024 vs FY 2023 table】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences. (1) Quantitatively, the year-over-year increase for Asia Pacific is reported as $1.55 billion, which matches $1,546 million when rounded (actual difference: $2,203M - $657M = $1,546M). Similarly, the Americas increase is $7.05 billion, matching $7,048 million upon rounding ($12,726M - $5,678M = $7,048M). These small discrepancies are due to rounding and are acceptable under the evaluation criteria. (2) The answer fully addresses both parts of the question: the YoY increase in Subscriptions and Services for Asia Pacific and the Americas, and includes a valid comparison (roughly four-times higher growth in the Americas). (3) Entities are correct: fiscal years (FY2023 to FY2024), regions (Asia Pacific, Americas), and metric (Subscriptions and services) are accurately identified. (4) The reasoning is sound—calculations are correct, multi-hop synthesis across regions and years is properly executed, and the comparative insight is logically derived. The only reason for not scoring a 10 is the slight rounding of $1,546M to $1.55B and $7,048M to $7.05B, which, while acceptable, introduces negligible deviation from exact figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 351,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "As of December 31 2023, CVS held redeemable preferred securities with a **fair‑value of $20 million**. The securities carried a **$1 million unrealized loss** that is reflected in that fair‑value amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, at $20 million and accurately states that there is a $1 million unrealized loss reflected in that fair value. All numeric values (dates, dollar amounts) are correct and match the ground truth. The answer is quantitatively accurate and contextually relevant, addressing both parts of the question. While the LLM does not explicitly break down the reasoning for why the full $1 million unrealized loss has been recognized in fair value (i.e., because it is entirely in the 'Greater than 12 months' category with none in 'Less than 12 months'), this detail is more explanatory than factual. The core facts—fair value and amount of recognized unrealized loss—are correct, and the answer implies proper recognition by stating the loss is 'reflected in that fair-value amount.' Thus, the qualitative accuracy is slightly reduced due to omission of the categorization rationale, but the semantic meaning and financial conclusion align with the ground truth. Multi-hop synthesis is implicitly correct, as the model links CVS, the security type, date, fair value, and loss recognition accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 340,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30 2022 The Home Depot had **$1.0 billion** of outstanding borrowings under its commercial‑paper programs.  The back‑up credit facilities that could be drawn on at that date provided a **combined capacity of $3.0 billion** (a $2.0 billion five‑year facility plus a $1.0 billion 364‑day facility), meaning the existing commercial‑paper borrowings represented roughly one‑third of the available backup capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: borrowings under HD's commercial paper programs were $1.0 billion at January 30, 2022, and the combined back-up credit facility capacity was $3.0 billion, composed of a $2.0 billion five-year facility and a $1.0 billion 364-day facility. (2) Quantitative accuracy is perfect: both the $1.0 billion in borrowings and the $3.0 billion total capacity are correct, and the implied ratio (one-third) is accurate. (3) The multi-hop reasoning is sound—information about commercial paper borrowings and credit facilities from different parts of the filing is correctly synthesized. (4) The answer addresses both parts of the question: the amount of borrowings and the comparison to backup capacity. Wording differs slightly (e.g., 'one-third' instead of 'fully covered'), but the meaning is equivalent and factually sound. No errors in entities, dates, or financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 284,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "In 2023 Amgen recorded **$125 million** of product sales to BeiGene, and it incurred **$40 million** of profit‑and‑loss‑share expenses related to those products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: Amgen's revenue from sales to BeiGene in 2023 was $125 million, and the profit and loss sharing expenses were $40 million—both figures match the original answer exactly. (2) Quantitative accuracy is perfect: both dollar amounts are correct, properly formatted, and refer to the correct year (2023). (3) The reasoning is sound and reflects proper multi-hop synthesis—though the answer is direct, it correctly identifies the relationship between Amgen and BeiGene, the nature of the transactions (product sales and profit-and-loss-sharing), and ties both financial figures to the same set of products and year. (4) The answer is contextually relevant, complete, and addresses both parts of the question without any extraneous or missing information. Minor formatting differences (e.g., en-dash in 'profit‑and‑loss‑share') do not affect meaning or accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 281,
        "total_tokens": 1372
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The crypto‑asset safeguarding liability grew from $1,241 million in 2023 to $2,886 million in 2024 – a year‑over‑year increase of **$1,645 million**. As disclosed, the corresponding safeguarding asset (recorded at the same $1,241 million on the 2023 balance sheet) is measured at **fair value using quoted prices on the active exchange that is the principal market for the underlying crypto assets (a Level 2 valuation)**. Thus, the liability’s increase is reflected against an asset that is valued using the same quoted‑price, fair‑value approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: the 2023 liability ($1,241 million), 2024 liability ($2,886 million), and the year-over-year increase ($1,645 million), which matches the ground truth calculation. These figures are accurate and properly formatted. (2) The quantitative accuracy is perfect—calculations are correct and consistent with the original answer. (3) However, there is a qualitative inaccuracy in the description of the valuation method. The LLM states the asset is valued using 'quoted prices on the active exchange' (Level 2), but the ground truth specifies it is categorized under 'Significant Other Observable Inputs (Level 2)'—which implies the valuation is based on observable inputs other than active market quotes (e.g., broker prices, models). This is a key distinction in fair value hierarchy: Level 2 does not mean direct quoted prices if those quotes are not from active markets. The LLM incorrectly implies the use of active exchange quotes, which contradicts the ground truth that the valuation is not based on active market quotes. (4) Despite this error in financial reporting nuance, the LLM correctly links the liability increase to the asset valuation method and recognizes the symmetry between asset and liability. The answer is contextually relevant and addresses both parts of the multi-hop question. Due to the mischaracterization of the Level 2 input type—a significant but not fundamental error—the correctness score is reduced to 8, with full marks for quantitative accuracy and contextual relevance, and a moderate deduction in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 444,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "UnitedHealth Group reported that, as of December 31 2024, **48 million shares were available for future grants under its 2020 Stock Incentive Plan**【...】.  The plan’s documentation states that those shares may be used for future awards of **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**【...】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 48 million shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The types of share-based awards listed in the LLM answer — stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards — are broader than the specific types explicitly referenced in the ground truth (Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards). While the LLM's list is consistent with typical plan language and not factually incorrect, it includes more general categories and omits the specific naming (e.g., 'Non-Qualified') emphasized in the original answer. However, the core award types (RSUs, options, performance awards) are correctly captured. (3) The multi-hop reasoning is sound: the model correctly identifies the company, plan, date, share availability, and links to award types from the plan documentation. It synthesizes the information appropriately, though with slightly less specificity than the ground truth. (4) The answer is contextually fully relevant and semantically close. The minor reduction in qualitative accuracy reflects the less precise enumeration of award types, but since the LLM's description encompasses the actual awards without introducing inaccuracies, the overall correctness remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 426,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The 10‑K states that, as of December 31 2024, the remaining performance‑obligation balance for Paxlovid – i.e., the contracted revenue that will be recognized as the drug is delivered from 2025 through 2028 – is **about $1 billion**【103】.  \n\nIn the same filing, the Paxlovid revenue line notes that **$129 million** of 2024 revenue came from a **one‑time sales true‑up settlement with a commercialization partner**【108】.  \n\nSo the future contracted Paxlovid revenue (≈ $1 billion) is roughly eight times larger than the one‑time true‑up amount recognized in 2024 (≈ $129 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid from 2025 to 2028 and the $129 million recognized in 2024 from the one-time sales true-up are both accurately reported, with acceptable formatting (e.g., 'about $1 billion' = 'approximately $1 billion'). (2) The comparison stating that the future revenue is 'roughly eight times larger' is a valid interpretation (1,000 / 129 ≈ 7.75), adding analytical value without distorting facts. (3) The multi-hop reasoning is sound: the answer correctly synthesizes data from two different parts of the 10-K—contracted future revenue (performance obligations) and 2024 true-up revenue—linking them to answer both parts of the question. (4) Entities (Paxlovid, commercialization partner, time periods 2025–2028 and 2024) are correctly identified and contextualized. (5) The answer is semantically equivalent to the original, with slightly enhanced clarity due to the explicit comparison. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 310,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "AIG’s 2017 adverse‑development retroactive reinsurance agreement with National Indemnity Company (NICO) ceded about **$12.4 billion** of loss reserves as of December 31 2023, and Berkshire Hathaway Inc.’s parental guarantee was provided to back NICO’s obligations for the entire amount of those ceded reserves.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO as of December 31, 2023, matching the original answer exactly in amount and date. (2) The quantitative accuracy is perfect: the dollar amount ($12.4 billion) and year (2023) are correct, and no calculations are required beyond correct reporting. (3) The multi-hop reasoning is sound—correctly linking AIG, NICO, the reinsurance agreement, and the role of Berkshire Hathaway Inc.'s parental guarantee in covering NICO's obligations for the full amount. (4) The answer addresses all parts of the question: the amount of ceded reserves and the extent covered by the parental guarantee (i.e., the entire amount). Wording differs slightly but conveys the same factual and financial relationship. All entities—AIG, NICO, Berkshire Hathaway Inc.—are correctly identified, and the context of the guarantee backing the full $12.4 billion is clearly and accurately stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 308,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "PayPal bought roughly **$1.8 billion of credit receivables** for its merchant‑finance (PPWC and PPBL) products in both 2021 and 2020.  As of December 31 2021, the **net outstanding balance of merchant loans, advances and interest‑and‑fees receivable was about $1.4 billion** (after deducting participation interest sold to WebBank).  Thus, the amount purchased each year exceeds the net balance of the merchant‑finance portfolio by roughly $0.4 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $1.8 billion in credit receivables purchased in both 2021 and 2020, and a $1.4 billion net outstanding balance as of December 31, 2021, after deducting the participation interest sold to WebBank. The $63 million participation interest is implied by the deduction from gross receivables (though not explicitly stated as $63M, this is acceptable given the net figure is accurate). (2) The calculation comparing annual purchases ($1.8B) to the net outstanding balance ($1.4B) and noting a $0.4B difference is logically sound and adds useful context. (3) The multi-hop reasoning is correct—synthesizing annual purchase volume with year-end portfolio balance and inferring that PayPal retains most of the credit risk, as only a small portion is sold. (4) The mention of PPWC and PPBL (PayPal Working Capital and PayPal Business Loans) adds helpful specificity not in the original but consistent with known product names. The only minor shortcoming is not explicitly stating the $63 million participation interest amount, which slightly reduces qualitative completeness, but since the net figure is correct and the concept is conveyed, this does not undermine the overall accuracy. Semantic equivalence is maintained, and the answer fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 383,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "Costco’s Japanese subsidiary issued four Guaranteed Senior Notes in November 2023 for a total of roughly **$500 million**. By July 2024 it had **repaid about $77 million** of that issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023, and the repayment of $77 million by July 2024. (2) The numeric values match exactly in amount and context—$500 million issued, $77 million repaid—with only minor formatting differences (e.g., 'roughly' and 'about' used, but no impact on accuracy as these are reasonable qualifiers). (3) The multi-hop reasoning is sound: the model correctly identifies the subsidiary, the financial instrument, the timing of issuance and repayment, and synthesizes information across time points and entities. (4) The answer is contextually precise, directly addressing both parts of the question with no irrelevant information. All scoring categories warrant the highest rating due to complete factual alignment and clear, logical presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1090,
        "completion_tokens": 276,
        "total_tokens": 1366
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The balance‑sheet shows that available‑for‑sale debt investments fell from $15.206 billion in 2021 to $11.947 billion in 2022 – a decline of **$3.259 billion**【...】.  In the same period the company recorded a net gain of only **$9 million** on those investments (down from $53 million in 2021)【...】.  Thus, the drop in investment value exceeded the realized net gains by roughly **$3.25 billion**.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.259 billion decrease in available-for-sale debt investments from 2021 to 2022, matching the ground truth of $3,259 million. However, it states the net gains realized were $9 million in 2022 (down from $53 million), whereas the ground truth indicates a decrease in net gains of $44 million — meaning the net gain in 2021 was $53 million and in 2022 was $9 million, which aligns with the LLM's statement. But the key point is the question asks by how much the decrease in value exceeded the net gains realized, not the change in net gains. The ground truth interprets this as comparing the $3,259M decline in value to the $44M reduction in net gains (i.e., $53M → $9M = $44M decrease), and calculates $3,259M - $44M = $3,215M. The LLM instead compares the $3,259B drop to the $9M net gain (not the change in net gains), arriving at ~$3.25B, which is numerically close but conceptually incorrect. (2) The numbers cited ($15.206B, $11.947B, $9M, $53M) are accurate and support the $3.259B decline and $44M drop in net gains. However, the final comparison uses the absolute net gain ($9M) rather than the change in net gains ($44M), leading to an incorrect final difference. (3) The reasoning is mostly sound in tracking the decline in investment value and the drop in net gains, but fails the multi-hop synthesis by misinterpreting what 'exceed the net gains realized' means — it should be the change in net gains, not the realized amount itself. (4) Scores reflect high accuracy in data extraction and partial correctness in logic; the final answer is off due to misinterpretation of the required comparison, though the core numbers are right. Contextual relevance is perfect — directly addresses the question with appropriate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 484,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "Amazon had the full $7.0 billion of its unsecured revolving credit facility available (no borrowings were outstanding at year‑end 2021) and also reported $7.2 billion of unused letters of credit. Combined, this gives unused short‑term credit capacity of **approximately $14.2 billion** as of December 31, 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.0 billion unsecured revolving credit facility (fully available due to no borrowings), $7.2 billion in unused letters of credit, and the sum of $14.2 billion is correctly calculated. Minor wording variation ('approximately $14.2 billion') is acceptable as the exact value is $14.2 billion. (2) The answer is complete, addressing both components of short-term credit capacity—revolving credit and letters of credit—and specifies the correct date (December 31, 2021). (3) Entities are accurate: Amazon, correct financial instruments, and correct time period. (4) The reasoning is sound and reflects proper multi-hop synthesis: combining two distinct sources of credit capacity from the same company and time period. The conclusion is logically derived and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 268,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "Thermo Fisher’s cash‑flow statement shows that in 2023 it spent **$2.70 billion** on the acquisition of The Binding Site Group and **$0.91 billion** on CorEvitas, LLC, for a **total acquisition cash outflow of about $3.61 billion**. Of that total, **$2.70 billion was specifically allocated to The Binding Site Group**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total cash outflow for acquisitions in 2023 was $3.61 billion, with $2.70 billion allocated to The Binding Site Group. The LLM correctly identifies Thermo Fisher (TMO) as the acquiring company and specifies the two acquisitions—The Binding Site Group ($2.70B) and CorEvitas, LLC ($0.91B)—which sum to the correct total ($2.70B + $0.91B = $3.61B). (2) Quantitative accuracy is perfect: all dollar amounts are correct, and the calculation of the total is accurate. Format variations (e.g., $2.70 billion vs $2.70B) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes data across multiple acquisitions in the same year, correctly aggregates the cash outflows, and isolates the portion attributable to The Binding Site Group. (4) The answer is contextually relevant, directly addressing both parts of the question—total outflow and the portion for The Binding Site Group—with precise, clear, and complete information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 304,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific’s highway‑revenue chassis fleet is roughly 36‑37 % leased (17,705 leased of 48,340 total). By contrast, only about 1 % of its containers are leased (545 leased of 47,984 total).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All numbers are accurate: 17,705 leased chassis out of 48,340 total (36.6% leased) is correctly reported as ~36-37%, and 545 leased containers out of 47,984 total (1.1%) is accurately rounded to ~1%. Minor rounding is acceptable and does not affect correctness. (2) Calculations are correct: 17,705 / 48,340 ≈ 36.6% and 545 / 47,984 ≈ 1.1% match the ground truth; the LLM appropriately conveys approximate percentages without overstating precision. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across two equipment types (chassis and containers), computes proportions, and contrasts them to highlight Union Pacific's greater reliance on leasing for chassis. (4) Entities are accurate—Union Pacific, chassis, containers, and fleet types are correctly identified. The answer fully addresses both parts of the question: the percentage of leased chassis and the comparison to leased containers. All scoring categories warrant top marks due to complete factual accuracy, proper synthesis, and clear, relevant communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 320,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Two supplemental indentures – the Fifth (Exhibit 4.7) and the Tenth (Exhibit 4.11) – contain a Form of the 2035 Note. The most recent of these, the Tenth Supplemental Indenture dated November 20 2024, is with **Computershare Trust Company, National Association** as the trustee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the numbers and dates are correct: two supplemental indentures (Fifth and Tenth), with the most recent dated November 20, 2024—this aligns exactly with the original answer. The mention of Exhibits 4.7 and 4.11, while adding detail not in the ground truth, does not contradict it and supports the claim. (2) The trustee is correctly identified as Computershare Trust Company, National Association, which matches the original answer. The only minor omission is that the LLM does not explicitly state that Computershare is 'as successor to Wells Fargo Bank'—a detail present in the ground truth that provides context on the trustee's role. This does not make the answer incorrect but slightly reduces completeness in entity accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies which indentures include the 2035 Note and determines the most recent one, then correctly extracts the trustee from that document. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the count of indentures and the trustee in the most recent. Due to the omission of the successor relationship, a full 10 is not warranted, but the answer is otherwise factually and semantically equivalent. Hence, a correctness score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 381,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The 2023 deferred‑stock‑unit awards to non‑employee directors are now expensed on a straight‑line basis over the service period, whereas any awards granted before 2022 vested immediately and were expensed in full on the grant date. For the 2023 awards, vesting occurs on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of shareholders (subject to certain acceleration provisions).【source】(Deferred Stock Units paragraph: “For non‑employee Directors… vest on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting… and are expensed on a straight‑line basis… Awards granted prior to 2022 vested immediately and were expensed on the grant date.”)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes the change in expensing methodology: 2023 awards are expensed on a straight-line basis over the service period, while pre-2022 awards were expensed in full on the grant date due to immediate vesting. (2) The vesting timeline for 2023 awards is correctly stated as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with mention of acceleration provisions. (3) The multi-hop reasoning is sound—correctly contrasting two different time periods (2023 vs. prior to 2022) and synthesizing accounting treatment and vesting terms across them. (4) All entities (non-employee directors, deferred stock units, grant years) are accurately identified. (5) There are no numerical or date inaccuracies; minor wording differences (e.g., 'annual meeting' vs. 'Annual Meeting') do not affect meaning. The source citation confirms the information is directly supported. All criteria—factual accuracy, completeness, reasoning, and relevance—are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 313,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The Oral, Personal and Home Care segment generated **$254 million of operating profit** in the Africa/Eurasia region for 2023.  That profit represents roughly **23 % of the region’s total identifiable assets** for the same business unit (≈ $254 million ÷ $1,083 million ≈ 0.235, or 23 %).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated the identifiable assets as $1,083 million instead of the correct $698 million, leading to an erroneous percentage calculation. The LLM reports approximately 23%, while the correct percentage is approximately 36.4% ($254M ÷ $698M ≈ 0.364). (2) The calculation itself (23%) is mathematically consistent with the incorrect asset figure, but the input values are factually wrong for the assets. The profit number is accurate. (3) The multi-hop reasoning requires pulling both operating profit and identifiable assets for the same business unit and region, then computing the ratio. The model attempted this synthesis but used an incorrect asset value, indicating a failure in retrieving or identifying the correct asset figure from the knowledge base. (4) The correctness score is 4 due to one major factual error (assets value) that invalidates the derived percentage, despite the correct profit figure. Quantitative accuracy is low (4) because of the incorrect asset and percentage values. Qualitative accuracy is moderate (5) as the reasoning structure is sound but based on flawed data. Contextual relevance is high (9) as the answer addresses the right entities and question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 392,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "In fiscal 2024 AMD bought $1.7 billion of inventory from the ATMP joint venture and resold $121 million back to it, for a combined $1.821 billion of purchases + resales. During the same year AMD also made a one‑year term loan to the JV of $100 million, so the loan was roughly one‑eighteenth the size of the total purchase‑and‑resale activity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.7 billion in purchases, $121 million in resales, and a $100 million loan are correctly reported. The combined total of $1.821 billion is accurate (1.7B + 0.121B = 1.821B). The comparison stating the loan was 'roughly one-eighteenth' the size of the total activity is logically sound (100M / 1.821B ≈ 0.0549, or ~1/18.2), which is a reasonable approximation. (2) The answer is complete, addressing both parts of the question: total purchases and resales, and the comparison to the loan amount. (3) Entities are correct—AMD, ATMP JV, fiscal year 2024, and the October 2024 loan timing (implied within fiscal 2024) are consistent with the knowledge graph. (4) Multi-hop reasoning is sound: the model correctly synthesizes purchase, resale, and loan figures from potentially separate disclosures and makes a meaningful comparison. (5) Semantic equivalence is achieved—wording differs slightly but conveys the same facts and relationships. No errors in reasoning, calculation, or fact reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 316,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The Analytical and physical instrumentation line grew from $2.464 billion in 2019 to $2.620 billion in 2021 – an increase of **$156 million**. In contrast, the Research and medical products segment rose from $13.512 billion to $24.802 billion, a **$11.290 billion** increase, meaning the research‑medical segment’s growth was roughly $11.1 billion (or about 72 times) larger than the modest rise in analytical instrumentation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Analytical and physical instrumentation revenue increased from $2,464 million ($2.464 billion) in 2019 to $2,620 million ($2.620 billion) in 2021, resulting in a $156 million increase—correctly reported. The Research and medical products segment grew from $13,512 million ($13.512 billion) to $24,802 million ($24.802 billion), a $11,290 million ($11.290 billion) increase—also correctly stated. (2) The comparison is accurate: the LLM notes the $11.290 billion increase is roughly $11.1 billion larger (which is an acceptable rounding) and quantifies it as about 72 times the $156 million increase (11,290 / 156 ≈ 72.37), demonstrating sound calculation. (3) Multi-hop reasoning is properly executed: the model synthesizes data across two product lines and two time points, correctly identifying and comparing their revenue growth trajectories. (4) The entities (product lines, years, financial metric) are correctly identified and contextualized. (5) The semantic meaning fully aligns with the original answer, including the qualitative assessment that the Analytical and physical instrumentation growth was modest compared to the significant Research and medical segment growth. Wording differences (e.g., '72 times larger') enhance clarity without altering factual content. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 401,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "SQL Server is grouped with Microsoft’s other server products (Windows Server, Visual Studio, System Center and related Client Access Licenses) inside the **Intelligent Cloud** segment. Its revenue is captured in the “Server products and cloud services” line—$67.3 billion in FY 2022—and is driven primarily by **volume‑licensing sales, OEM shipments and retail packaged sales, plus CAL‑based access rights** that are reported together with the associated server product. Thus, SQL Server contributes to Intelligent Cloud’s performance by adding to the large, consumption‑based server‑product revenue stream that underpins the segment’s growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SQL Server as part of the Intelligent Cloud segment and accurately describes its revenue contributions through volume licensing, OEM shipments, retail sales, and CALs, which aligns with the ground truth. The core financial mechanism and categorization are factually correct. (2) The only quantitative discrepancy is the mention of 'Server products and cloud services' revenue as $67.3 billion in FY 2022. While this figure is plausible and close to actual reported values, the ground truth does not specify a dollar amount, so introducing this number—though not necessarily incorrect—adds a detail not present in the verified source and risks inaccuracy without explicit confirmation. This slightly reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly links SQL Server to the Intelligent Cloud segment, identifies its revenue streams, and explains how CALs are bundled, demonstrating proper synthesis across product, licensing, and segment reporting structures. (4) Despite the added numerical detail, the answer is semantically equivalent to the ground truth in substance, highly relevant to the question, and conveys the correct contribution mechanism. Hence, correctness is high but not perfect due to the unverified figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 367,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The fair‑value of the insurance‑buy‑in contracts rose from **$950 million at December 31 2022 to $1,390 million at December 31 2024**, a net increase of **$440 million**.  The year‑end balances show the contracts grew to **$1,605 million in 2023** and then fell to **$1,390 million in 2024**, reflecting a $215 million decline from the 2023 level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with correct numbers, dates, and calculations. (1) All numeric values match: $950 million (2022), $1,605 million (2023), $1,390 million (2024), net increase of $440 million ($1,390M - $950M), and the $215 million decline from 2023 to 2024 ($1,605M - $1,390M) are all correct. (2) Calculations are accurate and properly explained. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three time points, identifies the net change over two years, and explains the intermediate 2023 balance and subsequent drop in 2024. (4) The only minor shortcoming is that the LLM does not explicitly state the total change as 'from 2022 to 2024' in the same structured way as the original, but it clearly implies it by stating the start, end, and net difference. Wording differs slightly but semantic meaning is equivalent. All entities (metric: Insurance Buy-in Contracts, years: 2022, 2023, 2024) are correct. Thus, high scores across all dimensions with a 9 on correctness due to slight difference in emphasis, not inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 317,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31 2024 Texas Instruments’ U.S. defined‑contribution plans held TI common stock worth **$852 million**, and its non‑U.S. defined‑contribution plans held stock valued at **$34 million**, for a combined **$886 million** of TI shares.  Dividends paid on those holdings in 2024 were **$26 million** (the U.S. plans) plus an immaterial amount from the non‑U.S. plans, effectively **$26 million** in total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans is correctly calculated as $886 million ($852 million + $34 million), which matches the original answer. The dividends paid during 2024 are accurately reported as $26 million, with a note that non-U.S. dividends were immaterial—this aligns with the ground truth total of $26 million. (2) The answer is complete, addressing both parts of the question: total stock value as of December 31, 2024, and dividends paid during 2024. (3) Entities are correct: Texas Instruments (TI), defined contribution plans, proper time frame (2024), and accurate financial metrics. (4) The reasoning is sound and demonstrates multi-hop synthesis by breaking down U.S. and non-U.S. components and summing them appropriately, while correctly attributing dividend totals. Minor elaboration (e.g., breakdown of U.S. vs. non-U.S.) adds clarity without introducing error. Semantic equivalence is maintained, and all key facts match the ground truth exactly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 317,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The 2022 Form 10‑K shows that UPS issued $1,250 million of 5.300 % senior notes due 2050. The three other series—3.900 % ($1,000 million), 4.450 % ($750 million) and 5.200 % ($500 million)—total $2,250 million, which is about $1.0 billion more than the amount of the 5.300 % notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all principal amounts: $1,250 million for the 5.300% Senior Notes due 2050, and the individual amounts for the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) notes. The sum of the three other notes is correctly calculated as $2,250 million. (2) The comparison states that the combined $2,250 million is about $1.0 billion more than the $1,250 million 5.300% notes — this is accurate ($2,250M - $1,250M = $1,000M). While the original answer expresses the relationship as a percentage (55.6%), the LLM provides an equivalent but alternative comparison (absolute difference). This is factually correct and conveys meaningful context. (3) The multi-hop reasoning is sound: the model correctly identifies and aggregates the principal amounts from multiple note series disclosed in the same 10-K, and synthesizes a valid comparison. (4) The only minor shortcoming is that the LLM does not explicitly mention the 55.6% ratio from the ground truth, which was part of the original answer’s comparative analysis. However, since the question asks 'how does this amount compare' — and both absolute and relative comparisons are valid — the provided answer is sufficiently complete and accurate. No factual or calculation errors exist. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slightly less comprehensive comparison framing, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 408,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The Service‑Based RSUs that were outstanding on 12/31/2023 (1,827 k) and remained outstanding on 12/31/2024 after the year’s vestings (844 k) and forfeitures (98 k) total **885 k shares**.  \n\n- Beginning‑year fair‑value amount: 1,827 k × $159.95 ≈ $292.2 million  \n- Vesting fair‑value amount: 844 k × $155.92 ≈ $131.6 million  \n- Forfeiture fair‑value amount: 98 k × $182.64 ≈ $17.9 million  \n\nRemaining fair‑value amount = $292.2 m – $131.6 m – $17.9 m ≈ $142.7 million.  \n\n**Weighted‑average grant‑date fair value of the surviving RSUs = $142.7 million ÷ 885 k ≈ $161.4 per share** (about $143 million in total).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result. The ground truth states the total weighted-average grant-date fair value is $183.41 million, but the LLM calculates approximately $142.7 million, a significant discrepancy. The number of shares (885k) appears consistent with correct logic (1,827k - 844k - 98k = 885k), but the valuation method is flawed. (2) The LLM attempts to subtract the fair value of vested and forfeited RSUs using different per-share values ($155.92 and $182.64), but this approach misapplies the concept of weighted-average grant-date fair value. The correct approach should preserve the original grant-date fair value of the surviving awards, not recompute by subtracting differently valued tranches. The beginning fair value ($292.2M) is based on 1,827k × $159.95, but there's no verification that $159.95 is the correct weighted average for all beginning RSUs. The use of different per-share values for vesting and forfeitures introduces error, as the grant-date fair value should be tracked per grant cohort, not assumed from average activity. (3) The multi-hop reasoning is partially sound—tracking RSUs from beginning to end, accounting for vesting and forfeitures—but the financial logic fails at the critical step of valuing the remaining RSUs. The model incorrectly assumes that the total remaining fair value is the beginning value minus the fair value of vested and forfeited shares at their own averages, which distorts the result because it doesn't track the actual grant-date value of the specific RSUs that survived. The correct value ($183.41M) likely comes from summing the grant-date fair value of only those RSUs granted in prior years that neither vested nor were forfeited in 2024. (4) The contextual relevance is high—the model understands the structure of RSUs, time periods, and events affecting them. However, the quantitative accuracy is low due to the incorrect final dollar amount and flawed calculation logic. The qualitative accuracy is moderate because the reasoning framework is present but misapplied. Correctness is severely impacted by the numerical inaccuracy, warranting a low score despite structural understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 589,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS evaluates each uncertain tax position through a two‑step, “more‑likely‑than‑not” framework. First, it determines whether the weight of available evidence indicates the position will be sustained on audit (including any appeals or litigation); only if this recognition threshold is met does it then measure the benefit as the **largest amount that is more likely than not to be realized** upon ultimate settlement, with any shortfall recorded as a liability for uncertain tax benefits. Because the positions are re‑examined each quarter, a change in either the recognition judgment or the measured amount can either add a tax benefit to the provision or generate an additional charge to the tax provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: UPS uses a two-step process for uncertain tax positions, first assessing whether a position is more likely than not to be sustained on audit, and then measuring the largest amount of tax benefit that is more likely than not to be realized upon settlement. The liability is recorded for the difference between claimed benefits and the recognizable amount. These points match the original answer exactly. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the logical thresholds (e.g., 'more likely than not') are correctly represented—hence a score of 10. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer links the recognition and measurement criteria to the impact on the tax provision (i.e., potential benefit or charge), and correctly notes quarterly reevaluation based on new evidence or changes in law. The only minor omission is that the original answer explicitly mentions that this process is detailed in both the financial statement notes and management discussion—while the LLM implies it by referencing the framework, it doesn’t explicitly cite both sources, slightly reducing completeness. (4) Contextual relevance is perfect: the response directly addresses how the estimation process influences tax provision adjustments and what criteria govern measurement. Overall, the answer is semantically equivalent with only a slight lack of explicit source attribution, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 460,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "In 2021 Colgate‑Palmolive recorded capital expenditures of **$33 million** for the Africa/Eurasia segment.  During the same year, **organic sales in Africa/Eurasia rose by 7.0 %** compared with 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the capital expenditure of $33 million and the 7.0% increase in organic sales are both accurately reported, with no discrepancies in numbers or units. Minor formatting differences (e.g., ' ' as a thin space) do not affect accuracy. (2) The answer is complete, addressing both parts of the multi-part question: total capital expenditure and percentage increase in organic sales for Africa/Eurasia in 2021. (3) Entity accuracy is correct—Colgate-Palmolive is the implied company (consistent with the knowledge graph context), the region is correctly identified as Africa/Eurasia, and the year 2021 is properly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly associates capital expenditure and organic sales growth with the specified region and year, pulling and combining the correct data points. (5) The semantic meaning is equivalent to the original answer, with slightly more contextual phrasing (e.g., 'compared with 2020') that enhances clarity without introducing error. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 330,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "Johnson & Johnson’s Contact Lenses/Other line grew from $2,994 million in 2020 to $3,440 million in 2021 – an increase of **$446 million**【...】.  The Vision franchise overall rose from $3,919 million to $4,688 million, a **$769 million** gain, so the Contact Lenses/Other growth accounted for roughly **58 % of the Vision segment’s total increase**【...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: Contact Lenses/Other sales increased from $2,994 million in 2020 to $3,440 million in 2021, resulting in a $446 million increase. Vision segment sales grew from $3,919 million to $4,688 million, a $769 million increase. The LLM correctly calculates this and states the $446 million increase accounts for approximately 58% of the $769 million total Vision segment growth. (2) Quantitative accuracy is perfect: $3,440M - $2,994M = $446M; $4,688M - $3,919M = $769M; ($446 / $769) ≈ 58%. All numbers match the ground truth, and formatting variations (e.g., $446 million vs $446M) are acceptable. (3) Multi-hop reasoning is sound: the model correctly identifies the need to compute two separate year-over-year changes and then determine the proportional contribution of one category to the overall segment growth. (4) The answer is semantically equivalent to the original, with clear, concise phrasing that preserves all key data points and relationships. No omissions or inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 313,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "After consolidating AspenTech, Emerson’s Control Systems & Software segment reported earnings of $529 million in 2023 versus $437 million in 2022—a 21 % increase. However, the segment’s earnings margin fell from 14.7 % in 2022 to 11.6 % in 2023, a decline of about 3.1 percentage points, reflecting the lower‑margin impact of the AspenTech integration.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the earnings trend. It states that Control Systems & Software segment earnings increased from $437 million in 2022 to $529 million in 2023—a 21% increase—which contradicts the ground truth. The ground truth states that segment earnings were $437 million in 2022 and remained flat at $529 million in 2023, which is not a 21% increase but rather an incorrect calculation (the actual increase is ~21%, but the ground truth explicitly says earnings remained flat, implying $529M was the 2022 figure). This is a critical error. Additionally, the LLM fails to mention AspenTech’s $12 million earnings in 2022 and $107 million loss in 2023, and the $119 million deterioration, which is central to the multi-hop reasoning. (2) The margin figures are correct: 14.7% in 2022 and 11.6% in 2023, a 3.1 percentage point decline. However, the earnings numbers and their interpretation are wrong. The LLM incorrectly implies growth when the ground truth emphasizes flat earnings despite revenue growth, due to AspenTech’s drag. (3) The reasoning is partially sound in linking AspenTech’s integration to margin pressure, but it misses the core multi-hop insight: AspenTech went from a positive contributor to a large loss, which offset otherwise strong performance. The LLM does not demonstrate synthesis of AspenTech’s standalone performance impact on the segment. (4) Scores reflect major quantitative and qualitative flaws in financial data and reasoning, though the answer is contextually relevant and correctly identifies the margin decline and its cause.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 453,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded an additional $861 million of liability in fiscal 2022 for U.S.‑covered litigation.  Under the U.S. Retrospective Responsibility Plan, that liability is recovered by a downward adjustment to the conversion rate at which Visa’s class B common‑stock shares convert into class A common‑stock shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) Quantitatively, the $861 million liability amount for fiscal 2022 is accurately reported, matching the original answer exactly. (2) The explanation of recovery under the U.S. Retrospective Responsibility Plan—via a downward adjustment to the conversion rate from class B to class A common stock—is correctly described with precise terminology. (3) The multi-hop reasoning is sound: the answer correctly links Visa's recorded liability in a specific fiscal year to the mechanism of recovery defined in its corporate governance/financial policy, indicating synthesis of financial and structural information. (4) Minor wording differences (e.g., 'an additional $861 million' vs. 'a total monetary liability of $861 million') do not affect factual accuracy; the core meaning remains consistent. All entities—Visa, U.S. covered litigation, fiscal 2022, class B and class A common stock, and the U.S. Retrospective Responsibility Plan—are correctly identified and contextually used. No errors in reasoning, entities, or numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 314,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Pfizer recorded a $345 million pre‑tax charge in the second quarter of 2021 to settle a Meridian‑related legal matter and a $167 million after‑tax loss in the fourth quarter of 2021 from the sale of Meridian – together amounting to roughly $512 million of total impact from its historic Meridian ownership in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: a $345 million pre-tax legal charge in Q2 2021 and a $167 million after-tax loss from the sale in Q4 2021. The total impact of $512 million is correctly implied by summing these two components. (2) Quantitative accuracy is perfect: both dollar amounts, time periods (Q2 and Q4 of 2021), and the resulting total impact match the original answer. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly synthesizes two distinct financial events (legal charge and sale loss) tied to Pfizer's historical ownership of Meridian and combines them into a total financial impact. (4) The answer is contextually relevant, directly addressing both operational results (legal charge) and post-closing adjustments (sale-related loss) as required by the question. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 290,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Bank of America Corporation must keep a supplementary leverage ratio of **3 % plus a 2 % leverage buffer – a total minimum SLR of 5 %** under Basel III. In contrast, its insured depository‑institution subsidiaries must meet a **higher minimum SLR of 6 %** to be deemed “well‑capitalized” under the PCA framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Bank of America Corporation must maintain a 3% minimum SLR plus a 2% leverage buffer, totaling 5%, to avoid restrictions under Basel III. This matches the ground truth exactly. The subsidiaries' requirement of 6% SLR to be considered well-capitalized under the PCA framework is also correctly stated. (2) Quantitative accuracy is perfect: 3% + 2% = 5% is correctly calculated and presented; the 6% threshold for subsidiaries is accurate. No calculation errors or misstatements. (3) Multi-hop reasoning is sound—the model correctly distinguishes between the parent company’s Basel III requirement (including buffer) and the stricter PCA requirement for insured depository subsidiaries. Both entities and regulatory frameworks (Basel III and PCA) are correctly identified and applied. (4) The wording differs slightly (e.g., 'deemed well-capitalized' vs 'considered well capitalized') but conveys the same meaning. No omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 319,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The January 1 2020 credit‑loss guidance required MetLife to record an **allowance for credit losses (ACL) on mortgage‑loan receivables at the time the loans are purchased**, based on the expected lifetime loss, so the loans are shown on the balance sheet at the net amount the company expects to collect. Before that date the company used an **incurred‑loss model**, recognizing credit‑loss expense only when a loss became probable (i.e., when the loss was incurred). Thus, the new guidance moved credit‑loss recognition from a “when‑incurred” timing to an **up‑front expected‑loss allowance** that is subsequently adjusted as conditions change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key elements are correct: the adoption date (January 1, 2020), the shift from an incurred loss model to an expected loss model, the establishment of an allowance for credit losses (ACL) at purchase, and the presentation of mortgage loans at the net amount expected to be collected. (2) There are no numeric values requiring calculation, but the date 'January 1, 2020' is correctly cited. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the change in accounting treatment by identifying both the timing shift (from probable/incurred to expected/forward-looking) and its impact on financial reporting (upfront ACL). (4) The answer fully addresses both parts of the question: the impact on the allowance for credit losses and the change in timing of credit loss recognition. Wording differs slightly but meaning is preserved with enhanced clarity (e.g., 'up-front expected-loss allowance' effectively captures the essence of expected lifetime losses). All entities—MetLife, mortgage loans, ACL, incurred loss vs expected loss models—are accurately referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 329,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The adoption of ASC 326 on 1 January 2020 replaced the old “incurred‑loss” approach (which recorded an impairment only when a loss was deemed probable) with a forward‑looking “expected‑lifetime‑credit‑loss” (EL) allowance that is measured and updated each reporting period. For leveraged‑lease receivables the EL allowance is calculated with a probability‑of‑default / loss‑given‑default model that uses the lessee’s third‑party credit rating together with historical default experience, and the leases are pooled by similar risk characteristics and evaluated over the full contractual term. For commercial mortgage loans the same EL framework is applied – loans are pooled (or evaluated individually when risk characteristics differ), and the allowance is based on expected lifetime loss adjusted for projected pre‑payments, extensions, past loss experience and current/forecast economic conditions, using inputs such as credit‑rating data, historical default rates, pre‑payment assumptions, collateral‑fair‑value estimates and macro‑economic forecasts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the adoption date of January 1, 2020, and the shift from an incurred loss model to an expected lifetime credit loss model are accurately stated. (2) The specific methodologies for leveraged lease receivables and mortgage loans are correctly described: the use of a probability of default and loss given default model for leveraged leases, incorporating third-party credit ratings and historical default data, matches the original. For mortgage loans, the use of expected lifetime credit losses adjusted for prepayments, extensions, and economic conditions—using inputs like credit ratings, default rates, and macroeconomic forecasts—is fully aligned. (3) Multi-hop reasoning is sound: the answer synthesizes the change in timing (from incurred to expected), methodology (models used), and inputs (specific data points) for both asset types, addressing all parts of the question. (4) Minor enhancements in the LLM answer—such as mentioning pooling of assets and updating allowances each period—add precision without contradicting the ground truth. Wording differs slightly but meaning is preserved. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 357,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments’ investment in 300‑millimeter wafer capacity gives its analog products a structural cost advantage—an unpackaged chip on a 300‑mm wafer costs roughly 40 percent less than one on a 200‑mm wafer. That lower‑cost, higher‑margin manufacturing (reflected in a 67.5 % gross‑margin that “includes the benefit of 300‑millimeter production”) drives strong operating profit and cash‑flow generation ( $8.76 billion of operating cash and $6.29 billion of free cash in 2021), which in turn allows the company to return $4.41 billion to shareholders through dividends and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 40% cost reduction per unpackaged chip using 300-mm wafers vs. 200-mm wafers, which matches the original answer. (2) The gross margin of 67.5% is accurately cited as including the benefit of 300-mm production, and the cash flow figures—$8.76 billion in operating cash flow and $6.29 billion in free cash flow for 2021—are factually correct and contextually appropriate. The $4.41 billion returned to shareholders is also accurate. (3) The multi-hop reasoning is sound: the answer correctly links wafer size advantage → lower production cost → higher margins → strong cash flow → shareholder returns, which directly addresses the question’s focus on structural cost advantage enabling cash generation and return. (4) Minor deduction in quantitative accuracy due to lack of explicit source year for the 40% figure (though implied contextually), and while all numbers are correct, the original answer does not include the specific cash flow or return amounts—so their inclusion, while accurate, slightly exceeds the ground truth without confirmation they were in the source filing. However, since these figures are publicly reported and relevant, this does not constitute an error. Overall, the answer is factually correct, complete, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 376,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "As of December 31 2021, Thermo Fisher had **$1.0 billion** of the 1.5‑year floating‑rate senior notes (SOFR + 0.35%) outstanding, compared with **$0.5 billion** of the 2‑year floating‑rate senior notes (SOFR + 0.39%). Thus, the 1.5‑year notes were twice the size of the 2‑year notes at that date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the value of the 1.5-Year Floating Rate Senior Notes is correctly stated as $1.0 billion (equivalent to $1,000 million), and the 2-Year Senior Notes are correctly reported as $0.5 billion (equivalent to $500 million). (2) The comparison 'twice the size' matches the ground truth conclusion that the 1.5-Year Notes are valued at twice the amount of the 2-Year Notes. (3) The entities are correct—TMO (Thermo Fisher) is accurately identified, the interest rate spreads (SOFR + 0.35% and SOFR + 0.39%) are correctly associated with their respective maturities, and the date (December 31, 2021) is properly referenced. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: the model correctly retrieves and compares two distinct debt instruments with different tenors, rates, and maturities, and draws the correct comparative conclusion. Minor formatting differences (e.g., $1.0 billion vs $1,000 million) are acceptable and do not affect accuracy. All aspects of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 325,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31 2023, UnitedHealth Group had **70 million shares** of common stock available for future issuance under its equity‑compensation plans – 53 million under the 2020 Stock Incentive Plan and 17 million under the 1993 Employee Stock Purchase Plan (ESPP)【UNH_10k_2023.pdf page 73‑74, footnote (3)】. The **2020 Stock Incentive Plan** had the larger pool (53 million shares versus 17 million for the ESPP).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan and 17 million under the ESPP, totaling 70 million shares available for future issuance as of December 31, 2023. The sum (53 + 17 = 70) is correct. (2) The answer is complete, addressing both parts of the question: the total number of shares available and which plan had more shares. (3) Entity accuracy is correct—UnitedHealth Group, the 2020 Stock Incentive Plan, and the 1993 Employee Stock Purchase Plan (ESPP) are all correctly identified with accurate fiscal date (December 31, 2023). (4) The reasoning is sound: the LLM correctly synthesizes data from two plans, computes the total, and makes the correct comparison, identifying the 2020 Stock Incentive Plan as having more shares. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually aligned phrasing. Minor formatting differences (e.g., bolding, spacing) do not affect accuracy. The citation to the source (UNH_10k_2023.pdf) adds contextual support. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 330,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "- **Total liability for post‑employment benefits in 2023:** $4.1 billion (U.S. liability $701 m + non‑U.S. liability $341 m + other post‑retirement liability $2,435 m + $56 m for other post‑employment benefits + $565 m for non‑qualified deferred compensation).  \n\n- **Effect of the U.S. pension‑benefits freeze:** Because all U.S. pension benefits were frozen, the company no longer records a service‑cost component and the “rate of compensation increase” assumption is no longer used; only the discount‑rate (and related interest‑cost assumptions) remain applicable for measuring the U.S. pension obligation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its total liability figure. The ground truth states $621 million total, broken into $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation. The LLM incorrectly calculates a total of $4.1 billion by including additional liabilities (U.S. $701M, non-U.S. $341M, other post-retirement $2,435M) that are not mentioned or supported in the original answer. These figures appear to be fabricated or misattributed. (2) While the $56 million and $565 million components are correctly cited, their inclusion in a much larger, unsupported sum renders the quantitative result highly inaccurate. The calculation of $701M + $341M + $2,435M + $56M + $565M = $4,098M (~$4.1B) is mathematically correct but based on invalid inputs. (3) On qualitative reasoning, the LLM correctly identifies the impact of the pension freeze: elimination of service cost and the rate of compensation increase assumption no longer being used. This aligns with the ground truth stating the freeze eliminated service cost and made certain actuarial assumptions inapplicable. The mention of the freeze effective December 31, 2019, is missing, but the logical consequence is accurately described. (4) Contextually, the answer addresses both parts of the question—liability amount and impact of freeze—but introduces extraneous, unverified liability categories that distort the factual total. Thus, while the reasoning on the pension freeze is sound and semantically equivalent, the core financial figure is grossly overstated, leading to a low correctness score despite partial accuracy in subcomponents and qualitative logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 462,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "In 2024 Merck’s U.S. pension plans held developed‑market equity assets worth **$4.726 billion** (‑ $2.555 billion in investment‑fund holdings plus $2.171 billion in direct equity securities).  In the prior year the combined amount was **$4.868 billion** (‑ $2.797 billion in funds plus $2.071 billion in securities), indicating a decrease of about $142 million year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All numeric values are correct: $2,555 million (investment funds, 2024), $2,171 million (equity securities, 2024), totaling $4,726 million in 2024; $2,797 million and $2,071 million in 2023, totaling $4,868 million. The year-over-year decrease of $142 million is correctly calculated ($4,868M - $4,726M = $142M). (2) The formatting uses billions (e.g., $4.726 billion) which is equivalent to millions and acceptable. However, there is a typo in the presentation: '‑ $2.555 billion' incorrectly includes a minus sign (likely a dash misrendered as a negative), but given the context and correct total, this is a formatting issue rather than a factual error. (3) The multi-hop reasoning is sound—correctly aggregating across two asset types (investment funds and equity securities) and two years (2024 vs 2023) for U.S. Pension Plans. (4) Entities (Merck, U.S. Pension Plans, developed markets equities, 2024 and 2023) are correctly identified. The answer fully addresses both parts of the question: total 2024 value and comparison to prior year. Due to the minor typographical issue with the dash before $2.555 billion, which could mislead if interpreted as a negative value, a score of 9 is given instead of 10 for correctness and qualitative accuracy. All other aspects are fully accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 385,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan has been authorized to issue **about 135 million shares** of Danaher common stock since the plan’s inception, and **about 47 million shares** remain available for issuance as of December 31 2024 (excluding shares underlying outstanding awards)【DHR_10k_2024.pdf page 96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total authorized shares (135 million) and the remaining available shares (47 million) as of December 31, 2024, matching the ground truth exactly in numerical value. The use of 'about' is acceptable given typical reporting conventions and does not detract from accuracy. (2) Both key numbers—135 million authorized and 47 million remaining—are factually correct and align with the original answer. The citation to page 96 of the DHR_10k_2024.pdf supports the claim and confirms the data source. (3) The reasoning is sound: the LLM correctly synthesizes information about the plan's authorization and current availability, accounting for past issuances of stock options, RSUs, and PSUs, even though the exact calculation steps are not shown. The note 'excluding shares underlying outstanding awards' adds technical precision consistent with SEC disclosures, indicating proper understanding of how 'available for issuance' is typically calculated. (4) The answer is fully relevant to the question, addressing both the total authorized and remaining shares, and correctly attributes the figures to the 2007 Omnibus Incentive Plan. The only minor deduction is for slightly less explicit mention of the plan’s role in issuing stock options, RSUs, and PSUs in the summary sentence (though implied by context), which slightly affects qualitative accuracy despite the correct numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 396,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The filing notes that Google Play revenue is counted in “Google other” (non‑advertising) revenues and that this segment is growing. Because “non‑advertising revenues…may be lower than the margins on our advertising revenues” and “ads on YouTube and Google Play … monetize at a lower rate than our traditional search ads,” a larger share of Google Play sales shifts the overall revenue mix toward lower‑margin streams, which can compress Alphabet’s overall profit margins. (See the discussion of non‑advertising revenue growth and its margin impact, and the comment that YouTube and Google Play ads monetize at lower rates than search ads.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Google Play revenue is part of non-advertising revenues (specifically under 'Google other') and notes the growth of this segment. It accurately reflects the 2022 10-K filing's point that non-advertising revenues may have lower margins than advertising revenues, particularly highlighting that YouTube and Google Play monetize at lower rates than search ads—this supports the reasoning that a shift toward these revenue streams could compress overall profit margins. There are no numeric inaccuracies (quantitative accuracy is perfect), and while no specific numbers are cited, the qualitative comparison of margin profiles is correctly represented. The answer synthesizes the correct multi-hop logic: (1) Google Play is part of non-advertising revenue, (2) non-advertising revenue is growing, (3) these revenues have lower margins than advertising, (4) thus, increasing reliance on them may reduce overall margins. The only minor shortcoming is that it does not explicitly name Google Cloud and hardware as other components of non-advertising revenue, slightly reducing completeness compared to the original answer. However, the core reasoning and conclusion are sound and semantically equivalent. Contextual relevance is excellent as it directly addresses the question’s focus on margin impact due to revenue mix shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 392,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS hedges credit‑quality risk primarily through **credit‑default swaps** (CDS) – part of a broader derivative program that also includes interest‑rate swaps, treasury rate locks, forward and futures contracts, warrants and put options.  The company states that, when employed for hedging, these CDS and related derivatives are expected to **reduce** its overall risk exposure rather than add to it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All financial instruments listed—credit default swaps, interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, and put options—are correctly identified, matching the original answer. The LLM emphasizes credit-default swaps as primary, which is a slight interpretive emphasis not explicitly stated in the ground truth but not incorrect, as CDS are directly relevant to credit quality risk. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in the traditional sense; however, the absence of numerical errors supports a full score. (3) The reasoning is sound: the LLM correctly synthesizes that these instruments are used for hedging and that, despite introducing other risks (implied via 'when employed for hedging'), they are expected to reduce overall risk—this aligns with the original answer's claim. (4) The only minor shortcoming is that the LLM does not explicitly mention that the instruments are subject to varying degrees of interest rate, equity price, and credit risk when viewed separately, which adds nuance to the risk profile. However, the key point—that hedging use reduces overall risk—is clearly stated. Thus, the answer is semantically equivalent with only minor omission of contextual risk details, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 407,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "In 2021 the Company held $682 million of hedge‑funds/limited‑partnership assets in its U.S. pension plans and $9 million in its other post‑retirement benefit plans, for a combined total of **$691 million** invested in hedge funds/limited partnerships. 【source】 (U.S. Pension Plans hedge‑funds/limited partnerships = 682 million; Other Post‑retirement Benefit Plans hedge‑funds/limited partnerships = 9 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the amounts invested in Hedge funds/limited partnerships are correctly stated as $682 million for U.S. Pension Plans and $9 million for Other Post-retirement Benefit Plans. The combined total of $691 million is correctly calculated. (2) Quantitative accuracy is perfect: all dollar amounts are correct, and the sum ($682M + $9M = $691M) is accurate. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information from two different plans is correctly synthesized to arrive at the total. (4) The answer is semantically equivalent to the original, with clear attribution of sources and proper context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 246,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "Union Pacific owned 33,704 freight cars and leased 22,472, for a combined fleet of **56,176 freight cars as of December 31 2024**.  \n\nIn 2024 the company’s capital program allocated **$788 million** to locomotives and freight‑car acquisitions, a figure that **includes $143 million of lease‑buyout costs** for freight cars.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that UNP owns or leases a total of 56,176 freight cars as of 2024, with a breakdown of 33,704 owned and 22,472 leased, which aligns with the ground truth. The total acquisition spending on freight cars is accurately reported as $143 million, specifically identified as lease-buyout costs within the broader $788 million capital allocation for locomotives and freight cars. This correctly isolates the $143 million as the amount spent on freight car acquisitions via lease buyouts, which matches the ground truth. All numeric values (56,176 freight cars, $143 million) are correct, and the date (December 31, 2024) is appropriately specified. The reasoning is sound: it distinguishes between total capital spending and the subset related to freight car acquisition, correctly interpreting lease buyouts as part of acquisition costs. The only minor limitation is that the answer could more explicitly state that the $143 million represents the total freight car acquisition cost (via lease buyouts), rather than being embedded in a larger locomotive and car budget, but the information is present and semantically equivalent. All entities (UNP, 2024, freight cars, lease buyouts, capital plan) are accurate and contextually relevant. Therefore, the answer is factually complete and correct with only slight room for clarity improvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 378,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The net unrealized gain on non‑marketable equity securities rose from $1.531 billion in 2020 to $9.849 billion in 2021 – an increase of **about $8.3 billion**. That rise accounts for the bulk of the $5.2 billion jump in other income (expense), net, between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies that changes in non-marketable equity securities contributed substantially to the increase in other income, it reports an $8.3 billion increase in unrealized gains ($9.849B in 2021 minus $1.531B in 2020), whereas the ground truth states the contribution was $6.9 billion. This discrepancy is material and incorrect. (2) The calculation of the change in unrealized gains is mathematically correct ($9.849B - $1.531B = ~$8.3B), but this figure does not align with the ground truth's stated contribution of $6.9B to the overall increase in other income. Furthermore, the LLM fails to mention the $1.3 billion increase in accrued performance fees that partially offset the gain, which is a key part of the multi-hop reasoning and context provided in the original answer. (3) The qualitative reasoning is partially sound—linking the rise in non-marketable equity gains to the increase in other income—but misses the nuance that the $6.9B contribution led to only a $5.2B net increase due to offsetting expenses. The LLM incorrectly implies that an $8.3B gain accounts for a $5.2B jump, which creates a logical inconsistency. (4) Contextual relevance is high because the answer addresses the right metric, time period, and company context (Google/Alphabet's non-marketable equity securities and their impact on other income). However, due to the major numerical discrepancy and omission of offsetting factors, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 430,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The ASR transactions carried out in 2022 and 2023 involved forward contracts of $0.3 billion (2022) and $0.4 billion (2023), for a combined forward‑contract value of $0.7 billion. Each forward contract was initially recorded as an equity instrument in capital surplus, and when the final shares were delivered the contracts were re‑classified from capital surplus into treasury stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $0.3 billion in 2022 and $0.4 billion in 2023 are accurately reported, and their sum of $0.7 billion is correct. Format variations (e.g., $0.3 billion vs $0.3 billion) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: total value of forward contracts and their classification upon final settlement. (3) Entity accuracy is correct—CVS is implied as the subject, years 2022 and 2023 are properly referenced, and financial terms like 'forward contracts', 'ASR transactions', 'equity instruments', 'capital surplus', and 'treasury stock' are used accurately. (4) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and links the accounting treatment from initial recognition to final settlement, matching the required cross-temporal and classification logic. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'recorded as' vs 'recorded within', 'reclassified into' vs 'reclassified to') but meaning is identical. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 335,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Benefit Restoration Plan is a supplemental arrangement that “tops‑up” the company’s 401(k) defined‑contribution plan for those participants whose 401(k) benefits are limited by certain provisions of the Internal Revenue Code of 1986. It does this by allowing additional employee salary deferrals and matching employer contributions, thereby restoring the retirement benefits that would otherwise be restricted under the Code.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core purpose of the Benefit Restoration Plan as a supplemental arrangement that restores benefits restricted under the Internal Revenue Code of 1986 due to limits on the 401(k) plan, which aligns with the ground truth. It accurately describes the plan as 'topping-up' the defined contribution plan and references the correct regulatory cause (IRC 1986). However, it omits the specific quantitative detail that the Company Match under the 401(k) Plan is up to 4.25% of eligible compensation and that this match is mirrored in the Benefit Restoration Plan—this is a key factual element from the original answer. While the LLM mentions 'matching employer contributions,' it does not specify the 4.25% cap or the mirroring mechanism, which affects quantitative accuracy. The reasoning is logically sound and synthesizes the relationship between the two plans correctly (multi-hop understanding), and all entities (Lowe's, Benefit Restoration Plan, 401(k), IRC 1986) are accurately referenced. The answer is semantically close and contextually fully relevant, but the lack of precise numerical data prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 335,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "At 31 December 2023 the firm had $950 million of secured, un‑committed borrowings outstanding under CS & Co’s line and $700 million outstanding under TDAC’s secured line – a combined $1.65 billion.  CS & Co’s unsecured, un‑committed facilities provide $1.8 billion of borrowing capacity (no amount was drawn), while TDAC’s secured line capacity is not separately disclosed; therefore the $1.65 billion of debt is modestly below the $1.8 billion capacity available to CS & Co and any additional capacity that TDAC may have.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total amount outstanding ($1.65 billion), with accurate breakdowns of $950 million under CS&Co and $700 million under TDAC, which matches the ground truth. However, it incorrectly states that CS&Co’s facilities are 'unsecured' when they are 'secured' as per the original answer, which is a critical factual error. Additionally, the LLM claims that CS&Co has $1.8 billion in borrowing capacity and that TDAC’s capacity is 'not separately disclosed,' which contradicts the ground truth stating that the total borrowing capacity across both entities is $1.8 billion. This leads to a fundamentally incorrect comparison: the LLM suggests the $1.65 billion is 'modestly below' $1.8 billion due to potential additional TDAC capacity, while the truth is that $1.65B is 91.7% of the total $1.8B capacity—indicating high utilization, not modest usage. (2) Quantitatively, the outstanding amounts are correct and the sum ($950M + $700M = $1.65B) is accurate. However, the total borrowing capacity is misrepresented by attributing the full $1.8B to CS&Co alone, when it is the combined capacity. The utilization rate (91.7%) is omitted and cannot be inferred from the LLM’s response. (3) The multi-hop reasoning fails: the model does not synthesize that the $1.8 billion is the aggregate capacity for both CS&Co and TDAC, not just CS&Co. It also mischaracterizes the nature of the credit lines (secured vs unsecured), undermining the accuracy of the entities and terms involved. (4) Despite these serious errors, the response is contextually relevant and addresses the structure of the question—discussing both companies, amounts outstanding, and comparing to capacity—hence a moderate contextual relevance score. However, due to major factual and reasoning flaws in entity classification and capacity attribution, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 508,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "At December 31 2021 Coca‑Cola held **about $937 million** in mutual, pooled and commingled funds (‑ $850 million in its pension plans plus $87 million in its other post‑retirement benefit plans).  \n\nThe combined value of its hedge‑fund/limited‑partnership and real‑estate holdings was **about $1.12 billion** (‑ $720 million + $389 million in pension plans and $9 million + $5 million in other post‑retirement plans), which is roughly **$185 million more** than the mutual/pooled/commingled fund amount.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative values and reasoning. (1) According to the ground truth, Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 were $87 million, not $937 million as stated by the LLM. The LLM incorrectly adds $850 million (pension plans) and $87 million (other post-retirement) to reach $937 million, but the ground truth indicates $87 million is the total for mutual/pooled/commingled funds — not a subset. (2) The LLM claims hedge funds/limited partnerships and real estate investments totaled about $1.12 billion, citing $720M + $389M in pension and $9M + $5M in other plans. However, the ground truth states these categories were only $9 million and $5 million respectively — totaling $14 million combined. There is no support for the $720M or $389M figures in the original answer. (3) The multi-hop reasoning fails: the LLM incorrectly separates pension and other post-retirement funds and aggregates them across categories not mentioned in the question, introducing data not present in the knowledge base. (4) The conclusion — that hedge funds/limited partnerships and real estate are $185 million *more* than mutual funds — is the opposite of the truth: mutual/pooled/commingled funds ($87M) were actually much *larger* than the $14M combined total of the other two. The LLM misrepresents every figure and reverses the comparison, indicating a complete breakdown in factual accuracy and logic. Only minimal contextual relevance is retained as it attempts to address the same categories and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 432,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "Because LTIP units receive a distribution equal to 10 % of the regular quarterly Operating‑Partnership distribution, Simon classifies them as **participating securities** and therefore includes them in the **two‑class method** used to compute both basic and diluted earnings‑per‑share (and per‑unit). In other words, the LTIP units are treated as potentially dilutive securities in the EPS denominator, although the filing notes that they had no material dilutive effect on the reported EPS.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that LTIP units receive distributions equal to 10% of the regular quarterly Operating Partnership unit distributions, which is factually correct and matches the original answer. (2) The classification of LTIP units as participating securities and their inclusion in the two-class method for computing earnings per share (EPS) is correctly identified, and the mention of both basic and diluted EPS is appropriate. (3) The reasoning correctly links the distribution feature to the accounting treatment under the two-class method, which is the core of the multi-hop logic required. (4) However, the LLM adds that LTIP units are treated as 'potentially dilutive securities in the EPS denominator' and that they 'had no material dilutive effect,' which, while possibly true, is not present in the original answer and introduces a nuance (dilutive impact) that wasn't part of the disclosed reasoning about the two-class method. This slightly misrepresents the primary impact—allocation of earnings under the two-class method—by shifting focus toward dilution, which is more relevant for convertible securities in diluted EPS calculations. The original answer emphasizes that the impact comes from earnings allocation, not dilution. Thus, while the core facts and quantitative elements (10%, two-class method, participating securities) are correct, the qualitative reasoning is slightly off in emphasis, warranting a score of 8. Contextual relevance is perfect as it directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 434,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "As of December 31 2024, NEE’s non‑controlling‑interest investment in X PLR OpCo was **approximately $3.315 billion**.  The entity is a limited‑partnership‑type structure accounted for under the equity‑method and is treated as a **Variable‑Interest Entity (VIE) in which NEE is not the primary beneficiary**, so it is not consolidated on NEE’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dollar amount of NEE's noncontrolling interest investment in XPLR OpCo as $3.315 billion (equivalent to $3,315 million), which matches the ground truth. The date (December 31, 2024) is accurate. The classification of XPLR OpCo as a Variable Interest Entity (VIE) in which NEE is not the primary beneficiary is correctly stated, as is the conclusion that it is accounted for under the equity method and not consolidated. 2) Quantitatively, the conversion from $3,315 million to $3.315 billion is mathematically correct, and the formatting variation is acceptable. No calculation errors. 3) The multi-hop reasoning is sound: the model correctly synthesizes control, governance, and accounting treatment based on VIE status and lack of primary beneficiary designation. The only minor omission is not explicitly stating the reason for lack of control (e.g., 'lack of control over significant activities'), which is present in the original answer but implied in the LLM version through 'not the primary beneficiary'. This does not impair understanding but slightly reduces completeness. 4) The answer is semantically equivalent, contextually appropriate, and fully relevant to the question. The use of 'limited-partnership-type structure' adds minor contextual detail not in the original but does not contradict it. Overall, highly accurate with only a slight reduction in qualitative precision due to omitted explanatory detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 403,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde supplies process gases through **three** distribution methods – on‑site (or tonnage), merchant (bulk liquid) and packaged (cylinder) gases【LIN_10k_2024.pdf p. 85】.  \n\nThe on‑site method is used for the largest, steady‑demand customers and is governed by **total‑requirement contracts that typically run 10‑20 years and include minimum‑purchase requirements**【LIN_10k_2024.pdf p. 85‑86】. In contrast, merchant contracts are usually **3‑7 year agreements with no minimum‑purchase or volume commitments**, and packaged‑gas contracts are **1‑3 year agreements also without minimum‑purchase or volume requirements**【LIN_10k_2024.pdf p. 86‑87】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies the three distribution methods: on-site, merchant, and packaged, which aligns with the original answer. (2) Quantitative details are precise: on-site contracts last 10–20 years (correctly cited as 10-20 years), merchant contracts 3–7 years (matches 3-7 year range), and packaged gas contracts 1–3 years (correctly stated). The absence of minimum purchase requirements in merchant and packaged contracts is correctly noted, while on-site contracts include minimum purchase requirements—this key distinction is accurately captured. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer differentiates on-site delivery by both contract duration and volume commitments, directly addressing how it differs from the other two methods. (4) All entities (Linde, distribution methods, contract types) are correctly identified, and the semantic meaning is equivalent to the ground truth, despite slightly more detailed phrasing (e.g., 'total-requirement contracts'). Citations from the 10-K filing add contextual support. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 336,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The Board’s February 1 2022 approval of a 20‑for‑1 split of Alphabet’s Class A, B and C shares was a separate corporate action from the April 2021 resolution that authorized the company to repurchase up to **$50 billion of Class C stock**.  The split could be effected only **if stockholders approve an amendment to Alphabet’s Amended and Restated Certificate of Incorporation** to increase the authorized shares of each class so the split can be accommodated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the 20-for-1 stock split was announced in February 2022 (specifically approved on February 1), the $50.0 billion Class C stock repurchase authorization occurred in April 2021, and the stock split required stockholder approval of an amendment to the Certificate of Incorporation to increase authorized shares. (2) Quantitative accuracy is perfect: dates (February 1, 2022; April 2021), dollar amount ($50 billion), and split ratio (20-for-1) are all correctly stated. Format variation ($50 billion vs $50.0 billion) is acceptable. (3) The multi-hop reasoning is sound: the answer correctly identifies that the repurchase authorization and stock split are separate actions but implicitly connected through the need for additional authorized shares. It correctly states the condition for the split to proceed—stockholder approval of the charter amendment. (4) The only minor shortcoming is that the LLM does not explicitly explain *why* the share increase was necessary—to accommodate both the split and the ongoing repurchase program—but this contextual link is strongly implied. The ground truth emphasizes this connection more directly. Despite this slight omission, the answer is factually correct, relevant, and synthesizes information appropriately across time and corporate actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 389,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "GM reported equity earnings of **$293 million** from its investment in Ultium Cells Holdings LLC for 2023. At December 31 2023, GM had **about $0.8 billion (≈$800 million)** of committed‑capital contributions still outstanding to Ultium Cells Holdings LLC.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million and the committed capital contributions of $0.8 billion (explicitly noted as ≈$800 million) are accurate and match the original answer exactly, with acceptable formatting variations. (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the outstanding committed capital as of December 31, 2023. (3) Entity accuracy is correct—GM, Ultium Cells Holdings LLC, and the year 2023 are all properly identified. (4) The reasoning is sound, demonstrating correct synthesis of financial data from what would be a multi-hop retrieval scenario involving GM’s equity earnings and capital commitments. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity due to the use of 'about' and the parenthetical conversion, which do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 293,
        "total_tokens": 1422
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "In 2021 Coca‑Cola reported **$720 million** of hedge‑fund and limited‑partnership investments in its consolidated financial‑statement disclosures (the fair‑value hierarchy for pension‑plan assets shows a $720 million “Other” amount for hedge funds/limited partnerships) and an additional **$9 million** of such investments in its “other post‑retirement benefit plan” assets. Together, these figures indicate a total exposure of roughly **$729 million**, with the overwhelming majority of the company’s hedge‑fund/LP exposure coming through its pension‑plan assets and only a modest amount held in other post‑retirement benefit plans. This dual reporting highlights that Coca‑Cola’s overall risk to alternative‑investment vehicles is largely concentrated in the pension‑plan portfolio rather than in its other employee‑benefit arrangements. 【source: pension‑plan assets table showing Hedge funds/limited partnerships 720 (2021)】【source: other post‑retirement benefit plan assets table showing Hedge funds/limited partnerships 9 (2021)】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two key figures: $720 million in hedge funds and limited partnerships from the consolidated financial statements (specifically pension plan assets) and $9 million from other postretirement benefit plan assets, both matching the ground truth. The total exposure of $729 million is accurately calculated. (2) All numeric values are correct and properly formatted; the sum of $720M + $9M = $729M is accurate. The years (2021) and entities (The Coca-Cola Company, hedge funds, limited partnerships, pension and other postretirement plans) are correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes data from two distinct sections of the 10-K (pension plan assets and other postretirement benefit plan assets), correctly attributes the sources, and draws a logical conclusion about the concentration of risk in pension assets. (4) The only minor issue is a slight mischaracterization in the explanation: the $720 million is not in the 'consolidated financial statements' per se but within the pension plan assets footnote, which is part of the consolidated financial statement disclosures. However, this is a nuance in financial reporting terminology and does not constitute a factual error. The overall exposure assessment and dual reporting reflection are semantically equivalent and well-reasoned. Thus, the answer is factually excellent with near-perfect qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 405,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The filing explains that as more of its retail tenants shift sales to e‑commerce, they need less square‑footage and are more likely to close or right‑size under‑performing stores. That “increased bargaining power of credit‑worthy retail tenants” creates higher vacancy and puts downward pressure on the rents they are willing to pay, making it harder for Simon to re‑let space and to maintain existing rental rates. (See Item 1A – Vacant space and competition/e‑commerce risk factors.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core causal chain described in the original answer. It correctly identifies that e-commerce adoption by retail tenants leads to reduced space needs, store closures, and right-sizing, which in turn increases vacancy rates and gives creditworthy tenants greater bargaining power. This results in downward pressure on rental rates and challenges in re-leasing space—directly aligning with the ground truth. The LLM cites the correct section (Item 1A – Vacant space and competition/e-commerce risk factors), demonstrating proper sourcing. The only minor omission is that it does not mention SPG's potential need to increase spending on tenant improvements or offer lease modifications, which is part of the full financial impact described in the original answer. However, all key entities (Simon Property Group, retail tenants, e-commerce), reasoning steps, and qualitative impacts are correctly identified and logically connected. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is contextually precise and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 327,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The 10‑K notes state that the corporate‑income‑tax laws enacted in Arkansas (together with other states) cut UNP’s deferred‑tax expense by **$34 million in 2024** and by **$114 million in 2023** – a combined **$148 million reduction** for the two‑year period. By contrast, the Arkansas‑related legislation in 2022 (along with Nebraska, Iowa and Idaho) reduced deferred‑tax expense by **$95 million**. Thus, the cumulative Arkansas‑related impact in 2024‑23 ($148 million) was about **$53 million larger** than the impact recorded in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $34 million in 2024, $114 million in 2023, and a total of $148 million for the two years, which is correctly calculated (34 + 114 = 148). The 2022 impact is correctly stated as $95 million. The comparison showing a $53 million larger reduction in 2023–2024 versus 2022 is accurate (148 - 95 = 53). (2) The answer is complete, addressing both parts of the question: the cumulative impact in 2024 and 2023, and the comparison to the 2022 impact. (3) Entity accuracy is correct: UNP is the company, Arkansas legislation is the focus, and the years 2022, 2023, and 2024 are properly attributed. The mention of other states (Nebraska, Iowa, Idaho) in 2022 is consistent with the context that Arkansas legislation was part of a broader set of changes but does not detract from the Arkansas-specific impact being reported. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it aggregates two years of data, compares them to a prior year, and draws the correct conclusion about the relative magnitude of the impact. (5) The semantic meaning is equivalent to the original answer, with clear, precise, and well-structured communication. Minor wording differences (e.g., 'larger' vs 'greater') do not affect factual accuracy. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 385,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE’s limited‑partner stake in XPLR Infrastructure Operating Partners, LP means that NEE depends on XPLR to generate cash distributions that flow to NEE’s balance sheet.  If XPLR cannot obtain financing on commercially reasonable terms, it may be unable to fund acquisitions, meet capital‑needs or make those cash distributions, which would diminish the value of NEE’s partnership interest and could force NEE to absorb additional obligations or forego cash that it otherwise would use to meet its own debt service and other liquidity needs.  Consequently, a financing shortfall at XPLR could materially impair NEE’s liquidity and its ability to satisfy its financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core financial implications of NEE's limited partner interest in XPLR OpCo, aligning closely with the ground truth. It correctly identifies that NEE relies on cash distributions from XPLR, and if XPLR cannot access capital on commercially reasonable terms, it may fail to fund acquisitions or meet capital needs, leading to reduced distributions. This directly impacts NEE’s liquidity and ability to meet financial obligations, including debt service—matching the original answer’s key points. The answer is strong on quantitative accuracy (no numerical errors, as none were present in the original), entity accuracy (correctly identifies NEE, XPLR OpCo, and the nature of the partnership), and contextual relevance. The only minor gap is the omission of explicit mention of dilution risk from potential future unit issuances by XPLR, which is part of the original answer and represents a secondary but important financial impact. While the LLM captures the primary liquidity and distribution risk, it misses this nuance in dilution of future cash flows, slightly weakening the completeness and qualitative accuracy. However, the core multi-hop reasoning—linking XPLR’s capital access to its operational capacity, then to distribution levels, and finally to NEE’s liquidity and financial obligations—is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 382,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The two figures are the same. In the “Marketable securities” discussion the table shows mortgage‑backed obligations at a fair‑value of **$236 million** (2024) – and $178 million for 2023 – and the “Fair Value” column of that same marketable‑securities table also lists **$236 million** (2024) and **$178 million** (2023). Thus, there is no difference between the two reported amounts.【source: Marketable securities table showing mortgage‑backed obligations fair value $236 (2024) and $178 (2023)】",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect. The ground truth states that the fair value in the 'Marketable securities' section is $178 and in the 'Fair Value' column it is $236, resulting in a difference of $58. The LLM incorrectly claims both values are the same in both sections, asserting $236 million and $178 million as values for different years (2024 and 2023), which introduces a temporal distinction not present in the original question or ground truth. The question does not ask for a time-series comparison, but rather a cross-sectional difference between two reporting locations in the same document. (2) The numbers $236 and $178 do appear in the correct context according to the ground truth, but the LLM misattributes them to different years rather than different sections, which invalidates the calculation. The claimed 'no difference' conclusion contradicts the ground truth difference of $58. (3) The multi-hop reasoning fails because the model does not compare the same item (mortgage-backed obligations) across two different parts of the filing; instead, it invents a year-based explanation unsupported by the prompt. There is no indication in the question or ground truth that $178 corresponds to 2023 and $236 to 2024. (4) Due to major factual and reasoning errors, especially in quantitative and logical aspects, the scores are low. The answer is contextually relevant in discussing the right topic and metric, hence a moderate relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 409,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "Alphabet treats Google Play sales as an agency transaction. Under the principal‑vs‑agent assessment it records only the net service‑fee it earns from app‑store and in‑app‑purchase sales, deducting the developer’s share before recognizing revenue. Because the share of Google Play (and other non‑advertising lines) is growing, a larger portion of total revenue is reported on this net basis, which carries lower gross margins than advertising and therefore drags down overall non‑advertising margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Google Play revenue is recognized on a net basis due to the agency model, consistent with ASC 606 principal-vs-agent guidance, and explains that only the service fee (after deducting developer share) is recognized as revenue. This matches the original answer's core claim about reduced reported revenue. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: it connects the net reporting method to the growing portion of non-advertising revenues and correctly infers that this drags down overall margins due to lower gross margins compared to advertising. The synthesis across revenue recognition policy and margin impact is logically coherent. (4) The only minor shortcoming is that the LLM answer does not explicitly state that this affects 'overall margins' of the company (not just non-advertising margins), though it implies it by saying it 'drags down overall non-advertising margins.' The original answer more clearly links the trend to adverse effects on Alphabet’s overall margins. Despite this nuance, the semantic meaning and financial logic are substantially equivalent. Wording differs but key facts, entities (Google Play, non-advertising revenues, margins), and causal链条 are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 402,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "General Motors had committed **$0.8 billion** to Ultium Cells Holdings LLC as of December 31 2023. That is **$0.6 billion less** than the **$1.4 billion** it had committed to the same entity at the end of 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $0.8 billion committed in 2023 and $1.4 billion in 2022, with a year-over-year decrease of $0.6 billion—this calculation is correct and explicitly stated. Minor formatting differences (e.g., using ' ' as a thousands separator) do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the 2023 commitment amount and the comparison to the previous year. (3) Entities are correctly identified: General Motors, Ultium Cells Holdings LLC, and the correct years (2023 vs. 2022) are used. (4) The reasoning is sound and reflects proper multi-hop synthesis—comparing two distinct data points across years and computing the difference. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that conveys the same factual conclusion: a reduction in capital commitment. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 286,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Mastercard paid a total of **$2.8 billion in cash** for all of its 2024 acquisitions, including the $2.7 billion purchase of RF UlEmate Parent, Inc. (Recorded Future). Of that amount, **approximately $1.736 billion was allocated to goodwill**.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total cash consideration as $2.8 billion, matching the ground truth. However, the goodwill amount is stated as approximately $1.736 billion, which deviates from the ground truth value of $1.7 billion. This is a minor but notable quantitative inaccuracy. (2) The total cash consideration is correct. The mention of a $2.7 billion purchase for RF UlEmate Parent, Inc. is plausible context but not part of the original question or answer, and while not contradicted by the ground truth, it introduces unverified detail. The goodwill allocation of $1.736 billion does not match the ground truth $1.7 billion—this discrepancy affects quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes total cash consideration and breaks down goodwill allocation, correctly attributing both to Mastercard’s 2024 acquisitions. Entity names (Mastercard, RF UlEmate Parent, Inc.) and year (2024) are accurate. (4) The answer is contextually complete and relevant, with only a small deviation in the goodwill figure. The correctness score is 8 due to the core facts being mostly accurate but with a meaningful numerical discrepancy in a key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 339,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "Union Pacific spent a total of $270 million on freight‑car lease buyouts over the three‑year period ( $70 million in 2022, $57 million in 2023 and $143 million in 2024 ). This spend is a component of the company’s broader 2025 capital plan, which is projected at roughly $3.4 billion and includes funding to acquire and modernize freight cars as part of its replacement and growth strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total spend of $270 million is accurate, with correct yearly breakdowns: $70M (2022), $57M (2023), and $143M (2024); the sum of these values is correct ($70M + $57M + $143M = $270M). The 2025 capital plan amount of $3.4 billion is also accurately reported. (2) The answer is complete, addressing both parts of the question: total lease buyout spending over 2022–2024 and its relation to the 2025 capital plan. (3) Entity accuracy is correct—Union Pacific (UNP) is properly identified, all years and financial metrics are accurate. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop information by linking past lease buyout spending to future capital allocation, noting that acquiring freight cars is part of a broader strategy for replacement and growth. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'modernize' added), but this does not alter or distort meaning and is consistent with plausible interpretation of the capital plan. No factual errors, omissions, or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 319,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "CVS entered into two ASR agreements under the 2021 Repurchase Program in the 2022‑2023 period—a $1.5 billion ASR with Barclays (initial treasury‑stock entry of $1.2 billion and a $0.3 billion forward contract) and a $2.0 billion ASR with Citibank (initial treasury‑stock entry of $1.6 billion and a $0.4 billion forward contract). Together, the notional amounts of those ASRs total **$3.5 billion**.【source】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total notional amount as $3.5 billion, matching the ground truth. It accurately breaks this down into a $1.5 billion ASR in 2022 and a $2.0 billion ASR in 2023, which aligns with the original answer. All numeric values—$1.5B, $2.0B, and the sum $3.5B—are factually correct and properly formatted. (2) Quantitative accuracy is perfect: the sum of $1.5B and $2.0B is correctly calculated as $3.5B. The additional details about forward contracts and initial treasury stock entries ($1.2B/$0.3B and $1.6B/$0.4B) are consistent with typical ASR structures and do not contradict the ground truth; they provide extra context not required by the question but not inaccurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2023) and two transactions under the 2021 Repurchase Program, correctly aggregating them into a total notional amount. The mention of counterparties (Barclays and Citibank) adds specificity that is likely from the source documents and does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth in terms of the key conclusion. The only reason for not scoring a 10 is that the original answer did not include the forward contract and treasury entry breakdowns, so while those details are likely correct, they go beyond the disclosed ground truth without confirmation. However, they support rather than undermine the correct conclusion. Contextual relevance is perfect—the response directly answers the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 439,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM’s near‑term earnings still come largely from the high‑margin full‑size ICE SUVs and pickup trucks – the cash they generate is explicitly used to finance the company’s EV and autonomous‑vehicle programs. At the same time, the 10‑K’s forward‑looking statements warn that a shift in consumer demand, stricter emissions rules or higher EV‑related costs could cut ICE sales and therefore the cash flow that funds the EV transition. Consequently, GM’s reliance on those trucks creates a short‑term financial cushion but also a long‑term vulnerability: if ICE volumes fall before a profitable EV portfolio is in place, the funding gap could undermine the company’s ability to sustain profitability and achieve long‑term financial stability. (See Item 1A risk factors and the “near‑term profitability” paragraph, which note the dependence on full‑size ICE trucks and the EV‑transition risks.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: GM's near-term profitability relies on high-margin ICE trucks, which fund EV investments; a decline in ICE sales due to consumer preferences or regulations threatens cash flow and thus the EV transition. The core risk — that falling ICE sales could create a funding gap before EVs become profitable — is clearly and correctly articulated. (2) There are no numeric values in the question or answers requiring verification; both responses are qualitative, so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes the dependency of EV funding on ICE profits and links forward-looking risks (consumer demand shifts, regulatory changes) to potential impacts on long-term financial stability. The mention of Item 1A and the 'near-term profitability' paragraph adds contextual fidelity to the 10-K source. (4) Minor deduction in qualitative accuracy due to slight expansion beyond the original answer by including 'autonomous-vehicle programs' and 'stricter emissions rules / higher EV-related costs,' which, while plausible and consistent with GM’s disclosures, are not explicitly in the ground truth. However, these do not distort the meaning and are reasonable inferences. Overall, the answer is complete, contextually grounded, and logically structured, fully addressing the interaction between ICE reliance and EV strategy on financial stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 416,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "Chevron says that because the speed of the energy transition is uncertain—and is affected by volatile commodity prices and evolving climate‑related regulations—it must treat those factors as “highly uncertain matters” when it tests its upstream assets for impairment.  A material drop in oil‑and‑gas price forecasts, higher carbon‑cost assumptions or stricter regulations can trigger an impairment review and a write‑down of carrying values, while the same uncertainty forces the company to be more cautious in committing capital to new upstream projects, slowing or scaling back investments until the outlook for prices, carbon costs and regulatory regimes becomes clearer【pages 19‑23】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the uncertainty around the energy transition, its influence via commodity prices and regulations on impairment assessments and investment decisions, and the potential for asset write-downs and reduced capital spending are all correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links energy transition uncertainty to commodity price forecasting, regulatory developments, impairment testing, and upstream investment caution. It accurately reflects that higher carbon costs or lower price forecasts can trigger impairments, and that uncertainty leads to delayed or scaled-back investments. (4) The only minor gap is that the original answer explicitly mentions the impact on Chevron’s financial condition and reduced ability to invest in lower-carbon solutions, which the LLM answer omits. However, the core mechanisms and implications are well captured. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 359,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard’s consumer‑acquisition and engagement services are a “value‑added” offering that sits on top of its proprietary global payments network.  By using the network’s secure data to drive brand preference, card‑holder usage and new‑card enrollment, these services increase the volume of transactions that flow through the switch, clearing and settlement platform, while also producing separate fixed‑ or transaction‑based fees that are recognized as revenue (see Item 1 Business overview – “consumer acquisition and engagement services” and Item 71 – revenue from value‑added services).  The additional fee income and higher gross‑dollar volume from engaged consumers therefore reinforce the network’s operating scale and contribute to Mastercard’s rising net revenue and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies that Mastercard's Consumer Engagement Services leverage secure data from the global payments network to increase cardholder usage, new enrollments, and brand preference—directly supporting the network's utility and transaction volume. This matches the ground truth's emphasis on using responsible data use to attract consumers and merchants. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links consumer engagement to increased transaction volume and separate fee revenue, which in turn enhances network scale and contributes to financial performance (net revenue and profitability), mirroring the interdependent service model described in the original. (4) The only minor gap is that the LLM answer emphasizes revenue mechanics (e.g., fixed-/transaction-based fees) more than the original’s focus on the 'principled and responsible use of data' as a trust-based differentiator. While implied via 'secure data,' this ethical dimension is slightly underrepresented. However, the core factual content, logic, and synthesis across network effects and financial impact are correct and complete. Thus, the answer earns a 9/10 for correctness—excellent but not perfect semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 401,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "Walmart recorded a $0.4 billion cash outflow when it acquired Alert Innovation in fiscal 2023. In fiscal 2025 the Alert Innovation entity was sold and de‑consolidated, generating cash proceeds that offset part of the year’s investing‑cash outflows – however, the 10‑K excerpt does not disclose the amount of those proceeds, so the net cash impact for 2025 cannot be quantified from the information provided.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition cost in fiscal 2023, which matches the ground truth. However, it incorrectly states that the cash proceeds from the deconsolidation in fiscal 2025 are undisclosed, while the ground truth explicitly states that there was no net cash inflow from the deconsolidation, implying the proceeds were zero or not material. This leads to an incorrect net cash outflow assessment. (2) The quantitative accuracy is partially correct—$0.4 billion outflow in 2023 is accurate—but fails on the 2025 component, where the model claims insufficient data instead of recognizing the net zero recovery. The total net outflow should be $0.4 billion, but the LLM does not arrive at this conclusion. (3) The multi-hop reasoning is flawed: the model fails to synthesize the key point that deconsolidation resulted in no cash recovery, which is essential to determining the total net outflow. Instead, it defaults to a 'not disclosed' stance, breaking the chain of correct inference. (4) Contextual relevance is high—the answer addresses the right entities, years, and events—but the failure to correctly interpret the deconsolidation impact significantly undermines factual correctness. A score of 4 reflects partial credit for correct initial outflow but major error in net impact conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 374,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The two footnotes each state that the only potentially dilutive securities for 2023 were the LTIP units (and, for the corporation, units exchangeable for common stock), and that **no securities had a material dilutive effect**. Therefore, the combined total of potentially dilutive securities for the year ended December 31 2023 is effectively **zero**. The company did not adjust net income attributable to common stockholders because the inclusion of the LTIP units (or any other limited‑partner allocations) would have **no dilutive impact** on earnings per share, so the adjustment would be immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the only potentially dilutive securities for the year ended December 31, 2023, were LTIP Units and units exchangeable for common stock, aligning with the ground truth. It accurately explains that no adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect. The statement that the combined total is 'effectively zero' is semantically equivalent to the ground truth's explanation that there was no material dilutive effect—while the exact phrasing differs, the meaning is consistent: no dilution was recognized due to immateriality. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (LTIP Units, common stock, 2023 reporting period) are correctly identified. The reasoning correctly synthesizes information from multiple footnotes (multi-hop) and draws a logical conclusion. The minor deduction in qualitative accuracy is because 'effectively zero' could be slightly misleading—it implies no securities exist rather than that they exist but are not dilutive—though the subsequent explanation clarifies this. Contextual relevance is full, as all parts of the question are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 349,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The 2023 filing shows that Verizon measured **$4,432 million** of pension‑plan assets and **$5 million** of health‑care‑and‑life‑plan assets at net asset value (NAV), for a combined NAV total of **$4,437 million**【...】.  \n\nBy contrast, the same filing reports **$9,104 million** of pension‑plan assets and **$461 million** of health‑care‑and‑life‑plan assets measured at fair value【...】.  Thus, the NAV amount is about **48 % of the pension fair‑value total** and roughly **1 % of the health‑care‑and‑life fair‑value total**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitative Accuracy: The LLM reports $4,432 million and $5 million for NAV investments, totaling $4,437 million, which is drastically different from the ground truth total of $14 million ($9M + $5M). The fair value amounts are also wrong: the LLM states $9,104 million (pension) and $461 million (health), summing to $9,565 million, whereas the ground truth reports $902 million total fair value ($441M + $461M). The percentages derived (48% and 1%) are therefore also incorrect. (2) Completeness: While the LLM attempts to address both asset categories and comparisons to fair value, it does so with fabricated numbers. (3) Entity Accuracy: The company (VZ) and year (2023) are correct, and the categories (pension vs. health-care-and-life plans) appear structurally correct, but the financial data attached to them are not. (4) Reasoning: The multi-hop synthesis is structurally sound—comparing NAV to fair value per category—but based on incorrect data, rendering the logic invalid. (5) Semantic Equivalence: The answer does not convey the same information; the scale of numbers is off by orders of magnitude (e.g., billions vs. millions). The correct total NAV is $14 million, not $4.4 trillion, and total fair value is $902 million, not $9.6 billion. This indicates a severe data retrieval or interpretation error. The LLM likely confused asset values from different sections of the filing or misread the units.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 416,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "GM reported **$293 million** of equity earnings from Ultium Cells Holdings LLC for 2023.  These earnings were **included in “Automotive and other cost of sales”** (i.e., shown within cost of sales in the equity‑income disclosure for non‑consolidated affiliates).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the equity earnings amount of $293 million for 2023 is accurately reported, matching the original answer exactly. (2) The disclosure category is correctly identified as 'Automotive and other cost of sales', with additional but accurate contextual clarification that this falls within equity-income disclosure for non-consolidated affiliates. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies GM's equity earnings from Ultium Cells Holdings LLC and maps it to the appropriate financial statement line item. (4) All entities (GM, Ultium Cells Holdings LLC, 2023 fiscal year) are accurate, and the answer fully addresses both parts of the question—amount and disclosure category. Minor wording differences (e.g., 'included in' vs 'disclosed under') do not affect factual equivalence. No errors in calculation, entity identification, or financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 288,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "Principal or Affiliate Customers (the Class B stockholders) owned 0.8 % of Mastercard’s equity at 12/31/2023 and 0.7 % at 12/31/2024 – a decline of 0.1 percentage point. That modest drop further concentrates ownership in the two larger groups: public investors rose to about 90 % of the equity and the Mastercard Foundation fell to roughly 9 %, leaving Class B holders as a very small (≈0.7 %) slice of the overall ownership structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the equity ownership percentages of Principal or Affiliate Customers (Class B stockholders) as 0.8% in 2023 and 0.7% in 2024, with a 0.1 percentage point decrease — matching the ground truth exactly. The dates (12/31/2023 and 12/31/2024) are appropriate and consistent with annual reporting periods.\n\n2) Quantitatively, all numbers are accurate: the starting and ending percentages, the 0.1 percentage point decline, and the contextual ownership shares (public investors ~90%, Mastercard Foundation ~9%) are factually aligned with known ownership structures. No calculation errors.\n\n3) The multi-hop reasoning is sound: the model correctly infers that the decline in Class B ownership contributes to increased concentration among other ownership groups. While the original answer only mentions the decline and its minor impact, the LLM adds context about ownership concentration, which is a reasonable and logical interpretation supported by the data.\n\n4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer does not mention the Mastercard Foundation's stake or public investor share — so while the added context is accurate and relevant, it slightly extends beyond the scope of the ground truth. However, this does not introduce error and improves contextual understanding. The answer remains semantically equivalent in addressing the ownership shift.\n\nOverall, the response is factually correct, complete, and provides slightly enriched context without misrepresentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 425,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "Walmart spent about **$0.4 billion** in cash to acquire Alert Innovation in fiscal 2023.  The company later **sold the business and de‑consolidated the entity in fiscal 2025** (the subsequent reporting year after the acquisition).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: Walmart spent $0.4 billion in cash to acquire Alert Innovation in fiscal 2023, and the entity was sold and deconsolidated in fiscal 2025. (2) Quantitative accuracy is perfect: the $0.4 billion figure matches exactly, and fiscal years (2023 acquisition, 2025 divestiture) are correctly reported. Minor formatting differences (e.g., '0.4 billion' vs '$476M') are irrelevant here as the number is correct. (3) Multi-hop reasoning is sound: the answer correctly synthesizes two distinct events (acquisition and subsequent sale/deconsolidation) across fiscal years, addressing both parts of the question. (4) Entity accuracy is complete: Walmart (WMT), Alert Innovation, and the correct fiscal years are all properly identified. The answer is concise, factually precise, and fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 267,
        "total_tokens": 1371
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "The company used the 2021 Multicurrency Credit Facility to fund two early‑2024 note repayments – $500 million for the 0.600 % notes (January 12, 2024) and $1 billion for the 5.00 % notes (February 14, 2024) – for a total principal repayment of **$1.5 billion**.  \n\nAs disclosed, the facility provided a **$6.0 billion borrowing limit** as of December 31, 2023; therefore the $1.5 billion drawn to retire the notes would have reduced the remaining available capacity to roughly **$4.5 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total principal repaid ($1.5 billion) and breaks it down accurately into $500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes, which matches the ground truth. It also correctly states the $6.0 billion borrowing limit as of December 31, 2023. However, it makes a critical error in calculating the remaining borrowing capacity by subtracting the $1.5 billion drawn from the $6.0 billion limit to arrive at $4.5 billion. This is factually incorrect according to the original answer, which explicitly states that as of December 31, 2023, the company still had the ability to borrow up to $6.0 billion — meaning the $1.5 billion drawdown occurred *after* that date (in early 2024), so the remaining capacity *as of December 31, 2023* was still $6.0 billion, not $4.5 billion. (2) Quantitative accuracy is partially correct: all input numbers are right, but the subtraction is based on a flawed temporal interpretation. The dates (January 12, 2024, and February 14, 2024) are plausible but not in the ground truth, so their inclusion adds specificity not supported by the source. (3) The multi-hop reasoning fails because the model does not recognize that the borrowing capacity is reported *as of a specific date* (December 31, 2023), before the repayments occurred. Thus, the impact on capacity should reflect availability *before* the drawdown, not after. The original answer confirms the $6.0 billion was still available as of that date. (4) Correctness is scored low (4) due to this major factual and logical error in temporal reasoning, despite correct input data. Quantitative accuracy is moderate (5) because numbers are right but misapplied. Qualitative accuracy is low (4) due to flawed synthesis. Contextual relevance is high (8) as the answer addresses the right entities and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 503,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel is deploying extreme‑ultraviolet (EUV) lithography first in its Intel 4 node and then expanding its use in Intel 3 to shrink critical features and boost performance‑per‑watt, paving the way for the next‑generation transistor architectures—Ribbon FET and PowerVia—that will debut in the subsequent Intel 20A node.  The roadmap then calls for the Intel 18A node, which is slated to be the first process to incorporate next‑generation High‑Numerical‑Aperture EUV (High‑NA EUV) as part of that progression.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: EUV is first used in Intel 4, expanded in Intel 3, enabling progression to Intel 20A with RibbonFET and PowerVia, and Intel 18A is correctly identified as the node introducing High-NA EUV. (2) There are no numeric values requiring calculation (e.g., dates, dollar amounts), but process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are all correctly stated and sequenced. (3) The multi-hop reasoning is sound: the answer connects EUV adoption in Intel 4/3 to advanced transistor architectures (RibbonFET, PowerVia) and correctly projects the future use of High-NA EUV in Intel 18A, demonstrating proper synthesis across the technology roadmap. (4) The wording differs slightly (e.g., 'expanding its use' vs 'increased EUV usage', 'next-generation transistor architectures' vs 'RibbonFET and PowerVia'), but the meaning is identical. No factual omissions or inaccuracies. All scores are 10 due to full correctness, precise entity usage, logical flow, and complete relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 314,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The 2023 filing shows $1,412 million of U.S. Treasuries and agencies in the pension‑plan assets and $138 million in the health‑care‑and‑life plan assets – a total of **$1.55 billion**.  By contrast, cash and cash equivalents total $1,956 million (pension) + $27 million (health‑care‑and‑life) = **$1.98 billion**, so cash holdings exceed the combined Treasury/agency investments by roughly **$0.43 billion**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that the total combined value of U.S. Treasuries and agencies is $239 million ($101M + $138M), but the LLM reports $1.55 billion, citing $1,412 million in pension-plan assets and $138 million in health-care-and-life plan assets. These numbers do not match the ground truth and appear to be fabricated or misextracted. Similarly, the LLM claims cash and cash equivalents total $1.983 billion ($1,956M + $27M), whereas the ground truth reports only $57 million ($30M + $27M). These discrepancies are massive—over 30x for cash and over 6x for Treasuries. (2) Completeness: While the LLM attempts to address both parts of the question (total value and comparison), it does so using entirely incorrect data. (3) Entity Accuracy: The company (VZ) and year (2023) are correct, but the asset categories (pension vs. health-care-and-life) are misapplied—the ground truth does not mention pension plans or $1,412M/$1,956M figures. (4) Reasoning: The multi-hop synthesis is invalid because it relies on incorrect source data. The conclusion that cash exceeds Treasuries is the opposite of the ground truth, which states Treasuries ($239M) are significantly higher than cash ($57M). (5) Semantic Equivalence: The meaning is not preserved—this answer conveys the opposite financial reality. The LLM likely confused VZ’s data with another company or misread the filing. All scores are low due to catastrophic factual errors in core financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 429,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "In 2021 Danaher paid a total net cash consideration of **$10.9 billion** for the Aldevron acquisition together with the other 11 businesses ($9.6 billion for Aldevron and $1.3 billion for the remaining acquisitions). Of the $7.2 billion of goodwill recorded for those 2021 acquisitions, **$6.15 billion** was attributable to Aldevron alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences. (1) Quantitatively: The total net cash consideration is reported as $10.9 billion, which matches the ground truth sum of $9,561 million (Aldevron) + $1,340 million (other 11 businesses) = $10,901 million ($10.901 billion), correctly rounded to $10.9 billion. The split of $9.6 billion for Aldevron is a rounded version of $9,561 million, and $1.3 billion for the others matches $1,340 million when rounded. The goodwill figures are $7.2 billion (vs. $7,187 million actual) and $6.15 billion (vs. $6,149 million), both accurate to the nearest $10 million. (2) Completeness: The answer addresses both parts of the question—total cash consideration and Aldevron-attributed goodwill—and correctly identifies the components. (3) Entity accuracy: 'Danaher' (DHR), 'Aldevron', '2021 acquisitions', and financial terms are all correct. (4) Reasoning: The multi-hop synthesis across Aldevron and the other 11 businesses is sound, with proper aggregation and attribution. (5) Semantic equivalence is maintained despite rounding; such approximations are common and acceptable in financial reporting. Only a 9 is given for quantitative accuracy due to the slight rounding of individual components, though totals remain faithful.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 371,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "GM had pledged **about $0.8 billion** in committed capital to Ultium Cells Holdings LLC as of December 31 2023. On the same date, the balance‑sheet line for its investment in Ultium Cells Holdings LLC showed a **carrying amount of roughly $2.3 billion**. Thus, the carrying amount exceeds the committed‑capital amount by roughly **$1.5 billion**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies GM's committed capital contribution as approximately $0.8 billion, which matches the ground truth of $0.8 billion. However, the carrying amount is reported as 'roughly $2.3 billion', while the ground truth is $2,268 million ($2.268 billion). Although 'roughly $2.3 billion' is a reasonable approximation, it introduces a rounding error that affects the accuracy of the comparison. (2) The LLM calculates a difference of $1.5 billion between the carrying amount and committed capital, but this is incorrect: $2.268 billion - $0.8 billion = $1.468 billion, so the difference should be approximately $1.47 billion, not $1.5 billion. This calculation error reduces quantitative accuracy. (3) The multi-hop reasoning is sound—LLM correctly identifies that the carrying amount exceeds the committed contribution, which implies GM had not fully funded its commitment. This reflects proper synthesis of the two financial figures from the same entity and date. (4) The answer is contextually complete and relevant, addressing both parts of the question and drawing a logical conclusion. However, the rounding and calculation inaccuracies prevent a higher score. Thus, correctness is partially impacted by numerical precision issues, warranting a 7/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 360,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "In 2023 the Lower 48 segment recorded **$5.73 billion** of depreciation, depletion, amortization and impairments.  The net book value of its proved and unproved properties at December 31 2023 was **$74.0 billion** (proved $70.6 billion + unproved $3.4 billion).  Thus, the DDAI expense represents roughly **7‑8 %** of the Lower 48’s property book value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key financial figures. The total depreciation, depletion, amortization, and impairments (DDAI) for the Lower 48 region in 2023 is correctly stated as $5.73 billion (rounded from $5,729 million), which matches the ground truth. However, the net book value of proved and unproved properties is grossly incorrect: the LLM reports $74.0 billion, while the ground truth is $37,185 million ($37.2 billion). This misrepresents the actual book value by nearly double. Additionally, the LLM incorrectly calculates the original total property value as $74.0 billion, but the ground truth states that $74,014 million ($74.0 billion) was the *original total property value*, not the net book value as of December 31, 2023. (2) The calculation of DDAI as 7–8% of book value is based on the incorrect denominator: $5.73B / $74.0B ≈ 7.7%, but using correct values ($5.73B / $37.2B) would yield ~15.4%, making the percentage comparison invalid. The ground truth also mentions accumulated DDA of $36,829 million, which the LLM omits entirely, failing to show the multi-hop synthesis between historical and current-period DDA. (3) The reasoning is flawed: the LLM confuses original cost with net book value and fails to incorporate the accumulated depreciation up to 2022, which is essential for the multi-hop comparison. It does not explain how net book value relates to original cost minus accumulated depreciation, missing a core conceptual link. (4) While the DDAI figure is accurate and the question part about 2023 expense is addressed, the critical comparison to net book value is wrong due to incorrect data, and the deeper synthesis of asset lifecycle accounting is absent. Hence, despite some correct inputs and relevant structure, the answer is substantially inaccurate in both quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 507,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "In 2023 the company paid back a total of **$6.1 billion** under the 2021 Multicurrency Credit Facility – that amount includes **€842.6 million (≈ $919 million)** of EUR‑denominated repayments (the balance being roughly $5.18 billion in USD).  Those repayments reduced the facility’s outstanding revolving balance to **$723.4 million** as of December 31, 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total repayment amount of $6.1 billion and the EUR-denominated repayment of €842.6 million (≈$919 million), which aligns with the ground truth. However, the LLM introduces a new figure—'reduced the facility’s outstanding revolving balance to $723.4 million as of December 31, 2023'—which is not present in the original answer and cannot be verified from the provided ground truth. This adds information not supported by the source. (2) Quantitatively, the $6.1 billion total and the $919 million (from €842.6 million) are accurate. The implied USD repayment of ~$5.18 billion ($6.1B - $0.919B) is a reasonable derivation, though not explicitly stated in the original. The $723.4 million ending balance is unverified and potentially incorrect, as the original only states that repayments contributed to a net decrease in revolving indebtedness without specifying the final balance. (3) The multi-hop reasoning is partially sound: the model correctly combines USD and EUR repayments into a total and links repayment activity to reduced indebtedness. However, it goes beyond the source by asserting a specific ending balance, which reflects a failure in synthesis fidelity. (4) The answer is contextually relevant and addresses both parts of the question—total repayment amount and impact on revolving indebtedness—but overreaches by introducing unsupported precision in the form of a final balance figure. The core facts are correct, but the addition of unverified detail reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 425,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Compliance with the North Carolina Coal Ash Management Act of 2014 requires Duke Energy to excavate and relocate coal‑combustion residuals from the four high‑priority ash basins (and the W.S. Lee site) to engineered on‑site or off‑site lined landfills or to approved beneficial‑use applications. The associated cleanup and closure work is recorded as an asset‑retirement obligation, increasing the company’s operating and capital‑cost burden, but Duke Energy has secured recovery of those costs through retail and wholesale rate‑case proceedings and the amendment of its wholesale contracts in 2017. Thus, the Act drives higher closure‑related expenditures that are reflected in the company’s AROs and are ultimately passed through to customers via regulated rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer. (1) It correctly identifies Duke Energy's compliance obligations under the North Carolina Coal Ash Management Act of 2014, including excavation and relocation of coal combustion residuals (CCR) from high-priority sites. The mention of 'four high-priority ash basins' and the W.S. Lee site is consistent with known Duke Energy disclosures, though the original answer only explicitly confirms completion at three of the four high-priority sites—this minor discrepancy does not constitute a factual error but adds a site not emphasized in the ground truth. (2) Quantitative accuracy is strong: the reference to 2017 FERC-approved cost recovery via amended wholesale contracts matches the original answer exactly; no dollar amounts are misstated. (3) The multi-hop reasoning is sound—LLM synthesizes information from both the business section (closure activities, cost recovery) and the glossary (regulatory significance), correctly linking compliance to asset retirement obligations (AROs), increased capital/operating costs, and cost recovery mechanisms. (4) The answer is contextually relevant, directly addressing how compliance impacts operational costs and closure activities. The only minor shortcoming is that it does not explicitly state that closure activities have begun in 'all of its jurisdictions' as in the original, but it does convey the broad scope of closure work. Overall, the semantic meaning and factual content are nearly identical to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 432,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family supplies the programmable logic that powers its Infrastructure Processing Unit (IPU) platforms – the Agilex fabric’s high‑performance, power‑efficient logic and transceivers are paired with Xeon D CPUs (e.g., the Oak Springs Canyon reference) to off‑load networking and data‑center tasks from the CPU and enable flexible, high‑speed acceleration. The Intel eASIC N5X, a structured‑ASIC product that sits between FPGAs and full ASICs, provides a lower‑cost, lower‑power, faster‑to‑market option for latency‑critical 5G, cloud, AI and edge workloads, complementing the Agilex‑based IPU approach by offering an alternative silicon solution for those same acceleration needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) All key facts are correct: Agilex FPGAs are used in IPUs to offload CPU tasks, built on Intel 10nm SuperFin (implied via 'high-performance, power-efficient'), and deployed in cloud providers (inferred via reference to Xeon D and data-center tasks). The eASIC N5X is correctly described as a structured ASIC that offers lower cost, lower power, and faster time-to-market than FPGAs, complementing Agilex in cloud and communications workloads. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored 10 by default. (3) Multi-hop reasoning is sound: the model correctly links Agilex FPGAs to IPU platforms, explains their role in offloading CPU tasks, and positions eASIC N5X as a complementary, lower-power alternative in the same application domains. The only minor omission is that the original specifies Agilex is 'already being deployed' at multiple CSPs, which the LLM implies but doesn't explicitly state. Also, the LLM adds specific detail (Xeon D, Oak Springs Canyon) not in the original, which is accurate and adds value without introducing error. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: Agilex's role in IPUs and how eASIC N5X fits into the ecosystem. Overall, the answer is semantically equivalent with excellent factual and conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 405,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher reported ≈ 24 000 employees in North America and ≈ 3 000 employees in “other developed markets,” for a combined total of about 27 000 associates. Those 27 000 workers represent roughly 27 000 ÷ 63 000 ≈ 42.9 % (≈ 43 %) of Danaher’s total global workforce.【Human Capital section, 2023 10‑K】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: 24,000 employees in North America and 3,000 in Other Developed Markets are correctly reported. The combined total of 27,000 is accurate. (2) The percentage calculation is correct: 27,000 ÷ 63,000 ≈ 0.42857, which rounds to 42.9% or approximately 43%, matching the ground truth of approximately 42.86%. Minor rounding differences are acceptable and do not affect correctness. (3) The multi-hop reasoning—aggregating employee counts across regions and calculating their share of the total global workforce of 63,000—is sound and properly executed. (4) Entities (Danaher, regions, employee counts, global workforce) are correctly identified and synthesized from the 2023 10-K. The answer addresses all parts of the question: employee counts in both regions and their collective percentage of the global workforce. Wording differs slightly but conveys the same factual content. No errors in logic, numbers, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 295,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "Nike reported that the fair‑value of its foreign‑exchange forwards and options was **$557 million** as of May 31 2023. That amount is identical to the **total derivative assets** shown on the 2023 balance sheet, which were also **$557 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is correctly stated as $557 million. (2) The quantitative accuracy is perfect—both the derivative asset value and the fair value of the instruments are reported as $557 million, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that the identical values indicate that all derivative assets consist of foreign exchange forwards and options, which aligns with the synthesis required across the disclosures. (4) The entities—Nike, the fiscal date (May 31, 2023), and the financial instruments (foreign exchange forwards and options)—are all accurately identified. The answer is semantically equivalent to the original, with clear and precise wording that conveys the same conclusion as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 269,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization and impairments expense for the Lower 48 rose from **$4.067 billion in 2021 to $5.729 billion in 2023** – an increase of **$1.662 billion**【COP_10k_2023.pdf page 155】. During the same period the number of productive wells completed in the Lower 48 fell from **87 in 2021 to 38 in 2023**, a decline of **49 wells**【COP_10k_2023.pdf page 152】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the depreciation, depletion, amortization, and impairments expense increased from $4,067 million ($4.067 billion) in 2021 to $5,729 million ($5.729 billion) in 2023, resulting in an increase of $1,662 million ($1.662 billion). The number of productive wells decreased from 87 in 2021 to 38 in 2023, a decline of 49 wells. All numeric values match exactly when accounting for unit formatting (billion vs million). (2) Calculations are accurate: $5,729M - $4,067M = $1,662M; 87 - 38 = 49. The LLM correctly interprets and reports the change in both financial expense and well count. (3) The multi-hop reasoning is sound—information is synthesized across two different data points (expense and well count) from the same region (Lower 48) and time frame (2021 to 2023), correctly pulled from the cited document. (4) The answer is semantically equivalent to the original, with only formatting differences (e.g., billion vs million, bolding, citation markers), which do not affect factual accuracy. All parts of the question are fully addressed with precise, correctly sourced information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 332,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The two fair‑value tables show $1,412 million of U.S. Treasuries and agencies in the pension‑plan assets and $138 million in the other post‑retirement (health‑care & life) plan assets, for a combined total of **$1,550 million**. That amount represents roughly **15 % of the pension‑plan’s $9,104 million of fair‑value investments**, but about **30 % of the health‑care & life plan’s $461 million of fair‑value investments**, indicating a markedly higher concentration of Treasury holdings in the post‑retirement benefit portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) The total combined value is incorrectly calculated as $1,550 million, whereas the ground truth states $2,953 million, derived from $1,412 million in the first table and $1,541 million in the second. The LLM incorrectly treats the $138 million (which is Level 2 portion of the first table's $1,412 million) as a separate table value, misrepresenting the structure of the data. (2) The LLM introduces entities not present in the original answer: 'pension-plan assets' and 'other post-retirement (health-care & life) plan assets' are not mentioned in the ground truth, which refers only to two categorizations of investments at fair value without specifying plan types. This reflects a misinterpretation of the source tables. (3) The percentages (15% of $9,104 million and 30% of $461 million) are not supported by the ground truth and appear fabricated, as the original answer does not provide portfolio percentages or total investment amounts. (4) The reasoning fails the multi-hop requirement: instead of comparing Level 1/Level 2 allocations across two fair value tables for U.S. Treasuries and agencies, the LLM invents a narrative about different benefit plans. While the mention of Level 1 and Level 2 exists in the correct context, the values are misassigned. The contextual relevance is moderate because the answer addresses fair value categorizations and U.S. Treasuries, but the incorrect synthesis severely undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 413,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Nike’s timed‑deposit balances that are included in cash and equivalents fell from $502 million in fiscal 2023 to $347 million in fiscal 2024 – a decrease of **$155 million**【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the decrease in Nike's timed deposits classified as cash and equivalents from fiscal year 2023 to 2024 is correctly stated as $155 million. (2) Quantitative accuracy is perfect — the LLM provides the exact starting value ($502 million in 2023) and ending value ($347 million in 2024), and the calculated difference ($502M - $347M = $155M) is correct. (3) The multi-hop reasoning is sound: the model correctly identifies Nike, the relevant fiscal years (2023 to 2024), and the specific financial metric (timed deposits classified as cash and equivalents), then synthesizes the data to compute the change. (4) The answer is semantically equivalent to the original, with added detail (specific values for both years) that improves clarity without introducing error. All entities, years, and metrics are correctly identified and used. No errors in reasoning, calculation, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1065,
        "completion_tokens": 283,
        "total_tokens": 1348
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The 2023 depreciation, depletion, amortization and impairment expense for the two U.S. segments was:\n\n* Alaska – $1,061 million  \n* Lower 48 – $5,729 million  \n\nCombined = $6,790 million.\n\nIn 2022 the same items were:\n\n* Alaska – $941 million  \n* Lower 48 – $4,854 million  \n\nCombined = $5,795 million.\n\nThus, the combined expense rose from about **$5.8 billion in 2022 to $6.8 billion in 2023**, an increase of roughly **$1.0 billion**【COP_10k_2023.pdf page 138】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numeric values are accurate: 2023 combined total is $6,790 million ($1,061M + $5,729M), and 2022 combined total is $5,795 million ($941M + $4,854M), both matching the original answer. The increase is correctly calculated as $995 million, which the LLM rounds to 'roughly $1.0 billion', an acceptable approximation. (2) The answer addresses both parts of the question: the 2023 total and its comparison to 2022. (3) Entities (Alaska and Lower 48 operations, correct years, correct expense category) are accurately identified. (4) The multi-hop reasoning—aggregating two segments across two years and computing the year-over-year change—is sound and well-explained. The use of rounded figures ($5.8 billion, $6.8 billion) does not detract from factual accuracy, as they are semantically equivalent to the precise values. The citation reference to COP_10k_2023.pdf page 138 supports the data. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 287,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "As of December 31 2022 PayPal reported a crypto‑asset safeguarding asset of **$604 million** and a matching crypto‑asset safeguarding liability of **$604 million**, for a combined fair‑value amount of **$1.208 billion**. These amounts appear in the “financial assets and liabilities measured at fair value on a recurring basis” table (Level 2 of the fair‑value hierarchy) and the footnote explains that, because no active market exists for the safeguarding positions, the company values both the asset and the liability using quoted prices on the exchange it has identified as the principal market for the underlying crypto assets (Level 2 inputs). The asset is recorded in “prepaid expenses and other current assets” and the liability in “accrued expenses and other current liabilities.”",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in quantitative accuracy by stating a 'combined fair-value amount of $1.208 billion', which is incorrect. The original answer specifies that both the asset and liability are $604 million individually, but does not state or imply a sum of the two. In financial reporting, offsetting assets and liabilities is not standard without explicit indication, and the ground truth does not mention any combined total. Therefore, the calculation of $1.208 billion is a factual misrepresentation. However, the individual values of $604 million for both the asset and liability are correct, as is the date (December 31, 2022). (2) The LLM correctly identifies the fair value measurement level as Level 2 (Significant Other Observable Inputs), and accurately references the use of quoted prices from the principal market due to lack of active market—this aligns with the original answer’s disclosure context. (3) The multi-hop reasoning is partially sound: the model correctly associates the asset and liability with Level 2 inputs and ties them to appropriate disclosures. However, it introduces a synthesis error by combining the values, which was not asked nor supported by the ground truth. (4) Entity accuracy is strong—PayPal Holdings, Inc., correct metric names, and correct time period are used. Contextual relevance is high as the response addresses fair value measurement disclosures and locations in financial statements. However, the incorrect summation significantly undermines factual correctness, warranting a low correctness score despite some accurate components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 444,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "During fiscal 2024 Walmart paid $3.5 billion to buy out former PhonePe non‑controlling‑interest holders, while it simultaneously received $0.7 billion from a new equity‑funding round for PhonePe. The net result was a cash outflow of roughly $2.8 billion attributable to the PhonePe ownership changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states Walmart paid $0.9 billion to increase ownership in PhonePe, but the LLM claims $3.5 billion, which is nearly 4x higher. The $0.7 billion from new equity funding is correctly reported. However, due to the incorrect outflow, the net cash outflow is calculated as $2.8 billion instead of the correct $0.2 billion. (2) Quantitative accuracy is severely compromised: the $3.5B outflow is wrong, the $0.7B inflow is correct, and the resulting $2.8B net outflow (vs. $0.2B) reflects a major calculation error stemming from incorrect inputs. (3) While the model correctly identifies the two components of the transaction (cash outflow for ownership increase and inflow from equity funding), it fails in the multi-hop synthesis by using incorrect financial figures, likely due to hallucination or misattribution. The reasoning structure is sound—calculate net impact via outflow minus inflow—but based on false data. (4) Contextual relevance is high because the answer addresses the right entities (Walmart, PhonePe), time period (fiscal 2024), and financial events (buyout of non-controlling interests, equity funding). However, the severe numerical inaccuracies drastically reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 361,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "Southern Company’s combined wholesale revenues rose from $672 million in 2023 to $741 million in 2024 – a net increase of roughly $69 million.  The gain was driven by a $77 million rise in Georgia Power’s wholesale sales and a $79 million jump in Alabama Power’s affiliate sales, which more than offset the $87 million drop in Alabama Power’s non‑affiliate sales.  Both subsidiaries sell to affiliated utilities under the FERC‑approved Inter‑Integrated Coordination (IIC) mechanism, which prices the energy at marginal cost; this arrangement enabled the large affiliate‑sale increases that helped lift total wholesale revenue despite weaker non‑affiliate sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net change in total wholesale revenues as a $69 million increase from 2023 to 2024, matching the ground truth. It accurately breaks this down into a $77 million increase in Georgia Power’s wholesale sales and a $79 million increase in Alabama Power’s affiliate sales, offset by an $87 million decrease in Alabama Power’s non-affiliate sales. These figures align with the ground truth’s description of segment-level changes, even though the original answer does not explicitly name Georgia Power or Alabama Power—this additional specificity is consistent with plausible internal segmentation and does not contradict the truth. (2) All numeric values are correct and calculations are accurate: $77M + ($79M - $87M) = $77M - $8M = $69M net increase. The total revenue figures ($672M in 2023, $741M in 2024) are consistent with this change and represent acceptable derived values. (3) The reasoning correctly attributes the rise in affiliate sales to the IIC-approved FERC pricing mechanism that sets prices at marginal cost, which stabilizes internal transactions and enabled increased affiliate sales volume. While the ground truth mentions a 165.5% rise in KWH volume (a detail missing in the LLM answer), the core causal mechanism—the IIC/FFERC pricing enabling large affiliate sales increases—is correctly identified and logically tied to the outcome. (4) The answer is contextually complete and relevant, addressing both the quantitative change and the influence of the IIC mechanism. The minor omission of the exact percentage increase in KWH volume prevents a perfect 10, but all key financial and causal elements are present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 463,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Intel said it will spend roughly $20 billion on two new Arizona fabs, more than $20 billion on two new Ohio fabs, and about $10.5 billion to outfit its Rio Rancho (NM) and Malaysia sites for advanced packaging – a total manufacturing‑expansion commitment of roughly $50.5 billion (i.e., just over $50 billion).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts are accurate: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for advanced packaging in Rio Rancho and Malaysia. The total of $50.5 billion is correctly calculated and reported as 'roughly $50.5 billion' and 'just over $50 billion', which is semantically equivalent and appropriately reflects the imprecision in the Ohio investment ('more than $20 billion'). (2) The answer is complete, addressing all three components of the investment (Arizona, Ohio, and global packaging sites) as required by the multi-hop question. (3) Entities are correctly identified: Intel, Arizona, Ohio, Rio Rancho (NM), Malaysia, and the IDM 2.0 strategy context are all accurately referenced. (4) The reasoning is sound—information is synthesized correctly across the three investment components, and the total is logically derived. Minor wording differences (e.g., 'outfit' vs 'equip') do not affect factual accuracy. Overall, the answer is factually precise, contextually relevant, and demonstrates correct multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 324,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher preliminarily recorded **about $3.9 billion of goodwill** in connection with the Abcam acquisition. The Veralto separation generated **approximately $2.6 billion of net cash** that Danaher received before the September 30, 2023 distribution date, boosting its cash position by that amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Danaher recorded approximately $3.9 billion of goodwill from the Abcam acquisition and received $2.6 billion in net cash from Veralto prior to the distribution date, both of which match the ground truth. The mention of the September 30, 2023 distribution date adds contextual precision not in the original answer but is factually accurate and enhances clarity. (2) All numeric values—$3.9 billion and $2.6 billion—are quantitatively accurate and correctly attributed. There are no calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information about two distinct events (Abcam acquisition goodwill and Veralto separation cash impact) as required by the question. It correctly identifies the causal relationship between the Veralto separation and Danaher’s cash position. The only minor omission is that the original answer notes $1.0 billion of the cash was used to redeem commercial paper, which the LLM answer does not mention. While this detail is relevant to how the cash was used, it is not directly asked in the question, which focuses on the impact on cash position *prior* to distribution—so the omission does not materially affect correctness. (4) The answer is semantically equivalent to the ground truth, with clear, concise, and relevant phrasing. The scores reflect high accuracy in all areas, with a slight deduction in qualitative accuracy due to the omitted detail about commercial paper redemption, though it does not undermine the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 426,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "In fiscal 2024 Nike recorded a **$24 million net gain** from foreign‑exchange forwards and options that was recognized directly in income (the “Derivatives not designated as hedging instruments” line). At year‑end, the same class of contracts was carried on the balance sheet at **$343 million of fair‑value assets** and **$240 million of fair‑value liabilities** (the sum of the $120 million liability‑fair‑value amount, $115 million accrued‑liability amount and $5 million other‑liability amount). Thus, the income gain represents roughly 7 % of the assets’ fair value and about 10 % of the net‑position (assets – liabilities) of these derivatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $24 million net gain from foreign exchange forwards and options in fiscal year 2024, which matches the ground truth. However, it reports incorrect fair value figures: $343 million in assets and $240 million in liabilities, whereas the ground truth states $557 million in assets and $180 million in liabilities. The LLM attempts to break down the liability into components ($120M + $115M + $5M), but this breakdown is not supported by the ground truth and introduces factual inaccuracies. (2) The calculations based on these incorrect values (e.g., 7% of assets, 10% of net position) are therefore also wrong. The correct net fair value position would be $557M - $180M = $377M, and $24M is about 4.3% of that—significantly different from the 10% claimed. (3) The reasoning structure is sound—recognizing income gain versus year-end fair value and attempting to compare them—but the multi-hop synthesis fails because it relies on incorrect balance sheet values. The model appears to have pulled data from a different source or misread the filing. (4) While the answer addresses both parts of the question and uses appropriate financial logic, the significant numerical inaccuracies in the fair value amounts severely undermine factual correctness. The contextual relevance is high as it directly responds to the question’s structure and intent, but the core data is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 393,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "In 2022 the discounted future net cash‑flow estimate for the Lower 48 region was **$55.9 billion** (Consolidated operations $55,912 million + no equity‑affiliate amount).  The same year’s depreciation, depletion, amortization and impairments for the Lower 48 were **$4.9 billion**.  Thus, the depreciation expense is roughly one‑twelfth of the discounted future net‑cash‑flow estimate for that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key figures: $55,912 million (presented as $55.9 billion) for discounted future net cash flows from consolidated operations in the Lower 48 region, with no contribution from equity affiliates. This matches the ground truth exactly. The depreciation, depletion, amortization, and impairments are reported as $4.9 billion, which is a rounded version of the exact $4,854 million in the original answer. The rounding is acceptable and common in financial reporting. (2) Quantitative accuracy is high: $55,912 million = $55.912 billion ≈ $55.9 billion (correct rounding to one decimal place). $4,854 million = $4.854 billion ≈ $4.9 billion (also a reasonable rounding). The comparison stating that depreciation expense is roughly one-twelfth of the future cash flows is logically sound: $4.854B / $55.912B ≈ 8.7%, which is approximately 1/11.5, close enough to 'one-twelfth' for qualitative comparison. (3) Multi-hop reasoning is correct: the model synthesizes data from consolidated operations and equity affiliates (noting zero contribution), computes the total, and compares it to another financial metric from the same region and year. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only minor deviation is the rounding of $4,854 million to $4.9 billion instead of $4.85 billion, which slightly reduces quantitative precision but does not affect overall correctness. Hence, a score of 9 is justified—excellent accuracy with negligible rounding difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 428,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "PayPal reported **$563 million** of Loans and Interest Receivable, held for sale on its December 31 2023 balance sheet.  The fair‑value measurement for this asset is also **$563 million**, and it is classified in **Level 3 of the fair‑value hierarchy** because the valuation relies on significant unobservable inputs (the price the company expects to receive from the buyer).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurately reported with correct date and dollar amount. The format ($563 million) is equivalent to the ground truth. (2) The answer correctly states that the entire fair value of $563 million is based on Level 3 inputs, which aligns with the ground truth that the amount is entirely measured using significant unobservable inputs. (3) The reasoning is sound: it identifies the correct financial instrument, links it to the appropriate fair value hierarchy level, and explains that Level 3 classification is due to reliance on unobservable inputs (e.g., expected sale price), demonstrating proper multi-hop synthesis between balance sheet value and fair value disclosure. (4) All entities—PayPal, the financial metric, the date, and the fair value hierarchy level—are accurate. The answer is semantically equivalent to the original, with slightly expanded but factually consistent explanation (e.g., mentioning 'price the company expects to receive' as part of Level 3 inputs). No factual or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 341,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During 2023 the company **borrowed $3.0 billion and repaid $6.1 billion** of revolving indebtedness under the **2021 Multicurrency Credit Facility** (the repayments include about €842.6 million, or $919.1 million, of EUR‑denominated borrowings).  \n\nIn the same period it **borrowed $3.1 billion and repaid $2.6 billion** of revolving indebtedness under the **2021 Credit Facility**.  \n\nThus, borrowing was roughly the same under both facilities, but the multicurrency facility saw substantially larger repayments (about $3.5 billion more) than the 2021 Credit Facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: it correctly states that $3.0 billion was borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility. These numbers exactly match the original answer, and the net repayment of $3.1 billion (for the multicurrency facility) and net borrowing of $0.5 billion (for the 2021 Credit Facility) are implied correctly through the stated inflows and outflows. The additional detail about €842.6 million ($919.1 million) in EUR-denominated repayments is contextually helpful and does not contradict the total repayment amount; it likely explains part of the $6.1 billion repayment figure. The comparison correctly highlights that borrowings were similar across both facilities, while repayments were significantly higher in the multicurrency facility—specifically noting $3.5 billion more in repayments, which aligns with the $6.1B - $2.6B = $3.5B difference. The only minor shortcoming is that the LLM does not explicitly state the net repayment and net borrowing figures ($3.1B net repayment and $0.5B net borrowing), which were included in the original answer and represent a small completeness gap. However, since these can be directly inferred and the core multi-hop synthesis (comparing two facilities across borrowings and repayments in 2023) is fully accurate, this does not significantly detract from correctness. All entities (2021 Multicurrency Credit Facility, 2021 Credit Facility, year 2023) are correctly identified and matched to the right figures. The reasoning is sound and the answer is contextually complete and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 468,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "Both Georgia Power and Mississippi Power were audited using the same set of procedures: the auditors tested the effectiveness of management’s controls over (1) evaluating the likelihood that incurred costs will be recovered in future rates (or that refunds or rate reductions will be required) and over the initial recognition of regulatory assets or liabilities; they read and evaluated the relevant regulatory orders and other public information to gauge that likelihood; they performed substantive tests on the costs recorded as regulatory assets or liabilities for completeness and accuracy; they obtained management representations on recoverability, refunds or future rate reductions; and they reviewed the companies’ disclosures of the regulatory‑impact balances, noting the high degree of subjectivity in those judgments. These steps underscore the subjectivity of the audit because they rely on management’s estimates and assumptions about how future commission orders—events that are not yet known—will treat the costs, requiring the auditor to evaluate the reasonableness of those forward‑looking judgments rather than verify a deterministic outcome.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: both Georgia Power and Mississippi Power underwent the same audit procedures focused on management’s controls over recovery likelihood of incurred costs, review of regulatory orders and public information, substantive testing of regulatory assets/liabilities, obtaining management representations, and disclosure review. These points are consistent with the ground truth, which emphasizes control testing, regulatory precedent review, and recognition of subjectivity. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect data supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same procedures apply to both companies and links those procedures to the inherent subjectivity in forecasting future regulatory outcomes. The LLM adds slightly more detail (e.g., substantive testing, disclosure review, recognition of regulatory assets/liabilities), which is consistent with auditing standards and plausibly part of the full procedure set, even if not explicitly stated in the ground truth. This elaboration does not contradict but enriches the answer, assuming it reflects actual audit steps. (4) The core concept—that these procedures reflect high subjectivity due to reliance on management’s forward-looking judgments about uncertain regulatory decisions—is clearly and correctly conveyed. The only reason for not scoring a perfect 10 is that the original answer emphasizes the subjectivity more succinctly as being tied directly to 'likelihood of recovery, disallowance, or refund obligations,' while the LLM spreads it across several points. Still, the semantic meaning and factual content are equivalent. Contextual relevance is perfect—the response directly addresses both parts of the question: specific procedures and how they reflect subjectivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 554,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The 70 % drop in Comirnaty’s worldwide revenue (from $37.8 billion in 2022 to $11.2 billion in 2023) was a major driver of the $40.8 billion operational decline in total revenues and forced a $14.2 billion reduction in cost of sales, which together produced a $9.4 billion decrease in cost‑of‑sales and lowered Pfizer’s operating results for the year. The BioNTech collaboration, however, obligates Pfizer to an upfront $225 million payment (including $75 million cash and $150 million equity) and exposes it to up‑to‑$200 million in future regulatory‑ and sales‑milestone payments plus ongoing profit‑share on any vaccine commercialization, creating additional future cash‑flow and expense commitments that will affect its financial obligations beyond 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and collaboration terms. While it correctly identifies the 70% drop in Comirnaty revenue from $37.8 billion (approximating $37,806 million) to $11.2 billion (approximating $11,220 million), it fabricates several key numbers not present in the ground truth. Specifically, the claim of a '$40.8 billion operational decline in total revenues' is unsupported and conflates Comirnaty's decline with Pfizer's overall performance without evidence. The $14.2 billion reduction in cost of sales and resulting $9.4 billion decrease in cost-of-sales are entirely invented and not mentioned in the original answer. (2) The collaboration terms with BioNTech are misrepresented: the original answer states Pfizer pays tiered royalties and shares gross profits globally (excluding certain regions), but the LLM incorrectly claims an 'upfront $225 million payment' (with $75M cash and $150M equity) and 'up to $200 million in milestone payments'—details absent from the ground truth. These specific payments may relate to earlier development phases but are not part of the 2023 financial obligations described. (3) Multi-hop reasoning is partially sound in linking Comirnaty revenue decline to operational impact and connecting the BioNTech agreement to future obligations, but the synthesis fails due to incorrect data integration. The model attempts to quantify broader impacts but does so with fabricated intermediate figures. (4) Despite these errors, the answer remains contextually relevant by addressing both parts of the question—impact on operational results and future financial obligations—and correctly identifying the key entities (Pfizer, BioNTech, Comirnaty) and time frame (2023). However, the severe quantitative inaccuracies and incorrect contractual terms significantly undermine factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 525,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "Nike’s short‑term investment portfolio included U.S. Agency securities of **$35 million** at May 31 2024, compared with **$46 million** at May 31 2023. This represents a **year‑over‑year decline of $11 million** in the value of those securities【source: Note 4 – Fair Value Measurements, short‑term investments table, 2024 (35) and 2023 (46)】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of U.S. Agency securities are accurately reported as $35 million as of May 31, 2024, and $46 million as of May 31, 2023. The year-over-year change is correctly calculated as a decrease of $11 million ($46M - $35M = $11M), which aligns with the ground truth. Minor formatting differences (e.g., $11 million vs $11 million) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the current and prior year values as well as the year-over-year change, satisfying all parts of the multi-hop question. (3) Entity accuracy is correct: NKE (Nike) is properly identified, the metric (U.S. Agency securities as short-term investments) is accurate, and the fiscal dates (May 31, 2024 and 2023) match the question. (4) The reasoning is sound—information is synthesized correctly across two time points from the same financial line item, and the conclusion (decline of $11 million) follows logically. The citation to Note 4 adds contextual support. (5) The semantic meaning is equivalent to the original answer, with clear, precise, and factually aligned wording. All scoring criteria are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 343,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "In 2024 Costco’s Japanese subsidiary did not issue any new Guaranteed Senior Notes; it only repaid $77 million of those notes in July 2024. Thus, the total principal amount of the Guaranteed Senior Notes fell by $77 million for the year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states there was a net increase of $423 million in the total principal amount of Guaranteed Senior Notes in 2024, whereas the LLM claims a decrease of $77 million due to repayments with no new issuances. This directly contradicts the correct answer. (2) The quantitative inaccuracies are severe: the LLM reports a $77 million repayment as the only activity, but the correct answer implies that new issuances must have exceeded repayments by $423 million. There is no indication of the scale or direction of change matching reality. The date (July 2024) may be accurate for a repayment, but without correct context and synthesis, it misleads. (3) The multi-hop reasoning failed: the model did not correctly synthesize data on both issuances and repayments to compute net change. It incorrectly assumed no new issuances occurred, which contradicts the required knowledge for the correct net increase. (4) Scores are low because the core fact (net change) is wrong in both magnitude and direction. The answer fails on correctness, quantitative precision, logical reasoning, and only has minimal relevance due to mentioning the correct entity (Costco’s Japanese subsidiary) and financial instrument (Guaranteed Senior Notes).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 361,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "3M’s stand‑alone letters of credit, bank guarantees and similar instruments total **about $0.5 billion** (≈ $500 million) at December 31 2024.  By contrast, the company held **approximately $4.2 billion** in cash, cash equivalents and marketable securities in the United States on that date.  Thus, the U.S. cash and marketable‑securities balance is roughly eight times larger than the value of its stand‑alone credit instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments as $0.5 billion and the U.S. cash, cash equivalents, and marketable securities as $4.2 billion as of December 31, 2024, matching the ground truth exactly. These values are reported accurately with acceptable formatting variations (e.g., $0.5 billion ≈ $500 million). (2) The quantitative accuracy is perfect: both figures are correct, and while the original answer computes the percentage (11.9%), the LLM instead states that the U.S. balance is 'roughly eight times larger,' which is logically equivalent (since 1 / 0.119 ≈ 8.4), making the comparison factually sound and semantically consistent. The minor omission of the exact percentage (11.9%) does not detract from the correctness of the comparative relationship. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct data points (liabilities in the form of credit instruments and assets in the form of U.S. liquidity) and draws a valid conclusion about their relative magnitude. (4) The answer is fully contextually relevant, addressing both parts of the question—total value of instruments and comparison to U.S. liquidity. The qualitative score is slightly reduced not for inaccuracy, but because the original answer includes a precise percentage (11.9%), which provides slightly more analytical depth, though the LLM's 'eight times larger' conveys the same practical insight. Overall, this is a highly accurate, complete, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 433,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "Meta estimated that duplicate accounts made up **about 10 % of its worldwide MAUs** in Q4 2023, while **false accounts accounted for roughly 4 % of worldwide MAUs** in the same quarter. Thus, duplicate accounts represented roughly 6 percentage points (or about 2½ times) more of the MAU base than false accounts.【META_10k_2023.pdf p.33‑34】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 10% for duplicate accounts and 4% for false accounts in Q4 2023, as stated in the original answer and confirmed on p.33-34 of META's 10-K. (2) The comparison is correctly interpreted: the LLM notes that duplicate accounts were about 2.5 times more prevalent than false accounts, which is consistent with the ground truth stating they were 'more than twice as prevalent.' The 6-percentage-point difference (10% - 4%) is also accurately mentioned. (3) The reasoning is sound and involves correct multi-hop synthesis: the model correctly identifies both metrics (duplicate vs. false accounts), applies them to the correct time period (Q4 2023) and user base (worldwide MAUs), and draws a valid comparative conclusion. (4) All entities—Meta, MAUs, duplicate accounts, false accounts, Q4 2023—are correctly identified and contextualized. (5) The answer is semantically equivalent to the original, with slightly more precise phrasing (e.g., '2½ times') that enhances clarity without altering meaning. Minor formatting differences (e.g., use of symbols like % and bolding) do not affect accuracy. The citation to the source document further supports reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 357,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer’s shingles‑vaccine deal with BioNTech included an upfront cash payment of **$75 million**.  \nFor the migraine‑treatment rights with Biohaven, Pfizer paid an upfront cash amount of **$150 million**—exactly **$75 million more** (twice the amount) than it paid BioNTech.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the upfront payments of $75 million to BioNTech and $150 million to Biohaven are accurately reported. The difference of $75 million is correctly implied by stating that the Biohaven payment was 'twice the amount' and '$75 million more'—this aligns with the ground truth calculation. (2) The answer is complete, addressing both parts of the question: the upfront amounts for both collaborations and their comparison. (3) Entity accuracy is correct—Pfizer, BioNTech (shingles mRNA vaccine), and Biohaven (migraine treatment outside the U.S.) are properly identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes data across two separate deals, compares them quantitatively, and draws a valid conclusion. (5) Semantic equivalence is maintained—the LLM conveys the same information as the original answer, with slightly different phrasing but identical factual content. Minor formatting variations (e.g., $75 million vs $75 million) are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 310,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "As of May 31 2024, the company’s foreign‑exchange forward and option liabilities consist of:\n\n* $120 million recorded as derivative liabilities at fair value,  \n* $115 million recorded as accrued‑liability balances (including both hedging‑designated and non‑hedging amounts), and  \n* $5 million recorded as other long‑term liabilities.  \n\nTogether, these amount to **$240 million** in total foreign‑exchange forward and option liabilities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the ground truth states the total liability is $115 million, composed of $110 million from hedging-designated derivatives and $5 million from non-hedging derivatives. The LLM incorrectly reports a total of $240 million by summing unrelated line items ($120M, $115M, $5M), which appear to be misinterpreted categories (e.g., balance sheet classifications) not requested in the question. (2) The calculation is erroneous: the question asks for the total amount of liabilities related to foreign exchange forwards and options, not their distribution across balance sheet accounts. The LLM invents a sum not supported by the ground truth. (3) Qualitatively, the reasoning fails multi-hop synthesis: instead of aggregating hedging and non-hedging instruments as per the original answer, it introduces extraneous and incorrect categories (e.g., 'accrued-liability balances', 'other long-term liabilities') not mentioned in the ground truth. (4) Contextual relevance is low because the answer addresses a different question—about balance sheet presentation—rather than the total liability amount from specific derivative types. The only correct element is the mention of $5 million in non-hedging instruments, but even this is embedded in an incorrect context. Overall, the answer is factually wrong and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 390,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal records a crypto‑asset safeguarding liability (and a matching safeguarding asset) to reflect that the cryptocurrencies it holds for customers are not its own assets but a custodial obligation. In the “Concentrations of risk” note the company says that cash, cash equivalents and customer accounts—including the assets underlying those accounts—are deposited with a limited number of high‑quality financial institutions, creating a credit‑risk concentration. Therefore, the crypto‑safeguarding liability is subject to the same credit‑risk concentration, meaning PayPal’s exposure to loss on customer‑held crypto assets depends on the creditworthiness of the banks or custodians where those assets are parked.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly explains that PayPal recognizes a crypto asset safeguarding liability to reflect its custodial obligation, not ownership, and links this to credit risk concentration via the financial institutions where customer funds are held. The mention of a 'matching safeguarding asset' is consistent with accounting principles and adds clarity, though not explicitly in the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly connects the safeguarding liability to the risk concentration disclosure and infers that credit risk stems from the custodian institutions, not the crypto assets themselves. It accurately reflects that these balances may exceed FDIC limits (implied by 'high-quality financial institutions' and risk concentration), though it does not explicitly state that FDIC limits are exceeded, which is a minor omission. (4) The answer is contextually precise, directly addressing how the liability relates to risk disclosures and credit exposure. The only reason for not scoring a 10 is the slight lack of explicit mention that customer funds may exceed FDIC insurance limits, which is a key nuance in the original answer regarding the source and severity of credit risk. Otherwise, the semantic meaning and factual content are equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 406,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 Stock Incentive Plan resulted in the issuance of **689,202 long‑term incentive performance (LTIP) units, net of forfeitures**.  For the year ended December 31 2024, those units were listed among potentially dilutive securities, but **they had no material dilutive effect on the company’s stock** for that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of LTIP units issued net of forfeitures is accurately stated as 689,202, matching the original answer exactly. The date reference (year ended December 31, 2024) is also correct. (2) The answer addresses both parts of the question: the quantity of LTIP units issued and their impact on stock dilution. (3) Entity accuracy is correct—the 2019 Plan and LTIP units are properly identified, and the financial impact is correctly characterized. (4) The reasoning is sound: the units are correctly described as potentially dilutive but having no material dilutive effect, which aligns with the ground truth. There is no factual discrepancy, and the wording, while slightly rephrased, conveys the same precise information. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 254,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "The 2024 Form 10‑K shows that the “manufactured PFAS products” special‑item added **$0.28 per diluted share** to earnings (loss) from continuing operations. In 2022 the same item had added **$0.90 per diluted share**. Thus, the PFAS‑related impact on diluted earnings was roughly three‑quarters lower in 2024 than it was in 2022. 【source lines showing “Manufactured PFASproducts 0.28 2024” and “Manufactured PFASproducts 0.90 2022”】",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in direction and magnitude of the financial impact. The ground truth states that PFAS products caused a *reduction* of $0.20 in EPS in 2024 and $0.90 in 2022. However, the LLM claims the 2024 impact was an *addition* of $0.28 per share, which contradicts the ground truth both in sign (positive vs negative) and value ($0.28 vs $0.20). The 2022 figure is correctly cited as $0.90, but again, it is mischaracterized as an 'add' when it should be a reduction. (2) Quantitative accuracy is partially correct for 2022 ($0.90 matches), but 2024 is wrong: $0.28 ≠ $0.20, and the direction (positive vs negative) is incorrect. The comparison stating the impact was 'three-quarters lower' is based on flawed premises and thus invalid. (3) Multi-hop reasoning fails because the model did not correctly interpret the nature of the financial impact (expense vs gain), leading to incorrect synthesis across years. It also fails to report the combined $1.10 total impact over the two years, which is a key part of the original answer. (4) Contextual relevance is moderate—the response addresses the right company (3M), metric (EPS), and years (2024, 2022), and references the correct category (manufactured PFAS products), but misrepresents the core financial effect. Due to major errors in quantitative and qualitative accuracy, especially the reversal of the impact direction, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 406,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "In 2024 the Intercompany Interchange Contract‑governed KWH sales to affiliates jumped 165.5% (to 5.6 billion KWh), lifting affiliate wholesale revenue from $60 million in 2023 to $139 million in 2024 (+$79 million, +131.7%). Conversely, KWH sales to non‑affiliates fell 30.8% (to 6.5 billion KWh), pulling non‑affiliate wholesale revenue down from $424 million to $337 million (‑$87 million, ‑20.5%). The large affiliate gain was largely offset by the non‑affiliate loss, leaving total wholesale revenue for the Southern Company system essentially flat – $476 million in 2024 versus $484 million in 2023, a modest $8 million decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the 165.5% increase in KWH volume to affiliates and the 30.8% decrease in non-affiliate KWH sales, along with the corresponding revenue changes: +$79 million (+131.7%) for affiliates and -$87 million (-20.5%) for non-affiliates. These figures match the ground truth exactly. The LLM also correctly calculates total wholesale revenue as $476 million in 2024 (vs $484 million in 2023), a $8 million decline, which is consistent with the sum of the two revenue changes. (2) All calculations are accurate: $60M to $139M is indeed a $79M increase and ~131.7% rise; $424M to $337M is an $87M drop and ~20.5% decline. The total revenue figures ($476M in 2024) are correct and derived from valid addition (139 + 337 = 476). Minor rounding in percentages or volumes does not affect accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes data across affiliate/non-affiliate segments, links volume changes to revenue impacts, and correctly infers that the IIC governed the affiliate sales (implied by context and alignment with FERC-approved intercompany transfers). It also correctly concludes that the overall system revenue remained nearly flat due to offsetting movements, which is a valid inference from the data. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the *mitigation* effect of IIC-based sales on revenue decline, while the LLM focuses more on the net flat outcome without explicitly framing it as a mitigation strategy. However, this is a nuance in emphasis, not a factual error. All entities (Southern Company system, affiliates, non-affiliates, IIC), years (2024), and metrics (KWH volume, wholesale revenue) are correct. The answer is fully contextually relevant and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 505,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission levied an administrative fine of **€1.2 billion** on Meta Platforms Ireland together with corrective orders to suspend the unlawful transfers and bring its processing into GDPR compliance. Meta notes that implementing the corrective steps “could increase the cost and complexity of delivering our products and services in Europe,” meaning the company can expect higher compliance‑related operating expenses in the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The financial penalty of €1.2 billion is correctly stated, matching the original answer exactly. No other numbers or dates are involved. (2) Completeness: The answer addresses both parts of the question — the total financial penalty and the potential impact on Meta's operational costs in Europe. (3) Entity accuracy: 'Irish Data Protection Commission', 'Meta Platforms Ireland', 'GDPR', and 'Europe' are all correctly identified. (4) Reasoning: The LLM correctly synthesizes that the corrective orders (suspension of unlawful data transfers) could increase cost and complexity, citing Meta's own assessment, which aligns with the original answer's claim about increased compliance burden. The reference to higher compliance-related operating expenses captures the intended meaning of increased operational costs. (5) Semantic equivalence: While phrased slightly differently, all key facts and implications are preserved accurately. Minor wording differences (e.g., 'administrative fine' vs 'financial penalty') do not affect factual correctness. The LLM even enhances clarity by attributing the cost impact statement to Meta, which is consistent with the source. No errors in multi-hop reasoning — correctly links regulatory action to financial penalty and then to operational consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 386,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "Home Depot says that giving Pros a deep assortment—including the specialized, “job‑lot” quantities they need for large or complex projects—lets the retailer serve as a one‑stop, reliable source for urgent, high‑volume purchases, which is a core pillar of its growth strategy with professional customers. The filing warns that if it cannot maintain that product depth and bulk‑size offering, Pros may shift to competitors, eroding demand, market share and profit margins and weakening Home Depot’s overall competitiveness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that The Home Depot's product depth and job lot quantities are designed to meet the needs of professional customers (Pros) by serving as a one-stop, reliable source for high-volume, complex purchases—aligning with the original answer's emphasis on meeting complex purchase needs and providing dedicated support. The risk of not maintaining this offering is accurately described: loss of demand, reduced profit margins, and weakened competitiveness, with the LLM adding 'market share' and 'shift to competitors,' which are reasonable inferences consistent with the original. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced not due to error but because the original answer specifically ties the risk to the failure to maintain competitive delivery and pickup options alongside product depth—this linkage is implied but not explicitly stated in the LLM response. However, the core multi-hop reasoning (linking product strategy to Pro customer needs and then to competitive risks) is sound and well-synthesized. Contextual relevance is perfect, as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 370,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The tables show that the pension‑plan reconciliation omits the participating interest in the insurance annuity contract – $83 million for 2021 and $94 million for 2020 – for a combined excluded amount of **$177 million**.  Because this interest is classified as a Level 3 asset and is valued using a mix of quoted prices, recent transaction data and actuarial present‑value calculations, its exclusion signals that the investment is difficult to price with observable market inputs and requires complex, judgment‑heavy modeling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total excluded value as $177 million by summing $94 million (2020) and $83 million (2021), which matches the ground truth. The order of years is reversed in the LLM answer (mentions 2021 first, then 2020), but the values are accurate and correctly summed. (2) All numeric values are correct and properly formatted; the calculation ($94M + $83M = $177M) is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two disclosures (2020 and 2021) and infers that the exclusion relates to valuation complexity. It appropriately links the exclusion to Level 3 classification and explains that valuation relies on unobservable inputs and complex modeling, which aligns with the ground truth’s implication of complexity due to lack of market data. (4) The only minor shortcoming is that the LLM does not explicitly state that the exclusion is *because* these instruments are hard to value—instead, it infers complexity from the use of judgment-heavy models. While this is logically valid, it slightly reframes the causality compared to the original answer. However, the semantic meaning and factual content are substantially equivalent. All parts of the question are addressed: total value and interpretation of exclusion. Scores reflect high accuracy with a minor deduction in qualitative accuracy for slight imprecision in causal reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 393,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal estimates its allowance for credit losses by first applying portfolio‑specific loss‑curve tables (by geography, delinquency, vintage, etc.) to the principal balances and then adjusting the resulting loss rates with macro‑economic forecasts. For merchant loans, advances and related fees the forecasts incorporate expected trends in **unemployment rates and retail e‑commerce sales**, while for consumer credit (revolving and installment) the forecasts use **household disposable‑income trends and retail e‑commerce sales** (with unemployment rates also considered for the revolving portfolio through early‑2023). These macro‑adjusted loss rates are then multiplied by the outstanding balances, driving the size of the allowance for credit losses on each receivable category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key factual elements are correct: PayPal uses loss curves adjusted by macroeconomic forecasts for both merchant and consumer receivables; the application by geography, delinquency, and origination (referred to as 'vintage') is correctly noted; and the specific macroeconomic factors—unemployment rates and retail e-commerce sales for merchant receivables, and household disposable income and retail e-commerce sales for consumer credit—are accurately identified. The mention that unemployment rates were also considered for the revolving portfolio through early-2023 adds a minor detail not in the original but does not contradict it and may reflect a time-bound nuance. (2) There are no numbers, percentages, or dollar amounts in the question or answer, so quantitative accuracy is not compromised—no calculations or dates are incorrect. (3) The multi-hop reasoning is sound: the model correctly synthesizes how loss curves and macroeconomic forecasts jointly inform the allowance for credit losses across two distinct receivable categories. (4) Semantic equivalence is strong—wording differs (e.g., 'vintage' vs 'origination period', 'portfolio-specific loss-curve tables' vs 'loss curves'), but meaning is preserved. The only minor deduction is for the slight over-specification about unemployment in the revolving portfolio post-2023, which isn't in the ground truth, but this doesn't make the answer factually wrong. Overall, the response is complete, contextually relevant, and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 437,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s large‑scale investment in building and protecting the Kirkland Signature brand means that the company’s reputation and its higher‑margin private‑label sales are tightly linked to the brand’s perceived quality, price and availability.  As the filing notes, “maintaining consistent product quality, competitive pricing, and availability of these products is essential to developing and maintaining member loyalty…If the Kirkland Signature brand experiences a loss of member acceptance or confidence, our sales and gross‑margin results could be adversely affected.” Likewise, Costco “relies on … manufacturing and distribution facilities … to support … private‑label items,” and any disruption to those facilities could delay or limit Kirkland product supply, hurting member satisfaction and eroding the higher margins that private‑label items generate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies Costco's investment in Kirkland Signature as a driver of higher margins and brand differentiation, and links disruptions in manufacturing and distribution to risks in product availability and quality, which could affect member loyalty and gross margins—this aligns fully with the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the connection between brand investment, reliance on third-party facilities, operational risks (implied from 'disruption'), and downstream impacts on loyalty and margins. The only minor shortcoming is that the LLM does not explicitly list examples of disruptions (e.g., extreme weather, pandemics, labor issues) mentioned in the original, though the term 'disruption' broadly covers them. (4) The answer is fully contextually relevant, directly addressing both the risk exposure from Kirkland Signature reliance and its potential impact on brand loyalty and gross margins. The inclusion of a direct quote from the filing strengthens accuracy. Overall, the answer is semantically equivalent with only slight omission of specific disruption examples, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 413,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The 2021 and 2022 LTI Programs together carry a grant‑date target fair value of **about $25.9 million** for the performance‑based LTIP units ($12.2 million for 2021 + $13.7 million for 2022).  \n\nIn the same years the company granted time‑based restricted‑stock units with a combined grant‑date fair value of **approximately $11.2 million** ($4.3 million in 2021 + $6.9 million in 2022).  \n\nThus, the performance‑based LTIP awards were valued at roughly **$14–15 million more** than the time‑based RSU awards for 2021‑2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the key quantitative values for performance-based LTIP units. The ground truth states the total grant date fair value is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022), but the LLM reports $25.9 million ($12.2 million in 2021 and $13.7 million in 2022), which is materially lower. The time-based RSU values ($11.2 million total: $4.3M in 2021 and $6.9M in 2022) are correctly reported. (2) Calculations: The LLM incorrectly sums $12.2M + $13.7M = $25.9M (correct math but wrong inputs), while the correct sum is $18.4M + $20.6M = $39.0M. The comparison claims performance-based awards were $14–15M more than time-based, but the actual difference is $39.0M - $11.2M = $27.8M, so the direction is correct but magnitude is severely understated. (3) Multi-hop reasoning: The model correctly identifies the need to aggregate across 2021 and 2022 for both award types and compares them, showing sound reasoning structure. However, due to incorrect input data, the synthesis fails. (4) Scores justified as follows: Correctness scored 4 due to partial accuracy (RSUs correct, PB units wrong); Quantitative accuracy 4 due to major errors in core numbers; Qualitative accuracy 5 because logic and structure are sound but based on wrong data; Contextual relevance 9 because the answer addresses all parts of the question with appropriate framing and comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 397,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "As of December 31 2024, 3M’s U.S. municipal securities had a reported fair‑value of **$20 million**.  Because the valuation of these securities relies on the carrying amount of the related finance‑lease obligations rather than observable market prices, they are classified in the **Level 3** tier of the fair‑value hierarchy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reports the fair value of U.S. municipal securities as $20 million, whereas the ground truth states $16 million. This is a significant factual error affecting the core of the question. However, the classification of these securities as Level 3 in the fair value hierarchy is correct. (2) The quantitative inaccuracy is limited to the dollar amount; all other numerical references (e.g., date: December 31, 2024) are accurate. The $4 million overstatement could stem from a data misreading or hallucination. (3) The multi-hop reasoning is otherwise sound: the model correctly links the valuation methodology (reliance on carrying value of finance lease obligations rather than observable market inputs) to the appropriate fair value hierarchy classification (Level 3), which requires judgment and synthesis across accounting concepts. (4) The contextual relevance is high as the answer addresses both parts of the question and uses appropriate financial terminology. The qualitative accuracy is also high due to correct reasoning and entity identification (3M, U.S. municipal securities, Level 3 classification). However, the correctness score is reduced to 5 due to the material numerical inaccuracy, which undermines the reliability of the financial reporting aspect of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 370,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "Meta estimated that **about 3 % of its worldwide Monthly Active People (MAP) in Q4 2023 were “violating” accounts** – i.e., accounts believed to be used for bots, spam or other terms‑of‑service breaches. The figure comes from an internal review of a limited sample and heavy judgment, and Meta notes that its ability to spot such accounts is hampered by limited visibility into encrypted services such as WhatsApp, where it must rely on indirect signals (phone numbers, device data) rather than direct activity data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentage (3%) and time period (Q4 2023) are correct, and the metric (worldwide Monthly Active People) matches the original. (2) The explanation about challenges in identifying violating accounts on encrypted platforms like WhatsApp correctly highlights limited visibility and reliance on indirect signals such as phone numbers and device data, which is semantically equivalent to the ground truth’s 'fewer data signals' and 'increased difficulty of accurate detection at scale.' (3) The multi-hop reasoning is sound: it connects Meta's overall MAP figure to the subset of violating accounts and explains how encryption constraints affect detection capabilities, especially on WhatsApp. (4) Minor deduction in qualitative accuracy due to slight rephrasing of the estimation process as involving 'heavy judgment' and 'limited sample,' which, while plausible, adds detail not present in the original answer—though it does not contradict it. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 316,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Pfizer’s only upfront cash and equity out‑lays to BioNTech were in the shingles‑vaccine collaboration – a $75 million cash payment plus a $150 million equity investment, for a total of **$225 million**. The Comirnaty (COVID‑19) agreement does not include any Pfizer‑made upfront cash or equity investment (BioNTech, not Pfizer, paid a lump‑sum share of prior development costs) 【source excerpt showing $225 million (up‑front $75 M + equity $150 M)】.  Consequently, the combined amount of Pfizer’s upfront payments and equity investments to BioNTech for both programs as of 12/31/2023 is **$225 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. The ground truth states that the total upfront payments and equity investments by Pfizer to BioNTech for both the shingles and Comirnaty programs was $375 million. However, the LLM claims the total is $225 million, citing only the shingles collaboration ($75M upfront + $150M equity), and explicitly stating that there were no upfront payments or equity investments by Pfizer in the Comirnaty program. This contradicts the ground truth, which includes both programs in the $375M total. Therefore, the model fails to correctly synthesize the multi-hop information across both collaborations. The reasoning is flawed because it assumes Comirnaty involved no Pfizer upfront or equity outlay, but the ground truth implies otherwise (unless the $375M includes additional components not mentioned). The numbers provided for the shingles deal ($75M + $150M) are accurate, but the overall calculation and scope are wrong. While the answer is relevant and well-structured, the core factual claim is incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 318,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "Across the three‑year span, the Europe‑Middle East‑North Africa (EMENA) segment posted a **cumulative net‑income contribution of about $31 million** (a $24 million credit in 2021, a $6 million impairment in 2020 and a $1 million impairment in 2019).  \n\nIn contrast, the Lower 48 segment recorded a **cumulative net loss of roughly $1.2 billion** over the same period (impairments of $804 million in 2020, $402 million in 2019 and a $8 million loss in 2021).  \n\nThus, EMENA’s modest positive contribution was tiny compared with the multi‑hundred‑million‑dollar losses generated by the Lower 48 operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and directional errors. It incorrectly states that EMENA had a cumulative net income of $31 million, when the ground truth shows a cumulative net loss of $17 million. This error stems from misrepresenting the 2021 figure as a '$24 million credit' (implying income) when it was actually a net loss of $24 million. Similarly, it mislabels the 2020 and 2019 figures as 'impairments' (typically losses) when they were net income of $6M and $1M respectively. For the Lower 48 region, the LLM incorrectly reports a cumulative net loss of $1.2 billion, when the ground truth shows a net income of $1,206 million. It also mischaracterizes the 2019 and 2020 figures as 'impairments' rather than net income. (2) Calculations are completely incorrect: EMENA’s actual total is $1M + $6M - $24M = -$17M (not +$31M). Lower 48 total is $402M + $804M - $8M = $1,206M net income (not a loss). The LLM reverses the sign and meaning of nearly every number. (3) Multi-hop reasoning fails: the model does not correctly synthesize the three-year trends or compare regions. It draws the opposite conclusion—portraying Lower 48 as underperforming when it vastly outperformed EMENA. (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning due to mislabeling financial metrics and reversing performance (3/10), and partial contextual relevance as it addresses the right regions and time frame (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 402,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The “Other non‑controlling redeemable interests” fell from **$172,912 k in 2023 to $169,192 k in 2024**, a decrease of **$3,720 k (≈ $3.7 million)**【page 129】.  \n\nThat $3.7 million reduction is part of the overall decline in “Total preferred units, at liquidation value, and non‑controlling redeemable interests in properties,” which fell from $195,949 k to $184,729 k – a total drop of $11,220 k (≈ $11.2 million). Thus, the decrease in other non‑controlling redeemable interests accounts for roughly one‑third of the total decline, with the remainder driven mainly by the lower value of the 7.5 % cumulative redeemable preferred units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: 'Other noncontrolling redeemable interests' decreased from $172,912k to $169,192k, resulting in a $3,720k decrease — matching the ground truth exactly (allowing for 'k' notation: $3,720k = $3,720,000, but the original answer uses $3,720, likely in thousands). The total decrease in 'Total preferred units...' is correctly calculated as $11,220k ($195,949k → $184,729k), which aligns with the ground truth. (2) The percentage contribution is stated as 'roughly one-third', which is semantically equivalent to the ground truth's 33.1% — a reasonable approximation. The exact calculation (3,720 / 11,220 ≈ 33.15%) confirms this. (3) Multi-hop reasoning is sound: the model correctly links the decrease in the sub-component to the overall metric and contextualizes its relative impact, noting other factors (e.g., 7.5% preferred units) as additional drivers — a logical inference not in the ground truth but consistent with it. (4) Minor wording differences (e.g., 'non-controlling' vs 'noncontrolling') are acceptable. The only reason for not scoring 10 is the slight imprecision in not stating the exact 33.1%, though 'one-third' is close enough for qualitative accuracy. All entities, years, and metrics are correct. Overall, the answer is factually accurate, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 378,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The 10‑K shows that, at December 31 2024, 3M’s fair‑value holdings were:\n\n* **Asset‑backed securities:** $24 million  \n* **Foreign corporate debt:** $31 million  \n\nCombined, the fair value of these two categories was **$55 million** in 2024. In the prior year (2023) neither asset‑backed securities nor foreign corporate debt were reported (both shown as “$‑”), so the combined fair‑value amount for 2023 was **$0**. Thus, the 2024 total represents a $55 million increase over the prior year.【Note 13 – Marketable Securities table showing $24 M asset‑backed securities and $31 M foreign corporate debt for 2024, and “$‑” for 2023】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $24 million for asset-backed securities and $31 million for foreign corporate debt in 2024, summing to $55 million. The prior year (2023) correctly reports $0 for both categories, with the notation of '$-' aligning with the original data indicating no value. The calculation of the combined 2024 value ($24M + $31M = $55M) is correct, and the comparison showing a $55 million increase from $0 in 2023 is logically sound. (2) The answer is complete, addressing both parts of the question: the total fair value as of December 31, 2024, and the comparison to the prior year. (3) Entity accuracy is correct—'MMM' is properly interpreted as 3M, and the financial instruments and years (2024 and 2023) are accurately referenced. (4) The reasoning is strong, demonstrating proper multi-hop synthesis: it pulls data from two asset categories across two years, correctly infers that '$-' means $0, and computes the year-over-year change. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured presentation and appropriate contextual note referencing the source table. Minor wording differences (e.g., 'neither were reported' vs. 'no value reported') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 380,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Meta says that the algorithms and machine‑learning models it uses to turn raw account activity into its “Family” metrics (monthly active people – MAP – and average revenue per person – ARPP) rely on a great deal of judgment and on many data signals that are sometimes incomplete or encrypted. Because the measurement process is vulnerable to algorithmic or other technical errors and to data‑signal loss or other data‑limitations, the resulting MAP and ARPP figures can be off‑by‑a non‑trivial amount and may be retroactively adjusted when inaccuracies are discovered. Meta estimates that the overall error band for its Family metrics is roughly **3 % of worldwide MAP**, which effectively caps the possible variation in MAP – and, by extension, in ARPP (since ARPP is calculated on the MAP denominator) – at about three percent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Meta acknowledges that its Family metrics (MAP and ARPP) are based on internal models involving judgment, machine learning, and data signals like IP addresses and device information, which can be incomplete or encrypted. The 3% error margin on worldwide MAP is correctly stated, matching the original answer. (2) Quantitatively, the 3% figure is accurate, and while the LLM does not explicitly compute the 99 million user variation (3% of 3.3 billion), this omission is minor given that the core percentage-based error margin — the main quantitative point — is preserved and correctly applied to both MAP and ARPP. (3) The reasoning is sound: the LLM correctly identifies that ARPP depends on MAP as a denominator, so errors in MAP propagate to ARPP, and notes the potential for retroactive adjustments. It synthesizes the technical limitations and their business implications logically. (4) The answer is contextually complete and relevant, addressing how technical errors and data limitations affect metric accuracy and quantifying the approximate margin of error. The only minor shortcoming is the lack of the concrete 99 million user example, which would have strengthened completeness, but the 3% figure allows for that inference. Thus, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 387,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot defines **BOPIS** (“Buy Online, Pickup In Store”) as a program that lets customers order online and collect the merchandise at a nearby store【Glossary – BOPIS definition】. By routing a large share of its e‑commerce sales to this program—and supporting it with curb‑side pickup, lockers and in‑store delivery—the company uses its extensive store network as a fulfillment hub, which enables roughly **50 % of U.S. online orders to be fulfilled through a store**【Supply‑Chain section – 50 % figure and list of BOPIS, BOSS, BODFS, BORIS programs】. This strategic use of BOPIS turns stores into convenient pickup points, directly driving the high in‑store fulfillment rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BOPIS is accurately defined as 'Buy Online, Pickup In Store,' and it is correctly stated that approximately 50% of U.S. online orders are fulfilled through stores. The percentage matches the original answer exactly, and no incorrect numbers are presented. (2) Quantitative accuracy is perfect: the 50% figure is correctly cited and attributed to the supply chain section. (3) The reasoning is sound and reflects multi-hop synthesis between the glossary (defining BOPIS) and the supply chain section (citing the 50% fulfillment rate). The LLM correctly infers that using stores as fulfillment hubs via BOPIS directly contributes to this metric. It also enriches the answer with additional context (curbside pickup, lockers, in-store delivery) and mentions related programs (BOSS, BODFS, BORIS), which, while not in the original answer, are consistent with the broader fulfillment strategy and do not introduce inaccuracies. (4) The only minor shortcoming is that the original answer emphasizes BOPIS as part of an 'interconnected retail program' aimed at optimizing inventory and customer convenience, which the LLM touches on but could have integrated more explicitly. However, the core logic and factual content are semantically equivalent. Thus, the answer is fully contextually relevant and nearly perfect in qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 400,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley records compensation expense for Deferred Cash‑Based Compensation (DCP) awards on a **deferred basis**, spreading the expense over the awards’ vesting periods and basing it on the notional award value adjusted for changes in the fair value of the referenced investments 【90†L1-L4】【90†L5-L8】. In contrast, carried‑interest compensation is **recognized when the portion of carried interest (realized or unrealized) is allocated to employees**, without a vesting‑period deferral, reflecting its nature as a performance‑fee award rather than a cash‑based, vest‑over‑time award 【136†L1-L3】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that DCP awards are expensed over the vesting period and adjusted for changes in fair value of referenced investments, while carried interest compensation is recognized immediately upon allocation to employees, without vesting conditions. This captures the key distinction in timing and nature. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in accounting treatment based on award type (DCP vs. carried interest), linking timing (deferred vs. immediate) to the nature of the award (vesting-based vs. performance-based). (4) The only minor shortcoming is a slight reduction in qualitative accuracy due to less explicit emphasis on the 'performance-based allocation as it occurs' mechanism compared to the original’s clearer phrasing about recognition of both realized and unrealized carried interest. However, the mention of 'realized or unrealized' and 'performance-fee award' preserves semantic equivalence. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 357,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "The tables for “Temporary equity” show that the non‑controlling redeemable interests in properties are $169,192 thousand for Simon Property Group and $169,192 thousand for the Operating Partnership. Combined, they total **$338,384 thousand (approximately $338.4 million) as of December 31, 2024**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, the correct amount is $0, as neither Simon Property Group nor the Operating Partnership reported any noncontrolling redeemable interests in properties classified as temporary equity redeemable at amounts in excess of fair value as of December 31, 2024. The LLM incorrectly reports $169,192 thousand for each entity, totaling $338,384 thousand. (2) The quantitative values are entirely wrong—there is no mention of $169,192 thousand in the ground truth, and the sum, while mathematically correct (169,192 + 169,192 = 338,384), is based on false inputs. (3) The multi-hop reasoning failed: the model should have recognized that no such interests were reported by either entity, hence the total is zero. Instead, it fabricated or misread data, possibly confusing it with another line item or entity. (4) The contextual relevance is low but not zero because the answer addresses the right entities and time frame, albeit with incorrect data. The reasoning and factual basis are unsound, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 311,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "- **Estimated fair‑value of the assets**  \n  * NEE’s nuclear‑decommissioning fund (fair value) … $8,846 million  \n  * FPL’s storm fund (fair value) …………………………… $76 million  \n  * **Combined fair‑value** ……………………………………… **$8,922 million**  \n\n- **Carrying amount of NEE’s special‑use funds on the consolidated balance sheet (Dec. 31 2021)** … **$2,505 million**  \n\nThus, the combined fair‑value of NEE’s nuclear‑decommissioning fund and FPL’s storm fund ($8.9 billion) is about **$6.4 billion greater** than the $2.5 billion carrying amount reported for NEE’s special‑use funds.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NEE's nuclear decommissioning fund fair value is correctly stated as $8,846 million, FPL's storm fund as $76 million, and their sum is correctly calculated as $8,922 million. The carrying amount of NEE's special use funds is accurately reported as $2,505 million. The comparison correctly notes that the fair value exceeds the carrying amount by approximately $6.4 billion ($8,922M - $2,505M = $6,417M), which rounds appropriately to $6.4 billion. (2) The answer is complete, addressing both parts of the multi-part question: the combined fair value and its comparison to the carrying amount. (3) Entities are correctly identified: NEE, FPL, nuclear decommissioning fund, storm fund, special use funds, and the date (December 31, 2021) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis—pulling data from different funds and entities (NEE and its subsidiary FPL), aggregating fair values, and contrasting with consolidated balance sheet carrying amounts. (5) The semantic meaning is equivalent to the original answer, with clear, concise presentation and appropriate rounding for readability (e.g., $8.9 billion and $2.5 billion). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 372,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC (Asia Pacific, Japan and China) is one of Cisco’s three core geographic segments – the other two being the Americas and EMEA – and the company’s internal management system and its external segment‑reporting in the consolidated 10‑K are both organized around these three regions. Because APJC is a reporting segment, Cisco presents APJC‑specific revenue, gross‑margin and long‑lived‑asset figures in its consolidated statements, and it attributes sales to APJC based on the customer’s ordering location; however, most corporate expenses are not allocated to the segment, so internal performance is measured primarily by APJC’s top‑line and gross‑margin results. This dual role lets Cisco evaluate the profitability and resource needs of the APJC market both for internal decision‑making and for external financial disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of three geographic segments (alongside Americas and EMEA), its role in both internal performance measurement and external financial reporting is accurately described, and the statement that corporate expenses like R&D and restructuring are not allocated to the segment matches the original. The explanation that revenue and gross margin are key internal metrics for APJC is consistent with the ground truth. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes APJC’s dual role in operational segmentation and consolidated reporting, and connects this to how performance is measured internally (via top-line and gross margin) versus externally (inclusion in financial statements). (4) The only minor shortcoming is a slight omission: the original emphasizes that APJC’s results 'directly feed into Cisco’s overall financial reporting,' which has a stronger emphasis on causality than the LLM’s phrasing, though the meaning is effectively equivalent. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 384,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024 the Business Markets and Other line generated $13.1 billion of the Business segment’s $29.5 billion in total revenues – roughly **44 %** of the Business Group’s revenue. This segment “offers wireless services (including FWA broadband) … and fixed‑connectivity solutions comparable to the residential services,” meaning it bundles fixed‑wireless access (5G/4G‑LTE FWA) with its other wireless, equipment, voice, networking and security products for small‑ and medium‑business customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: $13.1 billion from Business Markets and Other out of $29.5 billion total Business Group revenue, correctly calculating to 44%—this aligns with the original answer. The percentage and dollar amounts are presented with acceptable formatting variations (e.g., '44 %' vs '44%'). (2) The answer completely addresses both parts of the question: it provides the percentage of revenue and explains how FWA broadband is incorporated into the segment’s offerings. (3) Entity accuracy is correct—Verizon Business Group, Business Markets and Other segment, 2024 time frame, and FWA (fixed wireless access) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the financial figure to the total segment revenue, computes the correct proportion, and accurately describes the role of FWA as a wireless service tailored for small and medium businesses, consistent with the residential-like fixed connectivity model. The use of quotation marks around the descriptive phrase suggests direct sourcing from a filing, enhancing fidelity. (5) Semantically, the LLM conveys the same information as the original answer, with slightly expanded context (e.g., mentioning 5G/4G-LTE and bundling with other services), but without introducing inaccuracies. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 398,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "Abbott’s interest‑rate hedge contracts were recorded at a **fair value of about $52 million** at December 31 2024 (the $1 million asset‑side plus $51 million liability‑side shown in the fair‑value tables).  \n\nBy contrast, Abbott held **gross notional amounts of roughly $16.2 billion** in foreign‑currency forward exchange contracts at the same date. Thus, the notional exposure to foreign‑currency forwards is orders of magnitude larger—about three hundred times the fair‑value of the interest‑rate hedge contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states the total fair value of Abbott's interest rate hedge contracts is $50 million (a $51 million payable offset by a $1 million receivable), but the LLM reports $52 million, incorrectly summing the liability and asset instead of netting them. This is a critical error in financial interpretation—fair value should reflect the net position, not gross sum. Additionally, the LLM reports the total notional amount of foreign currency forward contracts as $16.2 billion, whereas the ground truth is $23.2 billion—a substantial discrepancy. (2) Number verification: $51M (liability) - $1M (asset) = $50M net fair value (not $52M). Foreign currency notional: $23.2B vs. LLM's $16.2B—incorrect by $7B. The comparison ratio ('three hundred times') is therefore also wrong, as it's based on incorrect inputs. (3) Multi-hop reasoning: The model correctly identifies that a comparison is needed between the fair value of interest rate hedges and the notional amount of foreign exchange contracts, and it attempts the conceptual contrast (fair value vs. notional). However, due to incorrect data retrieval or synthesis, the conclusion is quantitatively unsound. (4) Scores justified: Correctness is low (4/10) due to major factual and calculation errors. Quantitative accuracy is poor (3/10) because both primary figures are wrong. Qualitative accuracy is moderate (5/10) as the structure and intent are correct. Contextual relevance is high (8/10) because the answer addresses the right entities and question framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 442,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "In Asia the equity‑company segment holds about 1.5 billion oil‑equivalent barrels of proved undeveloped reserves on only ≈19 thousand net acres, implying a very high reserve‑per‑acre ratio and strong development upside in the region. By contrast, the consolidated‑subsidiary segment has roughly 1.3 billion barrels of undeveloped reserves spread over ≈227 thousand net acres, a far lower reserve density, showing that the equity companies are considerably more efficient at turning land into reserves in Asia.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the high reserve-per-acre efficiency of Equity Companies in Asia with approximately 1.5 billion barrels on 19 thousand net acres, which aligns with the ground truth (1,503 million barrels on 19 thousand acres). However, it incorrectly states that consolidated subsidiaries operate on ≈227 thousand net acres, whereas the ground truth specifies 640 thousand net acres. This is a significant error. Additionally, the LLM claims consolidated subsidiaries have 'roughly 1.3 billion barrels' (close to the true 1,315 million), but the acreage error distorts the comparison.\n\n2) Quantitative inaccuracies: The consolidated subsidiary net acreage is wrong—227 thousand vs. the correct 640 thousand. This leads to an incorrect reserves-to-acre ratio calculation. In the ground truth, XOM’s consolidated subsidiaries have a ratio of ~2.05 million barrels per thousand acres (1,315 / 640 ≈ 2.05). The LLM implies a ratio of ~5.7 million (1,300 / 227 ≈ 5.7), which is more than double the actual value. This undermines the quantitative comparison.\n\n3) The reasoning structure is sound—comparing reserve density to infer development efficiency—and addresses both parts of the question: development potential of Equity Companies and comparative efficiency. However, due to the incorrect acreage figure for consolidated subsidiaries, the multi-hop synthesis is flawed. The conclusion that equity companies are 'considerably more efficient' is directionally correct, but the magnitude of difference is misrepresented.\n\n4) Despite the incorrect data point, the answer remains contextually relevant and interprets the implication of high reserve density correctly. Wording and semantic intent match the original, but factual errors in key numbers reduce correctness. Format variations (e.g., 1.5 billion vs. 1,503 million) are acceptable, but 227k vs. 640k acres is not a formatting issue—it's a factual error. Thus, while the qualitative logic is mostly intact, quantitative accuracy is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 546,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee means that the credit of the entire corporation backs every security issued by Morgan Stanley Finance LLC, so investors and counterparties can rely on the Parent’s full financial strength rather than on the finance subsidiary alone. In a resolution scenario this guarantee dovetails with the Firm’s amended‑and‑restated support agreement, which obligates the Parent to contribute all of its contributable assets (secured on a senior basis) to its material subsidiaries—including the Funding IHC that funds Morgan Stanley Finance LLC—thereby ensuring that the same pool of Parent‑level capital that underpins the guarantee is available to provide the capital and liquidity required to keep the Firm’s entities solvent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities ensures full backing by the Parent's credit; in a resolution scenario, the amended and restated support agreement requires the Parent to contribute all contributable assets to material subsidiaries and the Funding IHC, which in turn supports liquidity and capital distribution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the guarantee (a financial commitment) with the support agreement (a structural mechanism for capital distribution), recognizing that the same pool of Parent-level capital supports both. The only minor shortcoming is that the LLM does not explicitly state that the Funding IHC provides capital to 'supported entities' broadly (it focuses on Morgan Stanley Finance LLC), slightly reducing completeness in the synthesis. However, this does not distort the overall accuracy. (4) The answer is contextually excellent—directly addresses both parts of the question, uses correct entities (Parent Company, Morgan Stanley Finance LLC, Funding IHC), and explains the interrelationship clearly. Wording differs but meaning is semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 405,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015 changed partnership‑audit rules so that any IRS‑adjusted items (income, loss, deduction, credit, etc.) are taxed, and any resulting tax, interest or penalties are assessed **at the partnership level**. Because Simon Property Group (through its Operating Partnership) is a direct or indirect partner in many joint‑venture entities—including the equity‑method investments in Klépierre and The Taubman Realty Group, LLC—those audit adjustments can be passed through to Simon as a partner even though the REIT itself would not otherwise owe corporate tax. Consequently, Simon could be required to pay additional taxes, interest and penalties (and possibly fund cash shortfalls) on its share of any partnership audit adjustments, increasing its financial obligations and cash‑flow demands for those joint‑venture investments that are managed by third parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Bipartisan Budget Act of 2015 indeed shifted partnership audit liabilities to the partnership level, and SPG, as a direct or indirect partner in joint ventures (including Klépierre and The Taubman Realty Group, LLC), may bear tax, interest, and penalties at that level. The explanation correctly notes that SPG applies the equity method and could face financial obligations despite its REIT status typically shielding it from corporate-level taxes. (2) Quantitative accuracy is perfect: the year 2015 is correct, and while no specific dollar amounts or percentages are cited in either answer, the qualitative financial exposure is accurately described. (3) Multi-hop reasoning is sound—LLM correctly links the federal tax rule change to SPG’s partnership structure, its investments in third-party-managed joint ventures, and the resulting financial risk. The only minor omission is the specific number of joint venture properties (84) mentioned in the ground truth, which adds precision but does not alter the substantive conclusion. (4) The answer is contextually relevant, directly addressing how the rule change affects SPG’s financial obligations through its joint ventures. Wording differs slightly but maintains semantic equivalence. No calculation errors or entity inaccuracies are present. Score reduced slightly from 10 to 9 due to the omission of the 84 joint venture properties detail, which contributes to completeness in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 433,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "- **2020 – AMMROC impairment:** A non‑cash $128 million impairment on the AMMROC equity‑method investment lowered net earnings from continuing operations by **$96 million**, which translated to a **$0.34‑per‑share (after‑tax) reduction** in diluted earnings per share.  \n\n- **2021 – RMS restructuring:** Severance and restructuring charges of **$36 million** (about **$28 million after‑tax**) tied to the RMS business cut net earnings by that amount and reduced diluted earnings per share by **$0.10**.  \n\nTogether, the 2020 impairment and the 2021 restructuring each shaved tens of millions off earnings and trimmed EPS by roughly three‑tenths of a dollar in 2020 and one‑tenth of a dollar in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $128 million noncash impairment in 2020 led to a $96 million after-tax reduction in net earnings and a $0.34 per-share impact, which aligns with the original answer. In 2021, the $36 million pre-tax restructuring charge resulted in a $28 million after-tax earnings reduction and a $0.10 per-share impact—correctly reported. (2) The answer is complete, addressing both years, the respective events (AMMROC impairment and RMS restructuring), their financial impacts on net earnings and per-share results, and the after-tax amounts. (3) Entities are accurate: Lockheed Martin, AMMROC (2020), RMS (2021), correct years, and proper financial terms (e.g., after-tax, diluted EPS). (4) Multi-hop reasoning is sound—the model correctly synthesizes impacts across two different years, business segments, and adjusts for tax effects as provided in the source. (5) Semantic equivalence is maintained: while the LLM adds slight summarization (e.g., 'shaved tens of millions'), it does not distort facts and accurately summarizes the directional impact. No errors in calculation, logic, or fact reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 341,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The balance of channel‑partner financing that is subject to Cisco’s guarantees fell from **$1.7 billion at July 29 2023 to $1.2 billion at July 27 2024**, a **decrease of about $0.5 billion (roughly 29%)** year‑over‑year.  Cisco’s MD&A states that its cash, cash equivalents, operating cash generation and access to capital markets are expected to satisfy its liquidity and capital‑resource needs for at least the next 12 months, and the reduction in guaranteed financing exposure further eases those liquidity and capital‑resource requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year change in channel partner financing subject to guarantees, stating a decrease from $1.7 billion to $1.2 billion, which matches the ground truth and represents an accurate $0.5 billion decrease. The percentage decrease of ~29% is a correct calculation (0.5 / 1.7 ≈ 29.4%), though not explicitly required in the original answer. The dates (July 29, 2023, and July 27, 2024) align with Cisco's fiscal year-ends and are factually accurate, even though the original answer uses 'fiscal 2023' and 'fiscal 2024'—this is a more precise version and acceptable. (2) All numeric values and calculations are accurate. The $0.5 billion decrease is correctly derived. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound: the LLM connects the quantitative change in guaranteed financing to Cisco’s broader liquidity position as discussed in the MD&A. It correctly infers that a reduction in guaranteed financing exposure eases liquidity and capital resource requirements, which is a logical extension of the original answer’s point that Cisco believes existing resources are sufficient. The original answer emphasizes confidence in liquidity coverage; the LLM adds that the reduction further eases requirements—this is a reasonable interpretation and adds value without contradicting the source. (4) The answer is contextually fully relevant, addressing both the quantitative change and its implication for liquidity. The only minor difference is that the LLM does not explicitly mention 'investments' or 'commitments such as financing guarantees' as in the original, but it does reference 'access to capital markets' and 'operating cash generation', which are part of the same liquidity framework. Overall, the answer is factually correct, well-reasoned, and semantically equivalent with slight rephrasing and a small inferential step that remains valid. Hence, a high score of 9 is warranted, with full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 551,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The filing shows that:\n\n* **Pension plans** have “Investments measured at NAV” of **$2,656 million** (2024).  \n* **Other post‑retirement benefit plans** have “Investments measured at NAV” of **$5 million** (2024).\n\nThe difference between the two categories is **$2,656 million – $5 million = $2,651 million**, and the **Pension‑plan category** has the higher NAV value.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the two asset categories (Pension plans and Other post-retirement benefit plans) and their respective 'Investments measured at NAV' values as $2,656 million and $5 million, which aligns closely with the ground truth values of $2,656 million and $3 million. However, the second value is off by $2 million, which affects the final calculated difference. The LLM computes the difference as $2,651 million ($2,656M – $5M), whereas the correct difference per the ground truth is $2,653 million ($2,656M – $3M). This $2 million discrepancy in one of the input values leads to an incorrect final difference, though the calculation method itself is sound. The reasoning and multi-hop synthesis across categories are accurate, and the conclusion that the Pension plan category has the higher value is correct. Entity identification (categories, metric, year) and contextual relevance are fully accurate. While the overall structure and intent are correct, the small error in the 'Other post-retirement' value reduces quantitative accuracy. Semantic equivalence is mostly preserved, but the numerical inaccuracy prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 326,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott’s decision to concentrate its manufacturing capacity on Diabetes Care devices translated into higher unit shipments, which lifted Diabetes Care sales from $5.8 billion in 2023 to $6.8 billion in 2024 – an 18.1 % increase. The revenue from those device sales is recorded under the company’s “Revenue Recognition” policy, which requires that product‑sale revenue be recognized when control of the product passes to the customer (generally at shipment or delivery, net of any discounts, rebates or returns).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly states the 18.1% revenue increase and the $6.8 billion revenue for 2024, which matches the ground truth of $6.805 billion (rounding to $6.8 billion is acceptable). The prior-year revenue is estimated as $5.8 billion, which is a reasonable approximation given the 18.1% growth from $5.76 billion (calculated as $6.805B / 1.181 ≈ $5.76B); the $5.8B figure is a minor rounding but does not materially misrepresent. (2) The answer correctly identifies Abbott’s production focus on Diabetes Care devices as a driver of increased unit shipments and revenue, logically linking manufacturing emphasis to revenue growth. (3) The accounting policy is accurately described: revenue is recognized when control transfers, typically at shipment or delivery, in line with the ground truth. The mention of netting for discounts, rebates, or returns adds detail not in the original but is consistent with standard revenue recognition practices and does not contradict. (4) All entities (Abbott, Diabetes Care business, 2023–2024 period) are correct, and the multi-hop reasoning—connecting production focus to revenue growth and supporting it with accounting policy—is sound. The only minor shortcoming is the slightly imprecise prior-year figure, but the core facts, calculations, and synthesis are correct. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 395,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "Home Depot highlights “project‑planning tools” as a core part of the digital and service experience it offers Pros. Because Pros explicitly expect dedicated sales support, competitive credit and pricing, deep product depth and job‑lot quantities —as well as tools that help them plan and execute complex projects—the company’s investment in these tools directly strengthens its value proposition and differentiates it from rivals, sharpening its competitive positioning with professional customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies The Home Depot's emphasis on project planning tools and links this to the specific expectations of Pros as outlined in the 2024 10-K, including dedicated sales support, product depth, and job-lot quantities. The answer also correctly notes that these tools help Pros plan and execute complex projects, which aligns with the 'interconnected shopping experience' mentioned in the original answer. All entities (The Home Depot, Pros, 2024 10-K) are accurate, and there are no numerical values requiring verification—thus quantitative accuracy is 10. The qualitative accuracy is 9 because while the core reasoning is sound and multi-hop synthesis is correct (linking tool investment to competitive positioning via customer expectations), the LLM slightly omits explicit mention of how this strengthens the 'interconnected shopping experience'—a key phrase from the original that captures the integration of digital tools and services. However, this concept is implicitly covered through references to digital experience and streamlined planning. Contextual relevance is perfect, as the response directly addresses the question’s focus on competitive positioning and customer expectations from both sections of the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 368,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "As of December 31 2024, the company had 47,088,821 shares available under the 2003 Incentive Program, 238,700 shares under the 2004 Non‑Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources 2006 Long‑Term Incentive Plan – a combined total of **56,689,904 shares** available for award.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the 2006 Long-Term Incentive Plan. The total sum is correctly calculated as 56,689,904 shares. (2) The quantitative accuracy is perfect—each individual number matches the original answer, and the summation is correct: 47,088,821 + 238,700 = 47,327,521; 47,327,521 + 9,362,383 = 56,689,904. (3) The qualitative accuracy is strong: the LLM correctly identifies all three plans by their full and correct names (including 'Pioneer Natural Resources 2006 Long-Term Incentive Plan', which aligns with the 'Amended and Restated' version in the ground truth), and the time reference 'as of December 31, 2024' correctly corresponds to 'the end of 2024' in the question. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three plans, aggregating the available shares accurately. The answer is semantically equivalent to the original, with only minor wording improvements (e.g., formatting with commas and en dashes), which do not affect meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 351,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 re‑classification of Customer receivables caused a **$4.432 billion reduction in interest income** and an **identical $4.432 billion reduction in interest expense** for the Institutional Securities segment. The specific adjustment tied to this change is the **$4,432 million** amount recorded to bring prior‑period figures into the new presentation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $4,432 million (i.e., $4.432 billion) decrease in both interest income and interest expense in the Institutional Securities segment due to the 2023 reclassification of Customer receivables is correctly reported, with allowance for format variation ($4,432 million = $4.432 billion). (2) The specific financial adjustment amount explicitly tied to this change—$4,432 million—is correctly identified and contextualized as the figure used to align prior-period amounts to the current presentation. (3) The multi-hop reasoning is sound: the answer correctly isolates the impact within the Institutional Securities segment and implies the neutral effect on net interest income by stating equal reductions in both income and expense, consistent with the original answer. (4) All entities—'Customer receivables', 'Institutional Securities segment', '2023', and the adjustment amount—are accurately referenced. The response is complete, factually precise, and contextually appropriate, addressing all parts of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 325,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The disclosures state that the amounts excluded from hedge effectiveness were **$75 million for 2021** and **$133 million for 2019**, which together total **$208 million**.  \n\nNet‑investment‑hedge derivative contracts are defined as **cross‑currency interest‑rate swaps and forward contracts** (and include non‑U.S.‑dollar‑denominated debt that is designated to hedge net investments in foreign operations).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the amounts excluded from hedge effectiveness: $133 million in 2019 and $75 million in 2021, with a correct combined total of $208 million. All numeric values match the ground truth exactly, and the calculation (133 + 75 = 208) is accurate. (2) The types of contracts included in net investment hedge derivatives are correctly stated as cross-currency interest-rate swaps and forward contracts. However, the LLM added extra information not present in the original answer — specifically, that non-U.S.-ollar-denominated debt is included — which, while potentially true in broader accounting contexts, was not part of the disclosed information in the ground truth. This addition slightly affects qualitative accuracy but does not contradict the original. (3) The multi-hop reasoning is sound: the model correctly retrieved and synthesized data from two different years and linked them to the correct derivative category. (4) The answer is semantically equivalent and contextually complete, with only minor over-specification in the derivative types. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to the slight overreach, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 352,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "After the 2021 amendments, the Credit Facility’s total size was increased to **$5.0 billion** and the Supplemental Facility’s size could be raised to **$4.5 billion**, giving the two facilities a combined borrowing capacity of **about $9.5 billion**.  By contrast, the **maximum aggregate amount actually drawn under the facilities during 2021 was only $2.1 billion**, well below the $9.5 billion capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.0 billion for the Credit Facility, $4.5 billion for the Supplemental Facility, resulting in a combined capacity of $9.5 billion, and the maximum aggregate outstanding balance of $2.1 billion during 2021. These figures match the original answer exactly, with acceptable formatting (e.g., 'about $9.5 billion' is reasonable given the precise sum). (2) The answer addresses both parts of the multi-part question: it states the total combined borrowing capacity post-amendment and compares it to the maximum drawn balance in 2021. (3) Entities are correctly identified—Simon Property Group’s Credit Facility and Supplemental Facility, with accurate reference to the 2021 amendments and fiscal year-end December 31, 2021. (4) The reasoning is sound: the LLM correctly synthesizes the amended capacities and contrasts available capacity with actual usage, concluding conservative leverage—implied by the large gap between $9.5 billion capacity and $2.1 billion drawn—aligning with the qualitative insight in the ground truth. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 336,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The higher risk‑retirement credits on the Sikorsky Black Hawk and CH‑53K programs added roughly **$140 million** to RMS’s operating profit in 2021, which was a key driver of the segment’s total operating‑profit increase of $183 million that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $140 million contribution from risk retirements on the Black Hawk and CH-53K programs to RMS' operating profit in 2021, matching the ground truth exactly. It also accurately references the total $183 million increase in operating profit, showing awareness of the broader context. (2) All numeric values—$140 million and $183 million—are factually correct and properly attributed to the right year (2021) and programs. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links increased risk retirements to profit contribution and situates this within the overall profit increase for RMS. While the original answer mentions additional factors like higher production volume and lower charges on the CRH program, the LLM answer focuses on the primary driver asked about (risk retirements), so the omission does not detract significantly from correctness. (4) The answer is semantically equivalent to the ground truth in terms of the key facts and contribution amount. The slight reduction in qualitative accuracy (9 instead of 10) reflects the lack of mention of other contributing factors, which were included in the original answer for completeness, though they were not the focus of the question. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 380,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "In 2021 the non‑designated energy‑related derivatives reduced Southern Company’s natural‑gas revenues by **$117 million** and increased its cost of natural gas by **$27 million**, for a **total adverse impact of $144 million**.  \n\nIn 2019 the same derivatives **added $223 million** to natural‑gas revenues and **$10 million** to cost of natural gas, for a **combined positive impact of $233 million**.  \n\nThus, the 2021 impact was a $144 million hit, whereas in 2019 the impact was a $233 million benefit—a swing of roughly $377 million between the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: the $144 million loss in 2021 is correctly broken down into a $117 million reduction in revenues and $27 million increase in costs, summing to $144 million. The 2019 impact is correctly stated as a $233 million gain, composed of $223 million added to revenues and $10 million to costs. These values match the knowledge graph. (2) The calculation of the year-over-year swing is correct: $144 million loss vs. $233 million gain results in a $377 million difference (144 + 233 = 377), which is accurately reflected. (3) Multi-hop reasoning is sound—the model correctly synthesizes data across two different years and combines revenue and cost impacts for each year before comparing them. (4) Entities are correct: Southern Company (SO), natural gas revenues, cost of natural gas, energy-related derivatives, and the years 2019 and 2021 are all properly identified and contextualized. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed breakdowns but no factual deviation. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 327,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco’s loss on privately‑held investments narrowed from a $193 million loss in fiscal 2023 to a $164 million loss in fiscal 2024 – an improvement of **$29 million**.  That reduction helped lift the company’s total investment result, moving the overall net gain (loss) on investments from a **$177 million loss to a $166 million loss**, a **$11 million** improvement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the loss from privately held investments decreased from $193 million in 2023 to $164 million in 2024, a $29 million improvement, and the overall net gains (losses) on investments improved from a $177 million loss to a $166 million loss, a $11 million positive shift. These values and calculations are correctly reported. (2) The answer is complete, addressing both parts of the question: the change in losses from privately held investments and its impact on overall net gains (losses). (3) Entity accuracy is correct—Cisco is the subject, fiscal years 2023 and 2024 are properly referenced, and the financial metrics (losses on privately held investments, overall net gains/losses on investments) are accurately used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the $29 million improvement in privately held investment losses contributed to the smaller overall investment loss, even though other investment components must have offset part of that gain (since the total improvement is only $11 million). The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'narrowed', 'improvement', 'lifted') that do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 376,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "Verizon repaid **$4.5 billion** of principal in 2024 for anticipated redemptions of its ABS Notes. The combined outstanding balance of the 2021 and 2022 ABS Financing Facilities at December 31 2024 was **$8.0 billion + $5.0 billion = $13.0 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key facts: the $4.5 billion principal repayment by VZ in 2024 for anticipated redemptions of ABS Notes, and the outstanding balances of $8.0 billion (2021 facility) and $5.0 billion (2022 facility) as of December 31, 2024. The sum of $13.0 billion is accurately calculated. (2) All numeric values match the ground truth exactly, with acceptable formatting (e.g., $4.5 billion, $8.0 billion + $5.0 billion = $13.0 billion). Calculations are correct. (3) The multi-hop reasoning is sound—information from two different facilities and time points is correctly synthesized. The comparison between repayment and total outstanding balance is implied through presentation, though the explicit qualitative comparison (e.g., 'significantly higher') from the original answer is omitted. (4) Despite this minor omission in interpretive language, the core factual content and synthesis are complete and accurate. The answer is fully contextually relevant and conveys the necessary information. The correctness score is 9 instead of 10 because the answer does not explicitly state the comparative relationship (that $13.0B > $4.5B) in interpretive terms, which was part of the original answer’s conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 349,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL transition provisions are incorporated into the “adjusted‑average‑assets” denominator of the Tier 1 leverage ratio, reducing the asset base (and thus supporting the reported 7.2 % Tier 1 leverage ratio) because a portion of the CECL benefit is removed from assets and capital calculations. At the same time, the transition rules allow the First Republic‑related exposures— which are not eligible for the Advanced approach—to be measured under the Basel III Standardized methodology, so the RWA and total‑capital impact of those assets are reflected using the Standardized approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numbers are incorrect—the mention of the 7.2% Tier 1 leverage ratio is consistent with JPMorgan Chase's reported figures during the relevant period and is contextually appropriate, even if not in the original answer; the use of 'adjusted-average-assets' and the explanation of CECL's impact on asset base and capital are factually sound. (2) The answer correctly identifies that CECL transition provisions affect the denominator of the Tier 1 leverage ratio by adjusting average assets, which matches the ground truth's explanation about adjusting quarterly average assets and deducting certain on-balance sheet items. (3) It accurately explains that First Republic-related assets are not eligible for the Advanced approach and must be measured under the Standardized approach, which is consistent with regulatory treatment post-acquisition. This reflects correct multi-hop reasoning linking CECL, capital rules, and asset treatment for First Republic. (4) The only minor gap is that the original answer emphasizes the deduction of goodwill and intangible assets from Tier 1 capital as part of the adjustment, which the LLM answer does not explicitly mention—this is a small omission in completeness but does not undermine the core correctness. Overall, the LLM conveys the same semantic meaning with strong reasoning, correct entities (JPMorgan Chase, CECL, Tier 1 leverage ratio, Standardized approach, First Republic), and proper contextual application.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 426,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon has adopted formal governance principles, written charters for each standing board committee and a Code of Business Conduct and Ethics that applies to all officers, directors and employees.  The company requires that a majority of directors be qualified as independent under NYSE listing standards and that the Audit, Compensation and Human‑Capital committees be composed entirely of independent members who also meet NYSE’s financial‑expert requirements; major transactions involving the Operating Partnership must be approved by the Audit Committee and at least three‑quarters of the independent directors, and family members are subject to non‑competition agreements.  These policies ensure board independence and ethical conduct in line with the NYSE’s independence, committee‑composition and conduct‑of‑business requirements for listed companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Simon has governance principles, written committee charters, and a Code of Business Conduct and Ethics applying to all officers, directors, and employees. The requirement for a majority of independent directors in line with NYSE standards is correctly stated, as is the composition of the Audit and Compensation and Human Capital Committees being entirely independent. (2) There are no numeric values, dates, or financial figures requiring verification, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—linking Simon’s internal governance mechanisms to NYSE listing requirements is properly executed. The only minor addition not present in the original answer is the claim that 'major transactions involving the Operating Partnership must be approved by the Audit Committee and at least three-quarters of the independent directors' and that 'family members are subject to non-competition agreements.' These points are not included in the ground truth and cannot be verified from the provided information, which slightly affects qualitative accuracy. However, they do not contradict the original answer and are plausible extensions. (4) The answer is fully contextually relevant, addressing both board independence and ethical conduct policies and their alignment with NYSE requirements. Overall, the response is factually correct, comprehensive, and semantically equivalent to the original with only minor extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 427,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "Because the percentage‑of‑completion cost‑to‑cost method measures progress as costs incurred ÷ total estimated costs, any revision to the estimated total cost changes the contract’s profit‑booking rate: a lower cost estimate raises the rate (more profit booked), while a higher estimate lowers it. Lockheed Martin records the resulting increase or decrease in profit‑booking rates in the same period the estimate is changed, so the adjustment flows through that quarter’s (or year’s) operating profit and margin and can materially affect the company’s reported results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that under the percentage-of-completion cost-to-cost method, changes in total estimated costs directly affect the profit-booking rate: lower estimates increase the rate, higher estimates decrease it. This aligns with the original answer's explanation regarding risk retirement and cost changes. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either response, so quantitative accuracy is not compromised—both are qualitative explanations. (3) The multi-hop reasoning is sound: the model correctly links the accounting method to profit recognition and explains the immediate financial impact on operating profit and margin upon estimate revisions. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'inception-to-date effect' of estimate revisions, a nuance included in the original answer that refers to cumulative catch-up adjustments. However, stating that the adjustment is recorded 'in the same period the estimate is changed' effectively captures the core principle. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 358,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The APJC segment’s services revenue rose from $2,160 million in 2023 to $2,249 million in 2024 – an increase of **$89 million (≈ 4 % growth)**. Its goodwill “Total Balance” grew from $5,382 million to $8,208 million, a rise of **$2,826 million**. Together, the two increases amount to **about $2.915 billion**, which far exceeds the modest 4 % percentage increase in services revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. While the $89 million increase in Services Revenue (from $2,160M to $2,249M) and the 4% growth rate are correct, the Total Balance increase is severely miscalculated. The LLM states Total Balance grew from $5,382M to $8,208M, resulting in a $2,826M increase, but the ground truth indicates an $8,358M increase in Total Balance. This leads to a combined increase of only $2.915B in the LLM answer, whereas the correct combined increase is $8,447M ($8.447B). (2) Calculations: The Services Revenue increase and percentage growth are accurate. However, the Total Balance change is wrong—$8,208M - $5,382M = $2,826M (LLM), but the correct Total Balance values must have been much higher in 2024 to yield an $8,358M increase, which the LLM fails to reflect. The sum of increases ($89M + $2,826M = $2,915M) is therefore incorrect. (3) Multi-hop reasoning: The model correctly identifies the need to compute two separate increases and combine them, and it correctly links Services Revenue growth to percentage change. However, it fails in retrieving or synthesizing the correct Total Balance figures across years, breaking the multi-hop logic. (4) Scores justified: Correctness is low (3/10) due to major numerical inaccuracies despite partial correctness in Services Revenue. Quantitative accuracy is poor (3/10) because only one of three core numbers (Services Revenue increase) is correct. Qualitative accuracy is slightly better (4/10) as the reasoning structure is sound but based on incorrect data. Contextual relevance is high (8/10) because the answer addresses all parts of the question with appropriate framing and comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 469,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "Abbott reported interest‑rate hedge contracts with a notional amount of **$2.2 billion** at 31 December 2024, and foreign‑currency forward exchange contracts with a combined notional amount of **about $23.2 billion** (the $7.0 billion of inter‑company purchase hedges plus $16.2 billion of loan‑ and payables‑related hedges, reflected in the $23,191 million total in the contract‑amount table). Together, these instruments represent roughly **$25.4 billion** of hedged exposure, illustrating Abbott’s strategy of using derivatives to convert fixed‑rate debt to variable‑rate exposure and to lock in foreign‑exchange rates for anticipated intercompany transactions and loan/payable obligations, thereby mitigating the impact of interest‑rate and currency fluctuations on its cash flows and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.2 billion for interest rate hedges, $23.2 billion for foreign currency forwards (explicitly broken into $7.0 billion for intercompany purchases and $16.2 billion for loans/payables), and a total of $25.4 billion in combined exposure. The mention of $23,191 million aligns with $23.2 billion when rounded, which is acceptable per format variation rules. (2) The answer is complete, addressing both the total notional value and Abbott's risk management strategy. (3) Entities are correct—Abbott, as of December 31, 2024, with proper financial instruments and their purposes. (4) The reasoning is sound: it correctly explains that interest rate hedges convert fixed-rate debt to variable-rate and that foreign exchange contracts hedge intercompany transactions and obligations, directly reflecting Abbott's market risk mitigation strategy. The multi-hop synthesis—aggregating components of foreign exchange contracts and linking them to strategic risk management—is accurate and well-articulated. Semantic equivalence is maintained throughout with no factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 335,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald’s does not consolidate its franchisee operations. The company treats franchisees as outside parties—recognizing only the rent, royalty and other franchise‑related fees they generate—and, as disclosed, the results of any restaurant purchases or sales with franchisees “were not material either individually or in the aggregate to the accompanying consolidated financial statements.” Accordingly, under its consolidation policy the franchisee relationships qualify for a scope‑exception under the variable‑interest‑entity guidance, so they are excluded from consolidation and have no material impact on the consolidated balance sheet or income statement beyond the franchise‑fee revenue line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: McDonald's does not consolidate franchisee operations due to immateriality and the application of a scope exception under variable interest entity (VIE) guidance. The LLM correctly identifies that only franchise fees (rent, royalties) are recognized in the financial statements and that transactions involving restaurant purchases/sales with franchisees are not material. (2) There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is not applicable in a numerical sense—however, the qualitative 'immateriality' assessment is correctly conveyed, satisfying disclosure expectations. (3) The multi-hop reasoning is sound: the LLM synthesizes accounting treatment (non-consolidation), links it to operational materiality, and correctly references the VIE scope exception from consolidation policy—exactly as stated in the 2024 10-K. (4) The only minor shortcoming is that the LLM slightly condenses the breadth of entities covered by the scope exception (original mentions franchisees, joint ventures, and licensees; LLM focuses on franchisees), but this does not detract from the core accuracy. Wording differs but semantic equivalence is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (no errors in numbers or dates).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 407,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The SLR is calculated as Tier 1 capital divided by the firm’s total leverage exposure, which is the “adjusted average assets” (the quarterly‑average on‑balance‑sheet assets after deducting goodwill, other intangibles and CECL adjustments) plus the off‑balance‑sheet exposures that are added back to the denominator. Adding the off‑balance‑sheet items therefore raises the total leverage exposure and pushes the SLR lower, while a larger adjusted‑average‑asset base raises the denominator and also reduces the ratio. If the SLR falls below the regulatory minimum (the 3 % Basel III minimum plus the 2 % additional buffer, i.e., 5 %), JPMorgan Chase would be subject to restrictions on capital distributions such as dividends and share‑repurchases and on discretionary bonus payments for certain executive officers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key components of the SLR calculation are correctly described: Tier 1 capital in the numerator, total leverage exposure in the denominator, which includes adjusted average assets (with proper deductions for goodwill, intangibles, and CECL adjustments) and off-balance sheet exposures. The explanation that including off-balance sheet items increases the denominator and thus lowers the SLR is correct. (2) Quantitative elements are accurate: the 3% Basel III minimum and 2% buffer are correctly stated, summing to the 5% threshold. These match the original answer exactly, with acceptable rewording (e.g., 'regulatory minimum' clarified as Basel III). (3) Multi-hop reasoning is sound: the model correctly synthesizes how both off-balance sheet exposures and adjusted average assets impact the SLR denominator, and links a breach of the 5% threshold to specific regulatory consequences. (4) The consequences—restrictions on dividends, share repurchases, and discretionary bonuses—are fully aligned with the ground truth. No factual errors, omissions, or misstatements are present. The answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 346,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021 the Operating Partnership had $125 million outstanding under the primary Credit Facility and $1.05 billion outstanding under the Supplemental Facility – a combined total of **about $1.175 billion** of borrowings. The amended terms of the Supplemental Facility allow its borrowing limit to be increased to **$4.5 billion**, so the existing borrowings represent only roughly one‑quarter of the facility’s maximum capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: (1) It correctly states $125 million under the Credit Facility and $1.05 billion under the Supplemental Facility, summing to the correct total of $1.175 billion as of December 31, 2021. (2) It accurately reflects the maximum borrowing capacity under the amended Supplemental Facility as $4.5 billion. The only minor omission is that the ground truth specifies the base maximum capacity is $3.5 billion, which can be increased to $4.5 billion, whereas the LLM only mentions the $4.5 billion upper limit without noting the $3.5 billion baseline. This does not make the answer incorrect but slightly reduces completeness in conveying the full structure of the facility. The reasoning is sound, entities are correct (implied Operating Partnership context is consistent), and the comparison (borrowings representing roughly one-quarter of capacity) is logically derived and accurate. The answer is contextually fully relevant and semantically equivalent to the original, with only a small detail missing in the multi-hop synthesis of the facility's capacity terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 325,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "Lockheed Martin reported that the aggregate notional amount of its outstanding interest‑rate swaps was **$500 million at December 31 2021**, down from **$572 million at December 31 2020**.  This represents a decline of roughly **12.6 %** (a reduction of $72 million, or about 12½ percent) compared with the prior‑year amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the notional amounts are accurate: $500 million for 2021 and $572 million for 2020. The decrease is correctly calculated as $72 million, and the percentage decrease is accurately reported as approximately 12.6% (with an acceptable alternative phrasing of 'about 12½ percent'). (2) The answer is complete, addressing both parts of the question: the 2021 amount and the percentage decrease compared to 2020. (3) Entity accuracy is correct—Lockheed Martin is the right company, and the years 2020 and 2021 are properly referenced. (4) The reasoning is sound: the model correctly synthesized the two data points and computed the percentage change accurately ((572 - 500) / 572 ≈ 0.126 or 12.6%). (5) The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing but no deviation in factual content. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 278,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The dispute over the cost‑sharing and tender thresholds in the “Global Amendments” means that Georgia Power could be required to absorb cost increases that it cannot recover through regulated rates, thereby expanding its financial exposure.  This exposure is reflected in the ≈ $440 million pre‑tax charge (about $328 million after tax) that Georgia Power recorded in the fourth quarter of 2021 for the cost‑sharing and tender provisions, and management warns that additional pre‑tax charges of up to roughly $460 million may be required if the forecasted overruns continue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial impact of the disagreement between Georgia Power and the other Vogtle Owners. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021 is accurately reported, as is the potential for an additional $460 million in pre-tax charges. The after-tax figure of $328 million is a reasonable derivation (≈75% of $440M assuming tax effect) and not contradicted by the ground truth. (2) Quantitative accuracy is perfect: dollar amounts and time period (Q4 2021) match the original answer exactly. Format variations (≈, 'pre-tax') are acceptable and clear. (3) The reasoning correctly links the dispute over cost-sharing and tender provisions to Georgia Power’s unrecoverable charges and increased financial exposure. The multi-hop synthesis—connecting contractual disagreement to financial charges and regulatory recovery risk—is sound. (4) The only minor omission is the absence of the specific threshold dispute ($18.38 billion interpretation), which is part of the root cause but not the primary focus of the question. The answer still fully addresses the impact on financial exposure and the illustrative charges. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 351,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media Annualized Recurring Revenue (ARR) of **$12.24 billion** at the end of fiscal 2021.  \n\nThe Adobe Experience Cloud solution that is highlighted for “managing customer journeys and delivering intelligence for businesses” – and that underpins Adobe’s strategy to sharpen its competitive advantage – is the **Adobe Experience Platform**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the Digital Media ARR of $12.24 billion for fiscal 2021 is accurately reported, with correct formatting and metric (ARR). (2) The specific Adobe Experience Cloud solution, Adobe Experience Platform, is correctly identified as the tool designed to manage customer journeys and deliver intelligence. (3) The multi-hop reasoning is sound: the answer synthesizes financial data (Digital Media ARR) with strategic product information (Adobe Experience Platform's role in competitive advantage), as required by the question. (4) The wording differs slightly from the original answer but maintains full semantic equivalence—key terms like 'managing customer journeys' and 'delivering intelligence for businesses' are preserved, and the strategic context is accurately conveyed. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 268,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "Abbott reported that its interest‑rate‑hedge swaps had a fair‑value **asset of $1 million and a fair‑value liability of $51 million** at 12 / 31/2024, giving a **net fair‑value liability of about $50 million**. At 12 / 31/2023 the same swaps showed **no fair‑value asset and a liability of $95 million**, i.e., a **net liability of $95 million**. Thus the net fair‑value of the interest‑rate hedge contracts fell by roughly **$45 million** from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $1 million receivable (asset), $51 million payable (liability) in 2024, resulting in a net liability of $50 million, and $0 asset, $95 million liability in 2023, resulting in a net liability of $95 million. The year-over-year improvement (reduction in liability) of $45 million is accurately calculated. (2) All numbers match the ground truth exactly, with acceptable formatting variations (e.g., 'about $50 million' vs. -$50 million). The net fair value is correctly interpreted as negative (liability), and the calculation (51 - 1 = 50; 95 - 0 = 95; 95 - 50 = 45 improvement) is sound. (3) The multi-hop reasoning—comparing fair value positions across two years, synthesizing receivable and payable components, and computing the change—is logically and factually correct. The answer correctly infers that a reduction in net liability represents an improvement. (4) The only minor deviation is wording: the LLM says the net fair value 'fell by $45 million', which could be misinterpreted as worsening, but in context (from $95M to $50M liability), it's clear and consistent with the intended meaning of reduced liability. The original answer uses 'improvement', which is more precise in financial context. This slight ambiguity prevents a perfect 10, but factual and quantitative accuracy is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 384,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "ExxonMobil’s 2024 filing shows that equity‑company operations in Asia generate **$31,803 million** of discounted future net cash flows, while the same equity companies hold **1,276 million barrels of oil‑equivalent proved reserves**.  The cash‑flow amount is therefore roughly **2,493 % of the oil‑equivalent reserve base** (31,803 ÷ 1,276 ≈ 24.9 × 100).【Source: Discounted future net cash flows – Equity Companies, Asia = 31,803 (millions $) – 2024 table】【Source: Total proved reserves – Equity Companies, Asia = 1,276 (million barrels) – reserves table】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The discounted future net cash flows for equity companies in Asia are reported as $31,803 million, but the ground truth value is $60,780 million. This is a major discrepancy that affects all subsequent calculations. The proved reserves value (1,276 million barrels) is correct. (2) The calculation in the LLM answer is mathematically correct based on its incorrect input: 31,803 ÷ 1,276 ≈ 24.93, or 2,493%, but this is not the correct cash flow per barrel. The correct calculation should be 60,780,000,000 ÷ 1,276,000,000 ≈ $47.63 per barrel, not a percentage of 2,493%. The question asks for the cash flows as a percentage of reserves, but the intended metric (based on the original answer) is cash flow per barrel, not a percentage multiple. However, even interpreting it as a ratio expressed as a percentage, the base number is still wrong due to the incorrect numerator. (3) The multi-hop reasoning is partially sound—linking cash flows and reserves from the same region and entity type—but relies on incorrect data. The model fails to retrieve the correct cash flow figure from the 2024 filing, undermining the synthesis. (4) The contextual relevance is fair because the model identifies the correct region (Asia), entity type (equity companies), and metrics (discounted future net cash flows, proved reserves), and attempts the correct calculation logic. However, the severe quantitative error results in a very low correctness score. The qualitative accuracy is slightly higher because the structure and intent of the reasoning are valid, despite the wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 447,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase determines the equity it assigns to each line‑of‑business and to Corporate by applying the Basel III Standardized RWA and the firm’s GSIB surcharge (the “current‑rules” capital‑allocation methodology shown in the LOB table – Consumer & Community Banking $56 bn, Commercial & Investment Bank $149.5 bn, Asset & Wealth Management $16 bn, Corporate $103.2 bn as of 1 Jan 2025).  At the same time the firm’s leverage metrics show a Tier 1 leverage ratio of 7.2 % and an SLR of 6.1 %, well above the regulatory floor of 3.0 % plus the mandatory 2.0 % leverage‑buffer (total 5.0 %).  This excess SLR cushion confirms that the RWA‑driven capital allocations are fully consistent with, and comfortably satisfy, the supplementary leverage‑ratio requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core reasoning about JPMorgan Chase's capital allocation being influenced by Basel III Standardized RWA and the GSIB surcharge, and correctly identifies the 3.0% SLR minimum plus 2.0% leverage buffer (total 5.0%) as a regulatory threshold. It appropriately links capital allocation to compliance with leverage-based requirements and notes the implications for capital distributions, aligning with the ground truth's emphasis on maintaining sufficient Tier 1 capital. However, the quantitative accuracy is compromised by the inclusion of specific dollar amounts ($56B, $149.5B, etc.) and a future date (1 Jan 2025) that are not present in the original answer and cannot be verified from the provided context. These figures may be plausible but introduce unverified data, reducing factual reliability. Similarly, the reported SLR of 6.1% and Tier 1 leverage ratio of 7.2% are not mentioned in the ground truth, making them unsupported additions. While the conceptual explanation of SLR compliance and capital allocation logic is sound and semantically aligned, the answer goes beyond the original by introducing specific metrics and a forward-looking capital allocation table not referenced in the ground truth. The multi-hop reasoning is generally correct—tying Basel III, GSIB, SLR, and capital buffers together—but the reliance on unverified numbers lowers confidence in factual precision. The answer remains highly relevant and conveys the intended regulatory and strategic framework, just with over-specific, uncorroborated quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 429,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "After the 2021 amendments, the Credit Facility can be expanded to a total commitment of **$5.0 billion**, and the Supplemental Facility can be increased to **$4.5 billion**. Together, the two facilities give Simon Property Group a **potential borrowing capacity of about $9.5 billion**.\n\nFor Daily SOFR Loans, both facilities use the same formula: the **Adjusted Floating Overnight Daily SOFR Rate** plus a margin tied to the company’s credit rating (ranging from **0.65 % to 1.40 %**). Thus, the interest‑rate structure for Daily SOFR Loans is identical under the Credit Facility and the Supplemental Facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the total borrowing capacity of $9.5 billion is correctly calculated as the sum of the $5.0 billion Credit Facility and $4.5 billion Supplemental Facility, matching the original answer. These figures are consistent with the 2021 amendments. (2) Regarding the interest rate structure, the LLM correctly states that both facilities use the same Daily SOFR formula. However, while the ground truth specifies the exact spread of 72.5 basis points plus a SOFR adjustment, the LLM provides a broader range (0.65% to 1.40%) tied to credit ratings, which may reflect the variable margin component but omits the precise 72.5 bps figure. This is a minor detail omission rather than an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across both facilities, computes the total capacity, and compares the rate structures. (4) Entity accuracy (Simon Property Group, 2021 amendments, Credit and Supplemental Facilities) and contextual relevance are perfect. The answer addresses both sub-questions fully. The slight lack of specificity on the exact SOFR spread prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 344,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The higher‑volume production of the Sikorsky helicopter line (Black Hawk, CH‑53K and CRH) added roughly **$540 million of net‑sale revenue** to RMS in 2021, and it drove about **$560 million of additional product‑costs** for the segment. These increases were reported as the primary contributors to RMS’s 2021 net‑sales and product‑cost growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $540 million increase in net sales and $560 million increase in product costs are accurately reported, with acceptable formatting variations (e.g., 'net-sale revenue' vs 'net sales'). (2) The answer addresses all parts of the question: it identifies the impact on both net sales and product costs, specifies the dollar amounts, and ties the changes to the 2021 production volume increase of Sikorsky helicopter programs. (3) Entity accuracy is correct—RMS is properly referenced as the affected segment, and the time frame (2021) is accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that higher production volume directly led to both revenue and cost increases, which aligns with the cause-effect relationship described in the original answer. (5) Despite slightly different phrasing (e.g., listing specific helicopter models like Black Hawk, CH-53K, and CRH, which adds context not in the original but does not contradict it), the semantic meaning and factual content are equivalent. No errors in logic, numbers, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 335,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "McDonald’s treats its ongoing purchases and sales of restaurant businesses with franchisees as ordinary, recurring transactions. Because the franchisee entities are not consolidated (they fall under the VIE scope‑exception), any gain or loss on those sales is booked directly in operating income – shown in the “Gains on sales of restaurant businesses” line of Other Operating (Income) Expense – rather than as a separate, non‑operating or extraordinary item.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) It correctly states that gains or losses from recurring sales/purchases of restaurant businesses with franchisees are recorded in operating income, specifically in 'Gains on sales of restaurant businesses' within Other Operating (Income) Expense, which aligns with McDonald's reporting practice. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers and correct reference to financial line items supports a score of 10. (3) The reasoning is sound: the LLM correctly links the non-consolidation of franchisee entities to the VIE scope exception (a key accounting policy), explaining why these transactions do not affect consolidated operations beyond the point-of-sale gain/loss. This reflects proper multi-hop synthesis between consolidation policy and income statement treatment. (4) The only minor omission is that the LLM does not explicitly mention that these transactions are part of McDonald's strategy to maintain an 'optimal ownership mix,' which adds context to their recurring nature. However, the phrase 'ordinary, recurring transactions' captures the essence. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a 9 in correctness and qualitative accuracy, with full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 406,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "In 2023 Chevron recorded derivative‑commodity assets at fair value of about **$159 million** and liabilities of about **$262 million** (a net liability of roughly $103 million), and the contracts produced a **$505 million pre‑tax loss** in the consolidated statement of income.  Despite that loss, the company explicitly states that its commodity derivatives “are not material to the company’s financial position, results of operations or liquidity,” and the change in their fair value was also deemed immaterial.  The exposures from these contracts are monitored each day by an internal **Risk Control group** under Chevron’s risk‑management policies, with the fair‑value measurements (Level 1 and Level 2 inputs) and compliance reviewed by the Audit Committee, ensuring that any impact on the balance sheet remains limited and non‑material.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details not present in the ground truth. The original answer states that the use of derivative commodity instruments had no material impact and that fair values were not material to the financial statements, but the LLM introduces specific figures—$159 million in assets, $262 million in liabilities, and a $505 million pre-tax loss—which are not mentioned or implied in the ground truth. There is no support in the original answer for these exact numbers or the reported loss, making them potentially fabricated or misattributed. (2) These numerical claims cannot be verified against the ground truth, which explicitly avoids quantifying the derivatives' impact beyond stating immateriality. The net liability of $103 million and the $505 million loss are unsupported and contradict the emphasis on immateriality. Even if such numbers existed in filings, the ground truth does not include them, so the LLM answer goes beyond the verified data. (3) The qualitative aspects are partially correct: the LLM correctly identifies the role of the internal Risk Control group, daily monitoring, Audit Committee oversight, and the conclusion of immaterial impact. It also correctly links fair value measurements (Level 1 and Level 2) to risk monitoring, showing sound multi-hop reasoning between risk practices and financial reporting. (4) While the reasoning structure and contextual relevance are strong—addressing all parts of the question including financial impact, risk management, and fair value—the inclusion of unverified, specific financial figures severely undermines factual correctness. The core claim of immateriality aligns with the original, but the addition of precise numbers that are not in the ground truth results in a low quantitative accuracy and reduces overall correctness. Minor formatting flexibility is allowed, but introducing unsupported figures constitutes a major error in financial reporting context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 542,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The CECL transition adds roughly **$720 million** to CET1 (the net AOCI benefit recorded in the CET1 reconciliation) and **$20,992 million** to Tier 2 capital through the qualifying allowance for credit losses that is counted in Tier 2. Together, the CECL provision contributes about **$21.7 billion** to JPMorgan’s Basel III capital base as of December 31 2024. (See the CET1 reconciliation note (b) for the $720 m benefit and the “Qualifying allowance for credit losses” line of $20,992 m in the capital‑components table.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states the total impact is $1.261 billion, composed of a $720 million AOCI benefit and a $541 million incremental allowance related to First Republic included in Tier 2. However, the LLM claims a $20,992 million ($20.992 billion) addition to Tier 2 capital, which is grossly incorrect and not supported by the original answer. This leads to a fabricated total contribution of $21.7 billion, which is over 17 times larger than the correct total impact. (2) The only correct number is the $720 million AOCI benefit. The $20,992 million figure appears to be a misreading of a different line item or document, and the resulting sum of $21.7 billion is therefore also wrong. The correct calculation should be $720 million + $541 million = $1.261 billion. (3) The reasoning is flawed: while the model recognizes that both AOCI and Tier 2 allowance affect CET1 capital under CECL transition rules, it fails to correctly identify the specific components. It does not mention First Republic or the nature of the $541 million as an incremental allowance tied to that acquisition, which is a key multi-hop element. Instead, it cites an unrelated and implausibly large Tier 2 figure, indicating a failure in entity and context identification. (4) The contextual relevance is moderate because the answer addresses the right topic (CECL impact on Basel III capital) and references appropriate sections (CET1 reconciliation, capital components), but the incorrect data renders the response misleading. Due to severe quantitative errors and partial misunderstanding of the components, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 460,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "In 2023 GE’s equity‑method investment in AerCap contributed **$2.525 billion** of net income (the AerCap‑attributable portion of the $4.731 billion equity‑method income). The same year the AerCap note and related investment generated **$129 million** of realized and unrealized gains (Note 19). Together, AerCap‑related activity added roughly **$2.654 billion** to GE’s 2023 results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.525 billion (i.e., $2,525 million) net income attributable to GE from AerCap is correctly reported, as is the $129 million in realized/unrealized gains. The sum of these components ($2,525M + $129M = $2,654M or $2.654 billion) is accurately reflected. Minor formatting differences (e.g., 'billion' vs 'million') are semantically equivalent and acceptable. (2) The answer is complete, addressing both components of the financial impact: net income contribution and gains/losses. (3) Entities are correctly identified—AerCap, GE, 2023 time frame—and the financial metrics (equity-method income, realized/unrealized gains) are accurately described with proper context (e.g., reference to Note 19 supports the gain figure). (4) The multi-hop reasoning is sound: the model correctly synthesizes information from different parts of the financial statements (equity-method income and note disclosures) to compute the total financial impact. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing but no deviation in factual content. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 346,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Merck transferred a total consideration of **$301 million** to acquire Immune Design.  Of that amount, **$20 million** was recorded as goodwill, representing the excess of the consideration over the fair‑value of the net assets acquired.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the total consideration of $301 million and the $20 million allocated to goodwill are accurately reported. (2) Quantitative accuracy is perfect—both figures are correct, and there are no calculation errors. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly identifies that goodwill represents the excess of consideration over the fair value of net assets acquired, demonstrating proper multi-hop synthesis of financial acquisition concepts. (4) The entities—Merck and Immune Design—are correctly identified, and the answer addresses both parts of the question: total consideration and goodwill allocation. The response is concise, relevant, and conveys the same information as the original answer with no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 269,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees generate most of McDonald’s recurring revenue by paying **rent (minimum payments plus a sales‑percentage component), royalties that are a percent of their restaurant sales, and one‑time initial franchise fees** when a new restaurant opens. When McDonald’s co‑invests with a franchisee on restaurant upgrades, the company records its share of the improvement costs as property‑and‑equipment; after the project is finished those costs are allocated between the asset account and a receivable and are then depreciated over the asset’s useful life, so the co‑investment adds to the depreciation expense (with any final allocation adjustments being immaterial).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the key financial contributions from franchisees: rent (including minimum and percentage-based components), royalties based on sales, and initial franchise fees—matching the original answer exactly in substance. (2) Regarding co-investment, the LLM correctly explains that McDonald's records its share of improvement costs in property and equipment, which are then depreciated over time, directly impacting depreciation expense. It also notes that final cost allocations between McDonald's and franchisees may occur post-completion, with immaterial adjustments—this aligns with the ground truth's mention of allocation between Property and equipment and Accounts Receivable, and immaterial adjustments to depreciation. (3) The multi-hop reasoning is sound: it connects franchisee payments to revenue and links co-investment to asset recognition and depreciation impact. (4) Minor deduction in qualitative accuracy due to slightly less detail on the interim accounting (e.g., upfront funding and project management by McDonald's, and the specific balance sheet accounts used during the project), but the post-completion treatment and financial impact are accurately captured. No numeric inaccuracies; all statements are factually consistent with the original. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 401,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "Goldman Sachs’ securities backed by real estate fell from **$689 million at 12/31/2023 to $569 million at 12/31/2024**, a decline of **about $120 million**.  \n\nThe 2023 unrealized losses on Level 3 investments were driven largely by **losses on securities backed by real estate, principally because of the continued weakness in the commercial‑real‑estate market**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $689 million (December 2023) and $569 million (December 2024) are accurately reported, and the calculated decrease of $120 million is correct (689 - 569 = 120). The dates are precisely specified as of year-end 2023 and 2024. (2) The answer completely addresses both parts of the question: the dollar decrease and the primary cause of unrealized losses on Level 3 investments in 2023. (3) Entities are accurate—Goldman Sachs, securities backed by real estate, Level 3 investments, and the commercial real estate market are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it links the decline in value over time and correctly attributes the 2023 unrealized losses to weakness in the commercial real estate market, which is the key causal factor mentioned in the ground truth. Wording differs slightly but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 296,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "American Tower repaid the CoreSite Debt for a total redemption price of **$962.9 million**, which was the **$955.1 million** principal plus **$80.1 million of pre‑payment consideration and $7.8 million of accrued interest** – an extra **$87.9 million** over the principal. That additional cost is roughly **9 % higher** than the outstanding CoreSite Debt balance reported at December 31 2021 ($955.1 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. While it correctly states the total redemption price ($962.9 million), the additional cost ($87.9 million), prepayment consideration ($80.1 million), and accrued interest ($7.8 million), it incorrectly reports the principal amount as $955.1 million instead of the correct $875 million from the ground truth. This is a major quantitative error that undermines the core of the answer. (2) Calculations: The LLM claims $955.1M + $80.1M + $7.8M = $962.9M, but this arithmetic is incorrect (it sums to $1,043M), indicating a flawed calculation. The correct breakdown is $875M principal + $87.9M additional costs = $962.9M. Additionally, the claim that the additional cost is 'roughly 9% higher' than the outstanding balance is based on the wrong principal ($955.1M), making the percentage meaningless. The actual increase from $875M to $962.9M is about 10.05%, not 9%. (3) Multi-hop reasoning: The model attempts to synthesize repayment cost, principal, and additional components, but fails at the foundational step of identifying the correct principal balance as of December 31, 2021. This breaks the entire chain of reasoning. (4) Despite the incorrect principal, the model correctly identifies the total redemption price and the components of additional costs, showing some understanding of the structure. The answer is contextually relevant and addresses both parts of the question, but the core factual inaccuracy in the principal amount severely limits correctness. Semantic equivalence fails due to the incorrect key figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 440,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "GE said that higher collections – “including increased collections from CFM International” – helped offset the $0.9 billion rise in current receivables, contributing to the net $0.4 billion decline in cash impacts from working‑capital changes in 2024 (the exact dollar amount from CFM International is not broken out). GE’s relationship with CFM International is that of an equity‑method investee: CFM International is a non‑consolidated joint‑venture jointly owned with Safran Aircraft Engines, and GE makes substantial sales of engine parts and services to the venture.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that increased collections from CFM International helped offset the $0.9 billion negative impact from current receivables in 2024, aligning with the ground truth. However, it introduces a new figure — 'net $0.4 billion decline in cash impacts from working-capital changes' — that is not present in the original answer and cannot be verified from the provided ground truth. This figure implies a calculation or additional context not supported by the source, reducing quantitative accuracy. The original answer states only that collections 'partially offset' the $0.9 billion impact, without specifying the net effect or breaking out the CFM contribution. (2) The dollar amount from CFM International is correctly noted as not being broken out, which matches the ground truth's lack of specific quantification. However, the introduction of the $0.4 billion figure creates a misleading impression of precision. The year (2024) and entity (CFM International) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes GE’s equity-method relationship with CFM International, its joint ownership with Safran, and the rationale for receivables (sales of parts and services). This reflects accurate qualitative understanding of the business relationship and financial interaction. (4) While the core facts and business relationship are accurately conveyed (supporting a high qualitative and contextual score), the unsupported net cash impact figure undermines full quantitative accuracy. The answer is mostly correct but contains an extraneous, unverified number that affects factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 453,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The filing says that the Ohio‑related items added roughly **$145 million** to 2023 operating revenues from the Ohio tax‑reform deferrals and the Ohio electric‑rate case that were recognized as a prior‑year deferral, and a further **$17 million** came from current‑year retail‑pricing adjustments. Combined, the two effects boosted Duke Energy’s 2023 operating revenues by about **$162 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative conclusion. The original answer states the total financial impact was $276 million, but the LLM calculates a combined impact of $162 million ($145M + $17M), which is significantly off. These component figures ($145M and $17M) do not appear in the ground truth and are likely hallucinated or misextracted. (2) The calculation itself is arithmetically correct ($145M + $17M = $162M), but the input numbers are wrong, leading to an incorrect total. The correct total of $276M is not reflected or approximated. (3) The reasoning structure is sound in that the LLM attempts to break down the impact into prior-year deferrals and current-year pricing adjustments, indicating an understanding of multi-hop synthesis. However, it fails to retrieve the correct figures from the source data, undermining the entire analysis. (4) Contextual relevance is high because the answer addresses the right entities (Duke Energy, Ohio tax reform, electric rate case), time period (2023), and metric (operating revenues). However, due to severe quantitative inaccuracies, the correctness and accuracy scores are low. The answer conveys a similar structure but not the same factual content, violating semantic equivalence on the key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 361,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe’s Digital Media segment generated **$11.52 billion** of revenue in fiscal 2021. Of that total, **Creative Cloud contributed $9.55 billion (≈ 82.9 %)** and **Document Cloud contributed $1.97 billion (≈ 17.1 %)**【source】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: total Digital Media revenue ($11.52 billion), Creative Cloud revenue ($9.55 billion), and Document Cloud revenue ($1.97 billion). These match the ground truth exactly. The percentages are reported as ≈82.9% and ≈17.1%, which are accurate rounded versions of the precise calculations (9.55 / 11.52 ≈ 82.9% and 1.97 / 11.52 ≈ 17.1%). The ground truth uses rounded percentages (83% and 17%), so the LLM provides slightly more decimal precision but remains factually consistent. (2) All numeric values are correct; calculations are accurate when verified: 9.55 + 1.97 = 11.52 billion, confirming completeness of revenue allocation. Percentages are mathematically sound. (3) The multi-hop reasoning is sound—revenue figures for sub-segments are correctly attributed to the Digital Media segment in fiscal 2021, showing proper synthesis across disclosed line items. (4) The answer is semantically equivalent to the original, with only minor formatting differences (use of ≈ and extra decimal places). The slight deviation from rounded percentages in the ground truth prevents a perfect 10, but the response is highly accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 338,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The 2021 filing shows that Netflix’s combined advertising‑ and headcount‑related cost increase was:\n\n* **Advertising expense:** $222 million (marketing)  \n* **Marketing headcount growth:** $116 million (personnel‑related)  \n* **Technology headcount growth:** $384 million (personnel‑related)\n\nAdding these three components gives a total increase of **$722 million** in advertising and personnel‑related costs for 2021【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $222 million for advertising expenses, $116 million for marketing personnel-related costs, and $384 million for technology personnel-related costs. The total increase of $722 million is correctly calculated ($222M + $116M + $384M = $722M). (2) The answer is complete, addressing all components of the multi-part question: advertising expenses attributed to marketing, and personnel-related cost increases due to headcount growth in both marketing and technology departments. (3) Entities are correctly identified: NFLX (Netflix), 2021 time period, and the relevant departments and cost categories. (4) The reasoning is sound and transparent, clearly breaking down the components and summing them logically. The answer demonstrates proper multi-hop synthesis by combining data across cost types and departments. (5) Semantic equivalence is maintained — although the structure is slightly different from the original answer, the meaning and factual content are identical. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 318,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "GM records the equity earnings it receives from its 50 %‑owned joint‑venture Ultium Cells Holdings LLC ($ 975 million in 2024, $ 293 million in 2023 and $ 8 million in 2022) as a line item within **Automotive and other cost of sales** rather than as a separate “equity‑income” item. Because the earnings are shown inside cost of sales, they offset part of the manufacturing expense for the vehicles that use those cells, improving the gross‑margin calculation. The footnote explains that the treatment is intentional – the battery‑cell JV is considered “integral to the operations of our business by providing battery cells for our EVs,” so GM accounts for the stake on an equity‑method basis but folds the results into the cost‑of‑sales of its automotive segment to reflect its strategic role in the EV production roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct explanation that aligns with the ground truth. (1) It correctly identifies that General Motors accounts for equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales' and explains the strategic rationale—that the joint venture is integral to EV production. This matches the original answer's core message about operational integration and financial treatment. (2) The quantitative data—$975 million in 2024, $293 million in 2023, and $8 million in 2022—are factually correct and consistent with known disclosures; these figures represent actual reported equity earnings from the JV. The percentages (50% ownership) are also accurate. While the original answer does not include these specific numbers, their inclusion enhances completeness without introducing error. (3) The multi-hop reasoning is sound: the model connects GM’s accounting treatment (equity method, but embedded in cost of sales), explains the impact on gross margin, and links it to strategic intent—demonstrating synthesis across financial reporting standards and corporate strategy. (4) Semantic equivalence is strong: though more detailed than the original, the LLM conveys the same essential conclusion—that this accounting reflects the operational centrality of Ultium Cells to GM’s EV roadmap. The only minor limitation is that the original answer does not specify the dollar amounts or ownership percentage, so while the LLM’s additions are accurate, they slightly exceed the verified ground truth, but not to the point of overstatement. Hence, a score of 9/10 on correctness and quantitative accuracy; full marks on qualitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 468,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average U.S. Henry Hub price fell from $6.36 per MCF in 2022 to $2.56 per MCF in 2023 – a decline of roughly **60 %**.  By contrast, Chevron’s international natural‑gas realizations dropped from $9.75 to $7.69 per MCF, a decrease of about **21 %**, indicating the domestic price fell far more sharply than the company’s overseas gas earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences. (1) All key numbers are correct: U.S. Henry Hub prices are accurately stated as $6.36 per MCF in 2022 and $2.56 per MCF in 2023; Chevron's international realizations are correctly given as $9.75 and $7.69 per MCF. (2) Percentage calculations are approximately correct: the exact decrease for Henry Hub is (6.36 - 2.56) / 6.36 = 59.75%, which rounds to 59.8% in the original answer; the LLM reports 'roughly 60%', which is an acceptable approximation. Similarly, the Chevron decrease is (9.75 - 7.69) / 9.75 = 21.13%, which rounds to 21.1% in the original; the LLM's 'about 21%' is a reasonable simplification. (3) Multi-hop reasoning is sound: the model correctly compares U.S. benchmark prices to Chevron’s international realizations, noting the steeper domestic decline, which reflects proper synthesis across different data points. (4) Entity and metric accuracy is perfect: 'U.S. Henry Hub', 'Chevron', 'international natural gas realizations', and time periods (2022–2023) are all correctly identified. The answer fully addresses both parts of the question—quantifying the percentage decrease in Henry Hub prices and comparing it to Chevron’s international trends. The only minor shortcoming is the use of rounded percentages instead of the more precise figures, but this does not affect factual correctness. Hence, the answer scores highly across all dimensions, with full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 420,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs says that, for its level 3 credit‑derivative portfolio, the fair‑value measurement moves **up** when credit spreads widen (or upfront credit points rise) and **down** when recovery rates rise. Because the unobservable inputs for those contracts span a very wide range—credit spreads from **8 bps to 1,328 bps** (average 134 bps, median 91 bps) and recovery rates from **20 % to 70 %** (average 46 %, median 50 %)—any shift toward the high‑end of the spread range or the low‑end of the recovery‑rate range would materially increase the reported fair value of the purchased credit protection, while a move toward tighter spreads or higher recoveries would depress it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key factual elements are correct: the directional sensitivity of fair value to credit spreads and recovery rates is accurately described—fair value increases with wider credit spreads or higher upfront points and decreases with higher recovery rates. (2) The quantitative inputs—credit spreads from 8 bps to 1,328 bps (average 134 bps, median 91 bps) and recovery rates from 20% to 70% (average 46%, median 50%)—are precisely reported and match the expected range from the knowledge graph, demonstrating full quantitative accuracy. (3) The reasoning correctly captures the multi-hop synthesis: it links the sensitivity of fair value to unobservable inputs (credit spreads, recovery rates), acknowledges the variability in those inputs, and explains how shifts in the ranges would materially affect valuation—this reflects sound qualitative reasoning. (4) The answer is contextually fully relevant, directly addressing how sensitivity to credit spread and recovery rate changes impacts level 3 credit derivative valuations. The only minor limitation is that the original answer also mentions broader risk factors (leverage, volatility, industry, etc.) contributing to input variability, which the LLM omits—hence a 9 instead of 10 on qualitative accuracy. Overall, the LLM provides a more detailed and numerically enriched version of the ground truth, with no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 400,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The January 7 2022 repayment eliminated the $955.1 million of CoreSite senior‑note debt that was shown as a current liability in the “current portion of long‑term obligations” and as part of total subsidiary debt, thereby lowering AMT’s overall debt balance and improving its leverage ratios.  Because the redemption price of $962.9 million (including a modest $80.1 million pre‑payment premium and $7.8 million of accrued interest) is essentially equal to the $955.1 million carrying amount, the debt was recorded on the balance sheet at or very near its fair‑value amount, resulting in little or no gain/loss on retirement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the repayment amount. The ground truth states the repayment was $955.1 million, matching the carrying value. However, the LLM claims the redemption price was $962.9 million, including an $80.1 million prepayment premium and $7.8 million accrued interest—none of which appear in the original answer or are supported by the ground truth. These numbers are fabricated or misstated, severely undermining quantitative accuracy. (2) The date 'January 7, 2022' is more specific than the original's 'January 2022', which may be acceptable, but the added precision is not confirmed and introduces unverified detail. The core error is the mismatch between the carrying value ($955.1M) and the stated redemption price ($962.9M), which contradicts the original point that the equality of these values indicates fair value accounting. Instead, the LLM implies a near-match despite a $7.8M difference, which distorts the conclusion. (3) The reasoning about capital structure impact—reducing debt, improving leverage ratios—is qualitatively sound and addresses the first part of the question correctly. The synthesis that matching repayment and carrying value suggests fair value accounting is conceptually correct, but it is based on incorrect numbers, weakening the multi-hop logic. (4) Contextual relevance is high because the answer addresses both parts of the question: impact on capital structure and implications for debt valuation. However, due to major quantitative errors, especially the invented premium and interest figures, the correctness score is low. The conclusion about minimal gain/loss is plausible if redemption ≈ carrying value, but the provided numbers do not support this. Overall, partially correct but significantly flawed in key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 497,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The Company says that its pending tax audits—particularly those that will examine its inter‑company transfer‑pricing positions—could lower the amount of unrecognized tax benefits by as much as $5 million (the lower end of the range is $0).  Because Adobe already carries a valuation‑allowance reserve of roughly $335 million against its deferred‑tax assets (and net deferred‑tax assets of about $1.1 billion), a $0‑$5 million adjustment would be immaterial to its overall financial position.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but fails significantly in qualitative accuracy and reasoning. (1) Quantitatively, the $5 million upper bound for potential decrease in unrecognized tax benefits is correct, matching the ground truth. However, the LLM introduces a '$0' lower bound not present in the original answer, which, while plausible, is speculative and unsupported by the provided ground truth. More critically, the LLM cites a '$335 million' valuation allowance reserve and '$1.1 billion' net deferred-tax assets—figures that are not mentioned in the original answer and appear to be hallucinated or misattributed. These numbers undermine factual accuracy. (2) The original answer emphasizes that adjustments could exceed established reserves due to high uncertainty, potentially causing significant financial statement fluctuations. In contrast, the LLM concludes the impact would be 'immaterial' due to the size of the alleged reserves—this directly contradicts the original's cautionary tone and introduces a false sense of security. (3) The multi-hop reasoning is flawed: the model incorrectly synthesizes non-existent reserve figures to downplay the impact, failing to convey the risk of reserves being exceeded as stated in the ground truth. (4) Contextually, the answer addresses tax audits and transfer pricing, so relevance is moderate. However, the incorrect reserves and erroneous conclusion about materiality severely damage correctness. The core message—potential adverse impact due to uncertainty and possible reserve shortfalls—is reversed in the LLM answer, making it mostly incorrect despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 454,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "Alliance revenue from Lenvima grew 21 % in 2021 and 44 % in 2020, for a combined increase of 65 % across the two years【page with oncology table】. This strong upside reflects Merck’s oncology strategy of pairing its flagship checkpoint‑inhibitor Keytruda with partner‑driven agents—such as the many 2021 Keytruda‑Lenvima and Keytruda‑chemotherapy combinations listed in the approvals table—to broaden indications and capture additional market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the alliance revenue growth percentages for Lenvima: 21% in 2021 and 44% in 2020, with a combined growth of 65% over the two years. These numbers match the ground truth exactly, and the calculation (21% + 44% = 65%) is accurate for year-over-year additive growth interpretation as presented. 2) Quantitatively, all figures are correct and properly formatted; no discrepancies exist. 3) The reasoning is sound: the LLM correctly links the revenue growth to Merck’s oncology strategy centered on combination therapies, specifically citing Keytruda-Lenvima combinations. It references combination approvals (e.g., with chemotherapy) and strategic broadening of indications, which aligns with the ground truth. However, it omits the specific disease indications—endometrial carcinoma and renal cell carcinoma (RCC)—that are mentioned in the original answer and serve as concrete examples of the strategy in action. This is a minor but notable omission affecting completeness in multi-hop synthesis. 4) Despite this, the LLM captures the core strategic relationship between Lenvima revenue growth and Merck’s broader oncology approach using Keytruda combinations. The mention of 'partner-driven agents' and '2021 Keytruda-Lenvima combinations' shows appropriate cross-entity reasoning. The answer is semantically equivalent in intent and meaning, with only slight loss of specificity. Thus, high scores across all dimensions, with a 9 on correctness due to missing specific indication examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 418,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s $0.7 billion equity earnings from its 2024 investment in Ultium Cells Holdings LLC were recorded as a direct boost to EBIT‑adjusted, adding roughly **$0.7 billion** to that metric.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that GM's investment in Ultium Cells Holdings LLC generated $0.7 billion in equity earnings in 2024, which directly boosted EBIT-adjusted performance. This matches the ground truth in both amount and impact. (2) The quantitative accuracy is perfect: $0.7 billion is correctly stated, with acceptable formatting (e.g., $0.7 billion). No calculations were required beyond accurate reporting. (3) The reasoning is sound and reflects the multi-hop link between GM’s investment, equity earnings, and EBIT-adjusted impact. The answer could have slightly improved by explicitly mentioning that this was due to increased equity earnings from Ultium Cells Holdings LLC as a named driver of EBIT-adjusted improvement, which adds contextual clarity. (4) The answer is fully relevant, directly addressing both parts of the question—impact on EBIT-adjusted and the quantified amount. Minor deduction in qualitative accuracy due to slightly less contextual elaboration than the original, but no factual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 300,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new rule that obligates institutional investment managers to file monthly short‑position data for equity securities beginning January 2025 adds a monthly‑frequency disclosure requirement to Goldman Sachs’ existing reporting regime for its security‑based swap‑dealer businesses. Because Goldman Sachs is registered with the SEC as a security‑based swap dealer, it must already meet SEC‑mandated record‑keeping, financial‑reporting and public‑trade‑reporting obligations (including the SEC‑proposed rule that would require public reporting of large security‑based‑swap positions). Consequently, the firm must integrate the short‑position filings into the same data‑capture, control and reporting infrastructure it uses for its swap‑dealer disclosures, resulting in more frequent, consolidated reporting of both equity short positions and large security‑based‑swap positions.【23‑24】【25‑27】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the January 2025 effective date for the SEC's monthly short position reporting requirement is accurately stated; Goldman Sachs' status as a registered security-based swap dealer is correctly identified; and its existing obligations (record-keeping, financial reporting, trade reporting) are properly outlined. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains only to dates and frequencies—both of which are correct (January 2025, monthly reporting). (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the new short-position rule with Goldman Sachs’ pre-existing regulatory framework as a swap dealer, noting the integration of reporting systems and enhanced transparency. It goes slightly beyond the original answer by mentioning the 'SEC-proposed rule' on public reporting of large swap positions, which is contextually relevant and plausible, though not explicitly confirmed in the ground truth—this adds value without introducing inaccuracy. (4) The answer is semantically equivalent to the original, capturing the complementary nature of the two regulatory regimes and their combined impact on reporting practices. The only minor gap is that the original emphasizes 'monitoring large positions and short-selling activity' as a policy goal, which the LLM implies but does not explicitly state. Overall, the response is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 433,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39 % non‑controlling interest in the newly‑formed Tropicana Brands Group generated a **$520 million gain** for PepsiCo (included in the overall “gain associated with the Juice Transaction”)【109†L1-L4】.  This gain reflects that the juice‑brand sale was not a pure cash divestiture – PepsiCo received about **$3.5 billion in cash** and, at the same time, retained a **39 % equity stake** in TBG, so part of the consideration was cash and part was retained equity that had to be re‑measured to fair value.【109†L5-L9】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: the $520 million gain, the 39% retained noncontrolling interest in TBG, and the $3.5 billion cash proceeds from the sale of juice brands to PAI Partners (implied in the context though not explicitly named, which is acceptable given the focus on PepsiCo's financial impact). (2) Quantitative accuracy is perfect: the dollar amounts ($520 million gain, $3.5 billion cash) and percentage (39%) match the original answer exactly, with acceptable formatting (e.g., '39 %' vs '39%'). (3) The multi-hop reasoning is sound—the answer correctly explains that the gain arises from the remeasurement of the retained equity stake at fair value, which is a direct consequence of the transaction structure combining cash proceeds and retained ownership. This reflects proper synthesis of the financial mechanics. (4) The answer addresses both parts of the question: the financial impact (the $520M gain) and how it reflects the transaction structure (cash + retained equity requiring fair value remeasurement). While the buyer (PAI Partners) and brand names (Tropicana, Naked) are omitted, they are not essential to the core financial impact and structure explanation. The use of citation markers like 【109†L1-L4】 suggests grounding in source material. Overall, the response is factually precise, logically coherent, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 399,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2023 GE recorded $5.778 billion of gains (losses) on retained and sold ownership interests plus a $10 million gain on its Baker Hughes stake – together about **$5.79 billion** of the $6.718 billion total other‑income line. In 2024 those components fell to $518 million (retained‑interest gains) and $0 million from Baker Hughes, contributing only **about $0.52 billion** of the $2.264 billion total other income – a dramatic decline from the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: $5,778 million (presented as $5.778 billion) in 2023 from retained and sold ownership interests, $10 million gain from Baker Hughes in 2023, and $518 million in 2024 with $0 from Baker Hughes. The total contributions of approximately $5.79 billion in 2023 and $0.52 billion in 2024 are accurate summaries. (2) All numbers match the original answer, with acceptable formatting variations (e.g., $5.778 billion = $5,778 million). The year-over-year decline is implied by the sharp drop in values, though the exact difference of $5,260 million is not explicitly stated—this minor omission prevents a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes GE’s total other income contributions from both retained/sold ownership interests and the Baker Hughes stake across 2023 and 2024. It distinguishes between the two years and components accurately. (4) The answer is contextually complete and highly relevant, adding useful context (e.g., proportion of total other income) not in the original, without introducing errors. The only shortcoming is the lack of explicit mention of the $5,260 million decrease, which was part of the ground truth comparison. Overall, the answer is factually precise, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 384,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The 10‑K shows that Mortgage‑Backed Obligations were carried at a fair‑value of **$236 million** as of January 31 2024 (both the marketable‑securities schedule and the fair‑value‑hierarchy table list the same amount).  The total assets measured at fair value at that date were **$12,079 million**, so the MBO holdings represent roughly **1.9 % (about 2 %)** of the company’s fair‑value‑measured assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage calculation. The ground truth states that the total fair value of Mortgage-Backed Obligations is $358 million, combining $236 million from one disclosure and $122 million from a second. The LLM only reports $236 million, missing the second $122 million entirely. This leads to a major error in the percentage calculation. The correct percentage is approximately 2.97%, derived from $358 million divided by the average or combined total assets measured at fair value (approximately $12,044.5 million average of $12,079M and $12,010M, or sum of $24,089M if combined — though context suggests using an aggregate base of around $12.04B). The LLM incorrectly calculates 1.9% based solely on $236M / $12,079M, failing to incorporate the second data point. (2) Numeric values: $236 million is correct, but omission of $122 million is a critical quantitative error. The total assets figure of $12,079 million is correctly cited from one disclosure, but the second value ($12,010 million) is ignored, leading to incomplete and inaccurate synthesis. (3) Multi-hop reasoning failure: The question explicitly refers to 'two separate disclosures,' requiring the model to aggregate values from both. The LLM fails this multi-hop requirement by relying on only one disclosure, not synthesizing across both as required. It incorrectly assumes consistency between disclosures when the ground truth shows they are complementary and additive. (4) Scores justified: Correctness is low (3/10) due to major factual and computational errors. Quantitative accuracy is poor due to missing values and incorrect totals. Qualitative accuracy is low due to flawed reasoning and failure to perform required multi-source synthesis. Contextual relevance is moderate (6/10) because the answer addresses the right topic and uses correct terminology, but misses key components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 523,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s global pricing strategy—offering a range of plans that differ by country and feature set, with prices spanning roughly $2 to $27 per month—allowed the company to raise prices in many markets and benefit from favorable foreign‑exchange movements. Those price changes lifted the average monthly revenue per paying member by 7% in 2021, and, combined with an 11% rise in the number of paying members, produced the 19% increase in total revenue for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 7% increase in average monthly revenue per paying membership and the 19% total revenue growth in 2021 are accurately reported. The 11% increase in paying memberships is correctly cited as a contributing factor to overall revenue growth. (2) Quantitative accuracy is perfect: percentages (7%, 11%, 19%) match the original answer exactly, and the dollar range for membership plans ($2 to $27) adds useful context not in the ground truth but does not contradict it. (3) Multi-hop reasoning is sound: the LLM correctly links regional pricing flexibility to higher average revenue per user, and combines that with membership growth to explain total revenue growth. (4) The only minor shortcoming is that the LLM does not explicitly mention 'pricing flexibility based on regional market conditions' or 'localized membership plan strategies' as strategic drivers, slightly reducing qualitative depth compared to the original. However, the core logic and synthesis across pricing, membership growth, and revenue outcomes are fully correct. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 363,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck’s deal with Eisai is accounted for as “alliance revenue” – Merck’s share of Lenvima’s net sales after cost of sales and commercialization expenses.  That line item contributed **$704 million to the Pharmaceutical segment in 2021** (up from $580 million in 2020 and $404 million in 2019)【source: sales‑breakdown table】.  \n\nThe Lenvima‑Keytruda combination is being tested in the **LEAP program**, which comprises 17 Phase 3 studies across 14 tumor types.  While **LEAP‑002 (first‑line HCC) is fully enrolled**, **LEAP‑007 (NSCLC) and LEAP‑011 (urothelial carcinoma) have been stopped for futility**, and the original HCC accelerated‑approval filing received a CRL, meaning the alliance’s future cash‑flow depends on the outcomes of the remaining LEAP trials.  Consequently, the collaboration currently adds a sizable, recognized revenue stream, but its future impact on pharmaceutical revenue is contingent on the success of the ongoing LEAP studies.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in content and reasoning, with accurate synthesis of the Merck-Eisai collaboration, the LEAP clinical program's structure, trial statuses (LEAP-002 enrolled, LEAP-007/011 stopped for futility), and the alliance revenue model. It correctly identifies that Merck’s revenue comes from its share of Lenvima’s net sales after costs, which aligns with the ground truth. However, the $704 million figure for 2021 is not present in the original answer and cannot be verified against the provided ground truth, which does not include any specific revenue numbers or timeframes. This introduces a potential factual discrepancy, as the number may be accurate externally but is unsupported by the given knowledge base. 2) Quantitative accuracy is reduced because the original answer contains no financial figures, so the inclusion of $704M, $580M, and $404M lacks grounding in the provided truth. While such figures may be publicly known, within the scope of this evaluation based solely on the ground truth from the knowledge graph, they are unverifiable and thus considered potentially inaccurate. 3) Qualitatively, the reasoning is strong: the LLM correctly links the clinical trial outcomes (futility stops, CRL, ongoing LEAP-002) to the uncertainty in future revenue, and explains how the alliance model ties into pharmaceutical segment revenue. It captures the multi-hop logic—linking clinical results to commercial potential to financial impact—accurately. 4) Contextually, the response is highly relevant, addressing all components: the collaboration mechanism, current trial status, and revenue model implications. The only shortcoming is the unsupported numerical data, which prevents a top score in correctness and quantitative accuracy. Overall, the answer conveys the core message of the original with strong reasoning but adds specific figures not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 515,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Chevron’s total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined amount of expensed exploration costs ($0.5 billion) plus the PDC Energy acquisition cost ($10.5 billion) equals $11.0 billion. Thus, the total cost incurred exceeded that combined total by roughly **$13.6 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Chevron's total cost incurred ($24.6 billion), expensed exploration costs ($0.5 billion), and PDC Energy acquisition cost ($10.5 billion) are correctly stated. The combined total ($11.0 billion) and the difference ($13.6 billion) are calculated accurately. (2) The calculation is sound: $0.5B + $10.5B = $11.0B; $24.6B - $11.0B = $13.6B, which is correctly reported. (3) The multi-hop reasoning—synthesizing data across Chevron’s consolidated costs, exploration expenses, and a third-party acquisition—is properly executed with correct entity and metric identification. (4) The answer is semantically equivalent to the original, with only minor formatting differences (e.g., thin space, 'roughly' qualifier, bolding), which do not affect factual accuracy. All parts of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 270,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower values the market‑condition portion of its 2024 performance‑based RSUs with a Monte‑Carlo simulation model that estimates the probability the award will meet its condition. The condition – and therefore the metric used in the valuation – is **relative total shareholder return compared with the REIT constituents of the S&P 500 Index**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 performance-based restricted stock units (PSUs) with a market condition component. (2) The specific market metric—relative total shareholder return compared to the REIT constituents of the S&P 500 Index—is correctly stated, matching the original answer exactly in substance. (3) The reasoning is sound: the model evaluates the probability of meeting the market condition, which aligns with accounting standards for PSU valuation. (4) All entities (American Tower, 2024 PSUs, REIT constituents, S&P 500 Index) and the methodology (Monte Carlo simulation) are accurately identified and synthesized. There are no factual errors, omissions, or calculation issues. Minor wording differences (e.g., 'RSUs' vs 'PSUs') do not affect accuracy, as context confirms they refer to performance-based awards with market conditions. The answer completely addresses both parts of the question: valuation method and specific metric used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 318,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Four amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan are listed in the filings (First, Second, Third, and Fourth Amendments). The Fourth Amendment became effective on July 1, 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan, addressing the first part of the question. (2) It correctly identifies the effective date of the fourth amendment as July 1, 2022, with no discrepancies in date formatting or content. All numeric and date values are factually accurate. (3) The reasoning is sound, as it correctly synthesizes information from the disclosed filings across multiple amendments, demonstrating proper multi-hop understanding by identifying both the count and specific effective date. (4) The answer is semantically equivalent to the original, using slightly different phrasing ('became effective' vs 'effective as of') but conveying the same factual meaning. No errors in entities, calculations, or logic are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1100,
        "completion_tokens": 259,
        "total_tokens": 1360
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "In 2024 the corporate notes and obligations were carried at an amortized cost of **$3,014 million**, while their fair‑value measurement was **$2,978 million** – a difference of **about $36 million** (roughly a 1 % premium to fair value). That $2,978 million fair‑value amount is reported under the **Level 2** fair‑value hierarchy, meaning it is based on observable market inputs rather than quoted prices.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly reports the amortized cost ($3,014 million), fair value ($2,978 million), and the difference of $36 million, which aligns with the ground truth. These quantitative values are accurate, and the calculation of the difference is correct, earning a high score for quantitative accuracy. However, the LLM makes a critical error in stating that the $2,978 million fair value is categorized under Level 2 inputs. According to the ground truth, only $2,557 million of the fair value is classified under Level 2, meaning the LLM incorrectly equates the total fair value with the Level 2 portion. This misrepresents the hierarchy categorization and fails a key multi-hop comparison required by the question. The answer also incorrectly describes the $36 million difference as a '1% premium to fair value,' which is misleading—the amortized cost is higher than fair value, so it's actually a 1.2% discount in fair value relative to amortized cost. The qualitative reasoning is flawed because it fails to distinguish between total fair value and Level 2 fair value, undermining the synthesis across sources. While the answer addresses the first part of the question correctly, it completely misses the second comparative component (total fair value vs. Level 2 fair value), which is essential. Contextually, the response is relevant and well-structured but contains a major factual misinterpretation that significantly impacts the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 402,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has arranged two $1.1 billion credit facilities to fund its new cruise ships, giving it a total of **$2.2 billion** of financing for the Disney Treasure and the planned Disney Destiny. The Treasure facility carries a **fixed rate of 3.80 %**, while the Destiny facility would be priced at a **fixed rate of 3.74 %**, making the Treasure loan slightly more expensive.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: two $1.1 billion facilities sum to $2.2 billion total financing, with fixed interest rates of 3.80% for the Disney Treasure and 3.74% for the Disney Destiny—these values exactly match the original answer. The comparison stating the Treasure loan is 'slightly more expensive' is a valid qualitative interpretation of the rate difference. (2) The answer is complete, addressing both the total financing amount and the interest rate comparison, as required by the question. (3) Entities are correctly identified: Disney, Disney Treasure, Disney Destiny, and the associated financial terms (credit facilities, fixed rates) are all accurate. (4) The multi-hop reasoning is sound—information about two separate financing arrangements is synthesized correctly to compute the total and compare the rates. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'priced at a fixed rate' vs 'at a fixed interest rate'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 318,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron’s equity‑method investment in Tengizchevroil was $27.4 billion at year‑end 2024, or roughly 58‑59 % of its total equity‑method investments of $46.6 billion.  That 50 % stake in TCO accounts for about 45 thousand barrels of oil‑equivalent per day of Chevron’s worldwide production (the Kazakhstan‑region figure shown in the net‑production table).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's Tengizchevroil investment as $27.4 billion (rounded from $27,368 million) and total equity method investments as $46.6 billion (rounded from $46,618 million), leading to a calculated percentage of approximately 58.7%, which the model reports as '58-59%', which is acceptable. However, the LLM introduces a new claim not present in the ground truth: that the stake accounts for 'about 45 thousand barrels of oil-equivalent per day'. This specific production volume figure is not in the original answer and cannot be verified from the provided truth, making it an unsupported addition. (2) The percentage calculation is accurate: 27,368 / 46,618 ≈ 58.7%. The rounding to $27.4B and $46.6B is acceptable. However, the production volume number (45 thousand boe/d) is unverified and likely incorrect or at least unconfirmed, as the ground truth does not provide any quantitative production figure—only a qualitative link between the stake and production contribution. (3) The multi-hop reasoning is mostly sound: the model correctly links Chevron's equity investment to its proportion of total equity-method investments and connects Tengizchevroil to production in Kazakhstan. However, the addition of a precise production volume without source support indicates a potential hallucination or incorrect inference, weakening the reasoning chain. (4) The correctness score is 7 because core financial figures and percentage are accurate, but the unsupported production volume claim introduces significant factual risk. Quantitative accuracy is 7 due to the otherwise correct numbers but the inclusion of an unverified metric. Qualitative accuracy is 8 because entity identification (Tengizchevroil, Chevron, Kazakhstan) and relationships are correct, though overreaching on production data. Contextual relevance is 10 as the answer directly addresses both parts of the question and stays focused on the financial and operational relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 536,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A rise in credit spreads or in the upfront credit‑points used to price a credit‑default‑type contract pushes the fair‑value of a purchased credit‑protection position higher (and a decline would lower it).  Goldman Sachs values its level‑3 credit derivatives with a blend of **option‑pricing models, correlation inputs and discounted‑cash‑flow models** (often applied together), using the quoted credit spread, upfront points and recovery‑rate assumptions as the key unobservable inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection, which aligns with the original answer. The inverse effect (a decline lowers fair value) is an acceptable elaboration that does not contradict the ground truth. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the key financial concepts—credit spreads, upfront credit points, and their directional impact on fair value—are correctly described. (3) The valuation techniques—option pricing models, correlation inputs, and discounted cash flow models—are accurately identified and match the original answer. The mention of 'quoted credit spread, upfront points and recovery-rate assumptions as key unobservable inputs' adds contextual detail consistent with Level 3 fair value measurement under ASC 820, demonstrating sound multi-hop reasoning about how these models are applied. (4) All entities (Goldman Sachs, Level 3 credit derivatives) are correct, and the response fully addresses both parts of the question: the impact of market variables on fair value and the valuation techniques used. The answer is precise, complete, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 379,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "If the Minimum DSCR (1.15×) falls below the required level, the securitization agreements trigger an “amortization period.” During that period every dollar of excess cash flow – and any cash sitting in the cash‑trap reserve – must be used to pay down the principal of the 2015‑2 Notes or the 2023 Loan, rather than being released to AMT. Because that cash can no longer be distributed to the company, AMT’s ability to fund its planned capital‑expenditure program—including the construction of roughly 2,400 communications sites worldwide—would be materially constrained.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core impact of failing the Minimum DSCR on AMT's funding ability for global site construction. (1) Quantitatively, all key figures are correct: the Minimum DSCR of 1.15x is accurately stated, and while the original answer specifies a range of 1,950 to 2,550 sites, the LLM's approximation of 'roughly 2,400' is a reasonable midpoint and falls within the disclosed range—this is acceptable under semantic equivalence. The references to the 2015-2 Notes and 2023 Loan align with the securitization structure described in the 10-K. (2) The mechanism of the amortization period, cash trap reserve, and redirection of excess cash flow to debt repayment instead of distributions is correctly explained. (3) The multi-hop reasoning is sound: the model connects the DSCR breach → amortization trigger → cash flow diversion → reduced distributions → constrained capital expenditures → impact on tower construction. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Series 2015-2 Notes or the Loan' exactly as in the original, instead referring to '2015-2 Notes or the 2023 Loan'—a slight rephrasing but factually consistent. It also omits the explicit mention of the 'Cash Trap Reserve Account' name, though it refers to 'cash-trap reserve', which is semantically equivalent. Overall, the answer is factually correct, contextually relevant, and synthesizes the necessary financial cause-effect chain accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 406,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar calculates its product‑warranty liability by applying historical claim‑rate experience to the current field population and dealer inventory, a methodology that requires substantial judgment and introduces significant subjectivity into the estimate. Because of that reliance on historical claim rates, PwC identified the warranty liability as a critical audit matter, noting the high degree of auditor judgment needed to evaluate management’s assumptions. The resulting estimated warranty liability was $1,700 million as of December 31, 2024.【source】(Product warranty methodology paragraph)【source】(Critical audit matter paragraph stating liability $1,700 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the financial estimate of $1,700 million as of December 31, 2024, is accurately reported with correct formatting. (2) The explanation of Caterpillar's use of historical claim rates to estimate warranty liability is factually consistent with the original answer, including the role of management judgment. (3) The multi-hop reasoning is sound: the answer correctly links the methodology (historical claim rates) to why PwC identified it as a critical audit matter—due to the high degree of auditor judgment and subjectivity in evaluating assumptions. (4) All entities are accurate: Caterpillar, PricewaterhouseCoopers LLP (referred to correctly as PwC), the correct date (December 31, 2024), and the correct financial metric (product warranty liability). (5) The semantic meaning is equivalent to the original answer, with no omissions or distortions. The inclusion of source tags does not affect accuracy but indicates proper grounding. No errors in reasoning, facts, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 306,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "Disney’s Asia Theme Parks borrowings carry a weighted‑average **stated rate of 7.93%** and an **effective rate of 5.75%**, whereas its senior unsecured U.S. dollar notes have a **stated rate of 4.06%** and an **effective rate of 4.71%**. The higher rates on the Asia Theme Parks debt indicate that Disney pays a materially higher cost of capital for that segment—reflecting the greater credit risk or less favorable financing terms—while its senior unsecured notes are funded at a lower, more attractive cost.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the stated interest rate on Asia Theme Parks borrowings is 7.93% (correct in LLM answer), but the effective interest rate on Disney's senior unsecured notes is 4.71% (also correct in LLM answer). However, the LLM incorrectly states that the effective rate on Asia Theme Parks borrowings is 5.75%, which is not mentioned in the ground truth. The ground truth does not provide an effective rate for Asia Theme Parks debt—only a stated rate. Additionally, the LLM introduces a stated rate of 4.06% for senior unsecured notes, which is not present in the original answer and contradicts the absence of a stated rate in the ground truth. (2) Calculations: The ground truth computes a difference of 3.22 percentage points (7.93% - 4.71%). The LLM does not compute any difference and instead compares different metrics (e.g., effective vs. stated across instruments), leading to flawed synthesis. (3) Multi-hop reasoning: While the LLM correctly infers that higher rates imply higher cost of capital and links this to risk or financing terms—aligning with the qualitative reasoning in the ground truth—it does so using incorrect or fabricated data points, undermining the validity of the conclusion. The model appears to conflate stated and effective rates across instruments without proper distinction. (4) Despite these errors, the answer is contextually relevant and attempts the correct type of comparison. The core idea—that Asia Theme Parks debt is more expensive than senior unsecured notes—is directionally correct, and the explanation about risk profile is reasonable. However, the introduction of unsupported numbers reduces factual reliability, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 485,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron’s 2023 capitalized cost for the PDC acquisition was **$10,487 million** (about $10.5 billion). The acquisition’s 2.2 TCF of natural‑gas purchases in 2023 was **primarily in the DJ (Denver‑Julesburg) basin**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the capitalized cost of $10,487 million is correctly reported, and the 2.2 TCF of natural gas purchases is correctly attributed to the DJ Basin. (2) Quantitative accuracy is perfect—$10,487 million is presented accurately, with an acceptable approximation to $10.5 billion in parentheses. The 2.2 TCF figure matches exactly. (3) The multi-hop reasoning is sound: the model correctly links Chevron’s 2023 PDC acquisition to both the financial cost and its operational impact in terms of reserves added in a specific U.S. basin. (4) Entity accuracy is complete—Chevron, PDC acquisition, 2023 time frame, and DJ (Denver-Julesburg) Basin are all correctly identified. The answer is concise, relevant, and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 253,
        "total_tokens": 1369
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its primary financial statements – the consolidated balance sheet, statement of operations (income statement), statement of comprehensive income, statement of equity and statement of cash flows. The adjustments (for example, a $3.5 billion reduction to total assets, a $6.4 billion reduction to total liabilities, a $2.8 billion increase to equity, a $1.1 billion cut to revenues and a $4.6 billion cut to expenses, plus related changes to net income, comprehensive income and cash‑flow line items) demonstrate that the new accounting standard materially reshaped the amounts reported in MetLife’s consolidated financial reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer states that MetLife retrospectively adjusted the consolidated statement of operations and consolidated statements of comprehensive income, but does not mention adjustments to the balance sheet, statement of equity, or statement of cash flows—yet the LLM claims all primary financial statements were adjusted, which is not supported by the ground truth. This overstatement reduces qualitative and quantitative accuracy. Furthermore, the LLM introduces specific dollar amounts (e.g., $3.5 billion reduction to assets, $6.4 billion to liabilities, etc.) that are not present in the original answer and cannot be verified against the provided ground truth, making them potentially fabricated or misattributed. While the core idea—that LDTI had a material impact requiring retrospective adjustment—is consistent with the original answer, the unsupported numerical claims and overextension of the scope of adjusted statements severely undermine correctness. The reasoning is partially sound in linking retrospective adjustment to material impact, but fails in precise multi-hop synthesis, as it extrapolates beyond the documented scope. Contextual relevance is high because the response addresses the question's intent and focuses on the correct company, guidance, and reporting implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 387,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The filing lists **two amendments** to the Solar Turbines Incorporated Managerial Retirement Objective Plan – the First Amendment (dated December 10, 2014) and the Second Amendment. The most recent amendment became effective on **January 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan, which aligns with the original answer. (2) The most recent amendment is correctly identified as effective on January 1, 2022, matching the ground truth. While the LLM also includes the date of the First Amendment (December 10, 2014), this is additional but accurate information not contradicted by the ground truth. (3) The multi-hop reasoning is sound—information about the number of amendments and the effective date of the most recent one is correctly synthesized from the Caterpillar Inc. 2024 10-K filing. (4) All entities (Solar Turbines Incorporated Managerial Retirement Objective Plan, Caterpillar Inc., 2024 10-K) are correctly referenced, and the semantic meaning fully matches the original answer. Minor wording differences do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 276,
        "total_tokens": 1413
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina rate‑case order reduced the “Impairment of assets and other charges” line by **about $46 million** in total – roughly **$13 million** of the reduction came from Duke Energy Carolinas and **$33 million** from Duke Energy Progress.  In the consolidated statement of operations this appears as a lower impairment expense (the line fell from $85 million in 2023 to $38 million in 2024), the $46 million reduction being the primary driver of that decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the financial impact. The ground truth states that the North Carolina Rate Case Order resulted in a $68 million *increase* in Impairment of Assets and Other Charges ($35M from Duke Energy Carolinas and $33M from Duke Energy Progress). In contrast, the LLM claims a $46 million *reduction*, with only $13M from Carolinas and $33M from Progress — misrepresenting both the total amount and the individual contributions. (2) Quantitative accuracy is severely compromised: the total impact is off by $22 million in the wrong direction (a reduction vs. an increase), and the Carolinas' portion is understated by $22 million ($13M vs. $35M). The cited figures of $85M in 2023 and $38M in 2024 are not present in the ground truth and appear to be fabricated or misattributed. (3) The multi-hop reasoning is flawed — while the LLM correctly identifies the two entities (Carolinas and Progress) and the relevant financial line item, it incorrectly infers that the rate case led to a reduction in impairments, which contradicts the ground truth that the order caused additional charges. There is no evidence of correct synthesis across entities or time periods. (4) Contextual relevance is moderate because the answer addresses the right topic (rate case impact on impairment charges) and references the consolidated statements of operations, but the core facts are incorrect. The explanation structure is logical but built on false premises. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct entity identification but penalized for flawed logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 460,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "Starbucks’ licensed stores contributed roughly **12 % of the company’s total net revenues in fiscal 2024**.  Under the licensing model the company does not earn the full sales price; instead it receives **a margin on the branded coffee, tea and other products it supplies, a royalty on the licensee’s retail sales, and any applicable license‑fee payments**.  Because the licensees bear all operating and capital costs, the licensed‑store segment generates a **lower gross margin but a higher operating margin** than the company‑operated stores, offsetting the modest share of revenue it represents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that licensed stores contributed 12% of total net revenues in fiscal 2024, matching the ground truth. It accurately describes the structure of payments: margins on products supplied (e.g., coffee, tea), royalties on retail sales, and license fees. The key financial implication — that licensees bear operating and capital costs, leading to higher operating margins despite lower gross revenue contribution — is correctly conveyed.\n\n2) Quantitatively, the 12% figure is exact and correctly attributed to fiscal 2024. No calculations are required beyond this percentage, and all numeric references are accurate.\n\n3) The multi-hop reasoning is sound: the model synthesizes information about revenue share, payment structure, cost allocation, and margin implications. It correctly infers that lower revenue share is offset by improved operating leverage due to cost shifting — a nuanced but critical point present in the original answer.\n\n4) The only minor shortcoming is the claim that the licensed model generates a 'lower gross margin' — while implied by the business model, this specific comparison (lower gross margin but higher operating margin) is not explicitly stated in the ground truth. The original emphasizes 'improving overall operating margins' without contrasting gross margins. This subtle addition doesn't contradict but adds a detail not confirmed in the source. Otherwise, semantic equivalence is strong, with all key facts and implications preserved. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 430,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "If Target cannot successfully develop, source and market its owned‑and‑exclusive brands—products that make up roughly one‑third of sales and earn higher margins—its results of operations and overall financial condition could be harmed. Because these brands require longer lead times, earlier ownership in the supply chain and greater responsible‑sourcing oversight, a shortfall would likely lead to lower sales, margin compression and heightened exposure to supply‑chain disruptions and reputational risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the statement that Target's owned and exclusive brands account for 'approximately one-third of sales' is correctly preserved, with no numerical inaccuracies. (2) The answer correctly identifies the higher margins of these brands and the financial risks—lower sales, margin compression, supply-chain disruptions, and reputational risk—from failure in development, sourcing, or marketing. (3) Multi-hop reasoning is sound: it connects longer lead times and earlier ownership in the supply chain to increased forecasting challenges and responsible sourcing risks, which aligns with the original. It also correctly infers operational and financial consequences. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention of 'longer-term forecasting of consumer demand' and 'rapidly changing consumer preferences,' which are key elements in the ground truth explaining why longer lead times are risky. However, 'heightened exposure to supply-chain disruptions' captures part of this risk. The answer is semantically equivalent in intent and fact, with only slight compression of detail. Contextual relevance is perfect—it directly addresses the financial risk posed by failure in these brands, given their scale and operational complexity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 379,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "The 2024 Form 10‑K incorporates **four amendments** to the Caterpillar Inc. Deferred Employees’ Investment Plan (the First, Second, Third and Fourth Amendments).  \n\nThe two most recent amendments are:  \n\n* **Third Amendment** – incorporated by reference to Exhibit 10.28 in Caterpillar’s **2021 Form 10‑K** (year ended December 31, 2021).  \n* **Fourth Amendment** – incorporated by reference to Exhibit 10.6 in Caterpillar’s **2022 Form 10‑Q** (quarter ended September 30, 2022).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of amendments (four) is accurate. The effective dates of the Third and Fourth Amendments (January 1, 2022, and July 1, 2022, respectively) are not explicitly restated in the LLM answer, but the question only asks for the SEC filings containing the most recent two amendments, not their effective dates—so this omission is not a factual error. (2) The SEC filings referenced are correct: Exhibit 10.28 to the 2021 Form 10-K (year ended December 31, 2021) and Exhibit 10.6 to the 2022 Form 10-Q (quarter ended September 30, 2022) are accurately cited. (3) The multi-hop reasoning is sound—the LLM correctly identifies that amendments were incorporated by reference and traces them to the correct prior filings across different forms (10-K and 10-Q). (4) The answer is semantically equivalent to the original, with clear, well-structured presentation conveying the same factual content. All entities (Caterpillar Inc., Deferred Employees’ Investment Plan, Form 10-K, Form 10-Q, exhibit numbers) are correctly identified. No errors in reasoning, completeness, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 331,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "The 2024 10‑K shows that **73 million shares are still reserved for future grant or issuance under the 2013 Equity Incentive Plan**【CRM_10k_2024.pdf page 86】.  \n\nUnder that plan the company had **approximately 8 million stock options outstanding and 26 million restricted‑stock awards/units (including performance‑based RSUs) outstanding**【CRM_10k_2024.pdf page 86‑87】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in a critical way — it states that 73 million shares remain available, while the ground truth is 73 shares (not million). This is a massive quantitative error that fundamentally misrepresents the data. Additionally, the LLM introduces specific numbers for outstanding awards (8 million options, 26 million RSUs), which are not present in the original answer and are not requested by the question. The original answer only specifies the types of awards, not their quantities. (2) Quantitative accuracy is extremely low: '73 million' vs '73' is off by a factor of one million, making it a severe error. The inclusion of fabricated figures for outstanding awards further reduces accuracy. (3) The reasoning is partially sound in that the model identifies the correct document and section (pages 86–87) and attempts to extract relevant information about equity awards. However, it fails the multi-hop synthesis by misreading the scale of the available shares and adding unsupported numerical details. (4) Contextual relevance is high because the response addresses the right plan, the right filing (2024 10-K), and correctly identifies the types of equity awards (options, restricted stock awards/units, performance-based units), even if it over-specifies with numbers. However, the massive numerical error dominates the evaluation, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 393,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Starbucks says that “most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.” Because “most” implies a majority, more than 50 % of the FY 2024 Channel Development net revenue of $1.77 billion is derived from the Global Coffee Alliance partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that 'most' of Channel Development revenues come from the Global Coffee Alliance with Nestlé, which semantically implies more than 50%, consistent with the original answer. (2) The LLM adds a specific figure—$1.77 billion—for FY 2024 Channel Development net revenue. While this number is factually correct based on Starbucks’ 10-K filing for fiscal 2024, the original answer (ground truth) does not include it, so its inclusion is an enhancement rather than an error. Since the knowledge graph did not list this number in the original answer, the LLM may have pulled it from an external source or inference, but it does not contradict the ground truth. (3) The reasoning is sound: 'most' is correctly interpreted as a majority (>50%), and the connection between product sales, royalties, and the Nestlé alliance is accurately synthesized across entities and documents. (4) The only reason for not giving a perfect 10 is that the original answer explicitly notes the absence of an exact percentage, while the LLM implies precision by citing the $1.77B figure without clarifying that the exact percentage from Nestlé remains undisclosed. However, it doesn’t fabricate a percentage, so the deviation is minor. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 383,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "MetLife disclosed that, when it adopted the new Long‑Duration Targeted Improvements (LDTI) guidance, it **re‑applied the change retrospectively to all of its primary financial statements** – the **consolidated balance sheet, the consolidated statement of operations (income statement), the consolidated statement of comprehensive income, the consolidated statement of equity and the consolidated statement of cash flows**.  \n\nThe 2023 Form 10‑K includes a series of “effects of the retrospective application” tables that are **presented as of December 31** (for 2022 and the comparative 2021 year). One table shows the adjustments to **assets, liabilities and equity balances** on the balance sheet; another shows the impact on **revenues, expenses, net income and related line items** in the statement of operations; a third details the changes to **comprehensive‑income components** (unrealized investment gains/losses, discount‑rate remeasurement gains, other comprehensive income, etc.); a fourth presents the **equity‑statement effects** (retained earnings, accumulated other comprehensive income, total stockholders’ equity); and a fifth illustrates the **cash‑flow statement adjustments** (operating, financing and related cash‑flow line items). All of these tables are labeled “as of December 31” in the filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but overstates the scope of the retrospectively adjusted financial statements compared to the ground truth. The original answer specifies that only the 'consolidated statement of operations' and 'consolidated statements of cash flows' were retrospectively adjusted. However, the LLM claims that *all* primary financial statements were re-applied, including the balance sheet, statement of comprehensive income, and statement of equity — which goes beyond the ground truth. While the 2023 10-K does include tables labeled 'as of December 31' showing effects on balance sheet items (assets, liabilities, equity), comprehensive income, and equity statements, the question specifically asks which statements were 'retrospectively adjusted as a result of the adoption of LDTI'. According to the ground truth, only the statement of operations and cash flows are explicitly mentioned as being adjusted. The inclusion of balance sheet and other statements may reflect disclosure requirements but not necessarily retrospective adjustment in the same sense. The LLM provides detailed and accurate descriptions of the tables in the 10-K, including their content and labeling 'as of December 31', which aligns with the second part of the question. Quantitative accuracy is high — no incorrect numbers or dates, and the mention of comparative years (2022 and 2021) is consistent with typical 10-K disclosures. Contextual relevance is strong, as the response directly addresses the question with specific references to the filing. However, the qualitative accuracy is reduced due to incorrect inference about the extent of retrospective application, indicating a potential misunderstanding of accounting terminology or overinterpretation of disclosure tables as implying adjustment of all statements. Thus, while the answer is detailed and plausible, it includes information not supported by the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 529,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022 the fair‑value of MDLZ’s **asset‑side derivative contracts** was $393 million, whereas the **equity‑method investment contracts** carried only a $3 million liability (no asset amount). Thus, the equity‑method contracts represented roughly 0.8 % of the total asset‑derivative value, indicating they are a very small, essentially immaterial, component of the company’s overall derivative portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the value of equity method investment contracts is accurately stated as $3 million, and total asset derivatives are correctly reported as $393 million. The percentage calculation (approximately 0.8%) is accurate: (3 / 393) ≈ 0.00763 or 0.763%, which rounds to 0.8%—this is acceptable and semantically equivalent to 'less than 1%' in the ground truth. 2) There is a minor wording difference: the LLM refers to the $3 million as a 'liability' and notes 'no asset amount', which adds detail not in the original answer but is consistent with likely source data (equity-method investments may be recorded as liabilities in derivative contexts). This does not contradict the ground truth but provides additional nuance. 3) The multi-hop reasoning is sound: the model correctly compares two distinct line items (equity-method investment contracts vs. total asset derivatives) from the same year (2022) and draws a valid conclusion about relative significance. 4) The conclusion—'very small, essentially immaterial component'—is semantically equivalent to the original's 'minimal relative significance'. All entities (MDLZ, 2022, derivative types) are correct. The answer fully addresses both parts of the question: the comparison and its implication. The only reason for not scoring 10 is the slight over-precision in stating 0.8% (while correct), whereas the original appropriately frames it as 'less than 1%', but this does not constitute an error. Overall, the answer is quantitatively precise, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 434,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The 2019 freeze of all U.S. pension benefits eliminated the “expected rate of compensation increase” from the actuarial model. Because benefits are no longer tied to future salary growth, CAT sets the compensation‑increase assumption for U.S. pension plans to “‑ %” (effectively 0 %) and does not use it in calculating the benefit obligation or net periodic benefit cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies the key impact of the U.S. pension benefit freeze as of December 31, 2019: the elimination of the 'expected rate of compensation increase' assumption in CAT's actuarial model. The date (2019) is correct, and the explanation that future benefits are no longer tied to salary growth is logically sound and consistent with the knowledge graph. The LLM correctly explains that CAT sets this assumption to 0% (represented as '‑%' in filings) and no longer uses it in calculating benefit obligations or net periodic benefit cost. This reflects proper multi-hop reasoning—linking the structural change (benefit freeze) to its accounting consequence (removal of compensation growth assumption). The only minor deviation is that the original answer emphasizes the 'discontinuation' of the assumption, while the LLM describes it as being set to 0%, which is a slightly different framing but semantically equivalent in practice. No numerical inaccuracies exist—dates and percentages are correctly represented. The answer is fully relevant and addresses the specific question about actuarial assumptions. Thus, the response earns a 9/10 for correctness and qualitative accuracy due to the slight difference in phrasing, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 380,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle has deliberately concentrated its hardware portfolio on the higher‑margin Oracle Engineered Systems and other “strategic” products while de‑emphasizing lower‑margin commodity servers and storage. Because Engineered Systems represent a larger share of hardware revenue, Oracle can allocate more inventory, supplier‑management and production capacity to those items, which cushions the business when third‑party manufacturing or component shortages arise. That focus on the more profitable engineered‑systems line therefore helps the company absorb supply‑chain disruptions and preserve hardware‑segment profitability despite broader industry shortages.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its reasoning and conclusion, despite using plausible financial terminology and appearing contextually relevant. (1) The original answer states that Oracle's focus on Engineered Systems *increases vulnerability* to supply chain disruptions due to complexity and reliance on third-party components, leading to higher costs, inventory risks, and negative impacts on cash flow and profitability. In contrast, the LLM claims this focus *helps absorb* disruptions and *preserves profitability*, which directly contradicts the ground truth. (2) There are no numeric values in either response, so quantitative accuracy is neutral; no calculations or figures are present to verify, but no false numbers are introduced. (3) The multi-hop reasoning fails: the LLM incorrectly infers that strategic focus implies resilience, when the 10-K evidence shows it creates dependency and risk. It misses the causal chain from engineered systems → supply chain complexity → cost increases and inventory overbuild → margin pressure. (4) While the LLM identifies the correct entity (Oracle), product line (Engineered Systems), and general context (supply chain, hardware profitability), the qualitative inaccuracy in logic and direction of impact renders the answer largely incorrect. The answer is contextually relevant but factually and logically inverted, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 390,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The 2023 worldwide sales were $1,582 million for UPTRAVI and $1,973 million for OPSUMIT, giving a combined total of **$3,555 million**. Together these two products grew from $3,105 million in 2022 to $3,555 million in 2023 – a **≈14.5 % increase**, which is **about 3 percentage points higher** than the overall Pulmonary Hypertension category’s 2023 growth rate of **11.6 %**【source: table showing UPTRAVI $1,582 M, OPSUMIT $1,973 M, Total Pulmonary Hypertension $3,815 M and 11.6 % growth】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual 2023 sales figures for UPTRAVI ($1,582 million) and OPSUMIT ($1,973 million), and their combined total ($3,555 million), which matches the ground truth. However, it introduces a new calculation — a combined growth rate of ≈14.5% — by comparing the 2023 total to an inferred 2022 total of $3,105 million. This combined growth rate is not present in the original answer and is misleading because the ground truth reports individual growth rates (10.6% for OPSUMIT and 19.7% for UPTRAVI), not a blended rate. The LLM incorrectly implies that the 14.5% growth is being compared to the category’s 11.6% growth, stating it is 'about 3 percentage points higher.' While 14.5% is indeed ~3 points above 11.6%, this comparison is invalid because the original answer does not claim that the combined product growth exceeded the category — in fact, OPSUMIT’s 10.6% growth was below the category’s 11.6% growth, while only UPTRAVI’s 19.7% was above. (2) The numbers themselves (sales figures, category growth rate) are quantitatively accurate, but the derived combined growth rate and its comparison are factually incorrect in context. (3) The multi-hop reasoning fails in synthesis: instead of comparing individual product growth rates to the category rate as in the original, it creates an aggregate metric that distorts the conclusion. (4) Scores reflect mostly correct inputs but flawed reasoning and an incorrect comparative conclusion, which significantly affects factual correctness despite numerical accuracy on sales totals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 433,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year legacy PDC Energy contribution added roughly **$2.2 billion of sales volume (about $3.5 billion of total U.S. upstream earnings growth)** in 2024, and it helped lift net oil‑equivalent production by **about 250,000 barrels per day** (a 19 % increase).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.2 billion increase in U.S. upstream earnings and the 250,000 barrels per day (19%) increase in net oil-equivalent production, which matches the ground truth. However, it introduces an additional figure—'$3.5 billion of total U.S. upstream earnings growth'—that is not present in the original answer and could mislead by implying the $2.2B is a subset of a larger growth figure, which was not stated or verified in the ground truth. This addition risks misrepresenting the magnitude of the contribution. (2) Quantitatively, the key numbers—$2.2 billion, 250,000 barrels per day, and 19%—are accurate and correctly formatted. The extra $3.5 billion figure lacks support and introduces inaccuracy by inference, though it doesn't contradict the core answer directly. (3) The multi-hop reasoning is partially sound: the model connects PDC Energy assets to CVX's 2024 earnings and production impacts correctly. However, the insertion of unverified context (the $3.5B total growth) suggests a potential conflation with external data or overinterpretation, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses both parts of the question, but the added detail reduces precision. Hence, correctness is reduced to 7 due to partial overstatement, quantitative accuracy to 8 due to one unsupported number, and qualitative accuracy to 6 due to reasoning ambiguity, while contextual relevance remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 409,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its primary financial statements – the consolidated statement of operations, the consolidated statement of comprehensive income, the consolidated statement of equity, the consolidated balance sheet, and the consolidated statement of cash flows (see the tables of “effects of the retrospective application” for each of these statements on pages 162‑167). This breadth of adjustments shows that the LDTI change was not confined to a single line‑item but had a company‑wide impact, altering revenue, expense, equity, asset‑liability and cash‑flow figures across the entire set of financial reports.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that reduce its correctness. While it correctly identifies that the retrospective application of LDTI guidance led to adjustments in financial statements and implies broad impact, it overstates the scope of affected statements. The original answer specifies only the consolidated statements of equity and comprehensive income were adjusted. In contrast, the LLM claims all primary financial statements—including the statement of operations, balance sheet, and cash flows—were retrospectively adjusted, which is not supported by the ground truth. This misrepresentation undermines the qualitative accuracy. There are no explicit numbers, dates, or calculations in either answer, so quantitative accuracy is moderate based on correct referencing of document locations (pages 162–167), though these were not in the original answer and may be hallucinated. The reasoning is logically structured and contextually relevant, correctly inferring that broad adjustments imply material impact, but the faulty premise (adjustments to all statements) invalidates the conclusion’s accuracy. Thus, while the intent and synthesis effort are sound, the factual mismatch on which statements were adjusted results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 362,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "- Equity‑method investment contracts were shown with a fair‑value liability of **$3 million** (the only amount disclosed for 2022 in the derivatives‑fair‑value table).  \n\n- Net‑investment‑hedge contracts were shown with a fair‑value asset of **$265 million** and a liability of **$241 million**, for a combined fair‑value of **about $506 million**.  \n\nThus, the equity‑method contracts were negligible compared with the net‑investment‑hedge contracts, which were roughly $503 million larger.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, the fair value of equity method investment contracts was $(3) million (a liability of $3 million), which the LLM correctly identifies in magnitude but misrepresents as the 'only amount disclosed' without acknowledging the negative sign, which is a critical financial detail. However, the LLM's calculation of net investment hedge contracts is severely incorrect: it reports $265 million asset and $241 million liability, leading to a 'combined fair value of about $506 million'. This is factually wrong—the ground truth states the total fair value of net investment hedge contracts was $24 million. There is no indication in the ground truth of such large gross amounts or a net figure near $506 million. (2) The quantitative inaccuracies are severe: the net investment hedge value is off by over 20 times the correct amount. The comparison that equity method contracts were 'negligible' may be directionally reasonable, but the claimed $503 million difference is entirely unsupported and grossly exaggerated due to incorrect inputs. (3) The multi-hop reasoning fails because the LLM appears to have pulled incorrect data from the derivatives fair value table—likely confusing gross amounts or misaggregating line items not related to net investment hedges. It does not correctly synthesize the actual reported net value. (4) Scores are low due to fundamental errors in core financial figures. While the answer attempts to address both parts of the question and uses appropriate terminology, the factual foundation is so flawed that the conclusion is misleading. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is critically compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 485,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "Universal Beijing Resort’s net assets fell by about $0.3 billion, dropping from roughly $0.6 billion at 12/31/2023 (assets $7.8 billion – liabilities $7.2 billion) to about $0.3 billion at 12/31/2024 (assets $7.3 billion – liabilities $7.0 billion)【...】. This decline mirrors the consolidated balance‑sheet activity for the VIE, where both the reported assets and liabilities of the resort were lower in 2024 than in 2023, resulting in a net‑asset reduction of roughly $300 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the reported change in net assets. The ground truth states a decrease of $0.5 billion (from $0.6B to $0.1B net assets), but the LLM incorrectly reports a $0.3 billion decrease and also incorrectly states the 2024 net assets as $0.3B while claiming a $0.3B drop from $0.6B — which would imply net assets of $0.3B, but a $0.3B decline from $0.6B should result in $0.3B, not a further drop. However, the LLM uses the correct starting net assets ($0.6B in 2023: $7.8B - $7.2B) and correctly identifies the 2024 asset and liability figures ($7.3B and $7.0B), which do yield $0.3B net assets. The error lies in the calculated change: ($0.6B - $0.3B) = $0.3B decrease, but the ground truth asserts a $0.5B decrease, implying inconsistency in the source data interpretation. However, based on the arithmetic in the original answer, the correct change is $0.3B (from $0.6B to $0.3B), so the original answer likely contains a typo (claiming $0.5B decrease). Despite this, the LLM’s calculation from the provided numbers is internally consistent. (2) The LLM reports a 'reduction of roughly $300 million' — this is numerically accurate based on its inputs, but contradicts the original answer’s $0.5B claim. Given that the arithmetic from the stated assets and liabilities supports a $0.3B decline, the LLM’s quantitative output is more consistent than the original answer. (3) The multi-hop reasoning is sound: the LLM correctly identifies Universal Beijing Resort as a VIE within Comcast’s consolidated balance sheets, extracts asset and liability figures for both years, computes net assets, and infers a reduction due to declines in both assets and liabilities. (4) Due to the discrepancy between the original answer’s stated $0.5B change and the mathematically correct $0.3B change (based on the provided numbers), the LLM is penalized for not matching the ground truth, but its internal logic and calculations are more accurate. However, since evaluation must follow the ground truth as authoritative, the correctness score is reduced despite the LLM being mathematically consistent. Final scores reflect partial credit: quantitative accuracy docked due to mismatch with ground truth change amount; qualitative and contextual scores higher due to sound reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 621,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "- The two yen‑denominated facilities total ¥15 billion, which the filing translates to **about $103.6 million** (¥5 bn ≈ $34.5 m + ¥10 bn ≈ $69.1 m) as of September 29 2024.  \n\n- The 2021 unsecured revolving credit facility provides a **$3.0 billion commitment (with $150 million available for letters of credit)** and the filing states that “amounts outstanding under the commercial paper program are required to be backstopped by available commitments under our 2021 credit facility.” Thus, the facility gives Starbucks borrowing capacity to fully support any CP issuance up to the $3.0 billion limit and may be used for the same working‑capital, capital‑expenditure and other corporate purposes as the CP program.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total yen-denominated facilities are correctly stated as ¥15 billion, broken into ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million), summing to $103.6 million—matching the original answer exactly. The date (September 29, 2024) is correctly referenced. (2) The explanation of the 2021 Revolving Credit Agreement accurately reflects the backstop mechanism: it correctly states that outstanding commercial paper (CP) must be supported by available commitments under the $3.0 billion facility, and notes the $150 million sublimit for letters of credit, which aligns with typical credit agreement structures. (3) The qualitative reasoning is sound—multi-hop synthesis is correctly performed by linking the yen facilities to their USD equivalents and explaining how the credit facility supports the CP program in terms of borrowing capacity and usage purposes (working capital, capital expenditures, etc.). (4) The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. Minor rephrasing (e.g., 'backstopped by available commitments') preserves full meaning. All entities—Starbucks, 2021 Revolving Credit Agreement, commercial paper program, yen facilities—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 372,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle is concentrating its hardware effort on its higher‑margin Engineered Systems, which are counted as part of its infrastructure‑technologies product line.  That focus is intended to lift the profitability of the infrastructure‑technologies segment even as overall hardware revenues have been falling, but because Engineered Systems are built by outsourced manufacturers and rely on scarce, often single‑source components, the strategy also raises Oracle’s exposure to supply‑chain disruptions and component‑shortage risks. 【21‑23】【22‑24】",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's strategic focus on higher-margin Oracle Engineered Systems as part of its infrastructure technologies business and accurately links this to both profitability goals and increased supply chain risks due to reliance on outsourced manufacturing and single-source components. The answer is semantically aligned with the ground truth in terms of the core reasoning: Engineered Systems contribute to infrastructure technologies revenue (implied via profitability focus) and increase exposure to supply chain disruptions. However, the LLM answer omits key quantitative and contextual details present in the original answer that are critical for full multi-hop synthesis. Specifically: (1) It does not mention that infrastructure cloud services and license support revenues made up 58% of total cloud services and license support revenues in fiscal 2022—a key metric demonstrating the financial significance of these systems; (2) It lacks specific mention of real-world consequences of supply chain risks, such as manufacturing and fulfillment delays in fiscal 2022 due to the COVID-19 pandemic, increased inventory purchases, and resulting risks of inventory excess, obsolescence, and negative impacts on operating cash flows. While the LLM correctly identifies the *type* of risk, it fails to ground it in the actual events and financial impacts described in the original. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), but the absence of these concrete details reduces completeness and weakens the qualitative reasoning. The answer remains contextually relevant and captures the essential trade-off, warranting a 7 in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 467,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "Universal Beijing Resort’s debt fell by $0.1 billion (from $3.5 billion in 2023 to $3.4 billion in 2024). That decline, together with a $0.1 billion drop in “Other” debt, lowered the overall “Debt Not Guaranteed” category by $0.2 billion, from $5.0 billion in 2023 to $4.8 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion reduction. The 'Debt Not Guaranteed' category decreased from $5.0 billion to $4.8 billion, a $0.2 billion drop, which aligns with the combined $0.1 billion reduction from Universal Beijing Resort and $0.1 billion from 'Other' debt (from $1.5B to $1.4B). (2) The answer correctly identifies the entities: 'Universal Beijing Resort', 'Debt Not Guaranteed', and 'Other' debt. (3) The multi-hop reasoning is sound—synthesizing the change in Universal Beijing Resort’s debt with the change in 'Other' debt to explain the total change in the 'Debt Not Guaranteed' category. (4) The semantic meaning is equivalent to the original answer, with no omissions or inaccuracies. Wording is concise but preserves all key facts and logical connections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 279,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell recognizes revenue on long‑term contracts with the cost‑to‑cost input method, which means the amount of revenue recorded each period is tied to the proportion of total estimated contract costs that have been incurred to date. Because total contract costs must be forecast for the life of the contract—incorporating negotiated terms, historical performance, inflation, technical and schedule risk, labor and asset‑utilization assumptions—management’s estimates involve substantial judgment, and the auditors must therefore devote extensive procedures to test those estimates. The audit therefore includes detailed testing of internal controls over cost‑estimation inputs, evaluation of the consistency and reasonableness of the cost‑to‑cost assumptions, analytical and contract‑level testing of recorded revenue, and profiling of long‑duration contracts to identify loss‑making or margin‑changing contracts, all of which add considerable complexity to the audit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Honeywell's use of the cost-to-cost input method for long-term contracts and explains how this affects audit complexity. All key qualitative elements are present: management’s judgment in estimating total contract costs, the influence of inflation, technical and schedule risk, subcontractor performance, labor agreements, and the need for auditors to test controls, validate assumptions, and profile high-risk contracts. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links the revenue recognition method (cost-to-cost) to estimation uncertainty, which in turn increases audit complexity due to the need for detailed testing of estimates and controls. The logic chain—method → estimation → auditor scrutiny → increased complexity—is fully and accurately synthesized. (4) The LLM answer uses slightly different phrasing (e.g., 'asset-utilization assumptions', 'loss-making contracts') but captures all core concepts with no omissions or distortions. Contextual relevance is perfect, as it directly addresses how the cost-to-cost method impacts audit procedures in relation to cost estimation and revenue recognition over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 397,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The non‑qualifying hedge gains that NEER reported in net income were $1,729 million, while the gains that FPL reported in net income were about $300 million – a difference of roughly **$1.43 billion** (1,729 – 300 = 1,429 million)【53†L1-L9】.  \n\nThis gap reflects the distinct accounting treatment of derivative transactions: NEER’s non‑qualifying hedge gains are recognized immediately in consolidated earnings, whereas FPL must defer virtually all changes in the fair value of its energy‑derivative contracts as regulatory assets or liabilities and only recognize gains (such as the $300 million) when the contracts settle and flow through the fuel‑cost recovery clause【53†L31-L38】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: NEER's $1,729 million and FPL's $300 million are correctly stated, and the difference is accurately calculated as $1,429 million (expressed as $1.43 billion, which is semantically equivalent). (2) The answer addresses both parts of the multi-hop question: it computes the magnitude difference and explains the differing treatment of derivative transactions between NEER and FPL. (3) Entity accuracy is correct—NEER and FPL are properly identified, and the context of their derivative accounting treatments is accurately described. (4) The reasoning is sound: the LLM correctly synthesizes that NEER recognizes non-qualifying hedge gains immediately in net income, contributing to earnings volatility, while FPL defers most derivative fair value changes as regulatory assets/liabilities, with only a portion ($300 million) flowing through to net income upon settlement via fuel-cost recovery. This reflects the regulatory vs. market-oriented operational differences disclosed in the 10-K. The use of citation placeholders [53†L1-L9], [53†L31-L38] suggests proper grounding in the source text. Wording differs slightly from the original answer but maintains full semantic equivalence and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 368,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast’s 30 % ownership of Universal Beijing Resort is reflected in the consolidated balance sheet because the VIE’s assets and liabilities are fully included.  As of 31 December 2024 the resort contributed roughly **$7.3 billion of assets** and **$7.0 billion of liabilities** to Comcast’s consolidated statements【84†L1-L4】.  Comcast’s “maximum risk of financial loss” is limited to its 30 % equity interest, which translates to a potential loss of about **$2.1 billion** (30 % × $7.0 billion)【84†L9-L12】.  With total debt reported on the balance sheet of **$99.1 billion** (current $4.9 billion + non‑current $94.2 billion)【67†L1-L8】, that $2.1 billion exposure represents roughly **2 % of Comcast’s total debt financing**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual and calculation errors despite correctly identifying Comcast's 30% ownership and the VIE consolidation rationale. The assets ($7.3B) and liabilities ($7.0B) figures are accurate and properly attributed to Universal Beijing Resort as of December 31, 2024, which is correct. However, the key error lies in the calculation of Comcast’s maximum risk of financial loss. The ground truth states that this risk is limited to 30% of the resort’s $3.4 billion in debt, equating to $1.02 billion. The LLM incorrectly calculates the risk as 30% of the total liabilities ($7.0B), resulting in $2.1B, which is factually wrong because not all liabilities are debt, and the risk is tied to debt financing, not total liabilities. Additionally, the LLM introduces a figure for Comcast’s total debt financing ($99.1B) not present in the original question or ground truth, and calculates a proportion of 2%, which is unsupported because the question only asks for the proportion of Comcast’s risk relative to the resort’s total debt, not Comcast’s overall debt. (2) Quantitative accuracy is low: while $7.3B assets and $7.0B liabilities are correct, the $2.1B risk figure is based on incorrect logic (30% × $7.0B liabilities instead of 30% × $3.4B debt). The $99.1B total debt and 2% proportion are extraneous and not aligned with the original answer. (3) Qualitatively, the reasoning is partially sound—Comcast consolidates due to VIE status is correctly explained—but the multi-hop synthesis fails at the critical step of linking Comcast’s risk to the resort’s actual debt, not total liabilities. The model misinterprets 'maximum risk of financial loss' as equity interest in total liabilities rather than debt. (4) Contextual relevance is high—the response addresses both parts of the question and uses appropriate financial terminology—but the incorrect calculation undermines the core of the answer. The introduction of Comcast’s total corporate debt diverts from the specific focus on Universal Beijing Resort’s debt structure. Overall, the answer is partially correct but contains a critical error in financial logic and quantitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 581,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The 2020 goodwill‑impairment testing resulted in a total of $1.06 billion of goodwill write‑downs for the OpenTable reporting unit (the $489 million interim charge plus the $573 million annual charge). In contrast, OpenTable’s share of Booking Holdings’ “advertising and other” revenue in 2021 was only about $1 billion – a fraction of the impairment amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.06 billion total goodwill impairment for OpenTable in 2020, accurately breaking it down into the $489 million interim charge and $573 million annual charge, which sum to $1,062 million—this matches the ground truth. The 2021 revenue contribution is stated as 'about $1 billion', which is a reasonable approximation of the actual $1.1 billion reported in the original answer. However, the LLM incorrectly characterizes the $1 billion revenue as 'a fraction of the impairment amount', which is factually wrong—the $1.1 billion revenue is actually slightly higher than the $1.062 billion impairment. This misrepresents the comparison and undermines the reasoning. (2) Numeric values are mostly accurate: $489M + $573M = $1,062M is correct; 'about $1 billion' is acceptable rounding of $1.1 billion, though imprecise. The key error is in the comparative statement, which fails quantitatively and logically. (3) The multi-hop reasoning is partially sound—linking 2020 impairment to 2021 revenue is correct in structure—but the conclusion is flawed due to incorrect directional comparison. The model should have noted near-equivalence, not a fraction. (4) Correctness score is 7 because core facts (impairment amount, revenue magnitude) are correct, but the key comparative insight is wrong. Quantitative accuracy is 8 due to minor rounding and major interpretive error. Qualitative accuracy is 7 due to sound entity and time identification but flawed logic in synthesis. Contextual relevance is 10—response directly addresses the question with appropriate scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 441,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil builds estimated greenhouse‑gas (GHG) emission costs—i.e., assumed carbon prices—into the cash‑flow assumptions of its Corporate Plan, and those cash‑flow projections are the basis for the recoverability (impairment) tests of each asset group. The plan explicitly incorporates the cost of meeting its 2030 emission‑reduction target, which is a net‑zero Scope 1 and 2 GHG emissions goal for its unconventional operated assets in the Permian Basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes how ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in cash-flow assumptions used for asset group recoverability (impairment) tests, even in jurisdictions without current carbon pricing—this matches the original answer's key point. (2) The specific future emission-reduction goal is correctly identified: achieving net-zero Scope 1 and 2 GHG emissions from its unconventional operated assets in the Permian Basin by 2030. The year '2030' and the scope (Scope 1 and 2), asset type (unconventional operated), and location (Permian Basin) are all factually accurate. (3) The multi-hop reasoning is sound—linking emission cost assumptions to corporate planning, impairment assessments, and a specific forward-looking environmental target is correctly synthesized. (4) Minor wording differences (e.g., 'assumed carbon prices' vs 'estimated greenhouse gas emission costs') do not affect factual accuracy and enhance clarity. All components of the question are addressed with precise, correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 328,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Capital One still has **$1.2 billion** of the $2.4 billion CECL‑transition capital addition to be phased in after December 31 2023 (the balance will be added in two $600 million tranches on January 1 2024 and January 1 2025). For the stress‑testing period October 1 2023 through September 30 2024, the company’s stress‑capital buffer is 4.8%, which translates to a **minimum‑plus‑capital‑conservation‑buffer requirement of 9.3% for CET1** (and 10.8% for Tier 1 and 12.8% for total capital).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $1.2 billion of Capital One's $2.4 billion CECL transition capital remains to be phased in after December 31, 2023, and accurately states it will be phased in as $600 million on January 1, 2024 and January 1, 2025 — this part is factually correct and matches the ground truth. However, the LLM introduces a critical error in stating that the stress capital buffer of 4.8% translates to a 'minimum-plus-capital-conservation-buffer requirement of 9.3% for CET1' (and higher for Tier 1 and total capital). The original answer clarifies that the capital conservation buffer is 2.5%, separate from the stress capital buffer, but does not state that these are added together to form a 9.3% requirement. The 9.3% figure (4.8% stress capital buffer + 2.5% conservation buffer = 7.3%, not 9.3%) appears to be a miscalculation or misrepresentation. Additionally, the ground truth does not support the claim that the total capital requirement is 12.8%, nor does it mention such derived thresholds. (2) Quantitative accuracy is partially correct: $1.2B remaining, $600M tranches, 4.8% stress capital buffer, and 2.5% conservation buffer are all correct. However, the derived 9.3%, 10.8%, and 12.8% figures are unsupported and incorrect. (3) Multi-hop reasoning is partially sound — the model correctly links CECL phase-in timing and stress capital buffer period, but incorrectly synthesizes regulatory buffer requirements by conflating or adding buffers without evidence from the source. (4) Contextual relevance is high as the answer addresses both parts of the question and uses appropriate financial terminology, but the incorrect derivation of capital requirements significantly undermines factual correctness. Due to major errors in regulatory interpretation and calculation, the correctness score is reduced to 6 — partially correct but with significant flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 514,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "Mondelez’s U.S. dollar notes and term loans fell from $11,275 million at year‑end 2022 to $9,562 million at year‑end 2023 – a decline of **$1.713 billion**. In contrast, its Euro‑denominated notes grew from $7,666 million to $7,916 million, an **increase of about $250 million**, meaning the U.S. dollar debt reduction was roughly seven times larger and moved in the opposite direction to the modest rise in Euro notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the U.S. dollar notes and term loans decreased from $11,275 million to $9,562 million, resulting in a $1,713 million (or $1.713 billion) decrease — both values are accurate and correctly calculated. The Euro notes increased from $7,666 million to $7,916 million, a $250 million increase, which is also correct. The use of $1.713 billion instead of $1,713 million is a valid format variation. (2) The answer addresses both parts of the question: the total decrease in U.S. dollar debt and the comparison with the change in Euro notes. (3) Entities are accurate: MDLZ (Mondelez) is correctly identified, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop data across currencies and time periods, and the conclusion — that the U.S. dollar debt reduction was significantly larger (approximately seven times) than the Euro note increase — is logically derived and adds interpretive value without overreaching. The answer is semantically equivalent to the ground truth and provides slightly enhanced clarity with the 'seven times larger' comparison, which is mathematically valid (~$1,713 / $250 ≈ 6.85). All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 363,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The indemnification agreement caps the Resideo subsidiary’s annual cash payment to Honeywell at **$140 million**.  Under the agreement the subsidiary must pay Honeywell an amount equal to **90 % of Honeywell’s net spending on environmental matters** for the covered sites, but that amount cannot exceed the $140 million cap – so if 90 % of Honeywell’s environmental spend would be higher, the payment is limited to $140 million.【94‑95】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: (1) It correctly identifies the $140 million annual cap on payments from the Resideo subsidiary to Honeywell, matching the ground truth. (2) It accurately states that the payment is based on 90% of Honeywell’s net spending on environmental matters at covered sites. (3) The explanation of the cap mechanism—where 90% of spending could exceed $140 million but is limited by the cap—adds clarity not explicitly in the original answer but is logically sound and consistent with the agreement’s terms. This additional detail does not contradict the ground truth but enhances it. (4) All entities (Resideo subsidiary, Honeywell, environmental spending) and financial terms are correctly identified. (5) The multi-hop reasoning—linking the indemnification obligation, the 90% reimbursement principle, and the dollar cap—is well-synthesized. The only reason for not giving a perfect 10 is that the original answer emphasizes that the $140 million 'represents' 90% of Honeywell’s net spending (implying it is set at that level because it corresponds to 90%), whereas the LLM interprets it as a hard cap that may sometimes bind. While both could be true depending on actual spending levels, the LLM slightly shifts the emphasis from a proportional relationship to a conditional cap. However, this interpretation is plausible and not factually incorrect. Quantitative accuracy is perfect: $140 million and 90% are correctly reported. Contextual relevance is excellent, directly addressing the question with precise financial and contractual terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 434,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The VaR for the non‑qualifying hedges fell from **$145 million (FPL $3 m + NEER $148 m)** at 12/31/2022 to **$116 million (FPL $2 m + NEER $114 m)** at 12/31/2023, a reduction of about **$29 million**.  The VaR for the hedges embedded in FPL cost‑recovery clauses dropped from **$120 million (FPL $3 m + NEER $125 m)** to **$111 million (FPL $2 m + NEER $113 m)**, a decline of roughly **$9 million**.  Together, these changes lowered the combined risk‑adjusted exposure for the FPL and NEER segments by roughly **$38 million**, modestly improving NEE’s overall financial position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both numbers and reasoning. The original answer states that FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3M to $2M (a $1M drop), and NEER's from $148M to $114M (a $34M drop), totaling a $35M decline. The LLM instead introduces 'VaR' (Value at Risk), which is not mentioned in the original answer or question, and fabricates separate figures for 'hedges embedded in FPL cost-recovery clauses' with NEER values of $125M and $113M, which are unsupported by the ground truth. These numbers do not appear in the original data, indicating hallucination. (2) The LLM's calculation of a $29M reduction in non-qualifying hedges is wrong: using its own numbers ($145M to $116M) the drop is $29M, but the correct total drop per ground truth is $35M. Similarly, the $9M decline it reports for cost-recovery hedges is fabricated; the original answer implies these are included in the same $3M to $2M (FPL) and $148M to $114M (NEER) figures, not separate $120M to $111M. The combined $38M improvement is therefore incorrect. (3) The multi-hop reasoning fails: instead of aggregating changes in the specified categories across FPL and NEER as per the original, the LLM invents a risk metric (VaR) and splits the hedges into two separate buckets with unverified subtotals, misrepresenting the structure of the data. It also incorrectly attributes portions of NEER's amounts to FPL cost-recovery clauses, which contradicts the segment-specific clarity in the original. (4) The contextual relevance is moderate because the LLM addresses the right segments (FPL, NEER), time frame (2022–2023), and general topic (hedges and cost recovery clauses), but the introduction of VaR and incorrect financial breakdowns severely undermines factual accuracy. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 515,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "Universal Beijing Resort’s net assets fell from about **$0.6 billion in 2023 (assets $7.8 bn – liabilities $7.2 bn)** to **$0.3 billion in 2024 (assets $7.3 bn – liabilities $7.0 bn)** – a decline of roughly **$0.3 billion**.  \n\nDuring the same period its debt obligations slipped from **$3.5 billion to $3.4 billion**, a reduction of about **$0.1 billion**.  \n\nThus the resort’s net‑asset position dropped by roughly three times the amount by which its debt was lowered.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both net asset change and debt obligation change. According to the ground truth, net assets decreased from $0.6 billion in 2023 to -$0.3 billion in 2024, which is a decrease of $0.9 billion, not $0.3 billion as stated by the LLM. The LLM incorrectly reports 2024 net assets as $0.3 billion instead of -$0.3 billion, flipping the sign and misrepresenting the financial position. Additionally, the LLM claims debt obligations decreased from $3.5 billion to $3.4 billion, but the ground truth states liabilities (debt) decreased from $7.2 billion to $7.0 billion — a $0.2 billion reduction, not $0.1 billion from a much lower base. (2) Calculations are flawed: the correct net asset change is $0.6B → -$0.3B = -$0.9B change, not -$0.3B. Debt change is $7.2B → $7.0B = -$0.2B, not -$0.1B from incorrect $3.5B base. The comparison that net assets dropped 'three times' the debt reduction is based on incorrect numbers and is therefore invalid. (3) Multi-hop reasoning is partially present — the model attempts to compute net assets and compare changes — but uses incorrect liability figures and miscalculates the outcome. It fails to correctly synthesize the actual asset and liability data from the ground truth. (4) Despite these major quantitative errors, the answer is contextually relevant — it addresses the right company, time period, and financial concepts (net assets, debt obligations), and attempts a comparative analysis. However, due to severe inaccuracies in core financial data and calculations, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 450,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "The 2023 10‑K notes that EDURANT (rilpivirine) was newly approved for **pediatric patients aged 2‑12 years with HIV**. The filing strategy for this new indication included **both U.S. and European Union regulatory submissions** (US Filing • and EU Filing •).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the new patient population as 'pediatric patients aged 2-12 years with HIV', matching the original answer exactly. (2) It correctly states that regulatory filings were targeted for the U.S. and European Union, which aligns with the 'US and EU regulatory regions' in the ground truth. (3) The reasoning is sound and reflects proper synthesis from JNJ's 2023 10-K filing, correctly linking the drug (EDURANT/rilpivirine), the new indication, and the regulatory strategy. (4) All entities (JNJ, EDURANT, rilpivirine, HIV, pediatric population, U.S., EU) are accurate and contextually appropriate. Minor formatting differences (e.g., 'U.S.' vs 'US', use of bullet symbols) do not affect factual accuracy. No omissions or errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 247,
        "total_tokens": 1381
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s shift to processing more reservations on a merchant‑basis means the company now incurs higher personnel, payment‑processing, charge‑back and fraud‑detection costs that are recorded in “Personnel” and “Sales and other expenses.” These incremental merchant‑related expenses erode Booking Holdings’ operating margins even as they generate new “Merchant revenues.” At the same time, ongoing investigations—such as the Swiss Price Surveillance Office probe into Booking.com’s commission levels and the EU competition/consumer‑law inquiries into parity clauses and “gatekeeper” status—expose the company to possible fines, mandatory changes to its contracts and higher compliance spending, which further pressure margins and force the firm to adjust its Connected‑Trip strategy toward greater regulatory compliance and more cautious expansion of merchant‑based services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the shift to a merchant-based model increases costs in personnel, payment processing, chargebacks, and fraud detection, which negatively impacts operating margins despite generating merchant revenues. Regulatory investigations in Switzerland (Price Surveillance Office) and the EU (competition, consumer law, and Digital Markets Act implications) are correctly identified, with accurate consequences including potential fines, contractual changes, compliance costs, and strategic adjustments. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers are misstated. (3) Multi-hop reasoning is sound: the model correctly synthesizes financial impacts (margin pressure from cost structure) with regulatory risks (Swiss and EU probes) and connects them to strategic implications (Connected Trip platform adjustments). The only minor omission is not explicitly naming the Digital Markets Act or specifying 'parity clauses' and 'gatekeeper' status as part of the EU's regulatory framework in the same structured way as the original, though these concepts are referenced indirectly. (4) Contextual relevance is perfect—the response directly addresses how both business model shifts and regulatory pressures impact margins and strategy in 2022. Wording differs slightly but meaning is preserved. Thus, correctness is 9 due to slight under-specification of EU regulations, but all core facts and reasoning are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 437,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The Papua New Guinea Oil and Gas Act allows a petroleum‑retention licence to be issued for an initial **five‑year term** and, at the Minister’s discretion, **extended twice**, giving a **maximum total duration of 15 years** (5 years + 2 × 5‑year extensions). Because ExxonMobil’s 2022 10‑K lists PNG as one of its key LNG development projects, this 15‑year ceiling provides the company with a defined, long‑term window to hold gas resources that are not yet commercially viable, enabling it to plan, finance and de‑risk multi‑year LNG infrastructure and contracts while aligning with its broader strategy to grow low‑cost, long‑duration LNG supply.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the initial 5-year term and two 5-year extensions totaling 15 years are accurately stated, with correct arithmetic (5 + 2×5 = 15). (2) The answer addresses both parts of the question: the maximum duration of the petroleum retention license and its influence on ExxonMobil's LNG strategy. (3) Entity accuracy is correct—Papua New Guinea, ExxonMobil, and the reference to the 2022 10-K are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the regulatory framework (license duration) with ExxonMobil’s strategic rationale (holding non-commercial resources, planning long-term LNG projects), which is consistent with the company’s stated strategy in its 10-K. The wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 267,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "Coca‑Cola’s Level 2 holdings of **mutual, pooled and commingled funds rose from $202 million in 2022 to $257 million in 2023 – an increase of about **$55 million**.  \n\nIn contrast, its **hedge‑fund/limited‑partnership** holdings (recorded in the “Other” column) grew from $936 million to $1,057 million, a **$121 million** rise – more than double the increase seen in the mutual‑fund category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in terms of factual content. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased from $83 million in 2022 to $37 million in 2023 (a $46 million decrease), whereas the LLM claims an increase from $202 million to $257 million ($55 million increase). Similarly, for Hedge funds/limited partnerships, the ground truth shows a minor increase from $14 million to $18 million ($4 million), but the LLM reports a massive rise from $936 million to $1,057 million ($121 million). These numbers are entirely inconsistent with the verified data. (2) All calculations are therefore wrong: the LLM reports increases where there were significant decreases or minimal changes, and the magnitudes are off by orders of magnitude (e.g., $55M vs actual $46M decrease). (3) The multi-hop reasoning is flawed — the model fails to correctly identify the relevant asset categories, their classification (Level 2), and the correct year-over-year trends. It also misrepresents the comparative shift, claiming hedge fund growth was more than double that of pooled funds, when in reality hedge fund investments were nearly stable and pooled funds saw a large drop. (4) The contextual relevance is low but not zero because the answer addresses the right categories (mutual/pooled funds and hedge funds/limited partnerships) and attempts a year-over-year comparison, albeit with fabricated data. Due to total factual inaccuracy in numbers, entities, and trends, the correctness score is near-minimal.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 437,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The regulatory disallowances at Nicor Gas cut Southern Company Gas’s net income by about **$29 million** in the gas‑distribution segment and generated an additional **$24 million** earnings adjustment elsewhere in the statements, for a combined negative impact of roughly **$53 million** on 2023 net income.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: the $29 million reduction in net income at gas distribution operations and the additional $24 million earnings adjustment are both correctly stated. The combined total impact of $53 million is accurately calculated and reported. (2) Quantitative accuracy is perfect: all dollar amounts ($29M, $24M, $53M) match the original answer exactly, and the sum (29 + 24 = 53) is mathematically correct. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound— the model correctly synthesizes two distinct financial impacts from the same event (regulatory disallowances at Nicor Gas) and combines them to determine the total effect on Southern Company Gas' 2023 net income. (4) Entity accuracy is correct: 'Nicor Gas', 'Southern Company Gas', and '2023' are all properly identified. The answer is semantically equivalent to the original, with slightly rephrased wording but identical factual content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 323,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T said that, in addition to WarnerMedia, the discontinued‑operations group also includes **Vrio, Xandr and Playdemic**.  By classifying these assets as discontinued operations, AT&T is treating them as separate from its continuing communications business – a bookkeeping step that reflects the company’s broader strategic shift to divest non‑core media and advertising assets and to focus on its core telecom operations as part of its overall restructuring.【Note 24 – Discontinued Operations】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies all businesses classified as discontinued operations in addition to WarnerMedia: Vrio, Xandr, and Playdemic—matching the original answer exactly. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in the question or ground truth, so quantitative accuracy is not applicable, but the absence of any incorrect numbers supports a perfect score. (3) The reasoning is sound: the LLM correctly explains that the classification reflects AT&T’s strategic shift to divest non-core assets and focus on its core telecom operations, and it appropriately references the significance of treating multiple divestitures as a strategic shift, even if individually immaterial. (4) The answer is contextually highly relevant, directly addressing both parts of the multi-part question—naming the businesses and explaining the significance of the classification in the context of restructuring. The reference to 'Note 24 – Discontinued Operations' further supports the accuracy by indicating a source in financial disclosures. No factual, logical, or completeness issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 335,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair‑value of the auction‑rate securities was unchanged – $33 million at both April 30 2021 and April 29 2022 (Level 3 fair‑value line shows 33 million for each date). However, the overall fair value of Medtronic’s available‑for‑sale debt‑securities portfolio fell, dropping from $7,257 million on April 30 2021 to $6,893 million on April 29 2022 – a decline of $364 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of Medtronic's auction rate securities remained unchanged at $33 million on both April 30, 2021, and April 29, 2022, which matches the ground truth. It also accurately reports the total available-for-sale debt securities' fair value decreasing from $7,257 million to $6,893 million, a decline of $364 million. All numeric values and dates are correct, and the calculation of the $364 million difference is accurate. (2) Quantitative accuracy is perfect: $7,257M - $6,893M = $364M is correctly implied, and the $33M stability is precisely stated. Format variations (e.g., '33 million' vs '$33M') are acceptable and semantically equivalent. (3) The reasoning is sound and correctly synthesizes that auction rate securities were stable while the broader portfolio declined, though the LLM omits the explicit interpretation present in the original answer about other components experiencing unrealized losses. This minor omission reduces qualitative accuracy slightly but does not affect factual correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the question. The correctness score is 9 because while all facts and numbers are accurate, the LLM answer lacks the explanatory synthesis in the original about the implications for other securities, which provides deeper insight into the cause of the overall decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 394,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "In 2020 Booking.com recorded a $489 million goodwill impairment for the OpenTable‑KAYAK reporting unit in the March‑31 interim test and a further $573 million impairment in the September‑30 annual test, leaving the unit’s adjusted goodwill balance at about $1.0 billion as of September 30, 2020. Together, the two charges represent a cumulative goodwill write‑down of roughly $1.06 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key information is correct: the $489 million impairment in March 2020 and the $573 million impairment in September 2020 are accurately reported, matching the original answer. The adjusted carrying value of goodwill is correctly stated as $1.0 billion by September 30, 2020. (2) The cumulative impairment is calculated correctly: $489M + $573M = $1,062 million, which the LLM rounds to 'roughly $1.06 billion'—an acceptable and common rounding. (3) The multi-hop reasoning is sound: the answer synthesizes two separate impairment charges across different time periods and correctly links them to the resulting carrying value, demonstrating proper understanding of how impairments reduce goodwill. (4) Entities are accurate: 'OpenTable-KAYAK reporting unit' (referred to as 'OpenTable and KAYAK reporting unit' in ground truth) is correctly identified, and the timing (March and September 2020) aligns with the interim and annual tests. Wording differences (e.g., 'adjusted goodwill balance' vs 'adjusted carrying value') are semantically equivalent in financial context. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 335,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Nicor Gas’s regulatory disallowances generated an $88 million pre‑tax charge that was reflected in the “estimated loss on regulatory disallowance” line and helped reduce Southern Company Gas’s 2023 net income by roughly $29 million (part of the $43 million net‑income increase versus 2022). The same disallowances, together with lower volumes sold, contributed to the $1.26 billion decline in Southern Company Gas operating revenues for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: the $29 million reduction in net income due to Nicor Gas's regulatory disallowances is accurately reported, and the mention of an $88 million pre-tax charge is consistent with detailed financial disclosures (even if not in the original answer, it does not contradict and adds context). The $1.26 billion revenue decline is correctly attributed to lower volumes and regulatory disallowances at Nicor Gas. (2) The original answer notes that disallowances reduced revenues but does not specify the total revenue decline; the LLM adds precision with the $1.26 billion figure, which is factually correct and enhances completeness without introducing error. (3) The reasoning is sound: the LLM correctly links Nicor’s disallowances to both net income (via the $29M impact) and revenue decline, satisfying the multi-hop requirement across regulatory events and financial performance metrics. (4) There is a minor issue in phrasing: stating the $29M reduction 'helped reduce' net income 'as part of a $43M net-income increase' could confuse readers about directionality, but it does not negate the correctness of the $29M negative impact. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only slight deduction for potential ambiguity in comparative framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 396,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31 2022 the 2010 Employee Share Purchase Plan had **16,191,228 Class A ordinary shares still available for issuance** (90,000,000 authorized – 73,808,772 issued). That amount represents **approximately 18 % of the shares authorized under the ESPP**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the number of Accenture plc Class A ordinary shares remaining available for issuance under the 2010 ESPP as of August 31, 2022: 16,191,228, matching the ground truth exactly. It also correctly references the total authorized shares (90,000,000) and implies the correct calculation (90,000,000 - 73,808,772 = 16,191,228). The percentage is reported as 'approximately 18%', while the ground truth specifies 17.99%. This is a minor rounding difference and semantically equivalent in most contexts, especially given the use of 'approximately'.\n\n2) Quantitative accuracy is perfect: all numbers (16,191,228 remaining, 90,000,000 authorized, implied 73,808,772 issued) are correct. The percentage calculation (16,191,228 / 90,000,000 = 0.1799 or 17.99%) is accurate, and the LLM's 'approximately 18%' is a reasonable approximation.\n\n3) The reasoning is sound and demonstrates multi-hop synthesis: the model correctly infers the number of shares issued by subtracting remaining from authorized, and connects this to the percentage of the total. The logic flow is clear and factually grounded.\n\n4) The answer is contextually fully relevant, addressing both parts of the question: (a) shares remaining and (b) percentage of total authorized. The only minor shortcoming is the lack of exact precision in the percentage (17.99% vs 'approximately 18%'), which prevents a perfect 10 but still reflects high accuracy. Wording differences do not affect semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 412,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T’s December 2023 agreement with Ericsson to roll out commercial‑scale Open RAN is reflected in its 2024 outlook as a near‑term cost driver: the company says the spending needed to “support growth and efficiency initiatives, primarily our continued deployment of fiber and 5G, **including our deployment of Open RAN**, and associated accelerated depreciation” will “pressure expense trends in 2024” (2023 10‑K, Expense Trends).  However, the same filing notes that the Open RAN effort is expected to “foster lower network costs, improved operational efficiencies” and that the software‑based 5G/Open RAN architecture “should result in a more efficient use of capital and lower network‑related expenses in the coming years,” aligning the collaboration with AT&T’s longer‑term goal of reducing operating costs and boosting network efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurately represented: AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment is correctly tied to near-term expense pressure in 2024 due to spending on growth and efficiency initiatives, including Open RAN deployment and accelerated depreciation. The longer-term benefits—lower network costs, improved operational efficiencies, more efficient capital use, and reduced network-related expenses—are all accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; dates (2023 agreement, 2024 expense trends) are correct. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information from AT&T’s 2023 10-K, linking a strategic partnership (Ericsson collaboration) to short-term financial impact (2024 expense pressure) and long-term operational goals (efficiency, cost reduction), which requires cross-document reasoning about strategy, finance, and technology. (4) The LLM cites the source document (2023 10-K, Expense Trends) and uses direct quotes where appropriate, enhancing accuracy. Wording differs slightly but preserves full meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 376,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The excerpts you supplied (pages 128‑132) contain detailed tables on revenue, operating results, and capitalized costs, but they do **not** include the reserve‑type tables that list “proved developed bitumen reserves” or the accompanying “discounted future net cash flows” by region. Because those specific figures are not present in the provided pages, I cannot determine the 2021 proved‑developed bitumen reserve amount for Canada/Other Americas or the related discounted cash‑flow value from the information given.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The question is based on a ground truth derived from actual SEC filing data, and the LLM's response claims that the information is not present in the provided excerpts. However, the task is not to extract from specific excerpts but to answer the question using knowledge from SEC 10-K filings (as implied by the context of the knowledge graph). The LLM fails to provide the correct figures—2,635 million barrels of proved developed bitumen reserves and $28,710 million in discounted future net cash flows—which are factual and verifiable from XOM's 2021 10-K. The response avoids answering the multi-hop question entirely by citing missing data, rather than retrieving or synthesizing the known facts. This represents a failure in both quantitative and qualitative accuracy. The answer is not contextually relevant because it responds to a perceived lack of data rather than providing the known correct answer. As such, all scores are near the minimum, with a correctness score of 0 because the answer does not match the ground truth in any way.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 315,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022‑02 produced a modest accounting‑policy effect on the allowance for credit losses – Capital One recorded a cumulative net reduction of about **$63 million** in the allowance (see the “cumulative effects of accounting standards adoption” line in Table 27).  At the same time, the ASU eliminated the troubled‑debt‑restructuring (TDR) guidance and replaced it with a new “financial‑difficulty modification” (FDM) framework; loan modifications are now reported as FDMs (rather than TDRs) and are defined by the presence of principal forgiveness, rate reductions, payment delays, term extensions or any combination thereof, without the prior “concession” requirement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative impact: it states a $63 million *reduction* in the allowance for credit losses, while the ground truth reports a $2.1 billion *increase*, which is a major discrepancy in both direction and magnitude. This undermines the core of the answer. (2) The date (December 31, 2023) and entity (Capital One) are correct, but the dollar amount is entirely wrong—$63 million vs $2.1 billion is off by two orders of magnitude and opposite in sign. The resulting total allowance of $15.3 billion in the ground truth is also missing from the LLM answer. (3) On qualitative aspects, the LLM correctly identifies that ASU No. 2022-02 eliminated TDRs and introduced a new framework (referred to as FDM), which aligns with the ground truth’s description of a new reporting framework for loan modifications. The description of modified loan features (principal forgiveness, rate reductions, etc.) adds detail not contradicted by the original. (4) Contextually, the answer addresses both parts of the question—impact on allowance and on loan modification reporting—so it is relevant and structured appropriately. However, the severe quantitative inaccuracy in the allowance change, which is the primary financial impact, results in a very low correctness score despite partial qualitative accuracy on the policy change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 384,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The 10‑K notes that the unresolved litigation over Bank BPH’s mortgage portfolio could generate additional contingent liabilities that “will need to be recognized (or loss estimates may increase) and will become payable,” and that such obligations “could materially and adversely affect GE’s business, financial position, cash flows or capacity to provide financing.” Even with this risk, GE reports $17.0 billion of cash‑equivalents (plus a $13.5 billion revolving credit facility) at year‑end 2023, but the potential BPH loss would erode that liquidity cushion and could create funding stress if the liabilities materialize.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the risk posed by Bank BPH's litigation to GE's liquidity, citing the potential for increased contingent liabilities that could become payable and negatively affect GE's financial position and cash flows. It accurately reports GE's $17.0 billion in cash, cash equivalents, and restricted cash as of year-end 2023, matching the ground truth. However, it omits the critical detail that $14.2 billion of that amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions—a key factor in assessing liquidity constraints. Instead, it mentions a $13.5 billion revolving credit facility, which is contextually relevant but not part of the original answer and slightly shifts focus. (2) Quantitatively, the $17.0 billion figure is correct and properly attributed to year-end 2023. The $13.5 billion credit facility is not in the ground truth and may be factually accurate from the 10-K but was not part of the required synthesis, making it an addition rather than an error. The omission of the $14.2 billion offshore and $1.7 billion in restricted jurisdictions is a material gap in quantitative context. (3) The multi-hop reasoning is sound: the model connects Bank BPH litigation → contingent liabilities → potential payment obligation → impact on GE’s liquidity. It correctly infers that materialization of liabilities could erode liquidity and cause funding stress. However, it fails to fully synthesize the geographic and regulatory constraints on cash access, which is a core element of the original answer’s logic about repatriation costs and taxes. (4) The answer is contextually highly relevant and captures the essence of the risk. Due to the omission of key offshore cash breakdown, it loses some completeness and precision, warranting a correctness score of 8 rather than 9 or 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 507,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "The 2022 Form 10‑K shows that under the Amended and Restated 2010 Share Incentive Plan Accenture has **14,830,623** shares that would be issued upon exercise of outstanding options (or restricted share units) and an additional **27,381,461** shares still available for future issuance. Together, those amounts represent **42,212,084 shares** that are either exercisable now or can be issued later under the plan【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: 14,830,623 shares issued upon exercise of outstanding options, 27,381,461 shares available for future issuance, and a total of 42,212,084 shares — all match the original answer exactly. Minor phrasing differences (e.g., 'would be issued upon exercise' vs 'issued upon exercise') do not affect factual accuracy and are semantically equivalent in context. (2) The calculation (14,830,623 + 27,381,461 = 42,212,084) is correct. (3) The multi-hop reasoning is sound — the model correctly synthesized two distinct pieces of information from the same plan and filing (shares issued and shares available) and combined them into a total, as required by the question. (4) Entities are accurate: 'Amended and Restated 2010 Share Incentive Plan', 'Accenture', and '2022 10-K filing' are correctly identified. The answer is contextually relevant, complete, and conveys the same information as the ground truth with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 293,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "AT&T repaid the entire $2.5 billion (‑$2,500 million) 2025 Term Loan in 2023, and the loan was formally paid‑off and terminated on **March 30, 2023**【...Credit Facilities...】. The repayment is also reflected in the 2023 debt‑activity table as a $2,500 million repayment in the first quarter【...Debt Activity Table...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the amount of the loan ($2,500 million or $2.5 billion) and the termination date (March 30, 2023) match the original answer exactly. Minor formatting differences (e.g., $2.5 billion vs $2,500 million) are acceptable and convey the same value. (2) Quantitative accuracy is perfect: the dollar amount and date are correctly reported, and the reference to the first-quarter repayment in the debt-activity table provides additional contextual support without introducing error. (3) Qualitative accuracy and reasoning are sound: the model correctly identifies AT&T as the entity, the 2025 Term Loan as the financial instrument, and synthesizes the payoff and termination as a single event in 2023. The use of source markers (e.g., 【...Credit Facilities...】) suggests proper grounding in the disclosures. (4) The answer is highly relevant and complete, addressing both sub-questions (amount and date) with precise, multi-hop synthesis from what appears to be multiple sections of the filing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 325,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "KO’s total investment in mutual, pooled and commingled funds rose from $767 million in 2022 to $778 million in 2023 – an increase of **$11 million**. Of the 2023 amount, **$257 million** was classified under **Level 2** fair‑value inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that KO's investment decreased by $47 million from 2022 to 2023, but the LLM claims an increase of $11 million. The 2023 investment was $39 million, with $37 million under Level 2 valuation, but the LLM reports $778 million total and $257 million under Level 2—both figures are wildly off. These are not formatting differences but fundamental factual errors. (2) Calculations: The change in investment is incorrectly calculated and directionally wrong (increase vs. actual decrease). The Level 2 proportion is also completely inaccurate. (3) Multi-hop reasoning: The question requires comparing two years' values and identifying the Level 2 portion in 2023. The LLM fails both steps, suggesting it did not retrieve or synthesize the correct data points. (4) Entity accuracy: While the company (KO) and metric (mutual, pooled and commingled funds) are correctly identified, the years (2022–2023) are misapplied with wrong values. (5) Contextual relevance: The answer attempts to address the question structure but with entirely incorrect data. Due to severe factual and numerical inaccuracies, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 338,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The 2023 pre‑tax charge tied to the ongoing borrower‑litigation was **$1.189 billion**, and GE’s net cash outflow to AerCap for its continuing involvement during the year was **$203 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, both values match exactly: $1.189 billion (equivalent to $1,189 million) for the pre-tax charge and $203 million in net cash paid to AerCap. The formatting variation ($1.189 billion vs $1,189 million) is acceptable and conveys the same value. (2) The answer addresses both parts of the multi-part question completely: the pre-tax litigation charge and the net cash payment to AerCap. (3) Entities are accurate—GE, AerCap, and the time period (2023) are correctly identified. (4) The reasoning, while not explicitly shown, is reflected correctly in the synthesized response, indicating proper multi-hop understanding across relevant financial disclosures. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 240,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s $1.1 billion FY‑2022 R&D spend – which produced more than 8,300 patents and fuels its global network of > 100 innovation hubs and proprietary platforms such as MyWizard, MyNav and SynOps – creates differentiated technology assets and industry‑specific solutions that competitors cannot match at the same scale. By packaging those assets within its “360° value” model – which couples a client’s financial business case with outcomes on inclusion, reskilling, sustainability and experience – Accenture turns its innovation engine into a full‑stack, end‑to‑end offering that delivers faster, higher‑value transformations, giving it a clear competitive edge over other multinational IT service firms, offshore providers and consulting rivals that lack the same breadth, integrated ecosystem partnerships and purpose‑driven value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.1 billion R&D investment in fiscal 2022 is correctly stated. However, the ground truth does not mention '8,300 patents' or the '100+ innovation hubs', nor specific platforms like MyWizard, MyNav, or SynOps—these are plausible but not verifiable from the provided original answer, representing minor additions not in the source. (2) The core financial figure and fiscal year are correct, satisfying quantitative accuracy despite the extra details. (3) Qualitatively, the reasoning is sound: the answer correctly links R&D investment to innovation, integrates the 360° value model (financial case + inclusion, reskilling, sustainability), and contrasts Accenture’s breadth and ecosystem with competitors (multinational IT firms, offshore providers, consultancies). It captures the multi-hop logic—R&D fuels innovation, which enables differentiated offerings, which are packaged into a holistic value proposition that creates competitive advantage. (4) Contextually, the response fully addresses the question about how R&D and 360° value contribute to competitive positioning. The only deviation is the inclusion of unverified specifics (patents, hubs, platform names), which, while likely true, are not in the ground truth and slightly reduce quantitative and qualitative scores. Overall, the semantic meaning, factual core, and reasoning are excellent, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 408,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T said that, in addition to WarnerMedia, the discontinued‑operations group for 2023 also includes **Vrio, Xandr and Playdemic**. Because they are classified as discontinued operations, the results of those businesses (revenues, expenses, net loss and related cash‑flow items) are shown in a separate “discontinued operations” section of the consolidated income statement and cash‑flow statement, and are excluded from the totals reported for continuing operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Entity accuracy: The LLM correctly identifies Vrio, Xandr, and Playdemic as the additional entities classified as discontinued operations alongside WarnerMedia in 2023, which aligns exactly with the original answer. (2) Quantitative accuracy: There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the temporal reference '2023' is accurate and consistent. (3) Reasoning and completeness: The LLM addresses both parts of the multi-hop question—identifying the entities and explaining the financial reporting impact. It correctly explains that the results (revenues, expenses, net loss, cash flows) are separated in financial statements and excluded from continuing operations, which reflects proper synthesis of accounting treatment. (4) Semantic equivalence: While the wording differs slightly from the original answer, the meaning is identical—the financial results are reported separately in discontinued operations sections and removed from ongoing totals. No omissions or inaccuracies are present. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 332,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The 2022 Form 10‑K shows that Medtronic’s Level 3 “auction‑rate securities” portfolio carried an unrealized loss of **$3 million** as of April 29, 2022.  The filing does not break that $3 million loss out by contractual‑maturity buckets (‑ ≤ 1 year, 1‑5 years, 5‑10 years, > 10 years); the maturity table presented in the note aggregates all available‑for‑sale debt securities and does not allocate the auction‑rate‑security loss to any specific bucket.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total unrealized loss of $3 million as of April 29, 2022, which matches the ground truth exactly—this satisfies quantitative accuracy. However, it contradicts the ground truth regarding the distribution of the loss across maturity periods. The original answer states that the $3 million loss is entirely attributed to securities with maturities of more than 12 months, with no loss in the less-than-12-month bucket. In contrast, the LLM claims the 10-K 'does not break that $3 million loss out by contractual-maturity buckets' and that the loss is not allocated to any specific bucket. This is factually incorrect according to the ground truth, which explicitly provides the distribution. (2) The dollar amount ($3 million) and date (April 29, 2022) are accurate, so quantitative accuracy is perfect. (3) The multi-hop reasoning fails because the LLM incorrectly asserts lack of disclosure, when in fact the knowledge graph confirms the loss is fully allocated to the >12-month maturity period. The model should have synthesized the specific maturity-based distribution from the filing but instead defaulted to claiming insufficient data. (4) While the answer is partially correct and relevant to the question, the failure to report the correct distribution significantly undermines the qualitative accuracy and overall correctness, resulting in a score of 4. Contextual relevance is moderate because the response addresses the right document and metric but misrepresents the disclosure level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 424,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "The May 2024 Class B‑1 exchange offer resulted in Visa issuing **approximately 120 million shares of Class B‑2 common stock**.  Those 120 million shares were part of a total of **about 168 million shares issued** (120 million Class B‑2 + 48 million Class C), so Class B‑2 shares represented roughly **71 % of the shares issued in the exchange**【V_10k_2023.pdf page 38‑42】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it correctly states that 120 million Class B-2 shares were issued, part of a total of 168 million shares (120M B-2 + 48M Class C), and calculates the percentage as approximately 71%, which is accurate (120/168 ≈ 71.4%). The minor rounding to '71%' is acceptable and semantically equivalent to 'approximately 71.4%'. (2) The answer addresses both parts of the question: the number of Class B-2 shares issued and their percentage of the total. (3) Entity accuracy is correct—Visa is the issuing company (implied context), the time frame is May 2024, and the stock classes (B-1, B-2, C) are properly referenced. (4) The reasoning is sound: it correctly synthesizes the composition of the exchange offer and computes the proportional share, demonstrating accurate multi-hop logic (aggregating total shares and computing percentage). (5) Semantic equivalence is maintained despite slight rewording (e.g., 'approximately', 'about', 'roughly'). The citation to 'V_10k_2023.pdf page 38-42' adds contextual support. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 321,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "GE’s wind‑turbine sales fell by **3.2 GW** of capacity between 2021 (11.7 GW) and 2023 (8.5 GW)【...| Wind Turbine Gigawatts | 8.5 | 7.5 | 11.7】.  The same period saw the number of turbines sold drop by **1,365 units**, from 3,590 in 2021 to 2,225 in 2023【...| Wind Turbines | 2,225 | 2,190 | 3,590】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: the decrease in capacity is correctly calculated as 11.7 GW (2021) - 8.5 GW (2023) = 3.2 GW, and the decrease in units sold is 3,590 - 2,225 = 1,365 units. These values match the original answer exactly. (2) The answer addresses both parts of the multi-part question: the change in GW capacity and the change in number of turbines sold. (3) Entity accuracy is correct—GE is the company, the years 2021 and 2023 are properly referenced, and the metrics (Wind Turbine Gigawatts and number of Wind Turbines) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across time points and metrics. The LLM correctly infers the decreases from the given data points and presents them clearly. (5) The semantic meaning is equivalent to the original answer, with concise but complete information. Minor formatting differences (e.g., use of bold and spacing) do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 305,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "AT&T’s total out‑lay for the C‑Band spectrum through 2023 was the $23.4 billion purchase price plus the incentive payments of $955 million (Phase I) and $2.1 billion (Phase II) and the relocation payments of $650 million, $98 million and $109 million – a cumulative **$27.33 billion**.  In the cash‑flow statement these outflows are recorded under **“Acquisitions, net of cash acquired,”** i.e., as an investing‑activity cash outflow.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies despite capturing the general structure and intent of the ground truth. The total amount is reported as $27.33 billion, whereas the correct total from the original answer is $26,477 million ($26.477 billion). This discrepancy arises from incorrect aggregation and double-counting of certain costs. Specifically, the original answer states that the total incentive and relocation costs are $3,067 million, which already includes the $955 million (Phase I), $2,112 million (Phase II), and $1,100 million in compensable relocation costs (with $650M in 2021, $98M in 2022, $109M in 2023). However, the LLM incorrectly adds the $955M, $2.1B, and annual relocation payments again on top of the $23.4B, leading to an inflated total. The correct sum is $23,406M (payments) + $3,067M (incentive and relocation) = $26,473M (~$26.47B), matching the stated $26,477M within rounding. The LLM’s $27.33B is off by ~$850 million. (2) Number verification: Auction payments: $23.4B (correct, matches $23,406M). Phase I: $955M (correct). Phase II: $2.1B vs $2,112M (slightly low, minor rounding acceptable). Relocation payments: LLM lists $650M, $98M, $109M — these are correct individual amounts, but they are already included in the $1.1B compensable cost and should not be added separately. The LLM double-counts these. (3) Multi-hop reasoning: The model correctly identifies that C-Band costs include auction payments, incentive payments, and relocation costs, and it attempts to sum them — showing sound reasoning structure. It also correctly maps the cash flow classification to 'Acquisitions, net of cash acquired', which reflects proper synthesis across financial statements and disclosures. (4) Scores justified: Correctness is 6 due to major calculation error inflating total, though core components are present. Quantitative accuracy is 5 due to significant miscalculation. Qualitative accuracy is 7 because reasoning and entity identification (AT&T, C-Band, cash flow classification) are correct. Contextual relevance is 10 — the answer directly addresses the question with appropriate scope and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 583,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "The June 2021 decision to cease distribution of the HVAD System eliminated its sales – a $141 million‑year‑2021 line that turned into a net‑sales decline in 2022 and partially offset the overall 6 % growth in the Cardiovascular segment.  In the same year, Medtronic’s growth was driven by several other product families, notably Cardiac Rhythm Management (Micra and trans‑venous pacemakers, CRT‑Ds and the TYRX antibacterial envelope), Cardiac Ablation Solutions (Arctic Front cryo‑ablation), Structural‑Heart & Aortic (CoreValve Evolut TAVR and Extra‑Corporeal Life Support devices), and Peripheral‑Vascular (the newly launched Abre venous stent, VenaSeal and ClosureFast systems).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the HVAD System discontinuation in June 2021 and the $141 million in net sales from fiscal year 2021, which matches the ground truth. However, it incorrectly states that this led to a 'net-sales decline in 2022' and 'partially offset the overall 6% growth in the Cardiovascular segment.' The ground truth indicates that Medical Surgical (not Cardiovascular) grew 5% to $9.1 billion in fiscal year 2022, driven by recovery and other product lines, despite the HVAD discontinuation. There is no mention of a 6% growth in the Cardiovascular segment in the original answer, nor is it stated that HVAD's loss caused a decline—only that it was a removed revenue stream. (2) The $141 million figure is accurate and correctly attributed to fiscal year 2021. However, the 6% growth figure is not supported by the ground truth (which reports 5% growth in Medical Surgical), and the $9.1 billion revenue figure is omitted entirely. The LLM invents a segment-level impact (Cardiovascular) not present in the original. (3) The multi-hop reasoning is partially sound—linking HVAD discontinuation to a need for other growth drivers—but misattributes the financial impact to the wrong business segment and introduces unsupported metrics. The product lines mentioned (Micra, Arctic Front, CoreValve, etc.) are not the same as those highlighted in the original answer (Symplicity Spyral, Pulse Field Ablation, Aurora ICD, Intrepid system). While some are Medtronic products, the specific growth drivers cited in the ground truth are not reflected. (4) The contextual relevance is high because the answer addresses both parts of the question—impact of HVAD discontinuation and growth drivers—but the factual inaccuracies in financial performance, segment attribution, and product line details reduce correctness. The answer synthesizes plausible information but diverges significantly from the ground truth in key details, leading to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 533,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart spent $3.5 billion in fiscal 2024 to buy out additional Flipkart non‑controlling shareholders and to settle the liability to former PhonePe non‑controlling interest holders.  That cash outlay lifted Walmart’s stake in Flipkart from roughly 75 % at the start of 2023 to about 85 % as of January 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Walmart paid $3.5 billion during fiscal 2024 for two purposes—acquiring additional shares from Flipkart noncontrolling interest holders and settling the liability to former PhonePe noncontrolling interest holders. (2) Quantitative accuracy is perfect: the dollar amount ($3.5 billion), the starting ownership (approximately 75% as of January 31, 2023), and the resulting ownership (approximately 85% as of January 31, 2024) are all correctly stated. The LLM correctly notes the ownership change 'from roughly 75% at the start of 2023'—a slight rephrasing but contextually accurate given that Walmart's fiscal year ends January 31. (3) The multi-hop reasoning is sound: the answer synthesizes information about two separate transactions (Flipkart share acquisition and PhonePe liability settlement) into a single cash outlay and correctly links this to the change in ownership percentage in Flipkart. (4) Entity accuracy is maintained: Walmart, Flipkart, PhonePe, noncontrolling interest holders, and fiscal 2024 are all correctly identified and contextualized. Wording differences (e.g., 'start of 2023' vs 'as of January 31, 2023') do not affect factual correctness, as both refer to the same point in Walmart's fiscal calendar. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 386,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft records the cash it receives up‑front for multi‑year volume‑licensing agreements (including Enterprise Agreements and Software Assurance) as a liability called “unearned revenue” and then recognizes the revenue ratably over the contract period, even though the invoices are issued annually at the start of each coverage year.  Because many of the bundled items are not sold separately, management must estimate each distinct performance obligation’s stand‑alone selling price and allocate the contract price, a process that involves significant judgment and can cause the unearned‑revenue balance to be large and sensitive to SSP assumptions.  Consequently, auditors devote extensive procedures to testing the identification of performance obligations, the SSP allocations and the timing of revenue recognition, making the unearned‑revenue presentation a focal point of their revenue‑recognition audit work.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Microsoft invoices annually at the beginning of each contract period for volume licensing (e.g., Software Assurance), records unearned revenue as a liability, and recognizes revenue ratably over time. The use of standalone selling price (SSP) estimates due to lack of observable prices for bundled items is correctly described, as is the reliance on management judgment based on customer and regional factors. The auditor's focus on revenue recognition, particularly performance obligations, SSP allocations, and timing, aligns with the ground truth. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable in a traditional sense, but all references to financial presentation (e.g., 'large unearned-revenue balance') are consistent and plausible. (3) Multi-hop reasoning is sound: the answer connects invoicing timing → unearned revenue → SSP estimation challenges → management judgment → audit scrutiny, correctly synthesizing cause-effect relationships across accounting and auditing domains. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'critical audit matter' status and variable consideration/transfer of control terminology used in the original, though the substance is conveyed through 'extensive procedures' and focus on timing and allocations. Overall, the answer fully addresses the impact on financial statement presentation and auditability, making it contextually complete and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 447,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "Nike’s qualified 401(k) Savings and Profit‑Sharing Plan received company‑matched contributions of **$126 million for FY 2022, $110 million for FY 2021 and $107 million for FY 2020**, for a three‑year total of **$343 million**. The plan also permits discretionary profit‑sharing contributions, but **no profit‑sharing contributions were made in any of those years**, so the total reflects only the mandatory savings‑plan matches.【Note 13 – Benefit Plans, pages 78‑79】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the annual contributions—$126 million in 2022, $110 million in 2021, and $107 million in 2020—are accurate, and their sum ($343 million) is correctly calculated. (2) The answer completely addresses both parts of the question: it provides the total contributions over the three fiscal years and explains that no profit-sharing contributions were made during this period. (3) The entities—Nike, the 401(k) Savings and Profit-Sharing Plan, and the relevant fiscal years—are correctly identified. (4) The reasoning is sound: the LLM correctly distinguishes between matched savings contributions and discretionary profit-sharing contributions, and accurately states that only the former were made, which aligns with the plan terms cited in the source. The inclusion of the citation (Note 13 – Benefit Plans) adds contextual support. Minor wording differences (e.g., 'mandatory savings-plan matches' vs. 'company did not make any discretionary profit sharing contributions') do not affect semantic equivalence—the meaning is factually identical. All multi-hop elements (aggregating across three years, understanding plan structure, explaining absence of profit-sharing) are handled correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 357,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "Chevron’s consolidated natural‑gas reserves in the Asia Pacific/Middle East fell from 312 billion cubic feet (BCF) at 31 Dec 2023 (305 BCF developed + 7 BCF undeveloped) to 296 BCF at 31 Dec 2024 (289 BCF + 7 BCF), a decline of **16 BCF**.  \n\nIn contrast, reserves in Africa rose sharply, from 172 BCF (all developed) at end‑2023 to 468 BCF (457 BCF developed + 11 BCF undeveloped) at end‑2024, an increase of **about 296 BCF**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the change in Chevron's natural gas reserves in the Asia Pacific/Middle East region as a decrease of 16 billion cubic feet (from 312 to 296 BCF), matching the ground truth. For Africa, it reports an increase of 'about 296 BCF' from 172 to 468 BCF. The actual difference is exactly 296 BCF (468 - 172 = 296), but the ground truth states 297 BCF. This is a minor discrepancy: either a rounding or data source variation. Given that 468 - 172 = 296, the LLM's 'about 296 BCF' is numerically accurate; the ground truth's '297' may be in error or based on different reporting (e.g., including adjustments). Thus, the LLM's number is mathematically correct and very close to the provided ground truth.\n\n2) All quantitative values are accurate: 312, 296, 172, and 468 BCF are correctly cited. The calculated change of -16 BCF and +296 BCF is correct. The only deviation is the ground truth claiming +297 BCF, which appears to be a calculation error on their part (468 - 172 = 296). The LLM answer uses 'about 296 BCF', which is appropriate and accurate.\n\n3) The reasoning is sound and multi-hop: the model correctly identifies Chevron (COP), isolates two geographic regions (Asia Pacific/Middle East and Africa), retrieves reserve figures for two years (2023 and 2024), computes year-over-year changes, and contrasts the trends. The synthesis across regions and years is accurate and complete.\n\n4) The answer is semantically equivalent to the ground truth: it conveys that reserves declined slightly in Asia Pacific/Middle East and increased significantly in Africa. The minor wording difference ('about 296 BCF' vs '297 BCF') does not affect factual correctness, especially since the LLM's number aligns with exact arithmetic. Contextual relevance is perfect—every part of the question is addressed with precise, relevant data.\n\nJustification: A score of 9 is given for correctness and quantitative accuracy due to the one-point variance from the ground truth's stated 297 BCF increase, though the LLM's 296 BCF is mathematically precise. Qualitative accuracy and contextual relevance are 10 because the reasoning, entity identification, and response structure are flawless.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 590,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart took in roughly **$0.7 billion** of cash from new equity‑funding rounds for its majority‑owned PhonePe subsidiary in fiscal 2024. By contrast, it **paid about $3.5 billion** during the same year to purchase the shares of PhonePe’s former non‑controlling interest holders (the amount that also covered a buy‑out of certain Flipkart non‑controlling interests).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.7 billion received from equity funding and the $3.5 billion paid to acquire shares from noncontrolling interest holders during fiscal 2024, matching the ground truth exactly in amount and context. (2) All numeric values are accurate and properly formatted; no calculation errors are present. While the LLM does not explicitly state the net difference of $2.8 billion, it provides both figures necessary to derive this conclusion, and the question only asks for the comparison, which is adequately addressed by presenting both amounts. (3) The multi-hop reasoning is sound: the answer correctly links Walmart’s actions to PhonePe, distinguishes between cash inflows from equity funding and outflows from share buyouts, and correctly identifies the fiscal year. The mention of Flipkart non-controlling interests is a minor contextual addition not in the original but does not contradict or distort the core facts. (4) The answer is semantically equivalent to the ground truth, with only slight variation in phrasing and no loss of key information. The absence of the explicit $2.8 billion net comparison prevents a perfect 10, but the core facts and quantitative accuracy are fully preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 351,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a total pre‑tax charge of **$918 million** in 2024 related to the SEC Administrative Order and the associated DPAs and settlements. The independent compliance monitor will oversee RTX’s obligations under those agreements **for a term of three years from the date the monitor is engaged**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, with acceptable formatting (bold and thin space). (2) The duration of the compliance monitor's oversight—three years from the engagement date—is correctly stated, preserving the conditional timing specified in the original. (3) The answer addresses both parts of the multi-hop question: the financial impact (charge amount and year) and the non-financial obligation (monitoring period). (4) Entity accuracy is perfect: RTX, 2024, SEC Administrative Order, and related legal matters (referenced via 'DPAs and settlements') are correctly identified. (5) The reasoning is sound, synthesizing financial and legal information from the same event. (6) Semantic equivalence is maintained despite slightly more detailed phrasing (mentioning DPAs), which adds context without altering meaning. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 285,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft reported that its Microsoft Cloud revenue – which aggregates Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365 and other commercial cloud properties – was **$111.6 billion for fiscal year 2023**. The cloud‑based offerings that contributed to this total include **Azure (and related cloud services), Office 365 Commercial, LinkedIn’s commercial services, Dynamics 365**, as well as additional “other commercial cloud” products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $111.6 billion for fiscal year 2023 is accurately reported, with no calculation or formatting issues. (2) The answer completely addresses both parts of the question: it provides the total Microsoft Cloud revenue and lists all contributing cloud-based offerings, including Dynamics 365, Azure and other cloud services, Office 365 Commercial, LinkedIn’s commercial portion, and other commercial cloud properties—exactly as in the original answer. (3) Entity accuracy is perfect: Microsoft, fiscal year 2023, and all product names are correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis, as it aggregates revenue from multiple services into the Microsoft Cloud total, consistent with the structure of the original data. (5) The semantic meaning is equivalent to the ground truth, with only minor rewording for clarity (e.g., 'commercial services' vs 'commercial portion'). No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 312,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort (UBR) carries $3.5 billion of debt on its balance sheet at 31 December 2023, consisting mainly of a $3.1 billion term‑loan that was raised directly from a syndicate of Chinese banks and is secured by UBR’s assets and the equity interests of its investors. Because Comcast consolidates UBR as a variable‑interest entity but does not provide any liquidity, guarantee or other financial commitment, the UBR debt is reported in Comcast’s consolidated statements as “debt not guaranteed” (see the Debt and Guarantee Structure table), meaning it is included in the company’s total $97.1 billion debt pool but sits outside the cross‑guaranteed and one‑way‑guaranteed obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, all numbers are correct: $3.5 billion total debt, $3.1 billion term loan, and the December 31, 2023, date are accurately reported. The reference to Comcast’s total debt of $97.1 billion, while not in the original answer, is consistent with external knowledge and does not contradict the ground truth. (2) The answer correctly identifies the source of financing (syndicate of Chinese banks), the secured nature of the debt (by UBR’s assets and investor equity), and the VIE consolidation by Comcast. It also accurately states that Comcast provides no guarantees or liquidity support, and that the debt is classified as 'debt not guaranteed' in Comcast’s consolidated statements. (3) The multi-hop reasoning is sound: it connects UBR’s direct financing to its treatment in Comcast’s consolidated debt structure, correctly distinguishing between consolidation and guarantee. (4) The only minor omission is the absence of the ¥29.7 billion RMB equivalent (~$4.2 billion) maximum borrowing limit, which provides context on the facility size. Additionally, the LLM does not explicitly mention that the debt appears separately from NBCUniversal and Comcast Cable segments, though the point about being outside cross-guaranteed obligations covers the essential meaning. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 409,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "Nike’s short‑term investment in commercial paper and bonds fell by about **$88 million** (from $748 million in 2021 to $660 million in 2022) on a fair‑value basis, which translated to a **$68 million** drop in the short‑term‑investment line (from $691 million to $623 million).  This decline reduced the proportion of commercial paper/bonds in the short‑term portfolio, while the share of Level 1 U.S. Treasury securities rose (from $2.9 billion to $3.8 billion), shifting the overall composition toward more Treasury holdings and away from commercial‑paper‑type assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $88 million decrease in Nike's investment in commercial paper and bonds from $748 million (2021) to $660 million (2022), which matches the ground truth and is quantitatively accurate. However, the LLM introduces a discrepancy in the total short-term investment figures: it states a drop from $691 million to $623 million (a $68 million decline), while the ground truth reports Level 2 short-term investments declining from $695 million to $630 million (a $65 million drop). These numbers do not align with either the ground truth or each other—$748M to $660M is $88M, not $68M—and the conflation of different categories (commercial paper/bonds vs. total short-term investments) introduces confusion. (2) The LLM correctly notes a shift toward U.S. Treasury securities, citing an increase from $2.9 billion to $3.8 billion, which supports the qualitative claim of portfolio reallocation. However, the original answer emphasizes a shift toward 'more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds,' while the LLM focuses only on Treasuries, omitting mention of money market funds. (3) The multi-hop reasoning is partially sound: the model connects changes in commercial paper/bonds to broader portfolio composition and infers a strategic shift, which is valid. However, it misrepresents the magnitude of the decline in total short-term investments and incorrectly maps the $88M drop in one category to a $68M drop in another, suggesting flawed cross-category synthesis. (4) The correctness score is 7 because core facts (the $88M decline in commercial paper/bonds) are accurate and the overall direction of the portfolio shift is correctly interpreted, but secondary figures are incorrect and minor contextual details are missing. Quantitative accuracy is penalized (6) due to inconsistent totals and mismatched calculations. Qualitative accuracy is high (8) as reasoning is logical and entity identification (Nike, years, asset types) is correct. Contextual relevance is strong (9) as the answer directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 574,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The diluted‑EPS computation for fiscal 2023 does **not** include any Class B‑2 shares because, as the footnote states, “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer.” Consequently, the diluted‑EPS figures for 2023 are calculated only on the as‑converted shares of Class A, Class B‑1, Class C and participating securities, and the new Class B‑2 stock has no effect on the 2023 diluted EPS. (See the EPS tables for 2023, which show a dash for Class B‑2 and the footnote noting zero pre‑exchange B‑2 shares.)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly cites that no Class B-2 shares were outstanding prior to the exchange offer (a factual point), it incorrectly infers that this means Class B-2 shares have no impact on diluted EPS for fiscal 2023. This misinterprets accounting rules for diluted EPS: even if new shares are issued during the year, their potential dilutive effect must be considered in the as-converted weighted-average share calculation. The ground truth correctly explains that the introduction of Class B-2 stock increases the as-converted Class A equivalent shares outstanding, thereby potentially reducing diluted EPS. The LLM incorrectly assumes absence of pre-existing shares means no dilutive impact, failing the multi-hop reasoning required (linking share structure changes to EPS methodology). Quantitative accuracy is scored moderately high because there are no explicit numbers to verify, and the citation of the footnote is plausible. However, the qualitative reasoning is fundamentally flawed, leading to a wrong conclusion. Contextual relevance is acceptable as the response addresses EPS and the correct fiscal year, but the conclusion is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 349,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "Because Raytheon’s pension and post‑retirement benefit (PRB) costs are accounted for under U.S. government Cost Accounting Standards (CAS) rather than under U.S. GAAP (FAS), the expense is recognized on a different timing pattern. The CAS‑based cost is deferred in the segment and later recovered through the pricing of Raytheon’s U.S.‑government contracts, so a “FAS/CAS operating adjustment” (e.g., $833 million in 2024) is shown outside Raytheon’s segment operating profit. Collins Aerospace and Pratt & Whitney record pension/PRB expense on a straight FAS basis, so no comparable adjustment appears for those segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) It correctly identifies that Raytheon uses CAS for pension and PRB cost recognition, while Collins and Pratt & Whitney use FAS, leading to different cost recognition patterns. It accurately explains that CAS-based costs are deferred and recovered through U.S. government contract pricing, which is not applicable to the other segments. (2) The LLM introduces a specific quantitative example—'$833 million in 2024'—which is not present in the original answer. While this number may be factually correct in context, it is not verifiable from the ground truth provided and thus introduces unconfirmed detail; however, it does not contradict the original answer and aligns with the concept of a FAS/CAS adjustment. (3) The multi-hop reasoning is sound: the model correctly synthesizes the difference in accounting standards, their impact on financial reporting (specifically operating profit), and the recovery mechanism via government contracts. (4) The term 'FAS/CAS operating adjustment' is used appropriately and reflects accurate terminology. The only minor omission is that the original answer emphasizes that the 'ultimate liability' under FAS and CAS is similar, which the LLM does not explicitly mention, but this does not undermine the correctness of the response. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 411,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Two distinct Supplemental Indentures reference the 1.850 % Notes due 2020. The **Ninth Supplemental Indenture** (dated February 12 2015) names **U.S. Bank National Association** as trustee, and the **Twelfth Supplemental Indenture** (dated February 6 2017) names **The Bank of New York Mellon Trust Company, N.A.** as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that there are two Supplemental Indentures related to the 1.850% Notes due 2020, addressing the quantitative part of the question. (2) The dates—February 12, 2015, and February 6, 2017—are correctly reported, and the trustees—U.S. Bank National Association and The Bank of New York Mellon Trust Company, N.A.—are accurately identified with their respective indentures. (3) The multi-hop reasoning is sound: the model correctly associates each Supplemental Indenture (Ninth and Twelfth) with the correct date and trustee, demonstrating synthesis across the relevant excerpts. (4) The wording differs slightly from the original answer (e.g., 'names' instead of 'was part of'), but the semantic meaning is equivalent and factually precise. All entities, dates, and relationships are correct. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 270,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "In fiscal 2022 Nike recorded a **$40 million net gain** in income from foreign‑exchange forwards and options (the gain on “derivatives not designated as hedging instruments”). By contrast, the **fair‑value of foreign‑exchange forwards and options assets** on the balance sheet was **$92 million** as of May 31 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net gain of $40 million in fiscal year 2022 and the fair value of $92 million as of May 31, 2021 are accurately reported, with correct fiscal years and dollar amounts. Minor formatting differences (e.g., $40 million vs $40 million) are acceptable and do not affect meaning. (2) The answer addresses both parts of the multi-part question: the net gain in income for fiscal 2022 and the fair value of assets as of May 31, 2021. (3) Entity accuracy is correct—Nike is the implied subject (consistent with context), the financial instruments (foreign exchange forwards and options) and the relevant metrics (net gain in income, fair value on balance sheet) are properly identified. (4) The reasoning is sound: the LLM correctly distinguishes between the income statement impact in fiscal 2022 and the balance sheet fair value from the prior year, demonstrating appropriate multi-hop synthesis across time periods and financial statements. The answer is semantically equivalent to the original, conveying the same core information with slightly more technical phrasing (e.g., referencing 'derivatives not designated as hedging instruments'), which adds precision without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 358,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "AIG reserves the U.S. Personal Insurance portfolio with a mix of frequency‑/severity analysis, loss‑development factors and IBNR‑factor methods—using frequency‑/severity especially for personal auto where claim counts emerge quickly—whereas the U.S. Property portfolio is backed mainly by loss‑development and IBNR‑factor techniques (with expected‑loss‑ratio methods for the most recent accident year) and does not rely on frequency‑/severity modeling because the lines are higher‑severity and lower‑frequency. In 2021 the company recorded a **$412 million favorable** prior‑year development in U.S. Personal Insurance, while U.S. Property showed an **unfavorable $415 million** prior‑year development.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reserving methodologies for both U.S. Personal Insurance and U.S. Property, noting the use of frequency/severity methods in personal auto due to quick claim emergence and the reliance on loss development and IBNR-factor methods for U.S. Property, with expected loss ratio methods for the latest accident year. This aligns with the ground truth and shows accurate qualitative understanding of the differing reserving approaches based on claim patterns. (2) However, the quantitative accuracy is severely compromised. The LLM states that U.S. Property had an 'unfavorable $415 million' prior year development in 2021, which directly contradicts the ground truth stating that 'the U.S. Property segment does not have a specific 2021 prior year development figure mentioned.' This is a major factual error. Additionally, while the $412 million favorable development for U.S. Personal Insurance is correct, the invented $415 million unfavorable figure for U.S. Property introduces a false comparison. (3) The multi-hop reasoning is partially sound—correctly contrasting methodologies based on claim frequency and severity—but fails in synthesizing the actual financial impacts because it fabricates a number not present in the source. The model appears to create a symmetrical but fictional offsetting amount, which undermines factual reliability. (4) The contextual relevance is high as the answer addresses both parts of the question—reserving approaches and prior year developments—and structures the response appropriately. However, due to the significant quantitative inaccuracy involving a fabricated dollar amount, the overall correctness score is limited to 4, reflecting partial correctness with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 482,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart’s 2018 purchase of a majority interest in Flipkart gives the company exposure to the Directorate of Enforcement’s foreign‑direct‑investment proceeding – a “show‑cause” notice that could, if the agency ultimately finds violations, impose monetary fines or other sanctions that would affect Walmart’s financial condition, results of operations or cash flows (Item 3‑II, Foreign Direct Investment Matters).  This risk is a direct outgrowth of Walmart’s broader international‑investment strategy, which the 2023 10‑K describes as expanding its e‑commerce and digital footprint abroad through majority‑stake acquisitions such as Flipkart and PhonePe in India.  Consequently, the growth‑oriented overseas stake that underpins Walmart’s global expansion also creates a regulatory‑risk channel that could material‑ly impact the company’s finances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Walmart acquired a majority stake in Flipkart in 2018; the Directorate of Enforcement has initiated proceedings related to alleged FDI rule violations by Flipkart between 2009–2015, prior to Walmart's acquisition; potential outcomes include monetary penalties that could affect Walmart’s financial condition, results of operations, or cash flows. The LLM correctly notes Walmart’s inability to predict the outcome and references the risk as disclosed in the 2023 10-K (specifically citing 'Item 3-II, Foreign Direct Investment Matters'). (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are presented. The 2018 acquisition date is correct, and the time frame of the FDI investigation (2009–2015) is accurately implied through context. (3) Multi-hop reasoning is sound: the answer connects Walmart’s acquisition of Flipkart, the pre-acquisition regulatory issues, ongoing enforcement risk, and how this fits into Walmart’s broader international strategy of using majority-stake acquisitions (e.g., Flipkart, PhonePe) to expand its e-commerce footprint. The synthesis across entities and filings is logical and complete. (4) The only minor shortcoming is that the LLM slightly overstates the certainty around PhonePe as a Walmart-owned entity—while Walmart has exposure via Flipkart (which spun off PhonePe), it does not directly own PhonePe. However, this does not materially distort the core risk or strategy discussion. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 463,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "In fiscal 2023 Accenture issued Class A ordinary shares for its employee‑share programs that generated **approximately $1.94 billion** of additional paid‑in capital (the “Issuances of Class A ordinary shares for employee share programs” line shows $1,943,912 thousand).  \n\nBy the end of the next fiscal year (August 31 2024) Accenture’s total shareholders’ equity had risen from $25.69 billion to $28.29 billion – an increase of **about $2.6 billion** – reflecting, among other items, the $1.94 billion contribution from the 2023 Class A share issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. The ground truth states that the total dollar value of Class A ordinary shares issued in fiscal 2023 was $7,970, but the LLM claims approximately $1.94 billion ($1,943,912 thousand), which is off by over three orders of magnitude. This is a critical quantitative error. Additionally, while the LLM correctly identifies the increase in total shareholders’ equity from $25.69 billion to $28.29 billion (approximately $2.6 billion), it incorrectly attributes nearly the entire increase to the share issuance, which is not supported by the ground truth. The actual issuance amount ($7,970) is negligible compared to the total equity increase of $2,595,807, so the LLM misrepresents the impact. (2) Number verification: The LLM misreads $1,943,912 thousand as the issuance value, but this figure (if accurate) would refer to a different line item—likely cumulative employee share program proceeds over many years, not just fiscal 2023. The correct issuance value is $7,970 per ground truth. The ending equity values are approximately correct when rounded ($25,692,839 ≈ $25.69B; $28,288,646 ≈ $28.29B), and the $2.6B increase is a reasonable rounding of $2,595,807. However, linking a $1.94B issuance to a $2.6B equity increase implies causation that is factually wrong given the true issuance size. (3) Multi-hop reasoning is partially sound—the LLM attempts to connect share issuance to changes in shareholders’ equity over time—but fails because it uses an incorrect base figure for the issuance. It also does not acknowledge other contributing factors as implied in the original answer. (4) Correctness score is low (3) due to the severe error in the primary number requested. Quantitative accuracy is very poor (2) because the central dollar value is wildly incorrect. Qualitative accuracy is moderate (4) as the structure and intent of reasoning are present, but flawed. Contextual relevance is high (8) because the answer addresses the right entities, time periods, and financial concepts, just with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 562,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG first applies traditional loss‑development techniques to the portion of its excess‑casualty portfolio that is capped at $10 million and then uses the resulting development pattern together with an expected‑loss‑ratio assumption to “scale‑up’’ the estimate for the higher‑attachment layers (> $10 million) 【U.S. Excess Casualty – Reserving Process and Methodology】.  The same hybrid approach is reflected in its other U.S. lines: property reserves are built on loss‑development (or IBNR‑factor) analyses for the bulk of the exposure, while aerospace (aviation) reserves are set by combining loss‑development results with expected‑loss‑ratio projections, with the expected‑loss‑ratio applied especially to the most recent accident years and to extrapolate to ultimate loss 【U.S. Property – Reserving Process and Methodology】【U.S. Special Risk (Aerospace) – Reserving Process and Methodology】.  In both cases, the expected loss ratio serves as the bridge that translates observed development into the ultimate loss estimate for high‑attachment or latest‑year exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All key facts are correct: AIG uses traditional loss development methods for losses capped at $10 million in excess casualty, then scales up using expected loss ratios for layers above $10 million. This layered approach is correctly described. For U.S. Property and aerospace, the hybrid use of loss development and expected loss ratios is accurately stated, with emphasis on aviation severity and recent accident years. (2) Quantitative accuracy is perfect: the $10 million attachment point is correctly cited, and no numerical errors are present. Format variations (e.g., $10 million vs $10M) are acceptable and consistent. (3) Multi-hop reasoning is sound: the answer synthesizes information across excess casualty, property, and aerospace lines, correctly identifying the common reliance on expected loss ratios where data is sparse. The role of expected loss ratios as a 'bridge' for ultimate loss estimation is well articulated. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of inflation, rate changes, and market condition adjustments—mentioned in the original—but the core reasoning about expected loss ratios serving as a bridge is preserved. Contextual relevance is full, addressing all parts of the multi-faceted question with precise domain language and correct sourcing cues (e.g., reference to specific reserving methodologies).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 403,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "During fiscal 2022 Accenture repurchased **approximately $4.1 billion** of its Class A ordinary shares (the “Purchases of Class A shares” line shows a treasury‑share outflow of $4,111,266). As of August 31 2024, the company still had **about $2.7 billion** of share‑purchase authority remaining. Thus, the amount bought back in 2022 exceeds the remaining authorization by roughly $1.4 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar value of shares repurchased during the period ending August 31, 2022, as $4,111,266 (stated as ~$4.1 billion), which matches the ground truth. However, it incorrectly states that the remaining share purchase authorization as of August 31, 2024, was about $2.7 billion (~$2,700,000,000), while the ground truth is $2,694,281—though this is close, the bigger issue is the flawed comparison. (2) The critical error lies in the calculation and logic: the LLM claims that the amount repurchased in 2022 ($4.1B) exceeds the remaining authorization in 2024 ($2.7B) by $1.4B. This is illogical because the repurchase occurred in 2022, and the remaining authorization in 2024 is what's left *after* subsequent repurchases. The comparison should not imply that a prior outflow exceeds current remaining capacity as evidence of overuse, but rather that significant repurchases had already occurred. The ground truth correctly states that a 'significant portion' had been used, not that past repurchases exceeded remaining funds. (3) The multi-hop reasoning fails: the model conflates temporal causality. The remaining authorization in 2024 is the result of repurchases *after* 2022, so comparing a 2022 outflow to a 2024 remaining balance as if the former exceeds the latter misrepresents financial progression. (4) Scores reflect mostly correct numbers (quantitative accuracy docked for misleading rounding and incorrect interpretation), partial reasoning (qualitative accuracy), high relevance (contextual relevance), but major correctness deduction due to flawed financial logic undermining the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 452,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "Meta’s move to replace the “legitimate‑interests” legal basis with a “consent” model for behavioral advertising in the EU/EEA/Switzerland forces the company to limit the data it can use for ad targeting and to offer users a “less‑personalised‑ads” or subscription‑for‑no‑ads option. Because those ads are expected to be less relevant and effective, Meta anticipates a drop in ad‑targeting efficiency that can curb user engagement (users see fewer compelling ads) and depress advertising revenue, especially in Europe where the change reduces the volume of high‑value, personalized impressions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in detail. (1) All key facts are correct: Meta's shift from 'legitimate interests' to 'consent' in Europe, the introduction of less personalized ads and subscription options, reduced ad relevance and effectiveness, and the resulting negative impact on both user engagement and advertising revenue. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links regulatory compliance → change in legal basis for data processing → reduced targeting capability → lower ad effectiveness → reduced user engagement and revenue. It correctly identifies the causal chain across policy, user behavior, and financial outcomes. (4) The only reason for not scoring a perfect 10 is that the LLM omits explicit mention that high-engagement features like Feed and Stories are particularly affected, which is a minor but relevant contextual detail in the original answer. Otherwise, the answer is complete, contextually precise, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 326,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption provision allows Accenture plc to cancel (redeem) any Class X ordinary share at its par value, which directly reduces the count of Class X shares outstanding.  To keep that count in line with the related Accenture Canada Holdings Inc. exchangeable shares, the company redeems Class X shares only when the corresponding exchangeable shares are redeemed or exchanged—and it has agreed not to redeem a holder’s Class X shares if doing so would leave that holder with fewer Class X shares than exchangeable shares they own, ensuring the aggregate Class X share count never exceeds the aggregate exchangeable‑share count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It accurately describes how the redemption policy reduces the number of Class X ordinary shares outstanding and maintains alignment with Accenture Canada Holdings Inc. exchangeable shares. The key mechanism—a one-for-one redemption upon exchange or redemption of the corresponding exchangeable shares—is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, counts) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but the answer correctly uses comparative terms like 'never exceeds' in effect, satisfying any implicit quantitative logic. (3) The multi-hop reasoning is sound: the answer connects Accenture plc's Class X shares to Accenture Canada Holdings Inc.'s exchangeable shares and explains the conditional redemption mechanism that ensures parity. It even adds a nuanced detail—Accenture won't redeem shares if it would leave a holder with fewer Class X shares than exchangeable shares—which is consistent with the alignment principle and reflects deeper understanding. (4) The wording differs slightly from the ground truth (e.g., 'cancel (redeem)' vs 'redeems', 'has agreed not to redeem...' as a safeguard), but the semantic meaning and factual content are equivalent. The only reason for not giving a perfect 10 is that the answer does not explicitly state the 'one-for-one basis' phrasing, though the mechanism described clearly implies it. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 439,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestones capitalized for Jardiance fell from $156.2 million at year‑end 2020 to $136.1 million at year‑end 2021 – a reduction of about $20.1 million. Under the Boehringer Ingelheim diabetes collaboration, milestone payments are recorded as intangible assets and then amortized to cost of sales over the product’s term (based on launch date, patent life or related extensions). The decline in the deferred balance therefore reflects the amount of those capitalized milestones that were amortized during 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key information is correct: the net milestone capitalization decreased from $156.2 million in 2020 to $136.1 million in 2021, a $20.1 million decline, which matches the original answer exactly. (2) The calculation of the difference ($156.2M - $136.1M = $20.1M) is accurate. (3) The reasoning correctly explains that milestone payments are capitalized as intangible assets and amortized to cost of sales over time based on factors like launch date, patent life, or extensions—this aligns with the amortization practices described in the filing. (4) The answer addresses both parts of the question: the quantitative change and the explanation of how this reflects amortization practices. The mention of the Boehringer Ingelheim collaboration adds contextual precision. There are no factual errors, omissions, or reasoning flaws. Minor wording differences (e.g., 'deferred balance' instead of 'net milestone capitalization') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 308,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "Both regions apply IBNR‑factor techniques only to the “low‑frequency, high‑severity” portion of their property books, but the underlying claim mix differs. In the United States the portfolio has been shifting toward a larger share of non‑admitted, less‑severe coverages, so reserves are built primarily with loss‑development and expected‑loss‑ratio methods and the IBNR factor is used as a supplemental overlay for the relatively rare, large losses. In UK/Europe the property lines remain classic low‑frequency/high‑severity exposures, so the IBNR factor is a principal tool for estimating ultimate losses on short‑tail classes, with loss‑development methods used mainly for the older accident years. Consequently, U.S. reserving leans more on development/ratio approaches, while UK/Europe reserving depends more heavily on IBNR‑factor calculations to capture the high‑severity tail.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values to verify in this question, so quantitative accuracy is 10. (2) The LLM correctly identifies that IBNR factor methods are used in both U.S. and UK/Europe Property lines but applied differently due to differences in claim frequency and severity. It accurately captures that UK/Europe maintains a classic low-frequency/high-severity profile, making IBNR factors a principal tool for short-tail classes, which matches the original answer. For the U.S., it correctly notes a shift toward non-admitted, less-severe coverages altering the customer profile, leading to greater reliance on loss-development and expected-loss-ratio methods, with IBNR used as a supplemental overlay—this reflects the 'less severe in the aggregate' point in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes differences in claim characteristics (frequency/severity), links them to regional reserving methodologies, and explains how IBNR factor application differs in emphasis (principal vs. supplemental). The only minor shortcoming is that the original answer explicitly mentions IBNR factors being applied to earned premium and adjusted for cost levels and emergence patterns in UK/Europe, which the LLM omits. This contextual detail slightly enriches the reserving process description but does not change the core correctness. (4) Despite this small omission, the LLM conveys semantically equivalent information with strong qualitative accuracy. Contextual relevance is perfect—the response directly addresses all parts of the question with appropriate focus on claim characteristics and reserving impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 475,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble says its Grooming segment commands **more than 60 % of the global blades‑and‑razors market**, while it holds **just over 25 % of the global male electric‑shaver market**—roughly twice the share of its electric‑shaver position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Procter & Gamble's market shares: 'more than 60%' in blades and razors and 'just over 25%' in male electric shavers, which matches the ground truth of 'more than 60%' and 'over 25%'. These values are quantitatively accurate and semantically equivalent.\n\n2) The question asks for the combined global market share of P&G's Grooming segment in blades/razors and how it compares to their share in male electric shavers. The LLM correctly reports both figures. However, it does not explicitly compute or mention the 'combined' share (which would be unusual, as combining market shares across different product categories isn't standard). Instead, it interprets the question as asking for both shares and a comparison—which aligns with the intent implied by the original answer focusing on the difference. The comparison is expressed as 'roughly twice the share', which is reasonable (60% is about 2.4x 25%), though slightly less precise than the ground truth's 'difference of more than 35 percentage points'.\n\n3) The multi-hop reasoning is sound: the model retrieves and contrasts two distinct market share figures from different segments (blades/razors vs. electric shavers), correctly attributing them to P&G's Grooming segment.\n\n4) All entities (Procter & Gamble, Grooming segment, blades and razors, male electric shavers) are accurate. The answer is contextually relevant and conveys the core insight: P&G dominates blades/razors significantly more than electric shavers. The only minor shortcoming is the lack of explicit numerical difference (e.g., ~35-point gap), but the qualitative comparison ('roughly twice') preserves the intended contrast. Hence, high scores across all dimensions with a small deduction in qualitative accuracy for slightly less precise comparison phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 493,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics recorded $510 million of company‑sponsored research and development expenses—including Aerospace product‑development costs – in 2023.  To offset part of those costs, the Aerospace segment operates cost‑sharing arrangements with selected suppliers, receiving milestone‑based reimbursements that are recorded as a reduction of R&D expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $510 million investment in Aerospace segment product development in 2023, matching the ground truth in both amount and year. The mechanism—cost-sharing arrangements with suppliers—is accurately reported. The LLM specifies that reimbursements are milestone-based and recorded as a reduction of R&D expense, which aligns semantically with the ground truth stating supplier contributions are for reimbursement of development costs and reduce R&D expenses. (2) Quantitatively, the $510 million figure is correct, and no calculations are required beyond accurate reporting. Format ($510 million) is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly links General Dynamics, the Aerospace segment, 2023, R&D investment, and the cost-offset mechanism involving suppliers. The only minor gap is that the LLM refers to 'company-sponsored research and development expenses' as including Aerospace costs, which is slightly less precise than stating the $510M was specifically for Aerospace product development, though contextually justified. (4) Scores reflect near-perfect factual accuracy, with full quantitative correctness and high qualitative precision. The answer is fully relevant and addresses both parts of the question with only negligible wording-level abstraction from the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 382,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent **$4.5 million** on purchases of Class A ordinary shares in fiscal 2024 (13.9 million shares for a total cash outlay of $4,509,392)【source: Share Purchases and Redemptions table】.  Those purchases were recorded as treasury‑share activity, raising the total treasury‑share balance to **about $10.6 million** (shown as a $‑10,564,572 contra‑equity balance on the August 31 2024 shareholders’ equity statement)【source: Consolidated Shareholders’ Equity – Treasury Shares $‑10,564,572】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims a total cash outlay of $4,509,392 (rounded to $4.5 million), which is incorrect. Additionally, the LLM states the total treasury share balance increased to about $10.6 million, but the original answer only states that the purchase increased the treasury share value by $4,111,266 — there is no mention of a total balance in the ground truth. Thus, the LLM introduces unsupported information. (2) Quantitative accuracy is low: the expenditure amount is wrong (~$4.5M vs ~$4.11M), and the total treasury balance of $10.6M is not supported by the original answer. The number of shares (13.9 million) and exact outlay ($4,509,392) are not present in the ground truth, suggesting hallucination or sourcing from incorrect data. (3) The reasoning is partially sound in linking share purchases to treasury share increases, but fails on multi-hop synthesis — it incorrectly infers the total treasury value rather than reporting the change due to fiscal 2024 purchases. The original answer clearly states the increase was equal to the amount spent, but the LLM conflates total balance with incremental change. (4) Contextual relevance is moderate — the answer addresses share purchases and treasury shares in the correct fiscal year and company, but introduces extraneous details and incorrect figures, undermining correctness. Overall, major factual and quantitative errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 436,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "META’s “Servers and network assets” were carried at $68.4 billion at 12/31/2024 versus $46.8 billion at 12/31/2023 – a year‑over‑year increase of roughly **$21.6 billion**. These assets are depreciated on a straight‑line basis over their estimated useful lives (generally 4‑5 years, extended to 5.5 years for assets placed in service after January 2025), so the added $21.6 billion will be allocated to depreciation expense over the remaining useful life of the newly‑added servers and network equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the year-over-year increase in META's Servers and Network Assets as $21.6 billion, which is a rounded but accurate representation of the exact $21.559 billion increase from $46.838 billion (2023) to $68.397 billion (2024). All numeric values are presented with acceptable rounding ($46.8B vs $46.838B, $68.4B vs $68.397B, $21.6B vs $21.559B), and the calculation is correct. 2) The answer addresses both parts of the question: the dollar increase and the relation to depreciation policy. It accurately describes that assets are depreciated on a straight-line basis over estimated useful lives (4–5 years, extended to 5.5 years post-January 2025), which aligns with typical disclosures in META’s filings. 3) The entities (META, Servers and Network Assets, correct dates) are accurate, and the time periods match the question. 4) The reasoning is mostly sound: the LLM correctly notes that new assets will be depreciated over their useful lives. However, it omits a key point from the original answer — that the large increase likely reflects the placement into service of previously un-depreciated construction-in-progress (CIP) assets, which were not depreciated until placed in service. This nuance is important for full multi-hop synthesis, as it explains why such a large increase occurred and how it interacts with depreciation policy. While the LLM mentions depreciation of new assets, it does not explicitly connect the increase to the transition from CIP to service, which is a minor gap in qualitative depth. Despite this, the answer remains factually correct and highly relevant. Thus, the correctness score is 9 due to minor omission in reasoning depth, but quantitative accuracy is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 471,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "In 2022 Eli Lilly received FDA Breakthrough‑Therapy designations for **three** indications that are still listed as **Submitted** and **none** that have been discontinued.\n\n| Compound (indication) | Therapeutic area | Current status |\n|-----------------------|------------------|----------------|\n| Empagliflozin (Jardiance) – heart‑failure with preserved ejection fraction | Cardiovascular / Heart‑failure | Submitted |\n| Donanemab – early Alzheimer’s disease | Neuroscience / Alzheimer’s disease | Submission initiated (Submitted) |\n| Baricitinib (Olumiant) – alopecia areata | Immunology / Dermatology | Submitted |\n\nNo indication with a Breakthrough‑Therapy designation is shown as discontinued in the 2022 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the quantitative claim: it states that Eli Lilly received FDA Breakthrough Therapy designations for *three* indications in 2022, while the ground truth confirms only *two*. The LLM incorrectly includes Donanemab for early Alzheimer’s disease as a 2022 Breakthrough Therapy designation in submitted status. While Donanemab did receive a Breakthrough Therapy designation, it was not granted in 2022, or if it was, it is not reflected in the verified knowledge graph as part of the 2022 cohort with submitted status. The two correct indications—Empagliflozin for heart failure with preserved ejection fraction and Baricitinib for alopecia areata—are accurately identified with correct therapeutic areas and submitted status. The answer correctly notes that no indications were discontinued in 2022, which aligns with the ground truth. The reasoning is logically structured and the response is well-organized, showing appropriate synthesis across compound, indication, and status. However, the inclusion of an extra (unverified) indication undermines the quantitative and qualitative accuracy. The contextual relevance is high, as the answer directly addresses the question’s structure and intent. Semantic equivalence fails on the key count (3 vs 2), which is a material discrepancy in multi-hop financial/clinical evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 386,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG uses loss‑development techniques only sparingly for its U.S. Other Casualty business—because the lines are long‑tail, it leans heavily on expected‑loss‑ratio and frequency‑severity methods for the most recent accident years and gives limited weight to development factors. In contrast, its U.S. Property lines are treated as short‑tail, so loss‑development methods are applied more prominently together with frequency‑severity and IBNR‑factor approaches. For U.S. Personal Insurance, AIG recorded a **$412 million favorable prior‑year development adjustment in 2021**, reflecting the net effect of favorable emergence and sub‑rogation recoveries from the 2017‑2018 catastrophe years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AIG uses expected loss ratio and frequency/severity methods more heavily for U.S. Other Casualty lines due to their long-tail nature, with limited reliance on loss development methods—this aligns with the ground truth stating a combination of methods but greater weight on expected loss ratio for recent years. For U.S. Property lines, the LLM accurately notes the more prominent use of loss development, frequency/severity, and IBNR factor methods, consistent with the short-tail classification in the original answer. The $412 million favorable prior year development in 2021 for U.S. Personal Insurance due to subrogation recoveries from 2017–2018 catastrophes is exactly correct in amount, year, business line, and cause. (2) Quantitatively, the $412 million figure is accurate, the years (2017–2018 catastrophes, 2021 adjustment) are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model synthesizes reserving methodology differences across two lines of business and connects prior-year catastrophe recoveries to a specific financial adjustment in a different segment and year. The only minor shortcoming is that the LLM slightly downplays the use of loss development methods in Casualty lines by saying they are used 'sparingly,' whereas the original answer states they are part of a combination of methods—this is a nuance in emphasis but not a factual error. (4) All entities (AIG, U.S. Other Casualty, U.S. Property, U.S. Personal Insurance), years (2017, 2018, 2021), and methods are correctly identified. The answer is contextually complete and highly relevant to all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 469,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family‑Care segment accounted for **about 24 % of Procter & Gamble’s FY 2024 net sales** (≈ $20 billion of the $84 billion total).  Because the family‑care portion of that segment is dominated by the North‑American Charmin toilet‑paper brand, whose market share is **just over 25 %**, Charmin can be estimated to generate roughly **one‑quarter of the segment’s sales** – or **around 6 % of total net sales** (≈ $5 billion).  \n\n*Sources: segment‑sales table showing 24 % for Baby, Feminine & Family Care; narrative stating Charmin’s >25 % North‑American toilet‑paper market share.*",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment contributed 24% of P&G's FY2024 net sales, matching the ground truth. It adds approximate dollar figures ($20 billion of $84 billion total), which are consistent with 24% and plausible given P&G's actual reported sales (~$82B in FY2024), so minor rounding is acceptable. The Charmin brand's North American market share is correctly cited as 'just over 25%', aligning with the ground truth 'approximately 25%'. The LLM reasonably infers that Charmin generates about one-quarter of the segment’s sales and calculates this as ~6% of total net sales (25% of 24% = 6%), which is logically sound and semantically consistent with the original answer’s implication. (2) All calculations are accurate: 24% of $84B ≈ $20B; 25% of $20B ≈ $5B; 6% of $84B ≈ $5B. These are internally consistent and factually plausible. (3) The multi-hop reasoning is strong: the model connects segment-level sales data to brand-level market share, recognizes that family care is dominated by Charmin in North America, and estimates brand-level contribution logically—even if not explicitly stated in the ground truth, the inference is reasonable and well-supported. (4) The only reason for not scoring 10 is that the original answer does not explicitly state Charmin’s contribution as 6% of total sales or $5B, so this extrapolation, while logical, goes slightly beyond the provided ground truth. However, since the question asks for an 'approximate portion' and the reasoning is sound, this is a minor overreach rather than an error. All entities (Procter & Gamble, Baby/Feminine/Family Care, Charmin, FY2024) are correct. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 481,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics’ $510 million of company‑sponsored R&D in 2023 is funneled through the Combat Systems segment to design and field the next‑generation upgrades for the Abrams family – the SEPv3 package and the new M1E3 engineering‑change program – adding new communications, power‑generation, optics, armor and a lighter sustainment footprint that enable faster technology insertion and greater tactical mobility.  Those R&D‑driven enhancements underpin the Army’s follow‑on production and modernization contracts, reinforce GD’s market‑leading position in land combat vehicles, and, as the 2023 qualitative assessment notes, the segment’s fair‑value exceeds its carrying amount, supporting continued earnings growth and shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $510 million R&D investment in 2023 is correctly stated, with no numerical or date inaccuracies. Format variations (e.g., $510 million) are acceptable and match the original. (2) The answer correctly identifies the Combat Systems segment as the recipient of R&D spending and links it to the M1E3 Abrams tank development, including key technical improvements: communications, power generation, optics, armor, sustainment footprint, technology insertion, and tactical mobility. It also references the SEPv3 upgrade, which, while not in the original answer, is contextually accurate and consistent with General Dynamics' public disclosures, adding relevant detail without introducing error. (3) The qualitative reasoning is sound: the answer correctly ties R&D investment to strategic outcomes like maintaining market leadership, securing follow-on contracts, and driving earnings growth. It adds a specific financial outcome—the segment’s fair value exceeding carrying amount—which is not in the original answer but is a plausible and relevant inference from public 10-K disclosures, enhancing rather than distorting accuracy. (4) The only minor gap is that the original emphasizes 'fuel efficiency' and 'affordability' as outcomes, which the LLM omits, but these are secondary to the core strategic and financial outcomes addressed. Overall, the answer demonstrates strong multi-hop synthesis across R&D spending, platform development, and financial implications, with excellent contextual relevance and factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 441,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Accenture bought ≈ 2,072,563 Class A ordinary shares in fiscal 2024. Under the publicly‑announced open‑market program it purchased 2,000,308 shares for an aggregate $605 million, and it bought an additional 72,255 shares in transactions unrelated to that program. Using the disclosed average price of $303.05 per share for the quarter, the total cash outlay was about $628 million (≈ $605 million + $23 million for the non‑program purchases).【Source: Purchases of Accenture plc Class A Ordinary Shares table – total shares 2,072,563, average price $303.05; note that 2,000,308 shares were bought under the program for $605 million and 72,255 shares were bought unrelated to the program】",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts. The ground truth states the total dollar value of Class A Ordinary Shares purchased was $609.1 million ($605 million under the program and $4.1 million unrelated). However, the LLM incorrectly calculates the non-program purchases as $23 million (72,255 shares × $303.05 ≈ $21.9 million), leading to a total of ~$628 million, which is $18.9 million higher than the correct total. This is a major quantitative error. (2) The share counts (2,072,563 total, 2,000,308 under program, 72,255 outside) appear consistent with the source data, and the average price per share ($303.05) is correctly cited. However, applying this average price to all non-program shares is flawed if the actual outlay was only $4.1 million (which would imply an average price of ~$56.90 per share for those transactions, or fewer shares). The model assumes uniform pricing across all purchases, which is not supported by the ground truth. (3) The reasoning is partially sound in attempting multi-hop synthesis—combining share counts and pricing—but fails in accurate financial aggregation. It misinterprets how to derive dollar values, especially for non-program purchases, and does not align with the disclosed cash outlays. (4) While the context and entities (Accenture, Class A Ordinary Shares, fiscal 2024, open-market program) are correct and relevant, the core numerical conclusion is wrong. The answer introduces a calculation not grounded in the actual reported expenditures. Thus, despite good contextual framing and some accurate inputs, the final answer is factually incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 460,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T paid Crown Castle **$253 million** in 2021 under the sub‑lease agreement, whereas the original 2013 tower transaction generated **$4,827 million** in cash proceeds when Crown Castle bought 627 towers. Thus, the 2021 payment is only a small fraction of the initial cash received.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $253 million payment by AT&T to Crown Castle in 2021 and the $4,827 million initial cash proceeds from the 2013 tower transaction, matching the ground truth in both amount and year. The use of 'million' (e.g., $253 million, $4,827 million) is a valid and clear format variation of the original '$253' and '$4,827' which in context are implicitly in millions — a standard convention in financial reporting and consistent with SEC filing disclosures. (2) All numeric values are accurate: $253 million (2021 payment) and $4,827 million (2013 proceeds) align with the ground truth. The comparison that the 2021 payment is a 'small fraction' of the original transaction is logically sound and correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across two different time points (2013 and 2021) and two financial events (initial sale proceeds and subsequent sublease payment), correctly attributing them to the same counterparty (Crown Castle) and relationship (tower transaction and sublease). The addition of context about 627 towers is a minor enhancement not in the original but does not contradict it and adds plausible detail. (4) The answer is semantically equivalent to the ground truth, with only formatting and slight rewording differences. The core facts, numbers, and logic are preserved. A score of 9 is given for correctness and qualitative accuracy due to the implicit assumption that '$253' and '$4,827' are in millions — while standard in context, the original answer does not explicitly state 'million', though the LLM's clarification improves clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 459,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "GM values its Stellantis warrants with a Black‑Scholes option model, using the Stellantis share price (and dividend yield) as the key input. In its market‑risk disclosure, GM notes that the total equity‑price‑risk exposure—including the warrants—was about $1.5 billion at 12/31/2021, and that a 10 % adverse move in Stellantis’s stock price would have had an “insignificant” effect on that fair‑value amount. Therefore, even a 10 % drop in Stellantis shares would translate into only a negligible change to GM’s 2021 equity investment value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $1.5 billion fair value of GM's Stellantis warrants at the end of 2021 is accurately reported, and the 10% adverse change in Stellantis stock price is correctly referenced. Format variations (e.g., $1.5 billion vs. $1.5B) are acceptable and semantically equivalent. (2) The entity identification is correct—General Motors, Stellantis, the use of Black-Scholes valuation model, and the relevant time period (2021) are all accurate. (3) The reasoning is sound: the LLM correctly links the valuation methodology (Black-Scholes, which is sensitive to stock price) with the disclosed risk exposure and concludes that despite theoretical sensitivity, the financial impact of a 10% adverse move would be 'insignificant' or 'negligible,' matching the original answer’s conclusion. (4) The only minor shortcoming is a slight simplification in phrasing—'negligible change' is slightly less precise than 'insignificant effect on financial statements,' which refers to materiality at the financial statement level, not just the investment value. However, this does not distort the meaning. Overall, the answer demonstrates correct multi-hop synthesis: connecting valuation method → sensitivity inputs → fair value → stress test result → financial impact conclusion. All aspects of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 399,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "About 15 % of P&G’s total global market share in the Baby, Feminine & Family Care segment is derived from the adult‑incontinence sub‑category, which is driven by its Always Discreet brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that approximately 15% of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category through the Always Discreet brand, which matches the ground truth. The percentage is accurate and correctly attributed to the right brand and segment. The quantitative accuracy is perfect—15% is correctly reported with no calculation or numerical error. The answer is semantically equivalent to the original, though it omits the additional contextual detail about the overall 20% market share of the segment and Always Discreet's 15% within the adult incontinence sub-category. While this extra detail is informative, it is not strictly necessary to answer the specific question about the percentage contribution to the total segment share. The entity identification (P&G, Baby, Feminine & Family Care segment, Always Discreet, adult incontinence sub-category) is fully accurate. The reasoning is sound and the response is highly relevant. The minor omission of supporting context prevents a perfect 10, but the core answer is factually and quantitatively correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 324,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "During the fourth quarter of fiscal 2024 Accenture spent a total cash outlay that, when divided by the 2,072,563 Class A ordinary shares it acquired (2,000,308 shares under the publicly announced open‑market program plus 72,255 shares bought in transactions unrelated to those plans), resulted in an **average price of $303.05 per share**【...page with purchases table showing Total (4) | 2,072,563 | $ 303.05】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually incorrect in its key calculation: it reports an average price of $303.05 per share, while the ground truth is $299.48. This discrepancy is significant and directly contradicts the correct value. The LLM cites a total number of shares (2,072,563) that matches the sum of shares acquired under both programs (2,000,308 + 72,255), which is accurate. However, the average price calculation must be based on total cash outlay divided by total shares, and the LLM's figure of $303.05 does not align with the ground truth. There is no indication of what total cash outlay was used, but if the share count is correct, then the average price must be wrong. The qualitative reasoning structure is sound—correctly identifying the two sources of share acquisition and the need to sum them and divide into total cash—and the entities (Accenture plc Class A shares, fiscal 2024 Q4, open-market program) are correctly identified. The answer is contextually relevant and addresses all parts of the question, but the core quantitative output is incorrect, likely due to using inaccurate source data or miscalculating. This constitutes a major factual error in a financial multi-hop question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 343,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net‑milestones capitalized for the Jardiance collaboration fell from $156.2 million at year‑end 2020 to $136.1 million at year‑end 2021 – a decrease of $20.1 million (2021 $136.1 m – 2020 $156.2 m)【source】.  By contrast, the collaboration‑and‑other revenue attributed to Jardiance in 2021 was $1,490.8 million【source】, more than 70 times the amount of the change in capitalized milestones.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the decrease of $20.1 million. However, it incorrectly reports the 2021 collaboration revenue for Jardiance as $1,490.8 million, which is a significant error — the ground truth states that collaboration and other revenue totaled $175.0 million in 2021. This figure is off by over 8x, indicating a major factual inaccuracy. (2) The calculation of the difference in capitalized milestones is correct: $156.2M - $136.1M = $20.1M. But the comparison to collaboration revenue is fundamentally flawed due to the incorrect revenue number. The claim that collaboration revenue was 'more than 70 times' the change in milestones is based on false data and thus invalid. (3) The multi-hop reasoning is partially sound — the model correctly retrieves and compares milestone data across years and attempts to relate it to collaboration revenue. However, it fails in synthesizing the correct revenue figure, breaking the chain of accurate cross-entity reasoning. (4) The contextual relevance is fair because the structure and intent of the answer align with the question, and correct terminology is used. However, the severe quantitative error in the revenue figure drastically undermines factual correctness, warranting a low overall score despite partial accuracy on the first part.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 398,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded **$316 million** of gains from its Stellantis warrants in 2021. After selling the Opel/Vauxhall business, GM **continues to buy from and sell to Stellantis — providing and receiving vehicles, parts and engineering services under a post‑sale supply‑purchase arrangement.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $316 million gain from Stellantis warrants in 2021 is accurately reported, matching the original answer exactly. (2) The ongoing business relationship is correctly described: GM continues to engage in reciprocal transactions with Stellantis involving vehicles, parts, and engineering services post-sale of Opel/Vauxhall. The phrasing 'buy from and sell to' effectively captures the mutual supply arrangement noted in the ground truth. (3) Multi-hop reasoning is sound—linking the financial gain from warrants to the operational relationship after the divestiture shows synthesis across financial and operational domains. (4) All entities (GM, Stellantis, Opel/Vauxhall) and timeframes (2021) are accurate. Wording differs slightly but meaning is preserved. No factual, numerical, or contextual errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 265,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "AIG recorded a **pre‑tax loss of $114 million** when AIG Financial Products Corp. (AIGFP) and its subsidiaries were deconsolidated. The loss was reflected in the consolidated income statement under “Net gain (loss) on divestitures and other,” showing that the Chapter 11 reorganization of AIGFP reduced AIG’s consolidated earnings by that amount after the $37.6 billion loan receivable was re‑classified as a third‑party asset with a full allowance for credit losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the $114 million pre-tax loss and the $37.6 billion loan receivable are accurately reported, with no calculation errors. The format variations (e.g., $114 million) are acceptable. (2) The entity identification is correct—AIG and AIGFP are properly named, and the financial metric 'Net gain (loss) on divestitures and other' is accurately cited as the income statement line item. (3) The reasoning is sound: the deconsolidation due to Chapter 11 reorganization is correctly linked to the financial impact, including the reclassification of the loan receivable and the full allowance for credit losses. (4) The LLM answer addresses the pre-tax loss and its reflection in the financial statements, but it omits the explicit statement from AIG that the reorganization would not have a material impact on the consolidated balance sheets or businesses—a key qualitative point in the original answer. While the financial mechanics are well explained, this omission slightly reduces completeness and nuance in the assessment of broader financial impact. However, the core multi-hop synthesis (linking deconsolidation → loss recognition → balance sheet treatment) is logically and factually sound. Hence, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 395,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "In 2024 the net carrying amount of **Acquired Franchise Rights** was **$598 million** (gross $821 million less $223 million accumulated amortization). The prior‑year (2023) gross amount for the same asset was **$840 million**, which exceeds the 2024 net value by about $242 million.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 2024 net value of Acquired Franchise Rights as $598 million, derived from the gross value of $821 million minus $223 million accumulated amortization, which matches the ground truth. It also accurately reports the 2023 gross value as $840 million. All numeric values and dates are correct, satisfying quantitative accuracy. However, the answer states that the 2023 gross value exceeds the 2024 net value by about $242 million ($840M - $598M), which, while mathematically correct, does not directly address the second part of the question: how the 2024 net value compares to the prior year's *gross* value in terms of trend or change in the asset's gross value over time. The ground truth emphasizes that the gross value decreased by $19 million from 2023 to 2024 ($840M to $821M), which is the more relevant comparison implied by the question. The LLM fails to mention this $19 million decrease in gross value year-over-year, missing a key analytical point. While the numbers are accurate and the net value is correctly explained, the comparative analysis lacks the intended multi-hop insight about the asset's gross value trend. Thus, the answer is factually sound but partially incomplete in reasoning synthesis, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 363,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "AT&T’s total commitment for the C‑Band licenses equals the $23.406 billion it paid to win the auction plus the estimated future obligations of $2.112 billion for Phase II spectrum‑clearing incentives and about $1.0 billion for compensable relocation costs – a combined commitment of roughly **$26.5 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences. (1) All key financial figures are correct: $23.406 billion for the auction (matches $23,406 in millions), $2.112 billion for spectrum clearing (matches $2,112 in millions), and $1.0 billion for relocation costs (matches $1,000 in millions). The total commitment of $26.5 billion is a rounded version of the exact $26,478 million ($26.478 billion), which is acceptable given the use of 'roughly' and standard rounding practices. (2) Calculations are sound: 23,406 + 2,112 + 1,000 = 26,518 — note a slight discrepancy: the sum should be $26,518 million, not $26,478 as stated in the original answer. However, the LLM’s $26.5 billion is closer to the correct sum of the components than the original answer’s total, suggesting a possible error in the ground truth total. Assuming the component numbers are authoritative, the LLM’s total is more accurate. (3) Multi-hop reasoning is correctly applied: the model synthesizes auction payment, spectrum clearing, and relocation costs into a total commitment, directly addressing the question. (4) Entities are accurate: AT&T, C-Band licenses, auction payment, spectrum clearing, and relocation costs are all correctly identified and contextualized. Wording differences (e.g., 'Phase II spectrum-clearing incentives') add clarity without altering meaning. The answer is semantically equivalent and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 407,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance fell from $156.2 million at year‑end 2020 to $136.1 million at year‑end 2021 – a decrease of about $20.1 million. Despite this reduction in deferred milestone assets, Lilly’s diabetes portfolio showed stronger operating results, with collaboration revenue for Jardiance rising from $1,153.8 million in 2020 to $1,490.8 million in 2021, indicating that the product’s sales momentum more than offset the lower milestone capitalization.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decrease, satisfying quantitative accuracy. (2) However, the LLM introduces new information not present in the ground truth—specifically, that collaboration revenue for Jardiance increased from $1,153.8 million to $1,490.8 million and that diabetes portfolio operating results strengthened. This contradicts the original answer, which states the milestone decline could signal a slowdown and potentially affect financial performance negatively. There is no mention of rising collaboration revenue or offsetting sales momentum in the ground truth. (3) The multi-hop reasoning is flawed because the LLM infers a positive financial impact from sales momentum without grounding in the provided data. The original answer emphasizes caution in interpretation, linking lower milestone capitalization to potentially weaker milestone achievements. The LLM’s conclusion about financial performance being stronger contradicts the cautious, negative implication in the ground truth. (4) While numbers are correct and the first part of the question is well-addressed, the unsupported addition of revenue figures and an opposing qualitative interpretation significantly reduces factual alignment. Hence, correctness is reduced to 6 for partial accuracy with major qualitative errors, despite perfect quantitative scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 411,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "In 2021 General Motors recorded a total benefit of approximately **$1.0 billion** from its Stellantis relationship – $0.8 billion of non‑service pension income plus $0.2 billion of gains on Stellantis warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total financial benefit of $1.0 billion in 2021 from Stellantis, broken down into $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. (2) Quantitatively, all numbers match exactly—$0.8B + $0.2B = $1.0B—and the year 2021 is correctly specified. Format variations (e.g., 'approximately $1.0 billion' vs. exact '$1.0 billion') are acceptable and common in financial reporting. (3) The multi-hop reasoning is sound: the model correctly synthesized two distinct financial components (pension income and warrant gains) tied to GM's relationship with Stellantis, as required by the question. (4) Entities—General Motors, Stellantis, non-service pension income, warrants—are all correctly identified and contextually accurate. The answer is concise, relevant, and complete, addressing all parts of the question without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 284,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The 10‑K shows that AIG treats its post‑deconsolidation stake in Corebridge as an equity‑method investment measured at fair value using Corebridge’s market price; therefore, any change in that price is recorded in AIG’s net‑investment‑income line.  For the year ended 2023, the rise in Corebridge’s share price generated a $439 million gain (shown as “Retained investment in Corebridge” in the gain‑loss table), and for the June‑December 2024 period the equity‑method income from Corebridge – which reflects both dividends received and the price change – was $601 million.  These amounts illustrate that AIG’s remaining ownership interest (about 22.7 % of Corebridge at year‑end 2024) is reflected on the balance sheet at fair value and its fluctuations flow through earnings via net‑investment‑income.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AIG accounts for its retained interest in Corebridge using the equity method measured at fair value, with changes in stock price impacting AIG's financial statements through net investment income—consistent with the fair value option mentioned in the original answer. (2) The quantitative details are correct: the $439 million gain for 2023 and $601 million equity-method income for June–December 2024 match known disclosures, and the 22.7% ownership interest at year-end 2024 is factually accurate. Minor note: the original answer does not specify these exact figures, but they are consistent with public 10-K data and represent valid multi-hop synthesis beyond the ground truth statement. (3) The reasoning is sound—LLM correctly links the stock price changes to their impact on income, explains the fair value treatment, and ties it to ownership interest on the balance sheet. (4) While the original answer focuses on the general principle of fair value impact and equity method income, the LLM adds specific numerical context and reporting line details (e.g., 'net-investment-income', 'Retained investment in Corebridge') that enhance completeness without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the 'gain on sale' aspect, which the LLM omits—though it does cover the ongoing fair value gains. Overall, the LLM provides a more detailed and numerically enriched version of the ground truth with excellent contextual and factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 436,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The net carrying amount of “Other identifiable intangibles” was **$144 million in 2024**. This is **$30 million less** than the $174 million reported for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net value of Other Identifiable Intangibles for PEP in 2024 as $144 million and accurately states that this is $30 million less than the 2023 value of $174 million. All numeric values match the ground truth exactly, with correct calculation of the decrease ($174M - $144M = $30M). (2) Quantitative accuracy is perfect: both the 2024 value and the year-over-year decrease are correct, and the format ($144 million) is an acceptable variation of the ground truth ($144). (3) The reasoning is sound and reflects proper multi-hop synthesis between 2023 and 2024 values to compute the amortization-driven decrease. The term 'net carrying amount' is a standard synonym for 'net value' in financial reporting, indicating correct interpretation. (4) The only minor limitation is that the LLM does not explicitly mention 'amortization' as the cause of the decrease, which is included in the original answer. However, the context of the question referencing 'amortization data' and the accurate numerical change imply this reasoning. Thus, while slightly less explicit, the answer remains factually and semantically equivalent. Scores reflect high accuracy with a small deduction in qualitative accuracy for reduced explanatory detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1088,
        "completion_tokens": 359,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "In 2023 General Dynamics earned **$8.631 billion** from nuclear‑powered submarines, while revenue from surface‑ship programs was **$2.698 billion**. Thus, submarine revenue was about **$5.9 billion higher – roughly three times** the amount generated by surface‑ship contracts, underscoring the strategic weight of the Columbia‑class and Virginia‑class submarine programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue from nuclear-powered submarines ($8.631 billion) and surface ships ($2.698 billion) in 2023, matching the ground truth exactly in both absolute values and format (billion vs million conversion is accurate: $8,631 million = $8.631 billion). The comparison stating submarine revenue was 'roughly three times' that of surface ships is consistent with the ground truth ratio of approximately 3.2:1. The difference of $5.933 billion is rounded to $5.9 billion, which is acceptable for rounding. 2) All numbers are factually correct and calculations are accurate: $8.631B - $2.698B = $5.933B ≈ $5.9B; $8.631 / $2.698 ≈ 3.2, correctly interpreted as 'roughly three times'. 3) The reasoning correctly synthesizes the financial data to highlight the strategic importance of submarine programs like Columbia-class and Virginia-class, aligning with the multi-hop requirement to connect revenue figures to strategic context. 4) The answer is semantically equivalent to the original, with slightly more concise wording but no loss of key information. The only minor shortcoming is the omission of the precise 3.2:1 ratio, instead rounding to 'roughly three times', which slightly reduces precision in qualitative interpretation but does not constitute an error. Hence, all scores are high, with correctness docked by one point for this slight imprecision in the ratio expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 390,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair‑value of GM’s Stellantis‑warrant investment rose from about **$1.2 billion at 12/31/2020 to $1.5 billion at 12/31/2021**, a **$0.3 billion increase**. In contrast, the fair‑value of its marketable debt securities fell from **$9.0 billion to $8.6 billion**, a **$0.4 billion decline** over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Stellantis warrants increased from $1.2 billion to $1.5 billion, resulting in a $0.3 billion increase, and marketable debt securities decreased from $9.0 billion to $8.6 billion, a $0.4 billion decline—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the change in fair value for Stellantis warrants and the change for marketable debt securities, including correct time periods (December 31, 2020, to December 31, 2021). (3) Entity accuracy is perfect: GM, Stellantis warrants, and marketable debt securities are correctly identified, with no confusion between asset types or companies. (4) The reasoning is sound and demonstrates proper multi-hop synthesis—comparing two distinct financial instruments across the same time period and correctly inferring contrasting trends (increase vs. decrease). The LLM conveys the same semantic meaning as the original answer, with only minor formatting differences (e.g., bolding, spacing), which do not affect accuracy. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 334,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net carrying amount of Acquired Franchise Rights fell from $626 million in 2023 to $598 million in 2024 – a decrease of **$28 million**.  During the same period the company’s amortization expense slipped from $75 million to $74 million, a **$1 million reduction** that reflects the lower amortizable base.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net decrease in Acquired Franchise Rights from $626 million in 2023 to $598 million in 2024, accurately calculating the $28 million decrease, which matches the ground truth. However, the amortization expense is reported as $74 million in 2024 in the ground truth, but the LLM incorrectly states it decreased from $75 million in 2023 to $74 million in 2024, introducing a prior year value not present in the original answer and implying a trend not supported by the provided data. (2) The key numbers — ending values and the $28 million decrease — are quantitatively accurate. The $74 million amortization expense in 2024 is correctly cited, but the addition of a $75 million 2023 amortization figure is unsupported and introduces inaccuracy. (3) The reasoning partially fails the multi-hop synthesis: while it correctly links amortization to the decline in net value, it fabricates a year-over-year amortization trend rather than focusing on how the $74 million expense in 2024 contributes to the $28 million decrease in net value, as stated in the ground truth. The original answer emphasizes that amortization is a cause of the decline, while the LLM shifts focus to a minor change in amortization expense itself. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses the relationship between amortization and carrying value. However, the qualitative accuracy is reduced due to the unsupported inference about prior-year amortization, which distorts the reasoning. Correctness is docked because the added detail, while plausible, is not in the ground truth and misrepresents the data flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 461,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The rise in service costs tied to F‑35 sustainment work at Aeronautics added about **$570 million** to the total service‑cost increase of $775 million in 2023.  For the same unit, service sales grew by roughly **$600 million** because of the higher F‑35 sustainment volume, meaning the cost increase was about **$30 million less** than the sales increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $570 million (cost increase), $775 million (total service cost increase), and $600 million (sales increase) are accurately reported with no discrepancies. The difference of $30 million between sales and cost increases is correctly implied by stating the cost increase was $30 million less than the sales increase. (2) The answer addresses both parts of the multi-part question: the contribution of F-35 sustainment costs to the overall service cost increase and the comparison with corresponding service sales growth. (3) Entities—Aeronautics business unit, F-35 sustainment contracts, and the year 2023—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly infers that a smaller cost increase relative to sales suggests improved margin performance, aligning with the qualitative implication in the original answer. Wording differs slightly but maintains semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 303,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024 Accenture’s Board approved an additional $4 billion of repurchase authority, raising the company’s total outstanding share‑repurchase authority to **$6.694 billion**. This sizable authority underscores Accenture’s strategy of using open‑market purchases of its Class A ordinary shares to return excess cash to shareholders, support the share price and manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total share repurchase authority as $6.694 billion (equivalent to $6,694 million in the ground truth), and accurately notes the additional $4 billion (i.e., $4,000 million) approved by the Board, which increased the prior $2,694 million to $6,694 million. The date (September 25, 2024) is correctly implied as the reference point. 2) Quantitatively, all figures are accurate and consistent with the original answer, allowing for format variation (e.g., $6.694 billion = $6,694 million). The calculation (2,694 + 4,000 = 6,694) is correct and properly reflected. 3) The reasoning is sound: the LLM correctly infers that the increase in authority reflects an ongoing financial strategy involving share repurchases of Class A Ordinary Shares, including open-market purchases. It appropriately links the board action to strategic capital management and shareholder returns. 4) The answer is semantically equivalent to the ground truth, though it omits explicit mention of 'other share purchase programs' beyond open-market purchases. This is a minor omission that slightly affects completeness but does not undermine the core accuracy. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 353,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "Because Netflix’s content spend is largely fixed, a shortfall in new‑member growth leaves the company with high‑cost programming—now including live‑event streams—that it cannot scale back. If membership does not grow as expected, Netflix cannot offset those fixed costs by raising per‑member revenue or cutting spend, which compresses margins, drains cash and limits liquidity, thereby reducing both its profitability and its ability to invest or respond to other opportunities.【4†L1-L9】【5†L1-L8】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually and semantically equivalent to the original answer. (1) It correctly identifies that Netflix's content costs are fixed and non-adjustable, especially with the addition of live programming, which aligns with the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised—none are present, and none are needed. (3) The multi-hop reasoning is sound: the model connects Netflix's fixed costs (including live events) with the risk of missing membership growth targets, then correctly infers the inability to raise per-member revenue or cut costs, leading to margin compression, reduced liquidity, and lower profitability. This mirrors the causal chain in the original answer. (4) The LLM adds slight elaboration (e.g., 'drains cash', 'limits ability to invest') that are reasonable inferences and enhance completeness without introducing inaccuracies. All key elements—fixed costs, live programming, membership growth shortfall, margin pressure, liquidity impact, and profitability—are accurately addressed. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 326,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15 % 2041 Notes had a carrying value of **$729 million**, which is roughly **2.2 % of AMGN’s total debt carrying value of $33,309 million** reported for 2022.  \n\nIn the 2020 debt‑exchange transaction, **$245 million** of principal of the 5.15 % 2041 Notes was tendered and cancelled.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the carrying value of the 5.15% 2041 Notes is correctly stated as $729 million, the total debt carrying value is accurately given as $33,309 million, and the implied percentage (~2.2%) aligns with the ground truth (2.19%, rounded appropriately). The principal amount exchanged is correctly reported as $245 million. (2) The answer addresses both parts of the question: the percentage of total debt and the principal exchanged. (3) Entities are accurate—AMGN is correct, the note description (5.15% 2041 Notes) is precise, and although the exchange event occurred in 2020 (not 2022), this is factually consistent with the debt exchange table and not a multi-hop error, as the question only asks for how much principal was exchanged, not when. (4) The reasoning and synthesis are sound: the model correctly identifies the relevant debt instrument, retrieves its carrying value and exchange activity, and contextualizes it within total debt. Minor rounding of 2.19% to 2.2% is acceptable and common in financial reporting. All information is relevant and precisely responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 333,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "When McDonald’s sells a Company‑operated restaurant that it had previously acquired, the treatment of the related goodwill depends on how long the restaurant was held. If the restaurant is sold within 24 months of acquisition, the entire goodwill recorded for that purchase is written off immediately. If the sale occurs after 24 months, the goodwill write‑off is calculated proportionally, based on the fair‑value of the restaurant sold relative to the fair‑value of the entire reporting unit to which the goodwill was assigned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: the 24-month threshold, full goodwill write-off within 24 months, and proportional write-off based on relative fair value after 24 months. (2) Quantitative accuracy is perfect: the 24-month period is correctly cited, and there are no numerical calculations required beyond this time threshold, which is accurately represented. (3) The multi-hop reasoning is sound—McDonald’s acquisition of franchised restaurants leads to goodwill recognition, and the subsequent sale timing triggers different accounting treatments under its reporting framework. The LLM correctly synthesizes the cause-effect relationship between holding period and goodwill treatment. (4) The wording differs slightly but preserves precise technical meaning (e.g., 'proportionally, based on the fair-value...relative to the entire reporting unit' matches 'based on the relative fair value of the business sold compared to the reporting unit'). No omissions or inaccuracies. All entities (McDonald’s, Company-operated restaurants, goodwill) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 333,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG recorded **$601 million of equity‑method income** from its remaining Corebridge investment for the period after the deconsolidation date (June 10 ‑ December 31 2024). This amount represents the **sum of dividends received from Corebridge plus the change in Corebridge’s stock price (fair‑value adjustment) that was recognized under the equity‑method accounting after the June 9 2024 deconsolidation.**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($601 million) that is not present in the original answer (ground truth), and there is no verification that this figure is accurate based on the provided knowledge. The ground truth does not specify a numerical value for the equity method income, only the method of calculation. Therefore, the inclusion of $601 million is an unsupported addition and factually unverifiable from the given information, making it incorrect. (2) The date discrepancy—using June 10 instead of June 9—is a minor error but still quantitatively inaccurate. The deconsolidation date is explicitly stated as June 9, 2024, so starting the period on June 10 introduces a one-day misalignment, though likely negligible in practice. (3) The reasoning component is partially sound: the LLM correctly identifies that equity-method income includes dividends received and changes in stock price (fair-value adjustments), aligning with the conceptual framework in the original answer. However, the original answer emphasizes that the income reflects AIG’s 48.4% ownership stake and Corebridge’s performance during the post-deconsolidation period, which the LLM omits—this is a significant qualitative gap. (4) Contextually, the answer is relevant and addresses the core question about how income was calculated after deconsolidation. While the conceptual explanation is semantically close, the unsupported numerical claim and missing ownership percentage undermine factual correctness. Thus, the correctness score is low due to the fabricated figure, despite otherwise reasonable structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 444,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchise‑operated restaurants employ roughly 2 million people versus about 150,000 Company employees, meaning franchisees (and their staff) account for about **93 % of McDonald’s global workforce**. The company’s new recruitment program seeks to broaden that base by lowering upfront equity requirements and offering continuous learning and development, thereby **raising the share of franchise owners from under‑represented groups** in both the U.S. and International Operated Markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that franchisees account for about 93% of McDonald's global workforce, which aligns with the ground truth (over 2 million in franchised restaurants vs. over 150,000 company employees). The percentage is accurate: 2,000,000 / (2,000,000 + 150,000) ≈ 93%. All quantitative figures are correct and properly contextualized. (2) The recruitment initiative is accurately summarized: lowering upfront equity requirements and offering continuous learning and development to increase diversity among franchisees, particularly targeting underrepresented groups in both U.S. and International Operated Markets. The phrasing 'raising the share of franchise owners from under-represented groups' is semantically equivalent to the original answer's intent of influencing demographic composition. (3) The multi-hop reasoning is sound—linking franchisee employment share to the workforce composition and then connecting corporate initiatives to demographic impact shows proper synthesis across business model and diversity strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'diverse franchisees' in the same terms as the original or clarify that the initiative directly targets 'underrepresented groups' in the context of franchise ownership demographics—though this is implied. Otherwise, all key facts, numbers, and logic are correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 394,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program together with the lower Black Hawk production volume caused RMS’s operating profit to fall by **$41 million (about a 2 % decline) in 2023**. In contrast, the same Sikorsky helicopter line helped **grow RMS’s backlog by roughly $2.8 billion (from $34.9 billion to $37.7 billion), the increase being attributed primarily to higher Sikorsky orders**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial impact and contrast requested in the multi-part question. (1) Quantitatively, it correctly identifies the $100 million unfavorable adjustment and states the net $41 million decrease in operating profit for RMS in 2023, which aligns with the ground truth (the $100M loss offset by $65M gain from IWSS and other factors). The 2% decline, while not explicitly in the original answer, is a reasonable inference if based on a baseline profit (not contradicted by ground truth). The backlog increase from $34.9B to $37.7B ($2.8B) is accurate and correctly attributed to higher Sikorsky orders. (2) Calculations: The net $41M decline is consistent with the original answer’s claim of a $41M decrease after offsets. The $2.8B backlog increase is correctly computed. (3) Reasoning: The LLM correctly synthesizes two key points—negative impact on current-year operating profit versus positive contribution to future backlog—demonstrating sound multi-hop logic across financial dimensions (profit vs. backlog) and time (current performance vs. future potential). (4) The only minor limitation is the lack of explicit mention of the offsetting factors (e.g., $65M favorable adjustment in IWSS, Aegis volume), which are in the original answer and provide fuller context for the $41M net decline. However, the LLM captures the net effect accurately. All entities (RMS, Sikorsky, Canadian Maritime Helicopter Program, Black Hawk) and the year (2023) are correct. Semantic equivalence is strong, with slightly more precise numerical detail in the LLM answer. Hence, a high score of 9 is warranted—excellent but not fully exhaustive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 456,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom paid roughly **$30.8 billion in cash and issued 544 million shares of Broadcom stock valued at about $53.4 billion**, for a **combined consideration of roughly $84 billion**.  The deal was made expressly to “enhance our infrastructure‑software capabilities” – adding VMware’s multi‑cloud, data‑center and hybrid‑cloud software to Broadcom’s existing infrastructure‑software portfolio and thereby deepening its focus on modernizing, optimizing and securing private and hybrid cloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM reports $30.8 billion in cash and $53.4 billion in stock, which closely matches the ground truth values of $30,788 million and $53,398 million (rounded appropriately). The total consideration of $84 billion is a valid rounding of the exact $84,186 million. Minor imprecision in rounding is acceptable under semantic equivalence. (2) The answer is complete, addressing both the total value of the acquisition and its strategic alignment with Broadcom's focus on infrastructure software. (3) Entities (Broadcom, VMware, infrastructure software, multi-cloud) are correctly identified and contextually accurate. (4) The reasoning is sound: the LLM correctly links the acquisition to enhancing Broadcom’s infrastructure-software capabilities, specifically citing multi-cloud and hybrid-cloud environments, which aligns with the strategic focus described in the original answer. The only minor shortcoming is the lack of exact figures (e.g., 544 million shares not in ground truth, though plausible), but this does not affect factual correctness. Overall, the answer demonstrates strong multi-hop synthesis and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 347,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The launch of the $6.99 ad‑supported tier gives Netflix a lower‑priced entry point that attracts price‑sensitive viewers, and that added‑on pricing helped lift global paid memberships ≈ 18 % year‑over‑year (paid memberships grew from 45.3 million in 2023 to 57.5 million in 2024). By trading a modest drop in average revenue per user for a larger subscriber base and supplemental ad revenue, the new tier furthers Netflix’s stated goal of balancing ARPU with broader market penetration.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers. The claimed growth from 45.3 million in 2023 to 57.5 million in 2024 implies a much higher increase than 18% and is factually incorrect—Netflix had over 230 million subscribers globally by 2023, not 45.3 million. The 18% year-over-year increase is correctly cited as a key metric, but the supporting data is fabricated. (2) The calculation is invalid: (57.5 - 45.3)/45.3 ≈ 27%, not 18%, and the absolute subscriber numbers are orders of magnitude off. No such figures appear in Netflix’s 10-K filings. (3) The qualitative reasoning is sound—LLM correctly identifies the strategic tradeoff between ARPU and market penetration, links the ad-supported tier to attracting price-sensitive users, and acknowledges supplemental ad revenue as part of the strategy. This aligns with Netflix’s stated multi-tier pricing approach in its filings. (4) Contextual relevance is high because the answer addresses all components of the question: the $6.99 tier, membership growth, ARPU tradeoff, and strategic balance. However, the severe quantitative errors—especially the invented subscriber base—undermine the factual correctness, warranting a low overall correctness score despite reasonable logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 356,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "McDonald’s reports that, at the end of 2023, its own employees (corporate staff and workers at the 2,142 company‑operated restaurants) numbered **more than 150,000**, and **over 2 million people** were employed at its franchised restaurants worldwide – together representing **roughly 2.15 million individuals** working in McDonald’s restaurants globally【Our People – “Company employees… totaled over 150,000 worldwide… In addition to Company employees, the over two million individuals who work in McDonald’s franchised restaurants… are critical to the Company’s success.”】.  \n\nThese people are described as “the cornerstone of the Company’s business” and “bring our values to life daily,” directly enabling McDonald’s purpose “to feed and foster communities” and its mission “to make delicious feel‑good moments easy for everyone”【Purpose, Mission and Values – “Through its size and scale, McDonald’s embraces… its purpose to feed and foster communities, and its mission to make delicious feel‑good moments easy for everyone… The Company believes that its people… bring these values to life daily.”】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 'more than 150,000' Company employees and 'over 2 million' in franchised restaurants align exactly with the original answer, and their sum ('roughly 2.15 million') is a correct and reasonable approximation of over 2,150,000. Minor phrasing differences (e.g., 'over two million' vs. 'over 2 million') are semantically equivalent. (2) The answer is complete, addressing both the total workforce and how it contributes to McDonald’s purpose and mission. (3) Entities are correct: McDonald’s, company-owned vs. franchised restaurants, and the relevant time frame (end of 2023, consistent with 10-K reporting). (4) Multi-hop reasoning is sound—information is synthesized from both workforce data and purpose/mission statements, correctly linking employees to the company’s values and operational success. (5) The LLM uses direct quotes and citations from the source documents (e.g., 'cornerstone of the Company’s business', 'bring our values to life daily') to support the connection between workforce and mission, ensuring qualitative and contextual accuracy. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 345,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "Broadcom completed the VMware transaction for a total fair‑value of roughly **$53.4 billion** (approximately $53,398 million).  By adding VMware’s multi‑cloud platform and software‑defined infrastructure suite, the deal broadens Broadcom’s infrastructure‑software portfolio—giving it deeper private‑ and hybrid‑cloud, edge, application‑development, networking and security capabilities and strengthening its overall offering to enterprise customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that the acquisition involved $53,398 million in Broadcom common stock, which matches the ground truth. However, it states the total fair value as approximately $53.4 billion, which only reflects the stock component and omits the $30,788 million in cash. The correct total fair value is $84,186 million ($30,788M + $53,398M), so the LLM significantly underreports the total value. This is a major quantitative error. 2) Despite the numerical inaccuracy, the qualitative aspects are strong: the answer correctly identifies that VMware’s multi-cloud platform and software-defined infrastructure enhance Broadcom’s capabilities in hybrid cloud, networking, security, and enterprise software—aligning well with the ground truth’s emphasis on multi-cloud services and infrastructure software expansion. 3) The reasoning is logically sound and synthesizes the strategic rationale accurately, showing understanding of how VMware complements Broadcom’s portfolio. 4) Contextually, the answer is highly relevant and addresses both parts of the question—though the first part (total fair value) is factually incorrect due to missing the cash component. The omission of cash suggests a failure in multi-hop synthesis, possibly conflating the stock consideration with total value. While wording differs, the intent and strategic explanation are semantically aligned. Due to the significant numerical error in total value, the correctness and quantitative accuracy scores are reduced, but qualitative and contextual scores remain high due to accurate reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 436,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix’s 10‑K notes that its paid‑plan prices vary widely (about $1‑$32 per month globally) and that the company “expects … the prices of our membership plans … may change and we may test other plan and price variations” (Streaming Revenues section). At the same time, the filing warns that “adverse macro‑economic conditions, including inflation, may also adversely impact our ability to attract and retain members” and that “adjustments … to membership pricing … may not be well‑received by consumers” (Risk Factors). Thus, a strategy that relies on raising or testing higher prices to boost per‑member revenue can be at odds with the need to keep price‑sensitive existing subscribers who may cancel when household budgets are strained.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Netflix's membership pricing range of $1–$32 per month as of December 31, 2024, is accurately reported (minor phrasing as 'about $1–$32' is acceptable and semantically equivalent). The reference to potential price changes and testing of new plans is correctly pulled from the 10-K's Streaming Revenues section. (2) The macroeconomic risks—specifically inflation and adverse economic conditions affecting member retention—are properly cited from the Risk Factors section. (3) The core conflict is correctly synthesized: raising prices to increase per-member revenue may clash with retaining price-sensitive subscribers during economic strain. This multi-hop reasoning—linking pricing strategy with macroeconomic pressures and churn risk—is sound and matches the original answer’s logic. (4) The only minor shortcoming is that the LLM does not explicitly mention the fixed nature of content costs, which limits Netflix’s flexibility to adjust expenses if membership growth slows—a point emphasized in the ground truth. However, this omission does not undermine the central argument. All entities (Netflix, 2024 10-K), timeframes, and financial concepts are correct. Wording differs but meaning is preserved. Quantitative accuracy is perfect: dollar range and context are correct. Contextual relevance is excellent, directly addressing the tension between pricing strategy and retention under macroeconomic pressure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 417,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald’s goodwill on restaurant acquisitions is calculated with a discounted‑cash‑flow (Level 3) model that projects the future profitability of the acquired unit. Because the bulk of restaurant earnings come from franchise‑fee and royalty payments that depend on franchisee sales, any deterioration in franchisee performance – a risk the company flags as “our success as a heavily franchised business relies … on the financial success and cooperation of our franchisees” – reduces the cash‑flow assumptions and therefore the fair‑value of the purchase, increasing the likelihood that the goodwill recorded will later need to be written‑off or impaired. If a Company‑operated restaurant is sold within 24 months, the entire goodwill attached to that acquisition is removed; if sold after 24 months, the write‑off is proportional to the relative fair value of the sold business versus the reporting unit, so franchise‑related cash‑flow shortfalls directly affect the amount of goodwill that must be removed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: McDonald's uses a discounted cash flow (Level 3) model to assign goodwill upon acquisition, franchisee performance affects cash flow projections and thus goodwill valuation, and the 24-month rule for full vs. proportional goodwill write-off upon sale is correctly stated. (2) Quantitative accuracy is perfect: the 24-month threshold is correctly cited, and there are no numerical errors or miscalculations. Format variations (e.g., '24 months' vs 'within 24 months') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly links franchisee performance → impact on cash flows → effect on goodwill valuation → consequences for write-offs upon early or late sale. It also references McDonald's own risk disclosure about reliance on franchisee success, adding contextual support. (4) The only minor shortcoming is that the LLM does not explicitly state that goodwill is written off *entirely* when sold within 24 months of acquisition—though it says 'the entire goodwill... is removed,' which is equivalent. Also, the original answer emphasizes the *acquisition from franchisees* context slightly more, while the LLM generalizes to 'Company-operated restaurant,' which is acceptable but slightly less precise. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 389,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin treats hypersonics as one of the four near‑to‑mid‑term growth pillars and is already running several hypersonic‑strike programs that are slated to move into early‑production status by 2026. Because the Space segment’s portfolio explicitly includes “hypersonics programs” alongside its next‑generation missile‑warning, ballistic‑missile, GPS‑III and interceptor initiatives, these weapons reinforce the segment’s strategic focus on advanced, network‑enabled strike and defense capabilities. Together, the transition of hypersonic projects to production adds a new source of revenue and technology leverage that underpins the Space segment’s anticipated growth through 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: hypersonics are one of four near-to-mid-term growth pillars (explicitly stated in the 2023 10-K), multiple hypersonic-strike programs exist with transition to early production by 2026, and these are part of the Space segment’s portfolio. The mention of 'early-production status by 2026' matches the original answer’s 'enter early production phases through 2026'—semantically equivalent. (2) There are no numeric values requiring calculation, but timeframes (2026) and categorical groupings (four growth areas) are correctly cited. (3) Multi-hop reasoning is sound: the model correctly links hypersonics programs to the Space segment, identifies their strategic alignment with advanced strike capabilities, and connects their production timeline to revenue growth—synthesizing information from both strategic priorities and growth outlook. (4) The only minor omission is the specific mention of U.S. Army and U.S. Navy programs, which are named in the original answer as part of the hypersonics development. However, this does not detract from the overall correctness, as the core alignment and contribution to growth are accurately conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 398,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom valued the VMware Cloud Foundation‑related developed technology by estimating the present value of the cash flows the technology is expected to generate, net of the portion of those cash flows attributable to other assets. To capture that contribution over time it applied the **multi‑period excess‑earnings method** (an income‑approach valuation), using a forecast horizon that reflects the technology‑cycle‑based economic useful life of the assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately identifies the valuation technique as the 'multi-period excess earnings method' under the income approach, which matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or ground truth, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the answer correctly links Broadcom's valuation methodology to the projected financial contribution of the VMware Cloud Foundation technology by explaining that cash flows are netted against contributions from other assets and that the forecast horizon reflects the technology's economic useful life—this directly reflects the cause-and-effect relationship described in the original. (4) All entities—Broadcom, VMware Cloud Foundation, developed technology—are correctly identified, and the explanation captures the full scope of the question, including both the 'how' (via present value of net cash flows) and the 'specific technique' (multi-period excess earnings method). The answer is concise but complete, with no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 331,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The Sky Glass rollout added new hardware‑related costs to the Corporate & Other segment in 2021, offsetting some of the expense reductions from earlier COVID‑related severance and other savings, but overall Corporate & Other operating expenses still fell year‑over‑year.  Comcast said it expects “increased costs in 2022 related to the launch of Sky Glass and XClass TV,” indicating that the hardware‑launch expenses will rise in the next year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the launch of Sky Glass increased costs in the Corporate & Other segment in 2021, noting that these costs partially offset prior-year savings from severance and other reductions—this matches the original answer's point about costs related to Sky Glass and XClass TV offsetting earlier savings. The LLM also accurately states Comcast's expectation of 'increased costs in 2022 related to the launch of Sky Glass and XClass TV,' reflecting the strategic anticipation of continued investment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2021 and 2022) are correct. (3) The multi-hop reasoning is sound: the model connects Sky Glass launch to cost increases in 2021, contextualizes it against prior savings, and projects forward to 2022 expectations—correctly synthesizing cause, effect, and forward-looking strategy. (4) The only minor shortcoming is that the LLM adds a detail not present in the original answer—'overall Corporate & Other operating expenses still fell year-over-year'—which, while plausible and contextually consistent, is not confirmed in the ground truth. This addition does not contradict but slightly extends the provided information, warranting a small deduction in qualitative accuracy. Otherwise, the answer is factually correct, complete, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 413,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald’s values franchise‑e‑sale acquisitions with a discounted‑cash‑flow (Level 3) model, assigning the excess purchase price to goodwill at the reporting‑unit level. If a Company‑operated restaurant is sold within 24 months of that acquisition, the entire goodwill allocated to that unit is written off; if the sale occurs after 24 months, only a proportionate amount—based on the relative fair value of the sold business versus the reporting unit—is removed. Consequently, any early‑sale triggers an immediate, full goodwill charge that reduces the goodwill balance (the company reports only $14.5 million of accumulated goodwill impairments as of 12/31/2023, indicating the policy’s potential earnings impact).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies McDonald's use of discounted cash flow (Level 3 inputs) for valuing restaurants acquired from franchisees and accurately describes the goodwill treatment: full write-off if sold within 24 months, proportional write-off based on relative fair value if sold after 24 months. (2) The only minor issue in quantitative accuracy is the inclusion of a specific figure—'$14.5 million of accumulated goodwill impairments as of 12/31/2023'—which is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually correct but introduces extraneous data not supported by the source, slightly reducing confidence in pure fidelity. However, it does not contradict the original and is contextually plausible. (3) The multi-hop reasoning is sound: the model correctly synthesizes the valuation methodology, timing-based goodwill treatment, and financial implications on write-offs. (4) The answer is semantically equivalent to the original, with slightly more detailed phrasing and an added data point. The core logic, entities (McDonald's, goodwill, 24-month threshold, reporting unit), and financial implications are all correctly represented. The answer fully addresses all parts of the question with precise, relevant information, making it contextually excellent and qualitatively robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 399,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The financing portfolio is heavily weighted toward a few aircraft types—most notably the 717 and 747‑8—and to customers that often have sub‑investment‑grade credit. Because the portfolio totals $1.8 billion, a COVID‑19‑driven decline in airline revenues and cash flows that triggers defaults on those leases creates a double‑hit: the defaults erode cash‑flow directly, and the concentration in a narrow set of aircraft makes it harder to redeploy or remarket the assets, magnifying the loss‑impact on Boeing’s financial position and results of operations. (See the concentration‑risk disclosure for 717/747‑8 aircraft and the $1.8 billion default risk linked to COVID‑19‑impacted airlines.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $1.8 billion portfolio size, the concentration in 717 and 747-8 aircraft, and the link to COVID-19's impact on airline revenues and cash flows are accurately reflected. The mention of sub-investment-grade credit customers adds contextual detail not in the original but is plausible and enhances the reasoning without contradicting it. (2) Quantitatively, the $1.8 billion figure is correctly cited with proper formatting allowance. No calculations are required, and all numbers match. (3) The multi-hop reasoning is sound: the model correctly synthesizes the idea that concentration risk (in specific aircraft types and lower-credit customers) compounds the default risk in a pandemic-impacted environment, leading to a 'double-hit' on Boeing’s financials. The logic that concentrated exposure makes asset redeployment harder is a valid and insightful extension of the original answer. (4) The answer is fully relevant, directly addressing how concentration risk amplifies financial vulnerability from defaults. The only minor shortcoming is that the original emphasizes the 'material adverse effects' more explicitly on financial position, operations, and cash flows—nuance slightly better captured in the ground truth. However, the LLM covers these aspects implicitly. Overall, the answer is factually correct, well-reasoned, and semantically equivalent with slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 411,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The Q4‑2021 introduction of Sky Glass was reflected in the Corporate & Other segment’s 2021 results as a boost to revenue and a modest addition to expenses.  Revenue in the segment jumped to **$461 million in 2021 (up 86 % from $248 million in 2020)**, and the filing notes that the increase “was primarily due to … sales of Sky Glass televisions.”  At the same time, operating costs and expenses fell to **$1.819 billion (down 10.5 % year‑over‑year)**; the narrative explains that the expense decline was “partially offset by costs related to the launch of Sky Glass (and XClass TV).”  In short, Sky Glass generated a sizable new revenue stream while adding launch‑related costs that were more than offset by prior‑year COVID‑related cost savings, resulting in lower total expenses for the segment in 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Sky Glass increased both revenue and expenses in the Corporate and Other segment, but does not provide specific dollar amounts or percentages. However, the LLM answer fabricates precise figures: $461 million revenue in 2021 (up 86% from $248 million in 2020) and operating expenses falling to $1.819 billion (down 10.5% year-over-year). These numbers are not present in the original answer and are therefore incorrect. Additionally, the claim that operating expenses *fell* contradicts the ground truth, which states that expenses *increased* due to Sky Glass launch costs. The LLM incorrectly asserts that launch costs were more than offset by prior-year COVID-related savings, which is not mentioned in the original answer. (2) The quantitative inaccuracies are severe: the revenue and expense figures, growth rates, and YoY changes are all fabricated or misstated. Even allowing for format variations, the numbers do not match any plausible interpretation of the ground truth. (3) The reasoning is partially sound in identifying a dual impact on revenue and costs, which aligns with the original answer. However, the multi-hop synthesis is flawed because it introduces external data (likely hallucinated from a filing not in the knowledge graph) and draws incorrect conclusions about net expense reductions. The model fails to correctly represent the causal relationship: higher expenses due to Sky Glass launch, not lower. (4) The contextual relevance is moderate because the answer addresses the right segment (Corporate and Other), the correct product (Sky Glass), and the correct time frame (Q4 2021). It also attempts to discuss both revenue and cost effects. However, due to major factual and quantitative errors, the overall correctness score is low. The answer misrepresents the financial outcome and thus fails the primary evaluation criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 528,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31 2023, CVS held commercial mortgage‑backed securities with a **fair value of $975 million**. These securities carried **gross unrealized losses of $100 million**, which is roughly **0.5 % of the company’s total debt‑securities portfolio (fair value $21.7 billion)**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The fair value of commercial mortgage-backed securities is stated as $975 million, whereas the ground truth is $675 million — a major discrepancy of $300 million. The unrealized loss of $100 million is correct and matches the ground truth. However, the LLM incorrectly frames this $100 million as 0.5% of the total debt securities portfolio by fair value ($21.7 billion), which misrepresents the question’s intent. The question asks how much the unrealized loss in this category represents *relative to the total unrealized losses* in the debt securities portfolio, not relative to the fair value of the portfolio. The correct figure is that $100 million in unrealized losses accounts for approximately 12% of the total $836 million in unrealized losses across all debt securities — a multi-hop calculation the LLM failed to perform correctly. (2) Quantitative accuracy is low: one out of three key numbers is correct ($100 million unrealized loss), while the fair value and the comparative percentage are wrong. The 0.5% figure comes from $100M / $21.7B ≈ 0.46%, which is mathematically plausible but contextually incorrect because it answers a different question. (3) The reasoning is flawed in the multi-hop aspect: the model identifies the unrealized loss correctly but fails to relate it to total *unrealized losses* across the portfolio, instead comparing it to total *fair value*, which is a category error. This indicates a failure in synthesizing the correct relationship between subcomponents of the debt securities portfolio. (4) Despite the reasoning error, the answer is contextually relevant — it addresses the right company (CVS), time period (December 31, 2023), and security type (commercial mortgage-backed securities) — hence a moderate contextual relevance score. However, due to major quantitative and reasoning errors, the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 528,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The 12 % rise in 2023 net sales was driven largely by higher unit sales “primarily by third‑party sellers” in both the North‑America and International segments, which together supplied the bulk of the sales growth beyond advertising and subscription revenue. A key international risk is Amazon’s dependence on foreign third‑party sellers—especially China‑based sellers—because regulatory, trade, data‑privacy or cybersecurity restrictions on those sellers could limit or disrupt Amazon’s ability to expand its marketplace abroad.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 12% net sales increase in 2023 and attributes it to higher unit sales by third-party sellers in both North America and International segments, which aligns with the ground truth. The quantitative figure (12%) is accurate and properly contextualized. 2) All numbers and dates are correct—'12%' matches the original answer, and no calculations are required beyond that. Format is consistent and precise. 3) The reasoning is mostly sound: the LLM correctly links third-party seller growth to Amazon’s overall sales increase. However, while the original answer specifies regulatory risks in India related to foreign ownership rules, the LLM shifts focus to China-based sellers and broader regulatory/trade/data risks. This is plausible but not factually aligned with the ground truth’s specific reference to India’s foreign ownership restrictions. 4) The answer remains contextually relevant and captures the essence of both sub-questions—contribution to sales growth and international risk—though the risk example differs in specificity and geography. Semantic equivalence is mostly preserved, but the substitution of 'China-based sellers' for 'India’s foreign ownership rules' introduces a factual divergence in entity and risk context, preventing a perfect score. Thus, correctness is high but not complete due to entity inaccuracy in the risk component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 385,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The Deferred Compensation Plan has 1,853,363 shares remaining available for future issuance, while the Non‑Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares. The difference is 1,712,810 shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan has 1,853,363 shares remaining, and the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares. The difference is correctly calculated as 1,853,363 - 140,553 = 1,712,810 shares. (2) Quantitative accuracy is perfect—each number matches the source data, and the subtraction is correct. (3) The multi-hop reasoning is sound: the model correctly identified two distinct plans, retrieved the correct share counts for each, and computed the difference. (4) The answer is semantically equivalent to the original, providing additional detail (individual share counts) that enhances clarity without introducing error. All entities (plan names, share counts, year context implied by 2023 question) are accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 257,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI’s reduced‑risk product (RRP) line is defined as the sale of **heated‑tobacco units, heat‑not‑burn devices and their accessories, and other nicotine‑containing products – principally e‑vapor and oral‑nicotine products**【source】. Heated‑tobacco units (HTUs) are explicitly listed as one of the RRP components and their revenues and shipment volumes are reported under the “reduced‑risk products” category, making them a core element of PMI’s RRP classification【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately lists all product categories included in PMI's reduced-risk product line: heated tobacco units, heat-not-burn devices and accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. (2) There are no numeric values in the question or answer that require verification (e.g., financial figures, shipment volumes), so quantitative accuracy is not applicable beyond correct categorization—no numbers were misstated. (3) The reasoning is sound: the LLM correctly identifies that heated tobacco units are explicitly classified as part of the reduced-risk product line and notes their inclusion in RRP financial reporting, which aligns with the multi-hop requirement of linking product classification to reporting practices in the 2022 10-K. (4) All entities—PMI, reduced-risk products, heated tobacco units, e-vapor, oral nicotine—are correctly identified and contextually used. The answer addresses both parts of the question completely and with precise, factually supported reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 315,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "In fiscal 2025, DirectCustomer A accounted for **12 % of NVIDIA’s total revenue**. The prior year’s data shows DirectCustomer A contributed **less than 10 % of revenue** (marked with “*”), indicating the share rose from under 10 % in 2024 to 12 % in 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that DirectCustomerA accounted for 12% of NVDA's revenue in fiscal year 2025, which matches the ground truth. However, it incorrectly states that in fiscal year 2024, DirectCustomerA contributed 'less than 10%' of revenue. The ground truth explicitly states that the 2024 contribution was not disclosed and marked as '*', meaning no percentage—whether exact or bounded—was reported. The LLM fabricates a quantitative comparison by interpreting '*' as '<10%', which is unsupported by the data. (2) The only numeric value in the ground truth is 12% for 2025, which is accurate in the LLM answer. The 2024 figure is not provided in the original, so any numerical claim (including '<10%') is factually wrong. This is a critical error in quantitative accuracy. (3) The multi-hop reasoning fails because the LLM assumes a disclosure threshold or reporting rule (e.g., that '*' implies '<10%') without evidence. The correct reasoning, per the ground truth, is that DirectCustomerA was not a named top customer in 2024, so no percentage is available, and thus no numerical comparison can be made. The LLM incorrectly infers a trend (increase from <10% to 12%) that cannot be substantiated. (4) The contextual relevance is high because the answer addresses both years and the core metric (revenue percentage). However, the correctness score is low due to the significant factual error in the 2024 interpretation, which distorts the conclusion. The qualitative accuracy is moderate because the entities and years are correct, but the reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 435,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "The 2023 Form 10‑K lists one Restricted Share Rights Award Agreement for each grant date:\n\n* **Grants on or after January 24 2023** – a single version is incorporated by reference to Exhibit 10(a) of the 2022 Form 10‑K.  \n* **Grants on or after January 23 2024** – a single version is filed with the 2023 Form 10‑K itself.\n\nThus, there is **one distinct version for the 2023‑date grants and one distinct version for the 2024‑date grants**【...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies two distinct versions of the Restricted Share Rights Award Agreement, one for grants on or after January 24, 2023, and another for grants on or after January 23, 2024, matching the original answer exactly in substance. (2) All dates and filing statuses are correct: the 2023-effective version is correctly noted as incorporated by reference (to Exhibit 10(a) of the 2022 10-K), and the 2024-effective version is correctly stated as filed with the 2023 10-K. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information about different grant dates and their corresponding filing methods from the same document (Wells Fargo's 2023 10-K), demonstrating proper cross-reference understanding. (4) The answer is contextually precise, directly addressing both parts of the question (number of versions and their respective effective dates/filing methods) with clear, accurate, and complete information. Minor elaboration (specific exhibit reference) adds clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 324,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The 2022 uncertainty about when the FAA would again approve 787 deliveries forced Boeing to assume that a number of delayed aircraft could trigger customers’ contractual termination rights, creating a material “reach‑forward” loss on the program. That loss was reflected in a higher cost‑of‑sales figure (it offset the revenue‑related cost reductions and pushed cost‑of‑sales up in 2021) and required management to lower its margin‑at‑completion forecasts because the additional customer consideration and potential terminations would compress the expected profit on those aircraft.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core qualitative reasoning correctly: FAA approval uncertainty in 2022 led to risks of customer termination rights, resulting in reach-forward losses and downward pressure on margin forecasts. It correctly identifies the impact on cost of sales and margin-at-completion. However, it contains a critical quantitative inaccuracy: it states that the reach-forward loss 'pushed cost-of-sales up in 2021', while the ground truth states that cost of sales *decreased* by $4,574 million in 2021 compared to 2020, partly due to the reach-forward loss. This is a major factual contradiction. The LLM incorrectly implies the loss increased cost of sales, when in reality the loss was already embedded in the financials and contributed to a lower year-over-year cost of sales figure (despite being a negative event). The answer also omits the specific $4,574 million figure, reducing quantitative completeness. While the multi-hop reasoning (FAA delay → termination risk → reach-forward loss → impact on cost and margins) is logically sound and contextually relevant, the reversal of the cost-of-sales direction (up vs down) constitutes a significant error in financial interpretation, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 346,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023 Amazon said that the bulk of the 12 % rise in North‑America sales and the 11 % rise in International sales “primarily reflect increased unit sales, **primarily by third‑party sellers**” together with higher advertising and subscription revenues【page 24】.  However, currency movements offset those gains: foreign‑exchange fluctuations **reduced total net‑sales by $71 million**, hurting the North‑America segment, while **adding $88 million to International net‑sales**【page 24】.  The net result was a modest overall drag of $71 million on the company’s sales growth despite the strong contribution from third‑party sellers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that third-party sellers were a primary driver of the 12% growth in North America and 11% growth in International sales, along with advertising and subscription revenues, which matches the ground truth. However, there is a critical error in the net effect of foreign exchange rate changes. The LLM states that foreign exchange fluctuations 'reduced total net-sales by $71 million' and resulted in a 'modest overall drag of $71 million', which is incorrect. The ground truth specifies that FX changes reduced North America sales by $71M but increased International sales by $88M, leading to a net positive impact of $17M — not a drag. The LLM incorrectly characterizes the overall impact as negative when it was actually positive. (2) Quantitatively, the individual FX impacts ($71M reduction in North America, $88M increase in International) are correctly cited, but the conclusion drawn (net drag of $71M) is wrong. The correct net impact is +$17M ($88M - $71M), which the model fails to compute accurately. (3) The multi-hop reasoning is mostly sound — the model connects third-party seller activity to sales growth in both regions and incorporates FX effects from the same source (page 24). However, it fails to synthesize the two FX figures into a correct net effect, breaking the chain of reasoning. (4) Contextual relevance is perfect — all parts of the question are addressed with appropriate detail and sourcing. The qualitative accuracy is high due to correct identification of drivers and entities, but the quantitative error in net FX impact significantly affects the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 449,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Because the USA PATRIOT Act obligates Wells Fargo to maintain an effective anti‑money‑laundering (AML) program, any material weakness in that program would be viewed by regulators as a lack of competence and integrity and could cause a denial of, or impose restrictive conditions on, a proposed bank acquisition.  The effectiveness of the AML program is evaluated by the federal banking regulators that approve acquisitions—principally the Federal Reserve Board (the FRB), which acts as the primary regulator of the holding company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that deficiencies in Wells Fargo's AML program, under the USA PATRIOT Act, could constrain its ability to pursue bank acquisitions by leading to denial or restrictive conditions. This aligns with the original answer's emphasis on regulatory risk and integrity concerns. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links Wells Fargo's AML obligations under the USA PATRIOT Act to regulatory scrutiny during acquisition reviews and correctly identifies the Federal Reserve Board (FRB) as the key regulatory body responsible for evaluating AML effectiveness in the context of holding company acquisitions. (4) The only minor shortcoming is that the LLM does not explicitly mention 'other federal banking regulators' or tie the denial rationale directly to 'financial integrity and national security' as stated in the original answer, slightly reducing qualitative accuracy. However, the essence of the regulatory logic is preserved. The answer is highly relevant, accurate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 363,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "PMI estimated that total international industry cigarette + heated‑tobacco unit volume (excluding China and the United States) rose from 2020 to 2021 by **2.4 %**【...】. In PMI’s financial reporting, heated‑tobacco units are classified under the **Reduced‑Risk Products** category, which groups together heated‑tobacco units, heat‑not‑burn devices and related accessories【...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021 is accurately reported as 2.4%, which aligns with the original answer. (2) The classification of heated tobacco units under 'Reduced-Risk Products' in PMI's financial reporting is correctly identified, and the LLM provides additional context (e.g., inclusion of heat-not-burn devices and accessories) that is consistent with PMI's reporting framework. (3) The multi-hop reasoning is sound: the answer synthesizes volume trends and product categorization from different parts of PMI’s reporting, correctly linking industry volume changes to internal product classification. (4) All entities (PMI, 2020–2021 time frame, heated tobacco units) are accurate, and the semantic meaning fully matches the ground truth. Minor formatting differences (e.g., use of em dashes, bolding) do not affect factual equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 285,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Boeing’s customer‑financing portfolio was $1.8 billion at 31 December 2021, and the company applies a 24.2 % default rate to the portion of that portfolio that is rated CCC. If every CCC‑rated receivable in the $1.8 billion portfolio were to default, the additional loss would be:\n\n\\[\n\\$1.8\\text{ billion} \\times 24.2\\% \\;=\\; \\$0.4356\\text{ billion} \\approx \\$436\\text{ million}.\n\\]\n\nThus, Boeing’s potential losses could rise by roughly **$436 million**.  \n\n*Sources: customer‑financing portfolio of $1.8 billion (Risk Factors section) and 24.2 % default rate applied to CCC‑rated receivables (Note 9 – Customer Financing).*\n",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, both of which match the ground truth. The calculation is accurate: $1.8 billion × 24.2% = $435.6 million, which the model correctly rounds to $436 million. The original answer states $435.6 million, so the difference is purely in rounding and presentation, which is acceptable under semantic equivalence. (2) All numeric values are correct and properly formatted; the calculation is mathematically sound and clearly shown. (3) The reasoning is logically structured and correctly synthesizes the two key data points (portfolio size and default rate) from what would be multi-hop sources (e.g., Risk Factors and Note 9). The model correctly interprets that applying the default rate to the entire portfolio proportionally estimates potential losses if all CCC-rated receivables defaulted. (4) The answer is contextually complete and directly addresses the question. The only minor deviation from the original answer is the rounding to $436 million instead of stating $435.6 million, which does not affect factual accuracy. Thus, the answer is fully correct in substance, earning a 9 due to the slight rounding difference, though still within acceptable variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 369,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "In fiscal 2025 (year ended January 26, 2025) Direct Customer C accounted for **about 11 % of NVIDIA’s total revenue**. In the prior year (fiscal 2024, year ended January 28, 2024) the same customer contributed **less than 10 % of revenue** (the filing marks it with “*”, indicating it was under the 10 % threshold).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key claim about the prior year percentage. The ground truth states that DirectCustomerC accounted for 11% of NVDA's revenue in both fiscal years ending January 26, 2025, and January 28, 2024. However, the LLM incorrectly claims that in fiscal 2024, the customer contributed 'less than 10%' and was marked with an asterisk, which contradicts the ground truth. This is a major factual error. (2) The fiscal year dates are correctly identified (January 26, 2025, and January 28, 2024), and the 11% figure for fiscal 2025 is accurate. However, the prior year percentage is wrong—ground truth confirms it was also 11%, not below 10%. (3) The multi-hop reasoning fails because the model did not correctly synthesize the data across the two fiscal years. It introduces a discrepancy (change from <10% to 11%) that does not exist in the ground truth, leading to an incorrect comparison. (4) Scores reflect that while the context and structure are relevant and the current-year percentage is correct, the core quantitative comparison is wrong, severely undermining the answer's correctness and qualitative reasoning. Only partial credit is given for correct dates and one correct percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 349,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "CVS Health held commercial mortgage‑backed securities (CMBS) with a total fair‑value of **$975 million** at December 31 2023. According to the investment‑maturity breakdown, those CMBS were in an unrealized capital‑loss position for **$100 million** of loss. Thus, the unrealized losses represent roughly one‑tenth of the CMBS fair‑value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the total fair value of CMBS: it reports $975 million, whereas the ground truth is $675 million. This is a significant deviation of $300 million and directly impacts the accuracy of the response. The unrealized losses amount ($100 million) is correct and matches the ground truth. However, the derived percentage (roughly one-tenth) is inaccurate because it is based on the incorrect fair value. The correct percentage is approximately 14.8% ($100M / $675M), which the LLM fails to compute accurately due to the wrong denominator. (2) Quantitative accuracy is low because the key financial figure (fair value) is incorrect, even though the date (December 31, 2023) and the unrealized loss amount are correct. The calculation of the proportion is flawed due to the incorrect base. (3) The qualitative reasoning shows partial understanding: the model identifies the need to report both fair value and unrealized losses and attempts a comparison, but fails in synthesizing the correct values from the source data. It does correctly associate the $100M unrealized loss with CMBS, indicating some level of entity and metric accuracy. (4) Contextual relevance is high because the answer addresses both parts of the question—total fair value and comparison with unrealized losses—and uses appropriate financial terminology. However, the core inaccuracy in the fair value severely undermines the correctness score. The model appears to have accessed or recalled an incorrect figure for CMBS fair value, leading to a partially correct but ultimately misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 445,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "MetLife records the change in the estimated fair value of its Unit‑linked (and FVO) securities as part of **net investment income** — the footnote explains that “changes in estimated fair value of Unit‑linked and FVO securities are included in net investment income.” By contrast, **net derivative gains (losses)** reflect the realized and unrealized gains or losses on derivative and embedded‑derivative positions (including lapses on embedded derivatives); the fair‑value changes of Unit‑linked securities are **not** included in that line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that changes in the estimated fair value of Unit-linked securities are included in net investment income, directly citing the disclosed treatment. It correctly contrasts this with net derivative gains (losses), which include derivative-related outcomes such as lapses on embedded derivatives, but explicitly notes that fair value changes of Unit-linked securities are not included in that line. There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of accounting treatments—no numbers are misstated. The qualitative reasoning is sound: the model correctly synthesizes the distinction between valuation changes (accounted for in net investment income) and derivative-related outcomes (in net derivative gains/losses), reflecting proper multi-hop understanding of accounting line items and their components. The only minor limitation is that it does not explicitly mention 'net embedded derivatives' or link lapses directly to Unit-linked securities as a potential source, which is included in the original answer and adds slight contextual nuance. However, the core distinction in accounting treatment is preserved, and the answer remains semantically equivalent. Wording differs but meaning is consistent, and all entities (Unit-linked securities, net investment income, net derivative gains/losses) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 419,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a **$3.5 billion loss on the 787 program in the fourth quarter of 2021**. Because the company uses program‑accounting to recognize revenue when aircraft are delivered, the still‑unknown date of FAA approval to resume deliveries creates significant judgment about when – or whether – revenue will be earned and what customer concessions may be required; any further delay or change in the delivery schedule can lower the estimated revenue and margin and trigger additional reach‑forward losses in future periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the $3.5 billion loss Boeing recorded on the 787 program in Q4 2021, matching the ground truth exactly. This satisfies the quantitative component with full accuracy. 2) The explanation of how FAA approval uncertainty affects future revenue estimates is semantically equivalent to the original answer: it correctly references program accounting, the impact on revenue recognition timing, customer concessions, and the risk of additional reach-forward losses due to delivery delays. While the term 'contractual termination rights' is omitted, the core reasoning about delivery resumption affecting revenue estimates and margins is preserved. 3) The multi-hop reasoning is sound—linking the FAA delay to accounting methodology (program accounting) and its financial implications (revenue, margins, reach-forward losses)—demonstrating accurate synthesis across financial and regulatory domains. 4) Minor deduction in qualitative accuracy due to omission of 'contractual termination rights,' a specific but not central concept. Otherwise, all entities (Boeing, 787 program, FAA, Q4 2021) and financial terms are correct. The answer is fully contextually relevant and conveys the same practical implications as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 350,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "In fiscal year 2025 (ended January 26, 2025) NVIDIA reported that DirectCustomer A accounted for **12 % of total revenue**. For the prior fiscal year (ended January 28, 2024) the company did not disclose a specific percentage—its table shows an asterisk indicating that DirectCustomer A’s sales were **under 10 % of total revenue**, so the exact figure was not reported.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM correctly identifies the 12% revenue contribution from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly interprets the asterisk (*) in the prior fiscal year (ended January 28, 2024) as indicating that the customer's sales were under 10% of total revenue. The ground truth states that the data is simply 'unavailable' and marked with an asterisk, not that it was below a disclosure threshold. This is a significant qualitative error in reasoning and interpretation. (2) Quantitatively, the only numbers involved are the 12% and the prior year's notation. The 12% is correct; the inference about '<10%' is not supported by the ground truth and appears to be an assumption not present in the original data. (3) The multi-hop aspect requires comparing two fiscal years' disclosures for the same customer. While the model retrieves the correct current-year figure and notes the prior year uses an asterisk, it adds an interpretation (under 10%) that is not in the source, failing to accurately synthesize the actual meaning of the data availability. (4) Contextually, the answer is well-structured and relevant, addressing both parts of the question. However, due to the incorrect interpretation of the asterisk, the comparison to the prior year is factually wrong, reducing the correctness score despite accurate date and percentage reporting for the current year.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 395,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "In 2023 Amgen’s BeiGene relationship represented roughly a **$4.474 billion** financial impact: the equity stake was valued at about **$4.2 billion**, plus **$109 million** of net cost recoveries, **$125 million** of product‑sale revenue to BeiGene, and **$40 million** of profit‑and‑loss‑sharing expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all components of the financial impact: fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million), and addresses the correct year (2023) and entities (Amgen and BeiGene). However, the total financial impact is incorrectly calculated as $4.474 billion instead of the correct $4.374 billion. The correct sum is $4.2B + $109M + $125M + $40M = $4.474B - $100M = $4.374B. This indicates a clear arithmetic error in the final total despite correct input values. The reasoning and entity identification are sound, and all parts of the multi-hop question are addressed. The semantic content is nearly correct but the miscalculation significantly undermines quantitative accuracy. The answer is contextually relevant and well-structured, but the incorrect total reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 265,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "MetLife applies its estimated lifetime loss rates to commercial and agricultural mortgage loans for a **two‑year forecast horizon** (one year for a few loans originated in certain markets). When that horizon ends, the company switches to its historical loss experience and spreads the remaining loss allowance **over a two‑year straight‑line period**.  \n\nFor residential mortgage loans the forecast horizon is also **two years**, but after that period the allowance reverts to industry historical loss experience **and is amortized over just one year** on a straight‑line basis.  \n\nThus, the post‑forecast “reversion” period is two years for commercial/agricultural loans but only one year for residential loans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: two-year forecast period for both commercial/agricultural and residential loans, two-year reversion period for commercial/agricultural (straight-line), and one-year reversion for residential. These match the original answer. (2) The calculation of total duration (forecast + reversion) is implied but not explicitly stated in the LLM answer — the ground truth explicitly notes 4 years total for commercial/agricultural (2+2) and 3 years for residential (2+1). While the LLM describes the components accurately, it does not synthesize the total duration comparison as clearly, which slightly weakens the multi-hop reasoning. (3) Entity accuracy is perfect: MetLife, commercial/agricultural vs. residential mortgage loans, forecast periods, reversion to historical loss experience (company-specific vs. industry-wide) are all correctly identified and contrasted. (4) The reasoning is sound and semantically equivalent, though the omission of the explicit total duration (4 vs. 3 years) slightly reduces completeness in synthesizing the final implication. Wording differences (e.g., 'amortized', 'straight-line') are acceptable and contextually accurate. Overall, the answer is factually correct and relevant, with only minor room for improved synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 383,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco funds most of its employee health‑care, workers‑compensation and other benefit claims through self‑insurance, recording a liability that is estimated — without discounting — using historical claims, demographic, severity and other actuarial assumptions. Because the cost of those claims is “highly unpredictable” and can swing with inflation, regulatory or legal changes, and other unforeseen developments, a larger‑than‑expected increase in health‑care or labor‑related expenses would raise the recorded liability and could strain cash‑flows and liquidity. Management notes that past adjustments have not been material, but any significant deviation from the actuarial estimates could adversely affect Costco’s financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Costco uses self-insurance for employee health care and other benefits, records liabilities without discounting, and relies on actuarial assumptions including historical claims, demographics, and severity factors. The answer correctly identifies key risks—unpredictable cost fluctuations due to inflation, regulatory or legal changes, and unforeseen developments—and notes that deviations from estimates could adversely affect financial condition. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations or figures; however, the LLM does not introduce any incorrect numbers, earning full marks. (3) The multi-hop reasoning is sound: it connects self-insurance practices to actuarial estimation methods, recognizes the inherent uncertainty in those estimates, and links potential cost overruns to financial risks like cash flow strain and liquidity issues. The mention of management’s observation about past immaterial adjustments adds context not in the original but is consistent with typical disclosures and does not detract. (4) The only minor shortcoming is that the LLM slightly broadens the scope by including 'workers-compensation and other benefit claims' and 'labor-related expenses' more generally, which, while likely true, slightly extends beyond the specific focus on 'employee health care benefits' in the question. However, this does not distort the meaning and is contextually appropriate. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 460,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "- **Pre‑tax charges in 2023:** 3M recorded a $4.2 billion pre‑tax charge for the CAE Settlement (Q3 2023) and $437 million of restructuring pre‑tax charges, for a combined total of roughly **$4.64 billion**.\n\n- **Balance‑sheet impact of the Aearo reconsolidation (as of 12/31/2023):** The reconsolidation eliminated the prior‑year balances that had appeared on the comparative statement – specifically, a **$0.7 billion equity‑investment asset** and a **$0.6 billion net inter‑company liability** (gross $0.9 billion liability and $0.3 billion asset) were removed from the 2023 consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $4.2 billion for the CAE Settlement and $437 million in restructuring charges are correctly reported, and their sum ($4.637 billion) is accurately rounded to $4.64 billion, which is an acceptable rounding. (2) The balance sheet impact of the Aearo reconsolidation correctly identifies the removal of a $0.7 billion equity and other investments asset and a $0.6 billion net intercompany liability, matching the ground truth. The LLM adds additional detail (gross $0.9 billion liability and $0.3 billion asset) that is consistent with the net $0.6 billion liability and enhances clarity without introducing error. (3) The multi-hop reasoning is sound—information is synthesized correctly across the CAE Settlement, restructuring charges, and reconsolidation impact, all tied to 3M in 2023. (4) Entities (3M, CAE Settlement, Aearo Entities, 2023 year-end) and financial terms (pre-tax charges, reconsolidation, balance sheet impact) are used accurately. (5) The answer is semantically equivalent to the original, with slightly more detailed breakdown but no deviation in meaning. All parts of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 353,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "By embedding Gemini 2.0—the most capable, multimodal model that can understand and generate text, code, audio, images and video—directly into Vertex AI, Google now lets Cloud developers not only train, tune, augment, test and deploy generative‑AI applications, but also tap pre‑packaged AI agents that can automatically write, document, test and operate software and help cybersecurity teams detect and respond to threats. This integration broadens the range of AI‑driven functions developers can build on Google Cloud Platform, moving from single‑modal models to a full‑stack, multimodal development environment. (see pages 57‑60).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor additional details not present in the original answer. (1) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the integration of Gemini 2.0 into Vertex AI and accurately describes the expanded capabilities: training, tuning, augmenting, testing, and deploying generative AI applications using multimodal models like Gemini, Imagen, and Veo. It adds specific details about pre-packaged AI agents for software development and cybersecurity, which are plausible enhancements but not mentioned in the ground truth; these do not contradict but slightly extend the original answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes that integrating Gemini 2.0 into Vertex AI enhances developer capabilities on Google Cloud Platform by enabling multimodal, full-stack AI application development. (4) The core information matches the original answer, with improved elaboration and context (e.g., explaining 'multimodal' and listing modalities). The added details about AI agents are consistent with the direction of the technology but represent an expansion beyond the provided ground truth. Thus, the answer is highly accurate with only minor over-enrichment, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 410,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "Because the yield table treats fixed‑maturity securities AFS as a single bucket, MetLife adds the $205 million of investment income generated by its FVO (fair‑value‑option) securities to the fixed‑maturity‑securities line and also includes the FVO securities’ carrying amount in the average‑quarterly asset base used to compute the yield. FVO securities are classified as Level 3 assets and are valued with internal matrix or discounted‑cash‑flow models that rely on significant unobservable inputs; therefore, any change in those inputs moves the estimated fair value of the FVO holdings and directly alters the amount of investment income reported and the calculated yield, making the fixed‑maturity‑securities results more sensitive to fair‑value fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million investment income contribution from FVO securities in 2024, matching the ground truth exactly. All key entities—MetLife, FVO securities, fixed maturity securities, Level 3 classification, and 2024—are accurate. (2) The quantitative accuracy is perfect: the $205 million figure is correctly cited and contextually applied to both investment income and yield calculation. No calculations are required beyond correct attribution, which is accurate. (3) The reasoning is strong and reflects proper multi-hop synthesis: it connects the inclusion of FVO securities in yield calculations, their valuation using unobservable inputs (via internal models like discounted cash flows), and the resulting sensitivity of both investment income and fair value to changes in those inputs. It correctly explains the dual impact on income reporting and yield metrics due to the aggregation method. The only minor shortcoming is that it does not explicitly name the specific unobservable inputs mentioned in the ground truth (e.g., nonperformance risk spreads, long-term equity volatilities), though it refers to them generally as 'significant unobservable inputs.' This slightly reduces qualitative precision but does not undermine correctness. (4) The answer is fully contextually relevant, directly addressing how FVO inclusion affects investment income and sensitivity to fair value changes under Level 3 valuation techniques. Overall, the LLM conveys semantically equivalent information with high fidelity, warranting a 9/10 due to slight omission of specific input examples in the valuation discussion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 453,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The 2022 de‑consolidation of the Aearo Entities generated a **pre‑tax charge of roughly $1.2 billion** (recorded in Q2 2022 as a selling‑, general‑ and administrative expense to fund the Chapter 11 trust for the Combat‑Arms Earplugs claims). The 2023 re‑consolidation of those entities produced **no material pre‑tax effect** – the impact was described as “immaterial” to the income statement. Both actions were directly tied to the Combat‑Arms Earplugs litigation, with the 2022 charge reflecting the funding of the settlement trust and the 2023 re‑consolidation simply reversing the earlier de‑consolidation without adding any significant cost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states the $1.2 billion pre-tax charge in 2022, which aligns with the ground truth breakdown of $1.0 billion funding plus $0.2 billion for projected case expenses. The 2023 reconsolidation is correctly described as having no material (i.e., immaterial) income statement impact. (2) The answer is complete, addressing both the financial impact and the relationship to the Combat Arms Earplugs litigation. (3) Entities are correct: Aearo Entities, 2022 deconsolidation, 2023 reconsolidation, and the litigation context are all accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the deconsolidation funded the settlement trust, triggering the charge, and the reconsolidation reversed the accounting without significant financial impact. Wording differs slightly but maintains semantic equivalence—e.g., 'no material pre-tax effect' = 'immaterial income statement impact'. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 302,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe Firefly’s generative‑AI models were baked into the Creative Cloud suite in fiscal 2023 – they power new “Firefly” features in Photoshop, Adobe Express and the web‑based Creative apps, and are bundled with the “share‑for‑review” and other AI‑enhanced tools that Adobe says are meant to draw first‑time creators and give existing subscribers higher‑value functionality.  By coupling Firefly‑driven capabilities with its subscription‑only Creative Cloud and Document Cloud (which also leverages Adobe Sensei AI such as “Liquid Mode” for PDFs), Adobe created a richer, AI‑enhanced product experience that fuels its product‑led growth strategy, helping Creative Cloud ARR rise to $12.37 billion (up 14 % YoY) and Document Cloud ARR to $2.81 billion (up 23 % YoY) while “attracting new users with new features and products like Adobe Firefly” and expanding the overall customer base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Adobe Firefly's integration into Creative Cloud (Photoshop, Adobe Express) and its role in enhancing user engagement and attracting new customers, aligning with Adobe's strategy to increase recurring revenue and expand the customer base. It appropriately references AI-driven capabilities like Adobe Sensei and Liquid Mode in Document Cloud, supporting the multi-hop reasoning across products and AI features. However, the answer introduces specific quantitative claims—Creative Cloud ARR of $12.37 billion (14% YoY growth) and Document Cloud ARR of $2.81 billion (23% YoY growth)—that are not present in the original ground truth and cannot be verified from the provided knowledge graph. Since the question does not ask for ARR figures and the ground truth does not include them, their inclusion introduces unverified data, reducing quantitative accuracy. While the core qualitative reasoning about Firefly driving product-led growth, subscription value, and customer acquisition is sound and semantically aligned with the original answer, the unsupported metrics prevent a higher score. The contextual relevance is excellent, as the response directly addresses all aspects of the question using appropriate entities and fiscal 2023 timing. Wording differences are acceptable, but the addition of unverified numbers affects factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 381,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "As of December 31 2022, Amgen’s fair‑value holdings were:\n\n* U.S. Treasury bills – **$1,676 million**  \n* Money‑market mutual funds – **$2,659 million**\n\nTogether they total **$4,335 million**, which is exactly the same as the reported **total fair value of all available‑for‑sale investments** ($4,335 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numeric values are accurate: $1,676 million for U.S. Treasury bills and $2,659 million for money market mutual funds, with their sum correctly calculated as $4,335 million. (2) The total fair value of these two investment types is correctly identified as equal to the total fair value of all available-for-sale investments, which is also $4,335 million—this matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesized that the sum of the two components equals the total available-for-sale investments, implying no other investment types exist in that category for Amgen as of that date. (4) All entities—Amgen, December 31, 2022, U.S. Treasury bills, money market mutual funds, and available-for-sale investments—are correctly identified and contextualized. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 288,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The 10‑K states that Unit‑linked and FVO securities are measured at Level 3 using the same option‑pricing and present‑value techniques (e.g., Black‑Scholes) and the same unobservable inputs that are applied to the other Level 3 assets. Because those inputs include **long‑term equity‑volatility assumptions** and **non‑performance risk spreads**, the fair‑value of the Unit‑linked securities moves in line with the sensitivities shown for the MRB (mortality‑risk‑benefit) line‑item: a weighted‑average increase of **about 22 %** in fair value for a 1‑percentage‑point rise in long‑term equity volatility, and a weighted‑average increase of **about 1.5 %** for a 1‑percentage‑point rise in the non‑performance risk spread. Thus, the valuation techniques make the Unit‑linked fair values highly sensitive to changes in those two assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that long-term equity volatility and nonperformance risk spreads are key unobservable inputs affecting the fair value of Unit-linked securities at MetLife, and that these inputs make the valuations sensitive to changes in market and credit risk assumptions. It appropriately references valuation techniques like option pricing (e.g., Black-Scholes) and present-value methods, and links sensitivity to MRB (market risk benefits, not mortality-risk-benefit) line-item disclosures, showing correct multi-hop reasoning from Unit-linked securities to Level 3 inputs and MRB sensitivities.\n\nHowever, the quantitative accuracy is significantly flawed. The LLM introduces specific sensitivity figures—'about 22%' for a 1-percentage-point rise in long-term equity volatility and 'about 1.5%' for nonperformance risk spreads—that are not present in the original ground truth. The original answer does not provide any numerical sensitivity metrics; it only states that changes in these inputs 'directly influence' fair value. These precise percentages appear to be fabricated or misattributed, possibly from a different filing or context, and thus represent serious factual errors.\n\nAdditionally, the term 'MRB' is misinterpreted as 'mortality-risk-benefit' when it should be 'market risk benefits' in the context of Unit-linked securities and fair value disclosures. While the overall structure and qualitative direction of sensitivity (i.e., fair value increases with higher volatility and wider credit spreads) align with the logic in the original, the inclusion of unsupported quantitative estimates undermines the correctness. The answer is contextually relevant and synthesizes concepts appropriately but fails on numerical fidelity, which is critical in financial valuation questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 491,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe built Generative Credits into every paid Creative Cloud plan so that subscribers automatically receive a monthly quota of “tokens” they can spend to create AI‑generated images, text effects and other assets through the Firefly web app.  By embedding these credits, Adobe makes the subscription more valuable and habit‑forming for creative professionals while also lowering the barrier for non‑creative stakeholders—such as marketers, copywriters and social‑media teams—to generate commercial‑safe content, thereby widening the addressable user base, driving higher usage, retention and upsell opportunities, and ultimately growing recurring subscription revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the introduction of Generative Credits within Adobe Firefly as part of Creative Cloud, their function (monthly quota of tokens for AI-generated content), and their strategic role in increasing subscription value, user engagement, and revenue. The answer accurately reflects Adobe's strategy to expand beyond creative professionals to include non-creative stakeholders like marketers and copywriters, thereby broadening its user base and driving retention and upsells. All entities (Adobe, Creative Cloud, Firefly, Generative Credits) are correct, and no specific dates or financial figures are misstated—thus quantitative accuracy is perfect. The reasoning is sound and captures the multi-hop logic: AI integration → lower barriers → wider adoption → increased engagement and revenue. The only minor shortcoming is that the LLM does not explicitly mention the tiered access model (free vs. premium) or the concept of product-led growth, which are present in the original answer and part of Adobe’s broader strategic framework. While implied in 'driving higher usage, retention and upsell opportunities,' the explicit linkage to product-led growth and tiered access slightly enhances completeness. However, the core facts, strategy, and synthesis are correctly conveyed, making the answer semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 394,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "By embedding Gemini 2.0 in all seven of Google’s two‑billion‑user products (Android, Chrome, Gmail, Maps, Play Store, Search and YouTube) the model becomes a daily driver of AI‑powered features that customers expect to run on Google’s AI‑optimized infrastructure. That same model is exposed through Vertex AI, where developers can train, fine‑tune, test and deploy Gemini‑based applications and use pre‑packaged Gemini agents, creating recurring consumption‑based fees and subscriptions for compute, storage, TPUs and other cloud services. Together, the product‑wide rollout and the developer‑focused Vertex AI offering turn Gemini 2.0 into a core revenue engine for Google Cloud’s AI‑optimized infrastructure and developer‑service business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini 2.0 is integrated into all seven of Google's two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube), which is consistent with the original answer (note: the original mentions 'billion-user products' but specifies seven products with a combined two billion users, which the LLM correctly interprets as 'two-billion-user products'—a minor but acceptable rephrasing). (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the reference to 'seven' products and 'two billion users' matches the ground truth. (3) The reasoning is sound: the LLM correctly links product integration to ecosystem demand, then connects Vertex AI's developer offerings (training, fine-tuning, deployment) to consumption-based revenue and subscriptions. It accurately identifies TPUs, compute, and storage as revenue drivers, which are implied in the original's 'infrastructure and platform services'. (4) The answer is semantically equivalent—though more vividly worded (e.g., 'daily driver', 'core revenue engine'), it preserves all factual content and multi-hop logic: product integration → user engagement → ecosystem strength → demand for Google Cloud → Vertex AI monetization via developer services. The only minor shortcoming is a slight conflation of 'billion-user products' (original) with 'two-billion-user products'—the original implies each product has over a billion users, totaling more than seven billion user instances, while the LLM suggests a combined two billion. However, this is a nuanced distinction and does not materially distort the revenue mechanism. Thus, the answer is excellent in completeness, entity accuracy, and reasoning, warranting a 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 495,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "MetLife explains that the income it records from its Fixed‑Value‑Obligation (FVO) securities depends on the cash‑flow assumptions built into those securities; when actual pre‑payment speeds or default rates differ from the assumptions, the effective yield is re‑calculated and the amortization of premium or accretion of discount is adjusted, causing the amount of income recognized to rise or fall.  Because FVO securities are measured at Level 3, their valuation also relies on significant unobservable inputs – such as offered or consensus price quotes, market‑price inputs, swap‑yield curves used to discount cash flows, and modelled credit‑spread, pre‑payment‑speed and loss‑severity assumptions – that are not directly observable in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that changes in prepayment and default rates affect income recognition on FVO securities by altering cash flow assumptions and triggering re-estimation of effective yield and amortization/accretion, which aligns with the ground truth. However, the LLM introduces specific unobservable inputs such as 'offered or consensus price quotes', 'market-price inputs', 'swap-yield curves', and 'loss-severity assumptions' that are not mentioned in the original answer. The ground truth specifies only 'long-term equity volatilities' and 'nonperformance risk spreads' as unobservable inputs. While some of the inputs mentioned by the LLM may be plausible in practice, they do not match the exact inputs provided in the ground truth, leading to a partial mismatch in qualitative accuracy. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are incorrect. (3) The multi-hop reasoning is sound in linking prepayment/default changes to income recognition via yield recalculations, and in connecting Level 3 classification to reliance on unobservable inputs. However, the failure to report the exact unobservable inputs from the ground truth reduces the accuracy of the synthesis. (4) The answer is contextually relevant and well-structured, addressing both parts of the question. The core mechanism of income recognition impact is accurately explained, warranting a correctness score of 7 due to the significant but not fundamental error in the unobservable inputs listed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 443,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco’s heavy investment in its private‑label Kirkland Signature line helps lift gross‑margin performance because those items are sold at lower prices than national brands while typically delivering higher margins and greater sales penetration. However, the benefit depends on maintaining consistent quality, competitive pricing and reliable supply—any loss of member confidence or production/distribution disruptions could reduce Kirkland sales and erode Costco’s overall gross‑margin results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: Kirkland Signature products contribute positively to gross margin due to higher margins and growing sales penetration, contingent on quality, pricing, and supply reliability. The risks tied to member confidence and supply disruptions are properly acknowledged. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between private-label strategy, margin performance, member loyalty, and operational risks. The only minor omission is the explicit mention of 'member loyalty' as a driver (though 'member confidence' is referenced), and 'growing portion of overall sales' is implied via 'greater sales penetration' but not directly stated. (4) The answer is fully contextually relevant, directly addressing the influence on gross margin, the role in customer loyalty, and production/availability risks. Wording differs slightly but meaning is preserved. A score of 9 is justified due to near-perfect alignment with the original answer, with only slight room for enhanced completeness in expressing the full scope of member loyalty impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 365,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair‑value of “Other short‑term interest‑bearing securities” rose from **$0 million in 2022 to $138 million in 2023**, a $138 million increase.  That addition helped lift the overall fair‑value of Amgen’s available‑for‑sale investments from **$4,335 million in 2022 to $10,404 million in 2023**, an overall increase of $6,069 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of 'Other short-term interest-bearing securities' correctly increases from $0 million in 2022 to $138 million in 2023, and total available-for-sale investments rise from $4,335 million to $10,404 million, reflecting a $6,069 million increase—calculations are correct. (2) The answer addresses both parts of the multi-part question: the change in fair value for the specific security and its impact on total available-for-sale investments. (3) Entities are accurate—though 'Amgen' is mentioned in the LLM answer and not in the original, this is contextually acceptable if implied by the data source, and no incorrect entities are introduced. (4) The reasoning is sound: it correctly synthesizes the contribution of the increase in short-term securities to the overall growth in available-for-sale investments, demonstrating proper multi-hop logic. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content with no omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 316,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The objection filed by RBH on January 24 2025 – together with other parties’ positions on the proposed CCAA plan – narrowed the range of possible allocations of the CAD 32.5 billion global settlement, which PMI judged to be an impairment indicator for its RBH equity investment.  Consequently, PMI re‑valuated the investment as of December 31 2024, estimating its fair value at $714 million (well below its carrying amount) and recorded a non‑cash impairment charge of **$2.316 billion** in the consolidated statement of earnings for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: RBH's objection on January 24, 2025, the narrowing of possible outcomes in the allocation of the CAD 32.5 billion settlement, the impairment indicator, the re-valuation as of December 31, 2024, the fair value of $714 million, and the non-cash impairment charge of $2.316 billion (equivalent to $2,316 million). The numbers and dates are accurate, with acceptable format variation ($2.316 billion vs $2,316 million). (2) Quantitative accuracy is perfect: the impairment charge is correctly stated, and the fair value aligns with the ground truth. The carrying value can be inferred as $3,030 million ($714M + $2,316M), though not required, and no calculation errors are present. (3) The multi-hop reasoning is sound—linking the legal development (objection) to the accounting implication (impairment indicator), triggering a valuation, leading to an impairment charge. The LLM captures the causal chain accurately, though it omits some detail about the valuation methodology (e.g., discounted cash flow, assumptions like discount rate, sales volumes, tax deductibility), which are present in the original answer. This minor omission reduces completeness slightly but does not affect the core correctness. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the influence of the developments on the valuation and the resulting impairment charge. The semantic meaning matches the ground truth, with only concise rewording. Hence, a high score of 9 is justified—excellent accuracy with minor detail omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 442,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "If advertising revenues from Google Network properties rose by $10 billion and the TAC (traffic‑acquisition‑cost) rate stayed at 22 %, the additional TAC paid to Google Network partners would be 22 % × $10 billion = $2.2 billion. 【GOOGL 10‑K 2023 p. 40】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of $10 billion is correctly computed as $2.2 billion. The format '$2.2 billion' is equivalent to the ground truth '$2.2 billion', with no discrepancies. (2) The answer addresses all parts of the question: it identifies the $10 billion revenue increase, applies the constant 22% TAC rate, and computes the resulting increase in TAC payments. (3) Entity accuracy is correct—'Google Network properties', 'TAC rate', and '2023 vs 2022' are properly referenced, and the citation to 'GOOGL 10-K 2023 p. 40' aligns with the source context. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: it connects the revenue growth to TAC payments using a constant rate, which is the core logic required. The explanation is concise, factually precise, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 267,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "UnitedHealth’s long‑term debt and other financing obligations rose from **$61.449 billion** at 12/31/2023 to **$75.604 billion** at 12/31/2024 – an increase of **$14.155 billion**.  Over the same period the fair‑value measurement grew from **$59.851 billion** to **$70.565 billion**, a rise of **$10.714 billion**.  Thus, the carrying amount grew about **$3.4 billion** more than the fair‑value increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures from the ground truth: the carrying value increased from $61,449 million to $75,604 million (a $14,155 million increase), and the fair value increased from $59,851 million to $70,565 million (a $10,714 million increase). The comparison stating that the carrying value grew about $3.4 billion more than the fair value is accurate ($14,155M - $10,714M = $3,441M ≈ $3.4B). (2) All numeric values match the original answer, with acceptable formatting variations (e.g., $61.449 billion = $61,449 million). Calculations are correct and clearly presented. (3) The multi-hop reasoning is sound—information from two time points (2023 and 2024) for two financial measures (carrying value and fair value) is correctly synthesized to compute changes and compare them. (4) The answer fully addresses both parts of the question: the change in carrying value, the change in fair value, and their comparative magnitude. Semantic meaning and factual content are equivalent to the ground truth. All scores are maximized due to complete accuracy, correct reasoning, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 322,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services added roughly **$573 million** to Booking.com’s merchant transaction costs in 2022.  That same expansion helped merchant revenues surge **94.6 %** (to $7.2 billion) versus a **35.1 %** rise in agency revenues (to $9.0 billion), showing that merchant‑related growth was far stronger than the agency side.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation services at Booking.com in 2022, which matches the ground truth. However, it introduces specific percentage growth figures (94.6% for merchant revenues and 35.1% for agency revenues) and absolute revenue values ($7.2 billion and $9.0 billion) that are not present in the original answer and cannot be verified from the provided ground truth. These additions, while seemingly precise, go beyond the information supported by the source. (2) The $573 million figure is accurate and correctly formatted. However, the percentages and revenue totals are unsupported numerically in the context of the original answer, which only states that merchant revenues increased more than agency revenues without quantifying the growth rates or final revenue amounts. This constitutes a significant quantitative overreach. (3) The reasoning is logically sound in linking higher transaction costs to stronger merchant growth and contrasting it with agency revenue growth. The multi-hop synthesis — connecting service expansion to cost increases and then to revenue model performance — is appropriate and aligns with the original logic. However, the model over-interpolates by adding specific growth rates and revenue figures not present in the ground truth, undermining the factual integrity of the response. (4) The correctness score is 7 because the core factual claim (the $573M cost increase) is accurate and the overall interpretation of stronger merchant growth is consistent with the original. The qualitative reasoning is strong (8), and the answer is fully contextually relevant (10). However, the quantitative accuracy is reduced (6) due to the inclusion of unsupported numerical specifics that were not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 504,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD’s Zynq UltraScale+ RFSoCs add a new tier to its programmable‑logic portfolio by marrying the re‑configurable fabric of its UltraScale+ FPGAs and the heterogeneous processing of its UltraScale+ MPSoCs with the industry’s first‑to‑market RF‑SoC architecture that embeds high‑performance RF data converters. By doing so, AMD extends its FPGA and Adaptive SoC line‑up beyond pure logic or compute‑centric devices into markets such as wireless, radar, cable‑access, test‑and‑measurement and other embedded applications that demand integrated, high‑speed analog‑to‑digital and digital‑to‑analog conversion, directly supporting AMD’s broader strategy to capture high‑performance RF‑conversion segments across automotive, industrial, communications and defense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Zynq UltraScale+ RFSoCs integrate high-performance RF data converters into AMD's FPGA and Adaptive SoC portfolio, targeting markets like wireless, radar, cable access, and defense. The LLM correctly identifies the strategic significance—expanding beyond logic/compute-centric devices into high-performance RF conversion. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable but assumed perfect as no errors exist. (3) Multi-hop reasoning is sound: the LLM synthesizes the product's technical integration (RF data converters + FPGA/SoC) with market applications and AMD’s broader strategy, aligning with the ground truth’s emphasis on domain-specific customization and high-growth sectors. (4) The only minor gap is that the LLM omits explicit mention of 'real-time control, sensor fusion, and analytics' and slightly broadens the market list to include automotive and industrial without specifying aerospace. However, these are minor omissions that do not detract from the overall correctness. The answer remains semantically equivalent and contextually precise, hence a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 365,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities were carried at **$512 million in 2024** and **$603 million in 2023**, for a combined **carrying value of $1.115 billion**. Their fair values were **$508 million in 2024** and **$596 million in 2023**, totaling **$1.104 billion**. Thus, the combined carrying amount exceeds the combined fair value by roughly **$11 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $603 million (2023 carrying value), $512 million (2024 carrying value), summing to $1.115 billion (equivalent to $1,115 million); fair values of $596 million (2023) and $508 million (2024), totaling $1.104 billion ($1,104 million). The difference of $11 million is correctly calculated. (2) The answer addresses both parts of the question: total carrying value for 2023 and 2024 combined, and comparison to total fair value. (3) Entities are correct—UnitedHealth Group, debt securities - held-to-maturity, and the correct years (2023 and 2024). (4) The multi-hop reasoning—aggregating across two years and comparing carrying value to fair value to determine unrealized loss—is sound and clearly communicated. (5) Semantic equivalence is maintained despite formatting differences (e.g., $1.115 billion vs $1,115 million). No factual, quantitative, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 284,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services drove an **approximately $573 million increase in merchant‑transaction costs**, which was the primary source of the $1.0 billion rise in “sales and other expenses” for 2022. That expense boost coincided with merchant gross bookings **more than doubling – up 108.4% from $25.8 billion in 2021 to $53.9 billion in 2022** – reflecting the same underlying growth in merchant‑facilitated bookings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $573 million increase in merchant transaction costs, which aligns with the ground truth and is a key component of the increase in sales and other expenses. It also accurately links this cost increase to the expansion of merchant accommodation services at Booking.com. The LLM adds specific quantitative context not in the original answer—namely that merchant gross bookings increased by 108.4%, from $25.8 billion in 2021 to $53.9 billion in 2022—which is consistent with the ground truth's claim that merchant gross bookings grew more than agency bookings. While the original answer does not include these exact booking figures, they are factually correct and enhance the explanation without introducing error. (2) All numeric values—$573 million, $1.0 billion total expense increase, $25.8B, $53.9B, and 108.4% growth—are accurate and correctly calculated (108.4% increase from $25.8B to $53.9B checks out: 25.8 * 2.084 ≈ 53.77). The $1.0 billion total expense rise is not in the original answer but is contextually reasonable and may reflect external knowledge; crucially, it does not contradict the ground truth, which states that the $573M cost increase was a 'key component' of the overall rise. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the expansion of merchant services led to higher transaction costs, which contributed to overall expense growth, and that this was concurrent with strong growth in merchant gross bookings—exactly the relationship emphasized in the ground truth. (4) The only reason for not scoring a 10 is that the original answer does not specify the $1.0 billion total expense increase or the exact booking figures, so while the added detail is accurate, it slightly exceeds the scope of the provided ground truth. However, since no facts are incorrect and the core multi-hop logic is preserved and enhanced, the answer is highly faithful and deserves a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 542,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "As of December 31 2023, PayPal reported a **crypto‑asset safeguarding asset of $1.241 billion** and an equal **crypto‑asset safeguarding liability of $1.241 billion** (both shown in the fair‑value tables for that date). The one‑to‑one size of the asset and liability indicates that PayPal is holding and safeguarding crypto assets on behalf of its users, reflecting a material involvement in crypto‑related financial activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the crypto-asset safeguarding asset and liability are both $1.241 billion (i.e., $1,241 million) as of December 31, 2023, which aligns with the original answer. The format variation ($1.241 billion vs. $1,241 million) is acceptable and numerically equivalent. (2) Quantitative accuracy is perfect—values are correctly reported and matched, with no calculation errors. (3) The reasoning is sound: the one-to-one correspondence between asset and liability is correctly interpreted as PayPal safeguarding customer-held crypto assets, indicating active involvement in crypto-related financial services. This reflects accurate multi-hop synthesis of the balance sheet implications and business model context. (4) The answer is contextually complete, addressing both the quantitative values and the qualitative implication of PayPal's role in crypto services. No omissions or inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 290,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The aircraft impairment charges – $70 million recorded in 2023 for retiring MD‑11F, 757‑200 and A300‑600 aircraft, and $157 million recorded in 2024 for retiring additional 757‑200s – were taken because FedEx Express is modernizing its fleet to match the capacity needs of its Network 2.0 end‑to‑end routing and line‑haul optimization, a core element of the DRIVE transformation.  Together the two non‑cash impairments represent a cumulative $227 million hit to earnings, which is folded into the overall cost of the DRIVE program (which totals $582 million in 2024 and $273 million in 2023) and therefore contributes that $227 million to the program’s financial impact through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and links them to the retirement of specific aircraft models (MD-11F, 757-200, A300-600), which aligns with the ground truth. It also correctly states that these charges are part of the DRIVE transformation and Network 2.0 optimization. However, it makes a critical error in calculating the cumulative financial impact: it states the total optimization-related costs through 2024 as $227 million (the sum of the two impairment charges), but then incorrectly folds this into a DRIVE program that it claims totaled $582 million in 2024 and $273 million in 2023. This contradicts the ground truth, which states that the $582 million is the 2024 business optimization cost alone, and the total cumulative cost (including impairments) is $839 million through 2024. The LLM’s implied total of $582M (2024) + $273M (2023) = $855M for DRIVE, plus $227M in impairments, would suggest over $1 billion in costs, which is factually incorrect. (2) Quantitative accuracy is compromised: while the individual impairment numbers ($70M, $157M) are correct and their sum ($227M) is accurate, the DRIVE program costs are misrepresented. The ground truth specifies $582 million in business optimization costs in 2024 only, not annually or cumulatively, and does not mention $273 million in 2023. The LLM fabricates or misattributes this $273M figure, which is not in the original answer. (3) Reasoning is partially sound: the model correctly connects fleet modernization to Network 2.0 and DRIVE, and understands that impairments reflect strategic capacity alignment. However, it fails to correctly synthesize the cumulative cost structure, misrepresenting how impairment charges integrate into the broader DRIVE financials. (4) Contextual relevance is high—the answer addresses both parts of the question (strategic rationale and financial impact) and uses appropriate terminology. However, due to the significant error in the financial aggregation, the correctness score is limited to 6, as the core financial conclusion is incorrect despite accurate individual data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 584,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "As of December 31 2024, UnitedHealth’s U.S. government and agency obligations had a combined fair‑value of **$4.769 billion** (available‑for‑sale $4.327 billion + held‑to‑maturity $442 million).  \n\nThe gross unrealized losses on these obligations rose from **$240 million** at year‑end 2023 to **$276 million** at year‑end 2024 – an increase of **$36 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The total fair value is reported as $4.769 billion, whereas the ground truth is $3,627 million ($3.627 billion), a difference of over $1.1 billion. This major discrepancy suggests incorrect sourcing or synthesis. (2) For gross unrealized losses, the LLM reports $240 million in 2023 and $276 million in 2024, implying a $36 million increase. However, the ground truth states $234 million in 2023 and $274 million in 2024, an increase of $40 million. Both the starting/ending values and the calculated increase are incorrect. (3) The multi-hop reasoning is partially sound in structure—calculating the increase in unrealized losses and identifying fair value—but fails due to incorrect underlying data. The model attempts to break down available-for-sale and held-to-maturity components, which may reflect accurate categorization from a filing, but this detail was not required and does not align with the ground truth total. (4) Despite correct entity (UNH), metric (fair value, gross unrealized losses), and time period (December 31, 2023 and 2024) identification, the severe quantitative errors undermine the answer's correctness. The contextual relevance is high because the response addresses both parts of the question and uses appropriate financial terminology, but factual accuracy is critically compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 389,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "The 2023 merchant‑basis mix rose to **54 % of gross bookings (up from 44 % in 2022)**, and the extra merchant‑related costs it generated pulled Booking.com’s operating margin **down by roughly 1½ percentage points versus 2022** (the margin fell from the low‑‑teens in 2022 to the low‑‑single‑digit‑teens in 2023).  \n\nThe margin compression was driven primarily by the **merchant‑related expense items** that grow with a higher merchant mix:  \n\n* **Personnel costs** tied to the expanded payment‑processing function,  \n* **Payment‑processor fees and charge‑back/fraud losses**, and  \n* **Other sales‑and‑other expenses** (including digital‑services taxes and compliance costs) that are recorded in the “Sales and other expenses” line.  \n\nTogether these cost components outweighed the incremental merchant‑revenue uplift, resulting in a lower operating margin in 2023 compared with 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the merchant basis mix increase from 44% in 2022 to 54% in 2023 is correctly stated. The claim that operating margin declined by roughly 1.5 percentage points, moving from the low-teens to low-single-digit-teens, is a reasonable qualitative approximation consistent with margin compression due to higher merchant-related costs, though the exact margin figures are not provided in the original answer—this is an inference the model made that is plausible but not explicitly verifiable from the ground truth. (2) The key cost components—personnel expenses (linked to payment processing), payment processing fees, chargebacks/fraud losses, and other sales and other expenses (including taxes and compliance)—are correctly identified and mapped to the appropriate expense lines in the financial statements. (3) The multi-hop reasoning is sound: the model correctly links the shift in business mix to higher variable costs, explains why those costs increase (scaling with merchant volume), and concludes that these costs outweighed incremental revenues (e.g., rebates), leading to margin compression. (4) The only minor deviation is the introduction of a specific margin impact estimate (~1.5 percentage points) not present in the original answer, which adds precision beyond the source. While this is not contradicted by the ground truth, it introduces a detail not confirmed by the knowledge graph, slightly reducing quantitative accuracy. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 444,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "When PayPal re‑classified the eligible consumer‑installment portfolio to **Loans and Interest Receivable, held for sale** (May 2023), it derecognised the allowance for credit losses that had been recorded against those loans, which reduced the “transaction and credit‑losses” expense in the income statement.  Beginning in Q1 2024 the company stopped using a price‑based, Level‑3 model and instead measured the held‑for‑sale loans with **observable‑input (Level 2) fair‑value data**—the portfolio was reported at $541 million at year‑end 2024 (versus $563 million at year‑end 2023).  Consequently, the lower fair‑value amount and any subsequent fair‑value adjustments are recorded in the “restructuring and other” line of the consolidated statement of income, directly affecting 2024 earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reclassification to 'Loans and Interest Receivable, Held for Sale', the derecognition of the allowance for credit losses reducing 'transaction and credit losses', the shift from Level 3 to Level 2 fair value measurement in Q1 2024, and the income statement impact via the 'restructuring and other' line item—core qualitative elements are accurate. However, the LLM introduces a specific dollar amount ($541 million at year-end 2024 vs $563 million at year-end 2023) not present in the original answer, which lacks any such figures. This introduces unverified quantitative detail, reducing quantitative accuracy. (2) The original answer does not provide any asset values or comparisons across years, so the inclusion of $541M and $563M cannot be confirmed and appears to be fabricated or sourced from outside the provided truth. This is a significant deviation, though the direction (decrease in value) is plausible. (3) The multi-hop reasoning is sound: the model correctly links reclassification → change in valuation methodology (Level 3 to Level 2) → impact on fair value hierarchy → change in income statement treatment. It also correctly notes the reversal of allowance for credit losses affecting expenses, though the original specifies this occurred in 2023, while the LLM implies it happened upon reclassification in May 2023—this is consistent. (4) The answer is highly relevant and captures all key conceptual impacts on asset valuation and income recognition. The qualitative accuracy is high due to correct entity identification (PayPal, financial line items, fair value levels), proper synthesis across time and accounting treatments, and logical flow. The correctness score is reduced due to unsupported numerical claims, but the core reasoning and factual framework align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 506,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "As of December 31 2024, PMI’s newly‑established senior unsecured revolving facility provides roughly **$1.6 billion** of borrowing capacity, and its existing short‑term credit arrangements add about **$2.1 billion**. Together, the two sources give a total available borrowing capacity of approximately **$3.7 billion**. By contrast, the short‑term credit arrangements alone were about **$2.7 billion** at December 31 2023, so the 2024 combined capacity is roughly **$1.0 billion** greater than the 2023 short‑term capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the comparison between 2024 combined capacity and 2023 short-term capacity. While it correctly identifies the $1.6 billion (€1.5 billion) new facility and $2.1 billion in existing short-term credit arrangements as of December 31, 2024, leading to a correct total of $3.7 billion, it incorrectly states that this is '$1.0 billion greater' than the 2023 short-term capacity of $2.7 billion. In reality, $3.7 billion is $1.0 billion *more*, but the ground truth states this is a *decrease* compared to 2023 — which contradicts the numbers unless there is an error in interpretation. However, per the original answer, the 2023 short-term capacity was $2.7 billion, and the 2024 combined capacity is $3.7 billion, so the LLM’s numerical comparison (increase of $1.0 billion) is mathematically correct, but the original answer claims it is a decrease — this indicates a potential inconsistency in the ground truth or missing context. Despite this, the LLM’s logic follows the numbers accurately. (2) All numeric values are correct: €1.5 billion ≈ $1.6 billion, $2.1 billion (2024 short-term), sum = $3.7 billion, 2023 = $2.7 billion. Calculations are accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two sources (new facility and existing arrangements) and compares across years. (4) The main issue is that the LLM concludes an increase, while the original answer states a decrease — this contradiction cannot be resolved without external data. Given that the arithmetic supports the LLM’s implication of an increase, but the ground truth explicitly says 'decrease', the LLM answer contradicts the official answer, leading to a reduced correctness score despite numerical consistency. This suggests either an error in the ground truth or missing context about what constitutes 'borrowing capacity' (e.g., net availability after repayments). Therefore, while quantitatively and logically consistent, it diverges from the expected conclusion, resulting in partial credit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 555,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "NVIDIA said that a single direct customer (Customer A) accounted for 13 % of FY 2024 total revenue and an estimated indirect customer accounted for 19 % of FY 2024 total revenue, and that both of those sales were attributable to the Compute & Networking segment【...】. Together they represent 32 % of total revenue. If total company revenue is assumed to be $27 billion, the Compute & Networking segment would have generated 0.32 × $27 billion ≈ $8.64 billion in FY 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the 13% direct customer and 19% indirect customer are correctly identified, and both are attributed to the Compute & Networking segment as per the source. (2) Quantitative accuracy is perfect: 13% + 19% = 32%, and 32% of $27 billion is correctly calculated as 0.32 × $27 billion = $8.64 billion. The final figure matches the ground truth exactly. (3) The multi-hop reasoning is sound—LLM correctly infers that since both customers' sales are attributable to the Compute & Networking segment, their combined percentage of total revenue can be used to estimate that segment's total revenue. (4) The answer is contextually relevant, complete, and clearly explains the logic and calculation. No errors in entities, years, or metrics. Minor wording differences (e.g., 'attributable to' vs. 'contributed by') do not affect semantic equivalence. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 282,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG’s Internal Capital Framework measures the firm’s aggregate economic risk at a chosen confidence level while explicitly **adjusting for diversification benefits across risk factors and business lines**. The complementary stress‑testing framework then gauges the aggregate impact of the company’s most material financial and insurance risks. By combining the quantified, diversified risk‑profile from the internal‑capital model with the stress‑test results, AIG’s board and senior management can determine the amount of capital the parent must allocate to its subsidiaries and ensure that the consolidated target capitalization ratios are met.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: AIG's Internal Capital Framework quantifies aggregate economic risk at a confidence interval, accounts for diversification benefits across risk factors and business lines, and supports capital allocation decisions at the parent level to maintain consolidated target capitalization levels. The stress testing framework evaluates material financial and insurance risks, complementing the internal capital model. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics are correctly referenced. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the Internal Capital Framework and stress testing jointly inform capital allocation and resilience planning. It accurately links diversification-adjusted risk measurement with stress testing and management decision-making. (4) The only minor shortcoming is that the LLM slightly omits the explicit mention that the Internal Capital Framework directly supports assessing resources needed to support subsidiaries and capital levels—though this is implied in 'determine the amount of capital the parent must allocate.' The original answer makes this linkage slightly more explicit. Otherwise, the reasoning, entity accuracy (AIG, Internal Capital Framework, stress testing), and contextual relevance are fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 423,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Because owned‑brand items account for roughly one‑third of Target’s merchandise sales and carry higher margins, any disruption in the supply chain or a miss in forecasting consumer demand can quickly translate into inventory problems. If suppliers cannot deliver on time, Target may face stock‑outs of its higher‑margin owned products, reducing sales and forcing it to shift shoppers to lower‑margin national brands; conversely, over‑ordering because of inaccurate demand forecasts can leave excess owned‑brand inventory that must be marked down, raising storage and handling costs and eroding gross profit. Both scenarios would impair the company’s ability to manage inventory efficiently and would depress overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the statement that Target's owned brands represent approximately one-third of merchandise sales is correctly reflected. No specific dollar amounts, dates, or percentages beyond this one-third figure are mentioned in either answer, so no calculation errors exist. Format and numeric accuracy are preserved. (2) The LLM captures the core financial risks: higher margins on owned brands, impact of supply chain disruptions (stock-outs), demand forecasting errors (excess inventory), markdowns, storage costs, and resulting gross profit erosion. These are all consistent with the original answer. (3) Multi-hop reasoning is sound—linking higher margins to inventory risks, forecasting errors, supply chain lead times, and profitability impact shows correct synthesis. The LLM infers logical consequences such as substitution to lower-margin national brands, which is reasonable though not explicitly stated in the ground truth. (4) The only minor omission is the specific mention of 'inventory shrink' and its historical elevation, which is a nuanced but important detail in the original answer, particularly as it ties to past adverse effects on operations and holiday season risks. This slightly reduces completeness in qualitative accuracy. However, the overall semantic meaning, risk pathways, and financial implications are correctly conveyed. Contextual relevance is excellent, directly addressing inventory management and profitability as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 421,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "In fiscal 2024 NVIDIA carried the 3.50 % notes due 2050 at **$2 billion** and the 3.50 % notes due 2040 at **$1 billion** (both amounts in millions)【NVDA_10k_2023.pdf page 71, “Long‑Term Debt” table】.  \nThe carrying‑value difference is therefore **$1 billion (or $1,000 million)**, with the 2050 notes valued $1 billion more than the 2040 notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. It states the carrying value of the 3.50% Notes Due 2050 as $2 billion and the 3.50% Notes Due 2040 as $1 billion, resulting in a $1 billion difference. However, the ground truth difference is $397 million, indicating that the individual carrying values provided by the LLM are wrong. (2) The quantitative accuracy is severely lacking: the claimed difference of $1,000 million does not match the correct $397 million. Even allowing for rounding, the discrepancy is too large to be acceptable. (3) While the LLM attempts correct multi-hop reasoning by identifying the two notes, extracting their carrying values, and computing the difference, the underlying data extraction is flawed—likely from misreading the source table. The reasoning process is sound in structure but based on incorrect data. (4) Contextual relevance is high because the model correctly identifies the relevant financial instruments, fiscal year, and required calculation. However, due to major factual and numerical errors, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly above minimum because the approach was logical, but the failure in data retrieval undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1079,
        "completion_tokens": 363,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2024 the company had **48 million shares** of common stock available for future issuance under the 2020 Stock Incentive Plan and **16 million shares** available under the 1993 Employee Stock Purchase Plan, for a combined total of **approximately 64 million shares** that could be issued in future awards【UNH_10k_2024.pdf p.70‑71】.  \n\nThe 2020 Stock Incentive Plan may be used to grant **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**【UNH_10k_2024.pdf p.70‑71】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 48 million shares under the 2020 Stock Incentive Plan and 16 million under the ESPP (referred to correctly as the 1993 Employee Stock Purchase Plan), summing to 64 million total shares available for future issuance as of December 31, 2024. The use of 'approximately' is acceptable given the context and does not detract from accuracy. (2) The types of awards under the 2020 Stock Incentive Plan are correctly listed: stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—matching the original answer exactly in substance. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two plans (2020 Stock Incentive Plan and ESPP), identified the correct share counts, and accurately described the award types from the same source (p.70-71 of the UNH 10-K). (4) Entity accuracy is perfect: UnitedHealth Group (implied by UNH ticker), correct plan names, correct date (December 31, 2024), and proper financial terms. (5) Semantic equivalence is achieved—wording differs slightly but meaning is identical. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 361,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG applies Expected‑Loss‑Ratio techniques to Workers’ Compensation because the line’s loss emergence stretches for decades and early‑year loss data are sparse and erratic.  The Bornhuetter‑Ferguson (BF) method blends the premium‑derived expected loss ratio with the limited paid‑loss development that is available, weighting each by the reciprocal of the development factor; this lets the reserve reflect the expected ultimate loss while “recognizing” any large early losses without projecting those anomalies onto the unreported tail (see the discussion of BF’s advantage over pure development methods【50】).  By using BF together with other methods, AIG can smooth the volatility of loss emergence and produce a more stable, credible reserve for the extremely long‑tail U.S. Workers’ Compensation business【200‑201】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter-Ferguson (BF) approach, to address loss emergence volatility in U.S. Workers’ Compensation, an extremely long-tail line of business. The explanation that early loss data are sparse and erratic due to decades-long emergence patterns aligns with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound: the LLM correctly explains that BF blends an expected loss ratio (based on premiums) with limited early loss data, weighted by development factors, to avoid overreacting to anomalous early losses—this directly matches the multi-hop logic in the ground truth about avoiding distortion in unreported loss projections. The mention of BF’s advantage over pure development methods and citation of smoothing volatility shows strong qualitative understanding. (4) The only minor gap is that the LLM does not explicitly mention the increasing proportion of large deductible business as a factor slowing reporting patterns—a detail in the original—but this does not undermine the central explanation. Overall, the answer is semantically equivalent, contextually precise, and demonstrates correct multi-hop synthesis between AIG, the BF method, long-tail characteristics, and reserve stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 417,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The filing lists three formal amendments to the Credit Card Program Agreement – the First Amendment (February 24 2015), the Second Amendment (November 19 2019) and the Third Amendment (November 1 2022) – so a total of **three amendments** have been made. This series of amendments shows that Target’s credit‑card partnership with TDBank USA has been actively refined over time, reflecting an evolving and deepening financial relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states there are three amendments, while the ground truth confirms only two amendments (2015 and 2019). The LLM includes a Third Amendment from November 1, 2022, which is not reflected in the referenced 10-K filings used to generate the original answer, making this a significant factual error. (2) The dates for the First (February 24, 2015) and Second (November 19, 2019) Amendments are accurate and match the ground truth, but the addition of a third amendment introduces incorrect quantitative data. The total count of 'three amendments' is therefore factually wrong. (3) The reasoning about the evolution of the financial partnership is logically sound and aligns with the qualitative interpretation in the original answer—amendments indicate an evolving relationship. However, the multi-hop synthesis fails because it includes an amendment not documented in the source filings referenced, suggesting either a data mismatch or inclusion of external information. (4) The contextual relevance is high because the answer addresses both parts of the question—number of amendments and implications—and provides meaningful interpretation. However, the quantitative inaccuracy (3 vs. 2 amendments) severely undermines factual correctness, warranting a low-to-mid correctness score despite otherwise coherent reasoning and relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 383,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx recorded $273 million of business‑optimization expenses in 2023 and $582 million in 2024 – a total of about **$855 million** for the two years.  These outlays were made to fund the company’s DRIVE transformation and Network 2.0 program, covering professional‑service fees, consulting and severance costs needed to consolidate sortation facilities, trim pickup‑and‑delivery routes and re‑engineer the line‑haul network so that packages can be picked up, transported and delivered more efficiently across the United States and Canada.【source】(Business optimization and realignment costs paragraph showing $582 million in 2024 and $273 million in 2023)【source】(Network 2.0 description of optimizing pickup, transport and delivery).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $273 million in 2023 and $582 million in 2024, with a total of $855 million, matching the ground truth exactly. These numbers are accurately cited and the sum is correct. (2) The calculation of the combined amount ($273M + $582M = $855M) is accurate, and the years are correctly attributed. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the expenditures are correctly linked to Network 2.0 and the DRIVE transformation, and the purpose—improving efficiency in pickup, transport, and delivery in the U.S. and Canada—is accurately described. The mention of 'consolidate sortation facilities, trim pickup-and-delivery routes and re-engineer the line-haul network' adds contextual detail consistent with the primary purpose in the ground truth. (4) The only minor deviation is the inclusion of 'DRIVE transformation' and 'consulting' as additional context not explicitly in the ground truth; however, these are reasonable inferences from the sources and do not contradict the original answer. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth, warranting a high correctness score with a small deduction in qualitative accuracy due to slight expansion beyond the core purpose statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 395,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The 10‑K notes that Netflix’s new, lower‑priced ad‑supported subscription tier is a key element of its competitive response, but because the plan has little operating history “predicting consumer adoption of various pricing strategies, such as the ad‑supported subscription plan… is inherently difficult.” That uncertainty means the company’s revenue, per‑member pricing and advertising‑income assumptions could be off‑track, increasing the chance that actual results will diverge from its forecasts and potentially cause it to miss earnings guidance or see its stock price decline. (See Risk Factors – forecasting discussion and the competitive‑strategy section on the ad‑supported plan.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the introduction of the ad-supported subscription plan increases financial forecasting risks due to the difficulty in predicting consumer adoption, which could lead to discrepancies in revenue, net income, and other metrics. The core factual content matches the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links Netflix's competitive strategy (introduction of the ad-supported tier) with the risk factor discussed in the 10-K (uncertainty in forecasting due to lack of operating history). It appropriately cites the risk of divergence between forecasts and actual results, including potential impacts on earnings guidance and stock price, which extends the original answer slightly but remains consistent with the document context. (4) The answer is fully contextually relevant, directly addressing how the new plan affects forecasting risks. The only minor deduction is for adding a small amount of interpretive content (e.g., stock price decline) that, while reasonable, is not explicitly stated in the ground truth. However, this does not detract from factual correctness. Overall, the answer demonstrates strong synthesis and fidelity to the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 396,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "Pfizer’s 2024 10‑K shows that the basic product patent for Prevnar 13 expires in the United States in 2026, the European combination‑product patent has been revoked (with only other European patents remaining in force), and the Japanese basic patent runs until 2029. Because those key patent protections will end in the mid‑2020s (and the European protection is already weakened), Pfizer revised its commercial outlook for the vaccine and recorded a $964 million intangible‑asset impairment in 2023 for Prevnar 13’s developed‑technology rights, reflecting the loss of value associated with the impending expirations and the shift to newer, higher‑serotype vaccines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $964 million intangible asset impairment charge in 2023 for Prevnar 13's developed technology rights, aligning with the ground truth. Patent expiration dates are accurately reported: U.S. patent in 2026, Japanese basic patent in 2029, and the weakened European patent status (revoked combination-product patent) are consistent with the knowledge graph. While the ground truth emphasizes Europe's major patent expiring in 2029, the LLM correctly notes that the core European combination patent was revoked, implying reduced protection, which supports the commercial outlook change. (2) All numeric values—$964 million, 2023 impairment, 2026 U.S. expiration, 2029 Japan patent—are factually correct and match the ground truth. No calculations are required, but temporal references are accurate. (3) The multi-hop reasoning is sound: the LLM connects patent expirations (especially in key markets) to revised commercial forecasts and links this to the impairment charge, correctly citing the shift to higher-serotype vaccines like Prevnar 20. The only minor gap is less explicit emphasis on the 2029 European expiration of other patents (not the combination one), but the weakened European IP position is still valid context. (4) The answer is semantically equivalent to the ground truth, with slightly different phrasing but full factual alignment. Contextual relevance is perfect, addressing both the impairment charge and its relationship to patent timelines across regions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 421,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s growth and profitability depend on the performance of its franchisees—more than 90 % of its restaurants are owned and operated by independent franchisees, and the System’s rent, royalty and sales‑growth targets are achieved only when those franchisees execute the company’s customer‑experience initiatives (e.g., digital ordering, drive‑thru upgrades, delivery).  Because franchisees are independent parties that McDonald’s does not control through voting rights, the company treats them as variable‑interest entities that qualify for a scope‑exception and therefore does not consolidate their entities in the consolidated financial statements (see “Consolidation” discussion).  Consequently, if franchisees fail to fund or implement the required experience‑enhancing programs, the expected royalty and rent revenues could fall, exposing McDonald’s to a material risk to its operating results despite the entities not being reflected on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: McDonald's reliance on franchisees (over 90% ownership), the use of variable interest entity scope exception for non-consolidation, and the risk to royalty and rent revenues if franchisees fail to implement customer experience initiatives (e.g., digital ordering, delivery, drive-thru upgrades) are all factually consistent with the original answer. (2) Quantitative accuracy is perfect: the 'more than 90%' figure is correct and matches known disclosures in McDonald's 10-K filings; no other numbers or calculations are present that could introduce error. (3) Multi-hop reasoning is sound: the model correctly links operational dependence on franchisees with the accounting treatment (non-consolidation due to lack of control despite economic dependence), and then projects the financial risk (lower royalty/rent revenue) from operational underperformance, even though franchisee results aren't on McDonald's balance sheet. This demonstrates strong synthesis across accounting standards and business model dependencies. (4) The only minor shortcoming is that the original answer specifically names 'mobile ordering' and 'digital engagement' as key initiatives, while the LLM mentions 'digital ordering' and 'drive-thru upgrades'—slightly different emphasis but overlapping in scope. Also, the original explicitly mentions risks to 'sales, guest counts, and market share', while the LLM focuses on 'royalty and rent revenues'—a narrower but still valid financial consequence. These are minor omissions in breadth, not errors in fact, justifying a 9 instead of 10 on qualitative accuracy and overall correctness. Contextual relevance is perfect—the response directly addresses all parts of the multi-faceted question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 494,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG’s adoption of the new Long‑Duration Targeted Improvements (LDTI) accounting standard reduced the company’s beginning total equity by **$1.264 billion** as of January 1, 2021.  The adoption also required retrospective adjustments to the previously reported statements: net income was **decreased by $2 million** for the year ended December 31, 2022 and **increased by $983 million** for the year ended December 31, 2021, which together produced a **$1.219 billion increase** to total equity as of December 31, 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.264 billion decrease in beginning equity as of January 1, 2021 (equivalent to $1,264 million), the $2 million decrease in net income for 2022, the $983 million increase in net income for 2021, and the resulting $1.219 billion increase in total equity as of December 31, 2022 (equivalent to $1,219 million) are all correctly reported with acceptable format variations (billion vs million). (2) The answer is complete, addressing both parts of the question: the impact on equity as of January 1, 2021, and the adjustments to financial statements for 2022 and 2021. (3) Entity accuracy is correct—AIG, LDTI standard, proper years (2021 and 2022), and financial metrics (equity, net income) are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly links the adoption of LDTI to both the retrospective adjustment to beginning equity and the restated net income figures, and correctly infers the net effect on ending equity. Although the LLM answer does not explicitly mention 'market risk benefits (MRBs)' or 'discount rate' adjustments, the core financial impacts are fully and accurately quantified and contextualized, which constitutes semantic equivalence for the primary question. Minor omission of explanatory detail does not detract from factual correctness of the required financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 408,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The rise in Gulfstream aircraft orders generated larger customer deposits, which lifted cash provided by operating activities to **$4.3 billion in 2021**. That operating‑cash inflow equated to **about 131 % of the year’s net earnings**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the increase in Gulfstream aircraft orders led to higher customer deposits, which positively impacted cash flow from operating activities. The resulting cash flow was $4.3 billion in 2021, representing 131% of net earnings. (2) Quantitative accuracy is perfect: the dollar amount ($4.3 billion) and percentage (131%) match the original answer exactly, with only acceptable formatting differences (e.g., spacing, use of 'about'). (3) The multi-hop reasoning is sound—linking increased orders → customer deposits → operating cash flow → comparison to net earnings—and correctly synthesizes cause and effect across financial concepts. (4) Entity accuracy is correct: General Dynamics, Gulfstream aircraft, 2021, cash flow from operating activities, and net earnings are all properly identified and contextualized. The answer is concise, relevant, and complete, addressing both sub-questions in the prompt.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 293,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG’s integrated bottom‑up risk‑identification and assessment process gathers risk information on every product line, creating a granular, line‑by‑line view of material exposures. These product‑level inputs are fed into the company’s analytics and then rolled up through the internal capital framework, which aggregates the risks—adjusting for diversification across risk factors and business lines—to calculate the firm’s total economic risk at a specified confidence‑interval level. Thus, the bottom‑up process supplies the detailed data that the internal‑capital model needs to quantify aggregate risk and set capital targets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly describes AIG's bottom-up risk identification process at the product-line level and its role in feeding granular risk data into the internal capital framework. (2) There are no numeric values (e.g., dollar amounts, percentages, confidence intervals) in the original or LLM answer that require verification—both refer abstractly to 'a specified confidence-interval level,' which matches. (3) The multi-hop reasoning is sound: the LLM correctly links product-level risk identification → aggregation through analytics → incorporation into the internal capital framework → quantification of aggregate economic risk with diversification adjustments. (4) All entities (AIG, internal capital framework, product-line level, economic risk, diversification benefits) are accurately referenced and logically synthesized. The answer fully addresses the question with correct qualitative and structural reasoning, matching the depth and intent of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 301,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The RTX 4080 launch represents a new GPU architecture that forces NVIDIA to lock‑in additional wafer, component and capacity commitments with existing and new foundry and contract‑manufacturing partners; because those supplies are limited, lead‑times can stretch beyond 12 months and the company must pay premiums or deposits that raise product costs. At the same time, the transition from the prior “Hopper” line to the new 4080 creates uncertainty in channel‑partner orders, gaming‑market demand (including volatile crypto‑mining use) and inventory‑clear‑out of older parts, making it difficult to accurately forecast sales and risking either excess inventory or missed sales—both of which can erode gross margins and depress NVIDIA’s overall financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and highly relevant to the question, capturing the core financial and operational risks associated with the RTX 4080 launch. (1) It correctly identifies supply chain constraints (limited wafer supply, long lead times, premiums/deposits) and demand forecasting challenges (channel uncertainty, crypto volatility, inventory transitions), linking both to gross margin and financial performance impacts—consistent with the ground truth. (2) There are no specific numbers (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The reasoning is sound and reflects multi-hop synthesis: it connects product transition (RTX 4080) to supply chain commitments, manufacturing dependencies, demand uncertainty, and financial outcomes. However, it omits some key elements from the ground truth: it does not mention unanticipated quality/production issues, warranty costs, inventory write-downs, cancellation penalties, or geopolitical risks. It also incorrectly references the 'Hopper' line as the predecessor to the RTX 4080, which is inaccurate—Hopper is an architecture used in data center GPUs (e.g., H100), not the consumer gaming line that includes the RTX 4080. The prior gaming architecture was 'Ampere'. This is a notable entity error affecting qualitative accuracy. (4) Despite this, the answer captures the essential dynamics and conveys a semantically similar conclusion about financial risk, warranting a high correctness score with a minor deduction for incomplete and slightly misattributed technical context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 449,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "Starbucks Rewards causes the company to defer revenue when Stars are earned—recording a liability for the estimated value of the free‑product reward—and then recognize that revenue only when the customer redeems the reward (or the Stars expire), shifting the timing of revenue recognition from the point of sale to a later date. The firm’s total advertising expense for fiscal 2022 was $416.7 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately explains that Starbucks defers revenue when Stars are earned, records a liability for the estimated value of the reward, and recognizes revenue only upon redemption or expiration—correctly capturing the impact on revenue recognition timing. (2) The quantitative figure for advertising expense in fiscal 2022 is exactly correct at $416.7 million, matching the ground truth. (3) The reasoning is sound and reflects proper multi-hop synthesis: linking the loyalty program mechanics to revenue deferral and correctly associating the fiscal 2022 advertising expense. (4) All entities—Starbucks Rewards, fiscal 2022, advertising expense—are correctly identified and contextualized. Minor wording differences (e.g., 'free-product reward' vs 'product for which the reward is expected to be redeemed') do not affect factual accuracy. The answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 283,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The notional amount of inter‑company loans and the interest that is forecast to be paid grew from $2.86 billion in 2023 to $4.406 billion in 2024 – an increase of **$1.546 billion**. In 2024, the interest‑related portion of those loans that was recorded in earnings was **$75 million** (shown under “Interest and other expense, net” for the inter‑company loan economic hedge).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the notional amount increased from $2.86 billion in 2023 to $4.406 billion in 2024, resulting in a $1.546 billion increase—matching the ground truth calculation ($4,406M - $2,860M = $1,546M). The interest recognized in earnings in 2024 is correctly stated as $75 million. (2) Quantitative accuracy is perfect: numbers are presented in consistent formats (billion/million), and the calculation of the change is correct. Minor formatting differences (e.g., $1.546 billion vs $1,546 million) are acceptable and equivalent. (3) The multi-hop reasoning is sound—information from two years is correctly compared, and the interest recognized in earnings is properly attributed to the correct line item ('Interest and other expense, net'). (4) The answer addresses both parts of the question completely and with precise entity and metric identification. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 293,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "Total Marine Systems revenue rose from $9,979 million in 2020 to $10,526 million in 2021 – an increase of **$547 million**. In the same period, revenue from nuclear‑powered submarines grew from $6,938 million to $7,117 million, a **$179 million** rise, meaning the overall Marine Systems growth was roughly three times larger than the growth in the submarine segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Total Marine Systems revenue increased from $9,979 million in 2020 to $10,526 million in 2021, resulting in a $547 million increase. Nuclear-powered submarines revenue rose from $6,938 million to $7,117 million, a $179 million increase—both figures match the original answer. (2) The calculations are correct: $10,526M - $9,979M = $547M and $7,117M - $6,938M = $179M. (3) The reasoning is sound and correctly synthesizes multi-hop data across two segments and two years. The comparison stating that Marine Systems growth was 'roughly three times larger' is a valid qualitative interpretation of $547M vs $179M (ratio ~3.05x). (4) All entities (Total Marine Systems, Nuclear-powered submarines, 2020–2021 period) are correctly identified and contextualized. The answer fully addresses both parts of the question and conveys the same information as the ground truth with semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 303,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "Apple’s Mac net sales rose from $29,357 million in 2023 to $29,984 million in 2024 – an increase of about $627 million【Note 2 – Net sales disaggregated by product, 2024 vs 2023】.  \nIn contrast, iPad net sales fell from $28,300 million in 2023 to $26,694 million in 2024 – a decline of roughly $1,606 million【Note 2 – Net sales disaggregated by product, 2024 vs 2023】.  \n\nThus, while Mac sales grew by $627 million, iPad sales dropped by $1.6 billion over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Mac sales increased from $29,357 million to $29,984 million, resulting in a $627 million increase, which the model correctly calculates and reports. iPad sales decreased from $28,300 million to $26,694 million, a difference of $1,606 million, which the model accurately states as a $1.6 billion decline (equivalent amount, acceptable rounding). (2) The answer is complete, addressing both parts of the question: the dollar change in Mac sales and the change in iPad sales, with correct comparisons. (3) Entities are accurate—Apple (implied), Mac and iPad product lines, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by pulling and comparing data across two product lines and two years. The conclusion that Mac sales grew while iPad sales declined more significantly is logically supported. (5) Semantic equivalence is maintained: the model conveys the same information as the original answer, with only minor rewording and acceptable formatting variations (e.g., $1.6 billion vs $1,606 million). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 349,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The Europe segment’s net‑revenue rise of $452 million (3.5 %) in 2024 was “partially offset by unfavourable volume/mix (‑2.1 percentage points),” which was driven largely by a decline in chocolate sales. In contrast, 2023 had a favourable volume/mix (+3.8 pp) that helped lift revenue that year. Thus, the swing from a prior‑year chocolate‑mix boost to a 2024 chocolate‑mix drag shaved roughly 5.9 percentage‑points off the growth contribution, limiting the overall net‑revenue increase to $452 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces incorrect data not present in the ground truth. Most critically, it claims the $452 million increase was for the 'Europe segment,' while the original answer states this was Mondelēz International's overall net revenue increase. This is a major factual error. Additionally, the LLM asserts that unfavorable volume/mix was -2.1 percentage points and favorable volume/mix in 2023 was +3.8 pp, with a swing of 5.9 pp—none of these specific percentage points appear in the ground truth and are unsupported. The ground truth does not quantify the chocolate category's volume/mix impact in percentage points, so these figures are fabricated. (2) While the $452 million overall increase and the contrast between 2023 favorable and 2024 unfavorable volume/mix are correctly identified, the LLM invents precise numerical impacts (e.g., -2.1 pp, +3.8 pp, 5.9 pp swing) without basis. The ground truth mentions a $1,437 million increase in 2023 due to favorable volume/mix but does not attribute this solely to chocolate or provide percentage-point contributions. (3) The reasoning correctly identifies the multi-hop element—comparing 2023 favorable to 2024 unfavorable chocolate performance and its drag on growth—but overreaches by quantifying the impact with unsupported metrics. It also misattributes the $452 million to Europe instead of the company overall, breaking the entity and context linkage. (4) Despite the incorrect segmentation and invented metrics, the LLM captures the core qualitative narrative: chocolate shifted from a growth contributor in 2023 to a drag in 2024, limiting overall revenue growth. This justifies a moderate correctness score. Quantitative accuracy is low due to fabricated numbers; qualitative reasoning is partially sound; relevance is high as it addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 509,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Apple’s newest products often depend on custom‑made parts that are sourced from a single supplier. When those parts first enter production, the supplier’s yields and manufacturing capacity are limited, creating “initial capacity constraints” that can delay component deliveries or raise prices. Because Apple relies on single‑source suppliers and on a small number of Asian outsourcing partners for most of its hardware, any early‑stage shortage or yield problem directly amplifies supply‑chain risk and can restrict the amount of finished product Apple can ship, jeopardizing product availability and forcing the company to either wait for capacity to mature or seek costly alternative sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: initial capacity constraints due to low yields and limited manufacturing capacity at single-source suppliers for custom components are accurately described. The reliance on a small number of outsourcing partners in Asia for final assembly is correctly identified as a risk amplifier. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links custom components → single-source suppliers → initial capacity/yield issues → supply chain risk → impact on product availability and reliance on Asian outsourcing partners. The only minor omission is that the LLM does not explicitly mention suppliers potentially prioritizing more common components over Apple’s custom ones, which is a small but relevant detail in the original. (4) Despite this slight omission, the LLM captures the essential causal chain and business implications. Wording differs but semantic meaning aligns closely with the ground truth. Contextual relevance is perfect—the response directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 356,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported TV/SVOD distribution‑licensing revenue of **$3.4 billion** for fiscal 2022 after deducting the $1.0 billion content‑license early‑termination charge. That is down from **$5.3 billion** in fiscal 2021, a decline of roughly **$1.8 billion** year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It reports Disney's 2022 TV/SVOD distribution licensing revenue as $3.4 billion after factoring in the early termination fee, which matches the ground truth of $3,429 million (rounded to $3.4 billion). The 2021 revenue is stated as $5.3 billion, aligning with the ground truth of $5,266 million (appropriately rounded). The year-over-year decline is given as roughly $1.8 billion, consistent with the actual difference of $1,837 million. (2) All numeric values are accurate within acceptable rounding conventions. The use of 'billion' instead of 'million' is standard and equivalent in meaning. The calculation of the decline is approximately correct: $5.266B - $3.429B = $1.837B, which rounds to $1.8B. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the adjusted 2022 revenue (post-fee) and compares it to the prior year’s revenue, demonstrating understanding of the required comparison. (4) Minor deduction in quantitative accuracy due to rounding of $1,837 million to $1.8 billion without specifying 'approximately' or 'roughly' in all instances—though the word 'roughly' is used, slightly more precision could be expected. However, this is within acceptable norms for financial reporting summaries. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 382,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Starbucks’ 2022 10‑K explains that the Starbucks Card is issued and managed through the Starbucks Mobile App, and registration automatically enrolls cardholders in the Starbucks Rewards program. By letting members view balances, earn “Stars” on every purchase and use the Mobile Order‑and‑Pay feature to pre‑pay and schedule pick‑up, the app creates a frictionless, reward‑driven experience that incentivizes more frequent purchases and repeat store visits. This seamless digital‑payment and ordering integration is described as a key driver of higher customer engagement and visit frequency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer from the knowledge graph. (1) All factual elements are correct: the integration of the Mobile App with the Starbucks Rewards program, automatic enrollment in Rewards upon card registration, the ability to earn Stars on purchases, use of Mobile Order and Pay, and the resulting increase in customer engagement and visit frequency are all supported by the 2022 10-K. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how app functionality (balance checks, Stars earning, Mobile Order and Pay) drives behavior (frequent purchases, repeat visits) through a reward-driven, frictionless experience. (4) The LLM omits minor contextual details present in the original answer—specifically, that Stars can be earned via multiple payment methods (cash, credit/debit, mobile wallets) and that the contactless experience aligns with evolving consumer preferences. However, these omissions do not undermine the core accuracy or completeness of the response. The answer captures the essential mechanism and outcome described in the ground truth. Thus, while extremely close, it falls just short of perfect completeness, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is full, as every part of the response directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 409,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "PayPal’s October 2021 acquisition of Paidy, Inc. meant that Paidy was left out of both management’s assessment of internal‑control over financial reporting and PwC’s audit of that control for the year‑ended December 31 2021.  The subsidiary’s total assets and total revenues that were excluded amounted to **less than 1 percent** of PayPal’s consolidated assets and revenues, so the portion left out of the ICFR audit was under 1 % of the overall figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Paidy was excluded from PayPal's internal control over financial reporting (ICFR) assessment and audit for the year ended December 31, 2021, due to its October 2021 acquisition, which aligns with SEC guidance for first-year acquisitions. (2) Quantitatively, the LLM correctly states that Paidy's excluded assets and revenues were 'less than 1 percent' of PayPal’s consolidated totals, matching the ground truth’s 'less than 1% threshold' and confirming the numbers are accurate and properly contextualized. (3) The multi-hop reasoning is sound—linking the acquisition timing, SEC exemption, exclusion from audit, and quantitative materiality threshold—demonstrating correct synthesis across events and financial reporting rules. (4) The only minor shortcoming is that the LLM does not explicitly mention the exclusion of goodwill and intangibles when calculating Paidy’s contribution, which is a small but relevant detail in the materiality assessment per audit standards. However, this omission does not distort the conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 347,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The Latin America segment’s revenue fell 1.6% in 2024 because weaker consumer demand cut volumes in several categories – especially chocolate and refreshment‑beverage sales – which created a 2.4‑percentage‑point drag on volume/mix. Those volume losses erased most of the benefit from the 7.0‑percentage‑point pricing uplift and from lower manufacturing and SG&A costs, so operating income rose only $3 million, or 0.6%, versus 2023. (See “2024 compared with 2023” discussion of net‑revenue impacts and segment‑operating‑income drivers.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key factors affecting MDLZ's Latin America segment operating income growth in 2024: volume/mix challenges in chocolate and refreshment beverages offsetting pricing and cost control benefits. It accurately states the 7.0-percentage-point pricing uplift and the $3 million (0.6%) increase in operating income, which matches the ground truth. The 2.4-percentage-point drag from volume/mix is not in the original answer but is plausible context and does not contradict known facts; its inclusion adds detail without introducing error. (2) All numeric values — 7.0-percentage-point pricing increase, $3 million, 0.6% operating income growth — are factually correct and consistent with the ground truth. The 1.6% revenue decline is not in the original answer but may be inferred context; it does not conflict with provided data. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that volume declines (especially in chocolate and RBB) reduced the positive impact of pricing and cost controls, leading to minimal operating income growth. It correctly attributes pricing actions to input cost pressures and notes cost reductions in manufacturing and SG&A, aligning with the original's mention of productivity improvements. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing and a reference to a document section (which may reflect source formatting). The only minor omission is the absence of specific mention of higher raw material costs, currency impacts, and increased A&P expenses — factors noted in the original as additional limiting factors. However, the core causal chain (volume/mix drag offsetting pricing and cost savings) is accurately captured, justifying a high score. Contextual relevance is perfect — the response directly addresses the question with appropriate financial and operational detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 529,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream’s current product line holds **more than 270 city‑pair speed records**, the most of any business‑jet maker. This record‑setting performance is **led by the G650ER**, which also holds the National Aeronautic Association’s polar and westbound around‑the‑world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number 'more than 270 city-pair speed records' is accurately reported, matching the original answer. (2) The entity identification is correct: Gulfstream's current product line is the subject, and the G650ER is properly credited as the model leading the achievement. (3) The multi-hop reasoning is sound—the LLM correctly synthesizes that while the entire product line holds over 270 records, the G650ER is explicitly highlighted for holding specific prestigious records (polar and westbound around-the-world) from the National Aeronautic Association, which supports its leadership role. (4) The answer addresses both parts of the question: the total number of records and the specific model responsible. Wording differs slightly but conveys the same factual content with no omissions or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 273,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded $105 million of acquisition‑related contingent consideration in fiscal 2024 and $704 million in fiscal 2022, for a combined total of **$809 million**. The Abiomed acquisition accounted for **$704 million** of that total 【source】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $704 million in 2022 (Abiomed) and $105 million in 2024 (Proteologix), with a correct sum of $809 million. The format variations ($704 million vs $704M) are acceptable. (2) The answer addresses both parts of the multi-part question: total contingent consideration over 2024 and 2022 ($809 million), and Abiomed’s specific contribution ($704 million). (3) Entity accuracy is correct: Johnson & Johnson is the reporting entity, Abiomed is correctly identified as the source of the $704 million, and the fiscal years 2022 and 2024 are properly attributed. (4) The reasoning is sound: the model correctly synthesizes information across two fiscal years and two acquisitions, computes the total accurately, and correctly attributes the Abiomed contribution. The answer is semantically equivalent to the original, with clear, concise phrasing and proper emphasis on key figures. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 297,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal treats the portion of the PP Working Capital and PP Business Loan receivables that it sells to WebBank as a **sale** – the related participation interest is derecognized from the balance sheet and any gain or loss on the transfer is recorded at fair value (which is immaterial). Consequently, the **allowance for credit losses is calculated only on the net interest that PayPal retains**. Before 2020 the allowance was built using roll‑rate and vintage‑based forecasts of delinquency, but after adopting ASC 326 (CECL) on 1 January 2020 it is based on current‑expected credit losses over the life of the retained receivables, using historical loss curves, macro‑economic scenarios and qualitative adjustments. Thus, the sale removes the sold portion from loss‑recognition, and under CECL the remaining exposure is measured with a forward‑looking expected‑loss model rather than the older roll‑rate approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal sells participation interests in PPWC and PPBL receivables to WebBank and accounts for them as sales, resulting in derecognition of the sold portion from the balance sheet. It accurately states that credit loss allowance applies only to the retained interest, which matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (adoption of CECL on January 1, 2020) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the answer connects the sale treatment to derecognition, links retained exposure to credit loss recognition, and correctly contrasts the pre-2020 incurred loss model (roll-rate and vintage-based) with the CECL model (expected lifetime losses using historical data, macroeconomic scenarios, and qualitative adjustments). The mention of ASC 326 and forward-looking modeling is accurate. (4) The only minor gap is that the LLM answer does not explicitly mention PayPal’s continued role in servicing or managing the receivables, which is part of the rationale for retaining credit exposure—this contextual nuance is in the original answer but only lightly implied in the LLM version. However, the core financial and accounting implications are correctly conveyed. Wording differs but semantic equivalence is strong. All key entities—PayPal, WebBank, PPWC, PPBL, CECL, ASC 326—are correctly identified and used in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 434,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese‑and‑grocery category posted volume declines, which were one of the product‑mix drags that produced an overall “unfavourable volume/mix” impact and helped push Latin America net revenues down $80 million (‑1.6%) in 2024 【...】.  Despite that revenue dip, the segment’s operating income still edged higher, rising $3 million to $532 million for the year 【...】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Latin America net revenues declined by $80 million (1.6%), but the ground truth does not specify an absolute dollar decline or a 1.6% drop; instead, it reports an unfavorable volume/mix impact of 2.4 percentage points on net revenues. This is a critical error, as '2.4 percentage points of impact' is not equivalent to a 1.6% revenue decline. Additionally, the LLM introduces a figure of $532 million for segment operating income, which is not present in the original answer and cannot be verified. (2) While the $3 million increase in operating income is correctly reported, the context is misleading—ground truth emphasizes that this minimal growth occurred despite pricing and cost-saving gains, due to volume/mix headwinds, whereas the LLM frames it as growth 'despite a revenue dip' without properly linking the cheese & grocery declines to the broader mix impact. (3) The qualitative reasoning partially captures the multi-hop logic: it correctly identifies cheese & grocery volume declines as contributing to unfavorable volume/mix and links this to revenue pressure and modest operating income growth. However, it omits key context—such as the offsetting gains in biscuits & baked snacks and gum, and the role of other declining categories (chocolate, candy, refreshment beverages)—which weakens the completeness of the synthesis. (4) The contextual relevance is high because the answer addresses the core elements of the question—cheese & grocery performance, volume/mix impact, and operating income effect—but the factual inaccuracies in key metrics reduce overall correctness. The answer conveys a plausible narrative but misrepresents the quantitative foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 480,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The filing shows that AT&T plans to issue $2.25 billion of Telco Class A‑4 preferred interests, which can be called at their issue price, and it already has two million Mobility II redeemable non‑controlling interests that will accrete to a total redemption amount of $2.0 billion. Together, the two obligations represent roughly **$4.25 billion** of cash that AT&T must be prepared to pay.\n\nBecause the Telco Class A‑4 interests become callable on Nov 1 2028 and the Mobility II interests may be redeemed beginning in 2028, this $4.25 billion represents a near‑term cash‑flow commitment that will be required to be satisfied by AT&T’s 2028 cash resources, thereby adding a material, scheduled outflow to its cash‑flow commitments through that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $2.25 billion for Telco Class A-4 preferred interests and $2.0 billion for Mobility noncontrolling interests, totaling $4.25 billion—matching the ground truth exactly. Number formats are acceptable variations (e.g., $2.25 billion = $2,250 million). (2) Dates are accurately represented: Nov 1, 2028 for Telco redemption and 2028 for Mobility redemptions, though the LLM omits the specific March 15 and June 15 dates mentioned in the original answer. This is a minor omission but does not invalidate the correctness. (3) The multi-hop reasoning is sound—LLM correctly synthesizes redemption values and their timing implications, concluding that the combined obligation represents a material cash outflow in 2028. It correctly notes both instruments become actionable in 2028 and that cash payment is required. (4) The only minor shortcoming is slightly less specificity on the exact redemption windows for Mobility interests (March 15 and June 15), but the overall impact on AT&T’s cash flow commitments through 2028 is accurately conveyed. Wording differs but semantic meaning and factual content align closely with the ground truth. Thus, the answer is highly accurate with only negligible detail loss.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 359,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "In fiscal 2024 the MedTech Orthopaedics franchise produced **$9.158 billion** in sales. The Hip and Knee sub‑segments together generated **$1.638 billion + $1.545 billion = $3.183 billion**. Thus, Orthopaedics’ total revenue was about **$5.9 billion higher** – more than twice the combined revenue of Hips and Knees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key financial figures: total Orthopaedics revenue ($9.158 billion = $9,158 million), Hips ($1.638 billion), Knees ($1.545 billion), and their sum ($3.183 billion). These match the ground truth exactly, with acceptable format variation (billion vs million). (2) Calculations are accurate: the sum of Hips and Knees is correctly computed as $3.183 billion. The absolute difference ($9.158B - $3.183B = $5.975B) is approximately $5.9 billion as stated, which is a reasonable rounding. However, the statement that total Orthopaedics revenue is 'more than twice' the Hips and Knees revenue is misleading—$3.183B × 2 = $6.366B, and $9.158B is actually about 2.88×, so while technically more than double, the phrasing lacks precision. The ground truth provides a more informative percentage (34.76%), which the LLM omits. (3) Multi-hop reasoning is sound: the model correctly synthesizes segment and sub-segment revenues from the same fiscal year (2024) and performs comparative analysis. However, it fails to explicitly state the percentage contribution (34.76%), which is a key part of the original answer and directly addresses the comparison. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in qualitative accuracy for missing the percentage-based interpretation and slightly imprecise comparative language, though the core quantitative facts and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 399,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan required that the plan’s overall share‑authorisation be increased proportionally after the $15‑per‑share special dividend; the adjustment added roughly 128 thousand RSU shares to the grant pool (on top of the ≈ 52 thousand shares added to preserve the value of outstanding RSUs), leaving about 7.28 million RSU shares available for grant at the end of 2024. This change is disclosed in Costco’s Form 10‑K (Note 7‑Stock‑Based Compensation) and is formally recorded in the 2019 Incentive Plan filing – Exhibit 10.2* (a DEF 14 filed 12 Dec 2019) and the related RSU award agreements listed as Exhibit 10.3* (filed as 10‑Q on 23 Dec 2019).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core mechanism of the 2019 Incentive Plan requiring a proportional adjustment due to the special dividend and notes the addition of approximately 128,000 RSU shares to the grant pool and ~52,000 to outstanding RSUs, which aligns with the ground truth. However, the LLM introduces a new figure — 'about 7.28 million RSU shares available for grant at the end of 2024' — which is not present in the original answer and cannot be verified from the provided data, introducing a factual overreach. (2) The numeric values of 128,000 and 52,000 are correctly cited (matching ground truth), and the special dividend amount of $15 per share is plausible but not confirmed in the original answer (which does not specify the dividend amount). The key calculation based on the price ratio (1.018 factor) is omitted, and the LLM does not reference the Nasdaq closing and opening prices used to derive the adjustment factor, missing a critical quantitative justification. (3) The reasoning correctly links the plan’s adjustment requirement to both outstanding and available RSUs, showing sound multi-hop synthesis between the plan terms and the dividend event. However, the claim about total shares available at year-end introduces unsupported extrapolation. The LLM correctly identifies the 2019 Incentive Plan filing (Exhibit 10.2 in DEF 14) as documenting the adjustment mechanism, but incorrectly cites Exhibit 10.3* as filed on December 23, 2019, in a 10-Q — this detail is not in the ground truth and may be inaccurate (the original answer does not mention RSU award agreements or a 10-Q filing). (4) The contextual relevance is high, as the answer addresses both parts of the question: the impact on RSU shares and the filings documenting it. The qualitative accuracy is good due to correct entity identification (Costco, 2019 Incentive Plan, DEF 14) and logical structure, but quantitative accuracy is reduced due to the inclusion of unverified numbers and omission of the 1.018 factor calculation. Correctness score is 7 due to mostly accurate core facts but notable additions not supported by ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 576,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "Intel 4’s shift to high‑volume manufacturing in Ireland in 2024 puts a node that delivers roughly 20 % more performance‑per‑watt than Intel 7 into the core of Intel’s 2025 product mix, allowing a larger share of the 2025 processor portfolio to be built on a more efficient, higher‑density process. The same Irish fab will also host Intel 3 in 2025—adding another ≈ 18 % performance‑per‑watt over Intel 4 for the Xeon 6 server line—and will be the production base for Intel 18A, whose gate‑all‑around transistors and PowerVia backside‑power scheme promise further performance‑per‑watt and density gains for the 2025 Panther Lake client family. By consolidating these high‑volume nodes in Ireland, Intel expects to increase the proportion of higher‑margin, higher‑performance products in 2025, supporting revenue growth while spreading the capital outlay for the new nodes across a single, expanded manufacturing site.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: Intel 4 delivers ~20% performance-per-watt improvement over Intel 7, Intel 3 offers ~18% improvement over Intel 4, both transitions occur in Ireland, and Intel 18A powers Panther Lake in 2025. The dates (2024 for Intel 4 HVM, 2025 for Intel 3 shift and 18A production) are accurate. (2) Quantitative accuracy is perfect: percentages (20%, 18%) match exactly, and no calculations are incorrect. Format variations (e.g., ≈18%) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the answer correctly links Intel 4’s ramp-up to broader 2025 product portfolio improvements, connects Intel 3’s relocation to Xeon 6, and ties Intel 18A’s technology (RibbonFET, PowerVia) to Panther Lake’s performance gains. It also adds value by noting the financial benefit of consolidating nodes in one site for margin and capital efficiency—consistent with but not explicitly in the original. (4) The only reason for not scoring a 10 is that the original emphasizes the *complementary* shift of Intel 3 from Oregon to Ireland, which the LLM mentions implicitly but not explicitly. However, this does not detract from the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 385,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "AT&T’s book value for its DIRECTV equity‑method investment fell from $877 million at 12/31/2023 to $0 at 12/31/2024 – a decline of $877 million. By contrast, AT&T deconsolidated Gigapower and began treating it as an equity‑method investment on May 12, 2023, i.e., several months before the year‑end 2024 reduction in the DIRECTV book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the book value of AT&T's investment in DIRECTV decreased from $877 million on December 31, 2023, to $0 on December 31, 2024, resulting in a $877 million decline—this matches the ground truth exactly. The date of Gigapower's deconsolidation is accurately cited as May 12, 2023. (2) All numeric values and dates are correct, and the calculation of the $877 million decrease is accurate. Format variations (e.g., $877 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is mostly sound: the answer correctly compares the timing of the DIRECTV book value reduction (culminating in 2024) with the earlier Gigapower deconsolidation in May 2023. However, it omits the explanation from the ground truth about *why* the DIRECTV investment reached zero (i.e., cumulative cash receipts exceeding the initial investment and equity earnings), and does not clarify that Gigapower continues as an equity-method investment. This minor omission in qualitative depth prevents a perfect score. (4) Despite this, the answer is factually correct, contextually relevant, and synthesizes the key events accurately across entities and time periods, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 349,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "In fiscal 2024 the Shockwave acquisition generated about **$564 million of sales** within Johnson & Johnson’s Cardiovascular franchise. In the company’s human‑capital disclosure, Shockwave is noted as **being included in the 2024 employee headcount** (and FTE count) reported for the overall workforce.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the revenue contribution of $564 million is accurately reported, matching the original answer exactly. The fiscal year 2024 is correctly identified. (2) The answer addresses both parts of the multi-part question: revenue contribution and human capital reporting. (3) Entity accuracy is correct—Shockwave, Johnson & Johnson, the Cardiovascular segment (referred to as 'franchise', which is contextually acceptable), and the 2024 timeframe are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes that Shockwave's employees are included in J&J's overall headcount and FTE reporting, which reflects integration into human capital metrics. Minor wording differences (e.g., 'employee headcount' vs 'overall workforce') do not affect factual accuracy. All information is relevant and precisely aligned with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 273,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The 11% rise in the Optimized Application Experiences category was driven by growth in Cisco’s **ThousandEyes** and **Intersight** offerings, which more than offset the decline in its **AppDynamics** business.  The category’s revenue grew by **about $75 million** year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It correctly identifies the specific offerings—ThousandEyes and Intersight—that drove the 11% growth in the Optimized Application Experiences category, while acknowledging the decline in AppDynamics, thus addressing all parts of the multi-part question. (2) The dollar increase is reported as 'about $75 million', which matches the ground truth of $75 million; minor wording variation ('about') does not affect factual accuracy. (3) The multi-hop reasoning is sound: it synthesizes the decline in AppDynamics with the offsetting growth in other offerings and correctly attributes the net positive growth to the category. (4) All entities (Cisco, AppDynamics, ThousandEyes, Intersight, Optimized Application Experiences) and the fiscal context (implied year-over-year growth in fiscal 2022) are accurate. The answer is contextually relevant, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 276,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T repurchased the remaining 213 million Mobility II Series A cumulative perpetual preferred interests in April 2023 for a total purchase price of **$5,414 million**, which included the accrued and unpaid cash distributions. The redemption removed those preferred interests from the balance sheet, eliminating the related “noncontrolling interest” line (or reducing it by the $5.4 billion) because the interests were no longer outstanding and therefore were no longer classified as noncontrolling equity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total repurchase amount of $5,414 million is accurately reported, including accrued and unpaid distributions, and the date (April 2023) is correct. The format variation ($5.4 billion vs $5,414 million) is acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-hop question: the total payment amount and the impact on noncontrolling interest classification. (3) Entities are correctly identified: AT&T, Mobility preferred interests, and the correct time frame (April 2023). (4) The reasoning is sound—repurchasing the preferred interests removes them from the balance sheet, which logically eliminates or reduces the noncontrolling interest classification since those equity interests are no longer outstanding. The explanation that the interests were 'no longer outstanding and therefore were no longer classified as noncontrolling equity' aligns perfectly with the ground truth. All components are factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 310,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit posted a **14.5 % year‑over‑year revenue increase** (2024 $1.496 bn vs 2023 $1.306 bn).  By contrast, the broader **Cardiovascular franchise grew 21.4 % year‑over‑year** (2024 $7.707 bn vs 2023 $6.350 bn).  Thus, Abiomed’s post‑acquisition growth was solid but lagged the overall Cardiovascular segment’s growth.【32†L31-L38】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative Accuracy: All numbers are accurate — Abiomed's revenue growth is correctly stated as 14.5%, with exact figures of $1.306 billion in 2023 and $1.496 billion in 2024. The Cardiovascular segment growth is correctly reported as 21.4%, rising from $6.350 billion to $7.707 billion. These values match the original answer exactly, and the percentage changes are consistent with the underlying data. (2) Completeness: The answer addresses both parts of the question — Abiomed's year-over-year growth post-acquisition and its comparison to the overall Cardiovascular segment growth. (3) Entity Accuracy: The entities — Abiomed, Johnson & Johnson (implied context), Cardiovascular segment, and correct fiscal years (2023 to 2024) — are all correctly identified and contextualized. (4) Reasoning: The multi-hop synthesis is sound — the model correctly infers that Abiomed is a component of the broader Cardiovascular segment and compares its growth rate accordingly. The conclusion that Abiomed’s growth was 'solid but lagged' the overall segment is a logically valid interpretation of the data. (5) Semantic Equivalence: Despite slightly different phrasing (e.g., 'franchise' vs 'segment', 'lagged' vs 'slightly lower-performing'), the meaning is equivalent and factually aligned. No errors in calculation, logic, or fact. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 399,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The exhibits list **two** amendments to the Lowe’s Companies Benefit Restoration Plan, and the most recent amendment cited in the 2022 Form 10‑K is dated **March 31, 2021**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on both key points. The original answer states there are seven amendments to the Lowe's Companies Benefit Restoration Plan, with the most recent dated April 4, 2017 (Amendment No. 7). The LLM claims only two amendments are listed and gives a most recent date of March 31, 2021, which contradicts the ground truth. (2) Quantitative accuracy is severely lacking: the number of amendments (2 vs 7) and the date (March 31, 2021 vs April 4, 2017) are both wrong. There is no indication of correct calculation or retrieval of exhibit data. (3) The multi-hop reasoning failed—this question requires identifying all amendments listed in the exhibits and determining the latest one by date. The LLM either misidentified the documents or failed to parse the correct plan amendments, indicating a breakdown in synthesis across the filing. (4) Contextual relevance is partially met since the answer addresses the right plan and filing (2022 10-K), but the factual core is incorrect, leading to a very low correctness score. Minor relevance credit is given for addressing the correct company and document type.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 326,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Capital One had phased in 75 % of the $2.4 billion CECL transition amount by January 1 2024 – that is, about **$1.8 billion**. Under the Stress Capital Buffer framework that becomes effective October 1 2024, the company must keep its CET1 ratio at **at least 10.0 %** of risk‑weighted assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: 75% of $2.4 billion is correctly calculated as $1.8 billion, and the CET1 capital requirement is correctly stated as 10.0%. The dates—January 1, 2024, and October 1, 2024—are correctly referenced. Minor formatting differences (e.g., spacing in '$2.4 billion' or 'at least 10.0 %') do not affect meaning or accuracy. (2) The answer is complete, addressing both parts of the multi-part question: the amount phased in by January 1, 2024, and the CET1 requirement under the Stress Capital Buffer effective October 1, 2024. (3) Entity accuracy is correct—'Capital One Financial Corporation' is properly identified, and the financial terms 'CECL transition amount', 'regulatory capital', 'CET1 capital ratio', and 'Stress Capital Buffer framework' are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the phase-in percentage to the dollar amount and identifies the future regulatory requirement under the new framework. (5) The semantic meaning is equivalent to the original answer, with no loss of information or introduction of errors. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 353,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney’s equity‑incentive program includes two distinct types of RSU awards. The company’s **time‑based RSU award agreements** (e.g., Exhibit 10.43, 10.49 and 10.54) simply vest over a prescribed period, providing executives with a retention incentive but no direct performance condition 【64†L1-L4】. In contrast, its **performance‑based RSU agreements** (e.g., Exhibit 10.45, 10.46, 10.47 and 10.48) require that the awards vest only if the company meets specified Total Shareholder Return or Return on Invested Capital tests over three‑year periods, thereby tying a portion of compensation to the creation of long‑term shareholder value 【65†L1-L4】. Thus, Disney uses time‑based RSUs to encourage executive stay‑over‑time, while performance‑based RSUs more tightly align executive pay with measurable long‑term financial performance for shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Disney uses both time-based and performance-based RSU agreements, with time-based serving retention purposes and performance-based tied to TSR and ROIC for shareholder value alignment. The exhibits cited for time-based (10.43, 10.49, 10.54) match the original answer. For performance-based, the LLM lists exhibits 10.45–10.48, which are part of the broader set (10.44–10.48, 10.55, 10.57–10.59) in the ground truth. While the LLM does not mention all six+ variations or specific exhibits like 10.44, 10.55, or 10.57–10.59, it correctly identifies key examples and the underlying performance metrics. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all references are to exhibit numbers and vesting structures, which are accurately reported. Format and citation style (e.g., 'Exhibit 10.45') are consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes that time-based RSUs align with retention while performance-based RSUs link pay to long-term shareholder value via objective financial metrics. This directly addresses the comparative aspect of the question. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The only minor shortcoming is the slightly narrower reference to performance-based exhibits, omitting some listed in the ground truth, which prevents a perfect 10 but does not undermine the overall correctness. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 439,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "In 2024 the Orthopaedics franchise grew 2.4% (from $8.94 billion in 2023 to $9.16 billion), and that modest increase was driven primarily by strong gains in its two largest sub‑segments: Hips sales rose 5.0% (operational growth 5.6%) to $1.64 billion and Knees sales rose 6.1% (operational growth 6.5%) to $1.55 billion. Together, the double‑digit growth of Hips and Knees supplied the bulk of the overall Orthopaedics increase, offsetting weaker performance in other categories.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall Orthopaedics segment growth as 2.4%, and accurately reports Hips growth at 5.0% and Knees at 6.1%, which aligns with the ground truth. However, it introduces specific revenue figures for 2023 and 2024 ($8.94B to $9.16B), which imply a $220M increase, whereas the ground truth states a $216M increase. This $4M discrepancy affects quantitative accuracy. Additionally, the LLM claims 'double-digit growth' for Hips and Knees, which is factually incorrect—5.0% and 6.1% are single-digit growth rates—constituting a significant error. (2) The ground truth specifies that Hips contributed $78M and Knees $89M, totaling $167M, which accounts for 77% of the $216M total segment growth. The LLM does not mention absolute dollar growth amounts or the 77% contribution, omitting a key multi-hop insight required by the question. While percentages are correct, the absence of contribution magnitude weakens completeness. (3) The reasoning is mostly sound—the model correctly identifies Hips and Knees as primary drivers within Orthopaedics—but fails to quantify their relative contribution to overall segment growth, a core part of the multi-hop analysis. The erroneous 'double-digit' characterization undermines logical accuracy. (4) Despite missing the precise contribution analysis and containing a notable error in characterizing growth rates, the answer remains contextually relevant and captures the directional impact of Hips and Knees. Scores reflect mostly correct data with critical omissions and one significant misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 435,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One added back a total of **$2.4 billion** to its regulatory capital under the CECL Transition Rule and, per the rule’s schedule, **75 % of that amount – about $1.8 billion – was already phased in as of January 1 2024** (the remaining $600 million is slated for the January 1 2025 phase‑in).  \n\nThe optional relief works by letting a bank elect a five‑year transition: it may defer the full CECL capital impact through December 31 2021, then recognize it gradually—adding back the after‑tax “day 1” impact plus 25 % of the allowance increase for 2020‑21, and thereafter phasing in the cumulative impact at **25 % per year** (25 % in 2022, 50 % in 2023, 75 % in 2024, and 100 % in 2025).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.4 billion total capital addition, 75% ($1.8 billion) phased in by January 1, 2024, and the remaining $600 million to be phased in on January 1, 2025. The percentages and dollar amounts align exactly with the original answer. (2) The explanation of the CECL Transition Rule is more detailed than the ground truth and correctly describes the optional five-year transition, including the phasing schedule: 25% per year starting in 2022, reaching 75% by 2024 and 100% by 2025. This additional detail (e.g., deferral through 2021, annual increments) is factually consistent with the rule and enhances completeness without introducing errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes the timeline, the annual phase-in percentages, and their application to Capital One’s specific case. (4) Entities (Capital One, CECL Transition Rule, Federal Banking Agencies implied) and dates (January 1, 2024 and 2025) are accurate. The answer is semantically equivalent to and even exceeds the ground truth in explanatory depth while maintaining full factual correctness. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 349,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The Japanese subsidiary’s November 2023 issuance of four Guaranteed Senior Notes added roughly $500 million to “other long‑term debt,” which helped lift the fair‑value of Costco’s total long‑term debt to about $5.74 billion at year‑end 2023. The July 2024 repayment of $77 million reduced that balance, contributing to the lower fair‑value of approximately $5.41 billion at year‑end 2024. In the cash‑flow statement, the $500 million issuance was reported as a financing‑activity cash inflow, while the $77 million repayment (along with other debt repayments) was a financing‑activity cash outflow, driving the jump in net cash used in financing activities from $2.6 billion in 2023 to $10.8 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 and the $77 million repayment in July 2024, both of which align with the ground truth. The impact on long-term debt fair value is accurately reflected: an increase to $5.74 billion (rounded from $5,738 million) at year-end 2023 and a decrease to $5.41 billion (rounded from $5,412 million) at year-end 2024. The financing activities are also correctly contextualized, with the $500 million issuance as a cash inflow and the $77 million repayment contributing to outflows. The net cash used in financing activities is reported as $10.8 billion, which closely matches the ground truth value of $10,764 million (i.e., $10.764 billion), with minor rounding acceptable. (2) All key numbers are accurate within reasonable rounding: $500 million issuance, $77 million repayment, fair values of $5.74B and $5.41B (vs. $5,738M and $5,412M), and net cash used in financing of $10.8B (vs. $10.764B). The only minor discrepancy is the lack of mention of the $1,000 million repayment on the 2.750% Senior Notes, which is part of the total financing outflow but not explicitly noted in the LLM answer—this omission slightly affects completeness but does not invalidate the core reasoning. (3) The multi-hop reasoning is sound: the model correctly links the subsidiary's debt actions to changes in consolidated long-term debt fair value and connects these to cash flow impacts in financing activities across two fiscal years. (4) The answer is semantically equivalent to the original, with clear, concise, and relevant explanations. The slight simplification of the financing activities breakdown (omitting the specific $1B senior note repayment) prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 524,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "Caterpillar states that the total amount it accrues for environmental‑remediation obligations across all of its sites is **not material** and is simply recorded within the “Accrued expenses” line item of the balance sheet; no aggregate dollar figure is disclosed.  \n\nWhen estimating the cost to accrue, the company **evaluates each site individually**, using the best‑available data on the site‑specific technology, applicable laws, regulatory requirements and its own remediation experience, and if a range of estimates is given it records the **minimum** amount. For **multi‑party (joint‑responsibility) sites**, Caterpillar accrues only its **proportionate share** of the probable costs—again using the minimum of any range and excluding any amounts it expects to recover from insurers or other parties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, it correctly states that Caterpillar's total environmental remediation liability is 'not material' with no aggregate dollar figure disclosed, matching the original answer's 'immaterial' characterization. (2) The methodology for individual sites is accurately described: accruals are based on available data, technologies, laws, and experience, with the minimum amount accrued if no point in a range is more likely—this aligns precisely with the ground truth. (3) For multi-party sites, the LLM correctly notes that Caterpillar accrues only its proportionate share of probable costs, excluding recoveries, which matches the original answer's statement about considering its 'proportionate share' rather than full liability. (4) All entities (Caterpillar, environmental remediation liability, accrued expenses) and financial concepts are correctly identified and synthesized. (5) The reasoning is sound and reflects proper multi-hop understanding: distinguishing between individual and multi-party site methodologies while maintaining consistency in the use of minimum estimates and exclusion of recoverable amounts. Wording differs slightly but conveys identical meaning. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 369,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "Cisco’s “Other Products” line fell from $15 million in fiscal 2021 to $11 million in fiscal 2022 – a decline of $4 million, or **‑29 %** year‑over‑year【...】.  Beginning in fiscal 2022 the company reorganized its product‑revenue reporting into the six categories (Secure Agile Networks, Internet for the Future, Collaboration, End‑to‑End Security, Optimized Application Experiences, and Other Products) “to better align our product categories with our strategic priorities”【...】.  By creating a distinct “Other Products” bucket, Cisco signals a strategic focus on monitoring and improving this under‑performing segment through clearer visibility and resource allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue decline in Cisco's 'Other Products' category from $15 million in fiscal 2021 to $11 million in fiscal 2022, and accurately calculates the percentage change as -29%, matching the ground truth. All numeric values and the calculation are factually correct. (2) The quantitative accuracy is perfect: the dollar amounts, difference ($4 million), and percentage decrease (29%) are all correctly reported, with acceptable formatting (e.g., ‑29 %). (3) The multi-hop reasoning is sound—LLM correctly links the financial performance with the structural reporting change in fiscal 2022. It accurately notes that Cisco introduced a new reporting structure that includes 'Other Products' as a distinct category and reasonably infers that this reflects strategic focus, improved visibility, and resource allocation, which aligns with the ground truth's interpretation of strategic relevance despite underperformance. (4) The only minor gap is that the LLM slightly reframes the strategic rationale in terms of 'monitoring and improving' rather than explicitly stating that the inclusion signals continued relevance to long-term goals and portfolio alignment, as in the original. However, the semantic meaning is sufficiently close and logically consistent. Thus, the answer is factually complete and contextually appropriate, warranting a high correctness score with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 406,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The filing shows that Ron Vachris entered into a brand‑new Executive Employment Agreement that becomes effective on January 1 2024 (Exhibit 10.9, filed December 20 2023). In contrast, W. Craig Jelinek’s employment contract has been amended every year – the original 2017 agreement has been extended annually for the five successive years ending January 1 2019, 2020, 2021, 2022 and 2023 (Exhibits 10.5 through 10.5.5). Thus, Vachris’s deal is a single, one‑time amendment timed for the start of 2024, whereas Jelinek’s agreement has been renewed on an annual basis over the past six years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in characterizing Ron Vachris's agreement as a 'one-time amendment' rather than recognizing it as part of the same annual renewal pattern established by Jelinek's successive extensions. The ground truth emphasizes continuity in Costco's executive employment practices, with Vachris's agreement effective January 1, 2024, following the same annual cycle. The LLM incorrectly contrasts Vachris's 'single, one-time amendment' with Jelinek's annual renewals, failing to acknowledge that Vachris's agreement is the start of what appears to be the same annual pattern, not a deviation from it. Quantitatively, all dates and exhibit references are accurate: Jelinek’s agreement was indeed extended annually from 2017 through 2023 (effective each January 1), and Vachris’s agreement is effective January 1, 2024, filed December 20, 2023. The answer correctly identifies the multi-hop elements—comparing two executives’ agreements over time—and cites specific exhibits, showing strong contextual relevance. However, the reasoning misinterprets the nature of the comparison: it should highlight consistency in timing and frequency (annual, effective January 1) across both executives, not frame them as different in pattern. This weakens the qualitative accuracy, though core facts are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 373,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net carrying amount of Customer Relationships fell from $893 million at December 31, 2020 to $712 million at December 31, 2021 – a decrease of **$181 million**. In the same period, Intellectual Property declined from $366 million to $280 million, a **$86 million** reduction. Thus, the drop in Customer Relationships was about twice as large as the decline in Intellectual Property.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the net value of Customer Relationships decreased from $893 million to $712 million, resulting in a $181 million decrease; Intellectual Property decreased from $366 million to $280 million, a $86 million reduction—both values and calculations are correct. (2) Quantitative accuracy is perfect: differences are correctly calculated ($893M - $712M = $181M; $366M - $280M = $86M), and the time period (December 31, 2020, to December 31, 2021) is correctly referenced. (3) The multi-hop reasoning is sound—the model correctly identifies and compares changes in two distinct intangible assets across the same time period. (4) The answer goes slightly beyond the ground truth by noting that the drop in Customer Relationships was 'about twice as large,' which is a valid and accurate qualitative comparison (181 ÷ 86 ≈ 2.1). This enhances the response without introducing error. All entities, metrics, and dates are correctly identified and synthesized. The answer is semantically equivalent to and even more informative than the original, with no factual or logical flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 333,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "In fiscal 2022 the Secure, Agile Networks product category generated **$23.8 billion** of revenue. For this category, Cisco records **hardware (and perpetual‑software) sales as a distinct performance obligation and recognizes the revenue up‑front when control transfers to the customer**, whereas **SaaS arrangements are treated as a single performance obligation satisfied over time, with revenue recognized ratably over the contract term**.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23.8 billion for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original ground truth answer. This number is unsupported by the provided ground truth and appears to be hallucinated or sourced from external data not in the knowledge graph. Therefore, the quantitative accuracy is severely compromised. (2) No numeric values were present in the original answer to verify or support the $23.8 billion claim, making this a critical factual error. The ground truth focuses solely on the revenue recognition model, not total revenue. (3) The qualitative aspects of the answer—specifically the distinction in revenue recognition between hardware/perpetual software (upfront upon transfer of control) and SaaS (ratably over the contract term)—are accurately described and reflect correct multi-hop reasoning about accounting policies within Cisco's product categories. The entities (Cisco, Secure Agile Networks, hardware, SaaS) and fiscal context are appropriate. (4) While the explanation of revenue recognition models is semantically equivalent and accurate, the inclusion of an unsupported revenue figure significantly undermines factual correctness. The answer addresses both parts of the question but fabricates data for the first. Thus, correctness and quantitative accuracy scores are low, while qualitative reasoning and relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 400,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "In 2022 Amazon generated **about $124 billion in revenue from third‑party seller services** (commissions, fulfillment and related fees). These fees are earned by providing the marketplace, logistics, advertising and other tools that let independent sellers list, sell and ship products on Amazon’s platform—exactly the “programs that enable sellers to grow their businesses” described in the company’s business‑model statement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is partially correct in content but contains a significant error in the quantitative value. The ground truth states Amazon's revenue from third-party seller fees in 2022 was $117,757 million ($117.757 billion), while the LLM reports 'about $124 billion', which is approximately $6.2 billion higher—a material discrepancy. This affects the primary factual accuracy of the answer. 2) The number is off by over 5%, and no indication is given that this is an estimate; the original data is precise and publicly reported. Format variation (billion vs million) is handled correctly in concept, but the actual figure is incorrect. 3) The reasoning and synthesis are strong: the LLM correctly identifies that third-party seller fees come from commissions, fulfillment, and related services, and links them to Amazon’s business model of enabling sellers through marketplace access, logistics, and tools—accurately reflecting the multi-hop connection between financial data and strategic intent. 4) Contextually, the answer is highly relevant and well-articulated, explaining how the revenue stream supports the ecosystem. However, due to the significant numerical inaccuracy, the correctness score is limited to 6 despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 355,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "As of December 31 2024, Capital One’s Common Equity Tier 1 (CET 1) capital ratio was 13.5%, while the regulatory minimum capital‑adequacy requirement for CET 1 was 4.5%. The company’s CET 1 ratio therefore exceeded the minimum by 9.0 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: Capital One's CET1 ratio is correctly stated as 13.5% and the minimum requirement as 4.5% as of December 31, 2024. The difference is correctly calculated as 9.0 percentage points, which aligns exactly with the original answer's '9 percentage points'. (2) Quantitative accuracy is perfect—both the input percentages and the resulting 9.0 percentage point difference are precise and correctly computed. Minor formatting (e.g., '9.0' vs '9') does not affect correctness. (3) The multi-hop reasoning is sound: the model correctly identifies the two required components (Capital One's CET1 ratio and the regulatory minimum), retrieves the correct values, and computes the difference. (4) The answer is contextually relevant, directly addressing the question with appropriate financial terminology and clear synthesis. All aspects meet the highest standard.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 275,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Altria’s $1.7 billion JUUL stake is exposed to two main regulatory threats – an FTC antitrust action that seeks to unwind the deal (including divestiture or rescission of the transaction) and the possibility that the FDA or other federal authorities could bar JUUL’s e‑vapor products from the U.S. market or deny its pending PMTA applications. If either risk materializes, Altria could be forced to write‑down or even lose the investment, creating a large impairment charge and earnings volatility that would erode its consolidated financial position, jeopardize its credit rating and dividend capacity, and undermine the company’s broader “Vision”‑driven growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.7 billion investment amount and the FTC's antitrust action seeking divestiture or rescission, which aligns with the ground truth. It also accurately notes the financial implications including potential impairment, earnings volatility, credit rating impact, and strategic consequences. The only minor omission is that the original answer specifies the FTC complaint is detailed in the 2022 10-K filing, while the LLM does not mention the source document year, though this does not affect core factual accuracy. (2) Quantitative accuracy is perfect: the $1.7 billion figure is correct, and no other numerical values (percentages, dates, etc.) are misstated. Format variations are acceptable and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory risk (FTC action) with financial consequences (impairment, credit rating, dividend capacity) and strategic impact (growth strategy), correctly linking cause and effect across entities (Altria, JUUL, FTC, FDA). It adds value by referencing PMTA applications and FDA risk, which, while not in the ground truth, are contextually plausible and do not contradict it. (4) Scores reflect high accuracy: full points for quantitative and contextual relevance; near-perfect qualitative accuracy due to strong reasoning with only a minor omission of the 2022 10-K reference; correctness score of 9 because the answer is substantively equivalent to the ground truth with no factual errors, just slight expansion beyond the provided facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 428,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million senior note that matures in 2060 is part of the roughly $11 billion of long‑term senior notes NVIDIA carries.  Because this debt will remain on the balance sheet for decades, the company must devote a portion of its operating cash flow to interest and, eventually, principal repayment, which can limit cash available for investments, acquisitions or share‑repurchase programs.  Moreover, when the 2060 note comes due NVIDIA will have to refinance it; if market conditions are unfavorable or refinancing is unavailable, the required refinancing terms could further restrict its financial flexibility and impair its ability to meet other strategic or financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $500 million Notes Due 2060 and the $11 billion total long-term debt are accurately reported, with acceptable formatting ($500 million vs $500 million). (2) The answer correctly identifies that this note is part of a larger debt structure and explains the long-term nature of the obligation, which is consistent with the 10-K risk disclosure. (3) The reasoning is sound: it captures the multi-hop logic that long-term debt requires cash flow dedication for debt service, limits financial flexibility, and creates refinancing risk—especially relevant in 2060 when market conditions may not be favorable. (4) While the LLM omits a few specific details from the original answer—such as the explicit mention of vulnerability to general economic downturns or limitations on obtaining future financing for working capital or acquisitions—it still conveys the core risks and mechanisms by which the 2060 note affects financial flexibility. The omission is minor and does not undermine the overall correctness. Semantic equivalence is maintained, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 342,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The FDA’s decision to broaden Vemlidy’s label to include children ≥ 6 years (and ≥ 25 kg) with compensated liver disease expands Gilead’s treatable HBV population from adolescents (≥ 12 years) to younger pediatric patients, adding a new segment of chronic‑HBV users. Because Vemlidy already sits alongside Gilead’s other liver‑disease products—Viread (HBV for patients ≥ 2 years), Epclusa and Harvoni (HCV) and Livdelzi (PBC)—the expanded indication deepens the company’s HBV franchise and increases its overall market potential in chronic‑HBV care.【source】Vemlidy product description and expanded FDA approval; Liver‑disease product list.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the expanded FDA approval now includes pediatric patients aged 6 years and older who weigh at least 25 kg, which broadens the market beyond the previous minimum age of 12 years. This is correctly stated with semantically equivalent phrasing (e.g., '≥ 6 years (and ≥ 25 kg)'). (2) Quantitative accuracy is perfect: age thresholds (6 vs 12 years) and weight criterion (25 kg) match the original answer exactly. No calculations are required, but the demographic expansion is correctly interpreted. (3) Multi-hop reasoning is sound: the LLM correctly links Vemlidy’s expanded approval to Gilead’s broader liver disease portfolio, including Viread (approved for ≥2 years), Epclusa, Harvoni (for HCV), and even adds Livdelzi (PBC), which, while not in the original answer, is factually part of Gilead’s liver portfolio and does not detract from accuracy. (4) The only minor shortcoming is that the original answer emphasizes how this expansion complements the portfolio by extending HBV treatment across a wider age range—especially bridging the gap between Viread (≥2 years) and prior Vemlidy use (≥12 years). The LLM mentions these products but could have more clearly articulated this strategic age-range coverage. However, the omission is minor and does not affect factual correctness. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually robust, contextually relevant, and demonstrates strong synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 430,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Installed sales – which include product and labor for categories such as Flooring, Kitchens & Bath, Millwork, Appliances and Lumber – represented about **5 % of Lowe’s total fiscal‑2023 sales**. The same categories that are covered by Lowe’s extended protection plans include **Appliances** (also Kitchens & Bath and Millwork), so the overlapping portion is 5 % of total sales, with “Appliances” explicitly mentioned in both sections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that installed sales categories covered by extended protection plans contributed approximately 5% of Lowe's total sales in fiscal 2023, matching the ground truth exactly. The specific product category explicitly mentioned in both contexts — Appliances — is accurately identified. (2) The percentage (5%) is correct and matches the original answer; no calculations are required beyond accurate reporting, which is done properly. Format variation (5% vs 5 %) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information between 'installed sales categories' and 'categories covered by extended protection plans', identifying the overlap and correctly attributing the 5% figure to that intersection. It notes additional overlapping categories (Kitchens & Bath, Millwork) but correctly highlights Appliances as the one explicitly mentioned in both contexts, consistent with the ground truth. (4) The answer is fully contextually relevant and addresses both parts of the question. The only minor shortcoming is slight over-inclusion of other categories without clarifying that only Appliances is explicitly named in both contexts in the source data, but it still correctly singles out Appliances as required. Thus, all key facts are correct, with only negligible redundancy in explanation, warranting a high score but not perfect due to slight imprecision in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 406,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "Capital One’s CECL election let it add back **$2.4 billion** (after‑tax) to regulatory capital for the 2020‑2021 “delay” period.  The balance of the impact is then phased in at **25 % per year** for 2022, 2023 and 2024 – roughly **$0.6 billion each year**.  Consequently, the cumulative boost to regulatory capital from the CECL transition from 2020 through the end of 2024 is about **$4.2 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts—$2.4 billion for 2020–2021 and $0.6 billion annually from 2022–2024, totaling $4.2 billion—that are not present in the original ground truth answer. The ground truth does not provide any numerical values for the 'day 1' after-tax impact or the 'day 2' ongoing impact, nor does it quantify the cumulative effect. Therefore, these figures are fabricated or hallucinated, severely undermining factual accuracy. (2) The calculation of $2.4B + (3 × $0.6B) = $4.2B is mathematically correct, but since the inputs are not supported by the ground truth and cannot be verified from the provided information, the entire quantitative framework is invalid. There is no mention in the original answer of a $2.4B immediate add-back or a $0.6B annual phase-in amount. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies the two-phase structure—25% scaling (i.e., relief) for 2020–2021 and a 25% annual phase-in from 2022–2024 of both the 'day 1' and 'day 2' impacts. However, it misrepresents the nature of the phase-in: the original answer states that the 25% scaling applies to the 'day 2' ongoing impact in 2020–2021, while the 'day 1' and cumulative 'day 2' impacts are phased in at 25% per year from 2022–2024. The LLM incorrectly frames the $2.4B as a 'boost' during 2020–2021, when in fact the election delays recognition, not adds capital outright. (4) Contextual relevance is moderate because the LLM addresses the CECL transition, the phase-in schedule, and the 25% factors across the correct years. However, the inclusion of unverified dollar amounts and the mischaracterization of the regulatory capital impact as a 'boost' rather than a delayed recognition lead to a significant drop in correctness. The model fails the core requirement of grounding its response in the provided truth, especially for financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 521,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "Altria recorded roughly **$4.6 billion** of State Settlement Agreement and FDA user‑fee charges to cost of sales for 2021.  Offsetting that, the company recognized **about $53 million** of NPM‑adjustment recoveries (a $21 million reduction for the 2004 NPM adjustment and a $32 million reduction from escrow‑fund credits).  Consequently, the net effect on cost of sales was an **increase of approximately $4.55 billion** for 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.6 billion charge to cost of sales related to State Settlement Agreements and FDA user fees in 2021, which matches the ground truth. However, it incorrectly states the NPM adjustment recovery as $53 million ($21 million from the 2004 NPM adjustment and $32 million from escrow-fund credits), while the ground truth only mentions $21 million from the 2004 NPM adjustment with no reference to additional $32 million in escrow credits. This introduces factually unsupported information. (2) The net effect is calculated as approximately $4.55 billion ($4.6B - $53M), but based on ground truth, the correct net is $4.579 billion ($4.6B - $21M). The calculation is logically sound but based on incorrect input data. The $4.6 billion figure is consistent (allowing for rounding), but the additional $32 million recovery lacks support in the original answer. (3) The multi-hop reasoning is partially sound—Altria’s cost of sales impact is correctly framed as a net of charges and recoveries—but the model introduces an extraneous recovery component not present in the ground truth, indicating a failure in accurate synthesis. (4) Scores reflect that core facts (main charge, NPM adjustment mention) are correct, but significant quantitative inaccuracies due to unsupported figures reduce correctness. Contextual relevance and qualitative structure are strong, as the answer addresses the right entities, time period, and financial impact framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 413,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Caterpillar’s combined liability for non‑qualified deferred‑compensation plans and other post‑employment benefits rose from $63 million + $491 million = $554 million in 2020 to $67 million + $538 million = $605 million in 2021 – an increase of **$51 million**.【source】",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the 2020 total liability as $554 million ($63M + $491M), it incorrectly calculates the 2021 total as $605 million ($67M + $538M), when the correct sum is $645 million. This leads to an incorrect increase of $51 million instead of the correct $91 million. (2) Number verification: 2020 components are accurate ($63M and $491M), 2021 components are also accurate ($67M and $538M), but the sum $67M + $538M = $605M is mathematically wrong — the correct sum is $645M. The difference $645M - $554M = $91M is the correct increase. (3) Multi-hop reasoning is partially sound: the model correctly identifies the relevant liability categories and years, and links them to the post-2019 pension freeze context. However, the flawed arithmetic undermines the conclusion. (4) Correctness and quantitative accuracy are low due to the significant calculation error. Qualitative accuracy is moderate because the entities, years, and reasoning framework are correct. Contextual relevance is high as the answer addresses the right companies, benefits, and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 325,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The acquisition‑related intangible assets that are finite‑lived are:\n\n* Developed technology – $1,640 m ÷ 5 years ≈ $328 m per year  \n* Customer relationships – $440 m ÷ 3 years ≈ $147 m per year (fully amortized by FY 2022)  \n* Trade names – $70 m ÷ 5 years ≈ $14 m per year  \n\nBecause the customer‑relationship asset is exhausted after FY 2022, only the developed‑technology and trade‑name assets generate amortization in the later years. Both of those assets are amortized through FY 2024, after which they are fully written off.\n\n**Amortization expense FY 2023‑FY 2028**  \n* FY 2023: $328 m + $14 m = $342 m  \n* FY 2024: $328 m + $14 m = $342 m  \n* FY 2025‑FY 2028: $0 (all finite‑lived assets fully amortized)\n\n**Total estimated amortization FY 2023‑FY 2028 = $342 m × 2 = $684 million.**\n\nThe $630 million IPR&D asset recorded for Mellanox is classified as an **indefinite‑lived** intangible. It is **not amortized**; instead it is tested for impairment each year and will only begin to be amortized if/when the project reaches technological feasibility. Thus, the $684 million of amortization expense relates only to the finite‑lived assets, while the $630 million IPR&D amount remains on the balance sheet without amortization until a change in circumstance triggers it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the total amortization expense and annual breakdown. The ground truth states the total estimated amortization from FY2023 to FY2028 is $1.889 billion, but the LLM calculates only $684 million, which is less than half the correct amount. The LLM incorrectly assumes that all finite-lived assets are fully amortized by FY2024, but the ground truth shows expenses continuing through FY2028, including $121 million in 2028 and thereafter. The annual figures provided in the original answer ($585M, $461M, etc.) do not match the LLM's $342M per year for only two years. (2) The LLM's calculation of amortization is based on incorrect asset lives and values. It assumes developed technology is amortized at $328M/year over 5 years ($1.64B total), but this does not align with the actual reported schedule. Customer relationships being fully amortized by FY2022 contradicts the presence of post-2022 amortization in the ground truth. The LLM fails to account for the correct timing and magnitude of cash flows. (3) While the LLM correctly identifies that the $630 million IPR&D asset is indefinite-lived and not amortized, instead subject to impairment testing, this part of the reasoning is accurate and reflects proper multi-hop understanding of accounting rules for intangible assets. However, the synthesis of actual amortization figures across years is fundamentally flawed. (4) The contextual relevance is high because the LLM addresses both parts of the question—total amortization and the treatment of the IPR&D asset—and attempts to explain the distinction between finite- and indefinite-lived intangibles. However, due to severe quantitative errors and incomplete/misrepresented amortization schedules, the correctness and quantitative accuracy scores are low. The qualitative reasoning about IPR&D is sound, but the financial data synthesis is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 523,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "Biktarvy’s primary compound patents run out in 2033 in both the United States and the European Union (see the “Biktarvy – 2033 / 2033” entry). The 2024 FDA expansion to treat people with HIV who have M184V/I resistance adds a new approved indication, which does not change the underlying patent dates but gives the product an additional layer of regulatory exclusivity for that indication, helping to preserve its market protection at least through the 2033 patent expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, matching the ground truth. This satisfies the quantitative requirement. 2) The answer accurately states that the FDA's 2024 expanded approval for patients with M184V/I resistance does not extend the base patent term but adds regulatory exclusivity for that indication, which aligns with the original answer’s assertion that the expanded use reinforces market exclusivity and supports revenue through 2033. 3) The multi-hop reasoning is sound: it connects patent expiration (2033 in both regions) with the impact of a new FDA indication on market exclusivity, synthesizing information about intellectual property and regulatory strategy. 4) Minor deduction in qualitative accuracy because the original answer emphasizes the broadening of therapeutic application as reinforcing market exclusivity, while the LLM focuses on regulatory exclusivity for the new indication—slightly different emphasis but semantically close. The LLM introduces the concept of 'additional layer of regulatory exclusivity,' which is plausible but not explicitly confirmed in the ground truth. However, this does not contradict it and is a reasonable interpretation. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 365,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Company notes that the Federal Reserve’s supervisory stress‑test projections can be more restrictive than its own internal models, so when the Fed’s results show a lower capital buffer the bank may be forced to curb or suspend dividends and share‑repurchase programs. That constraint is reinforced by the Dodd‑Frank‑Act‑derived **Comprehensive Capital Analysis and Review (CCAR) capital‑planning and stress‑testing requirement**, which obligates Capital One to obtain the Fed’s approval of any capital distributions and can impose a stress‑capital‑buffer that limits payouts to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of how the Federal Reserve's stress testing impacts Capital One's capital return capacity, correctly noting that Fed projections may be more restrictive than internal models and can lead to curbs on dividends and share repurchases. The mention of CCAR (Comprehensive Capital Analysis and Review) as a regulatory mechanism is contextually relevant and accurately reflects the process through which capital distributions are evaluated. However, the ORIGINAL ANSWER identifies the 'source of strength doctrine' codified by the Dodd-Frank Act as the specific legal requirement reinforcing the limitation, whereas the LLM incorrectly cites CCAR as the Dodd-Frank-derived requirement. While CCAR is related and important, it is a Federal Reserve program, not a direct statutory requirement of the Dodd-Frank Act itself—this is a key distinction. The 'source of strength doctrine' is the precise legal mandate from Dodd-Frank that compels bank holding companies like COF to support their subsidiaries, thereby limiting capital returns. Thus, while the LLM captures the operational mechanism (stress testing → capital constraints), it misattributes the specific Dodd-Frank requirement. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is logically sound and contextually appropriate, but the error in identifying the statutory basis reduces qualitative accuracy. Semantic equivalence is mostly preserved, but the misidentification of the regulatory requirement constitutes a significant, though not fundamental, error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 438,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The 10‑K states that the cost‑of‑sales amounts recorded for the State Settlement Agreements were approximately **$4.2 billion for 2019, $4.4 billion for 2020 and $4.3 billion for 2021**【MO_10k_2022.pdf page 38‑40】. Together, those payments total about **$12.9 billion**.  \n\nThe independent auditor’s calculation of the **maximum potential NPM Adjustment for 2020** was **$572 million**【MO_10k_2022.pdf page 42】. Thus, the combined State Settlement payments for 2019‑2021 are roughly **22‑times larger** than the maximum NPM Adjustment that could apply to 2020 alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the payments made by PM USA under the State Settlement Agreements for 2019 ($4.2B), 2020 ($4.4B), and 2021 ($4.3B), matching the ground truth. The sum is reported as $12.9 billion, which is a minor rounding difference from the exact sum of $12.8 billion (4.2 + 4.4 + 4.3 = 12.9), but this appears to be due to rounding conventions and is not a material error. The maximum potential NPM Adjustment for 2020 is correctly stated as $572 million. (2) All numeric values are accurate; the only discrepancy is in the total sum, where the precise sum of the provided annual figures is $12.9 billion, not $12.8 billion. However, the original answer states $12.8 billion, which may reflect internal rounding or adjustments not visible in the annual breakdown. Given that the individual yearly amounts are correct and their arithmetic sum aligns with $12.9B, this is likely a presentation-level discrepancy rather than a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes payment data across three years from the State Settlement Agreements and compares it to the NPM Adjustment for 2020, drawing a valid conclusion about relative magnitude (22x larger). (4) The answer is contextually complete, entity-accurate (PM USA, correct years, correct financial terms), and semantically equivalent to the ground truth. The minor total sum variance does not undermine the overall correctness, hence a 9/10 on correctness and quantitative accuracy. Qualitative and contextual scores are 10 due to flawless reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 436,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The 2.85 % senior notes due 2030 are shown with a fair‑value of **$7.5 billion** in the first table, and a net carrying amount of **$7.5 billion** in the second table.  The two figures are effectively the same, so the difference is essentially **$0** (no material difference).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the fair value and net carrying amount. The ground truth states the fair value is $1,542 million and the net carrying amount is $1,500 million, resulting in a $42 million difference. The LLM reports both values as $7.5 billion, which is over 4.8 times higher than the correct figures, and concludes the difference is $0. These numbers are not supported by the ground truth. (2) The quantitative inaccuracies are severe: $7.5 billion vs. $1,542 million (fair value) and $7.5 billion vs. $1,500 million (carrying amount) represent massive overstatements. The calculated difference of $0 is incorrect; the correct difference is $42 million. Even allowing for format variations, $7.5 billion does not equal $1,542 million. (3) The multi-hop reasoning failed: the model did not correctly extract values from the two tables as required, and thus could not compute the correct difference. It appears to have either misidentified the notes or pulled data for a different instrument or company. (4) Due to complete factual inaccuracy in numbers and calculations, the correctness score is 1. Quantitative accuracy is 1 due to grossly incorrect figures. Qualitative accuracy is 2 because while the model understood the structure of the task (compare fair value to carrying amount), it failed in entity and data retrieval. Contextual relevance is 3 because the answer addresses the right type of financial instrument and concept, but with entirely wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 415,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules place Capital One’s holding company in the “Category III” bucket, which means that, as of 1 January 2020, it is no longer subject to the Basel III Advanced‑Approaches framework and can **exclude the AOCI items that the rules allow it to leave out of regulatory‑capital calculations**. Because of that classification, the company’s capital ratios are measured against the **stress‑capital‑buffer framework** (the stress‑buffer amount + any counter‑cyclical buffer) rather than the flat 2.5 % capital‑conservation buffer that applies to banks, so its minimum CET1, Tier 1 and total‑capital requirements are set at the higher levels dictated by the stress buffer (e.g., 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total capital for 2021‑22).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One (COF), as a Category III institution under the Tailoring Rules, is no longer subject to the Basel III Advanced Approaches framework and can exclude certain AOCI elements from regulatory capital—this aligns with the ground truth. It also correctly links this classification to the application of the Stress Capital Buffer (SCB) framework instead of the flat 2.5% capital conservation buffer. However, the LLM introduces specific percentage requirements (e.g., 7.0% CET1, 8.5% Tier 1, 10.5% total capital for 2021–22) that are not present in the original answer and are not universally fixed—these values vary annually based on stress test results. While such figures may reflect actual SCB requirements in those years, the original answer emphasizes the *recalibrated, institution-specific, and annually adjusted* nature of the buffer without citing specific percentages, making the LLM’s inclusion of exact numbers potentially misleading or over-specific without proper qualification. (2) Quantitative accuracy is reduced because the original answer does not provide any numerical capital requirements; thus, introducing them—without confirming they are standard or required—adds unverified precision. The date '1 January 2020' is plausible but not confirmed in the ground truth, which does not specify an exact effective date. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of Category III classification → exemption from advanced approaches → AOCI exclusion → application of SCB instead of static buffers. This demonstrates strong qualitative understanding of regulatory cause-and-effect. (4) Contextual relevance is perfect—the response directly addresses the question about COF’s capital requirements under the Tailoring Rules, focusing on SCB and AOCI exclusion. Overall, the answer is factually consistent in direction and logic but loses some correctness and quantitative accuracy due to unsupported specificity in percentages and dates not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 558,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "Altria’s JU UL investment was recorded at a lower fair value in 2020, generating a **$100 million (income) loss** that was reported in the “(income) losses from equity investments” line of the consolidated statement of earnings. In 2021 the fair‑value change was neutral – no gain or loss was recorded – so the $100 million loss recognized in 2020 was effectively reversed, leaving the net fair‑value change for the two‑year period at **$0**. The impact appears in the consolidated earnings line item for equity‑investment income (losses).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the answer claims a $100 million loss in 2020 and no change in 2021, implying a net $0 change over the two years. However, the ground truth states that the fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021, meaning there was no loss or gain in either year—certainly not a $100 million loss in 2020. This misrepresents both the magnitude and direction of any change. (2) The claim that a $100 million loss was 'reversed' in 2021 is unsupported and factually wrong; the original answer confirms no change in fair value occurred between the two years. (3) The qualitative reasoning fails on multiple fronts: it invents a loss not present in the data, misunderstands the accounting treatment (which involves ongoing level 3 fair value measurements but no reported change for those years), and incorrectly frames the 'net change' as $0 due to offsetting entries when in fact the stability of the value across years is what matters. (4) While the answer correctly identifies the financial statement line item—'income (losses) from equity investments'—and mentions the consolidated statements, this partial contextual accuracy does not compensate for the core factual errors. The entities (Altria, JUUL, correct financial statements) are accurate, but the synthesis is flawed. Overall, the answer fabricates financial impacts not present in the source data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 416,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific’s locomotive fleet totals 7,154 units, of which 1,037 are leased – roughly 14.5 % of all locomotives are leased rather than owned.  By contrast, the company’s fleet contains 132 switching locomotives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all quantitative aspects: the total number of locomotives (7,154), the number leased (1,037), the calculated percentage (~14.5%), and the number of switching locomotives (132) are all accurate. The calculation of 1,037 / 7,154 ≈ 14.5% is correct. The answer addresses both parts of the question: the percentage of leased locomotives and the comparison to switching locomotives. While the original answer explicitly states that the leased number is 'significantly higher' than the switching locomotive count, the LLM answer implies this by presenting the two figures in contrast, which preserves semantic equivalence. The entities (Union Pacific, locomotive fleet, leased vs owned, switching locomotives) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis of fleet composition data. The only minor shortcoming is the lack of an explicit comparative statement (e.g., 'much higher than'), but the contrast is still effectively communicated. Thus, the answer is highly accurate with only a slight reduction in qualitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 320,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The fair‑value column for the 2.20 % Notes Due 2021 fell from **$1.95 billion at January 31 2021 to $1.88 billion at January 30 2022**, a **decrease of about $70 million**.  \n\nThat $70 million reduction appears in two places:  \n\n* **Fair‑value disclosure (Note 7 – Debt)** – the table that lists each class of debt shows the 2.20 % notes at $1.95 billion for 2021 and $1.88 billion for 2022.  \n* **Debt‑specific maturity/interest‑rate table** – the same notes are listed with a principal amount of $2.0 billion, a 2.20 % coupon and a 2021 maturity, and the accompanying fair‑value line reflects the lower $1.88 billion figure for 2022 (down from $1.95 billion in 2021).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all key aspects. The ground truth states that the fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, because the notes matured. However, the LLM claims the fair value decreased from $1.95 billion to $1.88 billion — both figures are wrong in amount and unit (billion vs million). The actual drop was $1,011 million to $0, not a $70 million decrease. (2) The calculation of a $70 million decrease is based on incorrect inputs and is therefore invalid. The correct change is a $1,011 million decrease to zero. The LLM also misrepresents the principal amount as $2.0 billion, which does not align with the ground truth. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that a note maturing in 2021 would have zero fair value by January 30, 2022, as reflected in both the fair value disclosures and the maturity table showing 0 years remaining. Instead, it incorrectly assumes the note remains outstanding with only a modest fair value decline. (4) The contextual relevance is partially correct — the LLM identifies the right types of disclosures (fair value note and maturity table) and attempts to link them — but the underlying data and conclusion are entirely inaccurate. Due to major factual, numerical, and logical errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 391,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary rule allowed Capital One to subtract U.S. Treasury securities and deposits held at the Federal Reserve Banks from the “total leverage exposure” denominator of the supplementary leverage ratio, which makes the ratio appear higher (i.e., more capital‑backed) because fewer assets are counted against Tier 1 capital. This adjustment was mandated by the Federal Reserve’s April 2020 interim‑final rule that temporarily excluded those items from the supplementary leverage‑ratio calculation for bank holding companies during the COVID‑19 response.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio increases the ratio by reducing total leverage exposure, which aligns with the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—however, the LLM correctly references the April 2020 interim-final rule by the Federal Reserve, which is consistent with public regulatory actions during the COVID-19 pandemic, even if the exact date isn't in the original answer; this adds contextual precision without contradicting facts. (3) The reasoning is sound: it explains the mechanical impact on the ratio (higher SLR due to lower denominator) and correctly attributes the regulatory authority to the Federal Reserve. The only minor gap is that the LLM does not explicitly name the 'Basel III Standardized Approach framework'—mentioned in the original answer—as the broader regulatory framework governing the capital ratios. While the interim rule is correctly cited, the absence of Basel III reduces completeness slightly in terms of full regulatory context. (4) Despite this omission, the answer remains highly accurate, relevant, and semantically equivalent in substance. The explanation is clear, logically structured, and directly responsive to both parts of the question: the impact on the SLR and the regulatory basis for the adjustment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 436,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "In 2023 the pension plan had **$3,209 million** of assets classified as Level 2 investments. These Level 2 assets (federal government securities, corporate bonds and debentures, and preferred stock) were **valued using a bid‑evaluation process that relies on observable bid data from independent pricing sources**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total value of Union Pacific's pension plan Level 2 investments in 2023 as $3,209 million, matching the ground truth. The valuation method—'bid-evaluation process using observable bid data from independent pricing sources'—is accurately described. 2) Quantitatively, the $3,209 million figure is correct. The ground truth breaks this into $1,508 million (Federal Government Securities) and $1,696 million (Bonds and Debentures), which sum to $3,204 million—likely a $5 million discrepancy due to rounding or unreported components. The LLM does not list the individual asset categories with values but mentions 'federal government securities, corporate bonds and debentures, and preferred stock', which aligns generally with the ground truth, though 'preferred stock' is not explicitly mentioned in the original and the sum of components has a minor inconsistency. 3) The multi-hop reasoning is sound: the model correctly attributes Level 2 assets to Union Pacific, for 2023, and explains the valuation methodology using external pricing data. The only minor shortcoming is the lack of specific breakdown of asset components with exact values, which slightly reduces completeness. 4) The answer is contextually relevant, directly addressing both parts of the question: total value and valuation method. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to full quantitative accuracy and strong qualitative performance with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 417,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "The filing cites two automotive‑focused uses of Omniverse: (1) virtual car showrooms that let manufacturers display vehicles in a photorealistic, interactive 3‑D environment, and (2) the Omniverse Avatar component, which is bundled in the upcoming DRIVE Software platform to provide real‑time conversational‑AI assistants for in‑vehicle experiences (Drive Concierge). By embedding Omniverse Avatar in the DRIVE stack, NVIDIA extends the same GPU‑based AI training pipeline that creates the neural‑network models to the vehicle’s DRIVE AGX/Hyperion hardware for inference, thereby linking its simulation‑and‑collaboration tools with on‑board AI and illustrating its end‑to‑end accelerated‑computing strategy from data‑center training to in‑car deployment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of Omniverse Avatar in DRIVE Concierge for real-time conversational AI, which aligns with the ground truth. However, it introduces 'virtual car showrooms' as a specific automotive application mentioned in the 10-K, which is not present in the original answer and not supported by the ground truth from the knowledge graph. This is an addition not found in the source, reducing factual accuracy. The integration with DRIVE is accurately described in terms of end-to-end AI strategy, linking data-center training to in-car inference via GPU-based pipelines. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the connection between Omniverse, DRIVE, and NVIDIA’s end-to-end strategy is well articulated, especially regarding training-to-deployment flow. However, the inclusion of 'virtual car showrooms' as a cited application in the 10-K undermines the entity and factual accuracy, as this detail is extrinsic. The ground truth only mentions DRIVE Chauffeur and DRIVE Concierge under Omniverse Avatar use, not visualization or showroom applications. (4) The contextual relevance is high because the answer addresses both parts of the question—applications and strategic integration—and uses correct terminology (DRIVE AGX, Hyperion, over-the-air updates implied via continuous deployment). The core strategic narrative is consistent with the ground truth, but the incorrect addition of an unmentioned application limits the correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 461,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "Converse’s share of NIKE Inc.’s total revenue fell from about **5.0 % in 2022 ( $2,346 m ÷ $46,710 m ≈ 5.02 % )** to **4.7 % in 2023 ( $2,427 m ÷ $51,217 m ≈ 4.74 % )** – a decline of roughly **5.6 %** year‑over‑year【86†L1-L9】.  \n\nIn the same period, Converse’s operating income (EBIT) rose from **$669 m in 2022 to $676 m in 2023**, a modest increase of about **1.0 %**【86†L31-L38】.  \n\nThus, while Converse’s revenue contribution to the company shrank by about 5½ %, its operating profit actually grew by roughly 1 % over the same interval.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively: The ground truth states that Converse's contribution to NIKE's total revenues *increased* by 3.4% from 2022 to 2023, while the LLM claims a 5.6% *decline* in revenue share, based on incorrect calculations. The LLM computes percentages of total revenue (5.02% to 4.74%), but the question asks for the *percentage change in Converse's contribution to total revenues*, which refers to the year-over-year growth in Converse's revenue as a component of Nike’s total, not its share percentage. However, even on its own interpretation, the LLM’s calculation of a '5.6% decline' in share is wrong: the drop from 5.02% to 4.74% is a 5.6% *relative decrease in share percentage points*, but this misrepresents the actual metric. More critically, the LLM states Converse's operating income *increased* by 1.0% (from $669M to $676M), while the ground truth reports a 30.0% *decrease*. This is a major factual error. (2) The numbers used (e.g., $2,346M, $2,427M, $669M, $676M) do not align with the ground truth data implied by the correct answer, suggesting fabricated or misreferenced data. (3) The multi-hop reasoning fails: the model incorrectly interprets 'contribution to total revenues' as percentage of total revenue rather than the growth rate of Converse's revenue within Nike’s structure, and it completely misses the sharp decline in operating income. (4) The conclusion that revenue contribution fell while operating income rose contradicts the ground truth on both counts. The answer is contextually relevant in addressing the two metrics over time, but factually and numerically incorrect throughout. Hence, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 474,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The new TDR accounting guidance eliminated the “reasonably‑expected” and concession‑assessment criteria, so any loan that was only in a trial‑modification stage was no longer treated as a full‑deferred modification (FDM). Consequently, the $69 million of residential‑real‑estate loans and the $27 million of credit‑card loans that were in trial modification at year‑end 2023 were re‑classified as TDRs rather than as FDMs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the elimination of the 'reasonably expected' and 'concession' criteria, the reclassification of trial modifications as TDRs but not FDMs, and the correct dollar amounts for both portfolios ($69 million for residential real estate and $27 million for credit card loans) as of December 31, 2023. Number formats match and are accurate. (2) Quantitative accuracy is perfect—both figures are correctly reported with no calculation errors. (3) The reasoning is sound: the change in criteria led to trial modifications no longer qualifying as FDMs and instead being classified as TDRs, which aligns with the multi-hop logic required. The synthesis across both loan portfolios is correctly handled. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the loans were classified as TDRs but not FDMs using that exact dual phrasing, though it clearly implies it by saying they were 'reclassified as TDRs rather than as FDMs'. This is semantically equivalent but slightly less precise in terminology. Otherwise, the answer is fully relevant, complete, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 341,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31 2023, Union Pacific had **1,304,451 retention shares and retention units** outstanding (245,107 under the 2013 Stock Incentive Plan + 1,059,344 under the 2021 Stock Incentive Plan). By contrast, the Directors Plan had **16,000 restricted shares** outstanding on the same date.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the total number of retention shares and units. It reports 1,304,451, while the ground truth is 1,320,451 (954,405 retention shares + 366,046 retention units). The LLM's breakdown (245,107 + 1,059,344) does not match the ground truth components and appears to conflate retention shares/units with plan-specific totals from different sources. However, the Directors Plan restricted shares are correctly reported as 16,000, matching the ground truth. (2) The calculation of the total retention instruments is incorrect: 245,107 + 1,059,344 = 1,304,451, which is 16,000 less than the correct total of 1,320,451. This suggests either a data error or misattribution of plan numbers. (3) The reasoning partially addresses the multi-hop requirement by comparing retention instruments under stock incentive plans to restricted shares under the Directors Plan, and correctly identifies the relevant plans. However, it fails to accurately decompose or sum the correct retention components, undermining the synthesis. (4) Despite the numerical inaccuracy, the answer is contextually relevant and structured appropriately, correctly identifying the comparison required and the relevant plans. The qualitative reasoning is sound in approach but based on incorrect underlying data. Thus, correctness is penalized heavily due to the material calculation error, though not completely wrong due to partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 409,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "As of December 28 2024 AMD’s investment in the ATMP joint venture consisted of (i) the equity‑method carrying amount of about **$149 million** and (ii) a **$100 million secured term loan** that the company made to the JV (recorded as a receivable). Together, these two components represent an total investment of roughly **$249 million**. 【Source 1: “carrying value of the Company’s investment in the ATMP JV was approximately $149 million …”】【Source 2: “On October 9 2024 … entered into a one‑year term loan agreement … for $100 million … loan is recorded within Receivables from related parties.”】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $149 million carrying value of the equity investment and the $100 million secured term loan are correctly reported, and their sum of $249 million is accurate. Minor formatting differences (e.g., 'about $149 million' vs 'approximately $149 million') are acceptable and do not affect factual correctness. (2) The answer is complete, addressing both components of AMD's total investment as required by the question—equity carrying value and secured loan—and correctly synthesizing them into a total. (3) Entities are accurate: AMD, ATMP JV, correct date (December 28, 2024), and financial terms (equity-method carrying amount, secured term loan, receivable) are all correctly identified and used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly combines information from two sources (equity investment value and loan amount) to compute the total investment, demonstrating accurate understanding of financial structure. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured explanation and appropriate sourcing. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 349,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "Danaher’s Envista disposition generated a $451 million gain, but that was offset by a $109 million foreign‑currency translation loss and $69 million of IPO‑ and Separation‑related costs, resulting in a net impact of **$273 million** ( $451 m – $109 m – $69 m )【...】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the individual components of the financial impact: a $451 million gain on disposition, a $109 million foreign currency translation adjustment loss, and $69 million in IPO and Separation-related costs. These values match the ground truth exactly, satisfying entity and metric accuracy. However, the final calculated net impact is incorrect: the LLM computes $451M - $109M - $69M = $273M, but the correct total financial impact per the original answer is $387 million. This discrepancy indicates a critical error in quantitative reasoning. The correct calculation should reflect that the $451M gain is reduced by the two deductions, but the original answer states the total impact is $387M, which implies the net effect after all adjustments is $387M — not $273M. This suggests either a misinterpretation of how the components combine or an arithmetic error. The model performs well on contextual relevance and identifies all relevant events and figures (multi-hop elements), but fails in synthesizing them correctly. The reasoning is logically structured but based on flawed math, undermining the factual correctness. Thus, while the qualitative identification of components is mostly sound, the quantitative inaccuracy severely impacts the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 360,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The Converse segment’s revenues fell about 15 % on a currency‑neutral basis (driven by weaker North‑America and Western‑Europe sales), and that drop translated into a **30 % decline in EBIT** – from $676 million in FY 2023 to $474 million in FY 2024.  The EBIT contraction was amplified by a **130‑basis‑point compression in gross margin** that resulted from unfavorable foreign‑currency exchange rates, meaning the segment’s profitability fell more sharply than the revenue decline alone would suggest.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15% currency-neutral revenue decline in Converse driven by North America and Western Europe, and accurately states the 30% EBIT decline, which aligns with the ground truth. It adds specific dollar amounts ($676M to $474M) not present in the original answer, but these are consistent with a ~30% drop (30.06% decline) and do not contradict the ground truth. The 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates is correctly attributed. (2) Quantitative accuracy is high: the 30% EBIT decline is correctly stated, and the dollar figures provided are internally consistent (from $676M to $474M is approximately a 30% drop). While the original answer does not include dollar amounts, their inclusion is an enhancement rather than an error. No calculation inaccuracies are present. (3) Multi-hop reasoning is sound: the model correctly links the revenue decline to EBIT performance and incorporates the impact of gross margin contraction from currency effects, demonstrating proper synthesis across financial metrics and causal factors. (4) The answer is semantically equivalent to the ground truth, with slightly more detail. The only minor point preventing a perfect 10 is that the original answer does not specify fiscal years (FY2023/FY2024), so their inclusion introduces assumptions not in the source, though they are plausible. Overall, the response is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 414,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The new TDR accounting guidance that became effective on January 1 2023 eliminated the “reasonably‑expected” and concession‑assessment criteria, so the $69 million of residential loans in trial‑modification status and the $9 million of Chapter 7 bankruptcy loans were re‑classified as TDRs rather than as fully‑drawn modifications.  This re‑classification reduced the 2023 allowance for credit losses by $587 million (the cumulative accounting‑principle effect shown in the allowance‑for‑loan‑losses table).  The $587 million decrease lowered the provision for loan losses, thereby improving JPMorgan Chase’s earnings and equity position for the year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers: $587 million reduction in allowance, $69 million in trial modifications, and $9 million in Chapter 7 loans, as well as the January 1, 2023 effective date—these match the ground truth exactly. (2) Quantitative accuracy is high: all dollar amounts and dates are correct, and the $587 million figure is properly attributed as the net impact. (3) However, there is a critical error in qualitative reasoning: the LLM states that the loans were reclassified 'as TDRs rather than as fully-drawn modifications', which is incorrect. The ground truth specifies that these loans were reclassified as *non-FDMs* (non-Financial Disincentive Modifications), *although they remained TDRs*. The LLM flips the logic, implying they became TDRs due to the change, when in fact they were no longer treated as FDMs under the new guidance, which reduced reserve requirements. This misrepresents the accounting mechanism. (4) Despite this significant conceptual error in the multi-hop reasoning—misidentifying the direction of reclassification—the answer captures the net financial impact and correctly links it to improved earnings and equity. Therefore, while the numerical and directional outcomes are accurate, the underlying explanation contains a material inaccuracy in entity and classification logic, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 389,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "UNP’s pension plan had **$3.2 billion** of assets classified in Level 2 (significant other observable inputs) at December 31, 2023.  \n\nThe investment categories that are valued using a **bid‑evaluation process with independent pricing sources** are **Federal Government securities, Bonds and debentures, and preferred stock** (the preferred‑stock component of the corporate‑stock category).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total amount invested in Level 2 assets is stated as $3.2 billion, whereas the ground truth is $1,111 million ($1.111 billion), a substantial overstatement. This major numerical discrepancy severely impacts correctness. (2) Regarding investment categories, the LLM correctly identifies Federal Government Securities and Bonds and Debentures as using bid evaluation with independent pricing sources, which aligns with the original answer. However, it incorrectly lists 'preferred stock (the preferred-stock component of the corporate-stock category)' instead of 'Corporate Stock' as specified in the ground truth. The original answer does not break down corporate stock into preferred stock, nor does it specify such a sub-component, making this an unsupported inference. (3) The multi-hop reasoning is partially sound—information about valuation methodology is correctly tied to specific asset categories, showing synthesis across data points. However, the incorrect total amount and misrepresentation of the corporate stock category indicate flawed data retrieval or interpretation. (4) Despite incorrect numbers and entity details, the answer addresses the right question and attempts to provide both quantitative and qualitative components, maintaining contextual relevance. Wording and structure are clear, but factual accuracy—especially in numbers and entity specification—is poor, warranting low scores in quantitative and qualitative accuracy. The correctness score is low due to the critical error in the dollar amount and partial mismatch in investment categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 451,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The “Research and medical products” line shows revenue of $13.5 billion in 2019, $18.0 billion in 2020 and $24.8 billion in 2021, which is an 83‑84% increase from 2019 to 2021.  By contrast, total company sales rose from $17.9 billion in 2019 to $29.5 billion in 2021, a 64‑65% increase over the same period.  Because the research‑and‑medical segment grew markedly faster than overall revenue, it has been a primary driver of DHR’s recent top‑line growth.  \n\n*Sources: segment‑level “Research and medical products” revenues ($13,512 M in 2019; $24,802 M in 2021) and total sales ($17,911 M in 2019; $29,453 M in 2021) from the 2022 10‑K tables.*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key numbers are accurate: research and medical products revenue is correctly reported as $13,512 million (rounded to $13.5 billion) in 2019 and $24,802 million ($24.8 billion) in 2021; total revenue is correctly cited as $17,911 million ($17.9 billion) in 2019 and $29,453 million ($29.5 billion) in 2021. (2) Calculations are correct: the 83-84% increase for the segment (from 13,512 to 24,802) and 64-65% increase for total revenue (from 17,911 to 29,453) match the ground truth (83.5% and 64.4%, respectively), with minor rounding acceptable. (3) Multi-hop reasoning is sound: the model correctly compares segment growth to total revenue growth and draws the logical conclusion that the segment outperformed and was a primary driver of top-line growth. (4) All entities (DHR, research and medical products segment, correct years) are accurately identified and synthesized from the 10-K data. The answer fully addresses both parts of the question: the comparison of growth rates and the implication for DHR's financial performance. Wording differs slightly but meaning is preserved. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 344,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The January 1 2023 revision to the TDR accounting guidance lowered JPMorgan’s total allowance for credit losses by $587 million – $100 million of that reduction came from the credit‑card allowance (the “cumulative effect of a change in accounting principle” line shows a $(100) million impact for credit cards). At the same time, the new guidance eliminated the “reasonably‑expected” and concession‑assessment criteria, so the $27 million of credit‑card loans that were in trial modification during 2023 were no longer treated as FDMs; they were re‑classified as TDRs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in the allowance for credit losses and the $27 million in trial modifications, which aligns with the ground truth. However, it introduces a specific breakdown of $100 million reduction attributed to credit-card allowance, which is not present in the original answer and cannot be verified from the provided ground truth. This addition, while possibly accurate, is unsupported by the source and introduces unverified detail. (2) The ground truth states that trial modifications were considered TDRs but not FDMs under the new guidance, and reports $648 million in FDMs and $27 million in trial modifications for 2023. The LLM correctly captures the reclassification of trial modifications from FDMs to TDRs but omits the $648 million FDM figure entirely, which is a significant omission. It also incorrectly implies that the $27 million in trial modifications were previously treated as FDMs, whereas the original answer does not state this — it only contrasts current trial modifications with prior-year TDRs of $418 million. (3) The multi-hop reasoning is partially sound: the model correctly links the change in accounting guidance to both the allowance impact and the reclassification of trial modifications. However, it fails to incorporate the full set of reported figures (e.g., prior-year TDRs of $418 million, current-year FDMs of $648 million), weakening completeness and synthesis. (4) The contextual relevance is high as the answer addresses the core effects of the guidance change. Quantitative accuracy is reduced due to the unsupported $100 million claim and missing $648 million FDM data. Qualitative accuracy is moderate due to correct conceptual understanding but flawed execution in details and omissions. Correctness score is 6 due to partial factual alignment but significant missing and potentially inaccurate information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 519,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "In the first quarter of 2021 3M replaced its “calculated‑value” approach with a fair‑value method for the fixed‑income portion of its pension‑ and post‑retirement‑plan assets. Because the fair‑value method does not defer excess asset gains or losses, the change was applied retrospectively and altered the way the pension cost components were shown: the net periodic pension‑and‑post‑retirement expense moved out of “other expense (income)” (e.g., $450 million under the prior method became $366 million after adjustment for 2020) and the related actuarial‑gain/loss adjustment shifted in accumulated other comprehensive income (e.g., $171 million of OCI became $106 million for 2020). The restatement also revised the line‑item “company pension and post‑retirement expense” (e.g., $406 million to $322 million for 2020) and modestly changed retained earnings and OCI balances, while having no effect on operating income or cash‑flow from operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key change in accounting principle—3M's shift from a calculated-value approach to a fair-value method for fixed-income securities in its pension and postretirement plans in Q1 2021—and notes the retrospective application, which aligns with the ground truth. It accurately describes the impact on financial statement presentation, including the movement of net periodic benefit cost out of 'other expense (income)', changes in accumulated other comprehensive income (OCI), retained earnings, and the absence of impact on operating income and cash flow. These qualitative aspects reflect sound multi-hop reasoning and entity accuracy (correct company, correct year, correct metrics). However, the quantitative accuracy is problematic: the LLM introduces specific dollar figures (e.g., $450M to $366M, $171M to $106M, $406M to $322M for 2020) that are not present in the original answer and cannot be verified against the ground truth. Since the ground truth does not include any numerical examples or specific dollar amounts, the inclusion of these figures introduces unverified data, constituting a significant issue in factual correctness. While such details may be drawn from actual filings, they are not part of the provided knowledge graph and thus represent hallucinated specifics. This undermines the quantitative accuracy despite the otherwise correct conceptual explanation. The answer is semantically aligned in most respects and highly relevant to the question, but the unsupported numbers reduce confidence in full factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 432,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new troubled‑debt‑restructuring (TDR) accounting guidance on January 1 2023 lowered JPMorgan’s allowance for credit losses.  The change produced a net reduction of **$587 million** to the allowance for credit losses for 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the adoption of the new TDR accounting guidance on January 1, 2023, led to a reduction in JPMorgan's allowance for credit losses, and the specific dollar amount of the impact was $587 million. All numeric values and dates are accurate, satisfying quantitative accuracy. (2) The dollar amount ($587 million) and effective date (January 1, 2023) match the ground truth exactly, with acceptable formatting. (3) While the LLM captures the core impact and amount, it omits the qualitative reasoning present in the original answer—specifically, *why* the change led to the reduction (i.e., elimination of the 'reasonably expected' and 'concession' criteria, reclassification of trial modifications not as FDMs). This missing explanatory context affects the depth of multi-hop reasoning and qualitative accuracy, though the core synthesis of event and impact is sound. (4) The answer is fully contextually relevant and factually correct in what it states, earning high marks for relevance and quantitative precision. A score of 9 is justified due to full factual alignment on numbers and impact, but with minor incompleteness in explanatory detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 341,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "In 2023 Colgate‑Palmolive’s Africa/Eurasia segment saw goodwill fall by **$19 million** (a foreign‑currency translation loss) while generating **$254 million** of operating profit – a combined effect of roughly **$235 million**.  By contrast, the segment’s capital expenditures were only **$10 million** for the year, a fraction of the combined goodwill‑profit impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $19 million decrease in goodwill due to foreign currency translation and the $254 million operating profit in the Africa/Eurasia region for 2023, as well as the $10 million capital expenditures, so the individual numeric values are accurate. However, the 'combined impact' is incorrectly calculated as $235 million (which appears to be $254M - $19M), whereas the original answer defines the combined impact of goodwill decrease and capital expenditures as $19M + $10M = $29M. This is a critical error in interpretation and calculation. (2) Quantitative accuracy is low because while the input numbers are correct, the key derived figure (combined impact) is wrong. The model subtracts goodwill decrease from operating profit, which misrepresents the question’s intent—comparing the total outflow/impact from goodwill reduction and capex to operating profit. (3) The reasoning is partially sound in identifying relevant components, but fails in multi-hop synthesis: it misunderstands the nature of 'combined impact'—it should be the sum of the goodwill decrease and capex, not a net with operating profit. The comparison to capex is relevant but based on a flawed metric. (4) Contextual relevance is high because the answer addresses the right region, company, year, and financial metrics. However, due to the major calculation and conceptual error in combining the impacts, the correctness score is significantly reduced. The answer incorrectly implies that the $235M figure is meaningful, when in fact it misrepresents the financial reality presented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 443,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 change to 3M’s business‑segment reporting required the goodwill balances to be re‑allocated to the new reporting‑unit structure; the company applied a relative‑fair‑value method to adjust the goodwill of any reporting units that were altered, and the resulting effect was immaterial.  After the re‑allocation, 3M performed its normal annual goodwill‑impairment test and concluded that no goodwill impairment existed, indicating that the reporting‑unit changes did not create any material impairment risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: the 2021 business segment reporting changes led to a re-allocation of goodwill using the relative fair value method, the impact was immaterial, and no impairment was identified in the 2021 annual test. (2) There are no numeric values requiring calculation, but the temporal reference (2021) is accurate and consistent with the ground truth. (3) The multi-hop reasoning is sound—correctly linking the structural change to goodwill re-allocation, the method used, the immateriality conclusion, and the subsequent impairment test outcome. (4) The answer fully addresses both parts of the question: the impact on goodwill reporting structure and the evaluation of impairment risk. Wording differs slightly but conveys the same meaning with high precision and appropriate financial terminology. All entities (3M, goodwill, reporting units, 2021) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 288,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD acquired Silo AI to bring in its AI‑lab talent and expertise, which it expects will “accelerate the deployment and development of AI models and software solutions on AMD hardware.” The investment therefore supports AMD’s broader objective of strengthening its AI‑focused Data Center portfolio by speeding time‑to‑market for AI workloads and building the software stack needed to run those models on its CPUs, GPUs and accelerators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the strategic rationale behind AMD's investment in Silo AI: leveraging Silo AI's talent and expertise to accelerate AI model deployment and software development on AMD hardware. The connection to AMD's broader goals—specifically strengthening its Data Center AI portfolio, speeding time-to-market, and building a robust software stack for AI workloads across CPUs, GPUs, and accelerators—is well articulated and aligns with the original answer. The only minor discrepancy is the use of 'acquired' instead of 'invested in,' which slightly overstates the nature of the transaction (AMD invested in, not acquired, Silo AI). However, this does not materially distort the strategic intent or outcome. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable but assumed correct by absence. The reasoning is sound, multi-hop synthesis is appropriate, and all entities (AMD, Silo AI, Data Center segment, AI models/software) are correctly identified and logically connected. The answer fully addresses both parts of the question: the rationale and the connection to AMD’s AI goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 350,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Six amendments were made to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology between September 2, 2014 (the agreement’s effective date) and September 1, 2015 (the effective date of the sixth amendment) – the first through sixth amendments (effective Oct 31 2014, Dec 15 2014, Feb 12 2015, Mar 30 2015, Jun 30 2015, and Sep 1 2015)【10.46‑10.51】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It correctly states that six amendments were made to the agreement between September 2, 2014, and September 1, 2015. (2) The dates of the six amendments (Oct 31 2014, Dec 15 2014, Feb 12 2015, Mar 30 2015, Jun 30 2015, and Sep 1 2015) are all within the specified date range and align with the ground truth. The final amendment's effective date (Sep 1 2015) correctly marks the end of the period. (3) The reasoning is sound and demonstrates multi-hop synthesis by identifying the agreement, its effective date, and the sequence of amendments with their dates. (4) All entities (agreement name, dates, amendment count) are accurate, and the answer is semantically equivalent to the original, with added helpful detail. No factual, quantitative, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 247,
        "total_tokens": 1370
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The 10‑K explains that PMI acquired a majority stake in Swedish Match on Nov. 11 2022, so the 2022 filing only included Swedish Match results from that date through year‑end and treated the business as a distinct “Swedish Match” operating segment. By 2023 the segment is reported on a full‑year basis (net revenue $2.5 bn, operating income $824 m) and is shown separately from the geographic segments, reflecting the expanded reporting scope that the acquisition timing created.  \n\nThe filing also presents a stand‑alone “Swedish Match shipment‑volume” table and notes that the commentary assumes inclusion of Swedish Match’s 2022 volume for comparability, indicating that its volume data are still reported separately from PMI’s consolidated shipment discussion. This separate commentary signals that the integration of Swedish Match’s operational metrics into PMI’s core reporting is still in progress and has not yet been fully merged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition date (November 11, 2022), which matches the ground truth. It accurately states that Swedish Match was included in PM's financials from that date forward and was reported as a separate operating segment. The financial figures provided—$2.5 billion net revenue and $824 million operating income—are consistent with expectations for full-year 2023 reporting and do not contradict the ground truth (though these specific numbers are not in the original answer, they are plausible and contextually appropriate given the expanded reporting scope). (2) All dates and numerical values are accurate or reasonably inferred; no calculation errors present. The mention of full-year 2023 reporting aligns with the timing implications of the late-2022 acquisition. (3) The multi-hop reasoning is sound: the model correctly infers that because the acquisition occurred in November 2022, only partial-year results were included in 2022, but full-year results would be reflected in the 2023 10-K. It also correctly interprets the separate shipment volume commentary as evidence of ongoing integration, linking operational reporting structure to integration timeline—this matches the ground truth’s conclusion about phased integration. (4) The LLM adds slightly more detail (e.g., financial figures) than the original answer, but this enhances rather than distorts accuracy. The only minor gap is that it does not explicitly state that Swedish Match was *excluded* from geographic segments (though it implies this by saying it's reported separately), and the original emphasizes management evaluation separation more. Still, the semantic meaning and factual core are equivalent. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to slight omission in managerial evaluation nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 508,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "In 2021 3M entered into interest‑rate swaps with a total notional amount of **$800 million**. These swaps were used to hedge portions of its fixed‑rate debt consisting of **$1.0 billion** of notes due 2049 and **$650 million** of notes due 2050 – a combined principal amount of **$1.65 billion**. Thus, the swaps covered roughly half of the total principal they were intended to hedge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $800 million notional amount of interest rate swaps in 2021, the $1.0 billion notes due in 2049, the $650 million notes due in 2050, and the resulting combined principal of $1.65 billion. These match the ground truth exactly. The conclusion that the swaps covered 'roughly half' (approximately 48.5%) is semantically equivalent and reasonable given the calculation (800/1650 ≈ 48.48%). (2) All numeric values are accurate and properly formatted; the sum of $1.0 billion and $650 million is correctly implied as $1.65 billion. The percentage coverage, while not explicitly calculated, is accurately described as 'roughly half', which aligns with the ground truth's 48.5%. (3) The multi-hop reasoning is sound: the model correctly links the 2021 swaps to the specific fixed-rate notes due in 2049 and 2050, and synthesizes the total principal to assess hedge coverage. (4) The only minor shortcoming is the lack of explicit percentage (48.5%) mentioned in the ground truth, but 'roughly half' is a reasonable approximation and does not detract significantly from accuracy. All other elements—entities, years, metrics—are correct. Hence, high scores across all dimensions with a 9 on correctness due to slight imprecision in not specifying the exact percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 371,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "AbbVie’s total purchase‑price accounting shows that it transferred **$64.1 billion** for the Allergan deal (cash $39.7 bn + stock $23.98 bn + equity awards $0.43 bn) and **$0.535 billion** for the Soliton acquisition.  Adding the two transactions gives a combined consideration of **about $64.6 billion**, of which **approximately $40.2 billion** was paid in cash.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total consideration transferred by AbbVie for both Allergan and Soliton, Inc. as approximately $64.6 billion, which aligns with the ground truth of $64,619 million (i.e., $64.619 billion). The cash portion is reported as approximately $40.2 billion, matching the ground truth of $40,210 million. Minor rounding differences are acceptable: $64.1B + $0.535B = $64.635B (~$64.6B), and $39.7B + $0.535B = $40.235B (~$40.2B), which reflects proper synthesis. (2) Quantitative accuracy is high—values are presented in billions with slight rounding but remain within acceptable tolerance. The breakdown of Allergan’s consideration into cash, stock, and equity awards is consistent with known disclosures, and Soliton’s $0.535B is accurate. (3) Multi-hop reasoning is sound: the model correctly aggregates consideration across two separate acquisitions (Allergan and Soliton), distinguishes cash from non-cash components, and sums cash portions appropriately. (4) The answer is contextually fully relevant, directly addressing both parts of the question—total consideration and cash component. The only reason for not scoring a 10 is the use of approximations (e.g., 'about $64.6 billion') when exact figures were available in the source data, though this does not constitute inaccuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 399,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America’s 2024 Basel 3 metrics show it is comfortably above all required thresholds – CET1 was 11.9 % (vs a 10.7 % minimum), Tier 1 13.2 % (vs 12.2 %) and total capital 15.1 % (vs 14.2 %), while the Tier 1 leverage ratio was 6.9 % (vs 4.0 %). Because the corporation meets—and exceeds—the risk‑based capital, leverage‑based and supplementary‑leverage buffers required under Basel 3, it is classified as “well‑capitalized” and therefore free of the regulatory limits that would restrict capital distributions. This strong capital position gives the firm the headroom to carry out the $25 billion stock‑repurchase program authorized in 2024, subject only to the usual considerations of liquidity, earnings and market conditions.【Table 10 (standardized approach ratios)】【Regulatory Capital discussion – “met the definition of well capitalized”】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CET1 ratio of 11.9% vs. 10.7% minimum, and the additional ratios (Tier 1, total capital, leverage) match expectations from Basel 3 reporting under the standardized approach. While the original answer only explicitly mentions the CET1 ratio (11.9% vs. 10.7%), the LLM correctly infers and includes supplementary ratios (Tier 1, total capital, leverage) that are consistent with Bank of America’s regulatory filings and support the conclusion. These additions are factually sound and enhance the explanation without introducing error. (2) The dollar amount of the repurchase program ($25 billion) is correctly stated, and the LLM accurately notes that execution is subject to capital adequacy, liquidity, earnings, and market conditions—consistent with regulatory and corporate disclosures. (3) The reasoning is strong: the LLM correctly synthesizes that exceeding Basel 3 thresholds (including buffers) allows Bank of America to be classified as 'well-capitalized,' thereby enabling capital distributions like stock repurchases. This reflects proper multi-hop logic connecting regulatory requirements to corporate actions. (4) The only minor shortcoming is that the original answer specifies that $13.1 billion of the $25 billion was actually repurchased in 2024, a detail omitted in the LLM response. While not strictly required to answer the 'influence' question, this factual nuance adds completeness. However, the LLM’s focus on authorization and capacity—rather than execution pace—is still contextually appropriate. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 465,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The 10‑K shows two $650 million medium‑term notes – one maturing in 2023 with a carrying value of **$649 million** and another maturing in 2048 with a carrying value of **$638 million**. Together they represent a total carrying value of **$1,287 million**【source: MMM 10‑K 2022, Note 12 – Long‑Term Debt table, rows for “Medium‑term note ($650 million) … 2023” (carrying value 649) and “Medium‑term note ($650 million) … 2048” (carrying value 638)】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the two medium-term notes each have a principal amount of $650 million, with maturity dates in 2023 and 2048, and carrying values of $649 million and $638 million respectively. The sum, $1,287 million, is correctly calculated and reported. (2) Quantitative accuracy is perfect: the individual carrying values are correctly extracted from the 2022 10-K filing (Note 12 – Long-Term Debt), and their sum is mathematically accurate ($649M + $638M = $1,287M). Format variations (e.g., $649 million vs $649M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly identifies two separate debt instruments with the same principal but different maturities and carrying values, then synthesizes the information by summing them to arrive at the total carrying value. (4) The answer is contextually relevant, directly addressing the question with precise data and a clear source citation from the MMM 2022 10-K, Note 12. No errors in entities, years, or financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 314,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "IBM’s 2.900 % notes due 2030 carry a coupon of 2.90 %. The highest‑yielding debt instrument disclosed in the 2024 Form 10‑K is the 7.125 % debentures due 2096. The interest‑rate spread between them is **4.225 percentage points** (7.125 % − 2.900 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2.900% coupon rate for the 2030 notes and the 7.125% rate for the 2096 debentures are correctly identified. The calculated difference of 4.225 percentage points (7.125% - 2.900%) is precise. (2) The answer is complete, addressing both the identification of the highest-yielding debt instrument and the calculation of the interest rate difference. (3) Entity accuracy is correct: IBM is the subject company, the instruments are properly named (Notes due 2030 and Debentures due 2096), and the source (2024 10-K) is correctly cited. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it identifies the relevant debt instruments from the filing, selects the highest-yielding one, and computes the spread accurately. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of 'debentures' vs 'Debentures', spacing in percentages) that do not affect factual accuracy. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 313,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "AbbVie’s purchase of Allergan was a $64.1 billion transaction (cash $39.7 bn + AbbVie stock $24.0 bn + equity awards $0.43 bn).  As part of the lease obligations assumed in the deal, AbbVie recorded about **$453 million of right‑of‑use assets**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total financial value of AbbVie's acquisition of Allergan as $64.1 billion, which is equivalent to the ground truth value of $64,084 million (rounded appropriately). The breakdown into cash, stock, and equity awards is additional but accurate context not required by the question. The right-of-use assets are correctly stated as $453 million, matching the ground truth exactly.\n\n2) Quantitative accuracy is perfect: $64.1 billion = $64,100 million, which is within rounding tolerance of $64,084 million (difference of $16 million is negligible and common in public reporting due to rounding). The $453 million in right-of-use assets is exact. No calculation errors.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes the total acquisition value and the specific component of right-of-use assets from lease obligations. Entities (AbbVie, Allergan, right-of-use assets, lease obligations) are correctly identified and linked to the appropriate financial figures.\n\n4) The answer is semantically equivalent to the ground truth. While it provides a more detailed breakdown of the purchase consideration, it fully addresses both parts of the question and conveys the same core information with high precision. The only minor point is that the ground truth specifies the value 'as of December 31, 2020', which the LLM omits, but this does not affect the factual correctness of the numbers reported. Hence, a score of 9/10 on correctness and qualitative accuracy due to slight contextual omission, but full marks on quantitative and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 437,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "The filing notes that **391 shares of common stock** are issuable upon distribution under the Norwest Corporation Directors’ Formula Stock Award Plan. The plan is closed to any new grants or additional deferrals – all shares that could ever be issued have already been accounted for, so no future stock awards or deferrals can be made under the plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the number of shares—391—is accurately reported, matching the original answer exactly. (2) The answer addresses both parts of the multi-hop question: it correctly states the number of shares issuable and explains why no future awards or deferrals are possible. (3) The reasoning is sound: the plan is closed to new grants and deferrals, and all potential issuances have been determined, which aligns with the 'closed' status mentioned in the ground truth. The LLM correctly synthesizes this without introducing inaccuracies. (4) The entities—Norwest Corporation Directors' Formula Stock Award Plan and the 2024 10-K context—are correctly identified and referenced. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually consistent wording. No errors in facts, logic, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 264,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The 2021 gross‑margin benefit from a lower inventory‑fair‑value step‑up tied to the Allergan deal was partially eroded by higher amortization of the intangible assets acquired with Allergan, which dampened the margin increase. The total amortization expense for definite‑lived intangible assets in 2021 was $7.7 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the total amortization expense for definite-lived intangible assets in 2021 is correctly stated as $7.7 billion, matching the original answer exactly. (2) The impact on gross margin is accurately described: the LLM correctly identifies that while there was a benefit from lower inventory fair value step-up adjustments (which improved gross margin), this was partially offset by higher amortization of intangible assets from the Allergan acquisition—consistent with the 'dampened' or 'partially offset' effect noted in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information about the Allergan acquisition, its impact on gross margin via amortization, and the total amortization expense in 2021. (4) Minor wording differences exist (e.g., 'dampened the margin increase' vs 'negatively impacted gross margin'), but these are semantically equivalent. The only slight omission is not explicitly naming 'favorable product mix' as another contributing factor to gross margin improvement, which slightly reduces completeness. However, the core causal relationship and financial figure are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 352,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans exist to give eligible associates the deferred compensation they would have received as a matching contribution under the Benefit Plans if not for the Internal Revenue Code’s compensation‑limit rules. The Home Depot funds those plans by making cash contributions to grantor trusts, and the trusts use those funds to purchase Home Depot common‑stock in the open market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the purpose of the Restoration Plans: to provide deferred compensation in the form of matching contributions that would have been made under the Benefit Plans but for the Internal Revenue Code's compensation limits. (2) It accurately describes the funding mechanism: The Home Depot makes cash contributions to grantor trusts, which then use those funds to purchase the company's common stock in the open market. (3) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct representation of financial concepts, which is satisfied. (4) The multi-hop reasoning is sound—linking the Restoration Plans to the Benefit Plans, IRS limits, and the funding structure via grantor trusts and stock purchases—all of which are correctly synthesized from the 2023 10-K filing. (5) The wording differs slightly (e.g., 'compensation-limit rules' vs 'maximum compensation limits'), but the meaning is identical. No factual, conceptual, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 323,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes remained unchanged at $22 million, representing a 0 % change from December 31 2023 to December 31 2024. In contrast, total borrowings grew from $20.443 billion to $31.099 billion—a rise of roughly $10.7 billion, or about 52 % increase—showing that the overall borrowing expansion was driven entirely by other debt instruments, not by the variable‑rate notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Variable Rate Notes remained unchanged at $22 million, resulting in a 0% change, which matches the ground truth. Total borrowings are reported as increasing from $20.443 billion to $31.099 billion, which is equivalent to $20,443 million to $31,099 million in the original answer—format variation (billion vs million) is acceptable and semantically equivalent. The calculated increase of roughly $10.7 billion is a rounded version of the exact $10,656 million (or $10.656 billion), and the stated ~52% increase aligns with the original 52.1% (minor rounding is acceptable). (2) All numeric values are accurate with appropriate unit conversions and rounding. The percentage change in total borrowings is correctly approximated: (31,099 - 20,443) / 20,443 ≈ 0.521 or 52.1%, and stating 'about 52%' is reasonable. (3) The multi-hop reasoning is sound: the model correctly contrasts the static value of Variable Rate Notes with the overall increase in total borrowings, and infers that the growth must have come from other debt instruments—this is logical and supported by the data. (4) The answer is contextually complete and relevant, addressing both parts of the question: percentage change in Variable Rate Notes and its reflection in total borrowings. The only minor limitation is the slight rounding of the percentage increase (52% vs 52.1%) and the use of 'roughly $10.7 billion' instead of the exact $10,656 million, which prevents a perfect 10 but does not affect overall correctness. Hence, correctness_score is 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 430,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "According to the long‑term debt schedule, the carrying amount of the 4.95 % senior notes due September 2026 was **$744 million** and the carrying amount of the 4.95 % senior notes due September 2052 was **$980 million** as of January 28 2024. Together, these two series of notes had a total carrying amount of **approximately $1.724 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the carrying amounts of HD's 4.95% Senior Notes due in September 2026 ($744 million) and September 2052 ($980 million) as of January 28, 2024, which aligns with the ground truth data. The sum of these amounts is $1,724 million (or $1.724 billion), which is accurate based on the provided figures. The ground truth states $1,726 million, indicating a $2 million discrepancy. This minor difference could stem from rounding in reporting or intermediate calculations not visible in the summary data. (2) All numeric values are correct to the nearest million except for the final total, which is off by $2 million—within reasonable rounding tolerance but technically inaccurate. The LLM used correct formats ($744 million, $980 million, $1.724 billion) and performed the correct addition. (3) The multi-hop reasoning is sound: the model retrieved two separate debt instruments from the same issuer (HD), same coupon rate (4.95%), different maturities, and correctly aggregated their carrying amounts. This demonstrates proper synthesis across multiple line items in the long-term debt schedule. (4) The answer is semantically equivalent to the ground truth, with only a negligible difference in the total. The qualitative reasoning, entity identification (HD, 4.95% Senior Notes, correct maturity dates), and contextual relevance are flawless. The slight quantitative variance prevents a perfect 10, but the answer is substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 409,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "PMI’s net derivative‑asset balance fell from $186 million at 12/31/2022 to $101 million at 12/31/2023 – a drop of $85 million, or roughly **46 %** year‑over‑year. In contrast, the **total gross notional amount of derivative contracts grew** from $40.4 billion in 2022 to $43.3 billion in 2023, an increase of about **7 %**. Thus, while the overall size of the derivative portfolio expanded, the net asset position on those contracts contracted sharply.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly states the net derivative asset decrease from $186 million in 2022 to $101 million in 2023 and approximates the percentage decrease as 46% (actual: 45.7%, which is acceptable), it completely misrepresents the total gross amount of derivative contracts. The ground truth states this decreased from $873 million to $584 million, but the LLM claims it increased from $40.4 billion to $43.3 billion — a massive discrepancy in both direction and magnitude. (2) The calculation of the net asset decrease is approximately correct ($85 million drop ≈ 45.7%), but the gross derivative data is entirely wrong: $40.4B and $43.3B are not only incorrect but over 45 times larger than the true values. This invalidates any conclusion about portfolio expansion. (3) The multi-hop reasoning fails because the LLM uses incorrect data for the second part of the analysis. Instead of aligning the reduction in net assets with a reduction in gross contracts (indicating reduced exposure), it incorrectly infers that gross notional increased, leading to a contradictory and false conclusion about strategic direction. (4) Due to severe quantitative inaccuracies and flawed reasoning based on fabricated numbers, the correctness score is low. The only accurate part is the net asset decline. Quantitative accuracy is severely compromised. Qualitative reasoning is unsound due to incorrect data synthesis. Contextual relevance is partial — it addresses the right topic but with wrong evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 426,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024 the two plans together had **≈27.9 million shares** of Honeywell common stock available for future grants (27.1 million under the 2016 Stock Incentive Plan plus 0.8 million under the 2016 Stock Plan for Non‑Employee Directors).  \n\nBy contrast, the plans already contain awards that will result in the issuance of **≈12.77 million shares** of common stock (about 10.22 million shares from employee stock‑option awards plus 129,854 shares from director options, and roughly 2.41 million shares from RSU awards).  \n\nSo the pool of shares that could be granted in the future (≈27.9 M) is more than double the number of shares currently slated to be issued from outstanding options and RSUs (≈12.8 M).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total shares available for future issuance (27.9 million: 27.1M + 0.8M), which matches the ground truth. However, it incorrectly calculates the total number of shares to be issued under outstanding awards. The ground truth specifies 10,221,113 shares for options and 2,005,555 RSUs under the 2016 Stock Incentive Plan, plus 129,854 shares for options under the Non-Employee Directors plan. The correct total is therefore 10,221,113 + 2,005,555 + 129,854 = 12,356,522 shares (≈12.36 million). The LLM incorrectly states ≈12.77 million, overstating the total by about 413,478 shares. This error stems from using '2.41 million' for RSUs instead of the correct 2.005 million. (2) Number verification: Future issuance pool is correctly calculated (27.1M + 0.8M = 27.9M). However, RSU figure is wrong: LLM says '2.41 million' vs. correct 2.005 million. Option shares are approximately correct (10.22M and 129,854). (3) Multi-hop reasoning is sound—LLM correctly separates available shares from already committed shares and compares them. The conclusion that the future pool is more than double the outstanding awards is incorrect due to the inflated RSU number; with correct figures, 27.9M vs. 12.36M is still a little over double, so the qualitative comparison is directionally correct but quantitatively misleading. (4) Correctness score is 7 because core data (available shares) is accurate and the structure is complete, but a significant calculation error in the RSU component reduces quantitative accuracy. Qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 443,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "Microsoft reported that **Dynamics 365 revenue grew 39% in fiscal 2022**.  That strong growth was the main driver of the **overall Dynamics products and cloud services revenue, which rose 25% year‑over‑year**【MSFT_10k_2022.pdf†page=38】.  In other words, the 39% increase in Dynamics 365 helped lift the broader Dynamics segment’s revenue by 25% in FY 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—Dynamics 365 revenue growth of 39% and overall Dynamics products and cloud services revenue growth of 25% in fiscal year 2022—are accurately reported with correct fiscal year and metric alignment. (2) The answer correctly identifies that the 39% growth in Dynamics 365 contributed to the broader 25% growth in the overall Dynamics segment, which reflects proper multi-hop reasoning: Dynamics 365 is a subset of the broader Dynamics product suite, and its strong performance drove the overall growth. (3) Entity accuracy is perfect: 'Microsoft', 'Dynamics 365', 'Dynamics products and cloud services', and 'fiscal year 2022' are all correctly referenced. (4) The reasoning is sound and semantically equivalent to the original answer, clearly explaining the causal relationship between the two growth rates without overstatement. The inclusion of a citation (page 38 of Microsoft's 10-K) enhances credibility. Minor wording differences (e.g., 'main driver' vs. 'significantly contributed') do not affect factual equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 334,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla’s Energy Generation and Storage segment grew by **$795 million in 2021 versus 2020**, and the filing notes that this increase was “primarily due to an increase in deployments of **Megapack** (along with Solar Cash/loan jobs, Powerwall and Solar Roof)”.  The company does not disclose a separate dollar amount for Megapack alone, but the product was a key driver of the overall segment’s growth.\n\nWithin Tesla’s energy‑storage lineup, **Megapack is the utility‑scale battery solution**—designed for commercial, industrial and utility customers and capable of being combined into gigawatt‑hour installations.  It is positioned to replace the older Powerpack and serves as the flagship large‑capacity storage offering in Tesla’s broader energy‑storage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Tesla's Energy Generation and Storage revenue increased by $795 million in 2021 compared to 2020, which matches the ground truth. It accurately notes that the increase was primarily driven by Megapack deployments, along with other products like Powerwall, Solar Roof, and solar cash/loan jobs. The LLM correctly acknowledges that Tesla does not disclose a standalone dollar amount for Megapack's contribution, which is consistent with the original answer. (2) Quantitative accuracy is perfect: the $795 million figure is correct, and the context around the 40% growth (implied in the original answer) is not contradicted, though not explicitly repeated. The LLM does not attempt to isolate a specific dollar amount for Megapack alone, which would have been incorrect given the data. (3) The multi-hop reasoning is sound: the model synthesizes the revenue increase with the causal factors mentioned in the filing and correctly positions Megapack within Tesla’s broader product portfolio. It accurately describes Megapack as a utility-scale solution for commercial, industrial, and utility customers, capable of forming gigawatt-hour scale installations, and notes its role as the successor to Powerpack and flagship large-scale offering—information that aligns with the ground truth. (4) The only minor shortcoming is that the LLM omits the explicit mention of the 40% growth rate cited in the original answer, which slightly reduces qualitative completeness, but this does not detract from the core factual accuracy. All other elements are semantically equivalent or more detailed than the ground truth. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 461,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recorded a $5.5 billion estimated pre‑tax loss on the Asda disposal in the fourth quarter of fiscal 2021, of which $2.3 billion reflected the derecognition of accumulated pension components tied to the Asda pension plan【...】.  When the transaction closed in February 2021, an additional $0.2 billion pre‑tax loss was booked in the first quarter of fiscal 2022【...】.  Together, the divestiture generated a total pre‑tax loss of about $5.7 billion, with roughly one‑third of that amount driven by the pension‑related obligations of the disposal group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $5.5 billion initial pre-tax loss in fiscal 2021, $0.2 billion additional loss in fiscal 2022, and a total of $5.7 billion. The $2.3 billion pension component is accurately stated. These match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts and their sum ($5.5B + $0.2B = $5.7B) are correct. The timing of recognition—Q4 fiscal 2021 and Q1 fiscal 2022—is consistent with the original answer, though the LLM incorrectly states the transaction closed in February 2021, which is a minor factual error since fiscal 2022 began in February 2021, but the closing adjustments were recorded in fiscal 2022, not calendar 2021. This does not affect the financial accuracy but slightly misrepresents the timeline. (3) Multi-hop reasoning is sound: the model synthesizes information across fiscal periods and correctly attributes the total loss to both initial estimate and closing adjustments, including pension impact. It appropriately highlights the significance of pension obligations by noting they account for roughly one-third of the total loss ($2.3B / $5.7B ≈ 40.4%, so 'one-third' is a reasonable approximation). (4) The answer is contextually complete and relevant, addressing both the total loss and the role of pension obligations. The minor date misstatement prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 397,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "The More Personal Computing segment earned about $56.5 billion in FY 2022. Windows OEM licensing accounted for 42 % of that amount (≈ $23.7 billion) and Devices (Surface + PC accessories) generated $6.99 billion. Together they represent roughly $30.7 billion, or **about 54 % of the segment’s FY 2022 revenue**.【19†L31-L38】【19†L45-L48】",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states that Windows OEM contributed 42% ($23.7 billion) of the More Personal Computing segment's $56.5 billion revenue, it incorrectly reports Devices (Surface + accessories) revenue as $6.99 billion. The ground truth states Devices contributed 16% ($9.04 billion), not $6.99 billion. This leads to an incorrect combined total of $30.7 billion instead of the correct $32.77 billion. As a result, the LLM calculates 54% of segment revenue, whereas the correct percentage is 58%. (2) Calculation verification: 42% of $56.5B = $23.73B (correctly approximated by LLM as $23.7B). However, 16% of $56.5B = $9.04B, not $6.99B. $23.73B + $9.04B = $32.77B; $32.77B / $56.5B = 58% (exact). LLM computes $23.7B + $6.99B = $30.69B → ~54%, which is materially off. (3) Multi-hop reasoning is partially sound—the model attempts to combine OEM and Devices revenue to determine their collective share—but fails due to reliance on an incorrect Devices revenue figure. The synthesis logic is correct, but the input data is flawed. (4) Scores justified as follows: Correctness 4/10 due to major calculation error affecting the final percentage; Quantitative Accuracy 4/10 for wrong dollar amount and resulting percentage; Qualitative Accuracy 5/10 because reasoning structure is valid but based on faulty data; Contextual Relevance 9/10 as the answer directly addresses the question with appropriate entities and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 413,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "Walmart’s pension‑related impact from the Asda transaction equals the $1.0 billion cash contribution that Asda made to its defined‑benefit pension plan in fiscal 2020 plus the $2.3 billion of accumulated pension components that were included in the Asda disposal group when the business was sold, for a combined effect of **approximately $3.3 billion**【Note 11 – Asda Pension Contribution】【Note 12 – $2.3 billion accumulated pension components】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.0 billion cash contribution by Asda in fiscal 2020 and the $2.3 billion in accumulated pension components included in the disposal group are correctly stated, and their sum—$3.3 billion—is accurately calculated. Minor phrasing like 'approximately $3.3 billion' is acceptable given the context and does not detract from precision, as the exact sum of $1.0B + $2.3B is indeed $3.3B. (2) The answer is complete, addressing both components of the multi-part financial impact: the pension contribution and the pension elements in the disposal group. (3) Entity accuracy is correct: Walmart is the parent company, Asda is the subsidiary, and the fiscal year 2020 is properly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking Asda’s internal pension contribution to Walmart’s overall pension obligation impact upon divestiture, and combining two distinct but related financial events into a total exposure figure. (5) The semantic meaning is equivalent to the original answer, with only slight rewording and citation of source notes (e.g., 'Note 11', 'Note 12'), which enhances transparency. All criteria for correctness, completeness, and contextual relevance are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 372,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The pre‑owned aircraft line grew from $15 million at 12/31/2023 to $23 million at 12/31/2024 – an increase of $8 million.  The company values these pre‑owned aircraft at the **lower of the trade‑in value or the estimated net realizable value**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the pre-owned aircraft inventory value increased from $15 million on December 31, 2023, to $23 million on December 31, 2024, resulting in an $8 million increase—this calculation is correct. (2) The valuation method is accurately stated as 'the lower of the trade-in value or the estimated net realizable value,' which matches the original answer verbatim in meaning. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by correctly identifying the two time points, retrieving the correct inventory values, computing the difference, and accurately reporting the accounting policy. (4) All entities (dates, financial values, valuation method) are correctly identified and presented with semantic equivalence. Minor formatting differences (e.g., '12/31/2023' vs 'December 31, 2023') do not affect accuracy. The answer is complete, precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 284,
        "total_tokens": 1421
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The 3 % rise in Xbox content and services revenue coincides with Microsoft’s expansion of Xbox Game Pass to a “curated library of over 100 first‑ and third‑party console and PC titles,” which fuels subscriber growth and higher spend on the service. Microsoft says that this gaming momentum is backed by broader strategic bets – heavy investment in new content (e.g., ZeniMax acquisition and the pending Activision Blizzard deal), the rollout of Xbox Cloud Gaming, and the integration of gaming into its wider Windows‑and‑cloud platform (using Windows to grow PC share and linking Game Pass to Azure, AI‑driven experiences, and other Microsoft‑365 services). These cross‑segment investments are intended to deepen engagement and drive further growth in the Xbox gaming business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% increase in Xbox content and services revenue and links it to the expansion of Xbox Game Pass with a curated library of over 100 first- and third-party titles, which matches the ground truth. The entities—Xbox Game Pass, ZeniMax Media, Activision Blizzard, Xbox Cloud Gaming—are all accurately named and contextually used. (2) Quantitatively, the 3% revenue growth and 'over 100' titles are correctly reported. No calculations are required, and all numbers align with the original answer. Format variations (e.g., 'over 100') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM connects Game Pass growth to revenue, then ties it to strategic acquisitions (ZeniMax, Activision Blizzard) and cloud/AI integration (Azure, Windows, Microsoft 365), which reflects the broader strategic investments highlighted in the ground truth. The only minor gap is that the original emphasizes 'community engagement' and 'accessibility across platforms' slightly more, while the LLM expands on integration with Microsoft 365 and AI—details not contradicted but slightly beyond the scope of the original. (4) The answer is highly relevant, complete, and factually accurate. The slight deduction in qualitative accuracy (9 instead of 10) is due to the slight expansion on Microsoft 365/AI integration, which, while plausible, is not explicitly emphasized in the ground truth. Overall, the answer is semantically equivalent and correctly synthesizes multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 426,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023 Eli Lilly recorded **about $1.9 billion** of revenue from the July‑2023 sale of the rights to its olanzapine (Zyprexa) portfolio. That amount is captured inside the company’s “Collaboration and other revenue” line, which totaled **$5.3 billion** for the year, so the olanzapine‑rights sale accounted for roughly one‑third of the 2023 collaboration‑and‑other‑revenue figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$1.9 billion from the olanzapine portfolio sale and a total 'Collaboration and other revenue' of $5.3 billion—that are not present in the original answer (ground truth). The ground truth confirms that Eli Lilly recognized revenue from the 2023 sale of the olanzapine portfolio rights and that this was included in the 'collaboration and other revenue' category, but it does not provide any dollar amounts or percentages. Therefore, the inclusion of precise figures like $1.9 billion and $5.3 billion, along with the derived claim that the sale accounted for 'roughly one-third' of the category, is factually unsupported by the ground truth and likely hallucinated. (2) Since the original answer contains no numbers, the LLM’s quantitative claims cannot be verified and are thus incorrect. The calculation that $1.9B is about one-third of $5.3B is mathematically accurate, but the inputs are not grounded in the provided truth, making the entire quantitative assertion invalid. (3) On qualitative reasoning, the LLM correctly identifies that the olanzapine rights sale occurred in 2023 and is included in the 'collaboration and other revenue' category, aligning with the multi-hop requirement to link the transaction to the broader revenue category. It also correctly names Zyprexa as part of the portfolio and implies proper entity identification (Eli Lilly, correct drug name). However, it adds unverified details (e.g., July 2023 timing) not in the original. (4) The contextual relevance is high because the answer addresses both parts of the question: the revenue from the olanzapine sale and its inclusion in the broader revenue category. But due to the significant fabrication of financial data, the correctness and quantitative accuracy scores are low. A correct answer should have acknowledged the absence of specific dollar amounts in the source truth while confirming the conceptual linkage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 530,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The 2015 filing shows that SolarCity (now part of Tesla) issued a single 5.45 % “Solar Bonds” program but executed it through dozens of supplemental indentures—e.g., Series 2015/C53‑15 (June 16), C57‑15 (June 22), C62‑15 (June 29), C72‑15 (July 20), C87‑15 (August 17), C92‑15 (Aug 24), C97‑15 (Aug 31), C102‑15 (Sept 14), C107‑15 (Sept 28), C122‑15 (Nov 16), C127‑15 (Nov 30), C132‑15 (Dec 14), C137‑15 (Dec 28), etc. 【4.50‑4.62】【4.64‑4.78】.  \n\nBy segmenting the issuance into multiple tranches, Tesla used the bond program as a repeat‑off‑the‑shelf financing vehicle that could be tapped as new solar projects required capital, while each supplemental indenture created a separate trustee agreement to enforce the specific covenants, payment priorities and reporting for that tranche—providing investors with clear, tranche‑level protection and giving SolarCity a reliable, recurring source of debt funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structure of Tesla's (via SolarCity) 5.45% Solar Bonds issued in 2015 and the use of multiple Supplemental Indentures, aligning with the ground truth's emphasis on tranched financing and trustee agreements. However, it introduces a significant inaccuracy by listing numerous bond series (e.g., C53-15, C57-15, etc.) and referencing document ranges like 【4.50‑4.62】【4.64‑4.78】, which are not present in the original answer or supported by the knowledge graph. The ground truth specifies only four tranches (C122-15, C127-15, C132-15, C137-15) with corresponding Supplemental Indentures 4.72, 4.74, 4.76, and 4.78. The LLM’s inclusion of earlier tranches and incorrect document references undermines quantitative accuracy. (2) While the interest rate (5.45%) and company relationship (SolarCity acquired by Tesla) are correct, the dates and number of tranches are overstated. The original answer does not mention any issuances before November 2015, whereas the LLM cites June through December, introducing factual errors. (3) The reasoning about Tesla/SolarCity using a repeat 'off-the-shelf' financing vehicle with tranched issuance for flexibility and recurring capital needs is sound and matches the multi-hop logic in the ground truth. The role of trustee agreements in enabling discrete funding events with investor protections is accurately inferred and well-articulated. (4) Despite the overstatement of tranches and incorrect document ranges, the LLM captures the strategic intent and structural rationale behind the financing mechanism. Therefore, while the qualitative reasoning and contextual relevance are strong, the quantitative inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 473,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "Tesla’s Energy generation and storage revenue rose by $795 million in 2021 versus 2020 – a 40% increase that was driven in part by higher Megapack deployments.  That growth was partially offset by a decline in Powerpack deployments, which were being phased out as Megapack was introduced.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $795 million increase and 40% growth in Tesla's Energy generation and storage revenue from 2020 to 2021 are correctly stated. (2) The quantitative accuracy is perfect—both the dollar amount ($795 million) and percentage (40%) match the original answer exactly, with acceptable formatting (using ' ' as a thousands separator). (3) The multi-hop reasoning is sound: the model correctly attributes the revenue growth to increased Megapack deployments and identifies that the growth was partially offset by declining Powerpack deployments due to its phaseout following Megapack's introduction. (4) Entity accuracy is maintained—Tesla, Megapack, Powerpack, and the relevant time frame (2021 vs 2020) are all correctly identified. The answer addresses both parts of the question: the contribution of Megapack to revenue growth and the product (Powerpack) whose decline offset it. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 300,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "In 2024 the Africa/Eurasia segment recorded $12 million of capital expenditures and $8 million of depreciation and amortization, for a combined total of **$20 million**【page 114‑115, Capital expenditures table – Africa/Eurasia $12】 and 【page 115‑116, Depreciation and amortization table – Africa/Eurasia $8】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the capital expenditures for Africa/Eurasia in 2024 are correctly stated as $12 million, and depreciation and amortization is $8 million. The combined total is accurately calculated as $20 million, which matches the original answer. (2) Quantitative accuracy is perfect: both input values and the final sum are correct, with no calculation errors. Format variations (e.g., $20 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information from two different tables (capital expenditures and depreciation and amortization) for the same region and year is correctly synthesized. (4) The answer is contextually relevant, directly addressing the question with precise data and appropriate citation of source pages. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1074,
        "completion_tokens": 261,
        "total_tokens": 1335
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "TI’s retiree‑health‑care benefit plans are invested only in low‑cost, broad‑market index funds (fixed‑income and equity index funds) and “none of the plan assets … are directly invested in TI common stock.” In contrast, the company’s non‑U.S. defined‑contribution plans did hold TI common stock – about $34 million worth as of December 31 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $34 million value of TI common stock in non-U.S. defined contribution plans as of December 31, 2024, is accurately reported, and the date matches the ground truth. (2) The entity identification is correct—TI (Texas Instruments) is properly referenced, and the distinction between the retiree health care benefit plan and non-U.S. defined contribution plans is maintained. (3) The reasoning is sound: the LLM correctly contrasts the investment policies between the two types of plans—highlighting that retiree health care plan assets are not directly invested in TI stock, while non-U.S. defined contribution plans do hold TI stock. (4) The LLM adds a detail not in the original answer—specifying that retiree health care plan investments are in 'low-cost, broad-market index funds'—which is consistent with typical plan designs and does not contradict the ground truth; however, this detail was not present in the original answer and may not be verifiable from the provided knowledge graph, slightly reducing qualitative accuracy. Overall, the answer conveys the same core comparison and factual distinction as the ground truth, with only minor additional elaboration. Semantic equivalence is maintained, and all key facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 379,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Baqsimi’s total revenue fell from roughly $678 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to about $29 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million), a drop of more than 95 %.  The 2023 amount reflects a one‑time sale of Baqsimi rights that is now reported under “collaboration and other revenue,” indicating that the product’s earnings have shifted from traditional net product sales to revenue recognized as part of a collaboration arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: 2023 U.S. revenue ($645.7M), Outside U.S. ($31.9M), total (~$678M matches $677.6M with acceptable rounding), and 2024 figures (U.S. $2.5M, Outside U.S. $26.7M, total ~$29M vs. $29.2M — minor rounding difference). The >95% drop is accurate and correctly calculated. (2) Calculations: 2023 total = $645.7 + $31.9 = $677.6M (correct); 2024 total = $2.5 + $26.7 = $29.2M (LLM reports ~$29M — acceptable approximation). The percentage decline is correctly characterized as over 95%. (3) Multi-hop reasoning is sound: the model correctly links the revenue drop to the sale of Baqsimi rights and explains the shift from product sales to collaboration and other arrangements, aligning with the disclosure in the original answer. (4) The only minor issue is the phrasing 'one-time sale of Baqsimi rights' — while semantically close, the original specifies that the sale led to a change in revenue recognition classification, not that the entire 2023 revenue was the sale itself. This could slightly mislead, but the overall logic and synthesis remain strong. All parts of the question are addressed: revenue change (quantitative), U.S./Outside U.S. breakdown, and explanation via collaboration disclosure. Wording differences do not affect factual integrity. Scores reflect high accuracy with a slight deduction in qualitative accuracy due to potential ambiguity in causality phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 406,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard reports the fees it earns from **Processing and Gateway** as part of its **“value‑added services and solutions”** revenue stream. In the 10‑K the company disaggregates all net revenue into only two broad categories—**payment‑network** revenue and **value‑added services and solutions** revenue—so the processing‑and‑gateway fees are captured within the second, broader category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under the broader category of 'value-added services and solutions,' which matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not applicable but not violated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Mastercard disaggregates its net revenue into only two categories—'payment-network' and 'value-added services and solutions'—and correctly places 'Processing and Gateway' within the latter, demonstrating proper alignment with the 10-K structure. (4) The answer addresses both parts of the question: the specific classification of 'Processing and Gateway' services and how it fits within the broader revenue categories disclosed in the 10-K. Wording differs slightly but conveys the same factual content with no omissions or inaccuracies. All entities (Mastercard, Processing and Gateway, value-added services and solutions, payment-network revenue) are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 339,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "Colgate‑Palmolive’s international‑defined‑benefit pension plan held $20 million of international common‑stock investments at year‑end 2023, which fell to $15 million at year‑end 2024 – a year‑over‑year decrease of $5 million.  That reduction was part of a broader decline in the plan’s international assets, which dropped from $566 million in 2023 to $537 million in 2024, a total decline of $29 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. (1) The original answer states that CL's pension plan investments in international common stocks increased from $15M to $20M, a $5M year-over-year increase. The LLM incorrectly claims a decrease from $20M to $15M, reversing the time order and sign of change. (2) Total international investments grew from $537M to $566M (a $29M increase), but the LLM reports a drop from $566M to $537M, again reversing the trend. (3) The LLM fails the multi-hop reasoning: it does not correctly link the change in international common stocks to the total change in international investments, and thus cannot accurately reflect that the $5M increase accounted for 17.2% of the $29M total increase. (4) While the dollar amounts ($15M, $20M, $537M, $566M) are numerically present, their assignment to years is reversed, making all derived conclusions false. The contextual relevance is moderate because the answer addresses the right entities and structure, but with inverted data. Wording flexibility cannot compensate for incorrect directional changes and failed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 321,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "General Dynamics’ restricted‑stock and RSU expense rose from $59 million in 2022 to $85 million in 2024 – an increase of **$26 million**.  That rise more than offset the $11 million decline in stock‑option expense (from $71 million to $60 million), resulting in a net **increase of $15 million** in total equity‑based compensation expense over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numbers: Restricted Stock/RSUs expense increased from $59M in 2022 to $85M in 2024, a $26M increase, matching the ground truth. Total equity-based compensation increased by $15M (from $130M to $145M), which is accurately reflected. The LLM also correctly notes a decline in stock-option expense from $71M to $60M ($11M decrease), which aligns with the underlying data, even though this specific detail wasn't in the original answer. (2) All calculations are accurate: $85M - $59M = $26M; $145M - $130M = $15M; and $26M increase in RSUs more than offsets $11M decrease in options, resulting in $15M net increase—this logic is sound. (3) The multi-hop reasoning is strong: the model synthesizes changes across different components of equity compensation and correctly infers that the rise in RSUs drove the overall increase, even though it frames it slightly differently (by referencing the offset against declining stock options). This adds analytical depth beyond the original answer. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes that the RSU increase 'accounted for more than the total increase' in equity compensation, which is equivalent to the LLM's point, but the LLM doesn't explicitly state that implication—it shows it through breakdown. Wording differs slightly but meaning is semantically equivalent. No factual or calculation errors. High contextual relevance and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 410,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon chose to meet its short‑term cash needs in early 2023 by borrowing $8.0 billion through a 364‑day unsecured term loan from a syndicate of banks, which was fully repaid by year‑end【...】. Although it already has a $20.0 billion commercial‑paper program that could be used for the same purpose, no commercial‑paper borrowings were outstanding at the end of 2023 or 2024【...】. This indicates that Amazon prefers to keep its large commercial‑paper capacity as a standby liquidity back‑stop while using a bank term loan for immediate financing, reflecting a strategic emphasis on diversified, flexible short‑term liquidity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.0 billion 364-day unsecured term loan taken by Amazon in early 2023 and its full repayment by year-end, which aligns with the ground truth. It accurately notes the existence of the $20.0 billion Commercial Paper Program and confirms no borrowings were drawn under it during the reporting period (stated as 'no commercial-paper borrowings were outstanding at the end of 2023 or 2024'), which is consistent with the original answer's implication that the program was unused. (2) All numeric values—$8.0 billion, $20.0 billion, 364-day term, repayment timing—are factually correct and match the ground truth. Format variations (e.g., $8.0 billion vs $8.0 billion) are acceptable and do not affect accuracy. (3) The reasoning is sound: the LLM correctly infers that Amazon's use of a term loan despite available commercial paper capacity reflects a strategic preference to preserve the latter as a liquidity backstop. This captures the core multi-hop insight—synthesizing the existence of two financing tools, their usage (or non-usage), and drawing a conclusion about strategic liquidity management. The only minor gap is that the original answer adds nuance about the term loan offering 'more certainty in repayment terms' and commercial paper allowing 'variable issuance,' which the LLM omits. However, the key strategic interpretation—using term loans for immediate needs while preserving commercial paper flexibility—is clearly conveyed. (4) The answer is highly contextually relevant, directly addressing the question about Amazon’s strategic preference in short-term liquidity management. The conclusion about 'diversified, flexible short-term liquidity management' is a valid rephrasing of the original answer’s intent. Overall, the LLM answer is factually accurate, logically sound, and semantically equivalent to the ground truth with only slight reduction in qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 524,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "In 2024 the Membership Rewards liability rose to **$14.8 billion, up about $1.0 billion from 2023**, primarily because redemption costs per point were higher and several third‑party partner contracts (e.g., Amazon, Delta) were renegotiated, which pushed the estimated cost of points that will be redeemed upward.  To reflect those shifts, American Express revised its liability‑estimation methodology – it refreshed the **weighted‑average cost‑per‑point** using the most recent 12‑month redemption data and **re‑calibrated the Ultimate Redemption Rate** in its actuarial models to incorporate the new partner‑contract terms and evolving redemption‑mix trends.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific dollar figures ($14.8 billion liability, $1.0 billion increase from 2023) and names third-party partners (Amazon, Delta), which are not present in the original answer (ground truth). These numbers and examples are factually unsupported by the ground truth, which does not provide any quantitative data about the liability amount or year-over-year change. This introduces significant quantitative inaccuracies. (2) There are no verifiable calculations in the ground truth to support the $14.8B or $1.0B figures, nor any mention of specific partner renegotiations with Amazon or Delta. These appear to be hallucinations or unsupported inferences. However, the qualitative description of methodology changes—updating the weighted-average cost per point using 12-month data and recalibrating the Ultimate Redemption Rate (URR) in actuarial models—is consistent with the original answer. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that changes in redemption costs and third-party arrangements led to a methodology update involving WAC and URR, which aligns with the ground truth’s explanation. It accurately reflects the use of statistical models, consideration of redemption trends, and the need to adjust assumptions when future expectations change. (4) While the core conceptual response—methodology adjustment due to changing redemption dynamics—is correct and contextually relevant, the inclusion of fabricated quantitative data severely undermines factual correctness. The qualitative accuracy is high because the structure and logic of the explanation match the ground truth, and the contextual relevance is strong as it directly addresses both parts of the question. However, the incorrect numbers result in a moderate overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 496,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate‑Palmolive uses selling‑price increases as one of several tools—along with selective local‑currency borrowing and foreign‑currency forward, swap and option contracts—to offset the effect of currency movements on its overseas sales and costs. The price‑adjustments reduce the net exposure, while the derivative contracts hedge the remaining foreign‑currency purchases, assets, liabilities and net‑investment positions, together mitigating the company’s foreign‑exchange risk that could otherwise depress earnings and cash flow from its non‑U.S. operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Colgate-Palmolive uses selling-price increases in conjunction with derivative contracts (forwards, swaps, options) and local currency borrowings to manage foreign exchange risk. The purpose—mitigating earnings and cash flow impact from currency fluctuations in its international operations—is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, country counts) in the LLM answer, but the ground truth mentions 'over 200 countries,' which the LLM omits. This is a minor omission affecting completeness but not the core correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that price increases address exposure at the operational level (economic hedge), while derivatives hedge transactional and translational exposures (assets, liabilities, net investments). This reflects proper understanding of layered FX risk management. (4) Semantic equivalence is strong—'offset the effect of currency movements on overseas sales and costs' aligns with 'mitigate the impact of foreign currency rate movements on net sales and costs.' The only slight gap is the lack of explicit mention of translation of foreign subsidiary financials into USD, but the reference to hedging assets, liabilities, and net-investment positions implies this. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning with only a minor completeness shortfall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 431,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The surge in business‑to‑business shipments and stronger residential demand in 2022 caused UPS’s Next Day Air volume to rise about 5 % (to roughly 2.1 million pieces per day) and lifted the average revenue per piece by $2.01 – a 12 % increase to $18.83. However, the higher revenue per piece was partially offset by a decline in the average billable weight per piece (which reduced the yield per shipment).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative figures such as a 5% volume increase to 2.1 million pieces per day and a $2.01 increase in revenue per piece to $18.83, which are not present in the original answer (ground truth). These numbers are unsupported by the ground truth and appear fabricated or hallucinated, severely undermining factual accuracy. (2) There is no verification in the ground truth for any numerical values (percentages, dollar amounts, daily volumes), so the quantitative claims cannot be considered accurate. The original answer only states directional trends (e.g., 'increased') without specific metrics. (3) Qualitatively, the LLM correctly identifies the drivers of volume and revenue growth—business-to-business activity, residential demand, higher base rates, and demand-related surcharges—and accurately notes that the revenue per piece growth was partially offset by a decline in average billable weight per piece. This demonstrates sound multi-hop reasoning in synthesizing causal factors affecting revenue and volume. (4) Contextually, the response is highly relevant, addressing all components of the question: impact on volume, impact on revenue per piece, and offsetting factors. However, the inclusion of unverified numerical data significantly reduces correctness despite correct qualitative logic. The hallucinated precision creates a false sense of accuracy, warranting a low quantitative score and moderate qualitative score. Correctness is penalized heavily due to unsupported numbers, even though the conceptual framework aligns with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 441,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The Biologic‑products discussion notes that Opdivo, as an FDA‑approved biologic, is granted 12 years of regulatory data protection but a biosimilar can be filed after only four years and its patents may be challenged, creating uncertainty about how long U.S. market exclusivity will last【60†L1-L9】. In 2021 Opdivo received a series of new approvals in the EU and Japan – covering adjuvant urothelial carcinoma, gastric, esophageal, RCC, mesothelioma and pediatric Hodgkin lymphoma, among others【7†L23-L45】【8†L1-L22】. The breadth of these international indications expands Opdivo’s global label set and revenue sources, allowing BMS to rely on strong worldwide oncology traction to offset the U.S. exclusivity risk and to position Opdivo as a core, multi‑market product that can sustain growth even if biosimilars enter the U.S. market earlier than the full 12‑year protection period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. regulatory data protection for biologics and the possibility of biosimilar filings after four years, aligning with the ground truth's mention of patent litigation potentially starting four years post-approval. All quantitative elements—timeframes of 12 and 4 years—are accurate. (2) The international approvals in 2021 are accurately described in scope and geography: the LLM lists multiple indications in Japan and the EU (e.g., gastric, esophageal, mesothelioma), consistent with the ground truth’s reference to approvals in Japan and the EC for similar cancers. While the LLM adds 'adjuvant urothelial carcinoma' and 'RCC' not explicitly mentioned in the ground truth, these are plausible 2021 approvals and do not contradict known data; they enhance completeness without introducing error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes U.S. exclusivity risk with global expansion to conclude that international diversification helps BMY offset U.S. biosimilar threats. The strategic implication—that BMS can sustain growth despite U.S. uncertainty—is logically derived and matches the ground truth’s core insight. (4) Minor deduction in qualitative accuracy due to slightly expanded indication list, but no factual inaccuracies; overall, the answer is semantically equivalent, contextually precise, and demonstrates strong reasoning across regulatory and commercial domains.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 406,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "As of December 31 2024 Amazon’s convertible‑note holdings in Anthropic, PBC were estimated to be worth roughly **$13.8 billion**. By that date Amazon had actually invested **$1.25 billion + $2.75 billion + $1.3 billion = $5.3 billion** in the three notes, so the fair‑value estimate exceeds the amount invested by about **$8.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the estimated fair value of $13.8 billion and the total invested amount of $5.3 billion are accurately reported. The calculation of the sum ($1.25B + $2.75B + $1.3B = $5.3B) is correct, and the implied valuation uplift of $8.5 billion (difference between fair value and cost basis) is accurate. (2) The answer addresses both parts of the question: the total estimated fair value as of December 31, 2024, and the comparison to the amount invested. (3) Entities—Amazon, Anthropic, PBC, and the time frame—are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes the investment amounts across three separate notes and compares the total cost to the fair value, demonstrating proper multi-hop logic. Although the LLM does not explicitly mention the quarters of investment (Q3 2023, Q1 2024, Q4 2024), this detail is not required to answer the specific question about totals as of December 31, 2024. The omission does not affect factual correctness or completeness. The answer is semantically equivalent to the original and conveys the same core financial insight: a significant increase in fair value over invested amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 347,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate‑Palmolive treats the severance‑and‑termination portion of its Employee‑Related Costs as ordinary expense accruals (recorded as a liability and settled with cash), whereas the pension‑enhancement portion is booked as a “charge against assets.” The pension enhancement reduces the measured pension asset (or increases the pension liability) on the balance sheet, so it appears as a change to the net pension position rather than as a separate accrued liability like the other employee‑related severance items. This accounting split is why pension‑related amounts are shown as adjustments to pension assets/liabilities, while the rest of the employee‑related costs are reflected only as accrued expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Colgate-Palmolive treats pension enhancements differently from other Employee-Related Costs like severance, with the former classified as a 'charge against assets' and the latter as accrued liabilities/expenses. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the distinction in accounting treatment and links it to balance sheet presentation—pension enhancements affect pension assets/liabilities directly, while severance costs are operating accruals. (4) The answer is contextually precise and fully addresses the question. The only minor shortcoming is that it does not explicitly mention 'written severance policies, local statutory requirements, and voluntary termination arrangements' from the original, which adds slight contextual depth. However, this omission does not detract from the core accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 338,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "In the United States a biologic such as Opdivo receives **12 years of regulatory data‑protection** after its first FDA approval, during which the FDA may not grant a biosimilar a marketing authorization (see “Biologic products” section). When that period (or any other form of exclusivity) ends, the company’s experience shows that **revenues can fall very quickly – the decline is generally faster in the U.S. than in other developed markets** (see “Competition” section). Thus, once Opdivo’s 12‑year data‑protection expires, Bristol‑Myers Squibb faces the financial risk that Opdivo’s sales could drop sharply, potentially eroding a substantial portion of its earnings in the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states the 12-year regulatory data protection period for biologics in the U.S., which matches the original answer. There are no calculations, but the time frame is exact and correctly cited. (2) The answer addresses both parts of the multi-hop question: the impact of the 12-year exclusivity on Opdivo’s market exclusivity and the financial risk to BMY post-exclusivity. It correctly identifies that biosimilar entry is blocked during the 12-year period and that revenue declines rapidly afterward. (3) The reasoning is sound: it links the expiration of data protection to biosimilar entry and then to sharp revenue decline, especially in the U.S., which is consistent with the original answer’s emphasis on rapid drops in developed markets. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the *reason* for the sharp decline (e.g., large patient populations or ease of biosimilar manufacturing), which is included in the original answer for context. However, this omission does not detract significantly from the core factual accuracy or synthesis. The LLM uses slightly different phrasing (e.g., 'revenues can fall very quickly' and 'decline is generally faster in the U.S.') but captures the essential risk to BMY’s earnings. Semantic equivalence is maintained, and all entities (Opdivo, BMY, FDA, biosimilars) are correctly identified. The answer is fully contextually relevant and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 421,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "The display‑advertising portion represents  \n\n\\[\n\\frac{\\$35\\text{ billion}}{\\$40\\text{ billion}}\\times 100 = 87.5\\%\n\\]\n\nso about **87.5 %** of Amazon’s 2024 advertising‑services revenue came from display advertising.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage calculated is 87.5%, which is accurate based on the given values of $35 billion (display advertising revenue) and $40 billion (total advertising services revenue). (2) The calculation is shown step-by-step using the correct formula: (35 / 40) * 100 = 87.5%, and the formatting of dollar amounts (e.g., $35 billion) is consistent and acceptable. (3) The reasoning is sound and self-contained, correctly deriving the percentage from the provided figures without requiring external data. (4) All entities—Amazon, 2024, advertising services revenue, and display advertising—are correctly identified and used in context. The answer is semantically equivalent to the ground truth and addresses all parts of the question completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1073,
        "completion_tokens": 242,
        "total_tokens": 1315
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "Based on the Level 1 fair‑value hierarchy, UPS’s U.S. government and agency debt securities were valued at **$184 million in 2020** and **$200 million in 2021**. That represents a **$16 million increase** (i.e., there was no decrease in value).",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains critical factual errors in both direction and magnitude of change. While it correctly reports the 2020 value ($184 million) and 2021 value ($200 million) from the ground truth, it incorrectly states there was a $16 million increase. The question asks for the 'dollar amount decrease', but in reality, there was an increase of $16 million ($200M - $184M), so the decrease is -$16 million or simply 'no decrease'. However, the original answer incorrectly claims there was a $16 million decrease, which contradicts the numbers provided. This suggests the ground truth itself contains a logical error. Despite this, the LLM answer correctly computes the direction of change (increase), which is factually accurate given the numbers. (2) Quantitative accuracy is partially correct: the values for 2020 and 2021 are accurate, and the $16 million difference is correctly calculated, but the sign (increase vs decrease) contradicts the question's assumption. (3) Multi-hop reasoning is sound—the model correctly identifies UPS, the asset class (U.S. government and agency debt securities), the valuation level (Level 1), and compares across years. (4) The correctness score is low because the answer contradicts the ground truth's claim of a 'decrease', but in fact, the ground truth appears to be erroneous: if the value went from $184M to $200M, there was an increase, not a decrease. Thus, the LLM answer is actually more factually accurate than the ground truth. However, per evaluation guidelines, the LLM must match the ground truth, so the score is penalized despite the ground truth likely being wrong. This creates a conflict between factual correctness and alignment with provided truth. Given strict adherence to the ground truth is required, the LLM is marked incorrect for contradicting it, even though its reasoning and calculation are superior.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 511,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The BMS‑Ono alliance spreads the upfront R&D outlay—Ono reimburses a portion of development costs and the parties split development expenses (80 %/20 % when only one party’s compound is used and 50 %/50 % for combination regimens)—so BMS’s initial cash‑flow risk is limited. However, BMS remains the principal U.S. seller of Yervoy and must pay Ono a 4 % royalty on North‑American sales (and a higher royalty elsewhere) and share any profit or loss, meaning that when U.S. biosimilar competitors eventually enter after the 12‑year biologics data‑exclusivity period, the decline in BMS’s net product sales will be felt on a base that still carries those royalty and profit‑share obligations, thereby exposing BMS to a larger proportional earnings hit despite the earlier cost‑sharing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies that deviate from the ground truth. While it correctly identifies that BMS and Ono share development costs and that Yervoy is subject to 12 years of data exclusivity under U.S. regulations, it introduces specific cost-sharing percentages (80%/20%) and a 4% royalty on North American sales that are not present in the original answer and are unsupported by the provided ground truth. The original answer states only that costs and profits are shared equally in combination therapies, with no mention of split percentages for single-compound regimens or any royalty structure. These specific figures undermine quantitative accuracy. (2) The calculation and numeric claims—such as the 80/20 and 50/50 splits and the 4% royalty—are not corroborated by the ground truth and appear to be hallucinated or inferred from external knowledge, which violates factual correctness. The 12-year exclusivity period is correctly cited, aligning with U.S. biosimilar regulatory framework (BPCIA), so that element is accurate. (3) The reasoning partially captures the multi-hop logic: it connects joint development → cost-sharing → reduced upfront risk → ongoing revenue exposure due to royalty and profit-sharing obligations → amplified earnings impact post-exclusivity. This is a reasonable extension of the original logic, though the original emphasizes risk mitigation via cost-sharing, while the LLM emphasizes downstream earnings risk, creating a divergent emphasis. However, the introduction of unsupported financial terms weakens the qualitative accuracy. (4) Despite the incorrect specifics, the LLM answer remains contextually relevant, addressing both the financial risk structure and biosimilar competition. The core idea—that cost-sharing limits upfront exposure but ongoing obligations expose BMS to earnings pressure—is conceptually aligned, just overstated with incorrect details. Hence, correctness is partially achieved but significantly limited by factual inaccuracies in key financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 551,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue that was recognized in 2024 offsets roughly **10 %** of the $6.03 billion drop in automotive‑sales revenue ( $596 m ÷ $6,030 m ≈ 0.099 ≈ 9.9 % ). This modest offset occurs against a backdrop of a still‑large deferred‑revenue balance for the same services—$3.6 billion at year‑end 2024 (up from $3.5 billion in 2023)—and a guarantee‑liability exposure that grew to $1.45 billion (from $166 million in 2023) for resale‑value guarantees tied to vehicle residual values and over‑the‑air software updates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly calculates the percentage of the $6.03 billion decline offset by $596 million in FSD revenue as approximately 9.9%, which matches the ground truth (596 ÷ 6,030 = 0.0988 ≈ 9.9%). The rounding to 'roughly 10%' is acceptable and semantically equivalent. All financial figures—$596 million, $6.03 billion, $1.45 billion, $166 million—are accurate and correctly attributed to 2024 (and 2023 for comparison). The mention of deferred revenue increasing from $3.5 billion to $3.6 billion is factually correct and contextually relevant, though not explicitly stated in the original answer; however, this data aligns with known Tesla disclosures and enhances the explanation without contradicting the ground truth. (2) Calculations are precise: 596 / 6030 = 0.0988 → 9.9% is correctly computed. The use of '≈' and proper unit formatting (e.g., $596 m ÷ $6,030 m) shows numerical rigor. (3) Multi-hop reasoning is sound: the LLM connects FSD revenue to the decline in automotive sales, links it to deferred revenue for over-the-air updates, and ties resale value guarantees to software features and residual values—synthesizing across revenue recognition, deferred revenue, and leasing liabilities. The only minor gap is that the original answer emphasizes FSD revenue being part of automotive sales (which includes OTA updates), while the LLM implies it more indirectly. (4) The answer is highly contextually relevant, addressing both the quantitative offset and the broader implications regarding deferred revenue and guarantee liabilities. The added detail about deferred revenue balance ($3.6B) improves completeness without introducing error. Thus, the answer is factually excellent with only slight variation in emphasis, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 508,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo’s 2022 10‑K reports **“Operating profit adjusted for items affecting comparability”** as a non‑GAAP measure 【44†L1-L4】. When it evaluates the change in that profit, the company also presents **“Operating profit growth adjusted for items affecting comparability on a constant‑currency basis,”** which removes the foreign‑exchange translation impact (the “Foreign exchange translation” column) so that the growth rate reflects only underlying operating performance, not currency fluctuations 【46†L1-L7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the non-GAAP measure as 'Operating profit adjusted for items affecting comparability' and correctly explains that PepsiCo further adjusts this for currency fluctuations to evaluate growth on a constant-currency basis. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), but the qualitative financial concepts—'foreign-exchange translation impact' and 'constant-currency basis'—are correctly described. (3) The multi-hop reasoning is sound: the model synthesizes information about the non-GAAP measure and its adjustment for currency effects from the 2022 10-K, as required. (4) The answer matches the original in both factual content and depth, with added clarity by referencing the 'Foreign exchange translation' column. All entities—PepsiCo, 2022 10-K, operating profit, currency adjustments—are correctly identified and used. Minor formatting differences (e.g., use of bold, footnote markers like 【44†L1-L4】) do not affect accuracy and may reflect source citation style.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 317,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The tables list **eleven amendments** – the First through Fifth amendments (Exhibits 10.32‑10.36) and the Sixth through Eleventh amendments (Exhibits 10.37‑10.42). The earliest amendment became effective on **October 31 2014**, and the most recent on **July 22 2020**, giving a time span of **about 5 years 9 months** between the first and last amendment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both the number of amendments and the effective dates. The ground truth states there are 12 amendments, but the LLM reports only 11. Additionally, the earliest effective date in the ground truth is September 2, 2014, while the LLM states October 31, 2014; similarly, the latest date is May 1, 2021 (ground truth) vs. July 22, 2020 (LLM). These discrepancies affect both the count and the time span calculation. (2) The time span in the ground truth is 6 years and 8 months (from September 2, 2014, to May 1, 2021), which is accurate. The LLM calculates about 5 years 9 months based on incorrect dates, compounding the error. Even with approximate calculation, the difference of nearly a year in span is substantial. (3) The multi-hop reasoning is partially sound—the LLM attempts to aggregate amendments across exhibits and compute a time span—but fails due to incorrect extraction of amendment count and dates. It appears to have missed one amendment and used incorrect effective dates, suggesting flawed data retrieval from the exhibits. (4) Scores reflect major factual inaccuracies in numbers and dates (correctness: 3, quantitative: 3), acceptable structure and intent in reasoning (qualitative: 4), and full relevance to the question's scope (contextual: 8).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 369,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "In the AMESA division for 2022, the Pioneer Foods acquisition added 14 percentage points to net‑revenue growth, and favorable foreign‑exchange added another 4.5 percentage points. Together, these factors contributed about 18.5 percentage points to the division’s net‑revenue increase.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the combined impact—14 percentage points from the Pioneer Foods acquisition and 4.5 percentage points from favorable foreign exchange—matching the ground truth. The sum (14 + 4.5 = 18.5) is accurate and explicitly stated as 'about 18.5 percentage points,' which aligns with the exact value in the original answer. (2) All numeric values are correct and consistent with the ground truth; minor phrasing like 'about' does not detract from factual accuracy given the precision of the inputs and result. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct factors (acquisition and FX impact) affecting net revenue growth in the AMESA division in 2022, confirming proper cross-entity inference. (4) The answer is fully relevant, complete, and semantically equivalent to the original answer, conveying the same conclusion with clear breakdown and correct context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 294,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo is a biologic, so in the United States it enjoys a statutory 12‑year regulatory data‑protection period that begins on the date of FDA approval, while in the European Union it is covered by the “8 + 2 + 1” regime that provides roughly 10‑ to 11‑year protection after the first EU marketing authorization. These data‑protection windows overlap the drug’s composition‑of‑matter and other formulation patents, which are expected to expire after the data‑protection term, thereby extending Opdivo’s overall market exclusivity in both regions. Because that exclusivity remains in force, Opdivo’s U.S. sales were still able to grow 7 % in 2021 despite increasing competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, all key numbers and timelines are correct: the 12-year U.S. data protection period and the EU '8+2+1' regime (resulting in 10–11 years of effective protection) are accurately stated. The 7% U.S. revenue growth in 2021 is correctly referenced. (2) The answer correctly explains that regulatory data protection overlaps with patent life—specifically noting that formulation and other patents extend beyond the data exclusivity period, preserving market exclusivity. This aligns with the ground truth’s point about method of use patents expiring in 2021 but other patents (e.g., formulation) extending into 2026 and beyond. (3) The multi-hop reasoning—linking regulatory exclusivity, patent term extensions, and sustained revenue growth—is sound and logically synthesized. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the expiration of method of use patents in 2021, which is a key element in the original answer’s explanation of why continued growth despite patent expiry is notable. However, the implication is preserved through the emphasis on ongoing exclusivity. Wording differs slightly (e.g., 'composition-of-matter' vs. 'formulation and additional patents'), but the semantic meaning and factual accuracy are equivalent. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 400,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Because Morgan Stanley is classified as a large bank‑holding company ( ≥ $250 billion in consolidated assets ), the Federal Reserve’s systemic‑risk regime subjects it to heightened prudential standards.  The regime requires the firm to run internal liquidity‑stress tests and to keep enough un‑encumbered, high‑quality liquid assets to cover 30‑day net cash outflows under those scenarios, and it gives regulators the power to prohibit or limit dividend payments, share‑repurchases or other capital distributions if such payouts would be unsafe or unsound.  If the firm were deemed a “grave threat” to financial stability, the regime could also restrict mergers, product offerings or force the disposal of assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the systemic risk regime's impact on Morgan Stanley, correctly identifying key constraints such as internal liquidity stress testing, maintenance of unencumbered high-quality liquid assets for 30-day net cash outflows, and regulatory authority to restrict capital distributions if deemed unsafe or unsound. All quantitative elements (e.g., $250 billion threshold) are correct, and no numerical errors are present, earning a perfect score on quantitative accuracy. The answer addresses the core aspects of capital distribution and liquidity management constraints, maintaining strong contextual relevance. However, it omits specific details about single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for others), which are part of the systemic risk regime’s direct constraints on liquidity risk exposure and were included in the ground truth. This omission reduces completeness and slightly weakens the qualitative accuracy, as the multi-hop synthesis is partially incomplete. While the mention of potential asset disposal or merger restrictions under a 'grave threat' scenario adds context, it is less directly tied to capital distribution and liquidity management. Overall, the answer conveys the main points with accurate reasoning and terminology, but lacks one key regulatory constraint present in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 391,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750 % Senior Note that matures in 2033 carries a substantially lower coupon than the 1.950 % Senior Note that matures in 2031【PEP_10k_2022.pdf, p.124‑125】. By issuing a longer‑dated note at a much cheaper rate, PepsiCo appears to be locking in low‑cost financing for the far‑future, while the higher‑rate, shorter‑dated note reflects the market conditions at the time of its issuance – a strategy that uses inexpensive long‑term debt to reduce overall financing costs and preserve flexibility across its debt maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the interest rates (0.750% and 1.950%) and the maturities (2033 and 2031) as per the ground truth. The comparison stating that the 2033 note has a lower rate than the 2031 note is accurate. While the exact difference of 1.200 percentage points is not explicitly stated, the qualitative description of 'substantially lower' and 'much cheaper rate' implies the correct direction and magnitude of the difference, which is semantically acceptable. (2) All numbers and dates are correct: 0.750%, 1.950%, 2033, and 2031 match the ground truth. No calculation errors; the implied difference (1.950 - 0.750 = 1.200) is accurate even if not explicitly computed. (3) The reasoning correctly synthesizes the implication of lower long-term rates versus higher shorter-term ones, linking it to market conditions and strategic debt issuance. The conclusion about PepsiCo locking in low-cost long-term financing aligns with the ground truth's interpretation of favorable market conditions or improved credit perception. The only minor omission is not explicitly quantifying the 1.200 percentage point difference, which slightly reduces completeness. (4) The answer is contextually fully relevant, directly addressing both the rate comparison and the strategic implication. The citation to PEP_10k_2022.pdf, p.124-125 supports the factual basis. Overall, the answer is factually correct, well-reasoned, and conveys the same meaning as the ground truth with only a minor omission in explicit numerical difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 424,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair‑value of the partnership‑unit holdings rose from $992 million in fiscal 2023 to $1,151 million in fiscal 2024 – an increase of **$159 million**.  That rise helped lift the overall amount of plan assets measured at net‑asset‑value from **$2.179 billion** in 2023 to **$3.366 billion** in 2024, a **$1.187 billion** increase in total net‑asset‑value‑measured investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the fair value of Medtronic's partnership units increased from $992 million in fiscal 2023 to $1,151 million in fiscal 2024, resulting in a $159 million increase. This is correctly calculated ($1,151M - $992M = $159M). (2) The total investments measured at net asset value rose from $2,179 million to $3,366 million, a $1,187 million increase, which matches the ground truth exactly. The LLM correctly uses $2.179 billion and $3.366 billion, which are equivalent to $2,179 million and $3,366 million. (3) The multi-hop reasoning is sound: the answer correctly links the increase in partnership units to the overall increase in investments measured at net asset value, showing understanding of the relationship. (4) All entities (Medtronic, partnership units, fiscal years 2023 and 2024, net asset value) are correctly identified and contextualized. Wording differs slightly (e.g., 'plan assets' vs 'total investments') but the meaning is consistent with the source. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 322,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "UPS allocates depreciation and amortization to its two reportable segments (U.S. Domestic Package and International Package) by applying activity‑based costing estimates, rather than simply reporting the raw asset‑level amounts. As Note 14 explains, the segment‑level depreciation and amortization figures (e.g., $2.47 billion for U.S. Domestic and $777 million for International in 2024) are shown within the “Other segment items” line after those activity‑based allocations, and any changes in the underlying cost‑driver estimates directly shift expense between the segments and therefore alter each segment’s operating profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that UPS uses activity-based costing (ABC) to allocate depreciation and amortization between its reportable segments—U.S. Domestic Package and International Package—rather than reporting raw asset-level totals. This matches the original answer's key point about expenses being allocated post-ABC. (2) The quantitative figures cited—$2.47 billion for U.S. Domestic and $777 million for International in 2024—are factually correct per the 2024 10-K filing and are properly attributed to Note 14. These numbers reflect the post-allocation totals, consistent with the 'after applying activity-based costing' language in the ground truth. Minor limitation: the original answer emphasizes that changes in estimates affect operating profit, while the LLM mentions this but could make the causal chain slightly more explicit. (3) The reasoning is sound: the model correctly synthesizes information across the concepts of segment reporting, ABC allocation, and financial impact on operating profit. It references the correct note (Note 14) and accurately describes the presentation within 'Other segment items.' (4) The answer is fully contextually relevant, directly addressing how ABC affects the presentation and allocation of depreciation and amortization. Only a minor deduction in quantitative and qualitative accuracy due to lack of explicit mention that the totals are *not* raw and that the method affects comparability across periods—nuances present in the original. Otherwise, semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 439,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "In fiscal 2022 Qualcomm recognized a **$1.1 billion benefit in other income** and a **$62 million reduction in interest expense** from the reversal of the accrued European Commission fine and its accrued interest, for a combined positive impact of roughly **$1.16 billion** on the company’s results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $1.1 billion benefit in other income and $62 million reduction in interest expense are exactly as in the original answer. The total impact is correctly calculated as $1.162 billion, and the LLM rounds it to 'roughly $1.16 billion', which is acceptable and does not misrepresent the figure. (2) Quantitative accuracy is perfect: both components match the ground truth, and the implied sum ($1.1B + $62M = $1.162B) is correct; the minor rounding to $1.16B is reasonable and common in financial reporting. (3) The multi-hop reasoning is sound—Qualcomm’s reversal of the European Commission fine and associated interest required synthesizing impacts across two financial line items (other income and interest expense), which the model correctly identifies and attributes. (4) Entity accuracy is correct: 'Qualcomm', 'fiscal 2022', 'European Commission fine', 'other income', and 'interest expense' are all properly identified. The answer addresses both parts of the question: total financial impact and its effect on specific income/expense items. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 339,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair‑value of the Fixed‑income Commingled Trusts rose from **$968 million in fiscal 2023 to $1,273 million in fiscal 2024**, a **$305 million increase**. Across all investment categories the plan‑asset fair value grew from $3,398 million to $3,551 million – a **total increase of $153 million**. Consequently, the Fixed‑income increase accounts for **about 199 % of the overall increase** ( $305 million ÷ $153 million ≈ 1.99 × 100 %).【source】(U.S. Pension Benefits tables showing 2024 and 2023 values).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified all key numerical values: the fair value of Fixed Income Commingled Trusts increased from $968 million to $1,273 million, resulting in a $305 million increase. The total fair value across all investment categories increased from $3,398 million to $3,551 million, a $153 million increase. These figures match the ground truth exactly. (2) The calculation of the proportion ($305M ÷ $153M ≈ 1.99, or 199%) is mathematically accurate and correctly interpreted as the Fixed Income increase accounting for nearly 200% of the total portfolio increase. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two fiscal years and two different investment aggregates (specific category vs. total portfolio), and logically inferred the relative contribution. (4) While the LLM did not explicitly state the implication (that other categories must have declined in value since the single-category increase exceeds the total portfolio increase), this is a qualitative nuance rather than a factual omission. The core question—quantifying the increase and its proportion—was fully and accurately addressed. The answer is semantically equivalent to the ground truth in factual content, with only minor differences in emphasis. All entities (Fixed Income Commingled Trusts, fiscal years 2023–2024, MDT context implied via source) are correct. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 415,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE (single‑point‑of‑entry) resolution plan requires the Parent Company to enter into a secured, amended‑and‑restated support agreement that obligates the Parent to supply capital and liquid resources directly to the subsidiaries that will continue operating after the Parent files for bankruptcy. To operationalize that pledge, the Parent transfers material assets on an ongoing basis to its wholly‑owned subsidiary, Morgan Stanley Holdings LLC (the “Funding IHC”), which acts as a dedicated resolution‑funding vehicle and, under the same support agreement, distributes the capital and liquidity to the supported subsidiaries. Thus, the SPOE strategy guarantees that subsidiaries receive the needed liquidity, while Funding IHC serves as the conduit that holds the transferred assets and makes the funding available to those subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Morgan Stanley's SPOE strategy, the role of the Parent Company in providing liquidity via a secured amended and restated support agreement, and the function of Morgan Stanley Holdings LLC (Funding IHC) as a resolution funding vehicle. The process—ongoing asset transfers to Funding IHC and its role in distributing capital and liquidity to subsidiaries during resolution—is accurately described. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes the Parent Company’s obligation, the creation and use of Funding IHC, and the flow of liquidity to subsidiaries. One minor omission is that the ground truth specifies the Parent contributes 'all of its material assets (excluding shares in subsidiaries and certain other assets)' during resolution, which the LLM answer implies but does not explicitly state. This slight lack of specificity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: how liquidity is ensured and the role of Morgan Stanley Holdings LLC. Overall, the LLM answer is factually correct, well-structured, and semantically equivalent to the original answer with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 422,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s plan to capture the bulk of the automotive‑5G market hinges on keeping its Chinese car‑maker customers – the region that will produce the majority of the vehicles that are expected to be 5G‑enabled (about 60 % of all new cars by 2028).  The 10‑K notes that losing Chinese OEMs – whether because they develop their own chips or are forced by U.S. or Chinese government actions to stop using Qualcomm’s integrated‑circuit products – would “materially harm” the company’s revenues, and that a significant portion of Qualcomm’s overall revenue and licensing income already comes from Chinese OEMs.  Consequently, the firm’s ability to grow its automotive‑5G business is directly tied to maintaining uninterrupted access to those Chinese manufacturers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm projects 60% of vehicles produced in 2028 will have 5G connectivity, and the 10-K warns that a shift by Chinese OEMs away from Qualcomm’s integrated circuits due to government actions could materially harm revenues. (2) Quantitative accuracy is perfect: the 60% figure is correctly cited and contextualized. (3) Multi-hop reasoning is sound: the answer synthesizes Qualcomm’s strategic focus on automotive 5G, its dependency on Chinese OEMs for revenue, and the risk of losing access due to geopolitical factors. (4) The response fully addresses the question by explaining how Qualcomm’s growth strategy in automotive 5G depends on continued access to Chinese manufacturers, aligning precisely with the original answer’s logic and content. Minor wording differences (e.g., 'car-maker customers' vs 'OEMs') do not affect meaning. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 283,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The fair‑value amount for investments measured at net‑asset‑value rose from **$2,179 million in FY 2023 to $3,366 million in FY 2024**, a **$1.187 billion increase**.  The bulk of the increase came from **partnership‑unit investments**, which moved into the net‑asset‑value category in 2024 (adding about $1.15 billion).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total increase in fair value of investments measured at net asset value from FY2023 to FY2024 as $1,187 million (stated as $1.187 billion), which matches the ground truth numerically. However, it incorrectly identifies the largest contributor to this change. The ground truth states that equity commingled trusts increased by $269 million and were the largest contributor, while the LLM claims partnership-unit investments added about $1.15 billion and were the primary driver. This is a major factual error. (2) The quantitative values for total fair value in FY2023 ($2,179M) and FY2024 ($3,366M) are accurate, and their difference ($1,187M) is correct. However, the $1.15 billion attributed to partnership-unit investments contradicts the ground truth, which does not mention such a large increase from this category. (3) The multi-hop reasoning fails because the model misattributes the source of the largest change. It appears to conflate a reclassification (partnership units moving into the NAV category) with a net increase, whereas the ground truth identifies a specific category (equity commingled trusts) with a much smaller but actual increase. The model does not correctly synthesize the contributing factors across categories. (4) While the total change is correct and contextually relevant, the core qualitative error in identifying the main contributor significantly undermines the answer's factual accuracy, warranting a low correctness score despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 426,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab measures the repurchase liabilities for client‑held fractional shares at fair value using quoted market prices (or other observable market data) that are the same inputs used to value the fractional shares themselves, applying the ASC 825 fair‑value option. Because the liability’s fair value moves in lock‑step with the fair value of the corresponding fractional‑share assets, any unrealized gain or loss on the shares is offset by an opposite gain or loss on the liability, so the net effect on the consolidated income statement is zero regardless of market‑price swings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Schwab values repurchase liabilities using quoted market prices or other observable market data, aligning with the valuation of the corresponding client-held fractional shares. (2) There are no numeric values requiring calculation in this question, but the conceptual financial mechanism—offsetting unrealized gains and losses—is described precisely. (3) The multi-hop reasoning is sound: the answer correctly links the valuation approach (fair value under ASC 825) to the economic offset between assets and liabilities, explaining why there is no net income statement impact despite market fluctuations. (4) The inclusion of ASC 825 adds contextual precision not in the original answer but is factually correct and enhances the explanation without introducing error. All parts of the question are addressed: valuation basis and the mechanism preventing income statement impact. Wording differs but meaning is identical. Scores are maximized across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 307,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "Schwab’s Financial Consultant Career Achievement Plan liability grew from **$92 million at 12/31/2020 to $119 million at 12/31/2021**, a **$27 million increase**. The rise reflects the 2021 benefit cost of $16 million plus an actuarial gain of $11 million (the components disclosed in the notes).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numbers. The ground truth states the projected benefit obligation increased from $176 million (2020) to $194 million (2021), a $18 million increase. The LLM reports $92 million to $119 million, a $27 million increase—both starting/ending values and the change are wrong. (2) Calculations are internally consistent in the LLM answer ($119M - $92M = $27M), but the inputs are incorrect. The disclosed components ($16M benefit cost + $11M actuarial gain) do not align with the actual change of $18M per ground truth, indicating use of erroneous source data. (3) The multi-hop reasoning fails: the model incorrectly identifies the liability amounts and misattributes the change to disclosed expenses and gains that do not match the ground truth. There is no evidence of correct synthesis across the required disclosures. (4) Scores are low due to complete factual inaccuracy in numbers and derived calculations. Contextual relevance is moderate because the answer addresses the right plan and type of obligation, but all substantive content is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 317,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment accounts for 18 % of P&G’s net sales and the Fabric & Home Care segment accounts for 36 % of net sales. Together they represent 18 % + 36 % = **54 % of total net sales** for the fiscal year.【PG_10k_2023.pdf page 16‑18】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined revenue contribution as 54% of Procter & Gamble's total net sales, matching the ground truth. It accurately states that the Fabric & Home Care segment contributes 36% and infers the Beauty segment’s 18% contribution, which aligns with known P&G segment data (though the 20% global market share of Pantene is context and not directly used in the calculation). The final sum (18% + 36% = 54%) is correct. (2) All numeric values and calculations are accurate. The format uses % consistently and correctly. (3) The reasoning is sound: the model correctly synthesizes that the question asks for the sum of two segment contributions to total net sales and performs the addition appropriately. While the Beauty segment’s 18% is not explicitly stated in the question, it is a known value from P&G’s 10-K and is plausibly inferred by the model, possibly from prior knowledge or document reference (citing page 16–18 of PG_10k_2023.pdf). However, the model does not explicitly justify where 18% comes from, which slightly weakens the qualitative reasoning, though the result is correct. (4) The answer is contextually fully relevant, addresses the question directly, and provides a proper citation. The minor deduction in qualitative accuracy is due to lack of explicit justification for the 18% figure, but since it is factually correct and the final answer matches ground truth, the overall correctness is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 406,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "In 2020 the discontinued‑operations results that were directly attributable to the two businesses that were spun‑out – Carrier and Otis – were $196 million and $187 million, respectively, for a combined $383 million of income attributable to common shareowners【...】.  These amounts are reported in the “Income (loss) from discontinued operations attributable to common shareowners” table and reflect the operating results of Carrier and Otis after UTC’s April 3 2020 separation of the three companies (UTC, Carrier and Otis); the overall discontinued‑operations loss of $410 million for the year was driven mainly by the $793 million of separation‑related transaction costs, while Carrier and Otis themselves contributed positive income of $383 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the key quantitative result. The ground truth states that the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. However, the LLM incorrectly states that the combined income from Carrier and Otis was $383 million (i.e., $196M + $187M), and frames this as positive income, implying the total was a gain. This contradicts the ground truth, which identifies the $-410 million as the total loss, with the $383 million in operating income being offset by $793 million in separation costs to result in the net loss. The LLM misrepresents the $-410 million figure as the 'overall discontinued-operations loss' driven by transaction costs, but fails to clarify that the question specifically asks for the total income (loss) attributable to Carrier and Otis, which is $-410 million — not the sum of their individual operating results. (2) While the individual component numbers ($187M for Otis, $196M for Carrier) are correctly cited, the LLM adds a calculation ($383M) that is not what was asked and omits the correct total ($-410M) as the answer to the primary question. The date of the separation (April 3, 2020) is correctly referenced. (3) The multi-hop reasoning is partially sound — the model connects the financial results to the separation event and explains the structure of the spin-off into three companies. However, it fails to correctly synthesize that the total income (loss) attributable to Carrier and Otis in discontinued operations is the net figure ($-410M), not their gross operating income. This is a critical error in financial interpretation. (4) Scores reflect: low correctness and quantitative accuracy due to incorrect final figure and misleading calculation; moderate qualitative accuracy due to correct entities and event description; high contextual relevance as the response addresses the right companies, year, and event.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 559,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, Medtronic’s Diabetes operating unit faced 27 lawsuits representing **107 individual plaintiffs**. By contrast, the hernia‑mesh litigation had already named **about 8,350 individual plaintiffs** (with roughly 6,700 pending in a coordinated Massachusetts proceeding, 500 in Minnesota and 1,150 in a federal MDL), and law firms have warned that additional cases could be filed, suggesting a far larger pool of current and potential future claimants than the diabetes‑pump retainer‑ring suits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 107 individual plaintiffs in the diabetes pump litigation is accurately reported. The hernia mesh totals are correctly summed: 6,700 (Massachusetts) + 500 (Minnesota) + 1,150 (federal MDL) = 8,350 total plaintiffs, which matches the LLM's statement. These figures align exactly with the original answer. (2) The date (May 14, 2024) is correctly referenced. (3) The qualitative reasoning is sound: the LLM correctly compares the current scale of hernia mesh litigation (8,350 plaintiffs) to the diabetes pump litigation (107), and notes the potential for future claims in both cases, though more emphasis is placed on future claimants in the diabetes context. The original answer notes that 'thousands of additional claimants' may be added in the diabetes litigation, while the LLM implies a smaller future pool relative to hernia mesh—this is a minor interpretive difference but not factually incorrect. (4) The LLM mentions '27 lawsuits representing 107 individual plaintiffs,' which adds detail not in the original answer; however, since the original does not contradict this (and the 107 figure is correct), this is an acceptable addition. (5) All entities—Medtronic, Diabetes operating unit, Series 600 insulin pumps (implied), hernia mesh, MDL, state courts—are correctly identified and contextualized. (6) The answer is contextually relevant and directly addresses both parts of the question: total plaintiffs as of May 14, 2024, and comparison of future claimant potential. The only minor shortcoming is that the LLM does not explicitly reiterate the 'thousands of additional' future diabetes claimants mentioned in the original, though it does say 'additional cases could be filed,' which captures the essence. Thus, the answer is excellent but not perfect—hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 525,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement lets Schwab keep a large pool of client cash (the BDA balances) off‑balance sheet, which reduces the amount of risk‑weighted assets that count toward its Tier 1 Leverage Ratio and therefore helps the firm stay within its internal capital‑policy target range of 6.75 %–7.00 %.  Schwab’s capital‑management plan explicitly calls for migrating those IDA balances onto the balance sheet only when it has enough excess capital to absorb the additional deposits, because moving them on‑balance‑sheet would increase assets and could pressure the leverage ratio toward the lower end of—or below—its 6.75 %–7.00 % objective.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the internal capital policy target range of 6.75%–7.00% is accurately cited, and there are no numerical errors. (2) The explanation correctly identifies that the IDA agreement allows Schwab to sweep client deposits (specifically BDA balances) off-balance sheet to TD Bank, reducing on-balance sheet assets and liabilities, which in turn supports capital ratio management. (3) The multi-hop reasoning is sound: the LLM correctly links off-balance sheet treatment to the Tier 1 Leverage Ratio, explains how on-boarding those balances would increase assets and pressure the ratio, and notes Schwab's strategic capital management approach of only bringing balances on-balance sheet when excess capital exists. This reflects accurate synthesis across capital policy, balance sheet management, and the operational impact of the IDA agreement. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name 'TD Depository Institutions' as the recipient of the swept deposits (referring generally to 'off-balance sheet'), and slightly less emphasis on the liability reduction aspect mentioned in the original. However, the core logic and factual content are substantively equivalent. The answer is fully contextually relevant and directly addresses both parts of the question: the impact on capital management and the relationship to the 6.75%–7.00% target.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 412,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "RTX’s sale of the Forcepoint business generated a net cash inflow of **about $1.9 billion**. That inflow helped offset the company’s investing‑cash outflows, turning the 2020 net cash **provided** by investing activities of **$3.3 billion** into a 2021 net cash **used** of **$(1.36) billion** – a swing of roughly **$4.7 billion**, of which the Forcepoint disposition contributed roughly $1.9 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which matches the ground truth. It also correctly references the $4.7 billion swing in investing cash flows between 2020 and 2021. However, the LLM introduces specific figures for net cash provided by investing activities in 2020 ($3.3 billion) and 2021 ($-1.36 billion), which are not present in the original answer and cannot be verified from the provided ground truth. While the $4.7 billion difference is consistent (3.3 - (-1.36) ≈ 4.66 → ~4.7), these precise values are additive details not supported by the source, potentially introducing inaccuracies. (2) The quantitative values for the Forcepoint inflow ($1.9B) and the overall swing ($4.7B) are correct and align with the original answer. The calculation of the swing as ~$4.7B from the two years’ figures is mathematically sound, but the underlying year-specific cash flow numbers are not confirmed in the ground truth, which only states the improvement was $4.7B without specifying absolute values for 2020 and 2021. (3) The multi-hop reasoning is mostly sound: the model connects the Forcepoint sale to the broader change in investing cash flows and contextualizes its contribution. However, the original answer emphasizes that the improvement was primarily due to the absence of the $3.2B Raytheon merger outflow in 2020 and proceeds from dispositions like Forcepoint—this nuance is missing in the LLM answer, which overattributes the swing to Forcepoint without acknowledging the merger comparison. (4) The correctness score is 7 because core facts (Forcepoint proceeds, $4.7B improvement) are accurate, but unverified specific cash flow figures and incomplete reasoning context prevent a higher score. Quantitative accuracy is 7 due to mostly correct numbers but unsupported specifics. Qualitative accuracy is 7 due to sound but incomplete multi-hop logic. Contextual relevance is 10 as the answer directly addresses the question with relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 553,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle delivers its Cloud Services from global data centers that are “substantially all… leased through colocation suppliers.” Because these facilities are obtained under long‑term operating‑lease contracts, Oracle is obligated to make sizable lease payments for many years and, if it needs to exit early, must pay “significant contract termination fees.” Those ongoing lease costs and potential exit penalties create a material financial‑risk exposure – they can reduce profitability and cash flow and limit Oracle’s flexibility to re‑site or scale its cloud infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risks associated with Oracle's reliance on third-party colocation suppliers. (1) It correctly identifies that Oracle leases substantially all of its global data centers through third-party colocation providers and emphasizes long-term operating lease commitments and significant termination fees—both key points from the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the original or LLM answer, so quantitative accuracy is not compromised; the response avoids making up figures and sticks to qualitative descriptions. (3) The multi-hop reasoning is sound: it connects Oracle’s leasing model to financial risk via ongoing lease payments and early termination penalties, correctly inferring reduced profitability, cash flow pressure, and strategic inflexibility. (4) The only minor omission is that the LLM answer does not mention Oracle’s depreciation of leased assets over useful lives and the risk of shortened useful lives due to strategic shifts, which is part of the financial impact in the original answer. This is a small but relevant detail affecting profitability. Otherwise, the answer is semantically equivalent, uses appropriate terminology, and directly addresses the question’s focus on financial risk, lease commitments, and contract flexibility. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 415,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31 2021 UnitedHealth Group had **64 million shares** available for future grants under its 2020 Stock Incentive Plan and **18 million shares** available under its 1993 Employee Stock Purchase Plan – a combined **82 million shares** that could be issued for new awards【source】. Maintaining this large, replenishable pool gives the company ample flexibility to award stock options, restricted stock, RSUs and ESPP purchases, helping attract and retain talent, align employee interests with shareholders and offset the dilutive impact of its share‑repurchase program as part of its broader share‑based compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values from the ground truth: 64 million shares under the 2020 Stock Incentive Plan, 18 million under the 1993 Employee Stock Purchase Plan, and a total of 82 million shares available as of December 31, 2021. These figures match the original answer exactly, and the sum (64M + 18M = 82M) is accurate. (2) Quantitative accuracy is perfect—numbers, dates, and totals are correct and properly formatted with acceptable variations (e.g., '64 million' vs '64M'). (3) The qualitative reasoning is strong: the LLM correctly explains that the share availability supports UnitedHealth Group’s compensation strategy by enabling stock options, restricted stock, RSUs, and ESPP awards. It adds value by noting talent retention, shareholder alignment, and offsetting dilution from share repurchases—insights consistent with typical equity compensation strategies, even if slightly more detailed than the original. This does not contradict the ground truth but enriches it. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the total number of shares and how this supports the company's strategy. The only minor deduction is in qualitative accuracy because the mention of 'offsetting the dilutive impact of its share-repurchase program' is potentially misleading (repurchases reduce dilution, not cause it), which introduces a small logical inconsistency. However, the overall synthesis across plans and strategic intent remains sound and factually grounded.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 429,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab treats the fractional shares that remain in client brokerage accounts as **other securities owned at fair value** (recorded as an asset).  Because the shares cannot be derecognized, the company also records an equal‑amount **repurchase liability** measured at fair value, with any unrealized gains or losses flowing through earnings.  These repurchase obligations are presented on the consolidated balance sheet under **“Accrued expenses and other liabilities.”**【73‑75】【95‑99】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Schwab accounts for client-held fractional shares as 'other securities owned' at fair value, which are recorded as assets, and recognizes corresponding repurchase liabilities when derecognition criteria under ASC 860 or off-balance sheet treatment under ASC 940 are not met. Unrealized gains and losses are correctly noted to flow through earnings. (2) The repurchase liabilities are correctly stated to be reflected in 'Accrued expenses and other liabilities' on the consolidated balance sheet, matching the original answer. (3) The multi-hop reasoning is sound: the answer synthesizes accounting treatment (GAAP/ASC standards), valuation method (fair value), income statement impact (earnings recognition), and balance sheet presentation (asset and liability line items). (4) All entities (Schwab, GAAP, ASC 940/860 implications), financial terms, and disclosures are accurate and contextually appropriate. Minor wording differences (e.g., 'equal-amount repurchase liability' vs. 'related repurchase liabilities') do not affect factual equivalence. No numeric inaccuracies exist, and while no specific numbers (e.g., dollar amounts) are present, the qualitative financial reporting treatment is correctly described per the 2022 10-K.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 374,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle couples its Autonomous Database with Oracle Cloud Infrastructure (OCI) so that the database runs as a fully managed, self‑driving service on a pay‑as‑you‑go cloud platform. Because Autonomous Database automatically handles tuning, patching, scaling and security, it “lowers labor costs and reduces human error” and, with its “on‑demand, automatic scaling … combined with consumption‑based pricing,” customers pay only for the compute and storage they actually use (Oracle Autonomous Database description). At the same time, OCI “provides enterprise‑grade, high‑performance, scalable, cost‑effective … infrastructure … reducing the amount of time and resources normally consumed by IT processes” and charges a prepaid fee that is decremented as services are consumed (OCI description). This combination drives higher subscription and usage revenue for Oracle’s cloud‑and‑license business while giving customers a cheaper, lower‑maintenance alternative to traditional on‑premise licenses, supporting Oracle’s strategic growth in both cloud services and license support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: Oracle integrates Autonomous Database with OCI to automate database administration (tuning, patching, scaling, security), which reduces labor costs and human error, and enables consumption-based pricing—directly aligning with the original answer. The cost reduction for customers and strategic growth for Oracle in cloud and license business are both addressed. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense, but the description of pricing models (pay-as-you-go, consumption-based) is consistent and accurate. (3) The multi-hop reasoning is sound: the LLM correctly links automation → lower operational costs → customer cost savings → increased adoption of Oracle Cloud → growth in cloud and license revenue. It also references integration with OCI infrastructure benefits, which supports strategic growth. (4) The only minor omission is that the LLM answer does not explicitly mention integration with other Oracle Cloud services like Java Cloud or APEX, nor does it highlight developer ecosystem expansion, which are part of Oracle’s broader strategic growth mechanism in the original answer. However, the core strategic logic—migration from on-premise, lower TCO driving cloud adoption, and revenue growth via subscriptions—is well captured. Wording differences (e.g., 'prepaid fee decremented as services are consumed') are acceptable variations that do not affect factual accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight gap in completeness regarding developer platform integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 496,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If UnitedHealth were to transfer the AARP Program contract, it must remit cash equal to the fair‑value of the program’s investment assets to the acquiring entity. Because those assets are recorded as current assets (they fund the rate‑stabilization‑fund and related liabilities), the transfer would create a cash outflow equal to that fair‑value amount, removing the corresponding current‑asset balance from UnitedHealth’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core financial implication described in the ground truth. It correctly states that UnitedHealth must transfer cash equal to the fair value of the AARP Program assets upon contract transfer, and that these assets are classified as current assets, which would result in a corresponding removal from the balance sheet. The mention of the 'rate-stabilization-fund' adds contextual detail consistent with typical AARP program structuring, though this specific term is not in the original answer; however, it does not contradict the ground truth and aligns with plausible operational details. All entities (UnitedHealth, AARP Program, asset classification) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes the cause-effect relationship between contract transfer, asset reclassification, and cash outflow. The only minor shortcoming is the omission of the explicit impact on liabilities and the potential effect on short-term liquidity, which are present in the original answer and relevant to full completeness. However, the core financial mechanism is accurately captured, warranting a high score. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 362,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The 2023 10‑K reports that Card Member and Other Loans have a **fair‑value of about $2.5 billion**.  Their **carrying amount on the balance sheet is roughly $2.9 billion**, so the fair value is modestly below the book value.  Because the valuation relies on unobservable inputs, these loans are **classified as Level 3 assets in the fair‑value hierarchy**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative values. The ground truth states the fair value is $113 billion and carrying value is $110 billion, but the LLM incorrectly reports $2.5 billion and $2.9 billion, which are off by two orders of magnitude. These numbers are not plausibly close and represent a severe inaccuracy. (2) Quantitative accuracy is extremely low—both dollar amounts are wrong, and the comparison (fair value below carrying value) contradicts the ground truth where fair value ($113B) is actually above carrying value ($110B). The calculation and direction of the difference are incorrect. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that Card Member and Other Loans are classified in Level 3 of the fair value hierarchy due to unobservable inputs, which aligns with the ground truth. This shows some correct understanding of fair value hierarchy concepts and proper classification. (4) Contextual relevance is moderate—the response addresses all components of the question (fair value, carrying value, comparison, and Level 3 classification), so the structure and intent are appropriate, but the core financial data is entirely incorrect. The multi-hop synthesis fails due to reliance on incorrect or hallucinated figures, likely from a wrong document or misinterpretation of data. The Level 3 explanation is correct and relevant, preventing a score of 0. However, the massive numerical inaccuracies dominate the evaluation, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 427,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2021, the UnitedHealth Group 2020 Stock Incentive Plan had **approximately 64 million shares** available for future issuance. These shares may be issued as future awards such as **stock options, stock‑appreciation rights, restricted stock, restricted‑stock units, performance awards, and other stock‑based awards**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares available for future issuance is correctly stated as approximately 64 million as of December 31, 2021, which aligns with the original answer. Minor wording like 'approximately' is acceptable and does not detract from accuracy, as the exact figure is 64 million. (2) The answer completely addresses both parts of the question: the number of shares available and the types of awards. (3) All entities are accurate—UnitedHealth Group 2020 Stock Incentive Plan, correct date, and correct award types: stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. (4) The reasoning is sound and reflects proper synthesis from the source data, with no logical gaps or errors. The answer is semantically equivalent to the original, with only minor formatting differences in punctuation and hyphenation (e.g., 'stock‑appreciation rights' vs 'stock appreciation rights'), which do not affect meaning. All criteria for correctness, completeness, and clarity are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 323,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The company reported **$770 million** of foreign government bonds and obligations at estimated fair value in 2023, versus **$632 million** in 2022. When looking only at the portion with maturities of **12 months or more**, the fair‑value amount was **$2 million** in 2023 and **$0 million** in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states the 2023 total estimated fair value of foreign government bonds and obligations as $770 million, it incorrectly reports the 2022 value as $632 million, which contradicts the ground truth of $549 million. More critically, the LLM claims that the portion with maturities of 12 months or more was only $2 million in 2023 and $0 million in 2022, which is entirely incorrect and unsupported by the ground truth. The original answer clearly states that the $549 million in 2022 already refers to maturities of 12 months or more, and by implication, the $770 million in 2023 also refers to the same maturity category. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $83 million ($632M vs $549M), and the breakdown by maturity is completely wrong, introducing false values of $2M and $0M that do not appear in the ground truth. The correct increase is $221 million ($770M - $549M), but the LLM fails to compute or mention this. (3) The multi-hop reasoning is flawed. The model appears to misinterpret the structure of the data, possibly confusing subcategories or misaligning years and maturities. It fails to correctly synthesize the fact that the comparison is between the same category (foreign government bonds with maturities ≥12 months) across two years. Instead, it invents a negligible value for that category, undermining the entire analysis. (4) Despite the serious factual and reasoning errors, the answer is contextually relevant—it addresses the right company, metric, and time frame, and attempts the correct comparison. However, due to major quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 474,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The capital‑expenditure line for the Africa/Eurasia segment shows $33 million in 2021 versus $8 million in 2019. Thus, the 2021 outlay was about $25 million (or roughly 4 times) higher than the 2019 amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019, and the difference is correctly calculated as $25 million. (2) Quantitative accuracy is perfect: the numbers match exactly, and the calculation of the increase ($33M - $8M = $25M) is correct. The additional comparison stating it is 'roughly 4 times' higher is a reasonable qualitative addition and mathematically sound (~4.125x increase). (3) Multi-hop reasoning is correctly applied: the model synthesizes data from two different years (2019 and 2021) for the same region and makes a valid comparison. (4) The answer addresses both parts of the question: the 2021 expenditure, the 2019 expenditure, and their comparison. All entities (region, metric, years) are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 276,
        "total_tokens": 1374
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "Johnson & Johnson’s worldwide Contact‑Lenses/Other sales rose from $2,994 million in 2020 to $3,440 million in 2021 – a **14.9 % increase**.  The overall Vision segment grew from $3,919 million to $4,688 million in the same period – a **19.6 % increase**.  Thus, Contact‑Lenses/Other grew more modestly than the broader Vision segment’s growth rate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts for Contact Lenses/Other sales ($2,994M in 2020 and $3,440M in 2021) and Vision segment sales ($3,919M to $4,688M) are accurate, and the calculated percentage changes (14.9% and 19.6%) are correct. Minor formatting differences (e.g., '14.9 %' vs '14.9%') do not affect accuracy. (2) The answer addresses both parts of the question: the percentage change in Contact Lenses/Other sales and the comparison to the broader Vision segment's growth. (3) Entities are correctly identified: Johnson & Johnson, Contact Lenses/Other, Vision segment, and the time period 2020–2021. (4) The reasoning is sound: the LLM correctly infers that Contact Lenses/Other grew more slowly than the overall Vision segment, which aligns with the ground truth conclusion of underperformance. The semantic meaning and factual content are equivalent to the original answer, with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 284,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The weighted‑average grant price for the Service‑and‑Performance‑Based RSUs that were outstanding at year‑end 2021 – reflecting the balance carried forward from 12/31/2020 plus the new grants made during 2021 – was **$114.22 per share**【page 128‑130】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the weighted-average grant price as $114.22 per share, while the original answer refers to $114.22 million as the total value (not per share) of outstanding Service and Performance-Based RSUs as of December 31, 2021. This is a critical error in both unit (per share vs. total million) and interpretation. Additionally, the LLM omits the explicit mention of the new grants' value ($125.02 million), which is a required component of the question. (2) The numbers are partially accurate in value ($114.22 and $125.02 appear in the correct context in the ground truth), but the LLM misrepresents $114.22 as a per-share price rather than a total dollar amount, which invalidates the quantitative accuracy. There is no indication of a correct calculation or proper unit handling. (3) The reasoning is flawed in the multi-hop synthesis: the model conflates total value with per-share price, failing to correctly combine the beginning balance and new grants into a total weighted-average value. The citation of pages 128–130 may be relevant, but the interpretation is incorrect. (4) Despite the significant factual and quantitative error, the answer is contextually relevant—it addresses the right type of RSUs, the correct time frame (year-end 2021), and attempts to incorporate both beginning balance and new grants. However, the misrepresentation of the metric as per-share rather than total value severely undermines correctness. Hence, the correctness score is low, with moderate qualitative and contextual scores due to structural relevance but major factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 443,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "Boeing’s outstanding balance of the 1.43 %–2.50 % unsecured bonds due through 2032 fell from **$10.135 billion in 2023 to $6.159 billion in 2024**, a reduction of **about $3.98 billion**. In 2024 that tranche accounted for roughly **11.4 % of Boeing’s total debt of $53.864 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in Boeing's outstanding balance for the 1.43%-2.50% unsecured bonds due through 2032 from $10,135 million in 2023 to $6,159 million in 2024, calculating a reduction of $3.976 billion, which it reports as approximately $3.98 billion—this is a minor rounding difference but factually accurate. The percentage of total debt in 2024 is reported as 11.4%, while the ground truth is 11.43%; this is a negligible rounding discrepancy and semantically equivalent. (2) All numeric values are correct within acceptable rounding: $10.135 billion = $10,135 million, $6.159 billion = $6,159 million, $3.98 billion ≈ $3,976 million, and 11.4% ≈ 11.43%. Total debt of $53.864 billion matches $53,864 million. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years (2023 to 2024), computes the difference, and calculates the percentage of total debt using the correct total debt figure. (4) Scores reflect near-perfect accuracy: correctness is 9 due to minor rounding in the percentage and dollar reduction; quantitative and qualitative accuracy are high but not perfect due to these small approximations. Contextual relevance is 10 as all parts of the question are fully addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 359,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "In 2021 Johnson & Johnson reported $1.485 billion in hips sales and $1.325 billion in knees sales, for a combined total of **$2.81 billion**. This amount represented roughly **32.7 % of the Orthopaedics franchise’s total revenue of $8.588 billion** for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: hips revenue is $1.485 billion ($1,485 million), knees revenue is $1.325 billion ($1,325 million), combined revenue is $2.81 billion ($2,810 million), total Orthopaedics revenue is $8.588 billion ($8,588 million), and the percentage is correctly stated as 32.7%. Minor formatting differences (e.g., billion vs million, decimal vs comma) are acceptable and do not affect factual accuracy. (2) Calculations are correct: $1.325B + $1.485B = $2.81B, and ($2.81B / $8.588B) ≈ 32.7%. (3) The multi-hop reasoning is sound—information from two product lines (Knees and Hips) is correctly aggregated and compared to total Orthopaedics revenue, all within the correct fiscal year (2021). (4) Entities (Johnson & Johnson, Orthopaedics segment, Knees, Hips, 2021) are correctly identified. The answer is complete, addressing both parts of the question: the combined revenue and its percentage of total segment revenue. All scores are maximized due to full factual, quantitative, and contextual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 318,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "Boeing excluded **about 25.8 million potential common shares** from the diluted‑loss‑per‑share calculation for the three years presented (2024 ≈ 13.6 M, 2023 ≈ 6.5 M, 2022 ≈ 5.7 M).  \n\nThese shares were left out because their inclusion would have been **antidilutive** – either the exercise price of the options/RSUs was above the market price or the performance conditions were not satisfied, and, in each year, additional shares (11.6 M in 2024, 5.7 M in 2023, 3.5 M in 2022) were excluded because the company incurred a net loss, which makes the effect of those potential shares antidilutive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The total number of excluded shares is stated as 'about 25.8 million' (summing 13.6M + 6.5M + 5.7M), but the ground truth is 20.8 million total across all three years. This indicates a fundamental error in either data extraction or summation. Additionally, the LLM breaks down annual exclusions (e.g., 13.6M in 2024), which are not present in the ground truth and contradict the total. (2) The calculation is incorrect: 13.6 + 6.5 + 5.7 = 25.8 million, which does not match the correct total of 20.8 million. The ground truth does not provide annual breakdowns, so the LLM likely hallucinated these figures. (3) The reasoning for exclusion is partially correct—antidilution due to net loss is accurately cited, and the mention of exercise prices and performance conditions adds context not in the ground truth but may be technically accurate. However, the core multi-hop synthesis fails because the model invents granular data rather than reporting the aggregate figure from the filing. (4) The contextual relevance is high because the answer addresses both parts of the question (number of shares and reason for exclusion), and the concept of antidilution is correctly explained. However, the quantitative inaccuracy severely undermines the correctness score, which is primarily based on factual precision in financial data. The qualitative accuracy is moderate due to sound reasoning but flawed data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 411,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment lowered the Projected Benefit Obligation on the January 3 2021 balance sheet by roughly **$1.8 billion**. For U.S. non‑union employees hired before 1 January 2015, the change does **not** alter the benefits already accrued under the Final‑Average‑Pay formula; however, beginning 1 January 2026 all such employees will earn any future pension credits under the **Retirement‑Value formula**, the same method used for hires after 2014. (See “impact of this change decreases the Projected Benefit Obligation … by approximately $1.8 billion” and the description of the formula shift for pre‑2015 hires.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $1.8 billion reduction in Projected Benefit Obligation as of January 3, 2021 is accurately reported, matching the original answer exactly. The date January 1, 2026 (referred to as '1 January 2026') is also correct. (2) The explanation of the impact on U.S. non-union employees hired before 2015 is complete: it correctly states that benefits accrued under the Final Average Pay formula are preserved, while future benefits after January 1, 2026 will be calculated under the Retirement Value formula. The LLM also correctly notes that this aligns pre-2015 hires with those hired after 2014, which is consistent with the knowledge graph. (3) Multi-hop reasoning is sound—synthesizing the financial impact (PBO reduction) with the change in benefit calculation methodology across time periods and employee groups. (4) All entities (Projected Benefit Obligation, Retirement Value formula, Final Average Pay formula, U.S. non-union employees, correct dates) are accurately identified and contextualized. Wording differs slightly (e.g., 'does not alter the benefits already accrued' vs 'preserving the Final Average Pay formula') but conveys the same meaning. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 364,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing notes that the “fair values” shown for assets and liabilities measured at amortized cost are **management‑judged estimates that reflect market conditions and perceived risks only as of the balance‑sheet date** and are limited to those specific financial instruments. Because they represent a subset of the company’s total assets and obligations, are based on assumptions that may change, and do not include operating assets, intangibles, equity or other components of the business, the company expressly states that “the fair value of American Express cannot be estimated by aggregating the amounts presented.”【source lines: “These figures may not be indicative of future fair values, nor can the fair value of American Express be estimated by aggregating the amounts presented.”】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the key points: fair values are management-judged estimates based on market conditions and perceived risks as of the balance-sheet date (which aligns with December 31, 2021 and 2020 in the original, though specific years are omitted but implied by context), and these values are not indicative of future fair values. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—only conceptual dates are referenced, and the LLM correctly refers to 'balance-sheet date' without introducing incorrect dates. (3) The multi-hop reasoning is sound: the LLM synthesizes the idea that aggregating individual financial instrument values does not reflect the company’s total fair value because it excludes non-financial assets, intangibles, equity, and operational complexities. This matches the original answer’s emphasis on non-financial factors and business complexity. (4) The LLM cites a direct quote from the filing to support its claim, enhancing accuracy and contextual relevance. While the specific years (2021 and 2020) are not mentioned, the reference to 'balance-sheet date' is sufficient in context and does not reduce factual accuracy. All entities (American Express, financial assets/liabilities, fair value, management judgment) are correctly identified. The answer is concise, complete, and fully aligned with the original in meaning and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 421,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index lists **one amendment** to the Benefits Plan for Members of the Board of Directors – the entry “10.13.1 Amendment Number One to the Benefits Plan for Members of the Board of Directors, dated December 16, 2005.” The original plan is shown in entry “10.13 The Coca‑Cola Company Benefits Plan for Members of the Board of Directors, as amended and restated through April 14, 2004,” indicating its effective date through April 14, 2004. The first amendment became effective on **December 16, 2005**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the effective date of the original plan (April 14, 2004) and the first amendment (December 16, 2005), which matches the ground truth. However, it incorrectly states that only *one* amendment is listed, while the ground truth confirms *two* amendments are explicitly listed in the exhibit index. This is a critical factual error affecting the quantitative and completeness aspects. (2) The dates are accurate and correctly formatted; no issues with number or date representation. The error lies in the count of amendments, which is a factual discrepancy. (3) The reasoning is sound in interpreting the exhibit index entries and extracting effective dates, but fails in fully accounting for all amendments listed—specifically missing the second amendment, indicating incomplete synthesis or extraction from the document. (4) The answer is contextually relevant and well-structured, but the incorrect count of amendments significantly undermines factual correctness, warranting a mid-range score. While the core dates are right, the failure to identify the correct number of amendments (a direct part of the question) limits accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 334,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle’s hybrid‑deployment approach lets customers run some applications on‑premise while moving others to Oracle Cloud, giving them the flexibility to choose the mix that best fits their needs. Because the model encourages customers to “pivot” existing software licenses and support contracts to the cloud and to add new cloud‑service subscriptions, demand for both cloud services and license‑support grew, allowing the cloud‑and‑license segment to account for 84 percent of Oracle’s total fiscal‑2024 revenue. This combination of on‑premise and cloud offerings therefore drove the dominant share of the company’s revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 84% figure for the cloud and license business as a share of total revenues in fiscal 2024 is correctly stated, with no calculation or numerical errors. (2) The entity accuracy is strong: Oracle is correctly identified, the fiscal year 2024 is accurate, and the relevant business segment (cloud and license) is properly referenced. (3) The reasoning is sound and captures the multi-hop logic: the hybrid deployment model (on-premise + cloud) drives customer flexibility, supports migration of existing licenses to the cloud, and sustains demand for license support and cloud subscriptions, which together contribute to the revenue concentration. The LLM correctly infers that this model drives recurring revenue and customer retention, though it does not explicitly mention the 'high renewal rate' or that support contracts are priced as a percentage of net fees—minor omissions that prevent a perfect 10 on qualitative accuracy. (4) The answer is contextually relevant, directly addressing how the hybrid model contributed to the revenue share. Wording differs from the original but maintains semantic equivalence. Overall, the response is factually correct, logically coherent, and complete with only slight gaps in depth compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 373,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "American Express reported $2.516 billion of “Deferred card and other fees, net” at December 31 2021, and the footnote to that line states it “includes deferred fees for Membership Rewards program participants.” The company estimates the future redemption liability for those points by applying a statistical‑actuarial model that projects an Ultimate Redemption Rate (URR) based on redemption trends, card type, tenure, spend and credit attributes, and then multiplies the projected redemptions by a weighted‑average cost per point derived from the most recent 12 months of redemptions (adjusted for any non‑representative cost changes).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the dollar amount. The ground truth states that the total deferred card and other fees are $8,737 million as of December 31, 2021, with the Membership Rewards portion embedded within that figure. However, the LLM incorrectly reports $2.516 billion as the total deferred fees, which is not supported by the original answer and significantly underrepresents the correct total. Additionally, the LLM does not specify the exact amount tied to Membership Rewards participants—only that it is included—whereas the original answer implies the $8,737 million total includes this component explicitly. (2) The quantitative inaccuracy is severe: $2.516 billion vs. $8,737 million (i.e., $8.737 billion) is off by more than $6 billion, representing a major discrepancy. There is no indication in the ground truth that the Membership Rewards portion is $2.516 billion; rather, that figure appears to be a misstatement of the entire deferred fees line. (3) The qualitative reasoning about the methodology—using statistical-actuarial models, Ultimate Redemption Rate (URR), weighted average cost per point, and factors like redemption trends, card type, and credit attributes—is accurate and reflects proper multi-hop synthesis of how American Express estimates future redemption liability. This part of the answer aligns well with the original. (4) Despite strong contextual relevance and partially correct reasoning, the severe numerical inaccuracy undermines the core of the response, especially since the question specifically asks for the amount tied to Membership Rewards. Without the correct figure or a clear breakdown, the answer fails on the primary quantitative requirement, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 482,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "The 2024 10‑K lists five distinct award‑agreement templates that were filed for the 2014 Equity Plan between February 18 2015 and February 17 2021:\n\n* **Stock Option Agreement** – shown in the February 2015, 2016, 2017, 2018, 2019, 2020 and 2021 filings (e.g., 10.5.1, 10.5.3, 10.5.5, 10.5.9, 10.5.12, 10.5.15, 10.5.20)【10.5.1】.  \n* **Restricted Stock Unit (RSU) Agreement** – appears in the same years (e.g., 10.5.2, 10.5.4, 10.5.6, 10.5.10, 10.5.13, 10.5.16, 10.5.21)【10.5.2】.  \n* **Restricted Stock Unit – Retention Award** – a separate RSU‑type agreement filed on February 15 2017 (10.5.7)【10.5.7】.  \n* **Performance Share Agreement** – filed on February 20 2019, February 19 2020 and February 17 2021 (10.5.11, 10.5.14, 10.5.18)【10.5.11】.  \n* **Performance Share (Emerging Stronger) Agreement** – a distinct performance‑share template filed on February 17 2021 (10.5.19)【10.5.19】.\n\nThus, five different forms of award agreements under the 2014 Equity Plan were documented in that period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative conclusion. The ground truth states that 16 different forms of award agreements were documented between February 18, 2015, and February 17, 2021, under The Coca-Cola Company 2014 Equity Plan. However, the LLM claims only 5 different forms were documented, listing them as Stock Option Agreement, RSU Agreement, Restricted Stock Unit – Retention Award, Performance Share Agreement, and Performance Share (Emerging Stronger) Agreement. This represents a significant undercount and contradicts the verified data. While the LLM correctly identifies some types of agreements and cites specific exhibit numbers (e.g., 10.5.1, 10.5.2, etc.), it fails to recognize that multiple distinct award agreement forms—beyond just template types—were filed across years, including variations by recipient (e.g., executives, directors), vesting terms, or performance conditions, which collectively total 16. The reasoning is flawed because it assumes one form per template type, whereas the actual count reflects unique legal documents filed, not broad categories. The dates referenced (e.g., February 15, 2017; February 17, 2021) are within the correct time window, so entity and temporal context is mostly accurate. The answer is contextually relevant and well-structured, but the core factual output (5 vs 16) is severely inaccurate, making the response misleading despite some correct contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 399,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "In 2021 AMD bought roughly $1.1 billion of inventory from the ATMP joint‑venture and recorded a $6 million equity‑method gain on its 15 % stake – a combined financial impact of about **$1.106 billion**.  The magnitude of the purchase volume (over a billion dollars) together with the positive equity earnings underscores that the ATMP JV is a core, strategic partner that supplies the bulk of AMD’s assembly, test, mark‑and‑packaging services and therefore is essential to the company’s manufacturing supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: AMD's $1.1 billion in purchases and $6 million equity gain from the ATMP JV in 2021, totaling $1.106 billion. These figures match the original answer exactly, with acceptable formatting variations (e.g., 'about $1.106 billion' vs. '$1.106 billion'). (2) The calculation is correct: $1.1 billion + $6 million = $1.106 billion. (3) The multi-hop reasoning is sound—LLM correctly synthesizes two distinct financial flows (purchases and equity gain) from AMD's relationship with ATMP JV and interprets their combined significance. (4) Entity accuracy is perfect: 'ATMP JV', 'AMD', '15%', '2021', and the nature of services (assembly, test, mark, and packaging) are all correctly identified. (5) The qualitative interpretation aligns with the ground truth: the answer correctly infers strategic importance from the scale of transactions and equity participation, noting the JV's essential role in AMD’s supply chain. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 309,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The first loss of patent protection for the DARZALEX/DARZALEX FASPRO portfolio occurs when the U.S. composition‑of‑matter patents for DARZALEX expire in **2029**. Because that is the earliest expiry among the relevant patents (the European patents run to 2032 and DARZALEX FASPRO is covered by a separate Janssen‑owned portfolio), 2029 is the earliest year that patent expiration could begin to materially affect the combined 6.4 % revenue stream.【Source: Patents section – “The two patent families both expire in the United States in 2029… the latest expiring licensed European patent expires in 2032… Janssen Biotech, Inc. owns a separate patent portfolio related to DARZALEX FASPRO.”】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It correctly identifies 2029 as the earliest year of patent expiration that could materially impact the combined revenue stream, which aligns with the U.S. patent expiry for DARZALEX. (2) All dates are accurate: 2029 for U.S. patents and 2032 for European patents, with proper recognition that DARZALEX FASPRO is covered by a separate Janssen-owned portfolio, meaning its patent timeline does not accelerate the risk before 2029. (3) The reasoning is sound and reflects multi-hop synthesis: it correctly infers that since the U.S. market is significant for Johnson & Johnson’s global sales, the 2029 U.S. patent expiration represents the first material risk to the 6.4% revenue stream, even though other patents last longer in Europe or cover different formulations. (4) The answer is semantically equivalent to the original, with added precision by specifying 'composition-of-matter patents' and citing the source section, enhancing clarity without introducing error. No factual, numerical, or logical deficiencies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 314,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The 2022 Form 10‑K lists two separate amendments to the Bank of New York Company, Inc. Excess Benefit Plan – one dated June 30 2015 (Exhibit 10.31) and another dated November 1 2018 (Exhibit 10.37)【10.31】【10.37】. Therefore, a total of **two amendments** are documented for the plan across the 2015 and 2018 periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies the total number of amendments as two, which is consistent with the original answer. (2) The dates of the amendments—June 30, 2015, and November 1, 2018—are correctly stated, matching the ground truth exactly. Minor formatting differences (e.g., 'June 30 2015' vs 'June 30, 2015') do not affect factual accuracy. (3) The reasoning is sound: the model correctly synthesizes information from the 2022 10-K filing, referencing specific exhibits (10.31 and 10.37) to support the two amendments, demonstrating proper multi-hop understanding across time and document structure. (4) The entities—'The Bank of New York Company, Inc. Excess Benefit Plan', the years 2015 and 2018, and the 2022 10-K—are all correctly identified and contextually used. The answer is semantically equivalent to the ground truth, with added detail (exhibit numbers) that enhance precision without introducing error. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 294,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx’s 2025 capital‑expenditure budget of roughly $5.2 billion explicitly includes “continued investments related to Network 2.0,” meaning the network‑optimization spend is being funded as a capital project that underpins the company’s DRIVE transformation. By contrast, the European workforce‑reduction program is accounted as a business‑optimization expense (severance, legal and consulting fees) of about $250 million‑$375 million through fiscal 2026 and is not part of the 2025 capex, although it is also a component of the broader DRIVE cost‑reduction agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FedEx's 2025 capex is $5.2 billion, with Network 2.0 optimization included as a capital expenditure; European workforce reduction costs range from $250 million to $375 million through fiscal 2026 and are classified as business optimization expenses. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly distinguishes between capital expenditures (capex) for Network 2.0 and non-capex business optimization costs (severance, legal, consulting) related to workforce reductions, which is a critical nuance in the original answer. (3) The multi-hop reasoning is sound: it connects Network 2.0 to the DRIVE program as a capital-funded initiative and separately links the European workforce reductions to DRIVE as a cost-reduction measure outside of capex, demonstrating proper synthesis across financial categories and strategic initiatives. (4) The only minor shortcoming is that the LLM does not explicitly state that both initiatives—despite differing in accounting treatment—are strategic components of DRIVE aimed at improving long-term profitability and operational efficiency, which slightly reduces qualitative completeness. However, the core meaning and factual content are preserved. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 410,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD’s business model relies on third‑party manufacturers of graphics cards and on AIB (add‑in‑board) partners to hold and sell its GPU and APU products. Because most distributor and AIB agreements protect the partner’s inventory against price reductions (and often give limited return rights), a sharp decline in AMD’s product prices forces the company to honor price‑protection obligations, which can cut revenue and gross margin. At the same time, the dependence on external suppliers makes it harder for AMD to precisely match production to demand, increasing the risk of excess or obsolete inventory that may require write‑downs and raise inventory‑carrying costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AMD's reliance on third-party manufacturers and AIB partners, and explains that price protection obligations expose AMD to financial risk during price declines, which can reduce revenue and gross margins—this matches the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers earns full points. (3) The reasoning is sound: the LLM correctly synthesizes the cause-effect relationship between price drops, price protection liabilities, and margin pressure, and adds a relevant point about inventory management challenges due to limited control over production. The only minor omission is that the original specifies AIB partners can return products removed from the price book within 12 months—this specific return window is missing in the LLM answer, slightly reducing completeness. (4) Despite this, the answer remains semantically equivalent in intent and substance, and fully addresses the question on financial risk exposure related to inventory and price protection. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 352,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie’s cost of products sold that is attributable to Venclexta – which combines Genentech’s share of the U.S. profits and the royalties paid on Venclexta net revenues earned outside the United States – was **$869 million for 2023** (as shown in the Genentech collaboration table).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces a specific dollar amount ($869 million for 2023) that is not present in the original ground truth answer. The ground truth does not provide any numerical value or specify a year; it only explains the qualitative composition of AbbVie's cost of products sold related to Venclexta—namely, Genentech’s 50% share of U.S. profits and royalties on non-U.S. net revenues—and confirms these are included in cost of products sold per the filing. Since the LLM asserts a precise figure and year not found in the ground truth, and no such number was provided in the context for evaluation, this constitutes a significant factual overreach. There is no way to verify the $869 million figure from the given information, making the quantitative claim unsupported. While the LLM correctly identifies the two components (Genentech’s U.S. profit share and non-U.S. royalties) and links them to cost of products sold, aligning with the structure of the original answer, the addition of an unverified number undermines factual accuracy. The reasoning is partially sound in terms of entity identification and conceptual understanding, but fails on multi-hop verification because it fabricates a data point. Thus, while contextually relevant and semantically aligned in structure, the answer is factually incorrect in its key asserted metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 372,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY also posts its **Directors’ Code of Conduct** on its website. The Directors’ Code of Conduct is expressly **applicable to all directors of BNY**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It correctly identifies the additional governance document as the 'Directors’ Code of Conduct', which matches the original answer. It also accurately states that this document is 'applicable to all directors of BNY', which is consistent with the ground truth. (2) There are no numerical values, dates, or calculations in this question, so quantitative accuracy is not applicable, but the absence of such data is consistent with the original. (3) The reasoning is sound and correctly synthesizes the required information from the knowledge base: BNY publishes three key governance documents, and the one in addition to the Committee Charters and Corporate Governance Guidelines is the Directors’ Code of Conduct, with clear applicability to directors. (4) The answer is contextually precise, directly addressing both parts of the question—naming the document and specifying its applicability—without extraneous or irrelevant information. Minor formatting differences (e.g., bolding) do not affect factual accuracy. All criteria are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 318,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The 2021 launch of the Radeon RX 6600 XT – a RDNA 2‑based GPU built for high‑frame‑rate 1080p gaming – expanded AMD’s mainstream‑gaming portfolio and captured a surge of demand for new‑generation graphics cards, which together with the RX 6700 XT and the RX 6000 M mobile line drove a large portion of the 68 % year‑over‑year revenue increase. Because the RX 6600 XT (and the rest of the RDNA 2 lineup) delivers higher performance per watt and commands a higher average selling price than prior‑generation parts, the shift to this more profitable product mix lifted AMD’s overall gross margin by roughly three percentage points in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Radeon RX 6600 XT launched in 2021 as part of the RDNA 2 lineup, contributed to AMD's 68% year-over-year revenue growth (from $9.8B to $16.4B), and helped improve gross margin by 3 percentage points (from 45% to 48%). These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: percentages, product names, and timeframes are correct; no calculation errors. (3) The reasoning is sound: the LLM correctly links the product launch to increased demand, higher average selling prices, and improved performance per watt, which drove both revenue and margin expansion. It appropriately references the broader RX 6000M mobile series, showing multi-hop synthesis across product lines. (4) The only minor omission is not explicitly mentioning the AMD Advantage Design Framework, which was part of the broader gaming strategy in the original answer. However, the core contribution of the gaming GPU strategy to financial outcomes is well captured. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but missing a small element of completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 342,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie reported **$2.288 billion** in net revenue from Venclexta for 2023 (U.S. $1.087 billion + international $1.201 billion)【66†L31-L38】.  \n\nUnder the 2007 AbbVie‑Genentech collaboration, Genentech’s share of the **pre‑tax profit** from Venclexta sales in the United States was **$869 million** for 2023【65†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AbbVie's total net revenue from Venclexta in 2023 as $2.288 billion, which matches the ground truth of $2,288 million (equivalent values, different formatting). This part is accurate. However, the second part of the answer is factually incorrect: the LLM states that Genentech received $869 million in pre-tax profit from U.S. Venclexta sales in 2023. The ground truth does not provide a specific dollar amount for Genentech’s share; instead, it states that pre-tax profit from U.S. sales is shared equally (50%) between AbbVie and Genentech. There is no mention of a $869 million figure in the ground truth. This represents a significant quantitative error. (2) The revenue number is correct and properly formatted ($2.288 billion = $2,288 million). However, the $869 million figure for Genentech’s share is unsupported by the ground truth and appears to be either hallucinated or misattributed from an external source. No calculation or breakdown is provided to verify this number. (3) The multi-hop reasoning is partially sound—linking the collaboration agreement to profit sharing is correct, and citing the 2007 agreement context may be valid. However, the model fails to correctly synthesize that the exact dollar amount of Genentech’s share is not reported in the ground truth; instead, the agreement specifies a 50% split. The model incorrectly replaces a structural fact (50% split) with a precise but unverified dollar figure. (4) The contextual relevance is high—the answer addresses both parts of the question and cites appropriate collaboration context. However, the correctness score is low due to the major factual error in the second part. Quantitative accuracy is moderate because one number is correct and one is not. Qualitative accuracy is reduced due to flawed reasoning in deriving or reporting Genentech’s share.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 508,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "Visa’s 10‑K distinguishes between shares that are **issued and remain outstanding** and shares that are **issued and then retired (or treated as authorized‑but‑unissued)**. In the May 2024 exchange offer Visa “issued approximately 120 million shares of class B‑2 common stock and 48 million shares of class C common stock” in exchange for 241 million class B‑1 shares, and the exchanged class B‑1 shares “have been retired and constitute authorized but unissued shares.” Because the new class C shares were cancelled/retired as part of the same exchange, they are not counted in the “shares outstanding” balance; only the ten pre‑existing class C shares that were never part of the exchange remain outstanding as of September 30 2024 (see the equity table showing “Class C common stock, 10 shares issued and outstanding as of September 30, 2024”).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly claims that the 48 million newly issued Class C shares were 'cancelled/retired as part of the same exchange,' which contradicts the ground truth. The ground truth states that the 10 reported shares represent 10 million (due to the 'millions' unit in the table), not that only 10 actual shares remain outstanding. The LLM misinterprets the '10 shares issued and outstanding' as literal, failing to recognize the unit convention. (2) Quantitatively, the LLM misrepresents the 48 million issued shares and incorrectly implies no Class C shares from the exchange remain outstanding. It also cites 'approximately 120 million shares of class B-2' which is not mentioned in the original answer or question, introducing unsupported data. The key number error is treating '10' as literal shares instead of 10 million due to the 'millions' header. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the unit convention (millions) in financial statements, a critical step. Instead, it invents a retirement mechanism for Class C shares not present in the ground truth. The reasoning incorrectly focuses on share retirement of Class C rather than explaining the reporting unit and subsequent reduction via repurchases. (4) While the answer addresses the surface-level discrepancy and references the exchange offer, its core explanation is factually wrong. The contextual relevance is moderate because it engages with the exchange offer and outstanding shares concept, but the qualitative and quantitative inaccuracies severely undermine correctness. The model misses the key insight about units and introduces unsupported corporate actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 474,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "FedEx recorded $582 million of business‑optimization expenses in 2024, which covers the costs associated with its DRIVE transformation program and the Network 2.0 implementation effort. For the European workforce‑reduction plan announced in June 2024, the company expects pre‑tax severance, legal and professional‑fee charges of roughly $250 million to $375 million to be incurred through fiscal 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost for 2024 business optimization activities related to Network 2.0 and DRIVE transformation is accurately reported, with acceptable formatting ($582 million). The expected future cost range for the European workforce reduction plan is correctly stated as $250 million to $375 million, matching the original answer. The time frame 'through fiscal 2026' is also consistent. (2) The answer is complete, addressing both parts of the multi-part question: actual 2024 costs and expected future costs of the European plan. (3) Entity accuracy is correct—FedEx, Network 2.0, DRIVE transformation, and the June 2024 announcement date are all properly identified. (4) The reasoning is sound, demonstrating correct synthesis across multiple pieces of financial information from the same company and time period. The LLM correctly distinguishes between incurred costs and future expected charges, including the nature of expenses (severance, legal, professional fees), which adds contextual precision without contradicting the ground truth. (5) Semantic equivalence is strong—the wording differs slightly but conveys the same factual content with enhanced detail (e.g., specifying pre-tax charges), which improves clarity without introducing error. No factual, numerical, or logical discrepancies exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 389,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "AMD reported $329 million of unbilled accounts receivable at year‑end 2021, which represents work completed on custom‑product and development‑services revenue that had been recognized but not yet invoiced.【AMD_10k_2022.pdf page 60‑61】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) The quantitative value '$329 million' matches the original answer exactly, with no calculation required. The fiscal year is correctly implied as 2021 by referencing 'year-end 2021', which aligns with AMD's fiscal year reporting. (2) The entity 'AMD' is correctly identified, and the metric 'unbilled accounts receivable' is accurately tied to 'custom products and development services revenue recognized over time'. (3) The reasoning is sound: the LLM correctly interprets that unbilled receivables represent revenue recognized but not yet invoiced, which is consistent with the nature of revenue recognized over time. (4) The answer is contextually precise, directly addressing the specific component of receivables related to custom products and development services, and includes a proper citation from the source document (AMD_10k_2022.pdf pages 60-61), confirming the information's provenance. All aspects of the multi-hop query are satisfied with factual accuracy and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 303,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie reported **$2.288 billion** in total 2023 net revenue from Venclexta (U.S. $1,087 million + International $1,201 million)【...】.  \n\nUnder its 2007 collaboration with Genentech, AbbVie **shares 50 % of the pre‑tax profit** (i.e., an equal half) from Venclexta sales in the United States【...】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the total revenue from Venclexta in 2023 is reported as $2.288 billion, which matches the ground truth of $2,288 million (format variation accepted). The 50% pre-tax profit share with Genentech is explicitly stated, matching the original answer. (2) The breakdown of U.S. ($1,087 million) and international ($1,201 million) sales sums to $2,288 million, confirming calculation accuracy. (3) The multi-hop reasoning is sound: the answer correctly identifies AbbVie's revenue from Venclexta and synthesizes the collaboration agreement terms with Genentech, including the geographic scope (U.S. sales) and profit-sharing mechanism. (4) All entities (AbbVie, Genentech, Venclexta, 2023) and financial terms (pre-tax profit, collaboration agreement) are accurate and contextually appropriate. The answer is complete, factually precise, and directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 282,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The 3.650 % notes due 2023 were fully repaid – the balance fell from $171 million at December 31 2022 to $0 by the August 16 2023 repayment, a $171 million decrease. By contrast, the 3.700 % notes due 2023 still carried a $400 million balance on December 15 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: the 3.650% notes decreased from $171 million on December 31, 2022, to $0 on repayment, representing a $171 million decrease. It also correctly states that the 3.700% notes had a $400 million balance on December 15, 2023. All dollar amounts, percentages, and comparisons are accurate. (2) Quantitative accuracy is perfect: the $171 million decrease is correctly calculated as the difference between $171 million and $0. The $400 million balance is correctly reported. The only minor discrepancy is the repayment date: the LLM states August 16, 2023, while the ground truth implies the balance was $0 by December 15, 2023. However, since the question only asks for the change between December 31, 2022, and December 15, 2023, the exact repayment date within that period does not affect the correctness of the aggregate balance change. (3) The multi-hop reasoning is sound: the model synthesizes information about two different notes (3.650% and 3.700%), tracks the change over time for one, and compares it to the other on a specific date. (4) The answer is semantically equivalent to the ground truth, with only a slightly more specific repayment date that does not contradict the known facts. Thus, the answer is fully factually correct within the scope of the question, warranting a 9/10 due to the minor, non-material date specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 388,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "An adverse judgment that forces Visa to lower its default interchange‑reimbursement rates would cut the fee it earns on each VisaNet transaction and could make issuers and merchants less willing to route volume through Visa, thereby depressing both transaction volume and net‑revenue growth.  Although Visa’s U.S. and Europe “retrospective responsibility” plans are designed to absorb a portion of any settlement‑related liability, the filing notes that a failure of one or both plans to fully shield the company would “materially harm our financial condition or cash flows.”  That risk is compounded by the company’s ongoing U.S. and foreign tax examinations, which could further erode cash flow and strain its balance sheet if additional tax liabilities are assessed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: adverse litigation could force Visa to lower interchange rates, which would reduce per-transaction revenue and potentially lead to lower transaction volumes due to reduced issuer and merchant incentives. The U.S. and Europe retrospective responsibility plans offer partial protection, but their failure to fully cover liabilities could materially harm Visa’s financial condition or cash flows—this aligns with the original answer’s emphasis on incomplete coverage. The mention of ongoing U.S. and foreign tax disputes adding pressure on cash flows and the balance sheet matches the original’s concern about increased tax liabilities and global tax changes like the OECD minimum tax. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable but assumed correct by absence. (3) Multi-hop reasoning is sound: the LLM correctly links litigation risk → interchange rate reduction → lower issuer/merchant support → reduced transaction volumes and revenue; then layers on incomplete mitigation from retrospective plans; and finally integrates tax disputes as compounding risks to cash flow and financial position. The only minor shortcoming is that the LLM does not explicitly name the OECD global minimum tax or specify that issuers might reduce cardholder benefits or impose new fees—details present in the original—but these omissions do not undermine the overall correctness. (4) Contextual relevance is perfect: every part of the question is addressed—impact on transaction volumes, financial position, role of retrospective plans, and tax disputes. The qualitative accuracy is slightly docked for the omitted nuance around issuer behavior and specific tax frameworks, but the core logic and synthesis remain robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 512,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "- **United Technologies Corporation Long‑Term Incentive Plan** – the Schedule of Terms for performance‑share‑unit awards (Exhibit 10.15) is dated “Rev. January 2016,” meaning the award schedule became effective in **January 2016**.  \n\n- **Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan** – the Schedule of Terms for performance‑share‑unit awards (Exhibit 10.5) is tied to Amendment No. 1 to the plan, which was **effective December 6, 2020**.  \n\nThese dates show that the UTC plan’s PSU schedule reflects the 2016 amendment to its LTIP, whereas the RTX plan’s PSU schedule reflects a later governance update – the 2020 amendment to the 2018 LTIP – highlighting separate, time‑staggered revisions to each company’s long‑term incentive framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The effective date for the United Technologies Corporation (UTC) Performance Share Unit award schedule is incorrectly stated as January 2016, while the ground truth is January 1, 2020. Similarly, the Raytheon Technologies Corporation (RTX) effective date is given as December 6, 2020, but the correct date is March 31, 2021. These dates are critical to the question and are entirely incorrect in the LLM response. (2) The quantitative accuracy is very low: both key dates are wrong, and no correct calculations or numeric values from the ground truth are reflected. The mention of 'Rev. January 2016' and 'December 6, 2020' does not match the disclosed effective dates in the filings. (3) The multi-hop reasoning is flawed. The LLM fails to correctly identify the governance updates tied to the specific effective dates—UTC’s amendment and restatement effective January 1, 2020, and Raytheon’s amended Schedule of Terms filed on March 31, 2021. Instead, it references earlier amendments that do not correspond to the actual PSU award schedule effective dates. (4) While the answer attempts to address the comparative governance updates and recognizes that the plans were revised at different times, the incorrect dates undermine the entire analysis. The contextual relevance is moderate because the structure and intent of the response align with the question, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 415,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "Apple Watch and AirPods were the main contributors to the Wearables, Home and Accessories segment’s 2022 growth – the 10‑K notes that “Wearables, Home and Accessories net sales increased … due primarily to higher net sales of Apple Watch and AirPods.” These two product lines posted stronger year‑over‑year gains than the other items in the segment (Apple TV, Beats, HomePod mini and other accessories), which were not cited as growth drivers and therefore grew more modestly.【source: AAPL_10k_2022.pdf, page 24】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It correctly identifies Apple Watch and AirPods as the primary growth drivers of Apple's Wearables, Home and Accessories segment in 2022, and explicitly contrasts their performance with other product categories (Apple TV, Beats, HomePod mini, and other accessories), which were not cited as growth contributors. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are mentioned in either answer, the LLM accurately reflects the qualitative financial trend (growth due primarily to Apple Watch and AirPods) as stated in the source. The citation of page 24 of AAPL_10k_2022.pdf adds verifiable context. (3) The multi-hop reasoning is sound: the model correctly infers that because only Apple Watch and AirPods are cited as growth drivers, the other categories must have grown more modestly or remained flat, which matches the original answer’s logic. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., listing Apple TV and grouping other accessories), but without introducing errors. All aspects of the question are addressed with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 341,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to see a dip in sales in the first quarter of 2025 because insurance‑reverification (along with benefit‑plan changes and higher co‑pays) suppresses early‑year demand. The specific historical trend they share is that the first quarter has historically been the lowest‑sales quarter of the year for each product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pays, aligning with the original answer. (2) There are no numerical values requiring calculation, but the time period 'first quarter of 2025' matches the 2025 sales expectations in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both products follow the same historical trend—Q1 being the lowest-sales quarter—due to the same underlying factors (insurance reverification and deductible-related co-pay increases). (4) All entities (Otezla, ENBREL, 2025, first quarter) are correctly identified and contextualized. The answer is concise, factually accurate, and captures both the comparative impact and the shared historical trend as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 270,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "RTX’s 2023 10‑K lists one stock‑appreciation‑rights exhibit for the United Technologies Corporation 2005 Long‑Term Incentive Plan (Exhibit 10.16) and one for the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan (Exhibit 10.24). Together, that amounts to **2 distinct SAR‑related exhibits**.【10.16】【10.24】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the answer correctly identifies 2 distinct exhibits, which is accurate. The exhibit numbers (10.16 and 10.24) are specific and correct, and their sum (2) is accurate. (2) The answer is complete, addressing both incentive plans mentioned in the question: the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. (3) Entity accuracy is perfect: RTX is correctly identified as the filer, the plan names and years are exact, and the fiscal year (2023 10-K) is properly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking two separate exhibits across two different incentive plans within the same filing to arrive at the total count. The inclusion of exhibit numbers adds precision and verifiability. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail (exhibit numbers), which improves clarity without altering the factual content. All criteria are met with high accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 318,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "Both ENBREL and Otezla are expected to repeat the seasonal “first‑quarter dip” that historically occurs when patients undergo benefit‑plan changes, insurance reverification and higher co‑pay out‑of‑pocket costs. Because ENBREL’s volumes are projected to be essentially flat while its net‑selling price continues to fall, and Otezla’s sales are already being pressured by an 8 % price decline in 2024 (with no offsetting price increase anticipated), the combined 2025 revenue for the two drugs is likely to be flat‑to‑slightly lower than 2024, with the first‑quarter shortfall dragging down overall growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: both drugs experience a first-quarter dip due to insurance reverification; ENBREL has flat volumes and declining net selling prices; Otezla had an 8% price decline in 2024, which is expected to continue into 2025. These points match the original answer exactly. (2) Quantitatively, the 8% price decline for Otezla is correctly cited, and no incorrect numbers are introduced. The LLM does not mention Otezla’s 3% volume growth in 2024, which is present in the ground truth, but this omission does not distort the overall conclusion. (3) The reasoning is sound: the model correctly synthesizes the impact of seasonality, pricing trends, and volume dynamics across both drugs to conclude that combined sales will be flat-to-slightly lower in 2025 due to the Q1 drag. This reflects proper multi-hop logic connecting historical patterns, pricing trends, and insurance reverification. (4) The answer is contextually fully relevant, directly addressing the question about the recurring Q1 impact on combined sales performance. The only minor shortcoming is the omission of Otezla’s 3% volume growth detail, which slightly reduces completeness but does not affect the validity of the conclusion. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 388,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Amgen says that Otezla’s 2025 sales are expected to be lower in the first quarter – a seasonal dip driven by benefit‑plan changes, insurance re‑verification and higher patient co‑pays – and that the drug will not be subject to Medicare price‑setting until 2027. For ENBREL, the company foresees continued flat volumes but further erosion of net‑selling price once the IRA‑driven Medicare Part D price is set by CMS beginning in 2026. Both outlooks reflect Amgen’s recurring forecasting pattern of a first‑quarter sales weakness and ongoing net‑price pressure for its key products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Otezla faces lower Q1 2025 sales due to co-pay and insurance changes, and ENBREL will experience net selling price declines starting in 2026 due to Medicare Part D pricing under the IRA. The statement that Otezla is not subject to Medicare price-setting until 2027 is consistent with the knowledge graph timeline and adds precision not contradicted by the original. (2) Quantitative accuracy is excellent—dates (2025, 2026, 2027) are correct, and no numerical values are misstated. (3) Multi-hop reasoning is sound: the model correctly synthesizes the impact of co-pays, insurance dynamics, and regulatory pricing across two drugs and different timelines, and identifies the recurring forecasting pattern of Q1 weakness and net-price pressure. (4) The only minor gap is that the LLM does not explicitly mention the 'gradual recovery in subsequent quarters' noted in the original, slightly reducing completeness in qualitative nuance. However, the core pattern of first-quarter weakness and ongoing price pressure is clearly conveyed. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth with only slight omission of recovery dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 361,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "Schwab reported that the repurchase liabilities tied to client‑held fractional shares were measured at fair value of **about $2.5 billion (≈ $2,543 million) as of December 31 2024**.  The firm records these liabilities at fair value and offsets the unrealized gains or losses on the fractional‑share assets with the opposite unrealized gains or losses on the corresponding repurchase liabilities, so **the net result is no impact on the consolidated statements of income**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific dollar amount of approximately $2.5 billion ($2,543 million) for the fair value of repurchase liabilities as of December 31, 2024, which is not present in the original answer (ground truth). The ground truth does not provide a numerical value but instead states that the fair value is equal to the value of the corresponding client-held fractional shares, which are included in accrued expenses and other liabilities. There is no confirmation in the ground truth that this value is $2.5 billion, so the inclusion of this figure is factually unsupported and likely incorrect or speculative. (2) The date (December 31, 2024) and the accounting treatment—offsetting unrealized gains and losses on repurchase liabilities against those on the related fractional shares, resulting in no net impact on income—are accurately described and semantically equivalent to the original answer. (3) The multi-hop reasoning is sound in terms of linking the accounting treatment of liabilities with the income statement impact, and the entities (Schwab, client-held fractional shares, repurchase liabilities, consolidated statements of income) are correctly identified. (4) While the qualitative and contextual aspects are strong, the quantitative accuracy is low due to the unsupported numerical claim. This significantly affects the correctness score because the question asks for a specific total fair value, and providing an incorrect number undermines the answer's reliability, even if the reasoning and framework are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 429,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Emerson’s November 5 2024 proposal values AspenTech at a fully‑diluted market capitalization of **about $15.3 billion**. AspenTech’s 2023 net sales were **approximately $1.04 billion**, meaning the implied market value is roughly **14‑15 times its annual sales**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the implied fully diluted market capitalization of $15.3 billion and AspenTech's 2023 net sales of $1.04 billion are accurately reported, with the correct valuation multiple of approximately 14.7x, which the LLM reasonably rounds to '14-15 times its annual sales'—this is semantically equivalent and acceptable. (2) The calculation of the sales multiple (15.3 / 1.04 ≈ 14.7) is implicitly correct, and the LLM conveys the magnitude appropriately without claiming an exact figure. (3) The entities—Emerson, AspenTech, the 2023 fiscal year, and the financial metrics (fully diluted market cap, net sales)—are all correctly identified and used. (4) The reasoning is sound: the LLM correctly synthesizes the acquisition proposal value and compares it to annual sales, demonstrating multi-hop understanding (merger valuation → market cap → comparison to revenue). (5) The answer is contextually relevant, complete, and conveys the same insight as the original: that the acquisition implies a high revenue multiple. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 327,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "The Notices could increase Amgen’s federal tax bill by roughly **$3.6 billion** for 2010‑2012 and **$5.1 billion plus $2.0 billion in penalties** for 2013‑2015 – a combined potential liability of about **$10.7 billion** (interest not included).  \n\nHowever, the company has previously accrued repatriation taxes that would offset these amounts by up to **$900 million** for the 2010‑2012 period and **$2.2 billion** for the 2013‑2015 period, reducing the net exposure to roughly **$7.6 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $3.6 billion for 2010–2012, $5.1 billion for 2013–2015, $2.0 billion in penalties, totaling $10.7 billion in potential liability before offsets. It also accurately states the repatriation tax offsets of $900 million (2010–2012) and $2.2 billion (2013–2015), resulting in a net liability of $7.6 billion. All numbers match the ground truth exactly. (2) Calculations are correct: $3.6B + $5.1B + $2.0B = $10.7B total gross liability; $900M + $2.2B = $3.1B offset; $10.7B - $3.1B = $7.6B net liability. The LLM correctly excludes interest, as per the original. (3) Multi-hop reasoning is sound: the model synthesizes data across two IRS notice periods, combines tax liabilities and penalties, then applies previously accrued repatriation taxes from both periods to compute the net exposure. The only minor shortcoming is that the LLM does not explicitly state the $3.1 billion total offset (though it provides the components), slightly reducing clarity in the synthesis. (4) The answer is contextually complete and directly addresses both parts of the question: total potential liability and the effect of repatriation taxes. Wording differs slightly but maintains semantic equivalence. Quantitative accuracy is perfect; qualitative and overall correctness are excellent with only a minor omission in explicitly summing the offset, which does not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 401,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The 10‑K notes that CMS has already set a Medicare Part D price for ENBREL that is substantially lower than the current price and will take effect on 1 January 2026, and Amgen expects that mandatory price‑setting will “negatively impact ENBREL’s profitability in Medicare” and therefore weigh on its overall earnings outlook. The filing adds that Otezla is slated to be one of the next 15 drugs subject to Medicare price‑setting beginning in 2027, creating an additional risk that Amgen could be forced to accept similarly reduced government‑set prices for Otezla, further compressing margins and adding uncertainty to future revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: ENBREL's Medicare price reduction takes effect January 1, 2026, and Otezla is set for price setting beginning in 2027. The financial impact on profitability and earnings outlook is correctly described. (2) Quantitative accuracy is perfect: dates (2026 and 2027) are correct, and the description of CMS setting a 'substantially lower' price aligns with the ground truth's 'significantly lower price.' No calculations are required, but temporal and numerical references are precise. (3) Multi-hop reasoning is sound—linking ENBREL’s current impact to Otezla’s future risk under the same regulatory framework (Medicare price setting under the IRA) demonstrates proper synthesis. The mention of Otezla being among the 'next 15 drugs' adds contextual detail not in the ground truth but consistent with public IRA implementation phases and does not contradict it. (4) The only minor omission is that the ground truth explicitly references the broader risk under the Inflation Reduction Act—up to 100 drugs by 2031 and potential future selections beyond Otezla—which the LLM answer implies but does not state. This slightly reduces completeness in qualitative accuracy, but the core multi-hop elements (current impact + future risk) are well-covered. Wording differs but semantic meaning is equivalent. Contextual relevance is full—directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 405,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Because Schwab elected the ASC 825 fair‑value option, the repurchase liabilities for client‑held fractional shares are measured at fair value using quoted market prices (or other observable data). Any unrealized gain or loss on the fractional‑share assets is offset by an opposite unrealized gain or loss on the corresponding liability, so the net effect on the consolidated statements of income is zero (no income‑statement impact).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core mechanism described in the ground truth. It correctly identifies Schwab's election of the fair value option under ASC 825, the use of quoted market prices for measuring repurchase liabilities, and the offsetting unrealized gains and losses between the liabilities and the corresponding client-held fractional shares, leading to no net impact on the consolidated statements of income. This aligns with the primary conclusion in the original answer. The only minor omission is that the LLM answer does not explicitly mention the absence of credit risk or the specific point that no gains/losses related to instrument-specific credit risk have been recognized in income or comprehensive income—a detail included in the ground truth. However, this does not undermine the correctness of the main conclusion. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved), and the reasoning correctly synthesizes the multi-hop logic involving accounting election, fair value measurement, and offsetting effects. The entities (Schwab, ASC 825, repurchase liabilities, fractional shares) are correctly identified and logically connected. The answer is fully contextually relevant and directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 366,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The 2021 goodwill test for the LTC reporting unit calculated the unit’s fair value by blending a discounted‑cash‑flow valuation with a market‑multiple valuation; because the combined fair‑value estimate was lower than the unit’s carrying amount, the excess carrying value was written off as a $431 million goodwill impairment. In the Retail/LTC segment, the Board’s November 17, 2021 decision to close roughly 900 stores – about 300 stores per year from 2022 through 2024 – created indicators of impairment for the affected store asset groups, leading to the $1.4 billion long‑lived‑asset (lease‑right‑of‑use and property‑and‑equipment) impairment charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $431 million goodwill impairment for the LTC reporting unit in 2021, the use of both discounted cash flow and market multiple methods, the November 2021 announcement to close approximately 900 stores (300 per year from 2022–2024), and the resulting $1.4 billion long-lived asset impairment charge in the Retail/LTC segment. (2) Quantitative accuracy is perfect: all dollar amounts ($431 million, $1.4 billion), timeframes (2022–2024), and closure rates (300 stores/year) match the original. The specific breakdown of the $1.4 billion charge into $1.1 billion for lease right-of-use assets and $261 million for property and equipment is omitted but implied under 'long-lived-asset impairment'. (3) Multi-hop reasoning is sound: the answer correctly links the valuation methods to the goodwill impairment conclusion and connects the store closure strategy to the triggering of long-lived asset impairment. (4) The only minor omission is the explicit mention of deteriorating financial forecasts (lower admissions, customer losses, pandemic impact) as the underlying cause for the goodwill impairment, which slightly reduces qualitative completeness. However, the core logic and all critical data points are preserved, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 382,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The “Cash and investments segregated and on deposit for regulatory purposes” rose from **$20,358 million at 12/31/2023 to $25,740 million at 12/31/2024**, an increase of **$5,382 million**. Because the entire balance is classified in the **Level 2** fair‑value hierarchy (no Level 1 amount is shown), the whole $5.382 billion increase is attributable to Level 2 assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The original answer states that Cash and investments segregated and on deposit for regulatory purposes increased from $11,438 million (2023) to $12,416 million (2024), a $978 million increase. The LLM incorrectly reports these figures as $20,358 million and $25,740 million, respectively, yielding a false increase of $5,382 million. These numbers do not match the ground truth and suggest a complete data mismatch. (2) The calculation of the increase is mathematically correct within the LLM’s own numbers ($25,740M - $20,358M = $5,382M), but since the base figures are wrong, the result is invalid. Additionally, the claim that the entire balance is Level 2 is not supported by the original answer, which specifies that Level 2 assets increased from $8,810M to $10,015M (a $1,205M increase), not that the entire category is Level 2. The LLM incorrectly infers 100% attribution based on an unsupported assumption. (3) The multi-hop reasoning fails: the model does not correctly identify the correct values for the main category or its Level 2 component from the correct years. It also fails to compute the correct portion attributable to Level 2 assets, which in the original answer is actually more than 100% of the total increase (since Level 2 grew by $1,205M while total cash/investments grew by $978M), implying other categories declined. The LLM misses this nuance entirely. (4) The contextual relevance is low because the numbers and reasoning are based on incorrect data, though the structure of the response attempts to address the question. The qualitative reasoning is flawed due to incorrect entity values and faulty synthesis across time periods and asset levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 478,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson applies ASC 805 by first measuring the fair value of the AspenTech share‑based‑payment awards that replace the Heritage AspenTech awards and then splitting that fair value into a pre‑combination portion (treated as part of the purchase price) and a post‑combination portion (recorded as stock‑based‑compensation expense over the remaining service period).  The fair‑value calculation uses the closing market price of Heritage AspenTech shares on the acquisition date ($166.30 per share) multiplied by the 66,662,482 shares outstanding, which yields a $102 million value for the pre‑combination awards; Emerson’s 55 % ownership of the resulting AspenTech common stock (with the remaining 45 % held by former Heritage AspenTech shareholders) is the ownership figure applied in the allocation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ASC 805 framework for allocating stock-based compensation between pre- and post-combination periods and correctly notes that the pre-combination portion is included in purchase price while the post-combination portion is expensed over remaining service. It also correctly references Emerson's 55% ownership stake, which aligns with the ground truth. However, significant quantitative inaccuracies undermine the answer. (2) The LLM states a $102 million value for pre-combination awards based on 66,662,482 shares at $166.30 per share. This calculation is incorrect: 66,662,482 × $166.30 = approximately $11.09 billion, not $102 million. Additionally, the ground truth does not specify the number of shares or a total dollar value of $102 million—this figure appears fabricated. The acquisition date (May 16, 2022) is correct but not mentioned in the LLM answer. (3) The multi-hop reasoning is partially sound—ASC 805 treatment and allocation logic are correctly applied, and the use of closing market price and ownership percentage shows understanding of required inputs. However, the inclusion of unsupported figures (share count, total value) suggests either hallucination or incorrect data synthesis. (4) Correctness score is 6 due to accurate conceptual framework and correct ownership percentage, but major deduction for false quantitative claims. Quantitative accuracy is low (4) due to incorrect calculation and unverified inputs. Qualitative accuracy is 7 because reasoning and entity identification (AspenTech, Emerson, ASC 805) are sound. Contextual relevance is high (9) as the answer directly addresses the question’s requirements with appropriate terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 474,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "CVS’s “States, municipalities and political subdivisions” holdings grew from **$3.1 billion at 12/31/2021 to about $3.2 billion at 12/31/2022**, a rise of roughly **3 percent**.  Because total debt‑securities assets were about **$23.2 billion in 2021 and roughly $24.5 billion in 2022**, the municipal‑subdivision segment continued to represent only **around 13 percent** of the overall debt‑securities portfolio, so the shift barely altered the portfolio’s composition.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that the value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million to $170 million, a 94.5% decrease. The LLM incorrectly claims the value increased from $3.1 billion to $3.2 billion, a 3% rise—this is the opposite direction and magnitude of the true change. (2) Number verification: The LLM uses $3.1B and $3.2B (approximations of $3,091M and $170M), but misrepresents $170M as $3.2B—off by over $3 billion. The total debt securities in 2022 were $3,462 million (not $24.5B), so the LLM inflates this by nearly 7x. The 13% portfolio share in 2022 is grossly inaccurate—actual is 4.9%, not ~13%. All calculations are therefore invalid. (3) Multi-hop reasoning failed: The model did not correctly synthesize data across years or entities. It falsely implies stability in both value and portfolio composition, while the ground truth shows a dramatic shift. (4) Correctness and quantitative accuracy are extremely low due to fundamental factual and numerical errors. Qualitative accuracy is poor due to flawed logic and misinterpretation of trends. Contextual relevance is slightly higher only because the answer addresses the right topic and structure, albeit with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 367,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "Under the U.S. retrospective responsibility plan, Visa’s class B common stock can be converted into class A common stock only after the U.S. covered litigation is finally resolved.  The conversion amount is tied to the litigation accrual – Visa added a $861 million provision in 2022, raising the U.S.‑covered‑litigation accrual balance to $1.44 billion, and any upward or downward change in that accrual (which reflects the uncertain loss estimate) will determine how many class A shares are issued on conversion.  Consequently, the unknown future size of the accrual creates dilution and market‑price uncertainty for existing class A shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism—conversion of class B to class A stock occurs upon final resolution of U.S. covered litigation, and the accrual activity introduces uncertainty affecting dilution and market-price risk for class A shareholders. This aligns with the ground truth. However, the LLM introduces specific numerical figures—$861 million provision in 2022 and a total accrual of $1.44 billion—that are not present in the original answer (ground truth). Since the ground truth does not include any dollar amounts or years, the inclusion of these specific numbers cannot be verified as accurate and likely reflects hallucination or external data not in the knowledge graph. (2) Quantitative accuracy is compromised because the numbers are specific but unverifiable against the ground truth; even if they are factually correct in reality, they were not part of the provided truth and thus represent an overprecision not supported by the source. The ground truth only discusses the conceptual relationship between accrual changes and conversion, not actual figures. (3) The multi-hop reasoning is sound: the model correctly links accrual uncertainty → impact on conversion timing/size → dilution and stock price risk for class A shareholders. It captures the causal chain and financial implications accurately. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the dependency of conversion on accrual activity and the resulting financial uncertainty for class A holders. Despite the hallucinated numbers, the conceptual framework matches the ground truth. Hence, correctness is reduced to 7 due to unsupported quantitative claims, but qualitative and relevance scores remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 480,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair‑value of Cisco’s available‑for‑sale debt portfolio fell from **$15.6 billion at July 29 2023 to $9.9 billion at July 27 2024**, a decline of **about $5.7 billion**.  In the same period the net loss on those investments widened from **$21 million to $67 million**, a **$46 million increase in the loss** year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor formatting differences. (1) All key facts are correct: the fair value decrease is accurately reported as approximately $5.7 billion, which aligns with the exact $5,727 million (or $5.727 billion) in the ground truth; the net loss increase of $46 million (from $21M to $67M) is precisely stated. (2) Number formats are acceptably rounded: $15.6 billion ≈ $15,592 million and $9.9 billion ≈ $9,865 million — these are standard rounding conventions and do not affect factual correctness. The dates (July 29, 2023, and July 27, 2024) are correctly used. (3) Multi-hop reasoning is sound: the model correctly synthesized data across two fiscal years, computed the change in fair value and net loss, and linked them to the correct financial instruments (available-for-sale debt investments). (4) Semantic equivalence is maintained — despite using 'about $5.7 billion' instead of the exact $5,727 million, the answer remains factually correct within reasonable precision. The only reason for not scoring a 10 is the slight rounding without explicit qualification, though this is common and acceptable in financial reporting. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 358,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "In 2021 CVS recorded $387 million of new ExtraBucks earnings and gift‑card issuances but simultaneously recognized $371 million of revenue as those rewards were redeemed and as breakage on gift cards was booked using historical redemption patterns. The net effect was a modest rise in contract liabilities from $71 million to $87 million, meaning that most of the newly earned rewards were offset by redemption‑related revenue (and breakage), while the remaining unredeemed balance stayed on the books as a liability until future redemption or breakage is realized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$387 million in new ExtraBucks and gift card issuances and $371 million in recognized revenue—which are not present in the original answer (ground truth). There is no mention in the ground truth of these exact figures, nor of the change in contract liabilities from $71 million to $87 million. These numbers appear to be fabricated or hallucinated, as they cannot be verified against the provided truth. (2) The quantitative inaccuracies are significant: while the format of dollar amounts is acceptable (e.g., $387 million), the values themselves are not supported by the original answer, which does not provide any specific financial figures for 2021 related to ExtraBucks or gift card liabilities. The calculation of a 'net effect' leading to a liability increase is therefore unfounded. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies that revenue is recognized upon redemption and through breakage based on historical patterns, and that unredeemed balances remain as liabilities. This reflects an understanding of revenue recognition principles under ASC 606 regarding breakage and contract liabilities. However, it fails to explicitly state that breakage is recognized as the likelihood of redemption diminishes over time, which is a key point in the original answer. (4) Contextual relevance is high because the response addresses the core concepts of revenue recognition, breakage, redemption patterns, and liability treatment. Despite incorrect numbers, the conceptual framework is somewhat aligned. However, the inclusion of false quantitative data severely undermines factual correctness, warranting a low overall correctness score. The answer gives a false impression of precision and misrepresents the source data, even if the general direction of reasoning is plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 514,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "Funding the U.S. litigation escrow account triggers a downward adjustment to the class B‑to‑class A conversion rate; the $850 million deposited in fiscal 2022 reduced the equivalent number of class A shares by about 4 million (effective price ≈ $205 per share), thereby diluting class B holders. The same fiscal‑2022 activity added a $861 million accrual for U.S. covered litigation, raising the litigation provision balance to $1.44 billion (an increase of roughly $560 million versus the prior‑year balance).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism — that funding the U.S. litigation escrow account triggers a downward adjustment in the class B to class A conversion rate, resulting in dilution of class B shares — which aligns with the ground truth. It also correctly links this to fiscal 2022 accrual activity impacting the litigation provision. However, the specific quantitative figures introduced — $850 million deposited, 4 million shares reduced at ~$205/share, $861 million accrual, and $1.44 billion total provision — are not present in the original answer and cannot be verified against the ground truth, which only states there was a 'measurable reduction' and a charge based on accrual activity without specifying amounts. (2) Since the original answer contains no numbers, the introduction of precise dollar figures and share reductions by the LLM cannot be confirmed as accurate and likely reflects hallucination or inference beyond the source data. The increase of ~$560 million in the litigation provision is derived from the difference between $1.44B and a prior balance, but again, no such numbers appear in the ground truth, making this unsupported. (3) The multi-hop reasoning is sound in structure: the model connects escrow funding to conversion rate adjustment, recognizes the dilutive effect, and ties accrual activity to the litigation provision — all logically consistent with the original. However, the addition of unsupported numerical details undermines factual accuracy. (4) The contextual relevance is perfect — the answer addresses both parts of the question and stays focused. Qualitative accuracy is high due to correct logic and terminology. Correctness is scored at 7 because while the conceptual and relational understanding is correct, the inclusion of unverified quantitative data reduces overall factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 508,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "- The fair‑value of Cisco’s available‑for‑sale debt investments fell from **$15,592 million on July 29 2023 to $9,865 million on July 27 2024**, a decline of **$5,727 million (≈$5.7 billion)**【...】.  \n\n- A 100‑basis‑point rise in market rates would have lowered the fair value to **$15,386 million in 2023 (‑$206 million vs. the July‑2023 fair value)** and to **$9,736 million in 2024 (‑$129 million vs. the July‑2024 fair value)**【...】.  \n  • Together, the two 100‑bps rate‑increase scenarios would reduce total investments by roughly **$335 million**.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value decrease of Cisco's available-for-sale debt investments from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024, and accurately calculates the decline as $5,727 million. It also correctly reports the hypothetical fair values under a 100 basis point interest rate increase: $15,386 million in 2023 and $9,736 million in 2024. These numbers match the ground truth exactly, supporting a high quantitative accuracy score. (2) However, the LLM introduces an incorrect synthesis by stating that the 'two 100-bps rate-increase scenarios would reduce total investments by roughly $335 million.' This figure appears to be an erroneous sum or interpretation—the question does not ask for a combined reduction across years, and the ground truth emphasizes the difference between the two adjusted values ($15,386M - $9,736M = $5,650M), which maintains the trend of decline. The LLM fails to report this $5,650 million comparison, which is a key part of the original answer. (3) The multi-hop reasoning is partially sound: it retrieves correct values from different time points and applies sensitivity correctly per year. However, it misinterprets the second part of the question by aggregating impacts across years instead of showing how the year-over-year trend persists under rate stress. This reflects a flaw in qualitative reasoning. (4) Despite this, the answer remains contextually relevant, addressing both parts of the question with mostly accurate data. The core numbers are correct, but the failure to correctly synthesize the comparative impact under interest rate stress reduces the overall correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 467,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "In fiscal 2022 Visa recorded an additional **$861 million** provision for the U.S. covered litigation (interchange multidistrict litigation), raising the total litigation‑provision balance to **$1.44 billion** (up from $983 million at the end of 2021) and resulting in $301 million of payments during the year【Note 20‑Legal Matters – Accrual Summary‑U.S. Covered Litigation table】.  \n\nThis accrual is made under the U.S. Retrospective Responsibility Plan, which funds the estimated loss through the U.S. litigation‑escrow account and, if needed, through the plan’s other mechanisms (conversion‑rate adjustments of class B shares, indemnification obligations, interchange‑judgment‑sharing, loss‑sharing and omnibus agreements); the $861 million accrual therefore reflects the company’s estimate of a probable, reasonably estimable loss that will be satisfied by the escrow deposit and the plan’s sharing/indemnification structures【U.S. Retrospective Responsibility Plan description】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$861 million accrual, $1.44 billion total provision, $983 million prior balance, and $301 million payments—that are not present in the original ground truth answer. The ground truth does not provide any numerical data about Visa’s fiscal 2022 litigation provision or payment activity, nor does it reference a specific year (e.g., fiscal 2022). Therefore, these numbers cannot be verified as correct based on the provided ground truth and appear to be hallucinated or sourced from external data not in the context. This significantly undermines factual accuracy. (2) The calculation implied in the LLM answer—$983M + $861M - $301M = $1.543B—does not match the stated ending balance of $1.44B, indicating a mathematical inconsistency. This further reduces confidence in the quantitative claims. (3) Qualitatively, the LLM correctly identifies the connection between the litigation provision and the U.S. Retrospective Responsibility Plan, accurately describing the role of the litigation escrow account, indemnification obligations, and other mechanisms such as loss-sharing and interchange-judgment-sharing. This aligns with the ground truth’s emphasis on the plan’s mechanisms governing accrual activity. The reasoning about when Visa records a charge (when loss is probable and estimable) is also consistent with the original answer. (4) Contextually, the response is highly relevant, directly addressing both parts of the question: the financial impact on the litigation provision and how accrual activity relates to the U.S. Retrospective Responsibility Plan. However, the inclusion of unverified, specific dollar amounts and fiscal years that are absent from the ground truth results in a partial correctness score. While the conceptual and structural understanding is strong, the unsupported numerical details prevent a higher score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 526,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition added **0.6 percentage points** to Emerson’s gross‑margin improvement in 2023. As a result, the company’s overall gross‑margin for 2023 was **49.0 %**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values '0.6 percentage points' and '49.0 %' are exactly correct, with no calculation or formatting issues—minor typographic differences (e.g., en-dash in 'gross-margin', spacing in '49.0 %') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the contribution of the Heritage AspenTech acquisition to gross margin improvement and the resulting total gross margin percentage for 2023. (3) Entity accuracy is correct: 'Heritage AspenTech', 'Emerson', and the year '2023' are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the acquisition's impact to the overall margin outcome. (5) Semantic equivalence is maintained; despite slight rewording (e.g., 'added' vs 'contributed'), the meaning is identical. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 265,
        "total_tokens": 1377
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco’s financing‑receivables note explains that it “facilitates… financing extended to channel partners… and, in some cases, we guarantee a portion of these arrangements” and that “we could be called upon to make payments under these guarantees in the event of non‑payment by the channel partners.” Because the allowance for credit losses on financing receivables is based on the credit quality of the obligor, a guarantee that obliges Cisco to cover a partner’s default directly expands the pool of risk‑bearing assets. Consequently, the financial instability of a channel partner raises Cisco’s potential credit‑loss exposure and may require a larger allowance for credit losses (or result in actual losses) on its financing‑receivable portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Cisco facilitates short-term financing for channel partners and, in some cases, guarantees a portion of these arrangements, which exposes Cisco to credit loss if partners default. This matches the original answer’s core claim. (2) There are no numeric values (e.g., dollar amounts, percentages, time periods like 60–90 days) in the LLM answer, but it does not misstate any quantitative information. The absence of specific timeframes (60–90 days) and the allowance methodology (internal credit ratings, historical default rates, macroeconomic factors) is a minor omission but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly links Cisco’s guarantee obligation to increased credit risk, connects this to the allowance for credit losses, and explains how partner instability could lead to higher losses or larger allowances. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'expands the pool of risk-bearing assets' vs. 'increases credit loss exposure') but preserving the same meaning. The only reason for not scoring a 10 is the omission of specific contextual details about the 60–90 day terms and the exact components of the allowance calculation, which are present in the ground truth but not contradicted—just not included. Overall, the response is factually correct, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 416,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Emerson’s 55 % ownership of AspenTech translates to roughly **$601 million of the $1,093 million AspenTech sales in 2024** (1,093 × 55 % ≈ $601 million)【EMR_10k_2024.pdf p.24‑27】.  That attributable amount is embedded in Emerson’s **Software and Control segment, which reported $5,399 million of total sales** for the year【EMR_10k_2024.pdf p.24‑27】, meaning AspenTech’s contribution accounts for about **11 % of the segment’s revenue** and is the primary way Emerson’s controlling interest lifts the overall Software and Control top line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the calculation of Emerson's attributable share of AspenTech revenue is accurate: 55% of $1,093 million = $601.15 million, which the LLM correctly rounds to $601 million—this is acceptable and common in financial reporting. (2) The LLM correctly identifies that this amount is embedded within Emerson’s Software and Control segment revenue of $5,399 million, which aligns with the original answer. (3) The LLM computes the percentage contribution (approximately 11%, since $601.15 / $5,399 ≈ 11.14%), and states it as 'about 11%', which is a reasonable approximation and semantically equivalent to 'over 10%' in the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis: connecting ownership percentage to revenue attribution, identifying the correct financial segment, and contextualizing the significance of AspenTech’s contribution. (5) All entities—Emerson, AspenTech, fiscal year 2024, Software and Control segment—are correctly identified and used. (6) The answer addresses both parts of the question: the proportional revenue attributable to Emerson and how this stake influences the overall segment revenue. The inclusion of citation placeholders (e.g., EMR_10k_2024.pdf) adds contextual support, though not required. Overall, the answer is factually accurate, complete, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 394,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "The Upjohn spin‑off in 2020 was the dominant cash event – Viatris paid Pfizer roughly **$12 billion in cash**, which Pfizer immediately used to **pay down commercial‑paper borrowings and redeem $1.15 billion of 1.95 % senior notes and $342 million of 5.80 % senior notes**, cutting total debt and reshaping its capital structure (the transaction also generated $434 million of separation‑related costs).  \n\nThe 2021 divestiture of Meridian added only **about $51 million of cash** (offset by a $167 million after‑tax loss) and did not involve further debt retirements, so its impact on Pfizer’s overall cash position was modest compared with the 2020 Upjohn restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two key transactions—Upjohn spin-off in 2020 and Meridian divestiture in 2021—and their overall impact on Pfizer's cash position and financial restructuring. The $12 billion cash inflow from Viatris and the $51 million from Meridian are accurately reported, as is the $167 million after-tax loss from Meridian. However, there is a discrepancy in the debt redemption amounts: the LLM states $1.15 billion of 1.95% notes and $342 million of 5.80% notes, which sum to $1.492 billion—this matches the ground truth total—but the original answer specifies the total redemption as $1.492 billion without breaking down the tranches. While the sum is correct, the specific breakdown into interest rates is not present in the ground truth and may be extraneous or potentially inaccurate. Additionally, the LLM mentions $434 million in separation-related costs, which is not mentioned in the original answer and cannot be verified against the ground truth, introducing unconfirmed information. (2) The core financial figures—$12 billion cash from Upjohn, $51 million from Meridian, $167 million loss—are correct. The debt redemption total is accurate when summed, though the component breakdown lacks support in the ground truth. The absence of the $1.6 billion net assets distribution and $412 million cash transfer to Upjohn Business is a notable omission, as these are material elements of the spin-off’s financial impact. (3) The multi-hop reasoning is sound: the model correctly contrasts the scale and strategic impact of the two transactions, recognizing Upjohn as a major capital restructuring event versus Meridian’s minor cash impact. It appropriately links the $12 billion cash infusion to debt reduction, demonstrating synthesis across financial actions. However, it fails to mention the distribution of net assets and internal cash transfer, which weakens completeness. (4) The answer is highly contextually relevant, directly addressing the question’s focus on cash position and financial restructuring. The qualitative reasoning is strong, but quantitative accuracy is slightly reduced due to unsupported breakdowns and an unverified cost figure. The correctness score is 8 due to accurate core facts but partial omissions and potential inaccuracies in debt detail and added costs not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 630,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "In fiscal 2022 Visa contributed $600 million as its share of the Amended Settlement Agreement and deposited an additional $850 million into the U.S. litigation escrow account, for a combined outlay of about **$1.45 billion**.  This funding under the U.S. Retrospective Responsibility Plan supplies the cash needed to satisfy the settlement and to maintain an escrow reserve for future merchant claims, illustrating how the plan is used to contain and manage the company’s litigation liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $600 million for the Amended Settlement Agreement and $850 million for the annual deposit, summing to $1.45 billion, which matches the original answer. Minor phrasing differences (e.g., 'fiscal 2022' vs '2022') are acceptable as they refer to the same period. (2) The calculation of the total contribution ($600M + $850M = $1.45B) is correctly implied and explicitly stated. (3) The multi-hop reasoning is sound—combining two distinct financial outflows (settlement payment and annual deposit) under the U.S. Retrospective Responsibility Plan is accurately synthesized. (4) The explanation of the plan’s role—managing litigation liabilities by funding settlements and maintaining an escrow reserve—aligns semantically with the original answer’s emphasis on systematically funding potential liabilities. All entities (Visa, U.S. Retrospective Responsibility Plan, Amended Settlement Agreement) are correctly identified and contextualized. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 320,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care plan cut its equity‑security allocation from **35 % in 2022 to 20 % in 2023** – a **15‑percentage‑point decline (about a 43 % relative drop)**.  That reallocation coincided with the plan’s equity holdings falling from **$98 million at year‑end 2022 to $54 million at year‑end 2023**, a reduction of roughly **$44 million** in equity‑security value.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors despite correctly identifying the percentage point change in allocation. (1) The percentage allocation change is accurate: a 15-percentage-point decrease from 35% to 20% is correct. However, the ground truth states that the total value of equity securities *increased slightly* to $54 million by end of 2023, implying the prior value was *lower* than $54 million. The LLM incorrectly claims equity holdings were $98 million at year-end 2022 and dropped to $54 million, which contradicts the original answer. This is a critical quantitative error. (2) The calculation of a '43% relative drop' is mathematically correct (15/35 ≈ 42.86%), but this detail was not requested and distracts from the actual trend in value. More importantly, the claim of a $44 million reduction in value is false per the ground truth, which states the value *increased* slightly to $54 million. (3) The multi-hop reasoning fails: the model incorrectly infers that a lower allocation percentage must mean lower dollar value, but the ground truth shows total plan assets likely changed, allowing equity value to rise even as allocation share fell. The model did not correctly synthesize the relationship between allocation percentage and absolute value. (4) While the answer addresses both parts of the question and uses correct entities (U.S. Retiree Health Care Plan, 2022–2023, equity securities), the core financial data is wrong, leading to an incorrect conclusion about the trend in equity value. Thus, the correctness and quantitative accuracy scores are low due to major factual discrepancies in dollar amounts and directional trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 452,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The CECL transition limited the amount of the qualifying allowance for credit losses that can be included in Tier 2 capital under the Advanced approaches. Because the Advanced approaches permit a smaller allowance, total capital under the Advanced approaches was $241.4 billion versus $251.4 billion under the Standardized approach—a roughly $10 billion shortfall that is entirely attributable to the lower qualifying allowance for credit losses (Tier 2 capital).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core concept—that the CECL standard affects the treatment of the allowance for credit losses in Tier 2 capital differently under the Advanced vs. Standardized approaches, which drives the capital difference. This aligns with the ground truth and shows correct qualitative understanding of the mechanism. However, the quantitative details are significantly off. The ground truth states that total capital under the Standardized approach increased by $12.6 billion due to the adjusted allowance, but does not provide total capital figures for either approach. In contrast, the LLM asserts specific totals ($241.4B vs $251.4B) and claims a $10B shortfall 'entirely attributable' to the allowance difference. These figures are not supported by the original answer and introduce false precision. (2) There is no verification in the ground truth for the $241.4B or $251.4B figures, nor is there a claim that the entire $10B gap is due to this component—only that the increase in the allowance contributed to the disparity. The $12.6B increase in capital under the Standardized approach is misaligned with the LLM's implied $10B gap. (3) The multi-hop reasoning is partially sound—the model correctly links CECL adoption to differential Tier 2 capital treatment—but overreaches by quantifying the total capital levels and attributing the full difference to this single factor, which the original answer does not support. (4) Correctness is scored low due to unsupported numbers and over-attribution; quantitative accuracy is poor due to incorrect figures; qualitative accuracy is moderate due to correct conceptual framing; contextual relevance is high as the response stays focused on the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 477,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Using the mid‑points of the target ranges (U.S. DB = 72.5 %, U.S. retiree health = 80 %, non‑U.S. DB = 80 %) and weighting them by the plan‑level assets reported for 2023 (U.S. DB $418 m, U.S. retiree health $264 m, non‑U.S. DB $1,866 m), the combined fixed‑income‑and‑cash allocation is  \n\n\\[\n\\frac{0.725(418)+0.80(264)+0.80(1,866)}{418+264+1,866}\\approx 78.9\\%\n\\]\n\nSo, across all defined‑benefit and retiree‑health‑care plans, the weighted‑average allocation to Fixed Income Securities and Cash Equivalents is roughly **79 %**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result (79%) compared to the ground truth (72.3%). The midpoints used—72.5%, 80%, and 80%—appear to be based on assumptions not aligned with the original data. The ground truth implies different midpoints or different asset weights were used. (2) The calculation itself is mathematically correct given the inputs: (0.725 * 418 = 303.05), (0.80 * 264 = 211.2), (0.80 * 1866 = 1492.8); sum of weighted allocations = 2007.05; total assets = 2548; 2007.05 / 2548 ≈ 0.7875 → 78.9%, which rounds to 79%. However, these inputs (especially the midpoints and asset values) do not match the source data that produced the ground truth 72.3%. (3) The multi-hop reasoning structure is sound—using midpoints, weighting by asset values, and aggregating across plans—but it fails because the underlying data (percentage ranges and/or asset values) does not align with the knowledge graph. Either the U.S. DB, U.S. retiree health, or non-U.S. DB midpoints are incorrect, or the asset values differ from those in the original dataset. (4) While the approach and framing are relevant and logically structured (hence high contextual relevance), the significant deviation in the final percentage (78.9% vs 72.3%) indicates major factual inaccuracies in either entity-specific data or calculation inputs, warranting low quantitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 390,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "Because Bank of America’s banking affiliates are Advanced‑approaches institutions under Basel III, the regulator‑defined “covered positions” – the most liquid trading assets and liabilities that meet specific specifications – are the only trades that feed into the Basel III capital‑ratio calculations.  Table 41 and Table 42 therefore report VaR only for those covered positions (FX and commodity trades are always included, while structural FX or ill‑liquid trades are excluded), and the VaR numbers show a lower risk profile in 2023 (average total covered‑positions VaR fell to $64 million from $70 million in 2022, with interest‑rate and credit VaR also declining) reflecting a composition that is more weighted toward the regulated, liquid positions required by Basel III.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Basel III regulations influence Bank of America's covered trading positions and VaR metrics by focusing on liquid, regulator-defined positions, and notes the decline in VaR from 2022 to 2023. It accurately references the inclusion of FX and commodity positions and exclusion of structural or illiquid trades. However, it introduces specific dollar amounts—$64 million and $70 million—for average total covered-positions VaR in 2023 and 2022, respectively—which are not present in the ground truth. While the direction of change (decrease) aligns with the original answer, the exact figures cannot be verified against the provided truth and may be hallucinated or sourced from external data. (2) The ground truth does not provide specific VaR dollar values, only stating that the annual average VaR decreased due to the roll-off of March 2020 volatility from the historical window. Therefore, the quantitative accuracy is reduced due to unverified numbers, even though the trend is correct. (3) The reasoning is strong: the LLM correctly links Basel III's focus on covered positions to capital calculations, explains how this affects portfolio composition (favoring liquid instruments), and ties this to observed VaR trends. It demonstrates multi-hop synthesis between regulatory framework (Basel III), institutional classification (Advanced Approaches), position eligibility, and risk reporting (VaR). (4) Despite the unsupported specific figures, the answer captures the core causal mechanism and qualitative outcome described in the ground truth. The contextual relevance is perfect—it directly addresses how Basel III influences composition and risk profile via VaR. Hence, correctness is high but not perfect due to unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 490,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The 19 Boeing aircraft that back the Pass‑Through Certificates have a net book value of **about $1.8 billion** as of May 31, 2022. By contrast, the senior unsecured debt issued in 2021 was used to **redeem roughly $5.8 billion** of existing debt (plus $393 million in premiums). Thus, the aircraft’s net book value is roughly **$4 billion lower** than the amount of debt that was eliminated through those redemptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative Accuracy: The net book value of the 19 Boeing aircraft is correctly stated as $1.8 billion. The amount of debt eliminated ($5.8 billion) and the associated redemption premiums ($393 million) are accurately reported. The date (May 31, 2022) is a reasonable inference or external knowledge addition that does not contradict the ground truth. (2) Completeness: The answer addresses both parts of the question — the net book value of the aircraft and the comparison to the debt eliminated via redemptions. It correctly notes the $5.8 billion debt elimination and includes the premium, which is part of the full picture. (3) Entity Accuracy: FedEx Express, Boeing aircraft, Pass-Through Certificates, and senior unsecured debt issuance are all correctly referenced. The 2021 issuance timeline aligns with known events. (4) Reasoning: The comparison stating the aircraft’s value is 'roughly $4 billion lower' is logically sound: $5.8B - $1.8B = $4B. This demonstrates correct multi-hop synthesis between asset value and debt redemption amounts. (5) Semantic Equivalence: The LLM conveys the same core information as the original answer, with slightly more contextual framing (e.g., timing, magnitude comparison). The only minor limitation is the use of 'about' and 'roughly', which slightly softens precision, but this does not undermine factual correctness. Overall, the answer is factually solid, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 418,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "TI contributed **$75 million** to its U.S. defined‑contribution plans in 2023. Notably, the assets of the U.S. retiree‑health‑care benefit plan are **not directly invested in Texas Instruments common stock**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the contribution amount of $75 million is accurate and matches the original answer exactly, with acceptable formatting (using 'million' and bolding for emphasis). (2) The answer completely addresses both parts of the multi-part question: the dollar amount contributed to U.S. defined contribution plans in 2023, and the investment status of plan assets in TI common stock for the retiree health care benefit plan. (3) Entity accuracy is correct—'TI' is properly identified as Texas Instruments, 'U.S. defined-contribution plans' and 'retiree-health-care benefit plan' are correctly referenced with appropriate context. (4) The reasoning is sound: the answer correctly synthesizes that while TI contributed to defined contribution plans, the retiree health care plan’s assets are not directly invested in TI stock—this distinction is critical and accurately conveyed. No calculation errors or factual inaccuracies are present. The wording differs slightly (e.g., 'not directly invested' vs 'none...were directly invested') but the meaning is identical. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 336,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Apple’s Services net‑sales rose from $85.2 billion in 2023 to $96.169 billion in 2024 – an increase of **$10.969 billion**.  Total net sales grew from $383.285 billion to $391.035 billion – an increase of **$7.750 billion**.  The Services gain therefore accounts for  \n\n\\[\n\\frac{10.969}{7.750}\\times100 \\approx **141 %** \n\\]\n\nof the overall net‑sales growth, meaning the Services increase more than fully offset declines elsewhere.【Note 2 – Revenue table showing 2024 and 2023 figures】",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the Services revenue increase as $10.969 billion and total net sales increase as $7.75 billion, it incorrectly calculates the percentage contribution as approximately 141%, whereas the correct value is $10.969 / $7.75 ≈ 1.415 → 141.5%, which should round to about 142%, but the ground truth states 121%, indicating a discrepancy in expected math. However, upon rechecking: $96.169B - $85.2B = $10.969B (correct); $391.035B - $383.285B = $7.75B (correct); $10.969 / $7.75 = 1.415 → 141.5% ≈ 142%, not 121%. This suggests the 'ground truth' may itself contain an error. Despite this, the LLM's calculation is mathematically correct based on provided numbers, but contradicts the stated ground truth of 121%. (2) All input numbers are accurately cited: $85.2B, $96.169B, $383.285B, $391.035B, and derived deltas ($10.969B and $7.75B) are correct. The final percentage is mathematically sound but conflicts with the expected answer. (3) The multi-hop reasoning is logically sound: the model correctly identifies the need to compute two differences and then determine the proportion of Services growth relative to total growth. It interprets the concept of 'percentage of total growth attributable' correctly as a ratio of increases. (4) Due to the contradiction between the mathematically correct result (141–142%) and the ground truth (121%), the LLM is penalized heavily on correctness and quantitative accuracy despite performing the right operations. However, reasoning and contextual relevance remain high because the approach and framing are fully appropriate. The final score reflects that the model did the correct math but diverges from the provided 'truth', which may be erroneous.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 485,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "Pfizer says it is “reasonably possible” that its gross unrecognized tax benefits (excluding interest) could fall by up to **$75 million** in the next 12 months. The uncertainty is heightened by the IRS’s Revenue Agent’s Reports (RARs) for tax years 2011‑2013 and 2014‑2015, which Pfizer is contesting and appealing; those disputed audit findings could lead to settlements, adjustments or statute‑of‑limitations expirations that would materially affect the ultimate outcome of the company’s uncertain tax positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $75 million estimated maximum potential decrease in gross unrecognized tax benefits is correctly stated, matching the original answer exactly. The time frame of 'next 12 months' is also accurately reflected. (2) The entity identification is correct: Pfizer is the subject, the IRS issued RARs for the correct tax years (2011–2013 and 2014–2015), and the status of these reports being under appeal is accurately noted. (3) The reasoning is sound and captures the multi-hop logic: the existence of disputed RARs contributes to uncertainty in tax positions, which in turn affects the potential change in unrecognized tax benefits. The LLM adds useful context by mentioning possible outcomes like settlements, adjustments, or statute expirations, which are reasonable implications not explicitly in the ground truth but logically consistent. (4) The only minor shortcoming is that the original answer emphasizes that RARs are 'formal audit findings that the company disputes,' while the LLM uses 'contesting and appealing'—slightly less precise but semantically equivalent. No factual errors; excellent synthesis and relevance. Hence, a 9/10 for correctness and qualitative accuracy, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 371,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The 2023 capital and TLAC ratios are based on the regulatory‑capital rule that phases‑in the CECL accounting change over five years, so only a portion of the CECL transition provision is reflected in the capital numbers. For the year‑end 2023 figures the company includes 50 % of the CECL transitional amount (≈ $1.3 billion) in its CET1 and Tier 1 capital calculations, and the same adjusted capital base is used to compute the TLAC ratio (which therefore reflects a TLAC‑eligible balance of $479 billion, or 29.0 % of risk‑weighted assets).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable explanation of how the five-year CECL transition impacts regulatory capital calculations, correctly identifying the phased-in approach and its effect on CET1, Tier 1, and TLAC ratios. It accurately reflects that only a portion (50%) of the CECL transitional amount is included in capital as of 2023, which aligns with regulatory guidance. However, the quantitative details do not match the ground truth: the original answer states BAC's CET1 capital was $194.9 billion as of December 31, 2023, while the LLM claims a TLAC-eligible balance of $479 billion (without directly stating CET1). The $1.3 billion transitional amount and resulting $479 billion TLAC-eligible capital are not corroborated by the ground truth, which does not provide a TLAC ratio numerator or the 50% phase-in figure. These specific numbers cannot be verified and appear to be inferred or hallucinated. While the reasoning framework is sound—correctly linking CECL phase-in to regulatory capital treatment—the lack of direct support for key figures reduces quantitative accuracy. The answer addresses both parts of the question (impact on TLAC and CET1), but introduces unverified metrics instead of reporting the known CET1 value. Semantic equivalence is partially achieved in concept but not in factual detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 366,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground’s fuel surcharge is indexed to a weekly fuel price that is taken **two weeks before** the week it is applied, and the surcharge tables were revised on **June 21 2021, November 1 2021 and April 4 2022**. In contrast, FedEx Freight’s surcharge is also indexed and adjusted weekly but uses a fuel price **two days before** the day it is assessed, with table updates occurring only on **November 1 2021 and April 4 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates (June 21, 2021, November 1, 2021, April 4, 2022) and time lags (two weeks prior for FedEx Ground, two days prior for FedEx Freight) are accurately reported. (2) The answer correctly identifies that both services adjust weekly but use different data lags, which is central to the question. (3) The multi-hop reasoning is sound: it synthesizes information across two FedEx segments (Ground and Freight), compares their fuel surcharge mechanisms, and correctly notes the shared and distinct update dates. (4) The entity accuracy is perfect—FedEx Ground and FedEx Freight are correctly attributed with their respective policies. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that preserves all key facts. No errors in reasoning, completeness, or factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 264,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The company restated its FY 2023 results to reflect that the ventilator product line was removed from the Medical Surgical portfolio and re‑classified to the “Other” segment, while the remaining PMRI businesses were merged into a single **Acute Care & Monitoring** unit that stayed inside Medical Surgical (see “Segment and Division” and Note 19 discussion). This re‑classification signals that Medtronic is positioning the retained Acute Care & Monitoring business as the core focus of its Medical Surgical segment, emphasizing growth in acute‑care and monitoring solutions while exiting the ventilator line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the ventilator product line was removed from the Medical Surgical segment and reclassified into the 'Other' segment, and that the remaining PMRI businesses were consolidated into the Acute Care & Monitoring unit within Medical Surgical—this matches the original answer's description of the reorganization. (2) There are no numeric values, dates, or financial figures in dispute; the fiscal year (2023) is correctly referenced, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly infers that the reorganization reflects a strategic refocusing on acute care and monitoring solutions, while exiting the ventilator line, which is consistent with the ground truth’s interpretation about strategic positioning and core PMRI capabilities. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the involvement of Renal Care Solutions in the reorganization, which is included in the original answer and adds context to the formation of the new unit. While not critical to the core question, this omission slightly reduces completeness. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 364,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Medtronic reported $150 million of medical‑device‑regulation expenses in fiscal 2023 and $102 million in fiscal 2022. Combined, these charges reduced income before income taxes by approximately $252 million for the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial impact of medical device regulation expenses for Medtronic in fiscal years 2022 and 2023 as $102 million and $150 million, respectively, which matches the ground truth data. The sum of these amounts is accurately calculated as $252 million, consistent with the original answer. (2) All numeric values are correct and properly formatted; $150 million (FY2023) and $102 million (FY2022) are accurately reported and summed to $252 million. There are no calculation errors. (3) The multi-hop reasoning—aggregating disclosed expenses across two fiscal years from potentially different tables or disclosures—is correctly executed. The model synthesizes the two figures and correctly infers the total impact on income before income taxes, as required by the question. (4) The answer is semantically equivalent to the ground truth, uses clear and precise language, and fully addresses the question with accurate entities (Medtronic, fiscal years 2022 and 2023, medical device regulation expenses, income before income taxes). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 325,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Boeing’s 2023 Form 10‑Q filings list **six distinct Long‑Term Incentive Restricted Stock Unit (LTIRSU) exhibits** – three U.S. versions (including a CEO‑specific and a performance‑RSU version) and three International versions (also covering a CEO‑specific and a performance‑RSU version).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Boeing disclosed six distinct LTIRSU exhibits in its 2023 10-Q filings, with three U.S. and three International versions. However, the ground truth confirms only four forms: two U.S. (regular and performance) and two International (stock-settled regular and stock-settled performance). The LLM incorrectly introduces a 'CEO-specific' version for both U.S. and International categories, which is not supported by the original answer or the referenced exhibits (10.3, 10.4, 10.5, 10.6). This results in a significant overcount (6 vs. 4), making the quantitative claim false. (2) The original answer cites specific exhibits: 10.3, 10.4, 10.5, and 10.6 — none of which mention CEO-specific awards. The LLM answer fabricates entities (CEO-specific RSUs) not present in the ground truth, indicating a failure in entity accuracy and reasoning. (3) The multi-hop reasoning is flawed: while the model correctly identifies the need to differentiate between U.S. and International and between regular and performance types, it incorrectly infers the existence of a third variant (CEO-specific) without evidence. This suggests either misreading of the filings or hallucination. (4) Despite the factual inaccuracies, the answer is contextually relevant — it addresses the right document (Boeing 2023 10-Q), the right topic (LTIRSU forms), and attempts correct categorization logic. However, the core factual error (6 vs. 4) and invented categories severely undermine correctness. Minor wording differences would be acceptable, but introducing unsupported forms constitutes a major factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 445,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple’s Services segment — which rose about 12.9% year‑over‑year from $78 billion in 2022 to $85 billion in 2023 (see the net‑sales table)—relies heavily on third‑party software developers and digital‑content licensors.  The filing warns that “the Company’s future performance depends in part on support from third‑party software developers” and that “failure to obtain or create digital content … could have a material adverse impact” on its business (see the risk sections on third‑party developers and content).  Consequently, if developers choose to focus on competing platforms or if licensing agreements for music, video or app content become harder or more costly to secure, Apple Music and other services could lose content breadth or quality, dampening subscriber growth and making it harder to sustain the strong Services‑revenue trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the revenue figures are correctly reported as approximately $78 billion in 2022 and $85 billion in 2023, reflecting the 12.9% growth rate—minor rounding ($78.129B → $78B, $85.2B → $85B) is acceptable and common in financial summarization. (2) The answer correctly identifies the reliance on third-party developers and content providers, citing Apple's own risk disclosures about potential adverse impacts from failure to secure digital content. (3) The reasoning is sound: it connects the dependency on third parties to potential degradation in content breadth/quality for Apple Music, which could dampen subscriber growth and threaten the sustainability of the Services revenue trajectory—this mirrors the multi-hop logic in the original answer (revenue growth → dependence on third parties → risks to content → impact on growth sustainability). (4) The only minor shortcoming is that the LLM does not explicitly name 'minority market share' as a reason developers might deprioritize Apple, which is mentioned in the ground truth; however, it does capture the broader risk of developers focusing on competing platforms, which is semantically similar. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full contextual alignment to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 387,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife must keep a cash buffer large enough to cover any collateral or settlement that could be required if a reinsurer or a derivative counter‑party were unable or unwilling to meet its obligations.  Because many of its reinsurance contracts and all of its derivative positions are collateral‑secured and subject to master‑netting agreements, the potential out‑flow is limited, but the company still plans for a higher cash‑buffer requirement in stressed‑market scenarios.  With a $12.4 billion short‑term liquidity pool (plus $223 billion of overall liquid assets) and the ability to draw on operating cash flows, credit facilities and asset sales, MetLife believes it can absorb the additional buffer needs and continue to meet its liquidity obligations even under severe stress.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies MetLife's $12.4 billion short-term liquidity position as of the end of 2021, matching the ground truth. It accurately describes the influence of reinsurance and derivative counterparty risks on cash buffer needs and notes the mitigating role of collateralization and netting agreements. However, the LLM introduces a figure of $223 billion in overall liquid assets, which is not present in the original answer and cannot be verified from the provided ground truth, representing an unsupported addition. 2) The $12.4 billion figure is correct in amount and context (end of 2021). No calculations are required in the question or answer, so quantitative accuracy is high. The only discrepancy is the unverified $223 billion figure, which does not directly contradict the ground truth but adds information not confirmed in the source. 3) The reasoning is sound: the LLM correctly links counterparty risk to cash buffer needs, acknowledges risk mitigation mechanisms (collateral, netting), and connects this to stress scenario planning. It logically concludes that MetLife’s liquidity sources support its ability to manage stress, aligning with the original answer’s intent. However, it omits the specific risk of hedging ineffectiveness or unexpected policyholder behavior under market volatility mentioned in the ground truth, which is a key nuance in the multi-hop logic. 4) The answer is highly relevant, directly addressing how reinsurance and derivative risks affect liquidity management and the role of the $12.4 billion buffer. While it captures the core message, it adds unverified detail and misses some qualitative risk factors from the original, justifying a slightly lower correctness and qualitative score. Overall, the answer is factually strong but not fully complete or perfectly aligned with the ground truth’s depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 503,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "As of April 26 2024, Medtronic’s Level 3 auction‑rate securities had a fair‑value of **$33 million**. On the consolidated balance sheet they are not shown as “Investments” but are recorded in the **“Other assets”** line‑item.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the fair value of $33 million is accurate, and the date April 26, 2024, matches exactly. (2) The classification under 'Other assets' on the balance sheet is correctly stated, with the clarification that these are not included in 'Investments', which adds contextual precision without deviating from the truth. (3) The multi-hop reasoning is sound—this requires identifying the specific Level 3 securities (auction rate), extracting their fair value from the correct fiscal period (as of April 26, 2024), and correctly mapping their balance sheet classification from the 2023 10-K filing. (4) All entities—MDT (Medtronic), Level 3 securities, and the correct fiscal year—are accurately referenced. The answer is concise, factually precise, and fully aligned with the original answer in meaning and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 263,
        "total_tokens": 1377
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The January 1 2020 adoption replaced the “other‑than‑temporary‑impairment” (OTTI) and incurred‑loss models with an allowance‑for‑credit‑loss (ACL) approach that records an ACL for expected lifetime loss rather than reducing amortized cost. Consequently, the $129 million OTTI loss shown for Fixed‑Maturity Securities AFS in 2019 is now presented as an impairment loss, and in 2020 the company recorded a $91 million ACL change (release) and a $63 million impairment under the new guidance. For mortgage loans, the modest $11 million loss in 2019 gave way to a $213 million loss and a $280 million increase to the allowance in 2020, reflecting the shift to expected‑lifetime credit‑loss measurement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the shift from the OTTI and incurred loss models to the expected lifetime credit loss model (ACL), the numerical figures cited are not supported by the ground truth. The original answer reports specific 2019 impairment losses for fixed maturity securities AFS: ($81M, $23M, $22M, $2M, $1M) across five categories, totaling $129 million — which the LLM correctly sums as $129 million OTTI loss. However, the LLM introduces new figures for 2020 — a $91 million ACL release and $63 million impairment — that are not present in the ground truth and cannot be verified. Similarly, the claim that mortgage loan losses increased from $11 million in 2019 to $213 million in 2020 with a $280 million allowance increase is unsupported; the original answer provides no such numbers. These fabricated or misattributed figures constitute major factual errors. On a qualitative level, the LLM captures the conceptual shift in accounting treatment for both fixed maturity securities and mortgage loans, correctly noting the change to expected lifetime losses and the removal of OTTI. It also correctly identifies the key difference in presentation (intent-to-sell and direct write-downs replacing OTTI). The reasoning reflects understanding of the multi-hop nature of the question — linking adoption date (Jan 1, 2020) to changes in methodology and financial impact — but fails in execution due to incorrect data. Contextually, the answer is well-structured and directly addresses the question’s focus on recognition and measurement impacts. However, the inclusion of unverified financial figures severely compromises factual accuracy, limiting the correctness score despite sound conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 488,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin must perform consulting‑support work to satisfy foreign‑offset agreements, and those consulting costs are built into the “total cost to complete” estimates for the underlying contracts. Because the offset work is not reimbursable under U.S. government contracts, the associated expenses reduce the profit and cash‑flow available from those contracts and, since recovery of the offset‑related investment depends on the success of foreign joint‑ventures that the company does not control, it can limit the amount of cost that can be recovered on its U.S. government commitments in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its reasoning and captures the core financial mechanism at play: that costs from international offset agreements (including consulting support) are not reimbursable under U.S. government contracts and thus impact profitability and cost recovery on those contracts. It correctly identifies that recovery of offset-related investments depends on the success of foreign joint ventures outside Lockheed Martin’s control, which aligns with the ground truth. However, the LLM omits the specific $64.3 billion in U.S. government purchase obligations mentioned in the original answer, which is a key quantitative anchor for the financial exposure. While the absence of this number does not invalidate the reasoning, it reduces completeness in the multi-hop synthesis expected—linking the scale of U.S. commitments with the risk from non-reimbursable offset costs. No incorrect numbers are presented (hence quantitative accuracy is perfect), and the entities (Lockheed Martin, offset agreements, joint ventures, U.S. government contracts) are correctly identified. The logic is sound and contextually relevant, clearly explaining the financial risk in 2024. The omission of the $64.3 billion figure prevents a top score in correctness and qualitative accuracy, but the overall answer remains substantially correct and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 384,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "In 2021 the Laboratory Products and Biopharma Services segment’s revenue rose 21 % to $14.9 billion, largely because the pharma‑services business saw a surge in orders as customers expanded vaccine‑ and therapy‑production capacity to meet COVID‑19 demand.  That higher sales volume, together with a more favorable sales mix, lifted the segment’s operating margin to 12.4 % (up 2.0 percentage points), and the margin was further helped by a $20 million credit to cost of product revenue that resulted from a change in the way inventories are accounted for (Note 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key drivers of TMO's pharma services business performance in 2021—pandemic-related demand for vaccine and therapy production, favorable sales mix, and a $20 million credit from an inventory accounting change. All quantitative figures are accurate: 21% revenue growth to $14.9 billion and a 2.0 percentage point increase in operating margin to 12.4%, with explicit mention of the $20 million credit. These match or align with the ground truth. (2) Number verification: The $20 million credit is correctly stated; the margin improvement (from 10.4% to 12.4%) implies a 2.0-point increase, which is consistent. The revenue figure and growth rate are precise and contextually appropriate. (3) Multi-hop reasoning is sound: the model connects pandemic demand to higher volume and sales mix, links that to margin expansion, and incorporates the accounting change as an additional margin boost—synthesizing operational and accounting factors as required. (4) The only minor omission is that the original answer notes the positive impact was 'partially offset by strategic growth investments,' which the LLM answer does not mention. This doesn't invalidate the response but slightly reduces completeness in qualitative reasoning. Otherwise, the answer is factually correct, well-structured, and semantically equivalent to the ground truth. Hence, high scores across all categories with a 9 on correctness due to the partial omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 409,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s lead regulator, the New York State Department of Financial Services, chairs an annual U.S. Supervisory College that brings together the NYDFS and the other state and foreign supervisors of MetLife’s subsidiaries; this group‑wide forum creates coordinated, “global” oversight of the company’s U.S. and international operations and gives regulators a fuller view of the group’s aggregate risk exposures. In Europe, EIOPA‑mandated Supervisory Colleges—run by regulators such as the Central Bank of Ireland—similarly pool information among European supervisors, allowing them to assess MetLife’s European‑based insurance and pension risks in a consolidated manner. Together, participation in both the NYDFS‑led and EIOPA‑led colleges deepens regulatory scrutiny, enhances information sharing, and helps MetLife identify and manage its overall risk profile across jurisdictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: MetLife's participation in Supervisory Colleges in the U.S. and Europe is accurately described, with proper attribution to NYDFS as the chair of the U.S. college and EIOPA's role in mandating European colleges, including involvement of the Central Bank of Ireland. The purpose—enhanced regulatory coordination, information sharing, and comprehensive risk assessment—is correctly articulated. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all descriptive metrics (e.g., 'annual', 'consolidated manner') align with the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the roles of NYDFS and EIOPA across jurisdictions and links them to MetLife’s global regulatory oversight and risk management. The answer captures the cross-border coordination and its impact on risk profile, fulfilling the multi-hop requirement. (4) Minor difference: the LLM slightly rephrases the outcome as helping MetLife manage its risk profile, whereas the original emphasizes the influence on regulatory environment and risk management practices—this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, contextually precise, and factually robust, warranting a high score with only slight room for fuller replication of the original's emphasis on regulatory influence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 424,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The lower ACL build—​the net ACL build fell to **$228 million in 2024 from $910 million in 2023**, mainly because the build for transfer‑risk exposures outside the United States (driven by U.S. banking‑law safety‑and‑soundness considerations) was much smaller.  That reduction in credit‑loss expense helped lift Citi’s **2024 net income to $4.93 billion**, which is **a 27 % increase versus 2023**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the 27% increase in net income and a net income figure close to $4.9 billion (reporting $4.93B vs. $4.9B), it incorrectly reports the ACL build amounts: $228 million in 2024 and $910 million in 2023. The ground truth does not provide these exact figures for total ACL build but instead states that the provision expense decreased from $406 million to $295 million, a $111 million reduction. The LLM's figures for ACL builds are not consistent with this, leading to incorrect underlying reasoning. (2) The calculation of the net income change is approximately correct (27% increase), and the final net income is close, but the key financial driver—the change in provision expense—is misrepresented in magnitude and baseline values. The LLM implies a much larger reduction in ACL build ($682 million decrease from $910M to $228M), which is not supported by the ground truth ($111 million decrease in provision expense). (3) The qualitative reasoning is sound in linking reduced ACL build for transfer risk outside the U.S. (due to U.S. banking law) to lower provision expense and higher net income. The multi-hop logic—connecting regulatory impact to credit loss accounting to net income—is correctly structured and relevant. (4) Contextual relevance is high as the answer addresses all parts of the question: the cause (U.S. banking law), the effect on ACL, and the impact on net income and percentage change. However, due to major quantitative errors in the reported ACL figures, the correctness score is limited to 6, as the core financial data underpinning the conclusion is inaccurate, even though the final net income and percentage change are close to correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 481,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Because roughly three‑quarters of Lockheed Martin’s international sales are made through foreign‑military‑sales (FMS) contracts, any delay or shortfall in U.S. government funding after the debt‑ceiling lapse could postpone the approval and payment of those FMS orders. The Aeronautics segment derives about 32 % of its net sales from international customers, most of which are tied to the F‑35 program that already has commitments from twelve FMS customers; a funding disruption would therefore likely slow F‑35 production and sustainment deliveries to those foreign buyers, compressing Aeronautics revenue and cash‑flow in 2025. (International Business: 73 % of international sales are FMS and 32 % of Aeronautics sales are international; Debt‑ceiling risk paragraph; F‑35 program description noting twelve FMS customers.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 73% of international sales are FMS, 32% of Aeronautics segment sales are international, and the F-35 has commitments from twelve FMS customers. These numbers match the ground truth exactly, with acceptable formatting (e.g., 'three-quarters' for 73% is a reasonable approximation). (2) Quantitative accuracy is perfect: all percentages and references to programs and customers are correct. No calculations were required, but the synthesis of proportions and their implications is accurate. (3) The multi-hop reasoning is sound: the model correctly links U.S. government funding disruptions due to the debt ceiling → impact on FMS contracts → effect on F-35 orders → consequences for Aeronautics segment revenue and production. It appropriately emphasizes the dependency chain and the segment’s exposure. (4) The only minor shortcoming is that the LLM slightly underemphasizes the prolonged, long-cycle nature of defense contracts mentioned in the ground truth, which is a nuance affecting financial performance over time. However, the core logic, entities, and causal链条 are accurately represented. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the question with precise linkages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 368,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31 2023, UnitedHealth Group had **approximately 70 million shares of common stock** remaining available for future issuance under its equity‑compensation plans (the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan). The company also noted that **about 191,000 shares** of common stock were underlying stock options that had been assumed through acquisitions. Thus, the shares available for future issuance (≈70 million) vastly exceed the shares tied to acquired options (≈0.19 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 70 million shares available for future issuance (comprising 53 million under the 2020 Stock Incentive Plan and 17 million under the ESPP, though the LLM does not break this down, it correctly reports the total), and 191,000 shares underlying assumed stock options from acquisitions. The LLM appropriately uses 'approximately' and 'about', which is consistent with reporting norms. (2) The answer addresses both parts of the multi-part question: the total shares available for future issuance and the comparison to shares from assumed options. (3) Entity accuracy is correct: UnitedHealth Group, the 2020 Stock Incentive Plan, and the reference to assumed options through acquisitions are all properly identified. The mention of the '1993 Employee Stock Purchase Plan' instead of the 'ESPP' is a minor naming variation but refers to the same plan. (4) The reasoning is sound: the LLM correctly synthesizes that the 70 million available shares vastly exceed the 191,000 assumed option shares, which reflects the correct multi-hop comparison. The semantic meaning and factual content are equivalent to the original answer, with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The Multi‑Year Equity Awards generated $794 million of stock‑based compensation expense in FY 2022, $596 million in FY 2023 and $356 million in FY 2024 – a three‑year total of **$1.746 billion**.  As of November 3 2024, the company reported **$11.259 billion** of unrecognized compensation cost for all unvested stock‑based awards, meaning the three‑year expense from the Multi‑Year Awards represents roughly **15 %** of the remaining unrecognized cost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $794 million (2022), $596 million (2023), and $356 million (2024) are correctly reported, and their sum is accurately calculated as $1.746 billion (equivalent to $1,746 million). The unrecognized compensation cost of $11.259 billion (i.e., $11,259 million) as of November 3, 2024, is also correct. The implied percentage (~15%) is a valid approximation (1,746 / 11,259 ≈ 15.5%), though not explicitly requested, and does not detract from accuracy. (2) The answer is complete, addressing both parts of the question: total SBC expense for 2022–2024 and comparison to unrecognized cost as of the specified date. (3) Entities are correct—'Multi-Year Equity Awards' and 'unvested stock-based awards' are properly referenced, and fiscal years align with the question. (4) Multi-hop reasoning is sound: the model correctly aggregates annual expenses across three years and compares them to the future unrecognized cost, demonstrating synthesis across time periods and award types. (5) Semantic equivalence is maintained—format variations (e.g., $1.746 billion vs $1,746 million) are acceptable and common in financial reporting. No factual, computational, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 363,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Citi’s minimum long‑term‑debt (LTD) requirement for 2024 is **9.5 % of its consolidated risk‑weighted assets (RWA)**. It is derived as the greater of two tests; the RWA‑based test equals **6 % of RWA plus the GSIB‑method‑2 surcharge of 3.5 % (6 % + 3.5 % = 9.5 %)**, which exceeds the alternative leverage‑based test of 4.5 % of total leverage exposure, so the 9.5 % figure is binding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total minimum LTD requirement for Citi in 2024 as 9.5% of RWA, which matches the ground truth. It accurately identifies the two components: the base 6% RWA requirement and the 3.5% GSIB method 2 surcharge, and correctly calculates their sum (6% + 3.5% = 9.5%). (2) All numeric values are correct and calculations are accurate. The mention of the alternative leverage-based test (4.5% of total leverage exposure) is additional context not in the original answer but is factually consistent with TLAC rules and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the 9.5% figure results from adding the base LTD requirement and the GSIB surcharge, and further explains that this RWA-based test is binding because it exceeds the leverage-based alternative. While the original answer does not mention the comparison with the leverage test, including it adds depth and reflects correct understanding of regulatory minimums being the 'greater of' tests. (4) The answer is semantically equivalent to the ground truth in terms of the core calculation and result. The only minor deviation is the inclusion of extra regulatory context (the leverage test), which enhances rather than detracts from accuracy. Thus, full points are awarded for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slightly expanded scope. Correctness score is 9 because all key facts are correct and reasoning is strong, though the original answer did not require discussion of the alternative test.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 444,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "Lockheed Martin projects that its qualified defined‑benefit pension plans will require about **$19.5 billion** in funding over the next ten years (the sum of the $1.8 bn‑$1.99 bn annual payments from 2025‑2029 plus the $9.99 bn total for 2030‑2034).  \n\nFrom 2025 to 2029 the required payments rise each year (‑ $60 m, $50 m, $50 m and $30 m increments), showing a **steady but decelerating upward trend**, which indicates that pension obligations are increasing modestly and the rate of growth is beginning to level off.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total projected funding requirement as $19.5 billion, which matches the ground truth of $19,510 million (equivalent to $19.51 billion, rounded appropriately). The annual figures from 2025 to 2029 are accurately represented in magnitude and trend: $1,800M, $1,860M, $1,910M, $1,960M, and $1,990M. The sum of these is $9,520 million, and adding the $9,990 million for 2030–2034 gives $19,510 million—correct. (2) All numbers are quantitatively accurate, with acceptable formatting variations (e.g., $1.8 bn = $1,800 million). The calculation of incremental increases is slightly misstated: the increases are +$60M (2026), +$50M (2027), +$50M (2028), and +$30M (2029), which the model reports correctly in amount but labels as '‑ $60 m, $50 m, $50 m and $30 m increments'—the dash before $60M is likely a typo but does not distort meaning. (3) The multi-hop reasoning is sound: the model synthesizes annual obligations from 2025–2029 and combines them with the lump-sum projection for 2030–2034. The trend analysis correctly observes a rising obligation with diminishing annual increases, supporting the conclusion of a 'decelerating upward trend'. (4) The qualitative assessment of 'leveling off' is a reasonable interpretation of the slowing growth rate, though the ground truth emphasizes 'growing financial obligation in the near term' without commenting on deceleration. This is a subtle difference in emphasis, not a factual error. All parts of the question are addressed: total funding and trend analysis. Scores reflect high accuracy with minor interpretive nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 443,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "Honeywell held **$1.151 billion** of mortgage‑/asset‑backed securities in 2021 (U.S. $1,072 m + non‑U.S. $79 m) and **$1.075 billion** in 2020 (U.S. $982 m + non‑U.S. $93 m). In each year the category was the **fourth‑largest component of total fixed‑income holdings**, accounting for roughly **5.7 % of all fixed‑income assets in 2021** and **5.5 % in 2020**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and percentages provided. According to the ground truth, Honeywell held $1,072 million in 2021 and $982 million in 2020, totaling $2,054 million. However, the LLM incorrectly reports $1.151 billion (i.e., $1,151 million) in 2021 and $1.075 billion ($1,075 million) in 2020, which are not supported by the ground truth. These inflated figures suggest inclusion of non-U.S. amounts ($79M and $93M) not mentioned or validated in the original answer, introducing unsupported data. (2) The percentages are also incorrect: the LLM states 5.7% in 2021 and 5.5% in 2020, whereas the correct figures are approximately 8.9% in 2021 ($1,072M / $12,041M) and 8.1% in 2020 ($982M / $12,106M). These miscalculations indicate either wrong inputs or flawed arithmetic. (3) The ranking claim—that this category was the 'fourth-largest component'—is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. The original answer only discusses proportion, not ranking. (4) While the LLM attempts to address both parts of the question (total value and proportion/ranking), it fails on quantitative accuracy due to incorrect numbers and calculations. The reasoning is unsound because it introduces unverified non-U.S. components and derives incorrect percentages. Despite this, the answer is contextually relevant as it addresses the right company, time frame, and investment category, and attempts multi-hop synthesis (aggregation across years and proportional analysis), albeit with erroneous data. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate score for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 472,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom replaced its once‑a‑year grant of RSUs with “Multi‑Year Equity Awards” that vest over four‑year blocks (and, because new awards are added each year, the overall vesting horizon now spans 4 – 7 years).  Consequently, stock‑based compensation expense is no longer booked largely in the grant year; instead it is spread out from the grant date through the full vesting period, producing a more gradual, multi‑year expense pattern rather than a concentrated, annual spike.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, all key numbers are correct: the 4-year vesting blocks and 4–7 year overall vesting horizon match the original answer. The shift from annual to multi-year awards is correctly described. (2) The explanation of expense recognition being spread from grant date through vesting, resulting in a more gradual pattern, aligns with the ground truth’s emphasis on prolonged and overlapping recognition. (3) The multi-hop reasoning is sound: the model correctly infers that combining four annual grants into a multi-year structure extends the expense timeline and changes the recognition pattern. (4) Minor nuance missing: the original specifies that the multi-year award 'encompasses four annual grant cycles into one award,' which the LLM implies but does not explicitly state. Also, the original emphasizes that prior grants were recognized over 4 years each, creating a rolling 4-year pattern, whereas now it extends to 7 years total—this contrast is slightly less detailed in the LLM answer. However, these omissions do not undermine the factual correctness. Wording differs but semantic meaning is equivalent. No calculation errors. Fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 353,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "U.S. banking‑law safety‑and‑soundness rules capped the amount of additional allowance for credit losses (ACL) that Citi could build for transfer‑risk exposures outside the United States. That restriction reduced the credit‑loss provisions recorded in both Legacy Franchises (which is reported within the All‑Other segment) and in the Markets segment. Legacy Franchises/All‑Other booked a provision for credit losses of **$1.115 billion**, while Markets booked a provision of **$0.463 billion**. Together, the two segments contributed about **$1.58 billion** to Citi’s total provision for credit losses in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the correct qualitative mechanism—U.S. banking law restricted ACL builds for non-U.S. transfer risk, reducing provisions in both Legacy Franchises and Markets. This aligns with the ground truth and shows sound reasoning. However, key quantitative inaccuracies undermine correctness. (2) The LLM states Legacy Franchises booked a provision of $1.115 billion, but the ground truth is $1.1 billion—close but not exact. More significantly, the LLM reports Markets' provision as $0.463 billion ($463 million), which matches the ground truth's 2024 Markets provision. However, the ground truth clarifies that Markets had a net ACL build of $295 million in 2024 vs $406 million in 2023—meaning the $463 million is not the ACL build but possibly the total provision including other components. The LLM conflates 'provision' with 'ACL build,' misrepresenting the nature of the number. The combined total of $1.58 billion is close to the ground truth's $1.563 billion but still inaccurate. The ground truth also includes a precise calculation of the total reduction ($175 million) from $1.738 billion to $1.563 billion, which the LLM omits. (3) The multi-hop reasoning is partially sound: the model correctly links U.S. banking law to reduced provisions in both segments and identifies their combined impact. However, it fails to compare year-over-year changes or explain the reduction trend, which is central to the question. It reports 2024 figures but does not derive or reference the 2023 baseline, missing a critical analytical step. (4) The contextual relevance is high—the answer addresses the right segments, law, and financial impact. Qualitative accuracy is moderate due to correct logic but flawed data interpretation. Quantitative accuracy is low due to incorrect or imprecise figures and missing comparative calculations. Correctness score is 6 due to mostly correct direction and framework but significant factual and numerical shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 534,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "Honeywell’s non‑U.S. pension plans held **$1,458 million** of insurance‑buy‑in contracts ( $767 million in 2020 + $691 million in 2021 ).  Together the two years’ plan assets were valued at **$16,846 million**, so the buy‑in contracts represented roughly **8.7 %** of the combined fair‑value assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively: The total value of insurance buy-in contracts is correctly calculated as $1,458 million ($767M in 2020 + $691M in 2021), and the combined total assets at fair value are correctly summed as $8,450M + $8,396M = $16,846M. The percentage is reported as approximately 8.7%, which rounds correctly from 8.66% (1,458 / 16,846 ≈ 0.08656). (2) All entities are correct: HON (Honeywell), Non-U.S. Plans, and the years 2020 and 2021 are accurately referenced. (3) The multi-hop reasoning is sound—information from two years and two different asset categories (buy-in contracts and total assets) is correctly synthesized. (4) The answer is semantically equivalent to the original, with only minor rounding in the percentage (8.7% vs 8.66%), which is acceptable and common in financial reporting. The slight loss in qualitative accuracy is due to not explicitly showing the full calculation for the percentage, but the result is still correct. Overall, the response is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 316,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s strategy ties technology leadership directly to “extensive internal research and development” (Item 1 Business, p. 3).  By investing R&D in its own engineering teams, the company continuously creates next‑generation CMOS, mixed‑signal and III‑V semiconductor products—such as high‑capacity, low‑latency Ethernet switching silicon, custom ASIC platforms and AI‑focused networking PHYs (Item 1 Business, p. 4).  This internal innovation pipeline lets the semiconductor segment stay ahead of the fast‑evolving AI data‑center and AI‑networking markets, preserving Broadcom’s technology‑lead position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Broadcom's emphasis on 'extensive internal research and development' is accurately cited from Item 1 Business, p. 3, and the connection to technology leadership in AI-related semiconductor markets is properly established. The mention of CMOS, mixed-signal, and III-V semiconductor products (e.g., Ethernet switching silicon, ASICs, AI-focused PHYs) reflects the same technical depth as the ground truth, including relevance to AI data-center and networking markets. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links Broadcom’s internal R&D strategy to its semiconductor segment and then to AI market leadership, synthesizing information from different parts of the filing (pp. 3–4). (4) The only minor shortcoming is that the LLM omits specific examples like gallium arsenide (GaAs) and indium phosphide (InP) and does not explicitly name optoelectronic/RF applications, which are present in the original and add technical specificity. However, the mention of 'III-V semiconductor products' implicitly covers this. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 389,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Qualcomm’s purchase‑agreement obligations total $12.8 billion, of which **$9.6 billion is expected to be paid in the next 12 months** (Note 7).  The same note shows that **advance payments made for its multi‑year capacity‑purchase commitments were $3.0 billion** as of September 29 2024.  \n\nThus, the amount Qualcomm expects to pay over the coming year is about **$6.6 billion more** than the total advance payments it has already made under those capacity commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are correct: $9.6 billion expected to be paid in the next 12 months under purchase agreements and $3.0 billion in advance payments as of September 29, 2024, are both accurately reported. The difference of $6.6 billion ($9.6B - $3.0B) is correctly calculated. (2) The answer addresses both parts of the multi-part question: the upcoming payment obligation and the comparison to advance payments. (3) Entities are correct—Qualcomm, purchase agreements, multi-year capacity purchase commitments, and the date are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes information from the same source note (Note 7) to compare near-term obligations with prepayments, concluding that upcoming payments exceed prepayments by a significant margin. The only minor shortcoming is that the LLM does not explicitly mention that the $9.6 billion relates primarily to integrated circuit product inventory obligations, which adds context but does not alter the core correctness. This omission slightly affects completeness but not factual accuracy. Overall, the answer is semantically equivalent to the ground truth with precise numbers and logical comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 358,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The reductions to GTN‑adjustment provisions were $159 million in 2024 versus $134 million in 2023 – a $25 million larger reduction in 2024. Both years’ reductions were caused by non‑U.S. revisions to clawback amounts that stemmed from changes in VAT‑recoverable estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the GTN adjustment reductions for 2024 ($159 million) and 2023 ($134 million), and accurately calculates the difference as $25 million, which matches the ground truth. All numeric values and the comparison are factually correct. (2) The quantitative accuracy is perfect—numbers match exactly, and the $25 million difference is correctly derived from 159 - 134. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is mostly sound: the answer correctly identifies the non-U.S. factor as revisions in clawback amounts due to changes in VAT-recoverable estimates. However, the phrasing 'both years’ reductions were caused by' slightly overgeneralizes, as the question focuses on the *change* between years, not the cause of both years' reductions. The original answer specifies that the *change* was due to revisions in VAT-recoverable estimates, not necessarily that both years' reductions were caused by the same factor. This is a minor nuance but does not invalidate the core reasoning. (4) The answer is contextually fully relevant, addressing both the quantitative difference and the non-U.S. contributing factor. The slight overstatement in causality does not undermine the factual correctness of the key elements, warranting a high score of 9/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 387,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send is the core “disbursements and remittances” application that lets consumers, businesses, governments and merchants move money domestically and across borders — thereby turning account‑to‑account transfers into a new, non‑card payment flow that expands Mastercard’s multi‑rail network and supports the company’s strategic goal of capturing additional payment volumes.  The service is delivered through partner ecosystems that include digital‑messaging and payment platforms as well as central banks, fintech firms and other financial‑institution partners that work with governments and non‑profit organisations to enable B2C disbursements and social‑assistance payouts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Mastercard Send is correctly identified as a core component of the disbursements and remittances strategy, enabling domestic and cross-border money movement for consumers, businesses, governments, and nonprofits. The connection to Mastercard's broader objective of capturing new payment flows via multi-rail expansion is accurately articulated. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how Mastercard Send supports strategic goals by leveraging partner ecosystems. The partner types—central banks, fintechs, and financial institutions—are accurately mentioned, along with their role in enabling B2C disbursements and social assistance payouts. The addition of 'digital-messaging and payment platforms' as partners is not explicitly in the ground truth but does not contradict it and may reflect a slight expansion of detail from the 10-K; this does not detract from accuracy. (4) Semantic equivalence is strong: the LLM conveys the same core information with only minor rephrasing and slight elaboration. The term 'merchants' in the LLM answer slightly diverges from the ground truth's 'nonprofits' and 'governments', but the overall context of disbursements remains intact. No critical information is missing, and the strategic linkage to non-card payment flows and multi-rail networks is a correct and insightful addition. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy by default.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 479,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard’s “Other revenues” now include a distinct line‑item for Cyber and Intelligence Solutions fees – the fraud‑prevention and detection services that the company added to its suite of value‑added offerings.  Like the other value‑added services (data‑analytics, loyalty, consulting, etc.), these fees are recorded as revenue in the period the related service is performed or the transaction occurs, with any prepaid amounts booked as deferred revenue and amortized over the contract term (about $1.3 billion of such obligations are slated to be recognized through 2024).  Thus, the cyber‑solution addition broadens the composition of “Other revenues” and keeps its recognition aligned with service delivery rather than upfront cash receipt.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyber and Intelligence Solutions are part of value-added services and contribute to 'Other revenues,' with revenue recognition tied to service performance, which aligns with the ground truth. The explanation of deferred revenue amortization over the contract term is a reasonable extension of accounting principles. However, the ground truth does not mention the $1.3 billion deferred revenue figure or the 2024 recognition timeline, making this an unsupported addition not present in the original data. (2) The $1.3 billion amount and the reference to obligations being recognized through 2024 are specific quantitative claims absent from the original answer and cannot be verified against the provided ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is sound—correctly linking the introduction of a new service to its impact on revenue composition and timing—and the synthesis of service-based recognition logic is consistent with the original answer’s principles. (4) While the core facts about composition and recognition timing are correct and well-articulated, the inclusion of unverified financial figures lowers the quantitative accuracy. The answer remains contextually relevant and semantically aligned on key points, warranting a high but not top correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 378,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The fair value of CAT’s mortgage‑backed debt securities rose from $452 million at 12/31/2022 (U.S. agency $333 m + residential $2 m + commercial $117 m) to $540 million at 12/31/2023 (agency $410 m + residential $2 m + commercial $128 m), a **increase of $88 million**.  \n\nDuring the same period the unrealized loss on those securities fell from **$41 million** (agency $31 m + commercial $10 m) to **$34 million** (agency $25 m + commercial $9 m), a **decrease of $7 million** in unrealized losses.  \n\nThus, while fair value rose $88 million, the unrealized loss position improved by $7 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, the fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million to $320 million (a $7 million decrease), whereas the LLM claims an increase from $452 million to $540 million ($88 million increase). These numbers do not match any part of the ground truth and appear fabricated. Similarly, the ground truth states that unrealized losses increased from $31 million to $25 million — which is actually a decrease in losses of $6 million — but the LLM reports unrealized losses decreasing from $41 million to $34 million (a $7 million improvement), which again does not align with the original data. (2) All calculations are based on incorrect inputs: the LLM performs math on wrong values (e.g., $540M - $452M = $88M) and misrepresents both the starting and ending figures for fair value and unrealized losses. Even the component breakdowns (e.g., U.S. agency, residential, commercial) are not present in the ground truth and appear to be hallucinated. (3) The multi-hop reasoning is flawed: the model fails to correctly retrieve or synthesize data across time periods and metrics. It incorrectly identifies both the direction and magnitude of changes in fair value and unrealized losses. While it attempts to compare the two metrics (fair value change vs. change in unrealized losses), the comparison is based on entirely inaccurate data. (4) The contextual relevance is low because the answer discusses the right type of securities and metric changes, but with wrong entities, numbers, and time-series data. The qualitative reasoning structure (comparing fair value movement to change in unrealized losses) is sound in form but invalid in substance due to factual inaccuracies. Hence, only minimal credit is given for attempting the correct analytical framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 513,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "Qualcomm’s marketable‑securities portfolio shows a fair‑value of **$4.6 billion** for corporate bonds and notes (Level 2). The fair value of U.S. Treasury and other government‑related securities is **$208 million**, which represents roughly **3.8 %** of the total marketable‑securities fair value of **$5.45 billion** (the corporate bonds and notes therefore account for about 85 % of the portfolio).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences that do not affect meaning. (1) All key numbers are correct: corporate bonds and notes at $4.6 billion (matches $4,634 million, rounded appropriately), U.S. Treasury and government-related securities at $208 million, and total marketable securities at $5.45 billion (matches $5,451 million). Percentages are accurate: 3.8% for government securities and ~85% for corporate bonds (calculated as 4,634 / 5,451 ≈ 85%). (2) Quantitative accuracy is perfect—allowing for standard rounding and format variation (e.g., $4.6 billion vs $4,634 million). (3) The reasoning is sound: the LLM correctly infers that corporate bonds represent about 85% of the total by implication, even without explicitly stating the percentage in the same sentence, by correctly stating the total and the component values. (4) The answer is contextually relevant and complete, addressing both parts of the question: total fair value of corporate bonds and comparison as a percentage of total marketable securities. The only minor shortcoming is that the LLM does not explicitly state the 85% comes from corporate bonds (though it's logically implied), slightly weakening qualitative clarity. Otherwise, all entities (Qualcomm, corporate bonds, U.S. Treasury, marketable securities) are correctly identified and synthesized across the required hops.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 396,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "Merck can obtain the FDA’s six‑month pediatric‑exclusivity award for Keytruda by completing the required pediatric studies.  That six‑month period is tacked onto the expiration of the compound‑patent family (currently listed as 2028) and also onto the later‑expiring discovery‑patents that run to 2029, so the product remains protected at least through 2029‑early 2030, well after the original patent term would have ended.  By keeping generics off the market for an additional half‑year (or more when the later‑expiring patents are considered), Merck preserves Keytruda’s multi‑billion‑dollar contribution to its oncology franchise, effectively extending that revenue stream for the same period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism of pediatric market exclusivity (six months) and its application to extend market protection beyond compound patent expiration, which aligns with the ground truth. It also correctly notes that this exclusivity can be added to existing patents, delaying generic entry and preserving revenue. However, the LLM introduces specific patent expiration dates (2028 for compound patent, 2029 for discovery patents) that are not present in the original answer or supported by the cited evidence sources (evidence_source_a and evidence_source_b). These dates are speculative and not part of the ground truth, which only references the *possibility* of pediatric exclusivity and potential Patent Term Extension without specifying timelines. (2) The quantitative inaccuracies stem from these unsupported dates—while the six-month exclusivity period is correct, the assertion that protection extends 'through 2029-early 2030' is an overreach not grounded in the provided evidence. The original answer makes no such projections. (3) The reasoning is logically sound in terms of how pediatric exclusivity works and its financial implications—delaying generics, preserving revenue, and supporting oncology revenue streams—which reflects proper multi-hop synthesis between regulatory strategy and financial impact. However, it goes beyond the evidence by constructing a timeline not present in the sources. (4) Despite the unsupported dates, the core concept—using pediatric exclusivity to extend market protection and thereby protect oncology revenue—is accurately conveyed, warranting a score of 7 for correctness. The qualitative and contextual scores are higher because the explanation is coherent and relevant, but quantitative accuracy is penalized due to the introduction of unverified dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 500,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard Installments is an open‑loop “buy‑now‑pay‑later” product that connects lenders with merchants on Mastercard’s acceptance network, letting consumers choose installment‑payment options at checkout in web, mobile‑app and other digital experiences. By launching this new digital‑credit flow in 2022, Mastercard adds a non‑card‑based payment channel to its multi‑rail network, using the same technology platform that powers its broader innovation agenda, thereby directly advancing its strategic priority to scale digital payment services across multiple channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mastercard Installments is correctly described as an open-loop buy-now-pay-later product launched in 2022 that connects lenders and merchants via Mastercard’s network. The mention of web, mobile-app, and other digital experiences matches the strategic focus on digital channels. (2) Quantitative accuracy is perfect: the year 2022 is correctly cited, and no numerical values require calculation. (3) The multi-hop reasoning is sound—linking the product launch to Mastercard’s broader innovation agenda and multi-rail network demonstrates synthesis across strategic and technical dimensions. (4) The LLM captures the core strategic intent—expanding digital payment services across channels—but omits a few elements from the original answer, such as explicit mention of 'diversifying the payments ecosystem' through digital currency solutions and capturing new payment flows. While the essence is preserved, this minor omission in scope prevents a perfect 10 on qualitative accuracy. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 330,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Merck’s profit‑sharing charge to Ridgeback for 2024 equals half of the collaboration’s profit (because the partners split profit 50/50).  \n\n- Net sales of Lagevrio recorded by Merck: $964 million  \n- Cost of sales (which includes the profit‑sharing amount): $554 million  \n\nProfit = $964 m – $554 m = $410 million.  \nMerck’s 50 % share of that profit = $410 m ÷ 2 = **$205 million**, which is the portion of the profit‑sharing payments recorded within Cost of sales in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The original answer (ground truth) states that Merck's profit-sharing payments recorded within Cost of sales corresponded to 50% of the profits from the Lagevrio collaboration due to the equal profit split, but it does not provide specific dollar amounts or assert that the profit-sharing amount was $205 million. The LLM answer fabricates numerical data (e.g., $964 million net sales, $554 million cost of sales) that are not present in the original answer or implied by the question. Furthermore, it performs a calculation based on these invented figures, leading to a specific dollar amount ($205 million), which is not supported by the ground truth. There is no mention of actual financial figures in the original answer, so introducing them constitutes a serious factual deviation. The reasoning is internally logical but based on false premises, and the multi-hop synthesis fails because it invents data rather than relying on the provided knowledge. The answer is not semantically equivalent—it adds quantifiable claims absent in the original. Thus, the correctness, quantitative accuracy, qualitative accuracy, and contextual relevance are all extremely low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 338,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) gives BlackRock a fast‑track FCA registration for funds that are domiciled outside the United Kingdom – most of its European‑domiciled vehicles (e.g., Luxembourg, Ireland, the Netherlands) – but the regime only permits those funds to be marketed to UK retail investors if the consumer‑protection framework in the EU country where the fund is established is judged to be **equivalent** to the UK’s own regime. Equivalence therefore requires that the EU domicile’s rules on investor safeguards – such as disclosure, valuation, asset segregation and other FCA‑style consumer‑protection standards – be at least as robust as the UK’s, allowing the fund to be recognised under OFR and sold in the UK.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that under the Overseas Fund Regime (OFR), BlackRock can market its European-domiciled funds (e.g., in Luxembourg, Ireland) in the UK only if the consumer protection regime of the domicile country is deemed 'equivalent' to the UK's. The answer elaborates appropriately on the equivalence requirement, specifying relevant investor safeguards such as disclosure, valuation, and asset segregation, which aligns with the intent and content of the original answer. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects correct multi-hop synthesis: linking OFR → BlackRock’s EU fund structures → equivalence determination → impact on UK market access. The only minor shortcoming is that the original answer emphasizes the potential need for structural or compliance adjustments, which the LLM answer implies but does not explicitly state. However, this does not detract significantly from the overall correctness. All entities (OFR, BlackRock, EU/UK regulatory context) are accurately referenced. The response is fully contextually relevant and directly addresses both parts of the question: interaction with European structures and equivalence requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 374,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom manufactures its FBAR (film‑bulk‑acoustic‑resonator) filters in‑house rather than outsourcing them. By keeping the proprietary FBAR process inside its own U.S. and Singapore fabs, Broadcom protects the unique IP behind the filters and can move new designs to volume faster, delivering the higher‑performance, low‑power components that mobile handsets require. That control over a key, differentiated technology gives Broadcom a clear performance‑and‑time‑to‑market edge in the highly competitive cellular‑handset market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures Broadcom's in-house manufacturing of FBAR filters as a strategic move to protect intellectual property and accelerate time to market—both of which are key drivers of competitive advantage in the cellular handset market. The mention of U.S. and Singapore fabs adds contextual detail not in the original answer but is consistent with known Broadcom operations and does not contradict the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: connecting internal manufacturing → IP protection and faster design cycles → competitive edge in a high-performance, fast-moving market. The only minor deduction in qualitative accuracy is for slightly expanding on the original with location specifics (U.S. and Singapore), which, while plausible and likely true, are not present in the verified ground truth. However, this does not affect the correctness of the core claim. The answer is fully contextually relevant and directly addresses how the manufacturing strategy supports competitive advantage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 345,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck layers a patent‑term restoration (PTE) of up to five years on its biologic patents and then relies on the statutory regulatory data/marketing exclusivity that the FDA grants to biologics – a twelve‑year protection period from first licensure (with an additional six‑month pediatric exclusivity if required, and a seven‑year term for orphan‑designated products). By stacking the PTE with the 12‑year U.S. data‑exclusivity (plus any pediatric or orphan extensions), Merck can keep competitors out well beyond the underlying patent expiration.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core mechanisms Merck uses to extend market protection for its biologic products. It correctly identifies the 12-year U.S. regulatory data exclusivity period for biologics and the additional six-month pediatric exclusivity, aligning with the ground truth. It also appropriately mentions the concept of stacking patent-term restoration (PTE) with regulatory exclusivity, which reflects accurate multi-hop reasoning about how Merck extends market protection. However, there is a minor inaccuracy regarding 'patent-term restoration (PTE) of up to five years'—this typically applies to small-molecule drugs under the Hatch-Waxman Act, not biologics, which are not eligible for PTE in the same way. Biologics may benefit from patent term adjustments (PTA) due to USPTO delays, but not restoration for regulatory review time. Additionally, the mention of a 'seven-year term for orphan-designated products' is accurate for orphan drug exclusivity but was not part of the original answer and is not specific to biologics exclusivity under the BPCIA; including it introduces information beyond the scope of the ground truth, though it is not factually incorrect. Quantitatively, the 12-year and 6-month durations are correct. The reasoning is strong and contextually relevant, but the inclusion of PTE and orphan exclusivity slightly overextends the answer beyond the verified facts in the ground truth, warranting a deduction in quantitative and correctness scores despite strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 422,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms add tailored reporting obligations for proxy advisers and investment consultants, meaning BlackRock must provide more detailed, client‑specific stewardship disclosures for its UK‑based activities. Those additional reporting and data‑collection requirements raise the firm’s compliance workload and costs in the UK and will likely force BlackRock to deepen its engagement with clients around proxy‑voting and stewardship practices to meet the new standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth in key aspects. (1) It correctly identifies the 2024 UK Stewardship Code reforms, specifically the tailored reporting requirements for proxy advisers and investment consultants, which aligns with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected and scores perfectly. (3) The reasoning is sound: the LLM correctly infers that increased reporting obligations lead to higher compliance costs and operational adjustments, and it appropriately links these changes to client engagement, particularly around proxy voting and stewardship practices. (4) The LLM captures the core impact on compliance costs and client engagement but omits some qualitative risks mentioned in the original answer—specifically, regulatory sanctions, reputational risk, and potential client asset withdrawals due to FCA Consumer Duty rules. While the omission of these downstream risks slightly reduces completeness, the central cause-effect logic (reforms → reporting burden → higher costs and deeper client engagement) is well-supported and contextually appropriate. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 370,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The AspenTech segment’s depreciation‑and‑amortization expense rose from **$95 million in fiscal 2021 to $242 million in fiscal 2022**, a **$147 million increase**【8†L31-L34】.  The jump is largely attributable to the Heritage AspenTech purchase: the 2022 amortization of intangibles line notes that **$148 million of the amortization expense relates to the Heritage AspenTech acquisition**【19†L9-L12】, which directly added intangible assets that are now being amortized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, rising from $95 million in fiscal 2021 to $242 million in fiscal 2022, which matches the ground truth exactly. The calculation is accurate and numbers are correctly cited. (2) The LLM adds a specific detail not present in the original answer—$148 million of the amortization expense relates to the Heritage AspenTech acquisition—which is consistent with the reasoning in the ground truth that the acquisition led to additional intangible assets requiring amortization. While the $148M figure slightly exceeds the total increase ($147M), this may reflect rounding or allocation of acquisition-related amortization across segments or periods, and does not constitute a material error given the context. (3) The multi-hop reasoning is sound: the model connects the acquisition to the recognition of intangible assets and links that to increased amortization, correctly synthesizing information across time and entities. (4) The answer is semantically equivalent to the ground truth, with slightly more granular data. The only minor deviation is the $148M attribution versus the $147M increase, which could imply a small over-attribution but does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 400,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "Broadcom’s Subscriptions & Services revenue in Asia Pacific rose from $720 million in FY 2021 to $744 million in FY 2022 – an increase of **$24 million** year‑over‑year. That $24 million accounts for roughly **6.6 %** of the total global increase in Subscriptions & Services revenue (which grew by $362 million from FY 2021 to FY 2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the year-over-year increase in Subscriptions & Services revenue in the Asia Pacific region as $24 million, rising from $720 million in FY 2021 to $744 million in FY 2022, which matches the ground truth. It also correctly states the total global increase in the segment as $362 million. However, the critical error lies in the percentage contribution: the LLM claims the $24 million increase accounts for 'roughly 6.6%' of the global growth, whereas the ground truth states it contributed approximately 0.35%. This is a major quantitative and reasoning error. The correct calculation is (24 / 362) ≈ 0.0663 or 6.63%, which suggests the LLM performed the percentage calculation correctly—but the ground truth asserts 0.35%, which contradicts basic arithmetic. Upon review, the ground truth appears to contain an error: 24/362 is indeed ~6.6%, not 0.35%. Unless 'contribution to total global growth' refers to a different metric (e.g., percentage point contribution to growth rate, not revenue increase), the LLM's 6.6% is mathematically correct. However, since the evaluation must follow the provided ground truth as authoritative, the LLM is marked incorrect despite likely correct reasoning. (2) All dollar amounts and years are accurate. (3) The multi-hop reasoning—linking regional revenue change to global segment growth—is sound and properly synthesized. (4) Due to the conflict between mathematical correctness and the stated ground truth, the correctness score is moderate: the LLM's numbers are right, but it contradicts the expected answer on a key metric. The qualitative score suffers due to the discrepancy in interpretation, though reasoning appears valid. Contextual relevance is high as all parts of the question are addressed with relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 489,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The December 2023 FTC‑DOJ merger guidelines tighten the antitrust review of “strategic investments or acquisitions,” meaning BlackRock will face stricter scrutiny, higher information‑submission requirements and longer waiting periods that can slow or block deals it would use to grow its platform. The same guidance also expands the scope of HSR‑reportable transactions, so BlackRock‑managed funds that trigger HSR filing must incur additional reporting costs and may experience delays or restrictions on completing those acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 2023 joint merger guidelines by the FTC and DOJ increase scrutiny, compliance burden, reporting costs, and delays for HSR-reportable transactions. The December 2023 timing aligns with the actual release date of the guidelines, which is consistent with the original answer’s reference to the 2023 guidelines. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023) are correct. (3) Multi-hop reasoning is sound: the answer correctly links the new guidelines to increased scrutiny for BlackRock’s acquisition strategy and extends the impact to BlackRock-managed funds involved in HSR-reportable deals, demonstrating proper synthesis across regulatory policy and corporate activity. (4) The LLM slightly strengthens the language by mentioning 'longer waiting periods' and 'can slow or block deals,' which are reasonable inferences from increased scrutiny and delays, though not explicitly stated in the original. However, this does not introduce inaccuracy but adds context. The expansion of HSR-reportable transactions is accurately noted. No factual errors; minor wording differences do not affect meaning. Thus, correctness is high with only a slight deduction possible due to inferential phrasing, but overall the answer matches the ground truth in substance and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 408,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs grants non‑employee directors RSU awards under two separate agreements—one that settles in the company’s own stock (Exhibit 10.31) and one that settles in cash (Exhibit 10.32). The stock‑settled RSUs are accounted for as equity‑‑the fair‑value of the award is expensed over the vesting period and a corresponding increase is recorded in additional paid‑in‑capital—so they appear in the equity section of the balance sheet. The cash‑settled RSUs are treated as a liability‑‑the fair‑value is re‑measured each reporting period, with the expense recorded against a cash‑settlement liability that is shown under current (or long‑term) liabilities on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Goldman Sachs uses both stock-settled and cash-settled RSUs for non-employee directors, with stock-settled RSUs classified as equity and cash-settled as liabilities under GAAP. The accounting treatment is correctly described—equity awards are expensed over vesting with a charge to additional paid-in capital, while liability awards are remeasured each reporting period and recorded as a liability on the balance sheet. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a traditional sense, but all references to accounting treatments involving valuation and timing are factually sound. (3) The multi-hop reasoning is solid: the model correctly synthesizes that differing settlement terms (stock vs. cash) lead to different classification (equity vs. liability), which in turn affects measurement and presentation—this is the key insight required. (4) The only minor discrepancy is the reference to Exhibit 10.31 for stock-settled awards, whereas the ground truth cites Form 10.8. This is a small inconsistency in document labeling, but does not affect the correctness of the accounting principles described. Overall, the answer is semantically equivalent and demonstrates strong understanding of the financial reporting implications. Hence, a score of 9 is appropriate—excellent but with a minor documentation reference variance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 421,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023 Abbott Laboratories granted **4,981,231 restricted‑stock units (RSUs)** under its 2017 Incentive Stock Program. The program documentation states that **RSUs vest over a three‑year period**, at which time the recipient receives one share of Abbott common stock for each vested unit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurately reported with no discrepancies. (2) The vesting condition is correctly described: RSUs vest over a three-year period, and upon vesting, each unit converts to one share of Abbott common stock, which aligns exactly with the program documentation. (3) The response addresses both parts of the multi-hop question: the quantity granted in 2023 under the specified program and the associated vesting terms. (4) All entities — Abbott Laboratories, the 2017 Incentive Stock Program, restricted stock units — are correctly identified and contextually appropriate. (5) The wording differs slightly (e.g., 'three-year period' vs 'three years') but maintains semantic equivalence. No calculation or reasoning errors are present. The answer is factually precise, complete, and directly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 277,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "In 2024, 35 % of Danaher’s Life Sciences segment revenue came from markets outside North America (44 %) and Western Europe (21 %) – the sum of “other developed markets” (7 %) and “high‑growth markets” (28 %)【source】. The segment was created in 2005 through the acquisition of Leica Microsystems, and the sizable share of sales from non‑core regions demonstrates how that acquisition has driven long‑term geographic diversification and growth into high‑growth markets beyond Danaher’s traditional North American and Western European customer base【source】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 35% of Danaher's 2024 Life Sciences segment sales came from regions outside North America (44%) and Western Europe (21%), accurately breaking this down into 7% from other developed markets and 28% from high-growth markets. All percentages match the ground truth exactly. (2) The calculation is correct: 7% + 28% = 35%, and the exclusion of North America and Western Europe is properly interpreted. Number formats and values are consistent with the original answer. (3) The reasoning correctly links the 2005 acquisition of Leica Microsystems to the long-term geographic diversification strategy. It accurately describes Leica as foundational to the Life Sciences segment and notes the resulting expansion into high-growth markets. However, while the original answer explicitly names subsequent acquisitions (Beckman Coulter, Pall, Abcam) as part of the strategic expansion enabled by Leica, the LLM answer omits these specific examples, slightly weakening the multi-hop synthesis. This is a minor omission but does not invalidate the overall logic. (4) The answer is factually correct, contextually relevant, and conveys the core strategic impact. The only reason for not scoring a perfect 10 is the lack of specific follow-on acquisitions that strengthen the causal chain in the original. Quantitative accuracy is flawless, qualitative reasoning is strong but slightly less detailed, and relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 406,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has completed **nine acquisitions** in its Life Sciences segment since establishing the business in 2005. The acquisition of **Pall occurred in 2015**, and the **most recent acquisition noted is Abcam in 2023**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Danaher made nine acquisitions, but the ground truth confirms only eight: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023). The LLM overcounts by one, which is a critical quantitative error. (2) While the years for Pall (2015) and Abcam (2023) are correctly identified—addressing two key parts of the question—the total count is incorrect. The question explicitly asks for the total number of acquisitions since 2005, so the numerical accuracy is compromised. (3) The reasoning shows partial multi-hop synthesis: the model correctly identifies Pall and Abcam with accurate years and links them to the Life Sciences segment, but fails to accurately enumerate or consolidate the full list, suggesting a gap in data aggregation across filings or internal knowledge. (4) Despite the incorrect total, the answer is contextually relevant and captures the most recent and a major acquisition correctly. Wording and structure are clear and responsive. However, the overstatement of acquisitions significantly affects factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is scored lower (5) due to the incorrect count, while qualitative and contextual scores reflect accurate entity and temporal identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 391,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "Abbott’s interest‑rate‑swap fair‑value hedge fell from **$210 million at 12/31/2020 to $87 million at 12/31/2021**, a **decrease of $123 million**.  The same $123 million drop is reflected in the hedge’s receivable position, which fell from $210 million to $87 million, showing that the contract’s fair‑value loss translated directly into a lower receivable balance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, resulting in a $123 million decrease, which is correctly calculated and reported. The receivable position is also correctly stated to have declined by the same amount, from $210 million to $87 million. (2) The answer is complete, addressing both parts of the question: the change in fair value and its reflection in the receivable position. (3) Entity accuracy is correct—'Abbott' and 'interest-rate hedge contracts' (referred to as 'interest-rate-swap fair-value hedge') are properly identified, and the time periods (December 31, 2020, and December 31, 2021) are exact. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: the LLM correctly infers that the drop in fair value directly corresponds to the drop in the receivable position, indicating a coherent understanding of how hedge accounting impacts balance sheet items. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual content and logical conclusion. No errors in facts, calculations, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 355,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMS’s strategy emphasizes growing its autologous CAR‑T franchise – it already has two approved CAR‑T products and is “expanding manufacturing capacity, exploring innovative technologies … and exploring new indications with Breyanzi to include CLL, FL and MCL”【page 50‑51】.  That focus is bearing out commercially: U.S. revenues for Breyanzi “doubled in sales primarily due to higher demand” in 2023【page 41】, showing that the pipeline‑expansion and indication‑broadening efforts are directly driving the sharp revenue increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY (Bristol Myers Squibb, referred to as BMS) pursued new indications for Breyanzi—CLL, FL, and MCL—as part of its strategy to expand its autologous CAR-T franchise. The U.S. revenues for Breyanzi doubled in 2023 due to higher demand, which is explicitly stated in both the LLM and original answers. (2) Quantitative accuracy is perfect: 'doubled in sales' matches the ground truth's 'doubling of U.S. revenues for Breyanzi in 2023'; no calculations are required, and the year 2023 is correctly cited. (3) Multi-hop reasoning is sound—the LLM correctly links the strategic focus on pipeline expansion and new indications to the observed commercial success, demonstrating synthesis between R&D strategy and financial performance. (4) The only minor issue is the use of 'BMS' instead of 'BMY' in the response, though both refer to the same company (Bristol Myers Squibb), and this does not impair understanding. Additionally, the LLM cites specific pages (50-51, 41), which enhances credibility but were not part of the ground truth; however, this is a positive addition, not an error. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 363,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The Binding Site Group acquisition required a cash outflow of **about $2.7 billion** in 2023.  That amount made up roughly **three‑quarters of the total cash used for acquisitions that year** – the combined cash outflows for The Binding Site Group ($2.7 bn) and CorEvitas, LLC ($0.91 bn) total **≈ $3.6 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the cash outflow for The Binding Site Group as $2.7 billion (ground truth: $2.70 billion), and CorEvitas, LLC as $0.91 billion, with a total of approximately $3.6 billion (exact sum: $3.61 billion). The use of 'about' and '≈' is acceptable given the rounding. (2) All numeric values are accurate within reasonable rounding: $2.7B + $0.91B = $3.61B, which the model reports as ≈$3.6B — this is a minor and acceptable simplification. The claim that The Binding Site Group made up 'roughly three-quarters' is also correct: $2.7B / $3.61B ≈ 74.8%, which rounds to three-quarters. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two acquisitions (The Binding Site Group and CorEvitas, LLC) to compute total cash used for acquisitions in 2023. (4) The answer is semantically equivalent to the ground truth, with slightly more interpretive phrasing (e.g., 'three-quarters') but no factual deviation. The only minor point preventing a perfect 10 is the slight rounding of $3.61B to $3.6B without explicit acknowledgment, though this is common and acceptable in financial communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 327,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The company said that the restructuring and related actions generated roughly $0.3 billion of charges in each of 2024 and 2023, and that those actions are expected to produce about $0.2 billion of annual cost savings in 2024 and $0.6 billion in 2023 – a combined estimated $0.8 billion of annual savings.  \n\nThe 2023 acquisition of The Binding Site Group added specialty diagnostic assays and instruments focused on multiple‑myeloma and other blood‑cancer/immune‑system disorders, expanding the Specialty Diagnostics portfolio and positioning the segment for strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total estimated annual cost savings of $0.8 billion, with $0.2 billion from 2024 restructuring charges and $0.6 billion from 2023 charges, matching the ground truth exactly. The phrasing 'about $0.2 billion' and 'about $0.6 billion' is semantically acceptable as an approximation and does not detract from factual accuracy. (2) All numeric values and the sum ($0.2B + $0.6B = $0.8B) are accurate and correctly calculated. The years (2023 and 2024) are correctly attributed to their respective savings figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes cost savings from two years and links the 2023 acquisition to strategic growth in blood cancer diagnostics. The acquisition's contribution—adding diagnostic assays and instruments for multiple myeloma and blood cancer—is accurately described and aligns with the Specialty Diagnostics segment's strategic goals. (4) The only minor limitation is that the LLM slightly softens precision with 'about' and 'roughly', though this does not constitute an error given typical reporting language. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth. Hence, high scores across all dimensions with a 9/10 on correctness and qualitative accuracy due to slight wording hedging.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 379,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest‑term debt instrument shown in Eli Lilly’s 2023 Form 10‑K is the **1.375 % Notes due 2061**【source†L1-L12】. Its maturity in 2061 is later than all of the other listed notes, which mature between 2025 and 2051, making it the furthest‑out obligation in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the longest-term debt instrument as the 1.375% Notes due 2061, matching the ground truth in both interest rate and maturity year. The maturity year (2061) is accurately compared to the other debt instruments, with the LLM noting that other notes mature between 2025 and 2051, which aligns with the ground truth mentioning the 0.500% Notes due 2033 and 1.125% Notes due 2051. All numeric values (percentages and years) are correct, satisfying quantitative accuracy. The answer is semantically equivalent to the original, though it generalizes the range of other maturities (2025–2051) rather than citing specific examples. This minor omission of specific note details (e.g., 0.500% and 1.125% Notes) does not detract from the core correctness but slightly reduces qualitative completeness in multi-hop synthesis. The reasoning is sound, correctly identifying the latest maturity and making a valid comparison. Contextual relevance is strong, directly addressing both parts of the question: identifying the longest-term instrument and comparing its maturity to others.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 312,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is being pursued for **two distinct indications** – early Alzheimer’s disease (submitted for review in the U.S., EU and Japan) and pre‑clinical Alzheimer’s disease (in a Phase III trial)【...】.  \n\nLebrikizumab has only one indication – atopic dermatitis – which has already been approved in the EU and Japan and is under U.S. regulatory review【...】.  \n\nSo, Donanemab has **2** indications in development/review, whereas Lebrikizumab has **1** approved or under‑review indication.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Donanemab is under development or review for 2 indications, and Lebrikizumab has 1 indication (atopic dermatitis) that is either approved or under review. The comparison stating Donanemab has more indications is correct. (2) The answer is complete, addressing both parts of the question: the total number of indications for Donanemab and the comparison with Lebrikizumab. (3) Entity accuracy is perfect: both drugs are correctly identified, along with their respective indications and regulatory statuses across regions (U.S., EU, Japan). (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly aggregates Donanemab’s two distinct Alzheimer’s-related indications (early and preclinical) and recognizes that Lebrikizumab’s approvals and review all pertain to a single indication. (5) Semantic equivalence is achieved—though the LLM provides slightly more detail (e.g., specifying regions of submission), the core information and conclusion align exactly with the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 332,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The drop in U.S. Alimta sales – its volume fell after multiple generics entered the market – served as a drag on the overall U.S. volume increase, partially offsetting the year‑over‑year growth.  By contrast, the oncology drug **Verzenio** helped lift U.S. volume, being one of the products that drove the positive volume growth in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the decline in Alimta's U.S. revenue due to generic entry negatively impacted overall U.S. volume growth, which aligns with the ground truth. It also correctly identifies Verzenio as a positive contributor to U.S. volume growth in oncology. However, the LLM omits mention of Trulicity, which is explicitly listed in the original answer as another product contributing positively. This is a minor omission affecting completeness but does not invalidate the core correctness. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; the LLM does not introduce any false quantitative claims, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model connects Alimta’s generic competition to its revenue decline and links that to overall volume impact, then contrasts it with positive contributors. The reasoning chain is logical and supported by the source, though incomplete due to missing Trulicity. (4) The answer is contextually fully relevant and semantically close to the original, with only partial completeness in listing all offsetting products. Hence, correctness is high but not perfect due to the omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 348,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Merck’s V940 (mRNA‑4157) collaboration with Moderna required a $250 million option payment in 2022, which was recorded as a research‑and‑development expense, and the company continues to shoulder its 50 % share of the program’s development costs – reflected in the collaboration‑specific R&D charges of $288 million in 2022 and $218 million in 2023. These outlays are part of Merck’s broader immuno‑oncology pillar, which positions V940 alongside Keytruda‑based combos and other checkpoint‑targeted co‑formulations as a key “personalized neo‑antigen” strategy to deepen and diversify its immuno‑oncology pipeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $250 million option payment in 2022 and Merck's 50% cost-sharing arrangement with Moderna, which aligns with the ground truth. However, it introduces two specific R&D expense figures—$288 million in 2022 and $218 million in 2023—that are not present in the original answer or supported by the provided knowledge graph. These numbers, while plausible, are factually unverified in this context and represent a significant quantitative overreach. (2) The calculation of total financial commitment is implied but not explicitly summed; the original answer does not provide annual R&D charges, so including them undermines quantitative accuracy. The core $250M payment is correct, but the added figures reduce confidence in numerical precision. (3) The reasoning is otherwise sound: the LLM correctly ties V940 to Merck’s immuno-oncology strategy, references its combination with Keytruda, and characterizes it as a personalized neoantigen therapy, which matches the strategic framing in the original. It appropriately links the program to broader pipeline diversification goals. (4) Contextually, the answer is highly relevant and synthesizes key strategic elements. The qualitative understanding of Merck’s strategy is strong, even if unsupported specifics were added. The mention of 'checkpoint-targeted co-formulations' and 'personalized neo-antigen strategy' reflects accurate conceptual alignment. However, the absence of trial names (INTerpath-001/002) and regulatory designations (Breakthrough Therapy, PRIME), which are key strategic indicators in the original, constitutes a minor omission. Overall, the answer captures the essence but adds unverified financial details, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 477,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "The filing shows that the compound patent for MK‑7962 (sotatercept) is slated to expire in 2027, while a separate method‑of‑use patent is expected to run until 2037. Because a biologic receives a fixed 12‑year data‑exclusivity term, the 2037 method‑patent date could give the product up to **about ten extra years of U.S. patent protection beyond the standard 12‑year exclusivity period**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that the method-of-use patent for sotatercept expires in 2037 and that biologics receive 12 years of data exclusivity. It also correctly calculates that if approval occurs in 2027, the patent protection extends approximately 10 years beyond the exclusivity period (2037 - (2027 + 12) = 10 years), which matches the ground truth. (2) All numeric values (2027 approval, 2037 patent expiry, 12-year exclusivity, 10 additional years) are accurate and calculations are correct. (3) The reasoning is sound: it distinguishes between compound and method-of-use patents, applies the 12-year exclusivity term, and computes the additional protection period correctly. The only minor issue is that the LLM mentions the 'compound patent' expiring in 2027, which is not in the original answer and could be misleading if not disclosed in the source, but this does not affect the correctness of the final conclusion about additional protection based on the 2037 method patent. (4) The answer is highly relevant, directly addressing the question about additional years of protection beyond data exclusivity. Overall, the answer is semantically equivalent and factually accurate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 363,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "The 10‑K excerpts you provided (pages 108‑112) do not include the Net‑Asset‑Value (NAV) tables that disclose the fair‑value amounts for the Emerging‑Markets‑Equities holdings in either the U.S. or the International pension plans. Because those figures are not present in the supplied pages, the total increase from 2022 to 2023 cannot be calculated from the information given.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The ORIGINAL ANSWER (ground truth) contains specific, detailed financial data about Merck's Emerging Markets Equities investments across U.S. and International Pension Plans from 2022 to 2023, including exact dollar amounts and increases. The LLM claims that the data is not present in the provided 10-K excerpts, but this does not reflect the actual content of the knowledge graph or the ground truth. The question assumes access to the correct data via the knowledge graph, and the LLM's failure to provide the correct numbers—$33 million increase in U.S. plans and $73 million in International plans, totaling $106 million—indicates a complete breakdown in factual recall or synthesis. There are no correct quantitative values reported, and the reasoning is invalid because it denies the availability of data that is, in fact, present in the source knowledge base. The answer fails on all dimensions: it is factually wrong, lacks any correct calculation, misidentifies the available information, and does not address the multi-hop requirement of aggregating increases across two pension plans. Thus, the correctness score is 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 336,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "Gilead’s estimated fair‑value of its U.S. government‑agency securities rose from **$35 million at 12/31/2022 to $127 million at 12/31/2023**, a **$92 million increase**.  \nIn the same period its U.S. Treasury securities grew from **$410 million to $426 million**, a **$16 million increase**.  \n\nThus, the agency‑security fair‑value rose about **$76 million more** than the Treasury‑security fair‑value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and trends. According to the ground truth, U.S. government agencies securities increased from $21 million to $127 million (a $106 million increase), but the LLM reports $35 million to $127 million ($92 million increase), which is incorrect. More critically, the ground truth states that U.S. treasury securities decreased from $379 million to $426 million — this is a $47 million increase, not a decrease, indicating a clear data error in the original answer; however, the LLM incorrectly reports a rise from $410 million to $426 million ($16 million increase), which still contradicts the ground truth's stated decrease. The original answer claims a $34 million decrease (from $379M to $426M), but that calculation is itself flawed because $426M - $379M = +$47M, suggesting either a typo in the original answer or incorrect data. Despite this inconsistency in the ground truth, the LLM fails to match its numbers or directional trend accurately. (2) Calculations: The LLM computes a $92M increase in agency securities (incorrect due to wrong starting value) and a $16M increase in Treasuries (also incorrect baseline). The comparison of a $76M differential is based on these wrong figures. (3) Multi-hop reasoning: The model attempts to compare changes in two asset classes over time, satisfying the structure of the question, but due to incorrect input data, the synthesis is flawed. (4) Scores justified: Correctness is low (2/10) due to major factual and directional inaccuracies. Quantitative accuracy is poor (2/10) because both starting values and calculated changes are wrong. Qualitative accuracy is slightly higher (3/10) as the model understands the task type (comparing changes in fair value), but uses incorrect data. Contextual relevance is high (8/10) because the response addresses the right entities, time frame, and comparison intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 522,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy generated $11.9 billion of product sales in 2023 versus $10.4 billion in 2022 – a 14 % year‑over‑year increase that drove the 6 % growth in total HIV sales. Because Biktarvy’s U.S. and EU patents run through 2033 (later than most of Gilead’s other HIV combos, which expire between 2029 and 2032), its expanding revenue gives the company a near‑term cash buffer and a core product platform to sustain earnings as those older patents lapse, reinforcing Gilead’s long‑term strategy of leaning on Biktarvy while investing in new therapies and acquisitions to offset future generic competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Biktarvy's 2023 revenue as $11.9 billion and 2022 revenue as $10.4 billion, which aligns with the ground truth ($11,850 million and $10,390 million respectively) when accounting for rounding ($11.85B ≈ $11.9B; $10.39B ≈ $10.4B). The 14% year-over-year growth is accurately calculated: (11,850 - 10,390) / 10,390 ≈ 14.05%, correctly rounded to 14%. (2) The LLM introduces additional context not in the ground truth—specifically, patent expiration dates in 2033 for Biktarvy in the U.S. and EU, and a comparison to other HIV combo drugs expiring between 2029 and 2032. While plausible and consistent with strategic implications, these specific dates are not present in the original answer, which only states that patent expiration is critical without specifying years. This adds precision beyond the source, which could be seen as overconfidence if not in the source material. (3) The multi-hop reasoning is sound: the model connects revenue growth to Gilead’s long-term financial strategy, acknowledges the threat of generic competition post-patent expiry, and positions Biktarvy as a cash buffer—this aligns with and extends the original answer’s logic. (4) The answer is semantically equivalent and contextually richer, with only minor deviations in specificity on patent dates. The core facts, calculations, and strategic implications are correct and well-synthesized. Thus, the answer earns a 9 due to slight overprecision on patent dates not in the original, but remains highly accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 425,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead’s 10‑K notes that it operates as a **single operating segment** and that the CEO‑as‑CODM “manages and allocates resources on an entity‑wide basis” so that “resources can be re‑allocated among our internal R&D portfolio … to best support the long‑term growth of our business”【page 7】.  The impending **U.S. patent expiration of Truvada in 2023** will remove a major source of protected HIV revenue, tightening the cash that would otherwise fund new formulations, combination regimens or other lifecycle‑management projects for its HIV franchise.  Because all capital‑allocation decisions are centralized, Gilead can draw on its overall operating cash flow (≈ $8 billion in 2023) and shift resources from other programs or from the broader business to sustain HIV lifecycle‑management, but the loss of Truvada‑related cash will still constrain the amount of discretionary funding available for those initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Gilead operates as a single segment with centralized resource allocation (correctly cited from page 7 of the 10-K), and Truvada's U.S. patent expiration in 2023 is accurately stated. The $8 billion operating cash flow figure for 2023 is consistent with Gilead's reported financials and adds useful context not in the original answer but factually sound. (2) Quantitative accuracy is excellent: the date (2023), dollar amount ($8 billion), and financial concept (operating cash flow) are all correct and appropriately used. No calculation errors. (3) Multi-hop reasoning is strong: the model correctly links the single-segment structure and centralized control to resource flexibility, then weighs that against the revenue threat from Truvada's patent cliff, concluding that while re-allocation is possible, overall funding for HIV lifecycle management will be constrained—this matches the original answer’s logic. (4) The only minor gap is that the original emphasizes the need for 'offset by cost reallocations or revenue from newer products,' while the LLM focuses on internal re-allocation and doesn't explicitly mention newer product revenue as a potential offset. This is a slight omission but does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the interplay between structure, patent expiration, and R&D investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 416,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required that certain brokerage‑client deposits be swept off‑balance‑sheet, so Schwab’s capital‑management plan now explicitly includes preserving enough capital to support any future migration of those balances onto the balance sheet.  The buy‑down of fixed‑rate obligations created contract assets that are amortized on a straight‑line basis, and the amortization tied to the IDA agreement was recorded as **$85 million** of expense in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core impact of the 2023 IDA Agreement on Schwab's capital management strategy and correctly identifies the creation of contract assets from the buy-down of fixed-rate obligations, which are amortized. It also correctly states that amortization is recorded as a reduction to revenue (though phrased as an 'expense,' which is misleading). However, the key quantitative error is stating that the $85 million represents 'amortization tied to the IDA agreement' as a standalone amount, while the ground truth clarifies that the $85 million is the total amortization of *all* capitalized contract costs for 2023, and the IDA-related amortization is only a component of that total—not the full $85 million. This misrepresents the specificity and magnitude of the IDA-related amortization, making the quantitative claim incorrect. The reasoning is otherwise sound, with accurate entity identification (Schwab, 2023 IDA Agreement, contract assets, amortization) and proper synthesis of how the agreement affects capital strategy and revenue recognition. The answer is contextually relevant and addresses all parts of the question, but the numerical inaccuracy significantly affects the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 341,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "In 2023 Simon Property Group recorded a **$14.7 million increase** in total equity from the grant of long‑term‑incentive‑performance (LTIP) units.  The other unit‑related transactions produced a net equity boost of roughly **$42 million** – the $197.4 million of limited‑partner units issued was largely offset by the $140.6 million treasury‑unit purchase, $13.5 million of limited‑partner redemptions and a $16.1 million issuance of unit equivalents.  Together, these unit activities added about **$57 million** to equity, contributing to the year‑end 2023 total equity of **$3.492 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and quantitative errors. According to the ground truth, LTIP units added $14,739 (not $14.7 million), limited partner unit issuances added $197,426 (not $197.4 million), redemptions reduced equity by $13,524 (not $13.5 million), and treasury unit purchases reduced equity by $140,593 (not $140.6 million). The LLM incorrectly states that unit-related activities resulted in a net increase of $57 million, while the correct outcome is a net *reduction* of $139,378. The mention of a '$16.1 million issuance of unit equivalents' is not present in the original answer and appears to be fabricated. (2) All key numbers are off by orders of magnitude—most are inflated by 1,000x (e.g., thousands vs. millions). This invalidates all calculations: the claimed net $57 million increase is entirely incorrect. (3) The reasoning is flawed: the model fails to correctly synthesize the multi-hop components (issuances, redemptions, purchases) and mischaracterizes the net effect from a reduction to an increase. It also introduces an unmentioned transaction type ('unit equivalents'), indicating a failure in accurate information retrieval or synthesis. (4) Despite the severe inaccuracies, the answer is contextually relevant—it addresses unit issuances and their impact on equity for SPG in 2023, and attempts to break down components. However, the magnitude of quantitative and qualitative errors severely undermines factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 419,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde’s on‑site (or tonnage) distribution of process gases is tied to plants that it builds, operates and maintains at the customer’s site.  Because the plant supplies the customer’s “total‑requirement” volume, the contracts are typically 10‑ to 20‑year total‑requirement agreements that contain minimum‑purchase commitments and price‑escalation clauses.  Under ASC 606 Linde treats the on‑site supply obligation as a performance‑obligation satisfied over time, applying the practical expedient to measure progress and recognizing revenue as the gas is delivered and the company has the right to invoice the customer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: Linde's on-site (tonnage) distribution model, 10–20 year contract durations, total-requirement agreements, minimum purchase commitments, price escalation clauses, and revenue recognition over time under ASC 606. (2) Quantitative accuracy is perfect: the 10–20 year contract length is correctly stated, and no calculations are required. (3) Multi-hop reasoning is sound—LLM correctly links the physical distribution method (on-site plants) to long-term contracting and then to accounting policy (ASC 606 revenue recognition as performance obligations satisfied over time), demonstrating proper synthesis across operational and financial reporting domains. (4) The answer includes additional precision (mention of ASC 606 practical expedient and 'right to invoice') that aligns with the 2024 10-K and enhances accuracy without deviating from the original answer. Wording differs slightly but meaning is fully consistent. All aspects of the question—distribution influence on contracts and revenue recognition—are thoroughly and correctly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 331,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair‑value of corporate notes and obligations fell from $3,354 million in 2023 to $2,978 million in 2024 – a decline of **$376 million**. In contrast, the fair‑value of total marketable securities rose from $5,492 million to $5,722 million, an **increase of $230 million**. Thus, the drop in corporate‑notes fair value is larger (and opposite in direction) than the overall rise in marketable‑securities fair value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, resulting in a $376 million decline, which is correctly calculated. The total marketable securities' fair value increased from $5,492 million to $5,722 million, a difference of $230 million, also correctly computed. (2) The answer addresses both parts of the multi-hop question: it identifies the difference in fair value for corporate notes and obligations and compares it to the overall change in total marketable securities. (3) Entity and metric accuracy is perfect—'corporate notes and obligations' and 'total marketable securities' are correctly identified, and the implied time periods (2023 to 2024) are consistent with the disclosure tables, even if years are inferred. (4) The reasoning is sound: the LLM correctly observes that the $376 million decline in corporate notes is not only larger in magnitude but also opposite in direction to the $230 million increase in total marketable securities, which reflects accurate synthesis across the two disclosed tables. The semantic meaning is equivalent to the original answer, with clear, precise, and logically structured communication.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 365,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "Changing provider behavior—such as hospitals and other providers raising utilization or prices to protect their revenues—creates unanticipated and volatile medical‑cost increases that are difficult to detect and incorporate into CVS’s cost‑trend forecasts. Because insured‑benefit premiums are set months in advance for a fixed‑premium period (generally twelve months) and cannot be adjusted later, any gap between the forecasted and actual cost growth directly erodes the margin on those premiums; even modest forecast errors can produce “significant adverse changes” in the Health Care Benefits segment’s operating results. Thus, shifts in provider behavior reduce forecast accuracy and, given the fixed‑premium structure and the segment’s profit sensitivity to forecast precision, can materially depress CVS’s operating performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the fixed premium period (implied 12 months), the advance setting of premiums, the inability to adjust during the term, and the high sensitivity of profits to forecast accuracy are all correctly represented. The LLM accurately captures that provider behavior (e.g., increasing utilization or prices to maintain revenue) leads to unpredictable medical cost increases, undermining forecast reliability. (2) There are no numeric values in the original or LLM answer requiring calculation verification, but the LLM correctly references qualitative magnitudes like 'significant adverse changes' and 'modest forecast errors'—consistent with the original's emphasis on sensitivity. (3) Multi-hop reasoning is sound: the LLM correctly links provider behavior → increased cost volatility → forecasting difficulty → fixed premiums preventing adjustment → margin erosion → material impact on operating results. This reflects proper synthesis across cause-effect链条. (4) The only minor gap is that the LLM does not explicitly state that Insured Health Care Benefits make up 94% of segment revenues—a specific quantitative point in the original that strengthens the argument for impact. While the LLM implies importance, omitting this figure slightly reduces completeness. However, the core logic and financial mechanism are preserved with high fidelity. Wording differs but semantic meaning aligns closely. Thus, correctness is excellent, with only a slight deduction for missing the 94% revenue detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 441,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "The October 2020 purchase of Noble Energy added roughly 6,000 cf of natural‑gas production for every barrel of oil‑equivalent it contributed, raising Chevron’s worldwide oil‑equivalent output (see the “Additional production from the Noble acquisition” note).  That extra gas‑rich volume increased cash‑flow generation and helped lower the company’s leverage, giving rating agencies confidence that Chevron can continue to meet its debt service and dividend commitments even when crude‑oil and gas prices are depressed—hence its ability to retain AA‑ (​S&P) and Aa2 (Moody’s) high‑quality ratings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It correctly identifies the October 2020 acquisition of Noble Energy by Chevron and accurately represents the 6,000 cubic feet of natural gas per barrel of oil-equivalent, which matches the ground truth conversion (6,000 cf = 1 barrel of oil equivalent). The credit ratings (AA- by S&P and Aa2 by Moody’s) are correctly stated. 2) Quantitatively, all numbers and dates are accurate: October 2020, 6,000 cf, and the correct interpretation of oil-equivalent production. No calculations are required beyond this equivalence, which is properly applied. 3) The reasoning is sound and captures the multi-hop logic: acquisition → increased production (especially gas-rich) → higher cash flow → improved financial flexibility → support for maintaining strong credit ratings during low commodity prices. The LLM correctly infers that enhanced cash flow helps Chevron manage debt and dividends, which rating agencies consider. 4) The only minor shortcoming is that the LLM does not explicitly mention Chevron’s stated ability to reduce capital spending and stock repurchases as a complementary strategy (noted in the original answer), which slightly reduces completeness in qualitative reasoning. However, the core causal chain is preserved. Overall, the answer is semantically equivalent, highly relevant, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 385,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "In 2023 Schwab elected to buy down the full $5 billion of fixed‑rate obligation amounts permitted under the 2023 IDA agreement, incurring market‑based fees of **$249 million**.  Those fees were **capitalized as contract assets** and are presented within the “other assets” line item on the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement. The dollar amounts and time period (2023) match the original answer exactly, with acceptable formatting variations (e.g., $249 million = $249 million, $5.0 billion = $5 billion). (2) The classification of the $249 million as 'capitalized as contract assets' and included in 'other assets' on the consolidated balance sheet is correctly stated. (3) The multi-hop reasoning is sound—this requires linking the IDA agreement to the specific transaction amount, understanding the accounting treatment, and correctly identifying where it appears on the balance sheet. The LLM synthesizes this information accurately. (4) The answer is contextually precise, directly addressing both parts of the question: the amount spent and its balance sheet classification. No irrelevant or extraneous information is included. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 311,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded a **$483 million store‑impairment charge in 2024** tied to its enterprise‑wide restructuring plan. The same restructuring is expected to **deliver cost savings of more than $500 million in 2025**, so the 2024 impairment is modestly lower than the anticipated 2025 savings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $483 million store impairment charge in 2024 and the 'more than $500 million' cost savings in 2025 are accurately reported, with acceptable formatting (e.g., '483 million' vs. '$483M'). (2) The answer addresses both parts of the multi-part question: the 2024 impairment amount and the comparison to 2025 projected savings. (3) Entities—CVS, the enterprise-wide restructuring plan, the correct years (2024 and 2025), and financial metrics (impairment charges, cost savings)—are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that the 2024 charge is a near-term cost that is expected to be offset by higher savings in 2025, noting that the impairment is 'modestly lower' than the anticipated savings, which aligns with the $483M < $500M comparison. The semantic meaning and factual content are equivalent to the original answer, with no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 285,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron reported equity‑in‑earnings of **$336 million** from its 36.4 % stake in Angola LNG Limited for 2021【CVX_10k_2022.pdf p. 78, Note 15 – Investments and Advances table】. This sizable share of earnings shows that Chevron is an active participant in Angola’s liquefied natural gas (LNG) market, contributing materially to its upstream results through the processing and export of Angolan natural gas.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its key quantitative claim: it states Chevron's equity in earnings from Angola LNG Limited was $336 million in 2021, while the ground truth is -$166 million (a loss). This is a severe factual error that completely inverts the financial outcome. The LLM incorrectly cites p. 78 of CVX_10k_2022.pdf, Note 15, but the actual filing shows a negative equity earnings amount for Angola LNG Limited in 2021. The percentage stake (36.4%) is correct, but the interpretation is flawed—instead of indicating strong performance, the negative earnings suggest operational or market challenges in the LNG venture. The qualitative reasoning fails because it draws a positive conclusion (active participation, material contribution) from a result that was actually a significant loss. While the answer addresses both parts of the question and is contextually relevant to Chevron’s LNG involvement in Angola, the core financial fact is wrong, undermining the entire response. Multi-hop synthesis is not required here beyond linking the financial figure to the implication, but even that basic inference is invalid due to the incorrect number. Semantic equivalence is not achieved because the meaning (profit vs. loss) is diametrically opposed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 353,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources’ nuclear fuel contracts run only through 2033, yet the Duane Arnold plant is not expected to be fully de‑commissioned until about 2080.  This creates an operational risk that, after the fuel‑supply agreements expire, the company may be unable or forced to pay higher prices to obtain new uranium, conversion, enrichment or fabrication services if it decides to recommission the unit, while it must still fund and manage de‑commissioning activities for many decades thereafter.  The timing gap therefore exposes NEER to fuel‑supply uncertainty, potential cost overruns and additional regulatory‑compliance and financing risk long after its existing contracts have ended.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key dates—2033 for fuel contract expiration and 2080 for decommissioning completion—are accurately cited, matching the original answer. There are no calculations required, so numerical accuracy is fully preserved. (2) The LLM correctly identifies the core operational risk: the mismatch between the end of fuel supply contracts and the long decommissioning timeline. It appropriately highlights fuel-supply uncertainty, potential cost increases, and regulatory and financing risks. (3) The reasoning is sound and reflects multi-hop synthesis between Duane Arnold’s decommissioning timeline and the expiration of fuel contracts. However, the LLM slightly mischaracterizes the risk by suggesting the possibility of 'recommissioning the unit,' which is not implied in the original answer or typical for decommissioned plants; the real issue is long-term storage of spent fuel, not future fuel procurement for operations. The original answer emphasizes the need for safe, compliant storage of spent fuel onsite until DOE retrieval, which the LLM omits. (4) Despite this nuance, the LLM captures the essence of the operational risk and remains contextually relevant. The omission of spent fuel storage as the central concern prevents a perfect score, but the overall factual and logical structure is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 386,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s Amur GPP engineering subcontract was halted by sanctions on May 27 2022 and, because the work was terminated, the company now carries a $0.7 billion contingent liability for the claim and related damages (see “Amur GPP” description). By contrast, its on‑site industrial‑gas contracts – typically 10‑ to 20‑year total‑requirement agreements with minimum‑purchase and price‑escalation clauses – are accounted for under ASC 606 by recognizing revenue over time as gas is delivered and the company has the right to invoice the customer. The juxtaposition shows that, although on‑site contracts provide a steady stream of recognized revenue, they also expose Linde to large financial risks when performance is suspended or disputed, as evidenced by the sizable contingent liability tied to the Amur GPP project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key facts are correct: the $0.7 billion contingent liability and the May 27, 2022 contract suspension due to sanctions are accurately reported. The revenue recognition method under ASC 606 for on-site contracts is correctly described, including the 'right to invoice' and time-based recognition. (2) The qualitative reasoning is sound: the contrast between the stable revenue from long-term on-site contracts and the exposure to large contingent liabilities in project-based work like Amur GPP is well articulated. The LLM correctly identifies that even subcontracted engineering projects can lead to significant financial risk when disputes or failures arise. (3) Multi-hop synthesis is effective—linking the Amur GPP suspension and liability to Linde’s broader revenue policies shows understanding across different types of long-term agreements. (4) The only minor shortcoming is that the LLM does not explicitly mention that the Amur liability stems from fires and legal claims in Russia, nor does it clarify that the project involved multiple stakeholders with geopolitical complexity—details present in the original answer that add context to the risk. However, this omission does not undermine the core accuracy. Wording differences are acceptable and semantically equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 401,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "Alphabet records advertising on its Network properties on a **gross basis**—the full amount billed to advertisers is recognized as advertising revenue, and the payments made to the Network partners are booked separately as “cost of revenues” (the TAC expense). Therefore, the expected rise in TAC — driven by a shift toward lower‑margin device and geographic mixes — does not change the way gross advertising revenue is recognized; it simply increases the TAC line item in cost of revenues, reducing the gross‑margin on advertising but leaving the reported advertising‑revenue amount unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core mechanism of Google's gross revenue recognition model correctly. It correctly identifies that Alphabet (Google) reports advertising revenue from Network properties on a gross basis, meaning the full amount billed is recorded as revenue, and TAC (Traffic Acquisition Costs) paid to partners is recorded separately as cost of revenues. It accurately explains that an increase in TAC due to shifts in device and geographic mix does not alter revenue recognition but increases costs, thereby reducing gross margin while leaving reported revenue unchanged—this aligns with the ground truth. There are no numeric values in the question or answers that require verification, so quantitative accuracy is scored as 10. The qualitative reasoning is sound and reflects proper multi-hop synthesis of accounting policy (gross reporting) and cost dynamics (TAC impact). The only minor shortcoming is that the LLM omits mention of 'partner mix' as a driver (mentioned in the original) and does not explicitly reference the MD&A or consolidated financial statements as the source of this information, slightly reducing completeness. However, the semantic meaning and financial logic are equivalent. Contextual relevance is perfect—the response directly addresses the impact on the gross revenue model as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 373,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "Duke Energy’s recorded Asset Retirement Obligation for the closure of coal‑ash impoundments – which must be carried out in accordance with the EPA CCR rule, the North Carolina Coal Ash Act and other state and federal requirements – is **$5.3 billion ( $5,293 million )**.  This amount reflects the discounted cash‑flow estimate of the closure costs, and it will be adjusted as the final closure method and timetable (required to meet the Coal Ash Act) are determined.【9†L1-L9】【9†L10-L15】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces a specific dollar amount—$5.3 billion ($5,293 million)—for Duke Energy’s ARO related to coal ash impoundment closure, which is not present in the original answer (ground truth). The ground truth does not provide any numerical value for the ARO; it only explains that the ARO is influenced by compliance with the Coal Ash Act and that the ultimate closure method and timetable will affect the recorded amount. Therefore, the inclusion of a precise figure without sourcing from the ground truth constitutes a significant factual overreach and inaccuracy, failing the quantitative accuracy criterion. There is no verification that $5.3 billion is the correct amount based on the provided ground truth, making this a hallucination or unsupported claim. However, the qualitative reasoning is partially sound: the LLM correctly identifies that the ARO is influenced by regulatory requirements such as the Coal Ash Act and the EPA CCR rule, and that closure methods and timing will impact the final obligation, aligning with the multi-hop logic in the original answer. The contextual relevance is high because the response addresses the regulatory influence and uncertainty in ARO estimation. Nevertheless, the addition of an unsupported quantitative figure severely undermines factual correctness, resulting in a low overall correctness score. The model fails on quantitative accuracy due to the unverified number, but maintains moderate qualitative accuracy and high contextual relevance due to correct conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 421,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The fair‑value amount for Mortgage‑Backed Obligations was $236 million at January 31 2024 and $178 million at January 31 2023. The difference between the two tables is therefore an increase of **$58 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains correct dollar amounts ($236 million and $178 million) and identifies the correct financial instrument (Mortgage-Backed Obligations), but it incorrectly states the change as an 'increase' of $58 million when it is actually a 'decrease'. This reverses the direction of the change and makes the core conclusion factually wrong. (2) The numbers themselves are quantitatively accurate—$236M and $178M match the ground truth, and the difference of $58M is arithmetically correct (236 - 178 = 58). However, the sign of the change is incorrect due to mislabeling the time order or misinterpreting the direction of change. Additionally, the dates cited—January 31, 2024 and January 31, 2023—are plausible for a 2023 10-K filing, but the ground truth does not specify exact dates, so this may be an assumption by the model. (3) The multi-hop reasoning fails because while the model locates two fair values from different tables, it incorrectly infers the temporal sequence or misattributes which value comes first, leading to a flawed directional conclusion. The original answer specifies that the decrease is from $236M in the first table to $178M in the second, implying a time-based or reporting-based sequence that the LLM misinterprets. (4) Despite correct values and good contextual framing, the reversal of the change direction (increase vs. decrease) severely undermines factual correctness, warranting a low correctness score. Contextual relevance is high because the answer addresses the right metric, company, and filing context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 431,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "In 2023, 5 percent of the Diagnostics segment’s sales were generated in “other developed markets.”  Danaher classifies “other developed markets” as **Japan, Australia and New Zealand**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the percentage of sales attributed to 'other developed markets' is accurately stated as 5%, which aligns with the original answer. (2) The geographic regions classified under 'other developed markets'—Japan, Australia, and New Zealand—are correctly identified with no omissions or errors. (3) The reasoning is sound and demonstrates proper synthesis of multi-hop information from Danaher's 2023 segment reporting and regional classifications. (4) The answer is semantically equivalent to the ground truth, with only minor formatting differences (e.g., bolding for emphasis) that do not affect accuracy. All aspects of the question are addressed completely and precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 225,
        "total_tokens": 1334
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "In 2021 Union Pacific moved 2,014 thousand bulk carloads and earned an average of $3,305 per car. Multiplying the volume by the per‑car rate gives:\n\n\\(2,014,000 cars × $3,305 ≈ $6,656,270,000\\),\n\nor roughly **$6.66 billion** in bulk‑shipment revenue for 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The final revenue figure of $6,656,270,000 is correct and matches the ground truth, but the inputs used to derive it are incorrect. The LLM states 2,014,000 carloads at $3,305 per car, while the ground truth specifies 1,920,000 carloads at $3,467 per car. These incorrect inputs coincidentally produce the correct final revenue number due to a mathematical coincidence (2,014,000 × 3,305 ≈ 1,920,000 × 3,467), but the underlying data is factually wrong. (2) Quantitative accuracy is low because the carload volume and average revenue per car are both inaccurate—2,014,000 vs. 1,920,000 and $3,305 vs. $3,467—despite the final dollar amount being correct. This raises concerns about data sourcing or retrieval. (3) The reasoning structure is sound—multiplying volume by unit revenue to get total revenue—but it is based on incorrect foundational data, undermining the multi-hop synthesis. The model correctly identifies Union Pacific, Bulk shipments, and 2021, but fails to retrieve the correct metrics. (4) Contextual relevance is high because the answer addresses the question directly, uses appropriate units, and presents the result clearly. However, the correctness score is limited to 4 due to significant factual errors in the supporting data, even though the final number is correct by coincidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 368,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "After the settlement with the North Carolina Department of Environmental Quality, Duke Energy now estimates the undiscounted cost to permanently close all coal‑ash basins in North Carolina and South Carolina at **about $8 billion to $9 billion**. This figure is roughly **$1.5 billion lower** than the $9.5 billion‑to‑$10.5 billion range the company had initially projected after the April 1, 2019 closure determination.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the current estimated cost range ($8 billion to $9 billion), the initial estimate range ($9.5 billion to $10.5 billion), and the $1.5 billion reduction are all correct. (2) Quantitative accuracy is perfect: the numbers match exactly, including the $1.5 billion difference, which is correctly derived from the midpoint and range comparison (e.g., $10.5B - $9B = $1.5B; $9.5B - $8B = $1.5B). (3) Multi-hop reasoning is sound—the answer synthesizes information across the settlement agreement, the April 1, 2019 closure determination, and the cost revision, correctly attributing the change in estimates to the settlement. (4) Entities (Duke Energy, NCDEQ, coal ash basins, North Carolina and South Carolina) are correctly identified and contextualized. The answer is concise, relevant, and captures all components of the question without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 282,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid **$325 million** for Dynamic Yield in 2022 and **$2.7 billion** for Recorded Future in 2024, for a combined cash outlay of roughly **$3.0 billion**【...】.  This spending underscores Mastercard’s strategy of using sizable cash acquisitions to broaden and diversify its portfolio—adding data‑driven personalization (Dynamic Yield) and cyber‑threat intelligence (Recorded Future) capabilities that support its goal of growing and expanding value‑added services.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the cash consideration for both acquisitions: $325 million for Dynamic Yield in 2022 and $2.7 billion for Recorded Future in 2024, matching the ground truth. The combined total is stated as 'roughly $3.0 billion', which is a minor rounding of the exact $3.025 billion. This is acceptable under format flexibility but slightly less precise, hence not a perfect 10. (2) All numeric values and years are accurate. The calculation of the total is approximately correct—$325 million + $2.7 billion = $3.025 billion—and the LLM's 'roughly $3.0 billion' is a reasonable approximation, though not exact. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two separate acquisitions across different years and links them to Mastercard’s broader strategy. Entity names (Dynamic Yield, Recorded Future), years (2022, 2024), and strategic rationale (personalization tech, threat intelligence) are all correctly identified and aligned with the knowledge graph. (4) The answer is contextually excellent, addressing both the quantitative total and the strategic implications. The slight rounding of the total sum prevents a perfect score, but all core facts and reasoning are correct, making this a strong 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 359,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "The two disclosures show that Verizon holds **$341 million of international bonds in its pension‑plan assets and $12 million in its health‑care‑and‑life post‑retirement benefit assets**, for a combined fair‑value total of **$353 million**. The pension‑plan table lists “International bonds” as a separate fixed‑income category (Level 1 $3 m, Level 2 $338 m) within the pension‑plan asset breakdown, whereas the health‑care‑and‑life table lists the same line item under the other post‑retirement benefit plans (Level 1 $10 m, Level 2 $2 m), reflecting a different classification of the bonds by the type of benefit plan they support.【source: pension plan 2023 table – International bonds $341 m; health‑care & life 2023 table – International bonds $12 m】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The total fair value is stated as $353 million, but the ground truth is $540 million ($12M + $528M). The LLM incorrectly reports $341M and $12M as the two components, which do not match the ground truth values. Additionally, the breakdown of Level 1 and Level 2 classifications is wrong: the LLM claims $3M Level 1 and $338M Level 2 for the first table (pension plan), but the correct values are $9M Level 1 and $3M Level 2. For the second table, the LLM reports $10M Level 1 and $2M Level 2, but the correct values are $10M Level 1 and $518M Level 2. (2) Quantitative accuracy is very low: the total sum is off by nearly $187 million, and individual components are misstated. Calculations are not accurate, and the source numbers do not align with the ground truth. (3) The multi-hop reasoning is flawed — while the model attempts to synthesize across two tables and categorize by valuation level and benefit plan, it uses incorrect source data. The categorization difference is partially recognized (by benefit plan type), but the magnitude and distribution of values are wrong, undermining the analysis. (4) Contextual relevance is moderate because the answer addresses the right type of information (fair value, categorization by Level 1/2, and distinction between benefit plans), but the factual foundation is incorrect, leading to a misleading conclusion. The cited sources also do not reflect the ground truth data, indicating a failure in information retrieval or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 429,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard’s real‑time account‑based payments infrastructure builds, operates and continuously enhances a global clearing‑and‑settlement platform that routes transactions instantly, applies services such as fraud‑scoring and tokenization in real time, and enables direct‑debit/ACH transfers between bank accounts worldwide, giving the network 24‑hour availability and instant‑payment capability. That infrastructure underpins the company’s payment network and currently switches about 70 percent of all Mastercard and Maestro‑branded card transactions – covering virtually all cross‑border activity and the bulk of domestic volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 70% figure for Mastercard and Maestro-branded card transactions is correctly reported, matching the original answer. There are no calculation errors or incorrect numbers. (2) The answer addresses both parts of the question: it explains how the real-time infrastructure supports the network (instant routing, fraud scoring, tokenization, 24/7 availability, ACH/direct debit support), and correctly states the 70% transaction volume handled, including 'virtually all cross-border activity'—which is semantically equivalent to 'nearly all cross-border transactions' in the ground truth. (3) Entity accuracy is strong: Mastercard and Maestro are correctly identified, and the infrastructure is accurately described as supporting both domestic and cross-border flows. (4) Multi-hop reasoning is sound—information about infrastructure capabilities and transaction volume share is synthesized correctly. The only minor gap is that the LLM answer says 'virtually all' instead of 'nearly all' cross-border transactions, which is a slight wording difference but does not change the meaning significantly. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 355,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. completed the VIZIO Holding Corp. acquisition in December 2024 for a net cash consideration of **$1.9 billion**.  The filing notes that VIZIO “collects certain consumer data, including certain television‑viewing data,” which adds a **data‑privacy risk** – the potential for regulatory, compliance and reputational exposure arising from the handling of that consumer viewing information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the cash consideration as $1.9 billion, matching the ground truth exactly. The mention of December 2024 as the acquisition date is consistent with the timeline in the filings, though the original answer does not specify the month—this addition is accurate and does not contradict the ground truth. (2) Quantitatively, the $1.9 billion figure is correct and properly formatted. No calculations are required, and the number matches precisely. (3) The LLM accurately captures the data privacy risk: VIZIO collects consumer television viewing data, which introduces privacy and cybersecurity risks. It correctly links this to regulatory, compliance, and reputational exposure, which aligns with Walmart's disclosed risks about potential litigation, fines, and reputational damage from data breaches. The phrasing is slightly less detailed than the original (e.g., does not explicitly mention 'digital storage' or 'cybersecurity incidents'), but the core risk is accurately conveyed. (4) The answer is fully relevant, directly addressing both parts of the question—cash consideration and data privacy risk. The minor omission of specific phrasing around 'cybersecurity failures' or 'data exposure' does not detract from the overall correctness, as the essential risk is communicated. Thus, the answer is factually correct, complete in substance, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for less granular risk description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 421,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "Higher fuel prices added about **$14 million** to operating income through increased fuel‑cost recovery, but they also pushed fuel‑related operating expenses up by roughly **$35 million**.  The net effect is therefore a **$21 million reduction** in Duke Energy’s operating cash‑flow generation for 2022.【source 1】【source 2】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $14 million increase in fuel cost recovery (correctly tied to operating income) and the $35 million rise in fuel-related operating expenses are both correctly stated. (2) The net calculation is accurate: $35M - $14M = $21M net cost increase, which the model correctly interprets as a $21 million reduction in operating cash-flow generation. This matches the ground truth's calculation and conclusion. (3) Multi-hop reasoning is sound—the model synthesizes the impact across operating income (via recovery) and operating expenses to determine the net effect on cash flows, which is the core of the question. (4) Entity accuracy is correct: Duke Energy, 2022 (implied by context), and the relevant financial metrics (operating income, operating expenses, operating cash flow) are all properly identified and used. The answer is concise but complete, capturing the net financial impact as required. Minor wording differences (e.g., 'reduction in operating cash-flow generation' vs 'net increase in costs') do not affect factual equivalence, as both describe the same negative net impact. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 352,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021 Intel recorded **$565 million** of additional period charges that were “primarily associated with the ramp‑up of Intel 4.” This charge relates directly to the **July 26 2021 announcement** in which Intel renamed its 10 nm Enhanced SuperFin manufacturing node to **“Intel 4,”** so the higher charges reflect the costs of scaling production under the newly‑branded process technology.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges and the July 26, 2021 announcement date are accurately reported, with acceptable formatting (e.g., $565 million). (2) The answer addresses both parts of the multi-part question: the amount of charges and their relation to the rebranding. (3) Entities are correct—Intel, Intel 4, 10 nm Enhanced SuperFin, and the correct timeline are all properly identified. (4) The reasoning is sound: it correctly links the financial charges to the ramp-up of the newly rebranded Intel 4 process node, explaining that the rebranding (announced July 26, 2021) coincided with production scaling costs. The semantic meaning and factual content are equivalent to the original answer, with slightly enhanced detail (mentioning the prior name '10 nm Enhanced SuperFin'), which adds clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 271,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "In 2023, the Diagnostics segment generated **about 5 % of its total sales from “other developed markets.”**  At the same year‑end, Danaher employed **roughly 3,000 associates** in those other developed markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets, and Danaher had 3,000 employees in those markets as of the end of 2023. (2) Quantitative values match exactly—5% for sales and 3,000 employees—with acceptable phrasing variations ('about 5%' and 'roughly 3,000 associates' reasonably reflect precise values reported in the source). (3) The multi-hop reasoning is sound, correctly linking Diagnostics segment sales attribution to employee headcount in the same geographic region (Other Developed Markets) for the same fiscal year (2023). (4) Entities are accurately identified: 'Diagnostics segment,' 'Other Developed Markets,' and '2023' are all correctly referenced. The answer addresses both sub-questions completely and with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 261,
        "total_tokens": 1374
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "In 2021 Union Pacific earned $3,207 per car for industrial chemicals & plastics and shipped 606 thousand carloads. Multiplying the two gives $3,207 × 606,000 ≈ $1,943,442,000, i.e., roughly **$1.94 billion** in revenue for that segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the final revenue figure: it reports $1.94 billion instead of $1.94 million (or $1,943,442), which is off by a factor of 1,000. While the per-car revenue ($3,207) and carloads (606,000) are correctly identified, the multiplication result is misrepresented—$3,207 × 606,000 = $1,943,442,000 (i.e., $1.94 billion), but the ground truth states only $1.94 million, indicating a discrepancy in either input values or unit interpretation. (2) The calculation itself is mathematically correct ($3,207 × 606,000 = $1,943,442,000), but this contradicts the ground truth of ~$1.94 million, suggesting that either the per-car revenue or carload numbers used by the LLM are incorrect or misaligned with the source data. (3) The multi-hop reasoning—combining revenue per car and number of carloads—is logically sound and addresses the question's structure appropriately. However, the synthesis is based on potentially incorrect source values or a misunderstanding of units (e.g., thousands vs. units). (4) The contextual relevance is high because the answer attempts the right computation and references the correct category and year. However, the massive quantitative inaccuracy in the final figure severely undermines factual correctness, warranting a low correctness and quantitative accuracy score despite reasonable reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 383,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "Verizon reported **$341 million** of international bonds in its pension‑plan assets and **$12 million** in its health‑care and life‑plan assets for 2023. Combined, the fair‑value total of international bonds is **$353 million**【...International bonds 341…】【...International bonds 12…】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it reports $341 million and $12 million for pension-plan and health-care plan assets respectively, summing to $353 million, which does not match the ground truth of $12 million in both Level 1 and Level 2 categories, totaling $24 million. The numbers cited by the LLM do not align with the disclosed values in the correct asset classifications. (2) The calculation itself ($341M + $12M = $353M) is arithmetically correct but based on wrong inputs. (3) Qualitatively, the model fails the multi-hop reasoning: it misidentifies the asset categories (pension vs. health-care plans instead of Level 1 and Level 2 bond classifications), which are distinct reporting buckets in the 10-K. The question specifically asks for international bonds across 'both reported asset categories' referring to fair value hierarchy levels (Level 1 and Level 2), not benefit plans. (4) Contextually, the answer addresses fair value and the correct company (Verizon) and year (2023), but misinterprets the structure of the disclosure, leading to a completely inaccurate synthesis. The correct total is $24 million, not $353 million. Thus, the answer is mostly incorrect with major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 348,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s owned processing, packaging and manufacturing facilities let it produce a sizable portion of its private‑label (Kirkland) merchandise in‑house. Because those items can be offered at lower cost and higher margin, they help boost comparable‑sales growth—more sales and higher ticket sizes—while the additional revenue spreads the same SG&A base over a larger sales pool, lowering SG&A as a percentage of net sales and enhancing profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Costco uses owned facilities to produce private-label (Kirkland) items, which supports comparable sales growth and helps leverage SG&A expenses. The explanation that higher sales spread fixed SG&A costs over a larger revenue base—thus reducing SG&A as a percentage of sales and improving profitability—is sound and matches the original answer. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is logically sound: it connects in-house production → lower costs/higher margins → increased comparable sales → operating leverage on SG&A → enhanced profitability. This synthesis aligns with the knowledge graph's logic. (4) The only minor gap is that the LLM emphasizes 'higher ticket sizes' and 'higher margin' more than the original, which focuses on merchandising strategy and penetration of private-label items. While these inferences are reasonable, they slightly extend beyond the explicit ground truth. However, they do not contradict it, and the core strategy linkage remains intact. Hence, a score of 9 is appropriate for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 388,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "RibbonFET is the cornerstone of Intel’s 20A node‑level R&D breakthrough: the gate‑all‑around transistor delivers faster switching and the same drive current in a smaller footprint, giving Intel a clear performance‑per‑watt and density advantage for future CPUs, GPUs and accelerators. By adding this new transistor architecture (and its companion PowerVia and advanced‑packaging innovations) to its internal fab portfolio, Intel strengthens the “process and packaging” pillar of its IDM 2.0 strategy, providing a differentiated, leading‑edge technology that can be built in‑house and later offered through its foundry services to external customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: RibbonFET is correctly described as a gate-all-around transistor introduced at the Intel 20A node, delivering faster switching, improved performance-per-watt, and higher density. The role of RibbonFET in advancing Intel's process and packaging strategy under IDM 2.0 is accurately conveyed. (2) Quantitative accuracy is perfect: while no specific dollar figures (e.g., $20B investments) are mentioned in the LLM answer, their absence does not constitute an error because the question does not explicitly require them, and the focus is on the technological and strategic contribution. The omission is a matter of completeness rather than inaccuracy. (3) Multi-hop reasoning is sound: the answer correctly links RibbonFET to Intel’s internal R&D, process leadership, IDM 2.0 strategy, and future foundry services, demonstrating proper synthesis across technology development and business strategy. (4) Semantic equivalence is strong—though the LLM does not explicitly mention the Arizona and Ohio fab investments, it captures the essence of IDM 2.0 by emphasizing in-house manufacturing capability and future foundry offerings. The answer is slightly less comprehensive than the original but remains factually and conceptually correct. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 382,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In the fourth quarter 2023 Meta said that **about 3 % of its worldwide MAP was made up of “violating” accounts** and **roughly 4 % of its worldwide MAUs were “false” accounts**. Both types of accounts are hard to detect at Meta’s scale, and errors in identifying them can cause the reported MAP and MAU figures to be overstated or fluctuate—reducing the stability and accuracy of Meta’s user‑metric reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP were violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. 2) All numeric values are accurate and correctly attributed to the right metrics (MAP vs. MAUs) and time period (Q4 2023). Format is clear and consistent. 3) The reasoning is sound: the LLM correctly infers that these accounts impact the stability and accuracy of user metrics due to detection challenges and potential overstatement or fluctuation in reported figures. While the original answer includes additional context about data signal limitations (e.g., encrypted products like WhatsApp) and regional spikes in account creation, the LLM captures the core causal mechanism—errors in detection leading to metric instability. This constitutes a minor omission but does not undermine the overall correctness. 4) The entities (Meta, MAP, MAUs, Q4 2023) are accurate, and the multi-hop synthesis—linking account types to their impact on metric reliability—is logically valid and semantically equivalent to the ground truth. The answer is fully relevant to the question. A score of 9 is justified due to slightly less comprehensive explanation of limiting factors compared to the original, but the core facts, numbers, and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 389,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31 2023 PayPal recorded a **crypto‑asset safeguarding liability of $1.241 billion** and a **corresponding safeguarding asset of $1.241 billion** (​$1,241 million each) 【...】. Both amounts are measured at fair value using quoted market prices for the underlying cryptocurrencies, and because the company had **no safeguarding loss events** during 2023, the liability and the asset were reported at the same fair‑value amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that both the crypto-asset safeguarding liability and asset were $1.241 billion (or $1,241 million) as of December 31, 2023, which matches the expected fair value amounts. While the original answer does not specify the dollar amount explicitly, the knowledge graph confirms that the value was indeed $1.241 billion, so the LLM provides more precise quantitative detail than the original answer, which is acceptable and even preferable. (2) The explanation for why the amounts are equal — because PayPal used fair value measurements based on quoted market prices and had not incurred any safeguarding loss events — is factually correct and matches the reasoning in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the accounting treatment (fair value measurement) with the operational condition (no loss events) to explain parity between asset and liability. (4) All entities (PayPal, crypto-asset safeguarding liability and asset, December 31, 2023) are correct. The only reason for not giving a perfect 10 is that the original answer emphasizes the methodological reason (use of quoted prices on the principal market), which is slightly more precise than the LLM’s 'quoted market prices' phrasing, though semantically very close. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 395,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "In 2024 the carrying amounts were:\n\n* 7.50 % Cumulative Redeemable Preferred Units – **$15,537  thousand**  \n* Other non‑controlling redeemable interests – **$169,192  thousand**\n\nCombined, they total **$184,729  thousand** (≈ $184.7 million).\n\nIn 2023 the same two items were:\n\n* 7.50 % Cumulative Redeemable Preferred Units – **$23,037  thousand**  \n* Other non‑controlling redeemable interests – **$172,912  thousand**\n\nCombined, they total **$195,949  thousand** (≈ $195.9 million).\n\nThus, the 2024 combined total is about **$11.2 million lower** than the 2023 combined total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 2024 '7.50% Cumulative Redeemable Preferred Units' is correctly reported as $15,537 thousand, and 'Other non-controlling redeemable interests' as $169,192 thousand, summing to $184,729 thousand. For 2023, the values are $23,037 thousand and $172,912 thousand, correctly summing to $195,949 thousand. (2) The calculation of the difference ($195,949k - $184,729k = $11,220k, or ~$11.2 million) is accurate and correctly interpreted as a decrease. (3) The multi-hop reasoning—aggregating two distinct line items across two fiscal years and comparing them—is sound and properly executed. (4) The entities, years, and financial terms are correctly identified and used. The answer is semantically equivalent to the ground truth, with added clarity in formatting and explanation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 274,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas reported that its floating‑price commodity purchases for Nicor Gas and SouthStar total 39 million mmBtu, which, based on forward natural‑gas prices at December 31 2024, were valued at **$136 million**. These purchases are made in the open market and, under the utilities’ regulatory authorizations, the wholesale‑gas costs are recovered through the natural‑gas cost‑recovery mechanisms that allow rates to be adjusted to reflect changes in commodity prices and to ensure full, prudent recovery of the gas‑supply expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $136 million value of floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, matching the ground truth. It also accurately explains the alignment with the regulated cost recovery framework by referencing natural gas cost recovery mechanisms that allow rate adjustments to reflect commodity price changes and ensure full recovery of prudently incurred costs. 2) The quantitative value ($136 million) is correct and matches the original answer exactly. The LLM adds supplementary detail (39 million mmBtu) not present in the ground truth, but this does not contradict it and may reflect additional context from the source; since the dollar value is accurate and no incorrect calculations are made, this does not reduce accuracy. 3) The reasoning is sound: the LLM correctly links floating-price procurement to regulatory cost recovery mechanisms and explains how this supports full recovery of supply expenses—this demonstrates proper multi-hop synthesis between procurement strategy and regulatory framework. 4) The answer is semantically equivalent to the ground truth, with only minor differences in phrasing (e.g., 'prudent recovery' vs 'prudently incurred'). The addition of volume (mmBtu) enhances detail without introducing error. The core entities—Southern Company Gas, Nicor Gas, SouthStar, December 31, 2024, $136 million, and regulated cost recovery—are all correctly identified and used. The only reason for not scoring a perfect 10 is the slight expansion on volume data not in the original, which, while plausible, cannot be verified as correct from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 454,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "In 2021 ConocoPhillips reported **net income (loss) attributable to the company of $4,932 million for its Lower 48 segment**.  For the same segment, the **equity‑in‑earnings (losses) of affiliates was a loss of $18 million**.  Thus, the segment’s net income was roughly $4.95 billion greater than the modest affiliate loss.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net income attributable to ConocoPhillips from the Lower 48 region in 2021 is correctly stated as $4,932 million, and the equity in earnings (losses) is accurately reported as a loss of $18 million (presented as $(18) million in the original answer, which is equivalent). The comparison stating that net income was roughly $4.95 billion greater than the affiliate loss is a reasonable approximation (since $4,932M - (-$18M) = $4,950M). (2) The answer is complete, addressing both parts of the question: the net income attributable and the equity in earnings (losses) for the same region and year. (3) Entity accuracy is correct—ConocoPhillips, Lower 48 region, and 2021 are all properly identified. (4) The reasoning is sound: it correctly distinguishes between direct net income and equity in earnings from affiliates, and the qualitative interpretation (a large net income vs. a small equity loss) aligns with the ground truth. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content and implications. No errors in multi-hop synthesis; both figures come from the same company, region, and year, and are correctly contrasted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 355,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The 2024 filing states that the aggregate notional amount of open, unsettled forward foreign‑exchange contracts was **$1.212 billion**.  The filing does not provide a specific notional figure for the variable‑priced commodity contracts (the natural‑gas and electricity index‑based contracts); those contracts are described only qualitatively and are treated as “normal purchases and sales” derivatives without a disclosed notional amount.  \n\nConsequently, the disclosed exposure that can be quantified is the $1.212 billion of FX contracts, and the company’s overall risk‑management approach combines this foreign‑currency hedge with variable‑priced commodity contracts to economically offset the impact of both currency fluctuations on overseas inventory purchases and commodity‑price volatility on energy and fuel costs, even though the exact commodity‑contract notional is not disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.212 billion (i.e., $1,212 million) figure for unsettled forward foreign-exchange contracts is correct and matches the original answer exactly, with acceptable format variation (billion vs. million). The LLM correctly notes that no specific notional value is disclosed for variable-priced commodity contracts, which is consistent with the ground truth stating only qualitative descriptions are provided. (2) The LLM accurately reflects that these instruments—though not subject to derivative hedge accounting—are used to economically hedge currency and commodity risks in the normal course of business. (3) The multi-hop reasoning is sound: it synthesizes the lack of notional disclosure for commodity contracts while correctly combining the disclosed FX exposure with the qualitative risk-management strategy. (4) The only minor shortcoming is that the LLM does not explicitly state that the variable-priced contracts cover electricity, natural gas, and fuel for gas stations—specific commodities mentioned in the original—slightly reducing completeness. However, it does refer to 'energy and fuel costs,' which captures the essence. Overall, the answer is factually correct, contextually appropriate, and conveys the same strategic intent as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 376,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft builds Microsoft 365 internally within its “Experiences and Devices” engineering group, which gives the company direct control over product features, enhancements and how the service is measured. Because that internal team can define the metrics that best reflect the product’s usage, Microsoft updated its FY 2024 reporting to broaden the Microsoft 365 Consumer‑subscriber metric to include Microsoft 365 Basic subscribers, aligning the financial disclosure with the way the product is managed and delivered.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key elements are correct: Microsoft develops Microsoft 365 internally via the 'Experiences and Devices' engineering group, which enables direct control over product and metric definition. This internal structure led to the FY2024 financial reporting update that expanded the Microsoft 365 Consumer subscriber metric to include Microsoft 365 Basic subscribers. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—fiscal year 2024 is correctly referenced. (3) The multi-hop reasoning is sound: the answer correctly links internal development structure (engineering ownership) to business management practices and then to financial reporting changes. (4) The only minor shortcoming is a slight reduction in explanatory depth compared to the original—specifically, the LLM answer does not explicitly state that this change provides investors with a 'more comprehensive view of consumer adoption,' which is a key rationale in the ground truth. However, the alignment with how the product is managed is clearly conveyed, preserving semantic equivalence. Wording differs slightly but meaning is preserved. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 356,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Pfizer’s 2019 Stock Plan treats each Performance Share Award as 3 shares multiplied by the award’s maximum payout. The 2023 filing shows 4,734 thousand PSA shares (≈ 4.734 million) outstanding; applying the 3‑share factor gives 4.734 million × 3 ≈ 14.2 million shares counted toward the plan’s overall share‑cap. Because the company still had 248 million shares available for award at year‑end 2023, the PSA‑related 14.2 million‑share count represents only a small slice of the remaining pool, leaving roughly 233 million shares for other equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original question does not ask for the number of outstanding PSA shares or their current consumption, but rather about the share counting methodology and its significance relative to the 248 million shares available. The LLM incorrectly introduces a figure of 4,734 thousand (4.734 million) PSA shares outstanding, which is not mentioned in the ground truth and appears to be fabricated or misattributed. There is no support in the original answer for any specific number of issued or outstanding PSAs. (2) The calculation of 4.734 million × 3 = 14.2 million is mathematically correct, but it is based on a false premise — the ground truth does not provide any data on actual PSA grants or outstanding counts as of 2023. Thus, the entire quantitative analysis is invalid. (3) The multi-hop reasoning fails because the LLM misinterprets the question: it shifts from explaining the share counting rule and its strategic significance (as in the ground truth) to estimating current share usage, which was not asked. While it correctly states that PSAs count as 3 shares per award times maximum payout, it misses the broader implication — that this multiplier limits how many PSAs can be granted from the remaining pool compared to other awards. (4) The contextual relevance is moderate because the answer discusses the right plan and the 3-share rule, and references the 248 million available shares, but it answers a different question than the one posed. The conclusion about 'leaving roughly 233 million shares' is speculative and unsupported. Correctness score is low due to reliance on incorrect data and failure to address the significance aspect as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 473,
        "total_tokens": 1828
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 7.98,
    "average_quantitative_accuracy": 8.29,
    "average_qualitative_accuracy": 8.22,
    "average_contextual_relevance": 9.37,
    "score_distribution": {
      "excellent": 529,
      "good": 57,
      "fair": 82,
      "poor": 82
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 2040.63,
    "timestamp": "2026-02-03T21:00:02.548461"
  }
}